PN 76001
RN 00356 
AN 77263078
AU Laszlo-A.  Penzes-P.  Gyurkovits-K.
TI Mucoviscidosis: total amylase activity of serum and mixed saliva in
   homozygous and heterozygous subjects.
SO Acta-Paediatr-Acad-Sci-Hung. 1976. 17(4). P 293-6.
MJ AMYLASES: an.  CYSTIC-FIBROSIS: me.
MN ADULT.  AMYLASES: bl.  CHILD.  CYSTIC-FIBROSIS: bl, fg.  FEMALE.
   HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.  MALE.  SALIVA: an.
AB Total amylase activity of serum and mixed saliva was studied in
   homozygotes and heterozygotes for mucoviscidosis and in healthy
   subjects. Mean serum total activity was 269.0 +/- 113.7 U/l in the
   homozygotes, exceeding in nearly 50% of the cases the values given in
   the literature and those observed in the normal controls. The
   difference against the control group was significant (P less than
   0.05). Mean serum total amylase activity of heterozygotes agreed with
   the mean value for the healthy group (203.5 +/- 79.5 U/l) without a
   significant difference. Total amylase activity in the saliva of
   homozygotes (148.700 +/- 65.700  U/l) was higher than in the
   heterozygotes /118.300 +/- 74.200 U/l) of the healthy children
   (51.700 +/- 26.500 U/l). The difference between the homozygous and
   healthy groups was strongly significant (P less than 0.01), and that
   between the heterozygous group and the combined healthy children and
   adult groups was also significant (P less than 0.05). In the
   heterozygotes, salivary amylase activity was slightly elevated but
   not significantly different from the control group and did not result
   in a change in serum total amylase activity.
RF 001A  CESKA M               EXPERIENTIA                     25   555 969
   001B  CESKA M               CLIN CHIM ACTA                  26   437 969
   001C  CESKA M               CLIN CHIM ACTA                  26   445 969
   002   CHERNICK WS           J PEDIATR                       65   694 964
   003   DI SANTAGNESE PA      PEDIATRICS                      22   507 958
   004   MCDOUGALL C           PEDIATRICS                       5   114 950
   005   GAUTIER E             HELV PAEDIATR ACTA              17   415 962
   006   GYURKOVITS K          ACTA PAEDIATR ACAD SCI HUNG     15    49 974
   007   HADORN B              J PEDIATR                       73    39 968
   008   KAMARYT J             Z KLIN CHEM KLIN BIOCHEM         8   564 970
   009   KLEINBAUM H           Z KINDERHEILK                   90     7 964
   010   MANDEL ID             AM J DIS CHILD                 113   431 967
   011   MAYER WB              ACTA PAEDIATR SCAND             63   389 974
   012   NICORY C              BIOCHEM J                        6   387 922
   014   ROSSITER MA           ACTA PAEDIATR SCAND             63   389 974
   015   SEARCY RL             AM J CLIN PATHOL                46   582 966
   016   SZCZEPANSKI Z         Z KINDERHEILK                  113   297 972

PN 76002
RN 00357 
AN 77062364
AU Baran-D.  Loeb-H.  Mozin-M-J.
TI Efficiency of two pancreatic extracts in patients with cystic
   fibrosis.
SO Acta-Paediatr-Belg. 1976 Apr-Jun. 29(2). P 117-22.
MJ CYSTIC-FIBROSIS: me.  INTESTINAL-ABSORPTION: de.  LIPIDS: me.
   NITROGEN: me.  PANCREATIC-EXTRACTS: tu.
MN CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: dt.  FEMALE.  HUMAN.
   INFANT.  MALE.
AB Nitrogen- and lipid absorption coefficients were studied in 62
   patients with cystic fibrosis, aged 2/12 to 12 years, and compared
   with the results obtained in 20 normal children.  In 59 of the 62
   patients nitrogen- and lipid absorption were grossly abnormal.
   Age-linked differences were not found.  The efficacy of two
   pancreatic enzymes preparations was found to be similar.  Both
   preparations produced the same significant improvement in the
   absorption of proteins and lipids.
RF 001   BEST EB               SOUTH MED J                     53  1091 960
   002   HAINES RD             JAMA                           180  1000 962
   003   HARRIS R              ARCH DIS CHILD                  30   424 955
   004   JENSEN SB             ACTA PAEDIATR SCAND             45    70 956
   005   LAPEY A               J PEDIATR                       84   328 974
   006   ROSS CAC              ARCH DIS CHILD                  30   316 955
   007   SHOHL AT              J PEDIATR                       23   267 943
   008   SNEDECOR GW           STATISTICAL METHODS                      967
   009   TREMOLIERES J         CAHIERS NUTR DIETET              1    13 966
CT   1   MALMENDIER CL         HELV PAEDIATR ACTA              32   115 977
     2   ROGIERS V             PEDIATR RES                     14  1088 980
     3   ROGIERS V             CLIN CHIM ACTA                 105   105 980
     4   TOLCKMITT W           KLIN PAEDIATR                  193   365 981
     5   ROGIERS V             EUR J PEDIATR                  141    39 983

PN 76003
RN 00358 
AN 76133375
AU Skorecki-K.  Levison-H.  Crozier-D-N.
TI Bronchial lability in cystic fibrosis.
SO Acta-Paediatr-Scand. 1976 Jan. 65(1). P 39-44.
MJ BRONCHI: pp.  CYSTIC-FIBROSIS: pp.  EXERTION.
MN ADOLESCENCE.  ADULT.  ASTHMA: pp.  CHILD.  FEMALE.
   FORCED-EXPIRATORY-VOLUME.  HUMAN.  HYPERSENSITIVITY-IMMEDIATE.  MALE.
   MAXIMAL-MIDEXPIRATORY-FLOW-RATE.  PEAK-EXPIRATORY-FLOW-RATE.
   RESPIRATORY-AIRFLOW.  VITAL-CAPACITY.
AB We investigated the airway's response to exercise in cystic fibrosis
   (CF).  Due to the reported high incidence of allergy in CF we tried
   to demonstrate the well documented post-exercise bronchospasm of
   asthma in patients with CF.  Subjects ran on a treadmill for 6
   minutes at a speed of 3 miles per hour and a gradient of 15 degrees.
   For the 12 controls studied, the mean % rise in peak expiratory flow
   rate (PEFR) during exercise was 4.7% and the mean % fall in PEFR
   during recovery was 0.7%.  For the eight atopic asthmatics studied
   the mean % rise in PEFR was 12.2% and the mean % fall in PEFR was
   33.7%.  For the 29 patients with CF, the mean % rise in PEFR was
   20.3% and the mean % fall in PEFR was 3.1%.  Patients with CF showed
   no statistically significant post-exercise constriction compared
   with controls, while asthmatic patients showed a post-exercise %
   fall in PEFR significantly greater than seen in controls (p < 0.001)
   or in CF patients (p < 0.001).  No patient with CF showed
   post-exercise bronchospasm, nor was there any difference between
   patients with CF who had positive skin tests to common allergens and
   those who did not in their pattern of bronchial liability.  It is
   suggested that the general desensitization therapy should not be
   instituted in patients with CF merely on the basis of positive skin
   tests, without more stringent criteria such as characteristic
   seasonal variation in respiratory symptomatology, family history of
   atopy and positive bronchial inhalation provocation tests.
RF 001   DAY G                 ARCH DIS CHILD                  48   355 973
   002   GODFREY S             J ALLERGY CLIN IMMUNOL          52   199 973
   003   HEIMLICH EM           J ALLERGY CLIN IMMUNOL          37   103 966
   004   JONES RS              BR J DIS CHEST                  56    78 962
   005   JONES RS              ARCH DIS CHILD                  38   539 963
   006   KULCZYCKI LL          JAMA                           175   358 961
   007   MCCARTHY DS           IN: LAWSON D PROC 5TH INT CF         194 969
   008   SILVERMAN M           ARCH DIS CHILD                  47   882 972
CT   1   MELLIS CM             PEDIATRICS                      61   446 978
     2   MITCHELL I            J PEDIATR                       93   744 978
     3   ANON                  LANCET                           1   708 979
     4   PRICE JF              CLIN ALLERGY                     9   563 979
     5   ZAMBIE MF             ANN ALLERGY                     42   290 979
     6   LARSEN GL             AM REV RESPIR DIS              119   399 979
     7   SVENONIUS E           RESPIRATION                     40   226 980
     8   HOLZER FJ             ARCH DIS CHILD                  56   455 981
     9   LOUGHLIN GM           CHEST                           79   206 981
    10   EGGLESTON PA          J ALLERGY CLIN IMMUNOL          73   666 984
    11   RICHARDSON VF         ACTA PAEDIATR SCAND             73    75 984
    12   CANNY GJ              ACTA PAEDIATR SCAND             74   451 985
    13   SLY RM                MED SCI SPORTS EXER             18   314 986

PN 76004
RN 00359 
AN 77084757
AU Waring-W-W.
TI Current management of cystic fibrosis.
SO Adv-Pediatr. 1976. 23. P 401-38. (REVIEW).
MJ CYSTIC-FIBROSIS: th.
MN ADOLESCENCE.  ADULT.  AEROSOLS.  AMYLASES: tu.
   BRONCHODILATOR-AGENTS: tu.  CALORIC-INTAKE.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: dh, di, dt.  DIETARY-FATS.  DIETARY-PROTEINS.
   DRAINAGE.  HUMAN.  INFANT.  IRRIGATION.  LIPASE: tu.
   PARENTERAL-FEEDING.  PEPTIDE-HYDROLASES: tu.  REVIEW.  TRIGLYCERIDES.
   SUPPORT-U-S-GOVT-NON-P-H-S.  VITAMINS: tu.  WATER.
EX Although forty years have passed since the discovery of the clinical
   entity called (for lack of a better name) cystic fibrosis, its
   treatment remains both symptomatic and controversial.  Moreover, the
   efficacy of therapy has been difficult to evaluate for several
   reasons: the lack of a suitable animal model for therapeutic
   experimentation, the protean manifestations of the disease, the
   natural variations in its severity, the prolonged periods of
   observation that are required by its very chronicity and frequently
   the lack of satisfactory clinical parameters by which to score
   response.  Stated in its simplest form, the treatment of cystic
   fibrosis is directed towards the long-term control of salt loss,
   malabsorption and bronchial obstruction, the management of several
   complications of the disease and the establishment of a positive
   therapeutic environment that minimizes anxiety and depression.  The
   purpose of this review are to help the pediatric practitioner gain
   security in his day-to-day management of children with the disease
   and to advocate an effective working relationship between the
   practitioner and a regional cystic fibrosis or pediatric pulmonary
   center for long-term patient management.  Problems in diagnosis,
   treatment of salt loss, the prevention and treatment of
   malabsorption, the prevention and treatment of bronchial obstruction,
   the prevention and treatment of certain complications, and the
   psychosocial support of the patient and family are discussed.
RF 001   SARSFIELD JK          ARCH DIS CHILD                  50   463 975
   002   WARING WW             AM REV RESPIR DIS              104   166 971
   003   GIBSON LE             CLIN PEDIATR                    12   450 973
   004   GIBSON LE             PEDIATRICS                      23   545 959
   005   ANON                  GAP CONF REP PROB SWEAT TESTI            975
   006   ANON                  STUDY EVAL OF TEST FOR CF                975
   007   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            971
   008   HUANG NN              GUIDE TO DRUG THERAPY IN PATI            974
   009   ANON                  CF Q ANNOTATED REFERENCES                   
   010   ANON                  DIRECTORY OF CF CARE TEACHING               
   011   SHWACHMAN H           IN: SHIRKEY HC                       651 975
   012   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   013   ANON                  AM REV RESPIR DIS PART 2       110     1 974
   014   MANGOS JA             SCIENCE                        158   135 967
   015   BERGNER A             PEDIATRICS                      55   814 975
   016   DOLAN TF JR           AM REV RESPIR DIS              110   812 974
   017   WARING WW             MINI GUIDE TO LUNG DISEASE     1-4          
   018   ALLAN JD              AM J DIS CHILD                 126    22 973
   019   KUO PT                J CLIN INVEST                   44  1924 965
   020   GRACEY M              ARCH DIS CHILD                  44   401 969
   021   GRACEY M              ARCH DIS CHILD                  45   445 970
   022   OURSO SR              MINI GUIDE TO LUNG DISEASE       8          
   023   OURSO SR              MORE COOKING TREASURES                   976
   024   BARCLAY RPC           ARCH DIS CHILD                  50   490 975
   025   MICHENER WM           PEDIATR CLIN NORTH AM           17   373 970
   026   FOX HA                PEDIATRICS                      52    14 973
   027   HARRIS JA             RESPIR CARE                     20  1164 975
   028   MELLINS RB            AM REV RESPIR DIS SUPPL        110   137 974
   029   MOTOYAMA EK           IN: MANGOS JA                        335 973
   030   LORIN MI              AM J PHYS MED                   50   215 971
   031   DENTON R              DIS CHEST                       28   123 955
   032   MATTHEWS LW           J PEDIATR                       65   558 964
   033   MATTHEWS LW           PEDIATRICS                      39   176 967
   034   DOERSHUK CF           PEDIATRICS                      41   723 968
   035   WOLFSDORF J           PEDIATRICS                      43   799 969
   036   BAU SK                PEDIATRICS                      48   605 971
   037   ALDERSON PO           J PEDIATR                       84   479 974
   038   NORMAN AP             PRACTITIONER                   206   786 971
   039   WARING WW             PEDIATR RES                      6   431 972
   040   CHANG N               AM REV RESPIR DIS              107   672 973
   041   ROSENBLUTH M          CLIN RES                        19   805 971
   042   MOTOYAMA EK           PEDIATRICS                      50   299 972
   043   MATTHEWS LW           IN: MANGOS JA                        303 973
   044   GIBSON LE             AM REV RESPIR DIS SUPPL        110   100 974
   045   CHANG N               AM REV RESPIR DIS              106   867 972
   046   LAWSON D              BR MED J                         1   317 965
   047   SOLOMONS CC           PEDIATRICS                      47   384 971
   048   LIEBERMAN J           JAMA                           205   312 968
   049   WILLIAMS MH JR        AM REV RESPIR DIS SUPPL        110   122 974
   050   KULCZYCKI LL          PROC INT CONG PEDIATR 13TH           577 971
   051   RUCKER RW             CF CLUB ABST                             974
   052   HACKETT RR            ANESTHESIOLOGY                  26   248 965
   053   RAMIREZ RJ            ANN INTERN MED                  63   819 965
   054   KYLSTRA JA            AM REV RESPIR DIS              103   651 971
   055   MUGGENBURG BA         J APPL PHYSIOL                  38   922 975
   057   CEZEAUX G JR          JAMA                           199    15 967
   058   BRAUNSTEIN MS         CHEST                           66    96 974
   059   HUBER GL              AM REV RESPIR DIS              104   337 971
   060   MUGGENBURG BA         AM REV RESPIR DIS              106   219 972
   061   LAWSON D              IN: LAWSON D PROC 5TH INT CF         225 969
   062   MARKS MI              J PEDIATR                       79   822 971
   063   HAWLEY HB             CURR THER RES                   16   414 974
   064   HOFF GE               SCAND J INFECT DIS               6   333 974
   065   STERN RC              CLIN PEDIATR                    11   521 972
   066   RUCKER RW             PEDIATRICS                      54   358 974
   067   LIFSCHITZ MI          AM J DIS CHILD                 116   633 968
   068   STOWE SM              AM REV RESPIR DIS              111   611 975
   069   ROYCE SW              PEDIATRICS                       8   255 951
   070   MONSET-COUCHARD M     CURR PROB PEDIATR NO 4           5       975
   071   SYMCHYCH PS           ARCH PATHOL                     92   409 971
   072   WHITMAN V             PEDIATRICS                      55    83 975
   073   KELMINSON LL          PEDIATRICS                      39    24 967
   074   PATTERSON PR          PSYCHOSOCIAL ASPECTS OF CF               973
CT   1   STERN RC              AM REV RESPIR DIS              118   821 978
     2   ROSENSTEIN BJ         JAMA                           240  1987 978
     3   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
     4   SACK J                ISR J MED SCI                   16   417 980
     5   CHRYMKO M             AM J HOSP PHARM                 37   713 980
     6   GOTZ M                EUR J RESPIR DIS                61   122 980
     7   PASSERO MA            CLIN PEDIATR                    20   264 981
     8   LAUGHLIN JJ           PEDIATRICS                      68   203 981
     9   DAVID TJ              LANCET                           2  1204 982
    10   MITCHELL EA           AUST PAEDIATR J                 18    40 982
    11   THOMASSEN MJ          J PEDIATR                      104   352 984
    12   KUHN RJ               CLIN PHARMACY                    4   555 985

PN 76005
RN 00360 
AN 76181528
AU Nadler-H-L.
TI Prenatal detection of genetic defects.
SO Adv-Pediatr. 1976. 22. P 1-81. (REVIEW).
MJ HEREDITARY-DISEASES: di.  PRENATAL-DIAGNOSIS: mt.
MN ADRENAL-HYPERPLASIA-CONGENITAL: di.  ALPHA-FETOPROTEINS: an.
   AMINO-ACID-METABOLISM-INBORN-ERRORS: di.  AMNIOCENTESIS: mt.
   AMNIOSCOPY: mt.  CARBOHYDRATE-METABOLISM-INBORN-ERRORS: di.
   CENTRAL-NERVOUS-SYSTEM-DISEASES: di, fg.
   CHROMOSOME-ABNORMALITIES:  di.  CYSTIC-FIBROSIS: di.  FEMALE.
   GENES-RECESSIVE.  HEMOGLOBINOPATHIES: di.  HUMAN.
   HYPERCHOLESTEROLEMIA: di, fg.  LIPID-METABOLISM-INBORN-ERRORS: di.
   MUCOPOLYSACCHARIDOSIS: di.  PREGNANCY.  REVIEW.
   SEX-CHROMOSOME-ABNORMALITIES: di.  ULTRASONICS:  du.
EX The intrauterine detection of genetic disorders represents one of the
   exciting advances in medicine.  The major emphasis in this chapter
   will be a detailed review of the newer approaches toward antenatal
   detection of congenital malformations and hemoglobinopathies as well
   as an overview of the experience and problems of antenatal detection
   for chromosomal aberrations and inborn errors of metabolism.
   Approaches to prenatal diagnosis of genetic disorders include
   amniocentesis, visualization of the fetus, and fetal blood sampling.
   Prenatal detection of genetic disorders has become a reality.  The
   area is evolving so rapidly that the major indications for
   intrauterine diagnosis have substantially changed within the past
   year.  Prior to this time, maternal age, previous Down's syndrome,
   inborn errors of metabolism and X-linked recessive disorders were the
   primary criteria, with approximately 85% of the cases being used for
   cytogenetic analysis.  Within the past year, in a number of
   laboratories, about half of the referrals for amniocentesis have been
   for central nervous system defects.  Certainly with the development
   of technics for fetal blood sampling, this distribution of the
   frequencies of indication may, once again, change substantially.
   Most probably for the next few years cytogenetic abnormalities and
   neural tube defects will be the most common indications for
   amniocentesis.  Amniocentesis will continue to be offered to many
   patients with inborn errors of metabolism and probably will be
   available for monitoring of hemoglobinopathies and other disorders of
   fetal blood as well as for accurate knowledge of the health of the
   fetus.
RF 001   BALLANTYNE JW         MANUAL OF ANTENATAL PATHOL HY            902
   002   DORFMAN A             ANTENATAL DIAGNOSIS                      972
   003   MILUNSKY A            PRENATAL DIAGNOSIS OF HEREDIT            973
   004   EMERY AEH             ANTENATAL DIAGNOSIS OF GENET             973
   005   HARRIS H              PRENATAL DIAG SELECTIVE ABORT            974
   006   BURTON BK             AM J OBSTET GYNECOL            118   718 974
   007   MILUNSKY A            JAMA                           230   232 974
   009   DORAN TA              AM J OBSTET GYNECOL            118   314 974
   010   ROBINSON A            AM J OBSTET GYNECOL            116   937 973
   011   FREDA VJ              BULL NY ACAD MED                42   475 966
   012   QUEENAN JT            CLIN OBSTET GYNECOL              9   491 966
   013   BURNETT RG            J IOWA MED SOC                  58   130 958
   014   LILEY AW              NZ MED J                        59   581 960
   015   CREASMAN WT           JAMA                           204   949 968
   017   FUCHS F               CLIN OBSTET GYNECOL              9   565 966
   019   JAVERT CT             SPONTANEOUS AND HABITUAL ABOR            957
   020   ANON                  NATIONAL AMNIOCENTESIS REG                  
   021   GEYER VH              Z KLIN CHEM KLIN BIOCHEM         8   145 970
   022   TORNQVIST A           ACTA OBSTET GYNECOL SCAND       50    79 971
   023   SALAFSKY IS           AM J OBSTET GYNECOL            111  1046 971
   024   NATELSON S            AMNIOTIC FLUID                           974
   025   NADLER HL             J PEDIATR                       74   132 969
   026   NADLER HL             LANCET                           2  1277 969
   027   SCHNECK L             LANCET                           1   582 970
   028   RATTAZZI MC           IN: DORFMAN A                        207 972
   029   NADLER HL             LANCET                           2   369 970
   030   HUG G                 LANCET                           1  1002 970
   031   GERBIE AB             AM J OBSTET GYNECOL            114   314 972
   032   MELANCON S            SCIENCE                        173   627 971
   033   BARNHISEL ML          J CELL PHYSIOL                  76     7 970
   034   KABACK MM             IN: DORFMAN A                         81 972
   035   NADLER HL             BIOCHEM GENET                    2   119 968
   036   KABACK MM             PEDIATR RES                      5   366 971
   037   UHLENDORF BW          SCIENCE                        160  1007 968
   038   SHIH VE               LANCET                           2    45 970
   039   SHIH VE               CLIN CHIM ACTA                  27    73 970
   040   RYAN CA               EXP CELL RES                    71   388 972
   041   NADLER HL             N ENGL J MED                   282   596 970
   042   GERBIE AB             AM J OBSTET GYNECOL            109   765 971
   044   GOLBUS MS             AM J OBSTET GYNECOL            118   897 974
   045   MILUNSKY A            N ENGL J MED                   283  1370 970
   046   HSU LYF               AM J DIS CHILD                 125   290 973
   047   MILUNSKY A            J PEDIATR                       79   303 971
   048   KOHN G                LANCET                           2   778 970
   049   MILUNSKY A            LANCET                           2   979 970
   050   KOHN G                PEDIATR RES                      1   461 967
   051   KLINGER HP            J BIOPHYS BIOCHEM CYTOL          8   345 960
   052   BOOK JA               J MED GENET                      5   224 968
   053   SCHLEGEL RJ           CYTOGENETICS                     5   430 968
   054   KARDON NB             J PEDIATR                       80   297 972
   055   RIIS P                LANCET                           2   180 960
   056   RIIS P                IN: MOORE KL                             966
   057   CEDERQVIST LL         CLIN OBSTET GYNECOL             13   159 970
   058   CASPERSSON T          CHROMOSOMA                      30   215 970
   059   DANES BS              SCIENCE                        149   987 965
   060   MILUNSKY A            N ENGL J MED                   281  1128 969
   061   MATALON R             LANCET                           1    83 970
   062   OMURA K               TOHOKU J EXP MED               111    87 973
   063   CRAWFURD MDA          J MED GENET                     10   144 973
   064   DANES BS              LANCET                           1   946 970
   065   MATALON R             LANCET                           1   798 972
   066   HARPER PS             J MED GENET                     11   123 974
   067   FRATANTONI JC         PROC NAT ACAD SCI USA           60   699 968
   068   FRATANTONI JC         N ENGL J MED                   280   686 969
   069   BOOTH CW              PEDIATRICS                      53   396 974
   070   FRATANTONI JC         SCIENCE                        162   570 968
   071   MATALON R             BIOCHEM BIOPHYS RES COMMUN      47   959 972
   072   BACH G                PROC NAT ACAD SCI USA           69  2048 972
   073   BACH G                FED PROC                        32   483 973
   074   MATALON R             PEDIATR RES                      7   384 973
   075   OBRIEN JS             PROC NAT ACAD SCI USA           69  1720 972
   076   VON FIGURA K          BIOCHEM BIOPHYS RES COMMUN      48   262 972
   077   MATALON R             BIOCHEM BIOPHYS RES COMMUN      61   759 974
   078   MATALON R             PEDIATR RES                      9   314 975
   079   SLY WS                J PEDIATR                       82   249 973
   080   WIRTSCHAFTER ZT       AM J OBSTET GYNECOL             76  1219 958
   081   LEVY HL               PEDIATR RES                      3   113 969
   082   COCKBURN F            J OBSTET GYNAECOL BR COMMONW    80    10 973
   083   SAIFER A              CLIN CHEM                       16   891 970
   084   EMERY AEH             LANCET                           1  1307 970
   085   SCOTT CR              PEDIATR RES                      6   659 972
   086   TADA K                TOHOKU J EXP MED               113   169 974
   087   MORROW G 3RD          J PEDIATR                       77   120 970
   088   GOMPERTZ D            PEDIATRICS                      54   511 974
   089   MAHONEY MJ            IN: DORFMAN A                         95 972
   090   MAHONEY MJ            PEDIATR RES                      7   342 973
   091   FRIMPTER GW           AM J DIS CHILD                 113   115 967
   092   SCHULMAN JD           J PEDIATR                       77   468 970
   093   SCHNEIDER JA          PEDIATR RES                      7   291 973
   094   SCHNEIDER JA          N ENGL J MED                   290   878 974
   096   WILLCOX P             ARCH DIS CHILD                  49   209 974
   097   GOODMAN SI            J CLIN GENET                     4   236 973
   098   ROERDINK FH           PEDIATR RES                      7   863 973
   101   DANCIS J              IN: DORFMAN A                        123 972
   102   HSIA YR               PROC AM PEDIATR SOC ANNU MTG          26 970
   103   GOMPERTZ D            LANCET                           1  1009 973
   104   WENDEL U              HUMANGENETIK                    19   127 973
   105   ELSAS LJ              METABOLISM                      23   569 974
   106   HARTLAGE PL           J PEDIATR                       85    86 974
   107   FLEISHER LD           J PEDIATR                       85   677 974
   108   BITTLES AH            J MED GENET                     10   120 973
   109   HERS HG               BIOCHEM J                       86    11 963
   110   NITOWSKY HM           J LAB CLIN MED                  69   472 967
   111   ANGELINI C            N ENGL J MED                   287   948 972
   112   KOSTER JF             CLIN CHIM ACTA                  40   294 972
   113   COX RP                LANCET                           2   893 970
   114   STEINITZ K            ISR J MED SCI                    3   411 967
   115   SALAFSKY IS           J PEDIATR                       79   794 971
   116   GALJAARD H            CLIN CHIM ACTA                  49   361 973
   117   JUSTICE P             BIOCHEM BIOPHYS RES COMMUN      39   301 970
   118   HOWELL RR             PROC AM PEDIATR SOC ANNU MTG         130 970
   119   HUIJING F             AM J HUM GENET                  21   275 969
   120   MIGEON BR             AM J HUM GENET                  26   360 974
   121   KROOTH RS             J EXP MED                      113  1155 961
   122   NADLER HL             PEDIATRICS                      42   912 968
   123   FENSOM AH             BR MED J                         2   386 974
   124   HILL HZ               SCIENCE                        179  1136 973
   125   BENSON PF             LANCET                           1   106 973
   126   DURAND P              LANCET                           1  1198 968
   127   VAN HOOF F            LANCET                           1  1198 968
   130   OCKERMAN PA           LANCET                           2   239 967
   131   KJELLMAN B            J PEDIATR                       75   366 969
   132   OBRIEN JS             J PEDIATR                       75   167 969
   133   OBRIEN JS             AM J DIS CHILD                 109   338 965
   134   OKADA S               SCIENCE                        160  1002 968
   135   SINGER HS             N ENGL J MED                   282   571 970
   136   SLOAN HR              PEDIATR RES                      3   532 969
   137   THOMAS GH             J LAB CLIN MED                  74   725 969
   138   LOWDEN JA             N ENGL J MED                   288   225 973
   139   KABACK MM             J PEDIATR                       82  1037 973
   140   OBRIEN JS             N ENGL J MED                   284   893 971
   141   WOLFE LS              NEUROLOGY (MINN)                20    23 970
   142   SINGER HS             AM J HUM GENET                  24   454 972
   143   BOOTH CW              PEDIATRICS                      52   521 973
   144   OKADA S               SCIENCE                        165   698 969
   145   OBRIEN JS             SCIENCE                        172    61 971
   146   FRIEDLAND J           PROC SOC EXP BIOL MED          136  1297 971
   147   RICHARDSON BJ         CLIN GENET                       4   376 973
   148   NAVON R               AM J HUM GENET                  25   287 973
   149   SANDHOFF K            LIFE SCI                         7   283 968
   150   OKADA S               AM J HUM GENET                  23    55 971
   151   DESNICK RJ            MIDWEST SOC PEDIAT RES PAPER             972
   152   OKADA S               CLIN RES                        19   216 971
   153   BRADY RO              BIOCHEM BIOPHYS RES COMMUN      18   221 965
   154   BEUTLER E             AM J HUM GENET                  23    62 971
   156   BRADY RO              PROC NAT ACAD SCI USA           55   366 966
   157   FREDRICKSON DS        IN: STANBURY JB                      783 972
   158   EPSTEIN CJ            AM J HUM GENET                  23   533 971
   159   SUZUKI K              PROC NAT ACAD SCI USA           66   302 970
   160   SUZUKI K              BIOCHEM BIOPHYS RES COMMUN      45  1363 971
   161   ELLIS WG              ARCH NEUROL                     29   253 973
   162   JATZKEWITZ H          J NEUROCHEM                     16    19 969
   163   KABACK MM             N ENGL J MED                   282  1336 970
   164   PORTER MT             PROC NAT ACAD SCI USA           62   887 969
   165   PERCY AK              SCIENCE                        161   594 968
   166   AUSTIN J              ARCH NEUROL                     14   259 966
   167   AUSTIN J              ARCH NEUROL                     13   593 965
   168   MURPHY JV             IN: BERNSOHN J                        67 971
   169   VAN DER HAGEN CB      CLIN GENET                       4   256 973
   170   LEROY JG              N ENGL J MED                   288  1365 973
   171   BORRESON AL           CLIN GENET                       4   442 973
   172   BOOTH CW              J PEDIATR                       86   560 975
   173   BRADY RO              N ENGL J MED                   276  1163 967
   174   BRADY RO              SCIENCE                        172   174 971
   175   KINT JA               SCIENCE                        167  1268 970
   176   BEUTLER E             AM J HUM GENET                  24   237 972
   177   WOOD S                AM J HUM GENET                  24   250 972
   178   GALJAARD H            CLIN GENET                       5   368 974
   179   HERNDON JH            J CLIN INVEST                   48  1017 969
   180   HERNDON JH            N ENGL J MED                   281  1034 969
   181   NADLER HL             AM J OBSTET GYNECOL            103   710 969
   182   DAWSON G              SCIENCE                        170   556 970
   183   LEROY JG              BIRTH DEF ORIG ART SER           5   174 969
   184   GLASER JH             PEDIATR RES                      7   342 973
   185   WARREN RJ             PEDIATR RES                      7   343 973
   186   PHILIPPART M          PEDIATR RES                      9   316 975
   187   KOHN G                PEDIATR RES                      9   314 975
   188   NADLER HL             N ENGL J MED                   282   302 970
   189   AULA P                HUMANGENETIK                    25   307 974
   190   SEEGMILLER JE         SCIENCE                        155  1682 967
   191   ROSENBLOOM FM         LANCET                           2   305 967
   192   FUJIMOTO WY           LANCET                           2   511 968
   193   DEMARS R              SCIENCE                        164  1303 969
   194   BOYLE JA              SCIENCE                        169   688 970
   195   JEFFCOATE TNA         LANCET                           2   553 965
   196   NICHOLS J             LANCET                           1    83 970
   197   FUCHS F               AM J OBSTET GYNECOL             99   806 967
   198   CATHRO DM             LANCET                           1   732 969
   199   NICHOLS J             LANCET                           2  1068 967
   200   FRASIER SL            J PEDIATR                       84   738 974
   201   GOLDSTEIN JL          AM J HUM GENET                  26   199 974
   202   KHACHADURIAN AK       LEB MED J                       26   325 973
   203   BEAUDET AL            J LAB CLIN MED                  84    54 974
   204   DANES BS              LANCET                           1  1061 968
   205   NADLER HL             LANCET                           2    84 969
   206   BOWMAN BH             SCIENCE                        164   325 969
   207   SPOCK A               PEDIATR RES                      1   173 967
   208   DANES BS              J EXP MED                      136  1313 972
   209   BARNETT DR            FED PROC                        32   677 973
   210   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   211   CONOVER JH            CLIN RES                        21   531 973
   212   BOWMAN BH             CLIN GENET                       4   461 973
   213   BERATIS NG            PEDIATR RES                      7   958 973
   214   GIBLETT ER            LANCET                           2  1067 972
   215   DISSING J             LANCET                           2  1316 972
   216   HIRSCHHORN R          LANCET                           2  1217 973
   217   HIRSCHHORN R          LANCET                           1    73 975
   218   ROMEO G               BIOCHEM GENET                    4   659 970
   219   REGAN JD              SCIENCE                        174   147 971
   220   RAMSAY CA             LANCET                           2  1109 974
   221   LORBER J              PEDIATRICS                      53   307 974
   222   STEIN SC              PEDIATRICS                      54   553 974
   223   CARTER CO             J MED GENET                     10   209 973
   224   CASSADY G             AM J OBSTET GYNECOL             97   395 967
   225   LEE TY                AM J OBSTET GYNECOL            107   917 970
   226   EMERY AEH             J OBSTET GYNAECOL BR COMMONW    79   154 972
   227   EMERY AEH             PROC INT CONG PEDIATR 14TH               974
   228   EMERY AEH             LANCET                           1   970 973
   229   BERGSTRAND CG         SCAND J CLIN LAB INVEST          8   174 956
   230   GITLIN D              J CLIN INVEST                   45  1826 966
   231   SEPPALA M             AM J OBSTET GYNECOL            114   595 972
   232   ADINOLFI A            BIOCHIM BIOPHYS ACTA           251   197 971
   233   ABELEV GI             ADV CANCER RES                  14   295 971
   234   MILUNSKY A            J PEDIATR                       84   889 974
   235   SELLER MJ             DEVELOP MED CHILD NEUROL        16   369 974
   236   BROCK DJH             LANCET                           2   197 972
   237   SEPPALA M             CLIN PERINATOL                   1   293 974
   238   SEPPALA M             ANN MED EXP BIOL FENNIAE        45    16 967
   239   SEPPALA M             LANCET                           1   155 973
   240   SEPPALA M             OBSTET GYNECOL                  42   701 973
   241   GUIBAUD S             LANCET                           1  1261 973
   242   WHYLEY GA             J OBSTET GYNAECOL BR COMMONW    81   459 974
   243   SEPPALA M             OBSTET GYNECOL                  42   613 973
   244   SEPPALA M             J OBSTET GYNAECOL BR COMMONW    81   827 974
   245   SEPPALA M             AM J OBSTET GYNECOL            119  2701 974
   246   DEBRUIJN AWA          LANCET                           1   525 975
   247   MILUNSKY A            PEDIATR RES                      9   360 975
   248   KJESSLER B            LANCET                           1   432 975
   249   BROCK DJH             CLIN CHIM ACTA                  57   315 974
   250   BROCK DJH             LANCET                           2   923 973
   251   ISHIGURO T            LANCET                           2  1214 973
   252   ISHIGURO T            AM J OBSTET GYNECOL            121   539 975
   253   WALDMANN TA           LANCET                           2  1112 972
   254   SIMONS MJ             LANCET                           1  1234 974
   255   NISHI S               CANCER RES                      30  2507 970
   256   KANG KY               CLIN CHIM ACTA                  42   175 972
   257   ZELTZER PM            LANCET                           2  7854 974
   258   BROCK DJH             LANCET                           1   745 975
   259   MACRI JN              NATURE NEW BIOL                246    89 973
   260   CLAUSEN J             PROC SOC EXP BIOL MED          107   170 961
   261   HEITMANN R            DTSCH Z NERVENHEILK            188   187 967
   262   MACRI JN              LANCET                           1    14 974
   263   MACRI JN              LANCET                           1  1109 974
   264   OLSSON JE             LANCET                           2   347 974
   265   OLSSON JE             J NEUROCHEM                     21  1153 973
   266   HOCHWALD GM           PROC SOC EXP BIOL MED          109    91 962
   267   LATERRE EC            CLIN CHIM ACTA                  10   197 964
   268   PENNY R               AUST J EXP BIOL MED SCI         49   111 971
   269   OLSSON JE             J NEUROCHEM                     21   625 973
   270   SUTHERLAND GR         LANCET                           2  1098 973
   271   NELSON MM             LANCET                           1   504 974
   272   RUSSELL JGB           J OBSTET GYNAECOL BR COMMONW    76   345 969
   273   HARTLEY JB            ST MARYS HOSPITAL MANCHESTER             966
   274   PAPP Z                LANCET                           1   729 973
   275   CAMPBELL S            LANCET                           2  1226 972
   276   THIERY M              LANCET                           1   599 973
   277   MICHELL RC            J OBSTET GYNAECOL BR COMMONW    80  1100 973
   278   FRIGOLETTO FD         OBSTET GYNECOL                  44   286 974
   279   NOONAN CD             AM J OBSTET GYNECOL            101   929 968
   280   OMENN GS              AM J HUM GENET                  24   31A 972
   281   QUEENAN JT            OBSTET GYNECOL                  35   648 970
   282   AGUERO O              SURG GYNECOL OBSTET            130   649 970
   283   AGUERO O              AM J OBSTET GYNECOL            107   971 970
   284   ERBSLOH J             ARCH GYNAEKOL                  173   160 942
   285   WIESENHAAN PF         AM J OBSTET GYNECOL            113   819 972
   286   OGITA S               OBSTET GYNECOL                  43   887 974
   287   BAUM G                FUND MEDICAL ULTRASONOGRAPHY             974
   288   GARRETT WJ            AUST NZ J OBSTET GYNAECOL       10     7 970
   289   HOULTON MCC           J OBSTET GYNAECOL BR COMMONW    81   818 974
   290   WESTIN B              LANCET                           2   872 954
   291   WESTIN B              ACTA PAEDIATR SCAND             46   117 957
   292   MANDELBAUM B          AM J OBSTET GYNECOL             98  1140 967
   293   EMERY AEH             IN: HARRIS M                          31 970
   294   SCRIMGEOUR JB         IN: EMERY AEH                         40 973
   295   VALENTI C             AM J OBSTET GYNECOL            114   561 972
   296   HOBBINS JC            AM J OBSTET GYNECOL            118  1069 974
   297   BENZIE RJ             AM J OBSTET GYNECOL            121   460 975
   298   MOTULSKY AG           N ENGL J MED                   288    31 973
   299   OSKI FA               HEMATOLOGIC PROBLEMS IN THE N            972
   300   BRINKMAN R            J PHYSIOL (LOND)                85   117 933
   301   WALKER J              ARCH DIS CHILD                  30   111 955
   302   DRESCHER H            WIEN KLIN WOCHENSCHR            32    92 954
   303   HOLLENBERG MD         SCIENCE                        174   698 971
   304   BASCH RS              BLOOD                           39   530 972
   305   PATARYAS HA           BLOOD                           39   688 972
   306   KAN YW                N ENGL J MED                   287     1 972
   307   KAZAZIAN HH JR        N ENGL J MED                   289    58 973
   308   CIVIDALLI G           PEDIATR RES                      8   553 974
   309   VALENTI C             AM J OBSTET GYNECOL            115   851 973
   310   KAN YW                LANCET                           1    79 974
   311   KAN YW                BLOOD                           43   411 974
   312   HOBBINS JC            N ENGL J MED                   290  1065 974
   313   CHANG H               N ENGL J MED                   290  1067 974
   314   ALTER BP              PEDIATR RES                      9   320 975
   315   BROCK DJH             LANCET                           2  1077 974
   316   HARRIS M              FOGARTY INT CENT PROC            6       970
   317   LEJEUNE J             AM J HUM GENET                  22   121 970
   318   CROW JF               ADV HUM GENET                    8     5 972
   319   RAMSEY P              THOMIST                         37   174 973
   320   KASS L                IN: HILTON B                             973
CT   1   GUSTAVSON KH          NEUROPADIATRIE                   8   293 977
     2   GOLDMAN B             BR J OBSTET GYNAECOL            84   808 977
     3   COOPERMAN EM          CAN MED ASSOC J                116  1339 977
     4   VALLE D               JOHNS HOPKINS MED J            141    35 977
     5   DANIEL A              MED J AUST                       2   352 978
     6   MILES JH              PEDIATR CLIN NORTH AM           25   593 978
     7   SELL RR               SOC BIOL                        25   288 978
     8   MAHONEY MJ            CLIN PERINATOL                   6   255 979
     9   SIMPSON JL            CLIN OBSTET GYNAECOL             6   259 979
    10   NORBY S               DAN MED BULL                    26   353 979
    11   TEICHLERZALLEN D      CLIN GENET                      18   257 980
    12   STEPHENSON SR         AM J OBSTET GYNECOL            141   319 981

PN 76006
RN 00361 
AN 77019322
AU Hawkins-E.  Singer-D-B.
TI The adrenal cortex in cystic fibrosis of the pancreas.
SO Am-J-Clin-Pathol. 1976 Oct. 66(4). P 710-4.
MJ ADRENAL-CORTEX: pa.  ADRENAL-GLANDS: pa.  CYSTIC-FIBROSIS: pa.
MN ADRENAL-CORTEX: me.  ALDOSTERONE: bi.  CHILD-PRESCHOOL.
   CHLORIDES:  me.  CYSTIC-FIBROSIS: me.  FEMALE.  HUMAN.  INFANT.
   INFANT-NEWBORN.  MALE.  SODIUM: me.
AB The morphologies of the adrenal cortical zones of 25 children with
   cystic fibrosis and 24 control patients are presented. A technic for
   objective measurement of these zones is described. Hyperplasia of the
   zona glomerulosa in the children with cystic fibrosis is significant
   and may be related to chronic loss of salt in the sweat or demands
   placed on renal salt-conserving mechanisms.
RF 001   NOUSIA-ARVANITAKIS S  J PEDIATR                       82   535 973
   002   BECH K                ACTA PATH MICROBIOL SCAND (A)   80   615 972
   003   CHODOS DD             AM J DIS CHILD                 110    76 965
   004$  COOKE CR              J LAB CLIN MED                  82   784 971
   005   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   006   DI SANTAGNESE PA      JAMA                           172  2014 960
   007   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   008   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   009   FINBERG L             J PEDIATR                       79   499 971
   010   GOTTLIEB RP           J PEDIATR                       79   930 971
   011   KESSLER WR            PEDIATRICS                       8   648 951
   012   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   013   MONTALVO JM           J CLIN ENDOCRINOL METAB         28   582 968
   014   RENDLE-SHORT J        ARCH DIS CHILD                  31    28 956
   015   ROBSON AM             J PEDIATR                       79    42 971
   016   SIEGENTHALER P        ARCH DIS CHILD                  39    61 964
   017   STOLL E               HELV PAEDIATR ACTA              25   234 970
   018   SYMINGTON T           PATHOLOGY HUMAN ADRENAL GLAND         66 969
   019   TALAMO RC             MED TIMES                       97   139 969
CT   1   RAPAPORT R            J PEDIATR                       98   768 981
     2   FORSYTH JS            SCOTT MED J                     27   333 982
     3   FERGUSSON RJ          ACTA PAEDIATR SCAND             75   124 986

PN 76007
RN 00362 
AN 77063079
AU Abernathy-R-S.
TI Bulging fontanelle as presenting sign in cystic fibrosis.  Vitamin A
   metabolism and effect on cerebrospinal fluid pressure.
SO Am-J-Dis-Child. 1976 Dec. 130(12). P 1360-2.
MJ CYSTIC-FIBROSIS: co.  INTRACRANIAL-PRESSURE.  SKULL.
   VITAMIN-A-DEFICIENCY: co.
MN CASE-REPORT.  CHILD-PRESCHOOL.  DIAGNOSIS-DIFFERENTIAL.  HUMAN.
   MALABSORPTION-SYNDROMES: co.  MALE.  VITAMIN-A-DEFICIENCY: di.
   VITAMIN-A: me.
AB A 51/2-month-old infant had the single problem of a bulging
   fontanelle. A diagnosis of cystic fibrosis with secondary
   hypovitaminosis A was made by the findings of high sweat chloride
   values and a low serum carotene level. A greatly accelerated rate of
   weight gain following the addition of pancreatic enzyme supplements
   confirmed the presence of malabsorption. The infant developed
   characteristic fibrosis pulmonary disease at 20 months of age. Animal
   studies have shown vitamin A deficiency to be associated with
   increased cerebrospinal fluid (CSF) pressure, diminished absorption
   of CSF, and pathological findings of thickening and infiltration with
   mucopolysaccharides of the dura mater around the arachnoid villi.
RF 001   KEATING JP            PEDIATRICS                      46    41 970
   002   CORNFELD D            PEDIATRICS                      10    33 952
   003   BASS MH               J PEDIATR                       47   690 955
   004   BUCHHEIT WA           N ENGL J MED                   280   938 969
   005   MOORE LA              AM J PHYSIOL                   130   684 940
   006   MILLEN JW             LANCET                           2   679 954
   007   EATON HD              AM J CLIN NUTR                  22  1070 969
   008   CALHOUN MC            J DAIRY SCI                     50  1486 967
   009   HAYES KC              ARCH OPHTHALMOL                 80   777 968
   010   COUSINS RJ            J NUTR                          97   409 969
   011   DANES BS              J EXP MED                      124  1181 966
   012   HURT HD               J DAIRY SCI                     50  1941 967
   013   MADDUX GW             J NUTR                         104   478 974
   014   GORGACZ EJ            J NUTR                         101  1541 971
   015   ROELS OA              JAMA                           214  1097 970
CT   1   EATON ML              AM J HOSP PHARM                 35  1099 978
     2   CHASE HP              J PEDIATR                       95   337 979
     3   ROACH ES              PEDIATRICS                      66   622 980
     4   MAGAZZU G             RIV ITAL PEDIATR                 7    73 981
     5   PARK RW               GASTROENTEROLOGY                81  1143 981
     6   KASARSKIS EJ          NEUROLOGY                       32  1292 982
     7   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982

PN 76008
RN 00363 
AN 76228819
AU Jones-R-E.  Giammona-S-T.
TI Intrapleural injection of quinacrine for pneumothorax in a child
   with cystic fibrosis.
SO Am-J-Dis-Child. 1976 Jul. 130(7). P 777-8.
MJ CYSTIC-FIBROSIS: co.PNEUMOTHORAX: dt.  QUINACRINE: ad.
MN CARBENICILLIN: tu.  CASE-REPORT.  CHILD.  GENTAMICINS: tu.  HUMAN.
   INJECTIONS: mt.  MALE.  MEDIASTINAL-EMPHYSEMA: co, dt.  PLEURA.
   PNEUMOTHORAX: su.  PSEUDOMONAS-INFECTIONS: dt.  QUINACRINE: tu.
   THORAX: su.  THORACIC-SURGERY.
EX Pneumothorax occurs in 2% to 4% of patients with cystic fibrosis
   following rupture of subpleural blebs into the pleural space.  Death
   can occur, and recurrences have been reported.  Therapeutic
   procedures include needle aspiration, closed thoracotomy drainage,
   open thoracotomy with pleural scarification, or intrapleural
   instillation of irritants.  When injected into the pleural space, the
   antimalarial drug quinacrine hydrochloride evokes an inflammatory
   response; the resultant fibrosis produces a tight adherence of the
   visceral and pleural surfaces.  Quinacrine therapy for pneumothorax
   has been frequently used in adults, but there are few pediatric case
   reports.
RF 001   LIFSCHITZ MI          AM J DIS CHILD                 116   633 968
   002   BOAT TF               JAMA                           209  1498 969
   003   CATTANEO SM           J THORAC CARDIOVASC SURG        66   467 973
   004   KATTWINKEL J          JAMA                           226   557 973
   005   BORDA I               JAMA                           201  1049 967
   006   BORJA ER              CANCER                          31   899 973
CT   1   RICH RH               J PEDIATR SURG                  13   237 978
     2   FURMAN WR             AM REV RESPIR DIS              121   137 980
     3   KISTLER I             HELV PAEDIATR ACTA              36   495 982
     4   MCLAUGHLIN FJ         J PEDIATR                      100   863 982
     5   SCHUSTER SR           J PEDIATR SURG                  18   492 983

PN 76009
RN 00364 
AN 76203208
AU Isenberg-J-N.  LHeureux-P-R.  Warwick-W-J.  Sharp-H-L.
TI Clinical observations on the biliary system in cystic fibrosis.
SO Am-J-Gastroenterol. 1976 Feb. 65(2). P 134-41.
MJ BILIARY-TRACT-DISEASES: ra.  CYSTIC-FIBROSIS: ra.
MN ADOLESCENCE.  ADULT.  BILIARY-TRACT-DISEASES: di.  BIOPSY.  CHILD.
   CHILD-PRESCHOOL.  CHOLECYSTOGRAPHY.  CYSTIC-FIBROSIS: di.  FEMALE.
   HUMAN.  INFANT.  LIVER-CIRRHOSIS-BILIARY: ra.  LIVER.  MALE.
   SUPPORT-U-S-GOVT-P-H-S.  SUPPORT-U-S-GOVT-NON-P-H-S.
AB The biliary tree of 66 patients with cystic fibrosis was examined by
   conventional roentgenographic methods. Forty-five per cent of the
   oral cholecystograms were judged abnormal by our criteria. A study
   was considered abnormal if there was no visualization or if there was
   visualization of a microgallbladder or structural abnormality
   including marginal irregularities, septate gallbladder or
   cholelithiasis. Intravenous cholangiography was used to further study
   the 22 patients who did not visualize on the oral study. Again,
   anatomic abnormalities were prevalent but six patients in this group
   had normal appearing gallbladders. Abdominal pain, a frequent symptom
   in cystic fibrosis, was not associated with roentgenographic
   abnormality. No correlation was seen between the external biliary
   tree abnormalities and multifocal biliary cirrhosis which was present
   in 40% of these patients. Further, no correlation was seen between
   serum gamma glutamyl transpeptidase levels and either of these
   lesions.
RF 001   POGUE RE              MINN MED                        52   279 969
   002   WARWICK WJ            CF DATA REGISTRY COMM REPORT             974
   003   GRAND RJ              CLIN PEDIATR                     9   588 970
   004   KOPEL FB              GASTROENTEROLOGY                62   483 972
   005   FEIGELSON J           NOUV PRESSE MED                  1  1899 972
   006   WALKER WA             PEDIATRICS                      40   946 967
   007   SHARP HL              CF CLUB ABST                           4 968
   008   DANKS DM              ANN HUM GENET                   28   323 965
   009   BAKER HL JR           RADIOLOGY                       74   239 960
   010   HODGSON JR            RADIOL CLIN NORTH AM             8    85 970
   011   WISE RE               RADIOL CLIN NORTH AM             4   521 966
   012   OPPENHEIMER EH        PERSPECT PEDIATR PATHOL          2   241 975
   013   JONES MD              J PEDIATR                       53   172 958
   014   FEIGELSON J           ACTA PAEDIATR SCAND             59   539 970
   015   SLOTH K               ACTA PAEDIATR SCAND             61   380 972
   016   LAPEY A               J PEDIATR                       84   328 974
   017   ESTERLY JR            BULL JOHNS HOPKINS HOSP        110   247 962
   018   SHARP HL              GAP CONF REP PATHOL OF CF                972
   019   OPPENHEIMER EH        J PEDIATR                       86   683 975
CT   1   LHEUREUX PR           AM J ROENTGENOL                128   953 977
     2   SANTAGNESE PAD        AM J MED                        66   121 979
     3   DAVIDSON GP           J CLIN PATHOL                   33   390 980
     4   PSACHAROPOULOS HT     LANCET                           2    78 981
     5   JACOBS WH             AM J GASTROENTEROL              76   342 981
     6   LAMBERT JR            GASTROENTEROLOGY                80   169 981
     7   PARK RW               GASTROENTEROLOGY                81  1143 981
     8   ROY CC                J PEDIATR GASTROENTEROL NUTR     1   469 982
     9   MOWAT AP              CLIN GASTROENTEROL              11   171 982
    10   TSCHOLAKOFF D         FORTSCHR GEB RONTG NUKL        137    18 982
    11   ROY CC                J PEDIATR GASTROENTEROL NUTR     2   152 983
    12   DOHERTY DE            SOUTH MED J                     76  1580 983
    13   BASS S                GASTROENTEROLOGY                84  1592 983
    14   HODSON ME             POSTGRAD MED J                  60   225 984
    15   STERN RC              J PEDIATR GASTROENTEROL NUTR     5    35 986
    16   WEIZMAN Z             GUT                             27  1043 986
    17   MCHUGO JM             BR J RADIOL                     60   137 987

PN 76010
RN 00365 
AN 77085034
AU Lederberg-S.  Sackett-D.
TI Distribution of complement C3 variants in individuals with cystic
   fibrosis.
SO Am-J-Hum-Genet. 1976 Nov. 28(6). P 597-601.
MJ COMPLEMENT-3.  COMPLEMENT.  CYSTIC-FIBROSIS: fg.
   VARIATION-GENETICS.
MN ELECTROPHORESIS-AGAR-GEL.  FEMALE.  GENE-FREQUENCY.  HUMAN.  MALE.
   PHENOTYPE.
AB The gene frequency for slow and fast electrophoretic variants of
   complement C3 in Caucasian individuals with cystic fibrosis was
   similar to the values expected for unaffected controls, thereby
   ruling out a suspected differential involvement of these phenotypes
   with the disease. In one family, cystic fibrosis and complement C3
   phenotypes segregated independently.
RF 001   SPOCK A               PEDIATR RES                      1   173 967
   002   BOWMAN BH             SCIENCE                        164   325 969
   003   MANGOS JA             SCIENCE                        158   135 967
   004   KAISER D              LANCET                           1  1003 970
   005   LEDERBERG S           IN: MANGOS JA                        259 976
   006   MULLER-EBERHARD HJ    ANNU REV BIOCHEM                44   697 975
   007   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   008   CONOVER JH            LANCET                           2  1501 973
   009   CONOVER JH            LIFE SCI                        14   253 974
   010   CONOVER JH            LANCET                           1    47 975
   011   RAO GJS               J PEDIATR                       80   573 972
   012   RAO GJS               PEDIATR RES                      8   684 974
   013   WILSON GB             PEDIATR RES                     10    87 976
   014   POLLEY MJ             J MED GENET                     11   249 974
   015   LIEBERMAN J           LANCET                           1  1230 974
   016   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   017   WRIGHT SW             AM J HUM GENET                  20   157 968
   018   KULCZYCKI LL          AM J DIS CHILD                 127    64 974
   019   ALPER CA              J CLIN INVEST                   47  2181 968
   020   AZEN EA               SCIENCE                        162   905 968
   021   ALPER CA              IN: PEETERS H                   17   295 969
   022   AZEN EA               BIOCHEM GENET                    3   215 969
   023   VISAKORPI JK          ISR J MED SCI                    9  1156 973
   024   ARVILOMMI H           HUMANGENETIK                    18   253 973
   025   FARHUD DD             HUMANGENETIK                    17    57 972
   026   DAVIS BJ              ANN NY ACAD SCI                121   404 964
   027   HOLZHAUER RJ          AM J HUM GENET                  28   602 976
CT   1   HOLZHAUER RJ          AM J HUM GENET                  28   602 976
     2   SCHIOTZ PO            HUM HERED                       28   293 978
     3   GOTZ M                EUR J PEDIATR                  127   133 978
     4   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     5   SCACCHI R             HUM HERED                       31   183 981
     6   BERNAL JE             HUM HERED                       36    97 986

PN 76011
RN 00366 
AN 77085035
AU Holzhauer-R-J.  Van-Ess-J-D.  Schwartz-R-H.
TI Third component of complement in cystic fibrosis.
SO Am-J-Hum-Genet. 1976 Nov. 28(6). P 602-6.
MJ COMPLEMENT-3.  COMPLEMENT.  CYSTIC-FIBROSIS: fg.
   POLYMORPHISM-GENETICS.
MN ELECTROPHORESIS-AGAR-GEL.  FEMALE.  HETEROZYGOTE.  HUMAN.  MALE.
   PEDIGREE.  PHENOTYPE.
AB In a study of C3 levels and phenotypes in 64 cystic fibrosis (CF)
   patients, 92 CF parents, 64 normal siblings, and 126 healthy
   controls, significant elevations of mean C3 levels were found in CF
   patients, their parents, and in one genetic sub-group of their
   siblins (SS females). C3 concentration in CF patients correlated with
   the degree of clinical impairment as measured by Shwachman-Kulczycki
   (S-K) score. No significant differences were found in the prevalences
   of C3 phenotypes or the S and F gene frequencies among the groups
   studied.
RF 001   POLLEY MJ             J MED GENET                     11   249 974
   002   CONOVER JH            LANCET                           2  1501 973
   003   CONOVER JH            LIFE SCI                        14   253 974
   004   LIEBERMAN J           LANCET                           1  1230 974
   005   HANN S                LANCET                           2   520 974
   006   SCANLIN TF JR         LANCET                           1  1382 974
   007   TAUSSIG LM            CF CLUB ABST                    17    21 976
   008   SERGENT JS            CLIN RES                        24  389A 976
   009   ALPER CA              J CLIN INVEST                   47  2181 968
   010   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   011   TEISBERG P            VOX SANG                        19    47 970
   012   LEDERBERG S           AM J HUM GENET                  28   597 976
CT   1   LEDERBERG S           AM J HUM GENET                  28   597 976
     2   SCHIOTZ PO            HUM HERED                       28   293 978
     3   MOSS RB               AM REV RESPIR DIS              121    23 980
     4   SCACCHI R             HUM HERED                       31   183 981
     5   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
     6   WISNIESKI JJ          AM REV RESPIR DIS              132   770 985
     7   BERNAL JE             HUM HERED                       36    97 986

PN 76012
RN 00367 
AN 76250273
AU Townes-P-L.  Moore-W-D.  White-M-R.
TI Amylase polymorphism: studies of sera and duodenal aspirates in
   normal individuals and in cystic fibrosis.
SO Am-J-Hum-Genet. 1976 Jul. 28(4). P 378-89.
MJ AMYLASES: me.  CYSTIC-FIBROSIS: en.  DUODENUM: se.
   POLYMORPHISM-GENETICS.
MN AMYLASES: bl.  ELECTROPHORESIS-POLYACRYLAMIDE-GEL.  HUMAN.
   PANCREAS:  en.  SALIVA: en.  SUPPORT-U-S-GOVT-P-H-S.
AB Prior genetic studies of the human pancreatic amylase (Amy2) locus
   have been directed principally to the electrophoretic analysis of
   serum and urine, on the assumption that these fluids receive
   negligible contributions from the salivary (Amy 1) locus. In support
   of that assumption was the observation that the isozyme bands were
   lacking in patients with cystic fibrosis and in a postpancreatectomy
   patient. We have examined the sera of 97 patients having cystic
   fibrosis and find normal levels of serum amylase. On electrophoresis,
   three-quarters of the cystic fibrosis patients have a pattern (F-
   pattern) not observed in normal sera. The pattern is characterized by
   the absence of Pa 1. Comparative electrophoresis and mixing
   experiments indicate that the F-pattern is of salivary origin and is
   unmasked in cystic fibrosis by the absence of a pancreatic
   contribution. The normal serum pattern is considered to be an
   admixture of salivary and pancreatic amylase. On the assumption that
   duodenal fluids might more closely reflect the pancreatic (Amy 2)
   locus, electrophoretic studies were performed on 148 normal
   individuals and 37 individuals with cystic fibrosis. Electrophoretic
   phenotypes in duodenal aspirates are more complex than previously
   reported in studies of urine and serum; presumably because of the
   higher concentrations of amylase in the aspirates. Comparative
   electrophoresis and mixing experiments indicate that the phenotypes
   observed in duodenal aspirates also reflect admixture of pancreatic
   and salivary amylase. This recognition of pancreatic and salivary
   admixture in sera fortunately does not alter our prior understanding
   of the genetics of the Amy 2 polymorphism. The extensive studies
   which led to the delineation of the Amy 2 polymorphism were
   essentially based on the presence or absence of a variant band which
   proves now to be outside the zone of admixture.
RF 001   KAMARYT J             HUMANGENETIK                     1   579 965
   002   KAMARYT J             HUMANGENETIK                     3    41 966
   003   BOETTCHER B           ANAL BIOCHEM                    28   510 969
   004   DE LA LANDE FA        ENZYMOLOGIA                     37   335 969
   005   BOETTCHER B           ENZYMOLOGIA                     40   234 970
   006   WARD JC               AM J HUM GENET                  23   403 971
   007   MERRITT AD            NATURE NEW BIOL                239   243 972
   008   MERRITT AD            AM J HUM GENET                  25   510 973
   009   MERRITT AD            AM J HUM GENET                  25   510 973
   010   FRIDHANDLER L         CLIN CHEM                       18  1493 972
   011   KLEIN B               CLIN CHEM                       16    32 970
   012   TOWNES PL             J PEDIATR                       75   221 969
   013   WEBB DR               AM REV RESPIR DIS              108   918 973
   014   BERK JE               AM J DIG DIS                    11   695 966
   015   HOBBS JR              IN: BERGMEYER HU                     909 974
   016   TAKEUCHI T            CLIN CHIM ACTA                  54   137 974
   017   OJALA K               SCAND J CLIN LAB INVEST         35   163 975
   018   KAMARYT J             Z KLIN CHEM KLIN BIOCHEM         7    51 969
   019   LEVITT MD             ANN INTERN MED                  71   919 969
   020   DUANE WC              J CLIN INVEST                   50   156 971
   021   ADLERCREUTZ H         CLIN CHIM ACTA                  43   187 973
   022   DI SANTAGNESE PA      PEDIATRICS                      22   507 958
   023   BARBERO GJ            PEDIATRICS                      22   945 958
   024   KARN RC               ISOZYMES                         4   745 975
   025   TOWNES PL             BIRTH DEF ORIG ART SER           8    95 972
   026   LILLIBRIDGE CB        J PEDIATR                       82   279 973
CT   1   MERRITT AD            ADV HUM GENET                    8   135 977
     2   TAUSSIG LM            AM J HUM GENET                  29   408 977
     3   TOWNES PL             AM J HUM GENET                  29   408 977
     4   WATSON RR             AM J CLIN NUTR                  30   599 977
     5   GILLARD BK            PEDIATR RES                     12   868 978
     6   BERK JE               AM J GASTROENTEROL              69   417 978
     7   CASOLA L              CLIN CHIM ACTA                  94    83 979
     8   TOWNES PL             AM J DIS CHILD                 135   248 981
     9   CLINK D               AM SURGEON                      48   422 982
    10   BARNETT JL            SOUTH MED J                     79   832 986

PN 76013
RN 00368 
AN 77020143
AU Neuburger-N.  Levison-H.  Kruger-K.
TI Transit time analysis of the forced expiratory vital capacity in
   cystic fibrosis.
SO Am-Rev-Respir-Dis. 1976 Oct. 114(4). P 753-9.
MJ CYSTIC-FIBROSIS: pp.  VITAL-CAPACITY.
MN ADOLESCENCE.  ADULT.  ANALYSIS-OF-VARIANCE.  CHILD.  FEMALE.
   FORCED-EXPIRATORY-VOLUME.  HUMAN.  MALE.  PEAK-EXPIRATORY-FLOW-RATE.
AB Transit time analysis of the forced expiratory vital capacity
   maneuver was applied to 37 patients with cystic fibrosis 8 to 22
   years of age. This analysis divides the vital capacity into segments
   of air and assigns a transit time to each segment. The
   characteristics of the distribution of these transit times are used
   as measurements of pulmonary function. The quantities were compared
   with the forced vital capacity, 1-sec forced expiratory volume, ratio
   of 1-sec forced expiratory volume to vital capacity, peak flow,
   forced expiratory flow during the middle half of the forced vital
   capacity, maximal expiratory flow at 25 per cent of the vital
   capacity, specific airway conductance, and arterial PO2 of these
   patients. The standard deviation of the transit times was the most
   frequently abnormal. The mean transit time had the largest range of
   values in terms of its own standard deviation, and it was the best
   single estimate of over-all lung function because it correlated
   almost equally with large and small airway function. The coefficient
   of cariance of transit times was specific in detecting abnormality of
   small airways and was as sensitive in the detection of minimal lung
   disease as the standard deviation of transit times.
RF 001   FISH J                AM REV RESPIR DIS              109   700 974
   002   NEUBURGER N           J APPL PHYSIOL                  40   329 976
   003   MANSELL A             J APPL PHYSIOL                  33   711 972
   004   MEAD J                J APPL PHYSIOL                  22    95 967
   005   MACKLEM PT            J APPL PHYSIOL                  22   395 967
CT   1   ZAPLETAL A            BULL EUR PHYSIOPATH RESP        15   575 979
     2   JORDANOGLOU J         THORAX                          34   187 979
     3   LIANG A               THORAX                          34   194 979
     4   BELLO R               THORAX                          35   225 980
     5   JORDANOGLOU J         THORAX                          35   375 980
     6   JANSEN JM             AM REV RESPIR DIS              122   221 980
     7   NICKERSON BG          AM REV RESPIR DIS              122   859 980
     8   JORDANOGLOU J         THORAX                          37   304 982
     9   MILLER MR             THORAX                          37   205 982
    10   EISER NM              BULL EUR PHYSIOPATH RESP        19   495 983
    11   QUANJER PH            BULL EUR PHYSIOPATH RESP        19     1 983
    12   ELDHAHER AHG          MED BIOL ENG COMPUT             21   277 983
    13   BUIST AS              AM REV RESPIR DIS              127   714 983
    14   OSMANLIEV DP          BULL EUR PHYSIOPATH RESP        20   285 984
    15   INCALZI RA            RESPIRATION                     48   145 985
    16   PEDERSEN OF           J APPL PHYSIOL                  58  1305 985
    17   MILLER MR             AM REV RESPIR DIS              132  1041 985
    18   CHINN DJ              BULL EUR PHYSIOPATH RESP        22   461 986

PN 76014
RN 00369 
AN 77020098
AU Galant-S-P.  Rucker-R-W.  Groncy-C-E.  Wells-I-D.  Novey-H-S.
TI Incidence of serum antibodies to several Aspergillus species and to
   Candida albicans in cystic fibrosis.
SO Am-Rev-Respir-Dis. 1976 Aug. 114(2). P 325-31.
MJ ANTIBODIES-FUNGAL: an.  ASPERGILLUS: im.  CANDIDA-ALBICANS: im.
   CYSTIC-FIBROSIS: im.
MN ADOLESCENCE.  ASPERGILLUS-NIGER: im.  ASPERGILLUS-FUMIGATUS: im.
   ASTHMA: im.  CHILD.  CHILD-PRESCHOOL.  COMPARATIVE-STUDY.  FEMALE.
   HUMAN.  IGE: an.  INFANT.  MALE.  PRECIPITIN-TESTS.
AB The incidence of serum IgE antibodies to several species of
   aspergillus and the incidence of serum precipitins to these species
   and to Candida albicans were determined in 22 children with cystic
   fibrosis, 17 children with bronchial asthma, and 18 control subjects.
   IgE antibodies were found in 50 per cent of the patients with cystic
   fibrosis and in 29 per cent of the patients with bronchial asthma;
   none was found in the control subjects. Precipitins to aspergillus
   species were present in 59 per cent of the patients with cystic
   fibrosis, 35 per cent of the patients with bronchial asthma, and 11
   per cent of the control subjects. Greater differences were noted when
   the total number of precipitin bands in each group was compared.
   There was a trend for the more severe cases of cystic fibrosis (based
   on the Shwachman-Kulczycki score) to have a greater incidence of
   precipitins and a lower frequency of IgE antibodies to aspergillus
   than the milder cases. Candida precipitins were found more frequently
   in patients with cystic fibrosis (45 per cent) than in patients with
   bronchial asthma (18 per cent); none was found in the control group.
   The potential role of fungal hypersensitivity in cystic fibrosis and
   the therapeutic implications are discussed in light of these
   findings.
RF 001   DI SANTAGNESE PA      IN: VAUGHAN VC III                   905 971
   002   SHWACHMAN H           IN: KENDIG EL JR                 1   524 972
   003   WARREN CPW            CLIN ALLERGY                     5     1 975
   004   MEARNS MB             LANCET                           1   538 967
   005   SCHWARTZ RH           AM J DIS CHILD                 120   432 970
   006   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   007   MEARNS MB             THORAX                          20   385 965
   008   BATTEN JC             MOD PROBL PEDIATR               10   227 967
   009   ORES CN               CF CLUB ABST                    16    48 975
   010   LEWISTON NJ           CF CLUB ABST                          47 973
   011   PEPYS J               HYPERSENSITIVITY DIS LUNGS DU            969
   012   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   013   OUCHTERLONY O         ACTA PATH MICROBIOL SCAND       32   231 953
   014   PEPYS J               AM REV RESPIR DIS               89   842 964
   015   WIDE L                LANCET                           2  1105 967
   016   HOFFMAN DR            J ALLERGY CLIN IMMUNOL          54   165 974
   017   FINEGOLD SM           AM J MED                        27   463 959
   018   YOUNG RC              MEDICINE (BALTIMORE)            49   147 970
   019   ARBESMAN CE           IN: GOODFRIEND L                     163 973
   020   PEPYS J               HYPERSENSITIVITY DIS LUNGS DU            969
   021   KULCZYCKI LL          JAMA                           175   358 961
   022   RACHELEFSKY GS        AM J DIS CHILD                 128   355 974
   023   SPITZ E               J ALLERGY CLIN IMMUNOL          49   337 972
   024   CRACCO G              PROC EWGCF 5TH ANNU MTG               16 974
   025   MCFARLANE H           BR MED J                         1   423 975
   026   BARDANA EJ JR         AM J DIS CHILD                 129  1164 975
   027   KATZENSTEIN AL        AM REV RESPIR DIS              111   497 975
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   COLLINS RF            AM J MED TECHNOLOGY             44   826 978
     3   NOVEY HS              J DIAL                           3   349 979
     4   MARSH PB              MYCOPATHOLOGIA                  69    67 979
     5   NELSON LA             AM REV RESPIR DIS              120   863 979
     6   MOSS RB               AM REV RESPIR DIS              121    23 980
     7   MARKS MI              J PEDIATR                       98   173 981
     8   MOSS RB               J PEDIATR                       99   215 981
     9   VOSS MJ               J ALLERGY CLIN IMMUNOL          69   536 982
    10   WONNE R               CLIN ALLERGY                    15   455 985
    11   SCHONHEYDER H         ACTA PATH MICROB IMMU SCA (B)   93   105 985
    12   MALFROOT A            PEDIATR INFECT DIS               5   376 986

PN 76015
RN 00370 
AN 76229764
AU Wood-R-E.  Boat-T-F.  Doershuk-C-F.
TI Cystic fibrosis.
SO Am-Rev-Respir-Dis. 1976 Jun. 113(6). P 833-78. (REVIEW).
MJ CYSTIC-FIBROSIS.
MN BIOLOGICAL-TRANSPORT.  CYSTIC-FIBROSIS: co, pp, th.
   EXOCRINE-GLANDS:  pp.  FEMALE.  GASTROINTESTINAL-DISEASES: et.
   GENITAL-DISEASES-MALE:  et.  GENITAL-DISEASES-FEMALE: et.  HUMAN.
   LUNG-DISEASES: et, pa.  MALE.  MUCUS: me.  PANCREAS: pp.  PROGNOSIS.
   PSYCHOLOGY.  REVIEW.  SOCIAL-ADJUSTMENT.  SWEAT.
   SUPPORT-U-S-GOVT-P-H-S.
EX Cystic fibrosis is the most frequent lethal genetic syndrome among
   white children and is the cause of much of the chronic progressive
   pulmonary disease encountered in children.  Because of the
   increasing adolescent and adult population of patients with cystic
   fibrosis and their psychosocial, employment, and treatment needs,
   this review, whenever possible, will emphasize aspects pertinent to
   older patients.  No known biochemical or structural defect will
   account for all the pathophysiologic phenomena of cystic fibrosis.
   Thus, the definition of the disease rests on the clinical findings;
   cystic fibrosis is a syndrome, and not yet a disease.  Incidence
   figures for cystic fibrosis are necessarily minimal.  The best
   diagnostic efforts currently available fail to detect all those who
   die at a young age or who have mild symptoms.  Several pieces of
   evidence indicate that cystic fibrosis is transmitted as an autosomal
   recessive trait.  An autosomal recessive inheritance for cystic
   fibrosis suggests a discrete biochemical or structural defect.  To
   date no single lesion has been proved to provide a unifying
   hypothesis for the pathophysiology of cystic fibrosis.  Exocrine
   gland dysfunction, mucociliary transport, immunology, ciliary
   factors and transport mechanisms are discussed.  The manifestations
   of cystic fibrosis involve many organ systems and the pattern of
   presentation is variable.  Respiratory, gastrointestinal,
   genitourinary, and sweat gland manifestations are discussed.  There
   are at least 3 possible approaches to screening for cystic fibrosis:
   sweat testing, evaluation of pancreatic function, or detection of
   some product of the defective gene.  Prenatal diagnosis and
   heterozygote testing, diagnosis in adults, and diagnostic problems
   are also examined.  Treatment includes prevention, pulmonary therapy,
   and gastrointestinal therapy. Pulmonary and other complications and
   their treatment are discussed, as well as psychosocial aspects, and
   evaluation and prognosis of cystic fibrosis.
RF 001   ROCHHOLZ EL           KINDERLIED UND KINDERSPIEL AU        280 857
   002   LANDSTEINER K         ZENTRALBL ALLG PATHOL           16   903 905
   003   GARROD AE             Q J MED                          6   242 913
   004   BLACKFAN KD           J PEDIATR                        3   679 933
   005   BLACKFAN KD           J PEDIATR                       13   627 938
   006   FANCONI G             WIEN MED WOCHENSCHR             86   753 936
   007   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   009   ANDERSEN DH           AM J DIS CHILD                  70   100 945
   010   HARRIS R              ARCH DIS CHILD                  30   424 955
   011   GIBSON LE             PEDIATRICS                      23   545 959
   012   DENTON R              AM J DIS CHILD                  82   433 951
   013   DOYLE B               PHYS THER REV                   39    24 959
   014   THACKER EW            POSTURAL DRAINAGE AND RESPIRA            959
   015   MATTHEWS LW           J PEDIATR                       65   558 964
   016   DOERSHUK CF           PEDIATRICS                      36   675 965
   017   WRIGHT SW             AM J HUM GENET                  20   157 968
   018   KULCZYCKI LL          AM J DIS CHILD                 127    64 974
   019   ANTONELLI M           FRACASTORO (VERONA)             63   207 970
   020   GOODCHILD MC          ARCH DIS CHILD                  49   739 974
   021   SELANDER P            ACTA PAEDIATR SCAND             51    65 962
   022   REIDERMAN MI          GENETIKA (SOV GENETICS)          7   148 971
   023   STEINBERG AG          AM J HUM GENET                  12   416 960
   024   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   025   VIVELL O              MONATSSCHR KINDERHEILKD        111    62 963
   026   BRUNECKY Z            J MED GENET                      9    33 972
   027   BERNHEIM M            PEDIATRIE                       16    17 961
   028   CARTER CO             MOD PROBL PEDIATR               10   372 967
   029   PUGH RJ               ARCH DIS CHILD                  42   544 967
   030   HOUSTEK J             REV MED LIEGE                   22   421 967
   031   SULTZ HA              AM J PUBLIC HEALTH              56  1461 966
   032   DANKS DM              ANN HUM GENET                   28   323 965
   033   HALL BD               J MED GENET                      5   262 968
   034   KRAMM ER              AM J PUBLIC HEALTH              52  2041 962
   035   MERRITT AD            J LAB CLIN MED                  60   998 962
   036   HONEYMAN MS           AM J HUM GENET                  17   461 965
   037   GOODMAN HO            AM J HUM GENET                   4    59 952
   038   SUPER M               S AFR MED J                     49   818 975
   039   HARRIS RL             PEDIATRICS                      41   733 968
   040   MACDOUGALL LG         LANCET                           2   409 962
   041   WANG CI               N ENGL J MED                   279  1216 968
   042   IKAI K                ACTA PAEDIATR JAP                7    23 965
   043   KANDAR HR             ANTISEPTIC                      58   863 961
   044   REDDY CR              J PEDIATR                       75   522 969
   045   COHEN LF              GAP CONF REP PROB REPRO PHYSI          6 975
   046   DANES BS              J EXP MED                      129   775 969
   047   BEARN AG              IN: MANGOS JA                         21 973
   048   DANES BS              AM J HUM GENET                  23   297 971
   049   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   050   TAYSI K               N ENGL J MED                   281  1108 969
   051   REED GB               J PATHOL                       101   251 970
   052   KULCZYCKI LL          CLIN PEDIATR                     3   692 964
   053   BATTEN J              LANCET                           1  1348 963
   054   ORZALESI MM           ACTA PAEDIATR SCAND             52   267 963
   055   HALLETT WY            AM REV RESPIR DIS               92   714 965
   056   BEARN AG              CLIN GASTROENTEROL               2   515 973
   057   BAUMANN T             HELV PAEDIATR ACTA SUPPL 8      13     1 958
   058   KNUDSON AG JR         AM J HUM GENET                  19   388 967
   059   VIRTANEN S            J PEDIATR                       68   139 966
   060   STEINBERG AG          AM J HUM GENET                   8   177 956
   061   GOTZ M                Z KINDERHEILK                  117   183 974
   062   MILUNSKY A            PEDIATRICS                      42   501 968
   063   SMITH DW              LANCET                           2   309 968
   064   LINDENBAUM RH         J MED GENET                      9   232 972
   065   TAUSSIG LM            AM J DIS CHILD                 125   495 973
   066   FLUGE G               AM J DIS CHILD                 127   760 974
   067   BURNELL RH            AM J DIS CHILD                 127   746 974
   068   LEWIS MB              AUSTRALAS J DERMATOL            13   105 972
   069   LOX CD                ARIZ MED                        31   508 974
   070   BITAR J               J PEDIATR                       71   123 967
   071   MATTHEWS LW           AM REV RESPIR DIS               88   199 963
   072   CHERNICK WS           PEDIATRICS                      24   739 959
   073   KOPITO L              J PEDIATR                       68   313 966
   074   KOPITO LE             FERTIL STERIL                   24   499 973
   075   HADORN B              J PEDIATR                       73    39 968
   076   ZOPPI G               ACTA PAEDIATR SCAND             59   692 970
   077   RULE AH               FERTIL STERIL                   21   515 970
   078   DEARBORN DG           IN: MANGOS JA                        179 976
   079   GIBSON LE             PEDIATRICS                      48   695 971
   080   MANGOS JA             TEX REP BIOL MED                31   651 973
   081   DI SANTAGNESE PA      ANN NY ACAD SCI                 93   555 962
   082   PAUNIER L             PEDIATRICS                      52   446 973
   083   KAISER D              PEDIATR RES                      5   167 971
   084   CHAUNCEY HH           ARCH ORAL BIOL                   7   707 962
   085   CHERNICK WS           J PEDIATR                       59   890 961
   086   SHWACHMAN H           ANN NY ACAD SCI                 93   600 962
   087   BOTELHO SY            J PEDIATR                       83   601 973
   088   DI SANTAGNESE PA      PEDIATRICS                      22   507 958
   089   DI SANTAGNESE PA      ANN NY ACAD SCI                 93   555 962
   090   MANDEL ID             AM J DIS CHILD                 110   646 965
   091   SCHULZ IJ             J CLIN INVEST                   48  1470 969
   092   MANGOS JA             PEDIATR RES                      1   436 967
   093   MANGOS JA             SCIENCE                        158   135 967
   094   MANGOS JA             PEDIATR RES                      2   378 968
   095   KAISER D              IN: MANGOS JA                        247 973
   096   GUGLER EC             J PEDIATR                       71   585 967
   097   BOAT TF               PEDIATR RES                      8   531 974
   098   WARTON KL             BR MED J                         3   570 971
   099   SATIR B               J CELL BIOL                     56   153 973
   100   BRADDOCK LI           CF CLUB ABST                          17 969
   101   LUNDGREN DW           CLIN CHIM ACTA                  62   357 975
   102   BAKER AP              ARCH BIOCHEM BIOPHYS           165   597 974
   103   MUNRO GF              J BIOL CHEM                    247  1272 972
   104   MANDEL ID             AM J DIS CHILD                 113   431 967
   105   CHERNICK WS           J PEDIATR                       65   694 964
   106   RAO GJS               J PEDIATR                       80   573 972
   107   BOAT TF               IN: MANGOS JA                        165 976
   108   LILLIBRIDGE CB        PEDIATRICS                      53   913 974
   109   BUTTERWORTH J         CLIN CHIM ACTA                  56   159 974
   110   BUTTERWORTH J         CLIN CHIM ACTA                  40   139 972
   111   LORIN MI              BIORHEOLOGY                      9    27 972
   112   BETTELHEIM FA         BIORHEOLOGY                      8   129 971
   113   STURGESS JM           CLIN SCI                        38   145 970
   114   POTTER JL             AM REV RESPIR DIS               99   909 969
   115   SNARY D               BIOCHEM BIOPHYS RES COMMUN      40   844 970
   116   DEMAN J               BIOCHIM BIOPHYS ACTA           297   486 973
   117   FRIBERG S             AM REV RESPIR DIS              108  1010 973
   119   BISERTE G             EXP ANNU BIOCHIM MED            24    85 963
   120   HAVEZ R               CLIN CHIM ACTA                  17   281 967
   121   HAVEZ R               CLIN CHIM ACTA                  17   463 967
   122   HAVEZ R               IN: PEETERS H                   16   343 968
   123   DEGAND P              IN: PEETERS H                   16   361 968
   124   HAVEZ R               BULL SOC CHIM BIOL              51   245 969
   125   ROUSSEL P             CLIN CHIM ACTA                  36   315 972
   126   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   127   DEGAND P              BULL PHYSIOPATH RESPIR NANCY     9   199 973
   128   ROUSSEL P             J BIOL CHEM                    250  2114 975
   129   BOAT TF               AM REV RESPIR DIS              110   428 974
   130   LAMB D                BR J DIS CHEST                  66   239 972
   131   RUBIN LS              J PEDIATR                       63  1120 963
   132   BOAT TF               CHEST                           67   325 975
   133   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   134   MANGOS JA             PEDIATR RES                      3   562 969
   135   STURGESS JM           BR J EXP PATHOL                 54   388 973
   136   MARTINEZ JR           PEDIATR RES                      9   463 975
   137   MARTINEZ JR           PEDIATR RES                      9   470 975
   138   SANCHIS J             N ENGL J MED                   288   651 973
   139   WOOD RE               AM REV RESPIR DIS              111   733 975
   140   WARING WW             N ENGL J MED                   288   681 973
   141   SANTA CRUZ R          AM REV RESPIR DIS              109   458 974
   142   HILDING AC            AM J PHYSIOL                   191   404 957
   143   VANAS A               S AFR MED J                     46   347 972
   144   MAGID SL              ARCH OTOLARYNGOL                86   212 967
   145   SADE J                AM REV RESPIR DIS              102    48 970
   146   KING MA               AM REV RESPIR DIS              110   740 974
   147   LUCAS AM              ARCH OTOLARYNGOL                20   518 934
   148   BLAKE J               J BIOMECH                        8   179 975
   149   ASMUNDSSON T          AM REV RESPIR DIS              102   388 970
   150   YEATES DB             ARCH DIS CHILD                  51    28 976
   151   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   152   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   153   SCHWARTZ RH           AM J DIS CHILD                 111   408 966
   154   SOUTH MA              J PEDIATR                       71   645 967
   155   HALBERT SP            PEDIATRICS                      26   792 960
   156   BURNS MW              LANCET                           1   270 968
   157   HABBOUSHE C           PEDIATRICS                      48   973 971
   158   MAY JR                ARCH DIS CHILD                  47   908 972
   159   HOIBY N               SCAND J RESPIR DIS              56    38 975
   160   CONOVER JH            LANCET                           2  1501 973
   161   POLLEY MJ             J MED GENET                     11   249 974
   162   PENNINGTON JE         AM J MED                        58   629 975
   163   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
   164   FALK GA               AM REV RESPIR DIS              105    14 972
   165   TURNER-WARWICK M      BR J DIS CHEST                  61   113 967
   166   GORDON DS             AM REV RESPIR DIS              108   127 973
   167   SPOCK A               PEDIATR RES                      1   173 967
   168   BOWMAN BH             SCIENCE                        164   325 969
   169   CHERRY JD             J PEDIATR                       79   937 971
   170   BESLEY GTN            J MED GENET                      6   278 969
   171   POSSELT HG            Z KINDERHEILK                  110    93 971
   172   MCCOMBS ML            CLIN GENET                       1   171 970
   173   CONOVER JH            PEDIATR RES                      7   220 973
   174   DANES BS              J EXP MED                      136  1313 972
   175   DOGGETT RG            NATURE NEW BIOL                243   251 973
   176   IACOCCA VF            J PEDIATR                       79   508 971
   177   BOWMAN BH             SCIENCE                        167   871 970
   178   DANES BS              J EXP MED                      137  1538 973
   179   SCHMOYER IR           LIFE SCI PART 2                 11  1037 972
   180   BERATIS NG            PEDIATR RES                      7   958 973
   181   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   182   BARNETT DR            TEX REP BIOL MED                31   691 973
   183   CONOVER JH            PEDIATR RES                      7   224 973
   184   BARNETT DR            TEX REP BIOL MED                31   703 973
   185   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   186   CONOVER JH            LIFE SCI                        14   253 974
   187   BOKISCH VA            J CLIN INVEST                   49  2427 970
   188   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   189   RAO GJS               SCIENCE                        177   610 972
   190   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   191   RAO GJS               PEDIATR RES                      8   684 974
   192   CONOVER JH            LANCET                           1  1194 973
   193   WILSON GB             PEDIATR RES                      9   635 975
   194   ALTLAND K             HUMANGENETIK                    28   207 975
   195   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   196   FARRELL PM            PEDIATR RES                     10   127 976
   197   COHEN FL              J MED GENET                     11   253 974
   198   WOOD RE               LANCET                           2  1452 973
   199   ANON                  GAP CONF REP CILIARY INHIBITO            973
   200   COLE CH               PEDIATR RES                      6   616 972
   201   BALFE JW              SCIENCE                        162   689 968
   202   LAPEY A               PEDIATR RES                      4   478 970
   203   FEIG SA               PEDIATR RES                      8   594 974
   204   HADDEN JW             PROC SOC EXP BIOL MED          142   577 973
   205   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   206   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   207   QUISSELL DO           NATURE                         247   115 974
   208   GIBBS GE              PEDIATR RES                      1    24 967
   209   BENKE PJ              LANCET                           1   182 972
   210   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   211   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   212   DUFFY MJ              CLIN CHIM ACTA                  49   397 973
   213   BAIG MM               J PEDIATR                       86    72 975
   214   CHANGUS JE            AM J PATHOL                     80   317 975
   215   BENKE PJ              PROC SOC EXP BIOL MED          137  1283 971
   216   TAYLOR A              PEDIATR RES                      8   861 974
   217   COLE CH               PEDIATR RES                      9   763 975
   218   TAUSSIG LM            LANCET                           1  1367 972
   219   BROWN GA              LANCET                           2   639 971
   220   MORIN CL              BIOMEDICINE EXPRESS             19   133 973
   221   ARAKI H               PEDIATR RES                      9   932 975
   222   SHAPIRO BL            BIOCHEM BIOPHYS RES COMMUN      39   816 970
   223   ZUELZER WW            PEDIATRICS                       4    53 949
   224   ESTERLY JR            JOHNS HOPKINS MED J            122    94 968
   225   REID L                MOD PROBL PEDIATR               10   195 967
   226   ESTERLY JR            THORAX                          23   670 968
   227   BOWDEN DH             AM J MED                        38   226 965
   228   WENTWORTH P           THORAX                          23   582 968
   229   LAMARRE A             PEDIATRICS                      50   291 972
   230   LANDAU LI             AM REV RESPIR DIS              108   593 973
   231   ZAPLETAL A            PEDIATRICS                      48    64 971
   232   FOX WW                PEDIATRICS                      54   293 974
   233   MELLINS RB            PEDIATRICS                      44   315 969
   234   MANSELL A             AM REV RESPIR DIS              109   190 974
   235   BEIER FR              AM REV RESPIR DIS               94   430 966
   236   COOK CD               PEDIATRICS                      24   181 959
   237   GODFREY S             ARCH DIS CHILD                  46   144 971
   238   ZELKOWITZ PS          J PEDIATR                       74   393 969
   239   DAY G                 ARCH DIS CHILD                  48   355 973
   240   LEVISON H             IN: MANGOS JA                          3 976
   240A  LIFSCHITZ MI          AM REV RESPIR DIS               99   399 969
   241   BOUHUYS A             J APPL PHYSIOL                  30   670 971
   242   MELLINS RB            PEDIATRICS                      41   560 968
   243   LANDAU LI             AM REV RESPIR DIS              111   725 975
   244   HODSON CJ             CLIN RADIOL                     13    54 962
   245   SCHWARTZ EE           AM J ROENTG RAD THER NUCL MED  122   708 974
   246   DI SANTAGNESE PA      DIS CHEST                       27   654 955
   247   HUANG NN              J PEDIATR                       59   512 961
   248   IACOCCA VF            AM J DIS CHILD                 106   315 963
   249   LAWSON D              IN: WATT PJ                           69 970
   250   MEARNS MB             ARCH DIS CHILD                  47   902 972
   251   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974
   252   REYNOLDS HY           ANN INTERN MED                  82   819 975
   253   DOGGETT RG            J PEDIATR                       68   215 966
   254   DOGGETT RG            INFECT IMMUN                     6   628 972
   255   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974
   256   HOLSCLAW DS           CLIN PEDIATR                     9   346 970
   257   LLOYD-STILL JD        PEDIATRICS                      53   678 974
   258   SHWACHMAN H           PEDIATRICS                      30   389 962
   259   RULON JT              ARCH OTOLARYNGOL                78   192 963
   260   HARRIS GBC            POSTGRAD MED                    34   251 963
   261   OPPENHEIMER EH        BULL JOHNS HOPKINS HOSP        111     1 962
   262   HOLSCLAW DS           AM J DIS CHILD                 109   101 965
   263   DONNISON AB           PEDIATRICS                      37   833 966
   264   BERDON WE             N ENGL J MED                   277   585 967
   265   MCPARTLIN JF          ARCH DIS CHILD                  47   207 972
   266   FISHER OD             ARCH DIS CHILD                  29   262 954
   267   CORDONNIER JK         SURGERY                         54   667 963
   268   HUNTON DB             GASTROENTEROLOGY                50    99 966
   269   HOLSCLAW DS           PEDIATRICS                      48    51 971
   270   DI SANTAGNESE PA      GASTROENTEROLOGY                40    64 961
   271   KOPEL FB              GASTROENTEROLOGY                62   483 972
   272   HADORN B              CAN MED ASSOC J                 98   377 968
   273   LAPEY A               J PEDIATR                       84   328 974
   274   REEMTSMA K            PEDIATRICS                      22   525 958
   275   GRYBOSKI JD           GASTROENTEROLOGY                45   633 963
   276   ANTONOWICZ I          PEDIATRICS                      42   492 968
   277   WEBER AM              N ENGL J MED                   289  1001 973
   278   HEIZER WD             N ENGL J MED                   285   257 971
   279   MOSS AJ               J PEDIATR                       86   295 975
   280   LEE PA                JAMA                           228   585 974
   281   DOLAN TF JR           CLIN PEDIATR                     9   295 970
   282   TORSTENSON OL         PEDIATRICS                      45   857 970
   283   PETERSEN RA           AM J DIS CHILD                 116   662 968
   284   UNDERWOOD BA          PEDIATR RES                      6    26 972
   285   BLANC WA              PEDIATRICS                      22   494 958
   286   KULCZYCKI LL          N ENGL J MED                   259   409 958
   287   TAUSSIG LM            RADIOLOGY                      106   369 973
   288   ALTERMAN K            AM J DIS CHILD                 101   210 961
   289   BRAY PF               AM J DIS CHILD                 126    78 973
   290   DOLAN TF JR           CLIN PEDIATR                    14   862 975
   291   CRAIG JM              AM J DIS CHILD                  93   357 957
   292   SHARP HL              CF CLUB ABST                           4 968
   293   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   294   VALMAN HB             ARCH DIS CHILD                  46   805 971
   295   COOPER HS             JOHNS HOPKINS MED J            135   268 974
   296   BOAT TF               CLIN PEDIATR                    13   505 974
   297   KATTWINKEL J          J PEDIATR                       82   234 973
   298   WEBSTER R             ARCH DIS CHILD                  28   343 953
   299   ROVSING H             ACTA RADIOL DIAGN STOCKH        14   588 973
   300   FEIGELSON J           ACTA PAEDIATR SCAND             59   539 970
   301   ESTERLY JR            BULL JOHNS HOPKINS HOSP        110   247 962
   302   SHWACHMAN H           PEDIATRICS                      55    86 975
   303   BARBERO GJ            PEDIATRICS                      29   788 962
   304   WARWICK WJ            PEDIATRICS                      34   621 964
   305   LEAKE D               J PEDIATR                       76   301 970
   306   DENNING CR            CF CLUB ABST                          18 966
   307   DENNING CR            PEDIATRICS                      41     7 968
   308   KAPLAN E              N ENGL J MED                   279    65 968
   309   FEIGELSON J           ARCH FR PEDIATR                 26   937 969
   310   TAUSSIG LM            N ENGL J MED                   287   586 972
   311   VALMAN HB             LANCET                           2   566 969
   312   HOLSCLAW DS           J UROL                         106   568 971
   313   LANDING BH            ARCH PATHOL                     88   569 969
   314   OPPENHEIMER EH        J PEDIATR                       75   806 969
   315   HOLSCLAW DS           PEDIATRICS                      48   442 971
   316   WANG CI               AM J DIS CHILD                 119   236 970
   317   OPPENHEIMER EH        J PEDIATR                       77   991 970
   318   DOOLEY RR             AM J OBSTET GYNECOL            118   971 974
   319   KOPITO LE             FERTIL STERIL                   24   512 973
   320   LOBECK CC             IN: STANBURY JB                     1605 972
   321   KESSLER WR            PEDIATRICS                       8   648 951
   322   DI SANTAGNESE PA      JAMA                           172  2014 960
   323   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   324   GOTTLIEB RP           J PEDIATR                       79   930 971
   325   LIEBERMAN J           ANN INTERN MED                  82   806 975
   326   ANON                  GAP CONF REP PROB SWEAT TESTI            975
   327   GIBSON LE             PROC FOR QUANTITATIVE ION                975
   328   JONES JD              MAYO CLIN PROC                  45   768 970
   329   COLTMAN CA JR         AM REV RESPIR DIS               93    63 966
   330   CONN JW               ARCH INTERN MED                 83   416 949
   331   ROBINSON GC           PEDIATRICS                      30   797 962
   332   MORSE WI              N ENGL J MED                   264  1021 961
   333   LOBECK CC             J PEDIATR                       62   868 963
   334   HARRIS RC             PEDIATRICS                      31  1044 963
   335   ESTERLY NB            J PEDIATR                       73   852 968
   336   STRICKLAND AL         J PEDIATR                       82   284 973
   337   DURAND P              RECENT PROG MED                 44   279 968
   338   MACE JW               CLIN PEDIATR                    10   285 971
   339   DURAND P              J PEDIATR                       75   665 969
   340   MACLEAN WC JR         J PEDIATR                       83    86 973
   341   VLACHOS P             J PEDIATR                       84   926 974
   342   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            971
   343   BARBERO GJ            AM J DIS CHILD                 112   536 966
   344   TAUSSIG LM            PEDIATRICS                      54   229 974
   345   HARDY JD              ARCH DIS CHILD                  48   316 973
   346   GREEN MN              PEDIATRICS                      41   989 968
   347   KOLLBERG H            ACTA PAEDIATR SCAND             64   477 975
   348   STEPHAN U             PEDIATRICS                      55    35 975
   349   TOMASHEFSKI JF        CHEST                           57    28 970
   350   LOBER CW              CHEST                           66   332 974
   351   LOBECK CC             J PEDIATR                       62   393 963
   352   GRAND RJ              J PEDIATR                       70   357 967
   353   RENNERT OM            ANN CLIN LAB SCI                 3     1 973
   354   STERN RC              CLIN PEDIATR                    11   521 972
   355   MEARNS MB             ARCH DIS CHILD                  47     5 972
   356   SAGGERS BA            ARCH DIS CHILD                  43   404 968
   357   DOERSHUK CF           IN: GREEN M                          707 968
   358   JUSKO WJ              PEDIATRICS                      56  1038 975
   360   RUCKER RW             PEDIATRICS                      54   358 974
   361   PHAIR JP              AM J DIS CHILD                 120    22 970
   362   MARKS MI              J PEDIATR                       79   822 971
   363   HUANG NN              J PEDIATR                       78   338 971
   364   BOXERBAUM B           J INFECT DIS SUPPL             122    59 970
   365   BOXERBAUM B           J INFECT DIS SUPPL             124   293 971
   366   KLUGE RM              ANN INTERN MED                  81   584 974
   367   HAWLEY HB             CURR THER RES                   16   414 974
   368   KLASTERSKY J          CHEST                           61   117 972
   369   DOERSHUK CF           PEDIATRICS                      41   723 968
   370   PARKS CR              J PEDIATR                       76   305 970
   371   MATTHEWS LW           PEDIATRICS                      39   176 967
   372   MOTOYAMA EK           PEDIATRICS                      50   299 972
   373   CHANG N               AM REV RESPIR DIS              107   672 973
   374   WOLFSDORF J           PEDIATRICS                      43   799 969
   375   BAU SK                PEDIATRICS                      48   605 971
   376   YEATES DB             AM REV RESPIR DIS              107   602 973
   377   ALDERSON PO           J PEDIATR                       84   479 974
   378   WEST JB               NATURE                         189   588 961
   379   MORROW PE             AM REV RESPIR DIS SUPPL        110    88 974
   380   PARKS CR              AM REV RESPIR DIS              104    99 971
   381   PARKS CR              AM REV RESPIR DIS              108   513 973
   382   GOLDBERG IS           ARCH INTERN MED                131    88 973
   383   DULFANO MJ            AM REV RESPIR DIS              112   341 975
   384   LIFSCHITZ MI          AM REV RESPIR DIS              102   456 970
   385   DULFANO MJ            AM REV RESPIR DIS              107   130 973
   386   ROSENBLUTH M          ARCH DIS CHILD                  49   606 974
   387   ANON                  AM REV RESPIR DIS PART 2       110     7 974
   388   PHELAN PD             ARCH DIS CHILD                  44   393 969
   389   LANDAU LI             J PEDIATR                       82   863 973
   390   BARKER R              J PEDIATR                       80   396 972
   391   CARSON S              AM REV RESPIR DIS SUPPL         93    86 966
   392   LAKE KB               CHEST                           68    62 975
   393   MELLINS RB            AM REV RESPIR DIS SUPPL        110   137 974
   394   LORIN MI              AM J PHYS MED                   50   215 971
   395   MOTOYAMA EK           IN: MANGOS JA                        335 973
   396   TECKLIN JS            PHYS THER                       55  1081 975
   397   SHARP JT              AM REV RESPIR DIS SUPPL        110   154 974
   398   SACKNER MA            AM REV RESPIR DIS              111    62 975
   399   CEZEAUX G JR          JAMA                           199    15 967
   400   KYLSTRA JA            AM REV RESPIR DIS              103   651 971
   401   ALTMAN RP             J PEDIATR SURG                   8   809 973
   402   SHEFFNER AL           AM REV RESPIR DIS               90   721 964
   403   HIRSCH SR             J LAB CLIN MED                  74   346 969
   404   LIEBERMAN J           AM J MED                        49     1 970
   405   LOURENCO RV           AM REV RESPIR DIS              106   857 972
   406   SHAW A                J PEDIATR SURG                   4   119 969
   407   LIEBERMAN J           AM REV RESPIR DIS               97   654 968
   408   BOYD EM               PHARMACOL REV                    6   521 954
   409   FORBES J              LANCET                           2   767 957
   410   DOLAN TF JR           J PEDIATR                       79   684 971
   410   HIRSCH SR             CHEST                           63     9 973
   411   PALMER KNV            LANCET                           1    91 960
   412   STOWE SM              AM REV RESPIR DIS              111   611 975
   413   DOERSHUK CF           ANESTH ANALG CLEVE              51   413 972
   414   KULCZYCKI LL          N ENGL J MED                   257   203 957
   415   STEIGMANN F           AM J DIG DIS                     7   464 962
   416   GOODCHILD MC          BR MED J                         3   712 974
   417   ANON                  NUTR REV                        32   232 974
   418   VEEGER W              N ENGL J MED                   267  1341 962
   419   HARO EN               CLIN RES                        12   207 964
   420   KATTWINKEL J          PEDIATRICS                      50   133 972
   421   LITTMAN A             N ENGL J MED                   281   201 969
   422   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   423   ROSENLUND ML          NATURE                         251   719 974
   424   BERGNER A             PEDIATRICS                      55   814 975
   425   DOLAN TF JR           AM REV RESPIR DIS              110   812 974
   426   PILAT L               AM REV RESPIR DIS              112   275 975
   427   HARRIES JT            ARCH DIS CHILD                  46   341 971
   428   FARRELL PM            ACTA PAEDIATR SCAND             64   150 975
   429   DEREN JJ              N ENGL J MED                   288   949 973
   430   TOSKES PP             GASTROENTEROLOGY                65   199 973
   431   BARNESS LA            N ENGL J MED                   289    45 973
   432   HUANG NN              IN: SENIOR JR                        207 968
   433   ALLAN JD              AM J DIS CHILD                 126    22 973
   434   BERRY HK              AM J DIS CHILD                 129   165 975
   435   BARCLAY RPC           ARCH DIS CHILD                  50   490 975
   436   DODGE JA              BR MED J                         2   192 975
   437   SHERMAN JO            J PEDIATR                       86   518 975
   438   DOOLEY RR             J PEDIATR                       74    95 969
   439   GOOD TA               AM J DIS CHILD                 111   272 966
   440   WARING WW             PEDIATRICS                      39   166 967
   441   BOAT TF               JAMA                           209  1498 969
   442   LIFSCHITZ MI          AM J DIS CHILD                 116   633 968
   443   KATTWINKEL J          JAMA                           226   557 973
   444   HOLSCLAW DS           J PEDIATR                       76   829 970
   445   SMIDDY JF             CHEST                           64   158 973
   446   GOTTLIEB LS           CHEST                           67   482 975
   447   FELLOWS KE            RADIOLOGY                      114   551 975
   448   GOLDRING RM           J PEDIATR                       65   501 964
   449   LIEBMAN J             CIRCULATION                     35   552 967
   450   SIASSI B              J PEDIATR                       78   794 971
   451   LIEBMAN J             CHEST                           63   218 973
   452   MOSS AJ               J PEDIATR                       67   797 965
   453   FLAHERTY JT           AM J CARDIOL                    20    29 967
   454   MILLERD FJC           BR HEART J                      29    43 967
   455   STROBER W             PEDIATRICS                      43   416 969
   456   PITTMAN FE            AM J DIS CHILD                 108   360 964
   457   WHITMAN V             PEDIATRICS                      55    83 975
   458   KELMINSON LL          PEDIATRICS                      39    24 967
   459   LIEBMAN J             IN: MANGOS JA                         41 976
   460   SUSMANO A             J APPL PHYSIOL                  31   531 971
   461   SCHWARTZ RH           AM J DIS CHILD                 120   432 970
   462   PEPYS J               AM REV RESPIR DIS               80   167 959
   463   SLAVIN RG             AM J MED                        47   306 969
   464   HENDERSON AH          THORAX                          23   501 968
   465   GROSSMAN H            AM J DIS CHILD                 107     1 964
   466   ATHREYA BH            AM J DIS CHILD                 129   634 975
   467   VAN LEERSUM HG        J BELGE RADIOL                  49    65 966
   468   WAGGET J              J PEDIATR                       77   407 970
   469   MCPARTLIN JF          BR J SURG                       60   707 973
   470   LILLIBRIDGE CB        J PEDIATR                       71   887 967
   472   DANIELSON GK          JAMA                           195   217 966
   473   TYSON KRT             J PEDIATR SURG                   3   271 968
   474   BANKS PA              GASTROENTEROLOGY                61   382 971
   475   MARBLE A              JOSLINS DIABETES MELLITUS ED          12 971
   476   ROSAN RC              AM J DIS CHILD                 104   625 962
   477   CHAZAN BI             J PEDIATR                       77    86 970
   478   WILMSHURST EG         PEDIATRICS                      55    75 975
   479   HANDWERGER S          N ENGL J MED                   281   451 969
   480   CLODI HP              N ENGL J MED                   282   455 970
   481   MILNER AD             ARCH DIS CHILD                  44   351 969
   482   MILUNSKY A            AM J DIS CHILD                 121    15 971
   483   OPPENHEIMER EH        JOHNS HOPKINS MED J            131   351 972
   483   KJELLMAN NIM          ARCH DIS CHILD                  50   205 975
   484   TURK J                PEDIATRICS                      34    67 964
   485   MEYEROWITZ JH         SOC SCI MED                      1   249 967
   486   TROPAUER A            AM J DIS CHILD                 119   424 970
   487   MCCOLLUM AT           J PEDIATR                       77   571 970
   488   MCCOLLUM AT           AM J PUBLIC HEALTH              61  1335 971
   489   PATTERSON PR          PSYCHOSOCIAL ASPECTS OF CF               973
   490   GAYTON WF             AM J DIS CHILD                 126   856 973
   491   GALDSTONE R           IN: MANGOS JA                        377 973
   492   MEYERS A              AM J DIS CHILD                 129  1011 975
   493   ALLAN JL              AUST PAEDIATR J                 10   136 974
   494   BOYLE IR              IN: MANGOS JA                        385 973
   495   ROSENLUND ML          ANN INTERN MED                  78   959 973
   496   ANON                  GAP CONF REP PROB REPRO PHYSI            975
   497   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   498   DOERSHUK CF           J PEDIATR                       65   677 964
   499   TAUSSIG LM            J PEDIATR                       82   380 973
   500   SHWACHMAN H           PEDIATRICS                      36   689 965
   501   HUANG NN              AM J DIS CHILD                 120   289 970
   502   CUTLER SJ             J CHRON DIS                      8   699 958
   503   MEARNS MB             THORAX                          28   537 973
CT   1   SANTAGNESE PAD        N ENGL J MED                   295   481 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   WILSON GB             PEDIATR RES                     11   986 977
     4   NEUTRA MR             LAB INVEST                      36   535 977
     5   SAKULA A              BR J DIS CHEST                  71   295 977
     6   TOS M                 J LARYNGOL OTOL                 91   827 977
     7   LIEBERMAN J           AM REV RESPIR DIS              116  1047 977
     8   HODSON ME             BR MED J                         1   971 978
     9   KATZNELSON D          ACTA PAEDIATR SCAND             67   607 978
    10   CHIPPS BE             CHEST                           73   519 978
    11   ARVANITAKIS C         GASTROENTEROLOGY                74   932 978
    12   NEUTRA MR             GASTROENTEROLOGY                75   701 978
    13   ROLLA G               ACTA PATH MICROBIOL SCAND (A)   86    83 978
    14   ANDREWS C             ANN INTERN MED                  88   128 978
    15   WILSON GB             J LAB CLIN MED                  92   463 978
    16   ROSENSTEIN BJ         J PEDIATR                       93   261 978
    17   LEMEN RJ              AM REV RESPIR DIS              117   639 978
    18   STERN RC              AM REV RESPIR DIS              117   825 978
    19   STERN RC              AM REV RESPIR DIS              118   821 978
    20   GOTZ M                EUR J PEDIATR                  127   133 978
    21   KLINGER JD            J INFECT DIS                   138    49 978
    22   STERN RC              JAMA                           239  2676 978
    23   ROSENSTEIN BJ         JAMA                           240  1987 978
    24   GRAHAM WGB            N ENGL J MED                   299   624 978
    25   SACHDEV GP            BIOCHIM BIOPHYS ACTA           536   184 978
    26   BOAT TF               ACS SYMPOSIUM SERIES          1978   108 978
    27   HOSLI P               LANCET                           2   543 979
    28   MICHALSEN H           MONOGR PAEDIATR                 10   148 979
    29   GABRIDGE MG           PEDIATR RES                     13    31 979
    30   NAGY EC               PEDIATR RES                     13   729 979
    31   PIVETTA OH            PEDIATR RES                     13  1160 979
    32   SORDELLI DO           LIFE SCI                        24  2003 979
    33   PENNINGTON JE         INFECT IMMUN                    25  1029 979
    34   GURWITZ D             PEDIATR CLIN NORTH AM           26   603 979
    35   BRASFIELD D           PEDIATRICS                      63    24 979
    36   SANTAGNESE PAD        AM J MED                        66   121 979
    37   KOLLBERG H            ACTA PAEDIATR SCAND             68   639 979
    38   WOOD RE               SOUTH MED J                     72   189 979
    39   HIRSCHFELD SS         CHEST                           75   351 979
    40   SCANLIN TF            CLIN CHIM ACTA                  91   197 979
    41   SOTER NA              J PEDIATR                       95   197 979
    42   HOSLI P               FEBS LETTERS                   104   271 979
    43   PENNINGTON JE         J INFECT DIS                   140    73 979
    44   KARAS JR              N ENGL J MED                   300   260 979
    45   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
    46   SCANLIN TF            CLIN CHEST MED                   1   424 980
    47   BURDON JGW            MED J AUST                       2    77 980
    48   BERDISCHEWSKY M       PEDIATR RES                     14   830 980
    49   CASSINO RJJ           PEDIATR RES                     14  1212 980
    50   ROULET M              PEDIATR RES                     14  1360 980
    51   THOMASSEN MJ          PEDIATR RES                     14   715 980
    52   WILL PC               PEDIATR RES                     14  1245 980
    53   LOPEZCORELLA E        PATOLOGIA (MEXICO CITY)         18   167 980
    54   SACHDEV GP            BIOCHEM MED                     24    82 980
    55   PIVETTA OH            LIFE SCI                        26  1349 980
    56   WOODS DE              INFECT IMMUN                    30   694 980
    57   BATTISTA SP           ARCH ENVIRON HEALTH             35   239 980
    58   HODSON ME             THORAX                          35   801 980
    59   ORMEROD LP            THORAX                          35   768 980
    60   CHRYMKO M             AM J HOSP PHARM                 37   713 980
    61   PRIMOSCH RE           ORAL SURG                       50   301 980
    62   BRUETON MJ            ARCH DIS CHILD                  55   348 980
    63   MARTIN AJ             ARCH DIS CHILD                  55   604 980
    64   WILSON GB             J CLIN INVEST                   66  1010 980
    65   ROSENBERG DM          AM J MED                        68   898 980
    66   DAVIS PB              AM J MED                        69   643 980
    67   SANDERS JS            CHEST                           77   226 980
    68   ANDERSEN J            J PEDIATR                       96   943 980
    69   BOXERBAUM B           J PEDIATR                       96   689 980
    70   BEAUDRY PH            J PEDIATR                       97   144 980
    71   MOSS RB               AM REV RESPIR DIS              121    23 980
    72   STERN RC              AM J DIS CHILD                 134   267 980
    73   WIENTZEN R            AM J DIS CHILD                 134  1134 980
    74   BALTIMORE RS          J INFECT DIS                   141   238 980
    75   ROSENSTEIN BJ         JOHNS HOPKINS MED J            147   188 980
    76   MATTHEWS WJ           N ENGL J MED                   302   245 980
    77   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    78   FICK RB               CLIN CHEST MED                   2    91 981
    79   REYNOLDS HY           CLIN CHEST MED                   2   103 981
    80   ZACH MS               LANCET                           2  1201 981
    81   REED MD               PEDIATR RES                     15  1234 981
    82   SANDERSON MJ          PEDIATR RES                     15   219 981
    83   FRYDMAN MI            AUST PAEDIATR J                 17    35 981
    84   PASSERO MA            CLIN PEDIATR                    20   264 981
    85   KIRBY LT              CLIN CHEM                       27   678 981
    86   PIVETTA OH            LIFE SCI                        28  2207 981
    87   BOWMAN BH             HUM HERED                       31   248 981
    88   BLACKWOOD LL          INFECT IMMUN                    32   443 981
    89   RYLEY HC              J CLIN PATHOL                   34   179 981
    90   RUTLAND J             THORAX                          36   654 981
    91   BELL L                J CAN DIET ASSOC                42    62 981
    92   DROTAR D              PEDIATRICS                      67   338 981
    93   BUREAU MA             PEDIATRICS                      68   187 981
    94   FICK RB               J CLIN INVEST                   68   899 981
    95   PENNINGTON JE         J CLIN INVEST                   68  1140 981
    96   WILSON GB             J CLIN INVEST                   68   171 981
    97   TEGNER H              ACTA PAEDIATR SCAND             70   629 981
    98   JACOBS WH             AM J GASTROENTEROL              76   342 981
    99   LAMBERT JR            GASTROENTEROLOGY                80   169 981
   100   PARK RW               GASTROENTEROLOGY                81  1143 981
   101   MARKS MI              J PEDIATR                       98   173 981
   102   HYATT AC              J PEDIATR                       99   307 981
   103   LLOYDSTILL JD         J PEDIATR                       99   580 981
   104   MOSS RB               J PEDIATR                       99   215 981
   105   SORENSEN RU           AM REV RESPIR DIS              123    37 981
   106   FRIEDMAN PJ           AM J ROENTGENOL                136  1131 981
   107   BRESLOW JL            N ENGL J MED                   304     1 981
   108   COLTEN HR             N ENGL J MED                   304   831 981
   109   MACONE AB             N ENGL J MED                   304  1445 981
   110   KNOWLES M             N ENGL J MED                   305  1489 981
   111   ROY CC                J PEDIATR GASTROENTEROL NUTR     1   469 982
   112   SORSCHER EJ           LANCET                           1   368 982
   113   STERN RC              LANCET                           1  1401 982
   114   PEDERSEN M            CLIN OTOLARYNGOL                 7   373 982
   115   WILSON GB             MED HYPOTHESES                   8   527 982
   116   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
   117   VANDERPUT JM          PEDIATR RADIOL                  12    57 982
   118   SING CF               AM J MED GENET                  13   179 982
   119   HENRY RL              AUST PAEDIATR J                 18   110 982
   120   HENRY RL              AUST PAEDIATR J                 18    43 982
   121   OHMAN DE              INFECT IMMUN                    37   662 982
   122   HOOKE AM              INFECT IMMUN                    38   136 982
   123   WINNIE GB             INFECT IMMUN                    38  1088 982
   124   KUHN RJ               AM J HOSP PHARM                 39   308 982
   125   MOSS RB               CLIN EXP IMMUNOL                47   301 982
   126   PITCHERWILMOTT RW     ARCH DIS CHILD                  57   577 982
   127   KANG SB               ANESTH ANALG CLEVE              61   793 982
   128   HILLEMEIER AC         PEDIATRICS                      69   325 982
   129   VOSS MJ               J ALLERGY CLIN IMMUNOL          69   536 982
   130   MOSS AJ               PEDIATRICS                      70   728 982
   131   YARNAL JR             POSTGRAD MED                    71   195 982
   132   SCOGGIN CH            CHEST                           82   394 982
   133   STERN RC              GASTROENTEROLOGY                82   707 982
   134   BENDIG DW             J PEDIATR                      100   536 982
   135   CORKEY CWB            J PEDIATR                      100   420 982
   136   GRAFT DF              J PEDIATR                      100   497 982
   137   KELLY HB              J PEDIATR                      100   318 982
   138   NOLAN G               J PEDIATR                      101   626 982
   139   SPEERT DP             J PEDIATR                      101   227 982
   140   BRIDGES MA            CLIN CHIM ACTA                 118    33 982
   141   GRAFT DF              AM REV RESPIR DIS              125   540 982
   142   TUMMLER B             CLIN CHIM ACTA                 125   219 982
   143   ASHER MI              AM REV RESPIR DIS              126   855 982
   144   LARSEN GL             AM REV RESPIR DIS              126   306 982
   145   REDDING GJ            AM REV RESPIR DIS              126    31 982
   146   RIVERA M              AM REV RESPIR DIS              126   833 982
   147   ROSSMAN CM            AM REV RESPIR DIS              126   131 982
   148   STERN RC              AM J DIS CHILD                 136  1067 982
   149   KRAEMER R             EUR J PEDIATR                  138   172 982
   150   NORDBRING F           ARCH INTERN MED                142  2010 982
   151   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982
   152   DOUGLAS WHJ           ANAT REC                       202   285 982
   153   KATZ SM               JAMA                           248  2284 982
   154   FARRELL PM            ANN NY ACAD SCI                393    96 982
   155   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
   156   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
   157   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
   158   ANON                  LANCET                           2   257 983
   159   PARSONS HG            J PEDIATR GASTROENTEROL NUTR     2    44 983
   160   ZIMAKOFF J            J HOSP INFECT                    4    31 983
   161   PENNINGTON JE         REV INFECT DIS                   5  S852 983
   162   KERCSMAR CM           J ANTIMICROB CHEMOTHER          12   289 983
   163   HARD R                TISSUE CELL                     15   217 983
   164   PENKETH ARL           J MED MICROBIOL                 16   401 983
   165   BALTIMORE RS          PEDIATR RES                     17   952 983
   166   ORENSTEIN DM          PEDIATR RES                     17   267 983
   167   SHIFFMAN ML           PEDIATR RES                     17   486 983
   168   BRYAN LE              J CLIN MICROBIOL                18   276 983
   169   WILL PC               TOXICOL LETT                    18   307 983
   170   FICK RB               BULL EUR PHYSIOPATH RESP        19   151 983
   171   JACQUOT J             BULL EUR PHYSIOPATH RESP        19   453 983
   172   REID L                INT REV EXP PATHOL              24   335 983
   173   BRECHER DB            AM FAM PHYSICIAN                28   187 983
   174   MASARYK TJ            DIG DIS SCI                     28   874 983
   175   RODMAN HM             DIABETES                        32   505 983
   176   PHELAN MS             CLIN RADIOL                     34   573 983
   177   DAVIS PB              J CHRON DIS                     36   269 983
   178   KLINGER JD            INFECT IMMUN                    39  1377 983
   179   DORING G              INFECT IMMUN                    42   197 983
   180   LEHRER RI             INFECT IMMUN                    42    10 983
   181   GUIDOTTI TL           RESPIRATION                     44   351 983
   182   FARRELL PM            J DENT CHILD                    50   385 983
   183   RUTLAND J             EUR J RESPIR DIS                64   451 983
   184   SORENSEN RU           EUR J RESPIR DIS                64   524 983
   185   KNOWLES M             J CLIN INVEST                   71  1410 983
   186   SINNEMA G             ACTA PAEDIATR SCAND             72   427 983
   187   LUKIE BE              J LAB CLIN MED                 101   426 983
   188   DAVIS PB              J PEDIATR                      102   177 983
   189   ROSARIO NA            J PEDIATR                      102   163 983
   190   DAVIS PB              AM REV RESPIR DIS              128    34 983
   191   RUTLAND J             AM REV RESPIR DIS              128  1030 983
   192   WALLACE JM            AM REV RESPIR DIS              128  1077 983
   193   MCCARTHY VP           AM J DIS CHILD                 137   802 983
   194   PORTER DK             ARCH INTERN MED                143   287 983
   195   DORING G              J INFECT DIS                   147   744 983
   196   PIER GB               J INFECT DIS                   147   494 983
   197   KOHLSCHUTTER A        FEBS LETTERS                   155   223 983
   198   BOUCHER RC            LUNG                           161     1 983
   199   KNOWLES MR            SCIENCE                        221  1067 983
   200   BRIDGES MA            ANN NY ACAD SCI                421   360 983
   201   SLOMIANY A            BIOCHIM BIOPHYS ACTA           750   253 983
   202   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983
   203   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983
   204   KATZ S                CELL CALC                        5   421 984
   205   WOOD RE               SEM RESPIR MED                   5   336 984
   206   VANDERMEER JWM        REV INFECT DIS                   6   107 984
   207   YOUNG LS              REV INFECT DIS                   6  S769 984
   208   WEIFFENBACH JM        CHEM SENSES                      9   193 984
   209   SHRYOCK TR            CURRENT MICROBIOL               10   323 984
   210   KOTTKE TE             PREV MED                        13    47 984
   211   BLYTHE SA             CLIN BIOCHEM                    17   277 984
   212   BOYD RL               PEDIATR RES                     18  1028 984
   213   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984
   214   SPEERT DP             PEDIATR RES                     18   431 984
   215   MCKEVITT AI           J CLIN MICROBIOL                19   291 984
   216   TANNENBAUM CS         ANTIMICROB AGENTS CHEMOTHER     25   673 984
   217   SCHIFF JB             ANTIMICROB AGENTS CHEMOTHER     26     1 984
   218   WILSON GB             CLIN GENET                      26   331 984
   219   MCCLURE HM            ADV VET SCI COMP MED            28   267 984
   220   MATTHEWS LW           PEDIATR CLIN NORTH AM           31   133 984
   221   SMITH MJ              THORAX                          39   369 984
   222   WELLS AL              J FOOD NUTR                     41    65 984
   223   SPEERT DP             INFECT IMMUN                    43  1006 984
   224   ORENSTEIN DM          J APPL PHYSIOL                  57   408 984
   225   HODSON ME             POSTGRAD MED J                  60   225 984
   226   JACKSON AH            EUR J RESPIR DIS                65   114 984
   227   LEWIS MI              S AFR MED J                     65   641 984
   228   FARRELL PM            PEDIATRICS                      73   115 984
   229   LINDEMANS J           ACTA PAEDIATR SCAND             73   768 984
   230   FICK RB               J CLIN INVEST                   74   236 984
   231   KLINGER JD            J CLIN INVEST                   74  1669 984
   232   PENNINGTON JE         AM J MED                        76    34 984
   233   ROSENSTEIN BJ         SOUTH MED J                     77  1383 984
   234   EFTHIMIOU J           BR J DIS CHEST                  78   299 984
   235   DAVIS PB              CHEST                           85   802 984
   236   THOMASSEN MJ          J PEDIATR                      104   352 984
   237   WHEELER WB            J PEDIATR                      104   695 984
   238   HENKE KG              AM REV RESPIR DIS              129   708 984
   239   WALL MA               AM REV RESPIR DIS              129   557 984
   240   PIER GB               J IMMUNOL                      133   734 984
   241   SHERBROCKCOX V        CARBOHYD RES                   135   147 984
   242   GILLARD BK            AM J DIS CHILD                 138   577 984
   243   HANDELSMAN DJ         N ENGL J MED                   310  1670 984
   244   ROOMANS GM            ANN NY ACAD SCI                428   121 984
   245   AUERBACH HS           LANCET                           2   686 985
   246   KLINGER JD            DIAGN MICROBIOL INFECT DIS       3   149 985
   247   FOULSTON C            J PEDIATR GASTROENTEROL NUTR     4   143 985
   248   GOLD R                PEDIATR INFECT DIS               4   172 985
   249   KUHN RJ               CLIN PHARMACY                    4   555 985
   250   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985
   251   DAVIS PB              SEM RESPIR MED                   6   261 985
   252   LESTER LA             SEM RESPIR MED                   6   285 985
   253   MISCHLER EH           SEM RESPIR MED                   6   271 985
   254   ORENSTEIN DM          SEM RESPIR MED                   6   252 985
   255   NEAL JL               EVOLUTIONARY THEORY              7   153 985
   256   SHRYOCK TR            CURRENT MICROBIOL               12    91 985
   257   SWOBODNIK W           J CLIN ULTRASOUND               13   469 985
   258   TOMASHEFSKI JF        HUM PATHOL                      16   253 985
   259   FARRELL PM            PEDIATR RES                     19   104 985
   260   FRASER GL             DRUG INTEL CLIN PHARM           19   757 985
   261   KNOWLES MR            PEDIATR RES                     19   676 985
   262   FINKELSTEIN SM        METH INF MED                    24   192 985
   263   REED MD               ANTIMICROB AGENTS CHEMOTHER     27   583 985
   264   IRVIN RT              CAN J MICROBIOL                 31   268 985
   265   REYNOLDS HY           DISEASE A MONTH                 31     1 985
   266   BARDON A              RES COMMUN CHEM PATH PHARM      47   449 985
   267   BLACKWOOD LL          INFECT IMMUN                    47   840 985
   268   ITANO M               RESPIRATION                     47   220 985
   269   DORING G              INFECT IMMUN                    49   557 985
   270   SORDELLI DO           INFECT IMMUN                    49   265 985
   271   LUZAR MA              INFECT IMMUN                    50   577 985
   272   BHAGAT RG             ANN ALLERGY                     54   297 985
   273   KOMIYAMA K            ORAL SURG                       59   590 985
   274   WINKLER U             KLIN WSCHR                      63   490 985
   275   COALSON JJ            BR J EXP PATHOL                 66   205 985
   276   SORDELLI DO           EUR J RESPIR DIS                66    31 985
   277   HAPONIK EF            EUR J RESPIR DIS                67   381 985
   278   SORDELLI DO           EUR J RESPIR DIS                67   118 985
   279   RAVIA Y               HUM GENET                       71   294 985
   280   CEDER O               ACTA PAEDIATR SCAND             74   102 985
   281   COLLINS JE            ACTA PAEDIATR SCAND             74   423 985
   282   SCOGGIN CH            POSTGRAD MED                    77   243 985
   283   BLUMER JL             AM J MED                        79    37 985
   284   STUTTS MJ             PROC NAT ACAD SCI USA           82  6677 985
   285   COTTON DJ             CHEST                           87   217 985
   286   STOKES DC             CHEST                           87   785 985
   287   BROWN DT              ANN OTOL RHINOL LARYNGOL        94     3 985
   288   TABLAN OC             J PEDIATR                      107   382 985
   289   TOMASHEFSKI JF        ARCH PATHOL LAB MED            109   910 985
   290   THOMASSEN MJ          AM REV RESPIR DIS              131   791 985
   291   ZACH MS               AM REV RESPIR DIS              131   537 985
   292   SZEINBERG A           AM REV RESPIR DIS              132   766 985
   293   TOURNIER JM           AM REV RESPIR DIS              132   524 985
   294   WISNIESKI JJ          AM REV RESPIR DIS              132   770 985
   295   DALEY L               J IMMUNOL                      134  3089 985
   296   BROWN J               AM J DIS CHILD                 139   836 985
   297   WILMOTT RW            AM J DIS CHILD                 139   669 985
   298   HILL DJS              MED J AUST                     143   230 985
   299   HUGHES RL             ACTA PAEDIATR SCAND SUPPL 317 1985    42 985
   300   OBERWALDNER B         PEDIATR PULMONOL                 2   358 986
   301   MCCARTHY VP           PEDIATR INFECT DIS               5   256 986
   302   OHMAN DE              EUR J CLIN MICROBIOL             5     6 986
   303   FRASER IM             CLIN CHEST MED                   7   131 986
   304   KNOWLES MR            CLIN CHEST MED                   7   285 986
   305   LEIGH MW              EXP LUNG RES                    10   153 986
   306   KOHLER D              ATEMWEGS LUNGENKRANKH           12   358 986
   307   FRIEND PA             J INFECT                        13    55 986
   308   PADGETT PJ            CURRENT MICROBIOL               14   187 986
   309   PEDERSEN SS           J ANTIMICROB CHEMOTHER          17   505 986
   310   BALTIMORE RS          PEDIATR RES                     20  1085 986
   311   STUTTS MJ             PEDIATR RES                     20  1316 986
   312   MACGEORGE J           J MED MICROBIOL                 21   331 986
   313   SHRYOCK TR            J CLIN MICROBIOL                23   513 986
   314   KRIEG DP              J CLIN MICROBIOL                24   986 986
   315   MAHANEY MC            ARCH ORAL BIOL                  31   363 986
   316   WARWICK WJ            CLIN CHEM                       32   850 986
   317   JACOBSEN LE           J CAN ASSOC RADIOL              37    17 986
   318   FINKELSTEIN SM        J CHRON DIS                     39   195 986
   319   HOIBY N               ANNU REV MICROBIOL              40    29 986
   320   MAHANEY MC            HUM BIOL                        58   445 986
   321   DORING G              CLIN EXP IMMUNOL                64   597 986
   322   RODMAN HM             MEDICINE                        65   389 986
   323   KOHLER D              EUR J RESPIR DIS                69   319 986
   324   MATTHYS H             EUR J RESPIR DIS                69   311 986
   325   BECK R                ACTA PAEDIATR SCAND             75   639 986
   326   KURLAND G             PEDIATRICS                      78  1097 986
   327   ORENSTEIN DM          PEDIATRICS                      78   621 986
   328   KUZEMKO JA            J ROY SOC MED                   79     2 986
   329   ROSENSTEIN BJ         SOUTH MED J                     79   319 986
   330   RUBIO TT              AM J MED                        81    73 986
   331   GOWEN CW              J PEDIATR                      108   517 986
   332   SMITH AL              J PEDIATR                      108   866 986
   333   TOMASHEFSKI JF        AM REV RESPIR DIS              133   535 986
   334   GOLDSTEIN W           AM REV RESPIR DIS              134    49 986
   335   MENTZ WM              AM REV RESPIR DIS              134   938 986
   336   STUTTS MJ             AM REV RESPIR DIS              134    17 986
   337   ROSENSTEIN BJ         AM J DIS CHILD                 140   966 986
   338   KRUHLAK RT            WEST J MED                     145   196 986
   339   PLOPPER CG            ANAT EMBRYOL                   174   167 986
   340   TRIBBLE CG            ANN SURG                       204   677 986
   341   DASGUPTA MK           J CLIN IMMUNOL                   7    51 987
   342   SPEERT DP             J HOSP INFECT                    9    11 987
   343   SHRYOCK TR            CURRENT MICROBIOL               14   251 987
   344   KOMIYAMA K            CAN J MICROBIOL                 33    27 987
   345   NIELSEN OH            CURR THER RES CLIN EXP          41   367 987
   346   HOOKE AM              INFECT IMMUN                    55    99 987
   347   COTTON CU             J CLIN INVEST                   79    80 987
   348   HENDERSON WR          J ALLERGY CLIN IMMUNOL          79   543 987
   349   NUTMAN J              J IMMUNOL                      138  3481 987
   350   DERETIC V             J BACTERIOL                    169   351 987
   351   EMMETT M              PROC SOC EXP BIOL MED          184    74 987

PN 76016
RN 00371 
AN 76182691
AU Isenberg-J-N.  Sahlstrom-S-J.  Sharp-H-L.
TI The glycoprotein-degrading potential of peripheral leukocytes in
   cystic fibrosis.
SO Am-Rev-Respir-Dis. 1976 Apr. 113(4). P 567-9.
MJ CYSTIC-FIBROSIS: bl.  GLYCOPROTEINS: me.  LEUKOCYTES: en.
MN ACETYLGLUCOSAMINIDASE: bl.  ADOLESCENCE.  ADULT.
   ASPARTYLGLUCOSYLAMINASE: bl.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: en.
   FEMALE.  FUCOSIDASE: bl.  GALACTOSIDASES: bl.  HUMAN.  IN-VITRO.
   LYSOSOMES: en.  MALE.  MANNOSIDASES: bl.  SUPPORT-U-S-GOVT-P-H-S.
AB In this study, the potential problems and discrepancies in cill
   culture techniques were avoided by isolating leukocytes from the
   peripheral blood of patients with cystic fibrosis and healthy human
   volunteers and preparing homogenates to determine the specific
   activities of 5 lysosomal enzymes involved in the degradation of
   glycoproteins. Four lysosomal hydrolases involved in the breakdown of
   the carbohydrate side chain were assayed using artificial substrates.
   The fifth enzyme, aspartylglucosamine amido hydrolase, which cleaves
   the linkage between this side chain and the peptide backbone, was
   assayed with natural substrate. No differences in enzyme activities
   between the 2 leukocyte sources were observed. Because no enzyme
   activities were deficient and no compensatory increases were noted,
   we concluded that the thick, glycoprotein-rich, exocrine secretions
   in cystic fibrosis cannot be attributed to a defect in their
   catabolism.
RF 001   DISCHE Z              ANN NY ACAD SCI                 93   526 962
   002   KNAUFF RE             CLIN CHIM ACTA                  19   245 968
   004   BARRETT AJ            IN: DINGLE JT                        116 973
   005   LOWRY OH              J BIOL CHEM                    193   265 951
   006   WIESMANN UN           J PEDIATR                       77   685 970
   007   KRAUS I               PEDIATRICS                      47  1010 971
   008   GIBBS GE              SCIENCE                        167   993 970
   009   RUSSELL SB            J MED GENET                      8   441 971
   010   BUTTERWORTH J         CLIN CHIM ACTA                  40   139 972
   011   SOMER H               CLIN CHIM ACTA                  60   219 975
   012   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   013   BUTTERWORTH J         CLIN CHIM ACTA                  56   159 974
CT   1   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     2   MARGOLIES R           PEDIATR RES                     17   931 983

PN 76017
RN 00372 
AN 77085824
AU Corey-M.  Levison-H.  Crozier-D.
TI Five- to seven-year course of pulmonary function in cystic fibrosis.
SO Am-Rev-Respir-Dis. 1976 Dec. 114(6). P 1085-92.
MJ CYSTIC-FIBROSIS: pp.  LUNG: pp.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.
   EXPIRATORY-RESERVE-VOLUME.  FEMALE.  FOLLOW-UP-STUDIES.  HUMAN.
   MALE.  RESPIRATION.  RESPIRATORY-FUNCTION-TESTS.  SEX-FACTORS.
AB The pulmonary function records of 132 patients with cystic fibrosis
   followed for 5 to 7 years were reviewed. Changes in forced vital
   capacity, 1-sec forced expiratory volume, mean forced expiratory flow
   during the middle half of the forced vital capacity, and 1-sec forced
   expiratory volume as a percentage of forced vital capacity were
   examined. There was considerable variation in the rates of change,
   but the general pattern was consistent with a theory of exponential
   decline, mean forced expiratory flow during the middle half of the
   forced vital capacity showing the earliest and most dramatic changes.
   The pulmonary function of 33 patients (25 per cent) remained stable
   or improved throughout follow-up, possibly reflecting mild forms of
   lung disease or the efficacy of therapy. Twenty of these patients (15
   per cent) maintained completely normal pulmonary function. The rate
   of decline in pulmonary function values, with progress of the
   disease, was steeper in the female patients.
RF 001   WARWICK WJ            IN: LAWSON D PROC 5TH INT CF         320 969
   002   HUANG NN              AM J DIS CHILD                 120   289 970
   003   SHWACHMAN H           PEDIATRICS                      46   335 970
   004   DOERSHUK CF           PEDIATRICS                      36   675 965
   005   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   006   TAUSSIG LM            J PEDIATR                       82   380 973
   007   MEARNS MB             THORAX                          28   537 973
   008   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   009   FEATHERBY EA          AM REV RESPIR DIS              102   737 970
   010   EMIRGIL C             AM J MED                        51   504 971
   011   SEELY JE              J APPL PHYSIOL                  36    34 974
   012   HIGGINS MW            AM REV RESPIR DIS              108   258 973
   013   SNEDECOR GW           STATISTICAL METHODS                      967
   014   BATES DV              AM REV RESPIR DIS              108  1043 973
   015   DIENER CF             AM REV RESPIR DIS              111   719 975
CT   1   DAVIDSON GP           J PEDIATR                       93   976 978
     2   MELLIS CM             AM REV RESPIR DIS              117   911 978
     3   ZAPLETAL A            BULL EUR PHYSIOPATH RESP        15   575 979
     4   GURWITZ D             PEDIATR CLIN NORTH AM           26   603 979
     5   KRAEMER R             HELV PAEDIATR ACTA              34   417 979
     6   SANTAGNESE PAD        AM J MED                        66   121 979
     7   MILLIGAN DWA          J PEDIATR                       95    24 979
     8   KRAEMER R             SCHWEIZ MED WOCHENSCHR         109    39 979
     9   SVENONIUS E           RESPIRATION                     40   226 980
    10   RUSSELL NJ            BR J DIS CHEST                  76    35 982
    11   GASKIN K              J PEDIATR                      100   857 982
    12   MCLAUGHLIN FJ         J PEDIATR                      100   863 982
    13   NOLAN G               J PEDIATR                      101   626 982
    14   REDDING GJ            AM REV RESPIR DIS              126    31 982
    15   PARSONS HG            J PEDIATR GASTROENTEROL NUTR     2    44 983
    16   WILMOTT RW            ARCH DIS CHILD                  58   835 983
    17   WELLS AL              J FOOD NUTR                     41    65 984
    18   LEWIS MI              S AFR MED J                     65   641 984
    19   WHEELER WB            J PEDIATR                      104   695 984
    20   WANG EEL              N ENGL J MED                   311  1653 984
    21   DAVIS PB              SEM RESPIR MED                   6   261 985
    22   LAMBERTY JM           ANAESTHESIA                     40   448 985
    23   WIESEMANN HG          MONATSSCHR KINDERHEILKD        133   726 985
    24   HUGHES RL             ACTA PAEDIATR SCAND SUPPL 317 1985    42 985
    25   GIBSON RA             J PEDIATR GASTROENTEROL NUTR     5   408 986
    26   MILLER RW             MED PEDIATR ONCOL               14   202 986
    27   RUSH PJ               SEM ARTHRITIS RHEUM             15   213 986
    28   PRICE JF              J ROY SOC MED                   79    10 986
    29   WANG EEL              PEDIATR INFECT DIS J             6   256 987
    30   ANDREASSON B          ACTA PAEDIATR SCAND             76    70 987

PN 76018
RN 00373 
AN 77132888
AU Yaffe-S-J.
TI Developmental factors influencing interactions of drugs.
SO Ann-NY-Acad-Sci. 1976. 281. P 90-7.
MJ AGING.  DRUGS: me.
MN BLOOD-PROTEINS: me.  CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: me.
   FEMALE.  FETUS: me.  GASTROINTESTINAL-SYSTEM: me.  HUMAN.
   HYPERBILIRUBINEMIA: me.  INFANT.  INFANT-NEWBORN.
   INFANT-NEWBORN-DISEASES: me.  INTESTINAL-ABSORPTION.  PREGNANCY.
   PROTEIN-BINDING.  SUPPORT-U-S-GOVT-P-H-S.
EX The author has attempted to summarize the current state of knowledge
   regarding dispositional processes in infants and children of various
   ages.  The traditional processes of absorption, distribution,
   metabolism, and excretion are described not only in newborn infants
   but also in infants and children of other age groups.  Knowledge of
   the effects of age and the effects of diseases, which are often
   unique to each stage of postnatal development, upon drug action and
   disposition is a vital and necessary prerequisite to a discussion of
   interactions of drugs of abuse in the pediatric population.  It is
   essential that the developmental status of the host be taken into
   consideration when examining interactions of drugs in infants and
   children.  The mechanisms of interactions are similar to those seen
   in the adult patient.  The developmental status of the pediatric
   patient also plays a significant role in the manifestations of
   disease seen in sick infants and children.  These are often profound
   and consequently may play a major role in modifying drug action and
   interaction.
RF 001   JUSKO WJ              PEDIATRICS                      45   945 970
   002   KRASNER J             ANN NY ACAD SCI                226   101 973
   003   RANE A                J PEDIATR                       78   877 971
   004   WINSBERG BG           IN: FORREST IS                           974
   005   CIANCIO SG            J PERIODONTOL                   43   411 972
   006   HOPPEL CC             IN: MORSELLI S                           975
   007   STERN L               AM J DIS CHILD                 120    26 970
   009   ALVARES AP            CLIN PHARMACOL THER             17   179 975
   010   JUSKO WJ              PEDIATRICS                      56  1038 975
   011   REIDENBERG MM         ANN NY ACAD SCI                281     1 976
   012   HURWITZ A             ANN NY ACAD SCI                281    98 976

PN 76019
RN 00374 
AN 77064517
AU Boat-T-F.  Cheng-P-W.  Iyer-R-N.  Carlson-D-M.  Polony-I.
TI Human respiratory tract secretion.  Mucous glycoproteins of
   nonpurulent tracheobronchial secretions, and sputum of patients with
   bronchitis and cystic fibrosis.
SO Arch-Biochem-Biophys. 1976 Nov. 177(1). P 95-104.
MJ BRONCHITIS: me.  CYSTIC-FIBROSIS: me.  GLYCOPROTEINS.  MUCUS: se.
   RESPIRATORY-SYSTEM: se.  SPUTUM: se.
MN ADOLESCENCE.  AMINO-ACIDS: an.  CASE-REPORT.  FEMALE.  FUCOSE: an.
   GALACTOSE: an.  GLYCOPROTEINS: se.  HEXOSAMINES: an.  HUMAN.
   SIALIC-ACIDS: an.  SULFURIC-ACIDS: an.  SUPPORT-U-S-GOVT-P-H-S.
AB Mucous glycoproteins were isolated by agarose gel filtration from
   nonpurulent tracheobronchial secretions and purulent sputum which
   had been reduced, carboxymethylated and, in the case of purulent
   secretions, treated with deoxyribonuclease.  The solubilized and
   purified glycoproteins were fractioned on diethylaminoethyl
   cellulose into two major (I, II) and two minor (Ia, III) blood group
   active components.  Components I and II had similar carbohydrate and
   amino acid compositions which were typical for human blood group
   substances.  These two components did differ in several respects.
   Component I contained 1.4-2.6% sulfate and did not inhibit influenza
   virus hemagglutination while component II contained 7.1-7.8% sulfate
   and was a potent inhibitor of virus hemagglutination.  Component II
   also migrated more rapidly on sodium dodecyl sulfate-3.3% acrylamide
   gel electrophoresis.  Components I and II in purulent secretions
   displayed only minor compositional differences from their
   counterparts in nonpurulent secretions.  Component II was more
   abundant in two sputum samples from subjects with cystic fibrosis
   than in purulent bronchitic secretions or in nonpurulent secretions.
RF 001   YEAGER H JR           AM J MED                        50   493 971
   002   TOREMALM NG           ACTA OTOLARYNGOL STOCKH SUPPL  158    43 960
   003   BISERTE G             EXP ANNU BIOCHIM MED            24    85 963
   004   HAVEZ R               CLIN CHIM ACTA                  17   281 967
   005   HAVEZ R               CLIN CHIM ACTA                  17   463 967
   006   HAVEZ R               BULL SOC CHIM BIOL              51   245 969
   007   HAVEZ R               IN: PEETERS H                   16   343 968
   008   ROUSSEL P             CLIN CHIM ACTA                  36   315 972
   009   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   010   DEGAND P              BULL PHYSIOPATH RESPIR NANCY     9   199 973
   011   MASSON PL             BIOCHIM BIOPHYS ACTA           111   466 965
   012   SCHULTZE HE           MOLECULAR BIOL OF HUMAN PROTE    1       966
   013   ROUSSEL P             J BIOL CHEM                    250  2114 975
   014   ROBERTS GP            EUR J BIOCHEM                   50   265 974
   015   LAMBLIN G             BIOCHIM BIOPHYS ACTA           322   372 973
   016   BROGAN TD             BIOCHEM J                       71   125 959
   017   BISERTE G             LILLE MED                        6    52 961
   018   BUKANTZ SC            J ALLERGY                       29    29 958
   019   BROGAN TD             BR J EXP PATHOL                 41   288 960
   020   LOWRY OH              J BIOL CHEM                    193   265 951
   021   BURTON K              BIOCHEM J                       62   315 956
   022   ANTONOPOULOS CA       ACTA CHEM SCAND                 16  1521 962
   023   COTLOVE E             J LAB CLIN MED                  51   461 958
   024   DUBOIS M              ANAL CHEM                       28   350 956
   025   BOAT TF               AM REV RESPIR DIS              110   428 974
   026   DAVIS BJ              ANN NY ACAD SCI                121   404 964
   027   REISFELD RA           NATURE                         195   281 962
   028   WEBER K               METHODS ENZYMOL                 26     3 972
   029   GLOSSMAN H            J BIOL CHEM                    246  6339 971
   030   KABAT EA              EXPERIMENTAL IMMUNOCHEMISTRY             961
   031   PRICE VE              J BIOL CHEM                    171   477 947
   032   IYER RN               ARCH BIOCHEM BIOPHYS           142   101 971
   033   ROVIS L               BIOCHEMISTRY                    12  1955 973
   034   LUCAS AM              ARCH OTOLARYNGOL                20   518 934
   035   SPIRO RG              ADV PROT CHEM                   27   349 973
   036   GOTTSCHALK A          IN: GOTTSCHALK A                 2   810 972
   037   WATKINS WM            IN: GOTTSCHALK A                     830 972
   038   HOLDEN KG             BIOCHEMISTRY                    10  3105 971
   039   PITT-RIVERS R         BIOCHEM J                      109   825 968
   040   SPRINGER GF           PROC NAT ACAD SCI USA           64   635 969
   041   SNARY D               BIOCHEM BIOPHYS RES COMMUN      40   844 970
   042   MOORE S               J BIOL CHEM                    238   235 963
   043   CRESTFIELD AM         J BIOL CHEM                    238   622 963
   044   JONES R               HISTOCHEM J                      5    19 973
   045   DEGAND P              BIOCHIM BIOPHYS ACTA           320   318 973
   046   NEUBERGER A           IN: GOTTSCHALK A                 1   474 972
   047   KEAL EE               THORAX                          27   643 972
   048   CARLSON DM            IN: AMINOFF D                        229 970
   049   LEV R                 AM J PATHOL                     46    23 965
   050   LAMB D                BR J DIS CHEST                  66   239 972
CT   1   BOAT TF               PEDIATR RES                     11   977 977
     2   CREETH JM             BIOCHEM J                      167   557 977
     3   GALLAGHER JT          TRENDS BIOCHEM SCI               3    38 978
     4   ALHADEFF JA           CLIN GENET                      14   189 978
     5   FORSTNER JF           DIGESTION                       17   234 978
     6   MARTIN GP             GUT                             19   103 978
     7   CLAMP JR              BR MED BULL                     34    25 978
     8   CREETH JM             BR MED BULL                     34    17 978
     9   CHENG PW              ANAL BIOCHEM                    85   276 978
    10   ROUSSEL P             LUNG                           154   241 978
    11   SACHDEV GP            BIOCHIM BIOPHYS ACTA           536   184 978
    12   BOAT TF               BIOCHIM BIOPHYS ACTA           540   127 978
    13   MAWHINNEY TP          PEDIATR RES                     13   760 979
    14   FELDHOFF PA           BIOCHEMISTRY                    18  2430 979
    15   ROSE MC               BIOCHEMISTRY                    18  4030 979
    16   LAMBLIN G             BIOCHIMIE                       61    23 979
    17   KAIZU T               COMP BIOCHEM PHYSIOL (B)        62   195 979
    18   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    19   HERZBERG MC           J BIOL CHEM                    254  1487 979
    20   LIAO TH               BIOCHIM BIOPHYS ACTA           577   442 979
    21   CLARK JN              BIOCHIM BIOPHYS ACTA           588   357 979
    22   SACHDEV GP            BIOCHEM MED                     24    82 980
    23   LAST JA               ENVIRON HEALTH PERSPECT         35   131 980
    24   BOAT TF               FED PROC                        39  3067 980
    25   SHELHAMER JH          J CLIN INVEST                   66  1400 980
    26   MAWHINNEY TP          ANAL BIOCHEM                   101   112 980
    27   ESTEP JA              J APPL PHYSIOL                  50   383 981
    28   CHENG PW              ANAL BIOCHEM                   117   301 981
    29   BROWN DT              AM REV RESPIR DIS              124   285 981
    30   SHERMAN JM            AM REV RESPIR DIS              124   476 981
    31   BHASKAR KR            J BIOL CHEM                    256  7583 981
    32   HOUDRET N             BIOCHIM BIOPHYS ACTA           668   413 981
    33   ADLER KB              EXP LUNG RES                     3    69 982
    34   TABAK LA              J ORAL PATHOL                   11     1 982
    35   BLITZER MG            PEDIATR RES                     16   203 982
    36   BOAT TF               PEDIATR RES                     16   792 982
    37   WOODWARD H            BIOCHEMISTRY                    21   694 982
    38   WILLIAMS IP           EUR J RESPIR DIS                63   510 982
    39   SNYDER CE             CARBOHYD RES                   105    87 982
    40   GALLAGHER JT          ADV EXP MED BIOL               144   335 982
    41   REID L                ADV EXP MED BIOL               144   369 982
    42   MIAN N                BIOCHEM J                      201   533 982
    43   DOUGLAS WHJ           ANAT REC                       202   285 982
    44   CHENG PW              J BIOL CHEM                    257  6251 982
    45   REID L                EXP LUNG RES                     4   157 983
    46   FRATES RC             PEDIATR RES                     17    30 983
    47   MARGOLIES R           PEDIATR RES                     17   931 983
    48   WESLEY A              PEDIATR RES                     17    65 983
    49   VERDUGO P             BIORHEOLOGY                     20   223 983
    50   BLOOMFIELD VA         BIOPOLYMERS                     22  2141 983
    51   KOHLER D              KLIN WSCHR                      61   243 983
    52   CHACE KV              CLIN CHIM ACTA                 132   143 983
    53   HOUDRET N             BIOCHIM BIOPHYS ACTA           758    24 983
    54   WOOD RE               SEM RESPIR MED                   5   336 984
    55   SHELHAMER JH          EXP LUNG RES                     7   149 984
    56   ROUSSEL P             BIOCHEM SOC TRANS               12   617 984
    57   LLOYD C               IN VITRO                        20   416 984
    58   WINGERT WE            BIOCHEMISTRY                    23   690 984
    59   VISHWANATH S          INFECT IMMUN                    45   197 984
    60   SPICER SS             ENVIRON HEALTH PERSPECT         55   193 984
    61   STELANDER M           EUR J RESPIR DIS                65     5 984
    62   KALINER M             J ALLERGY CLIN IMMUNOL          73   318 984
    63   BASBAUM CB            PROC NAT ACAD SCI USA           81  4419 984
    64   JAHNKE GD             PROC NAT ACAD SCI USA           81   578 984
    65   VERDUGO P             CIBA FOUND SYMP                109   212 984
    66   TABAK LA              CARBOHYD RES                   135   117 984
    67   BHASKAR KR            EXP LUNG RES                     9   289 985
    68   MIKKELSEN A           INT J BIOMEDICAL COMPUT         17   215 985
    69   RAM BP                CRC CRIT REV BIOCHEM            17   257 985
    70   CARLSTEDT I           ESSAYS BIOCHEM                  20    40 985
    71   CHACE KV              BIOCHEMISTRY                    24  7334 985
    72   MIKKELSEN A           BIOPOLYMERS                     24  1683 985
    73   REDDY MS              J DENT RES                      64    33 985
    74   CHENG PW              BIOCHEM J                      227   405 985
    75   KOHLER D              ATEMWEGS LUNGENKRANKH           12   358 986
    76   ROOMANS GM            J SUBMICROSC CYTOL              18   613 986
    77   MILLS AN              BR J EXP PATHOL                 67   821 986
    78   KOHLER D              EUR J RESPIR DIS                69   319 986
    79   KALINER M             AM REV RESPIR DIS              134   612 986
    80   LEIGH MW              AM REV RESPIR DIS              134   784 986
    81   CHENG PW              CARBOHYD RES                   149   253 986
    82   LHERMITTE M           LUNG                           164   217 986
    83   BASBAUM CB            ARCH BIOCHEM BIOPHYS           249   363 986
    84   MAWHINNEY TP          J CHROMATOGR                   351    91 986
    85   MAWHINNEY TP          J BIOL CHEM                    262  2994 987

PN 76020
RN 00375 
AN 76267483
AU Mayo-J-W.  Wallace-W-M.  Matthews-L-W.  Carlson-D-M.
TI Quantitation of submandibular proteins resolved from normal
   individuals and children with cystic fibrosis.
SO Arch-biochem-biophys. 1976 Aug. 175(2). P 507-13.
MJ CYSTIC-FIBROSIS: me.  PROTEINS: me.  SUBMANDIBULAR-GLAND: me.
MN ADOLESCENCE.  AMYLASES: me.  CHILD.
   ELECTROPHORESIS-POLYACRYLAMIDE-GEL.  FEMALE.  HUMAN.  KINETICS.
   MALE.  SUPPORT-U-S-GOVT-P-H-S.
AB Submandibular secretions collected from children with cystic
   fibrosis (CF) showed increased protein concentrations
   (milligrams/milliliter) and increased amylase specific activity
   (units/milligram of protein) relative to normals secretions.  These
   differences between normal (N) and CF secretions were as follows:
   protein, 1.25 plus or minus 0.51 (N), 1.75 plus or minus 0.35 (CF)
   (P < 0.02); and amylase, 58 plus or minus 18 (N), 80 plus or minus
   19 (CF) (P < 0.001).  To determine the basis for elevated protein in
   CF saliva, several major proteins resolved by polyacrylamide disc
   gel electrophoresis were quantitated by densitometry.  These
   included four phosphoproteins (PP), serum albumin, an acid
   phosphatase-containing fraction, amylase, and an unidentified
   protein referred to as PI-7.1.  Together, these proteins comprise
   greater than 75% of the total protein in the secretion.  Differences
   in individual protein concentrations (milligrams/milliliter)
   resolved from normal and CF secretions, respectively, were as
   follows: PP2, 0.02 plus or minus 0.01, 0.03 plus or minus 0.02 (NS,
   not significant); PP3, 0.06 plus or minus 0.04, 0.05 plus or minus
   0.03 (NS); acid phosphatase fraction, 0.06 plus or minus 0.04, 0.12
   plus or minus 0.07 (P < 0.05); amylase, 0.09 plus or minus 0.04,
   0.27 plus or minus 0.16 (P < 0.01); and pI-7.1, 0.04 plus or minus
   0.02, 0.13 plus or minus 0.08 (P < 0.02).  Amylase, the most
   significant contributor to the elevated protein, comprised 26% of
   the total protein of normal secretions and 38% of the total protein
   of CF secretions.  Thus, our results do not support the concept of a
   generalized increase in all organic components in CF submandibular
   secretions but, rather, increases in specific proteins, namely
   amylase, component pI-7.1, and an acid phosphatase-containing
   fraction.
RF 001   CHERNICK WS           J PEDIATR                       59   890 961
   002   CHERNICK WS           J PEDIATR                       65   694 964
   003   MANDEL ID             AM J DIS CHILD                 113   431 967
   004   BLOMFIELD J           ARCH DIS CHILD                  48   267 973
   005   BLOMFIELD J           AUST PAEDIATR J                  9   232 973
   006   BLOMFIELD J           GUT                             14   558 973
   007   MAYO JW               FED PROC                        29   409 970
   008   MAYO JW               ARCH BIOCHEM BIOPHYS           161   134 974
   009   DAVIS BJ              ANN NY ACAD SCI                121   404 964
   010   REISFELD RA           NATURE                         195   281 962
   011   KRUSKI AW             ANAL BIOCHEM                    60   431 974
   012   LOWRY OH              J BIOL CHEM                    193   265 951
   013   BERNFELD P            METHODS ENZYMOL                  1   149 955
   014   MAYO JW               ARCH BIOCHEM BIOPHYS           163   498 974
   015   HSIU J                BIOCHEMISTRY                     3    61 964
   016   BOAT TF               PEDIATR RES                      8   531 974
   017   GOROVSKY MA           ANAL BIOCHEM                    35   359 970
   018   DAWES C               ARCH ORAL BIOL                  19   887 974
   019   WALLACH D             EUR J BIOCHEM                   21   433 971
   020$  FISCHER EH            IN: BOYER PD                     4   322 960
   021   BDOLAH A              BIOCHEM BIOPHYS RES COMMUN       8   266 962
   022   SPEIRS R              ARCH ORAL BIOL                  19   747 974
   023   CHERNICK WS           MOD PROBL PEDIATR               10   125 967
   024   MARTINEZ JR           PEDIATR RES                      9   470 975
CT   1   GILLARD BK            PEDIATR RES                     12   868 978
     2   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     3   ROOMANS GM            ANN NY ACAD SCI                428   121 984
     4   VONEULER AM           EXP MOL PATH                    43   142 985
     5   DAVIS PB              J DENT RES                      66   667 987
     6   MCCARTHY D            BR DENT J                      162   148 987

PN 76021
RN 00376 
AN 76230443
AU Hochman-H-I.  Feins-N-R.  Rubin-R.  Gould-J.
TI Chloride losing diarrhoea and metabolic alkalosis in an infant with
   cystic fibrosis.
SO Arch-Dis-Child. 1976 May. 51(5). P 390-1.
MJ ALKALOSIS: et.  CYSTIC-FIBROSIS: co.  DIARRHEA-INFANTILE: et.
MN CASE-REPORT.  CHLORIDES: me.  FECES: an.  FEMALE.  HUMAN.
   ILEOSTOMY:  ae.  INFANT-NEWBORN.
AB A case of hypochloraemic metabolic alkalosis in an infant with
   chloride losing ileostomy drainage and cystic fibrosis is described.
   It is speculated that intestinal loss of chloride played a major role
   in the development of metabolic alkalosis.
RF 001   AARONSON I            ARCH DIS CHILD                  46   479 971
   002   NOUSIA-ARVANITAKIS S  J PEDIATR                       82   535 973
   003   DAVIDSON AG           AUST PAEDIATR J                  8   187 972
   004   DESOUSA RC            J CLIN INVEST                   53   465 974
   005   DI SANTAGNESE PA      JAMA                           172  2014 960
   006   GOTTLIEB RP           J PEDIATR                       79   930 971
   007   KESSLER WR            PEDIATRICS                       8   648 951
   008   RENDLE-SHORT J        ARCH DIS CHILD                  31    28 956
   009   SCHWARTZ WB           N ENGL J MED                   279   630 968
CT   1   HOCHMAN HI            PEDIATR CLIN NORTH AM           26   803 979
     2   BECKERMAN RC          PEDIATRICS                      63   580 979
     3   NUSSBAUM E            AM J DIS CHILD                 133   965 979
     4   ZAMMARCHI E           RIV ITAL PEDIATR                 9   505 983

PN 76022
RN 00377 
AN 76276665
AU Lacroix-J.
TI Letter: Life tables for cystic fibrosis.
SO Arch-Dis-Child. 1976 Aug. 51(8). P 645.
MJ CYSTIC-FIBROSIS: mo.  LIFE-EXPECTANCY.
MN AGE-FACTORS.  CYSTIC-FIBROSIS: di.  HUMAN.  INFANT.
EX I read the article by Drs. Robinson and Norman on life tables for
   cystic fibrosis with much interest.  They express their
   disappointment at not finding any difference between the life
   expectancy of children presenting during the first year and that of
   all cases.  In fact the former may be a little worse.  Is it not what
   should be expected?  Since infection is known to be present as early
   as the first month of life, the diagnosis is probably late in nearly
   all cases.  Do the authors not point out the necessity of an
   evaluation of neonatal screening?  On the other hand, and logically,
   one can expect that a very late diagnosis is consistent nowadays with
   a very mild case - and the best therapeutic results!  Shwachman's
   report of patients over 17 years of age seems to support this belief:
   only 12% of the series had been diagnosed before one year of age.
   Therefore I think we should evaluate the course of late presenting
   cases (after one year of age for instance) separately since a large
   delay in diagnosis may be a clue to the mildness of the disease.
RF 001   ROBINSON MJ           ARCH DIS CHILD                  50   962 975
   002   ESTERLY JR            JOHNS HOPKINS MED J            122    94 968
   003   SHWACHMAN H           PEDIATRICS                      36   689 965

PN 76023
RN 00378 
AN 76204630
AU Griffiths-A-D.  Bull-F-E.  Dykes-P.
TI Effect of gestational length on albumin content of meconium.
SO Arch-Dis-Child. 1976 Apr. 51(4). P 321-3.
MJ ALBUMINS: an.  GESTATIONAL-AGE.  MECONIUM: an.
MN CYSTIC-FIBROSIS: di.  FALSE-POSITIVE-REACTIONS.  FEMALE.  HUMAN.
   INFANT-NEWBORN.  INFANT-PREMATURE.  OCCULT-BLOOD.  PREGNANCY.
AB During a screening programme for the detection of CF using the
   meconium albumin technique, the overall false-positive rate was found
   to be approximately 1%. When the gestational age of the infants was
   taken into account the false-positive rate was found to be
   significantly higher in preterm (8%) as compared to term infants
   (0.55%). This was due largely but not solely to the presence of
   occult blood. Possible explanations for these findings are discussed
   and attention drawn to the limitation of meconium albumin content as
   a screening technique for CF in preterm infants.
RF 001   BUCHANAN DJ           PEDIATRICS                       9   304 952
   002   BULL FE               ARCH DIS CHILD                  49   602 974
   003   CAIN ARR              ARCH DIS CHILD                  47   131 972
   004   FORD-JONES AEA        ARCH DIS CHILD                  50   238 975
   005   GREEN MN              PEDIATRICS                      41   989 968
   006   GREEN MN              PEDIATRICS                      21   635 958
   007   KOLMER JA             APPROVED LABORATORY TECHNIC          266 952
   008   PROSSER R             ARCH DIS CHILD                  49   597 974
   009   SCHUTT WH             ARCH DIS CHILD                  43   178 968
   010   WERNER B              ACTA PAEDIATR SCAND SUPPL 6     35     1 948
   011   WISER WC              PEDIATRICS                      33   115 964
CT   1   UXA F                 MINERVA PEDIATR                 31   831 979
     2   RYLEY HC              ARCH DIS CHILD                  54    92 979

PN 76024
RN 00379 
AN 76204624
AU Robinson-P-G.  Elliot-R-B.
TI Cystic fibrosis screening in the newborn.
SO Arch-Dis-Child. 1976 Apr. 51(4). P 301-4.
MJ CYSTIC-FIBROSIS: di.  ENZYME-TESTS.  FECES: en.
MN CHYMOTRYPSIN: an.  HUMAN.  INFANT-NEWBORN.  SWEAT: en.
   TRYPSIN:  an.
AB A new technique of measuring stool enzyme activity on dry specimens
   of faeces from newborn children at 4-5 days of age has detected 3
   cases of cystic fibrosis in the first 6000 tests. No known cases of
   cystic fibrosis have been missed. Additionally, one case of
   pancreatic achylia of at least 4 months' duration has been detected.
   It is proposed that the detection of cystic fibrosis by this
   technique is sufficiently practical to be acceptable as a worthwhile
   newborn screening programme. The screening test has been in use in
   Auckland for over a year and is now being set up in Hamilton,
   Wellington, and Dunedin (New Zealand), and Sydney (Australia).
RF 001   BARBERO GJ            AM J DIS CHILD                 112   536 966
   002   GIBSON LE             PEDIATRICS                      23   545 959
   003   PROSSER R             ARCH DIS CHILD                  49   597 974
   004   ROBINSON PG           NZ MED J                        79  1024 974
   005   ROBINSON PG           CLIN CHIM ACTA                  62   225 975
   006   RYLEY HC              ARCH DIS CHILD                  49   901 974
   007   SCHWARTZ IL           J CLIN INVEST                   35   114 956
   008   SHWACHMAN H           PEDIATRICS                      46   335 970
   009   SHWACHMAN H           AM J DIS CHILD                  92   347 956
CT   1   CROSSLEY JR           LANCET                           2  1093 977
     2   ARVANITAKIS C         GASTROENTEROLOGY                74   932 978
     3   EVANS RT              J CLIN PATHOL                   34   911 981
     4   CRISTOL P             SEM HOP PARIS                   58   449 982

PN 76025
RN 00380 
AN 76276664
AU Ryley-H-C.  Neale-L-M.  Prosser-R.  Dodge-J.
TI Screening for cystic fibrosis by analysis of serum protein in faeces.
SO Arch-Dis-Child. 1976 Aug. 51(8). P 641-3.
MJ ALBUMINS: an.  ALPHA-1-ANTITRYPSIN: an.  CYSTIC-FIBROSIS: di.
   FECES:  an.
MN COMPARATIVE-STUDY.  HUMAN.  MECONIUM: an.
AB Faecal specimens from 51 infants free of cystic fibrosis (CF) and
   from 9 infants with the disease were analysed for albumin and alpha1-
   antitrypsin content. Faeces from infants with no CF had a mean
   albumin content of less than 0-1 mg/g dry weight and a mean albumin:
   alpha1-antitrypsin ratio value of less than 0-1. Faeces from infants
   with CF had, with one exception, an albumin content of more than 2-0
   mg/g dry weight and a ratio value greater than 3-0. It was
   subsequently found that the duodenal aspirate from the child with CF
   but whose faeces had a low albumin content and ratio value, had
   tryptic activity though at a much reduced level compared to the
   activity in aspirates from healthy infants.
RF 001   RYLEY HC              ARCH DIS CHILD                  49   901 974
   002   RYLEY HC              CLIN CHIM ACTA                  64   117 975
CT   1   RYLEY HC              ARCH DIS CHILD                  54    92 979
     2   MASTELLA G            RIV ITAL PEDIATR                 7   581 981

PN 76026
RN 00381 
AN 76276646
AU Mukherji-R-N.  Moss-P-H.  Heffernan-C-K.
TI Is cystic fibrosis an acid mucopolysaccharidosis?.
SO Arch-Dis-Child. 1976 Jul. 51(7). P 563-5.
MJ CYSTIC-FIBROSIS: cl.  MUCOPOLYSACCHARIDOSIS: cl.
   MYOCARDIAL-DISEASES: cl.
MN CASE-REPORT.  CYSTIC-FIBROSIS: pa.  FEMALE.  HUMAN.  INFANT.
   MUCOPOLYSACCHARIDOSIS: pa.  MYOCARDIAL-DISEASES: pa.  MYOCARDIUM: pa.
AB A case of cystic fibrosis with myocardial fibrosis and acid
   mucopolysaccharide deposits in the myocardium is described. The case
   supports the theory that cystic fibrosis may be a genetic acid
   mucopolysaccharidosis.
RF 001   BARNES GL             AUST PAEDIATR J                  6    81 970
   002   DANES BS              IN: LAWSON D PROC 5TH INT CF          67 969
   003   JOHANSEN PG           LANCET                           1   455 968
   004   MCGIVEN AR            ARCH DIS CHILD                  37   656 962
   005   MOSQUERA F            ARCH ARGENT PEDIATR             63   450 965
   006   NEZELOF C             ARCH FR PEDIATR                 16  1035 959
   007   OPPENHEIMER EH        LAB INVEST                      30   411 974
   008   POWELL LW JR          VA MED                          84   178 957
CT   1   HIDE DW               ARCH DIS CHILD                  52   163 977
     2   ZIMMERMANN A          HELV PAEDIATR ACTA              37   183 982

PN 76027
RN 00382 
AN 76276634
AU Warner-J-O.  Taylor-B-W.  Norman-A-P.  Soothill-J-F.
TI Association of cystic fibrosis with allergy.
SO Arch-Dis-Child. 1976 Jul. 51(7). P 507-11.
MJ CYSTIC-FIBROSIS: co.  HYPERSENSITIVITY: co.
MN ADOLESCENCE.  ALLERGENS.  ASPERGILLUS: im.  BREAST-FEEDING.  CHILD.
   CLADOSPORIUM: im.  FEMALE.  HAY-FEVER: co.  HUMAN.
   HYPERSENSITIVITY:  fg.  HYPERSENSITIVITY-IMMEDIATE.  INFANT.
   INTRADERMAL-TESTS.  LUNG-VOLUME-MEASUREMENTS.  MALE.
   PEAK-EXPIRATORY-FLOW-RATE.  RESPIRATORY-TRACT-INFECTIONS: co.
AB Immediate skin hypersensitivity to various inhalant allergens was
   present in 59% of 123 children with cystic fibrosis (CF), a much
   higher percentage than in the general population. This is consistent
   with the idea that atopy arises as a result of impaired handling of
   antigen at mucosal surfaces. The allergic CF children had more chest
   infections, a worse chest x-ray appearance, and lower peak expiratory
   flow rates. Allergic diseases were also frequent in the CF obligate
   heterozygotes (32% of mothers and 26% of fathers). It is suggested
   that the heterozygotes may also have a mucosal abnormality resulting
   in defective antigen handling.
RF 001   BLAIR H               CLIN ALLERGY                     4   389 974
   002   BOWMAN BH             SCIENCE                        164   325 969
   003   CARR RD               ARCH DERMATOL                   89    27 964
   004   CHANG N               AM REV RESPIR DIS              106   867 972
   005   CHRISPIN AR           PEDIATR RADIOL                   2   101 974
   006   CRACCO G              PROC EWGCF 5TH ANNU MTG               16 974
   007   DAY G                 ARCH DIS CHILD                  48   355 973
   008   FEATHERBY EA          CAN MED ASSOC J                102   835 970
   009   HORN MEC              CHEST SUPPL                     63    44 973
   010   KULCZYCKI LL          JAMA                           175   358 961
   011   LANDAU LI             J PEDIATR                       82   863 973
   012   LIFSCHITZ MI          AM REV RESPIR DIS               99   399 969
   013   MEARNS MB             LANCET                           1   538 967
   014   RACHELEFSKY GS        AM J DIS CHILD                 128   355 974
   015   ROTHSTEIN RJ          J ALLERGY CLIN IMMUNOL          53   100 974
   016   SPOCK A               PEDIATR RES                      1   173 967
   017   TAYLOR B              LANCET                           2   111 973
   018   VAN METRE TE JR       J ALLERGY CLIN IMMUNOL          31   141 960
   019   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   020   WARREN CPW            CLIN ALLERGY                     5     1 975
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   WARNER JO             CLIN ALLERGY                     7   385 977
     3   DESPRES P             NOUV PRESSE MED                  7  2566 978
     4   SILVERMAN M           ARCH DIS CHILD                  53   873 978
     5   TURNER MW             ARCH DIS CHILD                  53   631 978
     6   MELLIS CM             PEDIATRICS                      61   446 978
     7   MITCHELL I            J PEDIATR                       93   744 978
     8   ANON                  LANCET                           1   708 979
     9   PRICE JF              CLIN ALLERGY                     9   563 979
    10   CARSWELL F            MONOGR PAEDIATR                 10   144 979
    11   LEUPOLD W             MONOGR PAEDIATR                 10   119 979
    12   CARSWELL F            CLIN EXP IMMUNOL                35   141 979
    13   ZAMBIE MF             ANN ALLERGY                     42   290 979
    14   SANTAGNESE PAD        AM J MED                        66   121 979
    15   LARSEN GL             AM REV RESPIR DIS              119   399 979
    16   NELSON LA             AM REV RESPIR DIS              120   863 979
    17   SLY PD                AUST PAEDIATR J                 16   205 980
    18   VANASPEREN PP         AUST PAEDIATR J                 16    53 980
    19   HODSON ME             THORAX                          35   801 980
    20   ORMEROD LP            THORAX                          35   768 980
    21   SKOV PS               ALLERGY                         35    23 980
    22   TOBIN MJ              THORAX                          35   232 980
    23   TOBIN MJ              THORAX                          35   807 980
    24   BRUETON MJ            ARCH DIS CHILD                  55   348 980
    25   GEORGE RH             ARCH DIS CHILD                  55   910 980
    26   MOSS RB               AM REV RESPIR DIS              121    23 980
    27   LARSEN GL             AM J DIS CHILD                 134  1143 980
    28   CROMWELL O            LANCET                           2   164 981
    29   REEN DJ               CLIN ALLERGY                    11   571 981
    30   SHEN J                INFECT IMMUN                    32   967 981
    31   HOLZER FJ             ARCH DIS CHILD                  56   455 981
    32   CLARKE CW             BR J DIS CHEST                  75    15 981
    33   VANASPEREN P          AM J DIS CHILD                 135   815 981
    34   WILSON GB             MED HYPOTHESES                   8   527 982
    35   PITCHERWILMOTT RW     ARCH DIS CHILD                  57   582 982
    36   VOSS MJ               J ALLERGY CLIN IMMUNOL          69   536 982
    37   PRIGENT F             ANN DERMATOL VENEREOL          109   341 982
    38   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
    39   ANON                  LANCET                           2   257 983
    40   MURPHY MB             THORAX                          39   179 984
    41   LAUFER P              J ALLERGY CLIN IMMUNOL          73    44 984
    42   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985
    43   LAUFER P              CUTIS                           35   557 985
    44   LAUFER P              CUTIS                           36   245 985
    45   BERKIN KE             EUR J RESPIR DIS                67   103 985
    46   HORDVIK NL            AM REV RESPIR DIS              131   889 985
    47   WILMOTT RW            AM J DIS CHILD                 139   669 985
    48   DINWIDDIE R           J ROY SOC MED                   79     6 986
    49   PIEDRA P              J PEDIATR                      108   817 986

PN 76028
RN 00383 
AN 76251662
AU Yeates-D-B.  Sturgess-J-M.  Kahn-S-R.  Levison-H.  Aspin-N.
TI Mucociliary transport in trachea of patients with cystic fibrosis.
SO Arch-Dis-Child. 1976 Jan. 51(1). P 28-33.
MJ CYSTIC-FIBROSIS: pp.  TRACHEA: pp.
MN ADOLESCENCE.  ADULT.  CHILD.  CILIA.  CYSTIC-FIBROSIS: bl, co.
   FEMALE.  HUMAN.  MALE.  SPUTUM: se.
AB Mucociliary tracheal transport rates were measured in 20 patients
   with cystic fibrosis, in whom these rates ranged from 0 to 12.8
   mm/min. The patients were divided into 3 roughly equal groups on the
   basis of their transport rates. (1) Those in whom no abnormality in
   mucociliary transport was detected in the trachea; (2) those in whom
   normal transport rates were measured but in whom abnormalities such
   as cessation, or reversal of bolus movement were observed; (3) those
   in whom no normal transport rates were observed. In the first group
   the rates were similar to those observed in a population of healthy
   adults. These normal rates were observed in some patients who had a
   productive cough. The mean mucociliary tracheal transport rate
   increased with increasing maximum midexpiratory flow. Those patients
   with a low Shwachman score and poor arterial oxygen tension tended to
   fall into groups 2 and 3. In the ciliary dyskinesia assay in rabbit
   trachea the serum from the patients with the higher transport rates
   tended to initiate more rapid discharge of material from the
   epithelium and ciliary dyskinesia.
RF 001   CAMNER P              AM REV RESPIR DIS              108   131 973
   002   CAMNER P              IN: HERS JFP                         236 973
   003   CHARMAN J             BIORHEOLOGY                      9   185 972
   004   CONOVER JH            PEDIATR RES                      7   220 973
   005   DENTON R              PEDIATRICS                      25   611 960
   006   DUBOIS AB             J CLIN INVEST                   35   322 956
   007   ESTERLY JR            JOHNS HOPKINS MED J            122    94 968
   008   FEATHER EA            BR J DIS CHEST                  64   192 970
   009   HOORN B               ARCH GESAMTE VIRUSFORSCH        18   210 966
   010   LAMB D                BR J DIS CHEST                  66   239 972
   011   MATTHEWS LW           AM REV RESPIR DIS               88   199 963
   012   POTTER JL             ANN NY ACAD SCI                106   692 963
   013   REID L                MOD PROBL PEDIATR               10   195 967
   014   SAKAKURA Y            ANN OTOL RHINOL LARYNGOL        82   203 973
   015   SANCHIS J             N ENGL J MED                   288   651 973
   016   SPOCK A               PEDIATR RES                      1   173 967
   017   STURGESS JM           IN: LAWSON D PROC 5TH INT CF         368 969
   018   THOMSON ML            N ENGL J MED                   289   749 974
   019   WOOD RE               PEDIATR RES                      8   471 974
   020   YEATES DB             INT J APPL RADIAT ISOTOP        25   578 974
   021   YEATES DB             FED PROC                        33   365 974
   022   YEATES DB             J APPL PHYSIOL                  39   487 975
   023   ZUELZER WW            PEDIATRICS                       4    53 949
CT   1   CZEGLEDYNAGY E        LAB INVEST                      35   588 976
     2   SORENSEN RU           INFECT IMMUN                    18   735 977
     3   WONG JW               PEDIATRICS                      60   146 977
     4   ROSSMAN CM            J PEDIATR                       90   579 977
     5   LOPEZVIDRIERO MT      BR MED BULL                     34    63 978
     6   KOLLBERG H            SCAND J RESPIR DIS              59   297 978
     7   BASSETT PG            COMPUT BIOL MED                  9    97 979
     8   GABRIDGE MG           PEDIATR RES                     13    31 979
     9   NAGY EC               PEDIATR RES                     13   729 979
    10   AFZELIUS BA           INT REV EXP PATHOL              19     1 979
    11   STURGESS JM           PEDIATR CLIN NORTH AM           26   481 979
    12   MOSSBERG B            ACTA PHARMACOL TOXICOL          44    41 979
    13   CAMNER P              SCAND J RESPIR DIS              60    56 979
    14   PAVIA D               CLIN RESP PHYSIOL               16   335 980
    15   LIPPMANN M            BR J IND MED                    37   337 980
    16   CAMNER P              CLIN SCI                        59    79 980
    17   MOSSBERG B            EUR J RESPIR DIS                61    51 980
    18   KATZ SM               AM J CLIN PATHOL                73   682 980
    19   STURGESS JM           N ENGL J MED                   303   318 980
    20   SORENSEN RU           PEDIATR RES                     15    14 981
    21   RUTLAND J             THORAX                          36   654 981
    22   MORROW PE             CHEST                           80   809 981
    23   SORENSEN RU           AM REV RESPIR DIS              123    37 981
    24   MITCHELL EA           AUST PAEDIATR J                 18    40 982
    25   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
    26   SORENSEN RU           EUR J RESPIR DIS                64   524 983
    27   JACKSON AH            CLIN SCI                        65  P  3 983
    28   RUTLAND J             AM REV RESPIR DIS              128  1030 983
    29   KATZ S                CELL CALC                        5   421 984
    30   CAMNER P              ATEMWEGS LUNGENKRANKH           10   237 984
    31   JACKSON AH            EUR J RESPIR DIS                65   114 984
    32   DAVIS PB              SEM RESPIR MED                   6   261 985
    33   LEVANDOWSKI RA        J LAB CLIN MED                 106   428 985

PN 76029
RN 00384 
AN 77086296
AU Lawson-D.  Porter-J.
TI Serum precipitins against respiratory tract pathogens in 522
   "normal" children, and 48 cases of cystic fibrosis treated with
   cloxacillin.
SO Arch-Dis-Child. 1976 Nov. 51(11). P 890-1.
MJ CLOXACILLIN: tu.  CYSTIC-FIBROSIS: im.  PRECIPITINS: an.
   RESPIRATORY-TRACT-INFECTIONS: im.
MN ADOLESCENCE.  AGE-FACTORS.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: dt.  HUMAN.  INFANT.  INFANT-NEWBORN.
EX Well children show a steady increase of staphylococcal precipitins
   throughout life.  Lower incidences are found for precipitins against
   H. influenzae, Pneumococcus, and haemolytic streptococcus.
   Precipitins against Proteus, Pseudomonas, and Klibsiella are rare.
   There are marked differences between the normal children and the
   cloxacillin-treated children with cystic fibrosis in respect to
   Pseudomonas and H. influenzae which rise to over 50% of cystic
   fibrosis children in the third quinquennium.  However, the
   development of staphylococcal precipitins can be prevented by
   continuous antistaphylococcal therapy.
RF 001   BURNS MW              LANCET                           1   223 968
   002   BURNS MW              LANCET                           1   354 967
   003   BURNS MW              LANCET                           1   270 968
CT   1   PRESSLER T            ACTA PAEDIATR SCAND             73   541 984

PN 76030
RN 00385 
AN 76252000
AU Usatin-M-S.  Wigger-H-J.
TI Peliosis hepatis in a child.
SO Arch-Pathol-Lab-Med. 1976 Aug. 100(8). P 419-21.
MJ CYSTIC-FIBROSIS: co.  LIVER-DISEASES: pa.  LIVER: pa.
MN AGE-FACTORS.  AUTOPSY.  CASE-REPORT.  CHILD.  CYSTIC-FIBROSIS: pa.
   HUMAN.  LIVER-DISEASES: co.  MALE.
AB Peliosis hepatis, which has previously only been reported in adults,
   occurred in a chronically ill 11-year-old boy with cystic fibrosis.
   As in cases in adults, chronic illness, long-term anabolic steroid
   therapy, and right ventricular congestive failure may well have been
   the causative factors in this case. Histologically, the phlebectatic
   and parenchymal types, which were presumed to be separate, were found
   conjointly in this case. This is compatible with its origin from
   severe right ventricular congestive failure. The rarity of peliosis,
   however, indicates that one or more as yet unknown factors might be
   operative in its development.
RF 001   YANOFF M              ARCH PATHOL                     77   159 964
   002   WAGNER E              ARCH HEILKD                      2   369 861
   003   SCHOENLANK W          VIRCHOWS ARCH PATHOL ANAT      222   358 916
   004   ZAK FG                AM J PATHOL                     26     1 950
   005   CAROLI J              SEM HOP PARIS                   40  1709 964
   006   WEIR MR               TEX REP BIOL MED                27  1105 969
   007   ROSS RC               PATHOL EUR                       7   273 972
   008   BURGER RA             AM J CLIN PATHOL                22   569 962
   009   GORDON BS             AM J CLIN PATHOL                33   156 960
   010   KINTZEN W             CAN MED ASSOC J                 83   860 960
   011   MCGIVEN AR            J PATHOL                       101   283 970
   012   BERNSTEIN MS          N ENGL J MED                   284  1135 971
   013   NAEIM F               ARCH PATHOL                     95   284 973
   014   DELAGE C              UNION MED CAN                  102  1888 973
   015   BAGHERI SA            ANN INTERN MED                  81   610 974
   016   TRITES AEW            ARCH PATHOL                     63   183 957
   017   SEAWRIGHT AA          AUST VET J                      47    91 971
   018   WOLSTENHOLME JT       PROC SOC EXP BIOL MED           74   659 950
   019   BAGHERI SA            GASTROENTEROLOGY                64   879 973
   020   RUEBNER BH            AM J PATHOL                     60   247 970
   021   TUCHWEBER B           J MED (BASEL)                    4   327 973
   022   BERGS VV              SCIENCE                        158   377 967
   023   ORANDI M              CAN MED ASSOC J                 96  1219 967
CT   1   PARADINAS FJ          HISTOPATHOLOGY                   1   225 977
     2   ODIEVRE M             ARCH FR PEDIATR                 34   654 977
     3   TAXY JB               HUM PATHOL                       9   331 978
     4   BANK JI               ACTA PAEDIATR SCAND             67   105 978
     5   LUDWIG J              DIG DIS SCI                     24   785 979
     6   KARASAWA T            ACTA PATHOL JAP                 29   457 979
     7   WILLEN H              VIRCHOWS ARCH PATHOL ANAT HIS  383   233 979
     8   KAWAMOTO S            ARCH PATHOL LAB MED            104   444 980
     9   RYAN AJ               FED PROC                        40  2682 981
    10   BROCHARD P            ANN MED INTERNE (PARIS)        132   195 981
    11   ITO T                 ENDOSCOPY                       14    14 982
    12   TUCKER RA             DRUG INTEL CLIN PHARM           16   569 982
    13   SPECH HJ              Z GASTROENTEROL                 20   710 982
    14   CRAGG A               PEDIATR RADIOL                  14   340 984
    15   WAKABAYASHI T         ACTA PATHOL JAP                 34  1079 984
    16   GORDON SC             J HEPATOL                        2   475 986

PN 76031
RN 00386 
AN 76135028
AU Changus-J-E.  Pitot-H-C.
TI Cystic fibrosis.  A dilemma in the metabolic pathogenesis of genetic
   disease.
SO Arch-Pathol-Lab-Med. 1976 Jan. 100(1). P 7-11. (REVIEW).
MJ CYSTIC-FIBROSIS: me.
MN ANIMAL.  CELLS-CULTURED.  CYSTIC-FIBROSIS: pa, fg.  CYTOPLASM: ul.
   FIBROBLASTS: ul.  HUMAN.  IGG: an.  INFANT-NEWBORN.  LEUKOCYTES: ul.
   MUCINS: me.  MUCOPOLYSACCHARIDES: me.  PROTEIN-BINDING.  RABBITS.
   REVIEW.  SALIVA: an.  SALIVARY-GLANDS: ul.  SWEAT: an.
AB The fundamental pathological observations in cystic fibrosis (CF)
   were made over three decades ago.  More recently, physiological
   findings have directed investigation toward a plethora of humoral
   substances and their possible role in disturbances of the secretory
   processes in CF.  The application of the techniques of molecular
   biology and of tissue culture is beginning to increase our knowledge
   about the so-called CF factors and their diverse effects on
   epithelial and ciliated surfaces.  Emphasis in current research is
   on the chemical characterization of the CF factors, the metabolism
   of cells cultured from patients with CF, and the biochemical events
   controlling the processes of secretion.  Some current theories as to
   the metabolic pathogenesis of CF are considered in the context of
   existing findings.
RF 001   LOBECK CC             IN: STANBURY JB                     1605 972
   002   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   003   FARBER S              ARCH PATHOL                     37   238 944
   004   FARBER S              J MICH MED SOC                  44   587 945
   005   SWENEY LR             ARCH PATHOL                     86   413 968
   007   LEV R                 AM J PATHOL                     46    23 965
   008   STURGESS JM           IN: LAWSON D PROC 5TH INT CF         368 969
   009   MENGUY R              GASTROENTEROLOGY                59   257 970
   010   DOGGETT RG            J CLIN PATHOL                   24   270 971
   011   LITT M                BIOCHEM BIOPHYS RES COMMUN      43   919 971
   012   GUGLER EC             J PEDIATR                       71   585 967
   013   GUGLER EC             J PEDIATR                       73   548 968
   014   DISCHE Z              ANN NY ACAD SCI                 93   526 962
   015   DI SANTAGNESE PA      PEDIATRICS                      19   252 957
   016   BENKE PJ              PROC SOC EXP BIOL MED          137  1283 971
   017   CHERNICK WS           MOD PROBL PEDIATR               10   125 967
   018   CHERNICK WS           J PEDIATR                       59   890 961
   019   CHERNICK WS           J PEDIATR                       65   694 964
   020   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   021   MANGOS JA             PEDIATR RES                      1   436 967
   022   MANGOS JA             PEDIATR RES                      2   378 968
   023   BENKE PJ              LANCET                           1   182 972
   024   TAYLOR A              PEDIATR RES                      8   861 974
   025   RAO GJS               J PEDIATR                       80   573 972
   026   SPOCK A               PEDIATR RES                      1   173 967
   027   BESLEY GTN            J MED GENET                      6   278 969
   028   BOWMAN BH             SCIENCE                        164   325 969
   029   SPOCK A               GAP CONF REP CILIARY INHIBITO            973
   030   BOAT TF               AM REV RESPIR DIS              110   428 974
   031   BALFE JW              SCIENCE                        162   689 968
   032   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   033   HADDEN JW             PROC SOC EXP BIOL MED          142   577 973
   034   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   035   FEIG SA               PEDIATR RES                      8   594 974
   036   MORIN CL              BIOMEDICINE EXPRESS             19   133 973
   037   TAUSSIG LM            LANCET                           1  1367 972
   038   BROWN GA              LANCET                           2   639 971
   039   WILSON GB             PEDIATR RES                      9   635 975
   040   NOUSIA-ARVANITAKIS S  CF CLUB ABST                    14    43 973
   041   BOWMAN BH             IN: MANGOS JA                         29 973
   042   CONOVER JH            LANCET                           1  1194 973
   043   WOOD RE               LANCET                           2  1452 973
   044   CONOVER JH            LANCET                           2  1501 973
   045   DANES BS              LANCET                           1  1061 968
   046   DANES BS              J EXP MED                      129   775 969
   047   LIE SO                PEDIATR RES                      7    13 973
   048   LIE SO                PROC NAT ACAD SCI USA           69  2361 972
   049   DANES BS              J EXP MED                      136  1313 972
   050   BERATIS NG            PEDIATR RES                      7   958 973
   051   DANES BS              AM J HUM GENET                  25   323 973
   052   DANES BS              J EXP MED                      137  1538 973
   053   BARNETT DR            TEX REP BIOL MED                31   703 973
   054   CROW JF               IN: NEEL JV                           23 965
   055   DANES BS              LANCET                           2   765 973
   056   RENNERT OM            LANCET                           2  1091 973
   057   BARTMAN J             J PEDIATR                       76   430 970
   058   MATALON R             LANCET                           2   838 969
   059   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   060   WIESMANN UN           J PEDIATR                       77   685 970
   061   KRAUS I               PEDIATRICS                      47  1010 971
   062   BENKE PJ              N ENGL J MED                   284   731 971
   063   ROBERTSON JA          LANCET                           1  1256 974
   064   DANES BS              BIOCHEM GENET                   12   359 974
   065   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   066   QUISSELL DO           NATURE                         247   115 974
   068   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   069   BAIG MM               J PEDIATR                       86    72 975
   070   RENNERT OM            IN: MANGOS JA                         41 973
   071   COHEN LF              PEDIATR RES                      9   312 975
   072   HANN S                LANCET                           2   520 974
   073   LIEBERMAN J           LANCET                           1  1230 974
   074   RAO GJS               SCIENCE                        177   610 972
   075   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   076   COBURN MD             AM REV RESPIR DIS              110   368 974
   077   RAO GJS               PEDIATR RES                      8   684 974
   078   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   079   SINGER L              CLIN BIOCHEM                     7   146 974
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   CALLAHAN JW           PEDIATR RES                     11  1166 977
     3   SULLIVAN JL           BIOCHEM GENET                   15  1125 977
     4   NEUTRA MR             GASTROENTEROLOGY                75   701 978
     5   BANSCHBACH MW         BIOCHEM BIOPHYS RES COMMUN      84   922 978
     6   GABRIDGE MG           PEDIATR RES                     13    31 979
     7   PEARSON RD            PEDIATR RES                     13   834 979
     8   RIORDAN JR            BIOCHIM BIOPHYS ACTA           574    39 979
     9   LOPEZCORELLA E        PATOLOGIA (MEXICO CITY)         18   167 980
    10   MALER T               BIOCHIM BIOPHYS ACTA           598     1 980

PN 76032
RN 00387 
AN 77133875
AU Phelan-P-D.  Steiner-N.
TI Assessing obstructive airways disease in children.  Which test is
   best?.
SO Aust-Paediatr-J. 1976 Jun. 12(2). P 72-6.
MJ ASTHMA: di.  CYSTIC-FIBROSIS: di.  RESPIRATORY-AIRFLOW.
MN ADOLESCENCE.  CHILD.  COMPARATIVE-STUDY.
   FORCED-EXPIRATORY-FLOW-RATES.  HUMAN.
AB Tests for airways obstruction based on a forced expiration were
   carried out in 60 children with asthma and 15 with cystic fibrosis
   to determine which test or tests were the best in identifying
   children with airways disease, to determine the severity of disease
   and to document response to therapy.  Maximum expiratory flow,
   measured from a maximum expiratory flow volume curve, and maximum
   mid-expiratory flow measured from a spirogram, were the most
   sensitive tests in detecting early disease.  Maximum expiratory flow
   measured from the maximum expiratory flow volume curve, combined
   with measurement of lung volumes, gave the best overall estimate of
   severity.  Peak expiratory flow rate measured with a Peak Flow
   Meter, because of its simplicity of measurement, was the most useful
   test for routine use in the clinic and consulting room to monitor
   severity and response to therapy.
RF 001   CONNOLLY NM           J ASTHMA RES                     8    31 970
   002   FEATHERBY EA          AM REV RESPIR DIS              102   737 970
   003   HILL DJ               ARCH DIS CHILD                  47   874 972
   004   LANDAU LI             AM REV RESPIR DIS              108   593 973
   005   LANDAU LI             AUST NZ J MED                    3   557 973
   006   MEAD J                J APPL PHYSIOL                  22    95 967
   007   POLGAR G              PULMONARY FUNCTION TESTING IN            971
   009   WENG TR               AM REV RESPIR DIS               99   719 969
   010   WOOLCOCK AJ           LANCET                           2  1323 965
   011   ZAPLETAL A            J APPL PHYSIOL                  26   308 969
CT   1   MITCHELL EA           AUST PAEDIATR J                 18    40 982
     2   CASTELLO D            RIV ITAL PEDIATR                11   479 985

PN 76033
RN 00388 
AN 77133876
AU Mellis-C-M.  Landau-L-I.
TI Ventilatory disturbance in children with obstructive lung disease.
SO Aust-Paediatr-J. 1976 Jun. 12(2). P 77-82.
MJ ASTHMA: pp.  CYSTIC-FIBROSIS: pp.  LUNG: pp.
MN CHILD.  HUMAN.  RESPIRATORY-FUNCTION-TESTS.
AB Disease in the small airways leads to alteration in the slope of
   phase III of the single breath nitrogen washout following a breath
   of 100% oxygen.  Normal children and those with asthma and cystic
   fibrosis were studied by this technique.  Measurement of the slope
   of phase III of the single breath washout appeared to be a sensitive
   indicator of abnormal pulmonary function in children with these
   diseases.  Results obtained in many children with cystic fibrosis
   suggested that the upper lung regions were predominantly affected.
RF 001   ALDERSON PO           RADIOLOGY                      111   151 974
   002   ANTHONISEN NR         CLIN SCI                        35   495 968
   003   COOPER DM             AM REV RESPIR DIS              109   519 974
   004   DOLLFUSS RE           RESPIR PHYSIOL                   2   234 967
   005   FOWLER WS             J APPL PHYSIOL                   2   283 949
   006   MCFADDEN ER JR        J APPL PHYSIOL                  25   365 968
CT   1   LANDAU LI             THORAX                          34   217 979

PN 76034
RN 00389 
AN 76277421
AU Harrison-S-P.
TI Compliance or non-compliance with treatment?.
SO Australas-Nurses-J. 1976 May. 4(11). P 37.
MJ CYSTIC-FIBROSIS: th.  PATIENT-COMPLIANCE.
MN CHILD.  HUMAN.  PUBLIC-HEALTH-NURSING.
EX In a situation in which a patient, currently undergoing medical
   treatment at home requiring compliance and fairly rigid discipline
   for its effectiveness, is found by the health visitor not to be
   carrying out the prescribed treatment, should the health visitor's
   role always be to attempt to influence the patient to comply with the
   required treatment or are there occasions when it might be acceptable
   for her to disregard this positive role?  To illustrate such a
   situation, the real-life experience of two families will be
   discussed.
RF 001   NELSON WE             TEXTBOOK OF PEDIATRICS               854 969
   002   HARRISSON SP          THESIS                                   975
   003   THOMAS EJ             J HLTH HUM BEHAV                 7     2 966

PN 76035
RN 00390 
AN 77065277
AU Hosli-P.  Erickson-R-P.  Vogt-E.
TI Prospects for prenatal diagnosis of cystic fibrosis: induction of
   biochemical abnormalities in fibroblasts from patients with cystic
   fibrosis by a urinary glycoprotein.
SO Biochem-Biophys-Res-Commun. 1976 Nov 22. 73(2). P 209-16.
MJ ALKALINE-PHOSPHATASE: me.  CYSTIC-FIBROSIS: di.
   GLYCOPROTEINS:  ur.
MN CYSTIC-FIBROSIS: me.  ENZYME-INDUCTION: de.  FEMALE.
   FIBROBLASTS:  en.  GLUCOSIDASES: me.  GLYCOPROTEINS: du, pd.
   HETEROZYGOTE.  HUMAN.  MALE.  PREGNANCY.  PRENATAL-DIAGNOSIS.
AB Alkaline phosphatase activity, assayed on a per cell basis with an
   ultra micro-method, can be increased up to 7-fold in fibroblast
   cultures derived from patients with cystic fibrosis by induction
   with a urinary glycoprotein.  Fibroblasts from normal and
   heterozygous individuals are not significantly induced.  There is a
   suggestion of heterogeneity among cases as reflected in varying
   baseline alkaline phosphatase and alpha-glucosidase levels.
RF 001   DANES BS              J EXP MED                      129   775 969
   002   HOSLI P               PRENATAL DIAGNOSIS NEWSLETTER    1    10 972
   003   HOSLI P               PURINE METABOLISM IN MAN             811 974
   004   HOSLI P               TECNOMARA                                972
   005   HOSLI P               ADV EXP MED BIOL                68     1 976
   006   MAXFIELD M            J CLIN INVEST                   41   455 962
   007   STEVENSON FK          CLIN CHIM ACTA                  23   441 969
   008   FINNIGAN JA           BIOCHIM BIOPHYS ACTA           236    52 971
   009   CROSBY P              HISTOCHEM J                      3   223 971
   010   TAMM I                J EXP MED                       95    71 952
   011   MAXFIELD M            GLYCOPROTEINS                        446 964
   012   HOSLI P               IN: MOTULSKY AG                      226 974
   013   ANTONOWICZ I          PEDIATR RES                      6   803 972
CT   1   HOSLI P               CLIN CHEM                       23  1476 977
     2   HOSLI P               HUM GENET                       37   195 977
     3   HOSLI P               BIOCHEM BIOPHYS RES COMMUN      79   741 977
     4   OWEN E                J MOL MED                        3   203 978
     5   UITENDAAL MP          HUM HERED                       28   151 978
     6   ERICKSON RP           AM J HUM GENET                  30  A 28 978
     7   HOSLI P               HUM GENET                       41   169 978
     8   BRADY RO              ANNU REV BIOCHEM                47   687 978
     9   HOSLI P               ACTA PAEDIATR SCAND             67   617 978
    10   UITENDAAL MP          ANAL BIOCHEM                    84   147 978
    11   VANNEUVILLE FJ        ARCH INT PHYSIOL BIOCHIM        86   817 978
    12   SHWACHMAN H           AM J DIS CHILD                 132  1112 978
    13   CAREY WF              MED J AUST                       2   604 979
    14   HOSLI P               LANCET                           2   543 979
    15   CASOLA L              MONOGR PAEDIATR                 10    96 979
    16   DIMATTEO G            MONOGR PAEDIATR                 10    19 979
    17   HOSLI P               MONOGR PAEDIATR                 10    90 979
    18   KAISER E              CLIN BIOCHEM                    12   208 979
    19   HOSLI P               CLIN GENET                      15   487 979
    20   CAREY WF              AUST J EXP BIOL MED SCI         57   225 979
    21   CASOLA L              CLIN CHIM ACTA                  94    83 979
    22   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    23   HOSLI P               FEBS LETTERS                   104   271 979
    24   WIJCIK L              BIOCHIM BIOPHYS ACTA           585   374 979
    25   DAVIS PB              PEDIATR RES                     14    83 980
    26   AITKEN DA             J MED GENET                     17   187 980
    27   FASTH A               ACTA PAEDIATR SCAND             69   189 980
    28   ROOMANS GM            ULTRASTRUCTURAL PATHOL           2    53 981
    29   HARRIS A              CLIN GENET                      20   315 981
    30   JAKEL HP              BIOL ZENTRALBL                 100   273 981
    31   HOSLI P               EUR J PEDIATR                  137   116 981
    32   DODGE JA              ARCH DIS CHILD                  57   774 982
    33   CEDER O               SCANN ELECTRON MICROSC        1982   723 982
    34   JAKEL HP              BIOMED BIOCHIM ACTA             42  1123 983
    35   BUYS CHCM             CLIN CHIM ACTA                 136   229 984
    36   ANON                  LANCET                           1  1199 985
    37   PORTER WH             CLIN CHEM                       32   652 986
    38   BOUE A                HUM GENET                       74   288 986

PN 76036
RN 00391 
AN 76278044
AU Shapira-E.  Ben-Yoseph-Y.  Nadler-H-L.
TI Decreased formation of alpha 2-macroglobulin-protease complexes in
   plasma of patients with cystic fibrosis.
SO Biochem-Biophys-Res-Commun. 1976 Aug 9. 71(3). P 864-70.
MJ ALPHA-MACROGLOBULINS: me.  CYSTIC-FIBROSIS: me.
   PEPTIDE-HYDROLASES:  bl.
MN CYSTIC-FIBROSIS: en, fg.  GEL-DIFFUSION-TESTS.  HETEROZYGOTE.  HUMAN.
   KINETICS.  MACROMOLECULAR-SYSTEMS.  PAPAIN.  PRECIPITIN-TESTS.
   PROTEIN-BINDING.  TRYPSIN.  SUPPORT-U-S-GOVT-P-H-S.
AB Alpha2-macroglobulin from patients with cystic fibrosis is shown to
   have reduced binding with papain, trypsin, and thrombin.  The
   obligate heterozygotes for cystic fibrosis revealed intermediate
   values between the controls and the patients.  Since papain and
   trypsin are not plasma endopeptidases, it becomes evident that the
   absence of alpha2-macroglobulin-protease complex in cystic fibrosis
   is due to a molecular defect within the macroglobulin.
RF 001   LOBECK CC             IN: STANBURY JB                     1605 972
   002   RAO GJS               J PEDIATR                       80   573 972
   003   RAO GJS               PEDIATR RES                      8   684 974
   004   RAO GJS               PEDIATR RES                      9   739 975
   005   WILSON GB             PEDIATR RES                     10    87 976
   007   BARRETT AJ            BIOCHEM J                      133   709 973
   008   MANCINI G             IMMUNOCHEMISTRY                  2   235 965
   009   HUNTER WM             NATURE                         194   495 962
   010   TRAVIS J              J BIOL CHEM                    240  1962 965
   011   GLASER AN             J BIOL CHEM                    236  2948 961
   012   WINZOR DJ             ARCH BIOCHEM BIOPHYS           104   202 964
   013   LAURELL CB            IN: PUTNAM FW                        246 975
CT   1   RAO GJS               PEDIATR RES                     11   981 977
     2   SHAPIRA E             CLIN CHIM ACTA                  78   359 977
     3   SHAPIRA E             J BIOL CHEM                    252  7923 977
     4   WILSON GB             PEDIATR RES                     12   801 978
     5   ALHADEFF JA           CLIN GENET                      14   189 978
     6   CHOY H                BIOCHEM BIOPHYS RES COMMUN      82  1325 978
     7   GUY GJ                CLIN CHIM ACTA                  87    63 978
     8   VIRCA GD              ANAL BIOCHEM                    89   274 978
     9   ROMEO G               NATURE                         274   909 978
    10   APPLEGARTH DA         LANCET                           2  1236 979
    11   ROMEO G               PEDIATR RES                     13  1030 979
    12   WILSON GB             PEDIATR RES                     13  1079 979
    13   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    14   BENYOSEPH Y           CLIN CHIM ACTA                  99    31 979
    15   COMINGS DE            AM J HUM GENET                  32   273 980
    16   SHAPIRA E             BIOCHEM BIOPHYS RES COMMUN      93    50 980
    17   ROMEO G               J LAB CLIN MED                  95   116 980
    18   BURDON MG             CLIN CHIM ACTA                 100   225 980
    19   PARSONS M             CLIN CHIM ACTA                 100   215 980
    20   SCHIDLOW DV           AM REV RESPIR DIS              121    31 980
    21   BENYOSEPH Y           PEDIATR RES                     15   839 981
    22   BLITZER MG            J PEDIATR GASTROENTEROL NUTR     1   289 982
    23   COX KL                J PEDIATR GASTROENTEROL NUTR     1   345 982
    24   OWENSWILLIAMS L       J PEDIATR GASTROENTEROL NUTR     1   567 982
    25   BURY AF               IRCS MED SCI BIOCHEM            10   255 982
    26   BLITZER MG            PEDIATR RES                     16   203 982
    27   ROBERTS RC            PEDIATR RES                     16   416 982
    28   BRIDGES MA            CLIN CHIM ACTA                 118    33 982
    29   TUMMLER B             CLIN CHIM ACTA                 125   219 982
    30   BUCHANAN KD           SCAND J GASTROENTEROL           18   155 983
    31   BRIDGES MA            ANN NY ACAD SCI                421   360 983
    32   SHAPIRA E             ANN NY ACAD SCI                421   352 983
    33   HJELM M               CLIN BIOCHEM                    17   284 984
    34   EAGER KB              PEDIATR RES                     18   999 984
    35   ANON                  LANCET                           2   249 985

PN 76037
RN 00392 
AN 77022473
AU Bowman-B-H.  Barnett-D-R.
TI Recent advances in cystic fibrosis research.
SO Birth-Defects. 1976. 12(6). P 197-212. (REVIEW).
MJ CYSTIC-FIBROSIS.
MN ADOLESCENCE.  ADULT.  AGGLUTINATION.  BIOLOGICAL-TRANSPORT.  CHILD.
   CHILD-PRESCHOOL.  CHLORIDES: me.  CILIA: de.  COMPLEMENT-3: me.
   COMPLEMENT: me.  CYSTIC-FIBROSIS: bl, di, me, oc, pa.
   DEPRESSION-CHEMICAL.  HUMAN.  INFANT.  INFANT-NEWBORN.  MUCUS: me.
   PRENATAL-DIAGNOSIS.  RESEARCH.  REVIEW.  SODIUM: me.
   STAINS-AND-STAINING.  SWEAT: me.  SUPPORT-U-S-GOVT-P-H-S.
EX Cystic fibrosis at one time was considered to be a lethal condition
   with death occurring at birth or within the first year of life.  With
   the advent of antibiotic therapy, pancreatic enzyme replacement,
   extensive physical therapy and generally improved medical treatment,
   many patients now survive to adulthood.  Clinical manifestations in
   CF vary from patient to patient and may include pulmonary disease,
   malnutrition, pancreatic insufficiency and defective ion transport.
   The most reliable laboratory method for diagnosis of CF is testing
   for elevated sweat electrolyte levels.  Estimates of the incidence of
   CF vary from 1 in 2000 to 1 in 3500 among white populations of
   mid-European heritage.  The disease is rare in black populations and
   almost non-existent in Orientals.  Since 1967 there has been an
   intensive search for a circulating factor or factors which may be
   directly or indirectly responsible for the malfunctions manifest in
   this disease.  Sweat factors, serum factors, metachromasia, bioassay
   variations, and properties of the ciliary inhibitor are discussed.
   Several groups working in CF research have centered their attention
   on the serum complement system.  Agglutination and mucus factors,
   transport studies, enzyme studies, and prenatal diagnosis are also
   examined.
RF 001   FANCONI G             WIEN MED WOCHENSCHR             86   753 936
   002   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   003   DI SANTAGNESE PA      AM FAM PHYSICIAN                 7   102 973
   004   WARWICK WJ            J ASTHMA RES                     5   277 968
   005   BRUSILOW SW           ANNU REV MED                    21    99 970
   006   DOERSHUK CF           GAP CONF REP DATA REG CONF               971
   008   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   009   DENNING CR            PEDIATRICS                      41     7 968
   010   KAPLAN E              N ENGL J MED                   279    65 968
   012   BLOMFIELD J           ARCH ORAL BIOL                  19  1153 974
   013   KUO PT                J PEDIATR                       60   394 962
   014   ROSENLUND ML          NATURE                         251   719 974
   015   UNDERWOOD BA          ANN NY ACAD SCI                203   237 972
   016   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   017   STEPHAN U             PEDIATRICS                      55    35 975
   018   BRUNECKY Z            J MED GENET                      9    33 972
   019   MERRITT AD            J LAB CLIN MED                  60   998 962
   020   STEINBERG AG          AM J HUM GENET                  12   416 960
   021   KULCZYCKI LL          CLIN PEDIATR                     3   692 964
   022   OPPENHEIMER EH        PEDIATRICS                      42   547 968
   023   FEINGOLD J            ANN GENET (PARIS)               17   257 974
   024   DANKS DM              ANN HUM GENET                   28   323 965
   025   WRIGHT SW             AM J HUM GENET                  20   157 968
   026   KNUDSON AG JR         AM J HUM GENET                  19   388 967
   027   STUART AB             LANCET                           2  1521 974
   028   COHEN FL              J MED GENET                     11   253 974
   029   MANGOS JA             SCIENCE                        158   135 967
   030   MANGOS JA             PEDIATR RES                      1   436 967
   031   MANGOS JA             TEX REP BIOL MED                31   651 973
   032   SPOCK A               PEDIATR RES                      1   173 967
   033   BOWMAN BH             SCIENCE                        164   325 969
   034   BESLEY GTN            J MED GENET                      6   278 969
   035   CONOVER JH            PEDIATR RES                      7   220 973
   036   CONOVER JH            PEDIATR RES                      7   224 973
   037   DANES BS              J EXP MED                      129   775 969
   038   CONOVER JH            LANCET                           1  1194 973
   040   CONOVER JH            LANCET                           2  1501 973
   041   BERATIS NG            PEDIATR RES                      7   958 973
   042   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   043   BARNETT DR            TEX REP BIOL MED                31   703 973
   044   DANES BS              J EXP MED                      137  1538 973
   045   BARNETT DR            TEX REP BIOL MED                31   697 973
   046   BOWMAN BH             SCIENCE                        167   871 970
   047   DOGGETT RG            NATURE NEW BIOL                243   251 973
   048   DOGGETT RG            TEX REP BIOL MED                31   685 973
   049   DANES BS              J EXP MED                      136  1313 972
   050   BOWMAN BH             CLIN GENET                       4   461 973
   051   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   052   CONOVER JH            LIFE SCI                        14   253 974
   053   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   054   HANN S                LANCET                           2   520 974
   055   POLLEY MJ             J MED GENET                     11   249 974
   056   BARNETT DR            PEDIATR RES                      8   687 974
   057   WILSON GB             LIFE SCI                        15   551 974
   058   WILSON GB             CLIN CHIM ACTA                  49    79 973
   059   LITT M                BIOCHEM BIOPHYS RES COMMUN      43   919 971
   060   BOWMAN BH             FED PROC                        31   842 972
   061   KHAN MA               TEX REP BIOL MED                31   665 973
   062   BALFE JW              SCIENCE                        162   689 968
   063   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   064   LAPEY A               PEDIATR RES                      5   446 971
   065   COLE CH               PEDIATR RES                      6   616 972
   066   FEIG SA               PEDIATR RES                      8   594 974
   067   HADDEN JW             PROC SOC EXP BIOL MED          142   577 973
   068   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   069$  QUISSELL DO           ANN NY ACAD SCI                203   237 972
   070   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   071   BAGLIA FA             CF CLUB ABST                          23 975
   072   BROWN GA              LANCET                           2   639 971
   073   BENKE PJ              LANCET                           1   182 972
   074   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   075   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   076   RAO GJS               J PEDIATR                       80   573 972
   077   RAO GJS               PEDIATR RES                      8   684 974
   078   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   079   RENNERT OM            CLIN PEDIATR                    11   351 972
   080   KLAGSBRUN M           IN: MANGOS JA                         53 973
   081   RENNERT OM            IN: MANGOS JA                         41 973
   082   NADLER HL             LANCET                           2    84 969
   083   NEUFELD EF            REPORT ON STAINING FOR METACH            972
   084   JACOBSON CB           CF CLUB ABST                          23 974
   085   BOLTON WE             AM J HUM GENET                  27   394 975
   086   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
CT   1   KOLLBERG H            ACTA PAEDIATR SCAND             68   639 979
     2   ANON                  CAN MED ASSOC J                121  1193 979

PN 76038
RN 00393 
AN 76254571
AU Cohen-L-F.  Lundgren-D-W.  Farrell-P-M.
TI Distribution of spermidine and spermine in blood from cystic
   fibrosis patients and control subjects.
SO Blood. 1976 Sep. 48(3). P 469-75.
MJ CYSTIC-FIBROSIS: bl.  SPERMIDINE: bl.  SPERMINE: bl.
MN CELL-FRACTIONATION.  CELL-SEPARATION.  CITRATES: bl.
   COMPARATIVE-STUDY.  HEPARIN: bl.  HUMAN.  MALE.  POLYAMINES: bl.
AB Previous studies have shown an abnormality of the spermidine-to-
   spermine (Spd/Spm) ratio in whole blood of cystic fibrosis homo-and
   heterozygotes. To investigate Spd and Spm distribution amoung blood
   components as a possible cause of the abnormality, blood was
   fractionated using Rabinowitz's glass bead technique and Boyum's
   Ficoll-Hypaque method. Free (unconjugated) polyamines were  extracted
   with perchloric acid and quantitated on an amino acid analyzer. In
   controls, mean +/- SEM concentrations in nmoles/10(9) cells of Spd
   and Spm, respectively, were 1.02 +/- 0.08 and 0.894 +/- 0.28 for
   erythrocytes; 126 +/- 31 and 357 +/- 105 for lymphocytes; 36 +/- 16
   and 240 +/- 33 for granulocytes; and less than 0.5 and less than 0.5
   nmoles/ml for plasma. When converted to the concentration in whole
   blood, it was found that greater than 90% of Spd and over 70% of Spm
   was associated with erythrocytes. While the higher cellular
   concentration in leukocytes was not unexpected, the fact that Spd and
   Spm in whole blood were primarily associated with erythrocytes was a
   new finding. Comparison with controls revealed that the Spd/Spm ratio
   in both whole blood and erythrocytes was significantly higher in the
   group of cystic fibrosis patients.
RF 001   TABOR H               ADV ENZYMOL                     36   203 972
   002   COHEN SS              INTRODUCTION TO POLYAMINES               971
   003   RUSSELL DH            IN: RUSSELL DH                         1 973
   004   SCHIMPFF SC           IN: RUSSELL DH                       395 973
   005   RENNERT OM            IN: MANGOS JA                         41 973
   006   LUNDGREN DW           CLIN CHIM ACTA                  62   357 975
   007   TAUSSIG LM            J PEDIATR                       82   380 973
   008   RABINOWITZ Y          BLOOD                           23   811 964
   009   BOYUM A               SCAND J CLIN LAB INVEST SUPPL   97    77 968
   010   ROSENTHAL SM          J PHARMACOL EXP THER           116   131 956
   011   TABOR H               PHARMACOL REV                   16   245 964
   012   GRAZIANO KD           BIOMEDICINE                     21   197 974
   013   DESSER H              CLIN CHIM ACTA                  63   243 975
CT   1   RUSSELL DH            CLIN CHEM                       23    22 977
     2   INOUE H               SEIKAGAKU                       49   411 977
     3   LUNDGREN DW           J PEDIATR                       90  1034 977
     4   ALHADEFF JA           CLIN GENET                      14   189 978
     5   DUNZENDORFER U        CANCER RES                      38  2321 978
     6   SAEKI Y               J CHROMATOGR                   145   221 978
     7   ROSENBLUM MG          SCIENCE                        200  1496 978
     8   LUNDGREN DW           AM J PHYSIOL                   234  E451 978
     9   SAVORY J              LANCET                           2  1136 979
    10   TAKAMI H              LANCET                           2   912 979
    11   RUSSELL DH            PEDIATR RES                     13  1137 979
    12   WILSON GB             J LAB CLIN MED                  93   800 979
    13   RATTENBURY JM         CLIN CHIM ACTA                  95    61 979
    14   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    15   MILANO G              ONCODEVELOP BIOL MED             1   215 980
    16   SHIPE JR              ANN CLIN LAB SCI                10   128 980
    17   BAYLIN SB             PEDIATR RES                     14   921 980
    18   GAHL WA               PEDIATR RES                     14   118 980
    19   LEISTI S              PEDIATR RES                     14   339 980
    20   SCHAEFER GB           PEDIATR RES                     14   580 980
    21   SWENDSEID ME          LIFE SCI                        26   533 980
    22   THEOHARIDES TC        LIFE SCI                        27   703 980
    23   DUNZENDORFER U        ARZNEIMITTEL FORSCH DRUG RES  30-2  1801 980
    24   LORIA D               MED (BUENOS AIRES)              40   607 980
    25   TAKAMI H              BR J CANCER                     41   751 980
    26   UEHARA N              CANCER                          45   108 980
    27   UEHARA N              GANN                            71   393 980
    28   SHIPE JR              CRC CRIT REV CLIN LAB SCI       16     1 981
    29   MOULINOUX JP          LIFE SCI                        29   955 981
    30   RUSSELL DH            NEUROLOGY                       31    80 981
    31   CHENG PW              J BIOL CHEM                    257  6251 982
    32   RUSSELL DH            CRC CRIT REV CLIN LAB SCI       18   261 983
    33   TOKUNAGA A            HIROSHIMA J MED SCI             32   127 983
    34   TOKUNAGA A            HIROSHIMA J MED SCI             32   113 983
    35   EKSTROM J             ACTA PHYSIOL SCAND             119   287 983
    36   FUJIHARA S            J CHROMATOGR                   277    53 983
    37   CHAYEN R              CELL BIOCHEM FUNCT               2    15 984
    38   SHULL GE              J THEOR BIOL                   110   461 984
    39   VORONCHIKHINA LD      LAB DELO                             443 985
    40   RAM BP                CRC CRIT REV BIOCHEM            17   257 985
    41   MOULINOUX JP          CLIN CHIM ACTA                 145    77 985
    42   VORONCHIKHINA LD      VOPR MED KHIM                   32    43 986
    43   OTA DM                INT J CANCER                    38   245 986
    44   TADOLINI B            BIOCHEM BIOPHYS RES COMMUN     134  1365 986
    45   MOULINOUX JP          EUR J CANCER CLIN ONCOL         23   237 987
    46   ISOBE K               BIOCHEM MED METAB BIOL          37   110 987

PN 76039
RN 00394 
AN 76115480
AU Gibbons-A.  Allan-J-D.  Holzel-A.  McFarlane-H.
TI Cell-mediated immunity in patients with cystic fibrosis.
SO Br-Med-J. 1976 Jan 17. 1(6002). P 120-2.
MJ CYSTIC-FIBROSIS: im.  IMMUNITY-CELLULAR.
MN ADOLESCENCE.  ADULT.  ANTIGENS.  ANTIGENS-FUNGAL.
   ASPERGILLUS-FUMIGATUS: im.  CELL-MIGRATION-INHIBITION.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: dt.  FEMALE.  GUINEA-PIGS.  HUMAN.
   INFANT.  LEUKOCYTES: im.  LUNG: im.  MACROPHAGES: im.  MALE.
   PANCREAS: im.  PREDNISOLONE: tu.  PSEUDOMONAS-AERUGINOSA: im.
AB Leucocytes from 26 patients with cystic fibrosis (CF) and 18 healthy
   controls were investigated by migration inhibition induced by a
   variety of antigens. In patients with CF cell-mediated immunity was
   found to human lung and pancreatic tissue extracts as well as to
   Aspergillus fumigatus, Pseudomonas aeruginosa, and food antigens but
   not to brain, heart, or kidney. Those patients with the severest form
   of the disease had the greatest impairment of cell-mediated immunity,
   but this impairment could be reversed by steroid treatment. Cell-
   mediated cytotoxicity may also be concerned in the pathogenesis of
   CF.
RF 001   MURRAY MJ             ANN INTERN MED                  53   548 960
   002   STEIN AA              J PEDIATR                       65   495 964
   003   MEARNS MB             THORAX                          20   385 965
   004   MEARNS MB             LANCET                           1   538 967
   005   WARREN CPW            CLIN ALLERGY                     5     1 975
   006   MCFARLANE H           BR MED J                         1   423 975
   007   SOBORG M              ACTA MED SCAND                 181   247 967
   008   MORLEY J              IN: WEIR DM                      2    20 973
   009   PEPYS J               PROC INT CONG ALLERGOLOGY        6   221 968
   010   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   011   CRACCO G              PROC EWGCF 5TH ANNU MTG               16 974
   012   GELL PGH              CLINICAL ASPECTS OF IMMUNOLOG            968
   013   MCFARLANE H           CF NEWS                         10     6 975
CT   1   FEIGHERY C            BR MED J                         1   524 976
     2   MCFARLANE H           LANCET                           1  1241 976
     3   ANON                  NUTR REV                        34   210 976
     4   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     5   RAEBURN JA            PROC NUTR SOC                   36    77 977
     6   GORMAN NT             J NATL CANCER INST              61  1095 978
     7   GOTZ M                EUR J PEDIATR                  127   133 978
     8   HOIBY N               ACTA PAEDIATR SCAND             68   495 979
     9   HODSON ME             THORAX                          35   801 980
    10   MIELIVERGANI G        ARCH DIS CHILD                  55   696 980
    11   MARESZBABCZYSZYN J    ARCH IMMUNOL THER EXP           31   199 983
    12   MARESZBABCZYSZYN J    ARCH IMMUNOL THER EXP           31   217 983
    13   PORWOLL JM            INFECT IMMUN                    40   670 983
    14   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985
    15   FERGUSON A            HUM NUTR CLIN NUTR             40C   255 986

PN 76040
RN 00395 
AN 76254863
AU Williams-A-J.  McKiernan-J.  Harris-F.
TI Letter: Heat prostration in children with cystic fibrosis.
SO Br-Med-J. 1976 Jul 31. 2(6030). P 297.
MJ CYSTIC-FIBROSIS: co.  HEAT-EXHAUSTION: co.
MN CHILD.  CHILD-PRESCHOOL.  FEMALE.  HUMAN.  HYPONATREMIA: co.
   MALE.
EX We wish to report three cases of hyponatraemic dehydration in
   children with cystic fibrosis admitted to this hospital in late June
   and early July this year.  These three children with cystic fibrosis
   clearly illustrate the danger of the present unusual climatic
   conditions.  The necessity of salt supplementation in these
   environmental circumstances should be emphasised to all concerned
   and, above all, to parents.  The danger of the administration of
   salt-free glucose solutions also should be borne in mind.  In the
   past the case has been argued for a safe electrolyte solution that
   would be commercially available.  In the absence of such a readily
   available form of electrolyte-glucose solution parents will need
   explicit instructions on how the salt supplement should be
   administered.
RF 001   ANON                  BR MED J                         1   125 971


PN 76041
RN 00396 
AN 77023000
AU Hodson-M-E.  Mearns-M-B.  Batten-J-C.
TI Meconium ileus equivalent in adults with cystic fibrosis of
   pancreas: a report of six cases.
SO Br-Med-J. 1976 Oct 2. 2(6039). P 790-1.
MJ CYSTIC-FIBROSIS: co.  INTESTINAL-OBSTRUCTION: et.
MN ACETYLCYSTEINE: tu.  ADOLESCENCE.  ADULT.  CASE-REPORT.  COLON: ra.
   DIABETES-MELLITUS: co.  ENEMA.  FEMALE.  HUMAN.
   INTESTINAL-OBSTRUCTION: dt, su.  INTESTINE-SMALL: ra, su.  MALE.
AB Eleven episodes of "meconium ileus equivalent" have been seen in six
   adults with cystic fibrosis of the pancreas. Three patients were
   initially treated surgically; one died and the other two developed
   serious postoperative chest infections. Six episodes were
   successfully treated medically with acetylcysteine orally and by
   enema, nasogastric suction, and intravenous fluids. Operation should
   be avoided if possible, and maintenance treatment with acetylcysteine
   may be necessary to prevent relapse.
RF 001   DONNISON AB           PEDIATRICS                      37   833 966
   002   LEVY E                ARCH DIS CHILD                  26   335 951
   003   FISHER OD             ARCH DIS CHILD                  29   262 954
   004   FANCONI A             HELV PAEDIATR ACTA              15   566 960
   005   HUNTON DB             GASTROENTEROLOGY                50    99 966
   006   KOPEL FB              GASTROENTEROLOGY                62   483 972
   007   DI SANTAGNESE PA      PEDIATRICS                      19   252 957
   008   JOHANSEN PG           BIOCHEM J                       87    63 963
   009   THOMAIDIS TS          J PEDIATR                       63   444 963
   010   HALLBERG D            ACTA CHIR SCAND                128   201 964
   011   SNYDER WH JR          PEDIATRICS                      34    72 964
   012   GARNHAM JR            GUT                              5   256 964
   013   MULLINS F             JAMA                           192   741 965
   014   LILLIBRIDGE CB        J PEDIATR                       71   887 967
   015   GRACEY M              ARCH DIS CHILD                  44   404 969
   016   HANDWERGER S          N ENGL J MED                   281   451 969
CT   1   PRESCOTT LF           LANCET                           2   432 977
     2   ANGERPOINTNER T       Z KINDERCHIR GRENZGEB           24    99 978
     3   BENGHIAT A            BR J SURG                       65   215 978
     4   HOWIE AD              SCOTT MED J                     24   193 979
     5   SAUVEGRAIN J          J RADIOL ELECTROL MED NUCL      60     3 979
     6   SANTAGNESE PAD        AM J MED                        66   121 979
     7   ROGERS LF             RADIOLOGY                      133   807 979
     8   FERRARI V             EUR J RESPIR DIS                61   151 980
     9   REDMOND AOB           PRACTITIONER                   224   295 980
    10   PILLING DW            BR J RADIOL                     54   562 981
    11   PARK RW               GASTROENTEROLOGY                81  1143 981
    12   TABACHNIK NF          SURG GYNECOL OBSTET            152   837 981
    13   ZENTLERMUNRO PL       BR J HOSP MED                   28   653 982
    14   ROSENSTEIN BJ         J PEDIATR GASTROENTEROL NUTR     2   299 983
    15   BRECHER DB            AM FAM PHYSICIAN                28   187 983
    16   AZMY AF               Z KINDERCHIRURGIE               38   253 983
    17   ROSENBERG E           KLIN PAEDIATR                  195   323 983
    18   HANLY JG              BR MED J                       286  1411 983
    19   MEARNS MB             ARCH DIS CHILD                  60   272 985
    20   BERKIN KE             EUR J RESPIR DIS                67   103 985
    21   ISPIZUA AU            REV CLIN ESP                   176   417 985
    22   CLEGHORN GJ           LANCET                           1     8 986
    23   ZENTLERMUNRO P        LANCET                           1   328 986
    24   KOHLER JA             J CLIN HOSP PHARM               11    21 986
    25   OHALLORAN SM          ARCH DIS CHILD                  61  1128 986
    26   RUBINSTEIN S          PEDIATRICS                      78   473 986
    27   WELLER PH             J ROY SOC MED                   79    36 986
    28   BAILEY DJ             PEDIATRICS                      79   281 987

PN 76042
RN 00397 
AN 76137278
TI Letter: Cell-mediated immunity in patients with cystic fibrosis.
SO Br-Med-J. 1976 Feb 28. 1(6008). P 524.
MJ IMMUNITY-CELLULAR.
MN CYSTIC-FIBROSIS: dt.  HUMAN.  IMMUNITY-CELLULAR: de.
   PREDNISOLONE:  pd.
EX We agree with the comment of Dr Feighery and Mr Woods that a low
   migration index signifies sensitivity to an antigen which can be
   achieved only by functionally active immunocompetent cells.  However,
   we must emphasise that the functions of active immunocompetent cells
   may or may not be impaired, depending upon the antigens to which such
   cells are sensitised.  Since comparative cells from age-matched
   controls and from blood donors did not show such sensitisation to
   those antigens to which the cystic fibrosis cells were sensitised
   then there is no doubt that the normal function of these
   immunocompetent cells in the patients with CF is indeed impaired.
   When one considers that steroids are known immunosuppressants it is
   certainly not surprising that treatment of the CF patients with
   prednisolone caused a decreased sensitivity of these sensitised CF
   cells to the antigens.  Indeed, therapeutic concentrations of
   steroids were able to reduce the ability of sensitised spleen cells
   and of lymph-node cells to destroy target cells in vitro.  Apart from
   this inhibition of sensitised cells by steroids, 90% of sensitised
   lymphocytes were killed when prednisolone 1 mg/l was present during
   the sensitisation phase.  In addition it was observed in man that if
   cortisol or prednisolone was given two hours before abrading the
   skin, then there occurred a marked reduction of emigrations of both
   mononuclear cells and polymorphs into the area, thus inhibiting the
   mobilisation of macrophages.  We believe that the situation with
   regard to steroid therapy and inhibition of migration of leukocytes
   from CF patients is similar.
RF 001   GIBBONS A             BR MED J                         1   120 976
   002   ROSENAU W             J IMMUNOL                       89   422 962
   003   COHEN IR              J EXP MED                      132  1055 970
   004   BOGGS DR              AM J PATHOL                     44   763 964
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977

PN 76043
RN 00398 
AN 76207946
AU Cooperman-E-M.
TI Cystic fibrosis: physiology gone wrong.
SO Can-Med-Assoc-J. 1976 Jun 19. 114(12). P 1082-3.
MJ CYSTIC-FIBROSIS: pp.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  HUMAN.  INFANT.
   INFANT-NEWBORN.  INTESTINAL-OBSTRUCTION: pp.
   INTESTINAL-SECRETIONS:  ph.  INTUSSUSCEPTION: pp.
EX Cystic fibrosis (CF), like syphilis, could accurately be described as
   "the great imitator."  Many organ systems are involved, and a clear
   understanding of the disease and its many complications is a useful
   exercise in understanding human physiology.  CF could be called
   thick-secretion disease, because all exocrine fluids, like pancreatic
   juice, are thick, or it could be called multimystery disease, because
   there are so many unanswered questions about it.  Many manifestations
   of CF are understandable complications of malabsorption, malnutrition
   and the physical and chemical effects of abnormal exocrine secretion;
   others, including the susceptibility to recurrent nasal polyps, the
   hypersalinized sweat, low female fertility and male sterility, given
   present knowledge, do not make physiologic sense.
RF 001   KAPLAN E              N ENGL J MED                   279    65 968
   002   NOLAN AJ              CAN MED ASSOC J                114   142 976
   003   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   004   DARLING RC            AM J MED SCI                   225    67 953
   005   SHWACHMAN H           ANN NY ACAD SCI                 93   600 962
   006   GIBSON LE             PEDIATRICS                      23   545 959
   007   KOPEL FB              GASTROENTEROLOGY                62   483 972
   008   BERK RN               RADIOLOGY                      106   377 973
   009   DONNISON AB           PEDIATRICS                      37   833 966
   010   THOMAIDIS TS          J PEDIATR                       63   444 963
   011   SHWACHMAN H           N ENGL J MED                   286  1300 972
   012   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   013   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   014   FALLIS JC             CAN MED ASSOC J                114    38 976
   015   HOLSCLAW DS           PEDIATRICS                      48    51 971
   016   JENSEN KG             ACTA PAEDIATR SCAND             51   344 962

PN 76044
RN 00399 
AN 76163065
AU Webb-T.  Harnden-D-G.
TI The transformation by simian virus 40 of cells from patients with
   mucopolysaccharidosis and from normal controls.
SO Cancer-Res. 1976 Feb. 36(2 Pt 1). P 298-301.
MJ CELL-TRANSFORMATION-NEOPLASTIC.  MUCOPOLYSACCHARIDOSIS.
   SV40-VIRUS.
MN ADSORPTION.  CELL-LINE.  CELLS-CULTURED.  COMPARATIVE-STUDY.
   CYSTIC-FIBROSIS.  FIBROBLASTS.  GANGLIOSIDOSIS.  GAUCHERS-DISEASE.
AB Fibroblasts derived from individuals with mucopolysaccharidosis, an
   inborn error of metabolism, have been found to be more easily
   transformed by simian virus 40 than are cells derived from normal
   individuals. The increased susceptibility does not seem to depend
   upon changes in glycoprotein at the cell surface. Repeated
   observations were necessary to demonstrate these differences, and we
   do not believe that this test is suitable for routine screening for
   cancer susceptibility.
RF 001   AARONSON SA           J VIROL                          6   470 970
   002   AARONSON SA           NATURE                         228   359 970
   003   AARONSON SA           VIROLOGY                        36   254 968
   004   DANES BS              J EXP MED                      123     1 966
   005   KERSEY JH             PROC NAT ACAD SCI USA           69   980 972
   006   KOPROWSKI H           J CELL COMP PHYSIOL             59   281 962
   007   LEVIN S               ISR J MED SCI                    8   133 972
   008   MILLER RW             LANCET                           1    81 969
   009   MUKERJEE D            CANCER RES                      30  1769 970
   010   MUKERJEE D            CANCER RES                      32  1518 972
   011   MUKERJEE D            IN: BURDETTE WJ                      314 970
   012   POTTER AM             BR J CANCER                     31   348 975
   013   SHEIN HM              PROC NAT ACAD SCI USA           48  1164 962
   014   SNYDER AL             LANCET                           1   586 970
   015   TODARO GJ             NAT CANCER INST MONOGRAPH       29   271 969
   016   TODARO GJ             SCIENCE                        153  1252 966
   017   TODARO GJ             PROC SOC EXP BIOL MED          124  1232 967
   018   VELDHUISEN G          LANCET                           2   529 970
   019   YOUNG D               LANCET                           1   294 971
   020   YOUNG D               EUR J CANCER                     7   337 971
CT   1   WEBB T                BR J CANCER                     36   583 977
     2   WEBB T                CANCER RES                      37   997 977
     3   LI FP                 CANCER                          39  2633 977
     4   CONRAD GW             J BIOL CHEM                    252  6861 977
     5   SACK GH               IN VITRO                        17     1 981
     6   HAFEZ M               CANCER                          55  2434 985

PN 76045
RN 00400 
AN 76208332
AU Schneyer-C-A.  Wilborn-W-H.
TI Effects of cystic fibrosis serum on the rat parotid gland.
SO Cell-Tissue-Res. 1976 Jun 11. 169(1). P 111-21.
MJ CYSTIC-FIBROSIS: bl.  PAROTID-GLAND: de.
MN ANIMAL.  ATROPHY.  CHILD.  CYSTIC-FIBROSIS: im.  FEMALE.  HUMAN.
   MITOSIS: de.  PAROTID-GLAND: im, ul.  RATS.  TISSUE-EXTRACTS: pd.
   SUPPORT-U-S-GOVT-P-H-S.
AB Injections of serum from human patients with cystic fibrosis into
   adult rats caused pronounced structural modifications and increased
   mitotic rate in the parotid gland. Mitotic rate was increased from a
   low level of 0.02/1,000 acinar cells in parotid glands of adult rats
   to 6.5/1,000 acinar cells after 2 or 3 days of serum injection. At
   the light and electron microscopic levels, significant acinar cell
   atrophy and degranulation were observed. Cellular necrosis, and
   increases in quantity of lysosome-like dense bodies, mast cells, and
   macrophages were also detected. These changes are suggestive of
   tissue response to injurious foreign protein. Furthermore, the fact
   that normal sera pronounced the same kind of effects (but greatly
   reduced in extent) strengthens the view that these effects result
   from the immunologic response of the host organ to foreign antigen.
   Since, however, the responses of the rat parotid to cystic fibrosis
   serum were considerably more marked than those elicited by normal
   serum, the rat parotid may thus have potential usefulness in assaying
   for the presence of human cystic fibrosis factor.
RF 001   BLOMFIELD J           GUT                             14   558 973
   002   BOWMAN BH             IN: MANGOS JA                         29 973
   003   BOWMAN BH             SCIENCE                        164   325 969
   004   BURTON K              BIOCHEM J                       62   315 956
   005   CERIOTTI GJ           J BIOL CHEM                    214    59 955
   006   CONOD EJ              PEDIATR RES                      9   724 975
   007   DALCQ AM              IN: DE REUCK AVS                         963
   008   DOGGETT RG            TEX REP BIOL MED                31   685 973
   009   DEDUVE C              ANNU REV PHYSIOL                28   435 966
   010   EL-MOFTY S            EXPERIENTIA                     30   950 974
   011   ERSHOFF BH            PROC SOC EXP BIOL MED          110   262 965
   012   HERZBERG VL           AM J HUM GENET                  24   46A 972
   013   KABAT EA              EXPERIMENTAL IMMUNOCHEMISTRY             961
   014   RUTBERG U             ACTA ODONT SCAND SUPPL 30       19    11 961
   015   SCHNEYER CA           IN: GOSS R                               972
   016   SIMSON JV             Z ZELLFORSCH MIKROSK ANAT      101   175 969
   017   SPOCK A               PEDIATR RES                      1   173 967
   018   WEIL-MALBERBE H       METHODS BIOCHEM ANAL            16   293 968
   019   WILBORN WH            Z ZELLFORSCH MIKROSK ANAT      103     1 970
   020   WILBORN WH            Z ZELLFORSCH MIKROSK ANAT      130   471 972
CT   1   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     2   OLIVER C              AM J ANAT                      155   185 979
     3   HAND AR               ARCH ORAL BIOL                  26   369 981
     4   VONEULER AM           ULTRASTRUCTURAL PATHOL           5    37 983
     5   QWARNSTROM EE         J ORAL PATHOL                   12   430 983
     6   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983
     7   ROOMANS GM            ANN NY ACAD SCI                428   121 984
     8   VONEULER AM           EXP MOL PATH                    43   142 985

PN 76046
RN 00401 
AN 77001949
AU Wallwork-J-C.  McFarlane-H.
TI The SIgA system and hypersensitivity in patients with cystic
   fibrosis.
SO Clin-Allergy. 1976 Jul. 6(4). P 349-58.
MJ CYSTIC-FIBROSIS: co.  HYPERSENSITIVITY: et.  IGA.  IGA-SECRETORY.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: im.
   DYSGAMMAGLOBULINEMIA: et.  FEMALE.  HUMAN.  IGA: an.
   IGA-SECRETORY:  an.  IGE: an.  IMMUNOGLOBULINS-J-CHAIN: an.  INFANT.
   MALE.  SALIVA:  im.  SPUTUM: im.
AB A number of investigations have been used for the first time to
   examine the secretory IgA (SIgA) system in different body fluids from
   patients with cystic fibrosis (CF). Free J-chain was detected in all
   the sputum specimens examined. The isolated free secretory component
   (SC) from CF sputum differed in electrophoretic mobility from the SC
   isolated from normal human colostrum. In addition the free SC from
   some CF saliva formed precipitin lines of partial identity with
   normal human saliva or colostrum. A higher proportion of CF sera
   (33%) than of normal sera (10%) contained free SC. These
   investigations suggest that there may be some defect in the synthesis
   and/or the assembly of the SIgA immunoglobulins, which if confirmed,
   may help to explain the impaired Type I and Type III allergic
   manifestations in patients with CF.
RF 001   ALLAN JD              CLIN ALLERGY                     5   255 975
   003   CUATRECASAS P         PROC NAT ACAD SCI USA           61   636 968
   004   GRABAR P              IN: GRABAR P                           3 964
   005   KOHN J                J CLIN PATHOL                   23   733 970
   006   MANCINI G             IMMUNOCHEMISTRY                  2   235 965
   007   MEINKE GC             J IMMUNOL                      112  1401 974
   008   MCFARLANE H           BR MED J                         1   423 975
   009   NEVILLE DM            J BIOL CHEM                    246  6328 971
   010   OUCHTERLONY O         IN: KALTOS P                     5     1 958
   011   TAYLOR B              LANCET                           2   111 973
   012   THOMPSON RA           LANCET                           2   517 962
   013   TOMASI TB JR          J IMMUNOL                      112  2274 974
   014   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   015   WARNER JO             PROC EWGCF 5TH ANNU MTG                  975
CT   1   RAEBURN JA            PROC NUTR SOC                   36    77 977
     2   HOIBY N               MONOGR PAEDIATR                 10   138 979
     3   PRYJMA J              MONOGR PAEDIATR                 10   125 979
     4   HOIBY N               ACTA PAEDIATR SCAND             68   495 979
     5   HODSON ME             THORAX                          35   801 980
     6   TOBIN MJ              THORAX                          35   807 980
     7   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
     8   MOSS RB               CLIN EXP IMMUNOL                47   301 982
     9   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
    10   FICK RB               J CLIN INVEST                   74   236 984
    11   HANCOCK REW           J INFECT DIS                   149   220 984
    12   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985

PN 76047
RN 00402 
AN 76234309
AU Shakib-F.  Stanworth-D-R.  Smalley-C-A.  Brown-G-A.
TI Elevated serum IgG4 levels in cystic fibrosis patients.
SO Clin-Allergy. 1976 May. 6(3). P 237-40.
MJ CYSTIC-FIBROSIS: im.  IGG: an.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  FEMALE.  HUMAN.
   HYPERSENSITIVITY-IMMEDIATE: di.  INFANT.  MALE.
AB The quantitative measurement of the IgG subclass composition of the
   sera from sixteen patients with cystic fibrosis has revealed grossly
   elevated levels of IgG4 in seven patients. The possible significance
   of this observation is discussed in relation to recent reports of a
   high incidence of immediate-type hypersensitivity in such patients.
RF 001   ALLAN JD              CLIN ALLERGY                     5   255 975
   002   ANDERSON BR           NATURE                         217   174 968
   003   BERATIS NG            PEDIATR RES                      7   958 973
   004   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   005   CONOVER JH            PEDIATR RES                      7   224 973
   006   DANES BS              J EXP MED                      137  1538 973
   007   DEVEY M               THESIS                                   974
   008   MORELL A              J PEDIATR                       80   960 972
   009   MCLAUGHLAN P          PROC INT IMMUNOL CONG 2ND                974
   010   PARISH WE             LANCET                           2   591 970
   011   PARISH WE             IN: BRENT L                      4       974
   012   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   013   SHAKIB F              J IMMUNOL METH                   8    17 975
   014   SPOCK A               PEDIATR RES                      1   173 967
   015   STANWORTH DR          CLIN ALLERGY                     3    37 973
   016   VAN DER GIESSEN M     CLIN EXP IMMUNOL                21   501 975
CT   1   MCFARLANE H           CLIN ALLERGY                     7   279 977
     2   SHAKIB F              BR J DERMATOL                   97    59 977
     3   TURNER MW             ARCH DIS CHILD                  53   631 978
     4   SHAKIB F              CLIN ALLERGY                     9   597 979
     5   CARSWELL F            MONOGR PAEDIATR                 10   144 979
     6   CARSWELL F            CLIN EXP IMMUNOL                35   141 979
     7   SHAKIE F              RIC CLIN LAB                    10   561 980
     8   TOBIN MJ              THORAX                          35   807 980
     9   LEA T                 ACTA DERM VENEREOL SUPPL 92   1980    73 980
    10   MARGOLIES R           PEDIATR RES                     16   181 982
    11   SCHLUEDERBERG A       YALE J BIOL MED                 55   317 982
    12   WUTHRICH B            DERMATOLOGICA                  166   229 983
    13   STANLEY PJ            CLIN EXP IMMUNOL                58   703 984
    14   HEINER DC             AM J MED                        76     1 984
    15   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985
    16   SHRYOCK TR            CURRENT MICROBIOL               12    91 985
    17   MOSS RB               MONOGR ALLERGY                  19   202 986
    18   MOSS RB               PEDIATR RES                     20   453 986
    19   SHRYOCK TR            J CLIN MICROBIOL                23   513 986
    20   FICK RB               AM REV RESPIR DIS              133   418 986
    21   SCHUR PH              ANN ALLERGY                     58    89 987
    22   MOSS RB               CHEST                           91   522 987

PN 76048
RN 00403 
AN 77024509
AU Tocci-P-M.  McKey-R-M-Jr.
TI Laboratory confirmation of the diagnosis of cystic fibrosis.
SO Clin-Chem. 1976 Nov. 22(11). P 1841-4.
MJ CYSTIC-FIBROSIS: di.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  CHLORIDES: me.
   CYSTIC-FIBROSIS: me.  DIAGNOSIS-LABORATORY.  ELECTRODES.  FEMALE.
   HUMAN.  INFANT.  IONTOPHORESIS.  MALE.  METHODS.  PHOTOMETRY.
   PILOCARPINE: du.  POTASSIUM: me.  QUALITY-CONTROL.  SODIUM: me.
   SWEAT: me.  SUPPORT-U-S-GOVT-NON-P-H-S.
AB The recent commercial introduction of a method for detecting albumin
   in meconium makes screening for cystic fibrosis feasible for many
   hospitals. If the tests is adopted, confirmatory tests should be
   available. Quantitative analyses of sweat for sodium by flame
   photometry and for chloride by silver titration and ion-sleective
   electrodes are now used as confirmatory tests. We compare results of
   these confirmatory methods applied to presons with cystic fibrosis,
   respiratory disorders, or digestive disorders, and to control
   subjects.
RF 001   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            963
   002   DOERSHUK CF           J PEDIATR                       65   677 964
   003   SHWACHMAN H           PEDIATRICS                      46   335 970
   004   STEPHAN U             IN: MANGOS JA                        281 973
   005   BUCHANAN DJ           PEDIATRICS                       9   304 952
   006   RULE AH               PEDIATRICS                      45   847 970
   007   SITZMANN FC           PADIATRISCHE PRAXIS             11    85 972
   008   DARLING RC            AM J MED SCI                   225    67 953
   009   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   010   SHWACHMAN H           ADV PEDIATR                      7   249 955
   011   GIBSON LE             PEDIATRICS                      23   545 959
   012   SHWACHMAN H           PEDIATRICS                      30   167 962
   013   GIBSON LE             GAP CONF REP PROB SWEAT TESTI            975
   014   ANON                  J PEDIATR                       88   711 976
   015   KOPITO L              PEDIATRICS                      43   794 969
   016   SHWACHMAN H           PEDIATRICS                      32    85 963
   017   GALEN RS              BEYOND NORMALITY THE PREDICTI            975
   018   COLEMAN RL            CLIN CHEM                       19  1319 973
CT   1   WARWICK WJ            CLIN CHEM                       24  2050 978
     2   BOWLING SA            AM J MED TECHNOLOGY             48    25 982
     3   RANDOLPH VS           AM J MED TECHNOLOGY             48    15 982
     4   WEBSTER HL            CRC CRIT REV CLIN LAB SCI       18   313 983

PN 76049
RN 00404 
AN 76234389
AU Tarnoky-A-L.  Bayliss-V-M.  Bowen-H-J.  Burnow-R-N.  Sherington-J.
TI The use of electrolyte measurements in the detection of cystic
   fibrosis.
SO Clin-Chim-Acta. 1976 Jun 15. 69(3). P 505-13.
MJ CHLORIDES: me.  CYSTIC-FIBROSIS: di.  SODIUM: me.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  COMPARATIVE-STUDY.
   CYSTIC-FIBROSIS: fg, me.  FEMALE.  HETEROZYGOTE.  HUMAN.  MALE.
   MIDDLE-AGE.  NAILS: me.  PILOCARPINE: du.  PROBABILITY.  SALIVA: me.
   SWEAT: me.
AB Six tests recommended for use in the diagnosis of cystic fibrosis
   (CF) have been compared in the same subjects. The tests were carried
   out on 165 normal persons, 64 known cases of CF, their 67 parents and
   18 sibs. The tests measured sodium in fingernails by activation,
   sodium in saliva and chloride in saliva and in thermal and
   pilocarpine-induced sweat by means of ion-specific electrodes, and
   chloride in pilocarpine-sweat by the standard titrimetric method. The
   tests ranged in complexity from simple screening methods to
   individual clinical procedures. None of the simpler tests matched the
   standard pilocarpine method in diagnostic efficiency, whether they
   were used singly or in combination.
RF 001   BRIMBLECOMBE FSW      LANCET                           2  1428 973
   002   GIBSON LE             PEDIATRICS                      23   545 959
   003   KOPITO L              PEDIATRICS                      43   794 969
   004   BUFFATTI G            FRACASTORO (VERONA)             63   307 970
   005   GURSON CT             HELV PAEDIATR ACTA              28   165 973
   006   SZABO L               CLIN CHEM                       19   727 973
   007   TARNOKY AL            CLIN BIOCHEM                     4    29 971
   008   SCHALES O             J BIOL CHEM                    140   879 941
   009   LAWSON D              ARCH DIS CHILD                  44   715 969
   010   BOWEN HJM             INT ATOMIC ENERGY AGENCY REP   122   145 970
   011   BOX GEP               J ROY STATIST SOC (B)           26   211 964
   012   KENDALL MG            ADVANCED THEORY OF STATISTICS    3       966
   013   LACHENBRUCH PA        TECHNOMETRICS                   10     1 968
   014   KOLLBERG H            ACTA PAEDIATR SCAND             63   405 974
   015   KOLLBERG H            ACTA PAEDIATR SCAND             63   411 974
CT   1   BRAY PT               CLIN CHIM ACTA                  80   333 977
     2   TARNOKY AL            J ROY SOC MED                   73    73 980
     3   HEELEY AF             CLIN CHEM                       29  2011 983

PN 76050
RN 00405 
AN 76163916
AU Bardon-A.  Slerakowska-H.  Shugar-D.
TI Purification and properties of human acid-thermostable
   ribonucleases, and diagnosis of childhood pancreatic fibrosis.
SO Clin-Chim-Acta. 1976 Mar 15. 67(3). P 231-43.
MJ CYSTIC-FIBROSIS: di.  RIBONUCLEASES: me.
MN CHILD.  COPPER: pd.  CYSTIC-FIBROSIS: en.  DUODENUM: en.  HUMAN.
   KINETICS.  LIVER: en.  ORGAN-SPECIFICITY.  PANCREAS: en.
   HYDROGEN-ION-CONCENTRATION.  RIBONUCLEASES: bl, ip.  SPLEEN: en.
   ZINC: pd.
AB Acid-thermostable ribonucleases were isolated from human pancreas,
   duodenal contents, liver, spleen, serum and urine, and purified 15--
   1000-fold. The pH optima, ionic requirements, and some of the
   specificity requirements, of these enzymes were investigated. The
   isolated enzymes formed two distinct groups: (a) The ribonucleases of
   the pancreas, duodenal contents and fraction A of serum and urine
   exhibit a pH optimum of 8.5, are inhibited by An2+ and Cu2+, and
   relatively rapidly hydrolyze the synthetic substrate uridine 3'-
   (alpha-naphthylphosphate); (b) the ribonucleases of the liver and
   spleen, and of fractions B of the serum and urine, with a pH optimum
   of 7, are less sensitive to An2+ and Cu2+, and exhibit negligible
   activity versus uridine 3'-(alpha-naphthylphosphate). Determination
   of the serum level of pancreatic-type ribonuclease activity, with the
   use of uridine 3'-(alpha-naphthylphosphate) or RNA as substrates,
   appears to be a valid diagnostic tool for pancreatic fibrosis in
   children.
RF 001   ZAN-KOWALCZEWSKA M    BIOCHIM BIOPHYS ACTA           341   138 974
   002   ALPERS DH             J BIOL CHEM                    242  5617 967
   003   DAVIDSON SJ           EXP CELL RES                    67   171 971
   004   DAVIDSON SJ           J CELL BIOL                     59   213 973
   005   DELANEY R             BIOCHEMISTRY                     2   438 963
   006   NASKALSKI J           PRZEGL LEK                      29   394 972
   007   NASKALSKI J           PRZEGL LEK                      29   548 972
   008   SZNAJD J              FOLIA MED CRACOV                14   297 972
   009   NASKALSKI J           PRZEGL LEK                      29   295 972
   010   CONNOLLY JH           BR J EXP PATHOL                 43   402 962
   011   LEEPER RD             J CLIN ENDOCRINOL METAB         23   426 963
   012   BARDON A              ACTA BIOCHIM POLON              14   341 967
   013   SZER W                BIOCHEM PREP                    10   139 963
   014   KOLE R                ACTA BIOCHIM POLON              18   187 971
   015   REISFELD RA           NATURE                         195   281 962
   016   GABRIEL O             IN: JAKOBY WV                   22   565 971
   017   DAVIS MT              ANALYST                         84   248 959
   018   BEARD JR              J BIOL CHEM                    239  4186 964
   019   RAZZELL WE            METHODS ENZYMOL                  6   236 963
   020   SUNG SC               J BIOL CHEM                    237   506 962
   021   BESSEY OA             J BIOL CHEM                    196   175 952
   022   LOWRY OH              J BIOL CHEM                    193   265 951
   023   KAPLAN HS             J BIOL CHEM                    222   907 956
   024   GORDON J              ARCH BIOCHEM BIOPHYS           112   421 965
   025   BERMAN LB             PROC SOC EXP BIOL MED           97   175 958
   026   SCHULTZE-JENA BS      IN: KOCH E                            43 964
   027   RESSLER N             NATURE                         210   695 966
   028   HOUCK JC              ARCH BIOCHEM BIOPHYS            73   384 958
   029   POLATNICK J           PROC SOC EXP BIOL MED          105   486 960
   030   GUPTA S               ARCH BIOCHEM BIOPHYS           101    88 963
   031   EICHEL HJ             ARCH BIOCHEM BIOPHYS           107   197 964
   032   BARNARD EA            NATURE                         221   340 969
CT   1   SZCZESNAKACZMAREK A   EXPERIENTIA                     32  1499 976
     2   BARDON A              BIOCHIM BIOPHYS ACTA           438   461 976
     3   KOLE R                BIOCHIM BIOPHYS ACTA           438   540 976
     4   REDDI KK              PREPAR BIOCHEM                   7   283 977
     5   SIERAKOWSKA H         PROG NUCLEI ACID RES MOL BIOL   20    59 977
     6   RABIN EZ              CLIN CHIM ACTA                  78   235 977
     7   NEUWELT EA            BIOCHEM J                      163   419 977
     8   GAHL WA               BIOCHEM MED                     19   294 978
     9   NEUWELT EA            CANCER RES                      38    88 978
    10   WARSHAW AL            SURGERY                         86   227 979
    11   AKSOY M               EUR J CANCER                    16  1041 980
    12   BARDON A              CLIN CHIM ACTA                 101    17 980
    13   CRANSTON JW           BIOCHIM BIOPHYS ACTA           616   239 980
    14   THOMAS JM             ELECTROPHORESIS                  2   104 981
    15   REDDI KK              CLIN BIOCHEM                    14   191 981
    16   BLANK A               BIOCHEMISTRY                    20  2261 981
    17   SUGIYAMA RH           BIOCHEMISTRY                    20  2268 981
    18   CRANSTON JW           CLIN CHEM                       27  1362 981
    19   IWAMA M               J BIOCHEM                       89  1005 981
    20   THOMAS JM             CLIN CHIM ACTA                 111   199 981
    21   THOMAS JM             CLIN CHIM ACTA                 111   185 981
    22   MARET A               C R ACAD SCI SER III           293   741 981
    23   WEICKMANN JL          J BIOL CHEM                    257  8705 982
    24   FABRIS C              IRCS MED SCI BIOCHEM            11   775 983
    25   KUROKAWA E            CLIN CHIM ACTA                 128    83 983
    26   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983
    27   WEICKMANN JL          CANCER RES                      44  1682 984
    28   BARDON A              ACTA PAEDIATR SCAND             73   263 984
    29   HISHIKI S             CLIN CHIM ACTA                 136   155 984
    30   THOMAS JM             CLIN CHIM ACTA                 142    73 984
    31   DEPRISCO R            BIOCHIM BIOPHYS ACTA           788   356 984
    32   CEDER O               ACTA PAEDIATR SCAND             74   102 985
    33   NIWATA Y              J BIOCHEM                       97   923 985
    34   BEINTEMA JJ           MOL BIOL EVOLUT                  3   262 986
    35   JUNG K                J CLIN CHEM CLIN BIOCHEM        24   243 986
    36   SHAPIRO R             BIOCHEMISTRY                    25  7255 986
    37   HITOI A               J BIOCHEM                      101    29 987

PN 76051
RN 00406 
AN 76234394
AU Biswas-S.  Norman-A-P.  Baffoe-G.  Graves-L.
TI Prolactin, growth hormone and alpha-fetoprotein in children with
   cystic fibrosis.
SO Clin-Chim-Acta. 1976 Jun 15. 69(3). P 541-2.
MJ ALPHA-FETOPROTEINS: me.  CYSTIC-FIBROSIS: bl.  FETAL-PROTEINS: me.
   PROLACTIN: bl.  SOMATOTROPIN: bl.
MN ADULT.  CHILD.  FEMALE.  HUMAN.  MENSTRUATION.  MICROCHEMISTRY.
   PREGNANCY.  RADIOIMMUNOASSAY: mt.
EX Prolactin is credited to have a role in the maintenance of
   electrolytic and water balance by the kidneys although its effect on
   the composition of sweat is unknown.  We assayed prolactin, growth
   hormone and alpha-fetoprotein in the sera of 69 children with cystic
   fibrosis attending the Hospital for Sick Children.  Sera from 12
   children without cystic fibrosis were used as control.  It appears
   that children with cystic fibrosis have serum levels of prolactin, GH
   and alpha-FP similar to those without this disease and that children
   have significantly higher levels of alpha-FP than women of
   reproductive age.
RF 001   BECKER DJ             J CLIN ENDOCRINOL METAB         41   782 975
   002   PIMSTONE BL           LANCET                           2   799 966
   003   CHANDRA RK            BR MED J                         1   714 975
   004   SMITH JA              BR MED J                         2   392 975
   005   WALLWORK JC           BR MED J                         2   392 975
   006   BROCK DJH             BR MED J                         2   392 975
   007   FITZSIMMONS JS        BR MED J                         3   544 975
   008   KNOPFLE G             BR MED J                         4   459 975
   009   BISWAS S              J ENDOCRINOL                    54   251 975
   010   RODECK CH             BR J OBSTET GYNAECOL            83    24 976
CT   1   BISWAS S              CLIN CHIM ACTA                  73   363 976
     2   BISWAS S              BR J OBSTET GYNAECOL            83   683 976
     3   ALHADEFF JA           CLIN GENET                      14   189 978
     4   BISWAS S              FERTIL STERIL                   30   200 978
     5   MONTGOMERY ACV        J ROY SOC MED                   72   489 979
     6   HUBBARD VS            AM J DIS CHILD                 134   317 980
     7   PEDERSEN PS           ACTA PAEDIATR SCAND             72   757 983
     8   PREECE MA             CLIN ENDOCRINOL METAB           15   453 986

PN 76052
RN 00407 
AN 76234440
AU Forstner-G.  Koheil-A.  Forstner-J.
TI Isoelectric focusing of serum in cystic fibrosis: failure to
   distinguish between homozygote and heterozygote sera.
SO Clin-Chim-Acta. 1976 Aug 2. 70(3). P 459-62.
MJ BLOOD-PROTEINS: me.  CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.
   HOMOZYGOTE.
MN ADOLESCENCE.  ADULT.  BLOOD-PROTEIN-ELECTROPHORESIS.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: bl.  FEMALE.  HUMAN.
   ISOELECTRIC-FOCUSING.  MALE.  MIDDLE-AGE.  PEDIGREE.
AB Thin-layer isoelectric focusing was performed on samples of sera from
   patients with Cystic Fibrosis, siblings and obligate heterozygotes
   (parents), and children without cystic fibrosis (controls). The
   protein band with an isoelectric point of pH 5.48, previously
   reported to be absent in homozygote cystic fibrosis sera, was found
   to have a pI of 5.25. It was present in approximately one-half of the
   homozygote and heterozygote sera tested, and absent from 18 percent
   of control sera. The presence of this band is not therefore a
   reliable marker for the normal gene, and cannot be used to identify
   the heterozygous carrier for cystic fibrosis.
RF 001   SPROUL A              J PEDIATR                       69   759 966
   002   SPOCK A               PEDIATR RES                      1   173 967
   003   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      46  1923 972
   004   FORSTNER GG           CAN MED ASSOC J                113   550 975
   005   WILSON GB             CLIN CHIM ACTA                  49    79 973
   006   WILSON GB             PEDIATR RES                     10    87 976
   007   ALTLAND K             HUMANGENETIK                    28   207 975
CT   1   JAKEL HP              BIOL ZENTRALBL                  98    55 979

PN 76053
RN 00408 
AN 77002035
AU Norgaard-Pedersen-B.  Axelsen-N-H.
TI Alpha-fetoprotein-like activity in sera from patients with malignant
   and non-malignant disease and healthy individuals.
SO Clin-Chim-Acta. 1976 Sep 6. 71(2). P 343-7.
MJ ALPHA-FETOPROTEINS: me.  FETAL-PROTEINS: me.  LIVER-DISEASES: me.
MN COMPARATIVE-STUDY.  CYSTIC-FIBROSIS: me.  FEMALE.  HEPATITIS: me.
   HUMAN.  IMMUNOELECTROPHORESIS.  LIVER-CIRRHOSIS: me.
   LIVER-NEOPLASMS: me.  PREGNANCY.
AB A new method, radio-crossed immunoelectrophoresis, demonstrates alpha-
   fetoprotein (AFP) in sera with a sensitivity of 1 mug/1. By this
   method AFP with alpha mobility was not found in sera from healthy
   individuals, patients with chronic active hepatitis and cirrhosis,
   primary biliary cirrhosis, secondary liver cancer and cystic
   fibrosis. In some of the sera, AFP was elevated when measured by
   conventional radioimmunoassay method and the sera contained an AFP-
   like substance with gamma mobility when analyzed by radio-crossed
   immunoelectrophoresis. The nature of this gamma substance is still
   obscure and needs further investigation.
RF 001   ABELEV GI             ADV CANCER RES                  14   295 971
   002   NORGAARD-PEDERSEN B   ACTA PATH MICROBIOL SCAND       83   275 975
   003   RUOSLAHTI E           BR MED J                         2   527 974
   004   BELANGER L            PATHOL BIOL (PARIS)             21   449 973
   005   WALDMANN TA           LANCET                           2  1112 972
   006   CHANDRA RK            BR MED J                         1   714 975
   007   SEPPALA M             LANCET                           1   375 972
   008   RUOSLAHTI E           NATURE                         235   161 972
   009   RUOSLAHTI E           TRANSPLANT REV                  20    38 974
   010   NORGAARD-PEDERSEN B   CLIN CHIM ACTA                  48   345 973
   011   LEEK AE               COLLOQ INSERM ALPHA-FETOPRO          563 974
   012   DAMBRUYANT C          J IMMUNOL METH                   7   387 975
   013   MORGAN CR             DIABETES                        13   579 964
   014   PAGE LB               CLIN CHIM ACTA                  34    55 971
   015   FLORIN-CHRISTENSEN A  BR MED J                         2    94 973
CT   1   BROCK DJH             PROG MED GENET                   2     1 977
     2   NORGAARDPEDERSEN B    SCAND J CLIN LAB INVEST         37    46 977
     3   BJERRUM OJ            BIOCHIM BIOPHYS ACTA           472   135 977
     4   NORGAARDPEDERSEN B    CANCER                          41  2315 978
     5   SCHULTZ H             CANCER                          42  2182 978
     6   ADINOLFI M            ADV HUM GENET                    9   165 979
     7   RUOSLAHTI E           ADV CANCER RES                  29   275 979
     8   SOKOLENKO AA          BULL EXP BIOL MED               88  1093 979
     9   NORGAARDPEDERSEN B    CLIN GENET                      17   355 980

PN 76054
RN 00409 
AN 77067410
AU Anderson-L-C.  Smith-Q-T.  Shapiro-B-L.
TI Cellular glycosaminoglycans in lymphocytes from patients with cystic
   fibrosis.
SO Clin-Chim-Acta. 1976 Nov 15. 73(1). P 63-5.
MJ CYSTIC-FIBROSIS: bl.  GLYCOSAMINOGLYCANS: bl.  LYMPHOCYTES: me.
MN ELECTROPHORESIS-CELLULOSE-ACETATE.  GALACTOSAMINE: an.
   GLUCOSAMINE:  an.  HUMAN.
AB Cellular glycosaminoglycans were isolated from lymphocytes from
   patients with cystic fibrosis and controls. The isolated
   glycosaminoglycans were fractionated by cellulose acetate
   electrophoresis, analyzed for glucosamine and galactosamine content,
   and subjected to hydrolysis with bovine testicular hyaluronidase. The
   total glycosaminoglycan content, the per cent glucosamine and
   galactosamine, and the distribution of cellular glycosaminoglycans in
   circulating lymphocytes in cystic fibrosis were no different from
   controls.
RF 001   DANES BS              BIOCHEM GENET                   12   359 974
   002   BOYUM A               SCAND J CLIN LAB INVEST SUPPL   97    77 968
   003   LINDE A               CALC TISS RES                   12   281 973
   004   BREEN M               ANAL BIOCHEM                    35   146 970
   005   MURPHY D              CLIN CHIM ACTA                  53   145 974
   006   SCHUBERT M            PRIMER ON CONNECTIVE TISS             68 968
   007   MURATA K              CLIN CHIM ACTA                  57   115 974
   008   TANIGUCHI N           BIOCHEM MED                     11   217 974
   009   WELCH DW              PEDIATR RES                      9   698 975
CT   1   CAPEAU J              BIOMEDICINE                     28   124 978
     2   HUESO P               REV ESP FISIOL                  34   339 978
     3   LATIF KA              NUTR REP INT                    24   471 981
     4   SHAPIRO BL            SCIENCE                        216   417 982
     5   ASTAKHOVA TA          TER ARKH                        59    62 987

PN 76055
RN 00410 
AN 76256081
AU Alhadeff-J-A.  Tennant-L.  Obrien-J-S.
TI Altered isoenzyme patterns of liver alpha-L-fucosidase in cystic
   fibrosis.
SO Clin-Genet. 1976 Aug. 10(2NA-NA-760903-760909). P 63-72.
MJ CYSTIC-FIBROSIS: en.  DISACCHARIDASES: me.  FUCOSIDASE: me.
   ISOENZYMES: me.  LIVER: en.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  FEMALE.  HUMAN.
   INFANT-NEWBORN.  ISOELECTRIC-FOCUSING.  MALE.  MIDDLE-AGE.
   NEURAMINIDASE: pd.  SIALIC-ACIDS: an.
AB The isoenzyme pattern of alpha-L-fucosidase was studied by
   isoelectric focusing in livers from seven patients with cystic
   fibrosis and in normal and pathological (GM1-gangliosidosis, Type II
   and Sanfilippo disease) controls. The controls had very reproducible
   patterns consisting of seven isoenzymes of alpha-L-fucosidase with
   the most neutral from (I) representing a small proportion of the
   total activity. All seven of the cystic fibrosis livers had altered
   alpha-L-fucosidase isoenzyme patterns. The chemical relationship of
   the seven isoenzymes of normal liver alpha-L-fucosidase was
   investigated using neuramindase. The five most acidic forms of alpha-
   L-fucosidase appear to be related to the most neutral form by sialic
   acid residues. Since the isoenzymes of liver alpha-L-fucosidase
   appear to be related by sialic acid residues, it is possible that the
   altered alpha-L-fucosidase isoenzyme patterns found in cystic
   fibrosis livers may result from aberrant sialylation.
RF 001   ALHADEFF JA           CLIN CHIM ACTA                  57   307 974
   002   ALHADEFF JA           J BIOL CHEM                    250  7106 975
   003   ALHADEFF JA           DEVELOP BIOL                    47   319 975
   004   ANTONOWICZ I          PEDIATR RES                      6   803 972
   005   BOAT TF               CLIN PEDIATR                    13   505 974
   006   BUTTERWORTH J         CLIN CHIM ACTA                  41   367 972
   007   DISCHE Z              PEDIATRICS                      24    74 959
   008   DISCHE Z              AM J DIS CHILD                 102   733 961
   009   DISCHE Z              ANN NY ACAD SCI                 93   526 962
   010   DOMINICK HC           KINDERHEILK                    119   261 975
   011   FILLIAT M             PATHOL BIOL (PARIS)             21    13 973
   012   GILLY R               PEDIATRIE                       29   465 974
   013   GOLDSTONE AP          FEBS LETTERS                    13    68 971
   014   GRIFFIN GD            PROC SOC EXP BIOL MED          137   438 971
   015   KATTWINKEL J          J PEDIATR                       82   234 973
   016   KIM YS                J CLIN INVEST                   51  2033 972
   017   KINT JA               ARCH INTERN PHYSIOL BIOCHIM     79   633 971
   018   KNAUFF RE             CLIN CHIM ACTA                  19   245 968
   019   KRAUS I               PEDIATRICS                      47  1010 971
   020   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   021   LOBECK CC             IN: STANBURY JB                     1605 972
   022   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   023   LOWRY OH              J BIOL CHEM                    193   265 951
   024   MANDEL ID             AM J DIS CHILD                 113   431 967
   025   MARCHI AG             HELV PAEDIATR ACTA              28   427 973
   026   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   027   MOOKERJEA S           CAN J BIOCHEM                   50   738 972
   028   NEAL JL               UNION MED CAN                  102  1465 973
   029   RAO GJS               PEDIATR RES                      8   684 974
   030   ROSSITER MA           ACTA PAEDIATR SCAND             63   389 974
   031   SHAPIRO BL            LANCET                           2  1020 974
   032   SINGER L              CLIN BIOCHEM                     7   146 974
   033   TAUSSIG LM            PEDIATRICS                      54   229 974
   034   TURNER BM             AM J HUM GENET                  27   651 975
   035   WRIGHT SW             AM J HUM GENET                  20   157 968
CT   1   CALLAHAN JW           PEDIATR RES                     11  1166 977
     2   ALHADEFF JA           CLIN GENET                      13   417 978
     3   ALHADEFF JA           CLIN GENET                      13   207 978
     4   ALHADEFF JA           CLIN GENET                      14   189 978
     5   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
     6   ALHADEFF JA           CLIN CHIM ACTA                  89   469 978
     7   CASOLA L              MONOGR PAEDIATR                 10    96 979
     8   ALHADEFF JA           BIOCHEM BIOPHYS RES COMMUN      86   787 979
     9   SCANLIN TF            CLIN CHIM ACTA                  91   197 979
    10   WILLCOX P             CLIN CHIM ACTA                  91    81 979
    11   BUTTERWORTH J         CLIN CHIM ACTA                  92   109 979
    12   CASOLA L              CLIN CHIM ACTA                  94    83 979
    13   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    14   SCANLIN TF            CLIN CHEST MED                   1   424 980
    15   ALHADEFF JA           CLIN CHIM ACTA                 105   131 980
    16   JAKEL HP              BIOL ZENTRALBL                 100   273 981
    17   BUTTERWORTH J         CLIN CHIM ACTA                 110   319 981
    18   HULTBERG B            CLIN CHIM ACTA                 112   167 981
    19   SCANLIN TF            CLIN CHIM ACTA                 114   269 981
    20   HARRIS A              CLIN CHIM ACTA                 116   171 981
    21   MARGOLIES R           PEDIATR RES                     17   931 983
    22   GUEANT JL             CLIN CHIM ACTA                 143   217 984

PN 76056
RN 00411 
AN 76186625
AU Danes-B-S.  Hodson-M-E.  Batten-J.
TI Cystic fibrosis: a cell culture study on an adult patient population.
SO Clin-Genet. 1976 May. 9(5). P 527-32.
MJ CYSTIC-FIBROSIS: fg.  PHENOTYPE.
MN ADOLESCENCE.  ADULT.  CELLS-CULTURED.  FEMALE.  FIBROBLASTS: pa.
   HUMAN.  MALE.  SKIN: pa.
AB Skin fibroblast cultures from an adult population of cystic fibrosis
   (CF) patients have been studied to determine any possible genetic or
   clinical significance of the two classes described for cultured CF
   skin fibroblasts (Danes 1973). On the basis of clinical course, the
   46 adult patients from 43 unrelated families studied were divided
   into two groups (40 typical, 6 atypical). The cultured fibroblasts
   from 37 of the 40 patients with typical CF were Class I
   (metachromatic, cystic fibrosis factor activity (CFFA) in the culture
   medium, and metabolic cooperation with normal fibroblasts), and the
   cultures from the remaining three patients were Class II
   (ametachromatic, no CFFA in the culture medium and no metabolic
   cooperation with metachromatic CF fibroblasts). During the 4-year
   research period one of the 37 patients from Class I and all three
   Class II patients with typical CF succumbed. The cultured skin
   fibroblasts from two of the six patients who had an atypical course
   for CF were Class I and four were Class II. When the parents of three
   of these atypical CF Class II patients were studied, the cultured
   fibroblasts from one parent in each family in each family were Class
   I and the other Class II. The affected offspring from such Class I-II
   matings may represent genetic compounds.
RF 001   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   002   BERATIS NG            PEDIATR RES                      7   958 973
   003   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   004   DANES BS              BIRTH DEF ORIG ART SER           8   114 972
   005   DANES BS              LANCET                           2   765 973
   006   DANES BS              J EXP MED                      129   775 969
   007   DANES BS              AM J HUM GENET                  23   297 971
   008   GRAHAM JB             AM J MED SCI                   225    46 953
   010   MCKUSICK VA           AM J HUM GENET                  25   446 973
   011   MCKUSICK VA           LANCET                           1   993 972
   012   SHWACHMAN H           BIRTH DEF ORIG ART SER           8   102 972
CT   1   DANES BS              CLIN GENET                      11    83 977
     2   DANES BS              CLIN GENET                      13   327 978
     3   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     4   WINGE P               DAN MED BULL                    29   358 982

PN 76057
RN 00412 
AN 78042375
AU Chilla-R.  Arglebe-C.  Lubahn-H.  Doering-K-M.
TI 'Fast isoamylases' in parotid saliva of heterozygous carriers of
   cystic fibrosis.
SO Clin-Otolaryngol. 1976. 1(4). P 309-13.
MJ CYSTIC-FIBROSIS: en.  GLYCOSIDE-HYDROLASES: ge.  HETEROZYGOTE.
   ISOAMYLASE: ge.  SALIVA: en.
MN ADULT.  CHILD.  CYSTIC-FIBROSIS: fg.  FEMALE.  HUMAN.  MALE.
   PAROTID-GLAND: en.
AB An increased number of 'fast isoamylases' is found in the parotid
   saliva of children with cystic fibrosis and their heterozygous
   parents who are clinically healthy. 'Fast isoamylases' are generated,
   at least in part, from the 6 isoamylases of the basic pattern by
   deamidation of asparagine and glutamine residues. This basic pattern
   is present in the parotid saliva of all subjects we have tested so
   far. A shift in the equilibrium between amidation and deamidation
   processes is discussed in terms of its possible significance for the
   pathogenesis of cystic fibrosis and for ageing.
RF 002   ARGLEBE C             CLIN OTOLARYNGOLOGY              1   249 976
   003   KELLER PJ             BIOCHEMISTRY                    10  4867 971
   004   LOWRY OH              J BIOL CHEM                    193   265 951
   005   STREET HV             CLIN CHIM ACTA                   1   256 956
   006   ARGLEBE C             LARYNGOL RHINOL OTOL            54   542 975
   007   VAN KLEEF FSM         NATURE                         258   264 975
   008   ROBINSON AB           PROC NAT ACAD SCI USA           66   753 970
   009   GREENBERG DM          METABOLIC PATHWAYS               2       968

PN 76058
RN 00413 
AN 76209110
AU Dolan-T-F-Jr.
TI Hemolytic anemia and edema as the initial signs in infants with
   cystic fibrosis.  Consider this diagnosis even in absence of
   pulmonary symptoms.
SO Clin-Pediatr (Phila). 1976 Jul. 15(7). P 597-600.
MJ ANEMIA-HEMOLYTIC: co.  CYSTIC-FIBROSIS: di.  EDEMA: co.
   PANCREATIC-DISEASES: di.
MN CASE-REPORT.  CYSTIC-FIBROSIS: co.  DIET.  HUMAN.  INFANT.
   INFANT-NEWBORN.  MALE.  PANCREATIC-DISEASES: co.
   VITAMIN-E-DEFICIENCY: co.
AB This is a report of five infants eventually proven to have cystic
   fibrosis of the pancreas, who presented with hemolytic anemia and
   edema. Since the sweat test is often unreliable in edematous states,
   the possibility of cystic fibrosis should be considered. Use of
   either a protein hydrolysate or addition of pancreatic enzymes will
   improve nutritional status, and when edema disappears, a definite
   sweat test can be performed. Evidence of vitamin E deficiency in some
   of the cases is presented, and the possibility of this as a cause of
   anemia is raised.
RF 001   SHAHIDI NT            J PEDIATR                       59   533 961
   002   LEE PA                JAMA                           228   585 974
   003   FLEISHER DS           J PEDIATR                       64   341 964
   004   OSKI FA               J PEDIATR                       70   211 967
   005   HASSAN H              AM J CLIN NUTR                  19   147 966
   006   RITCHIE JH            N ENGL J MED                   279  1185 968
   007   BLANC WA              PEDIATRICS                      22   494 958
   008   MELHORN DK            BLOOD                           37   438 971
   009   HARRIS PL             AM J CLIN NUTR                  13   385 963
   010   WILLIAMS ML           N ENGL J MED                   292   887 975
   011   MELHORN DK            J PEDIATR                       79   569 971
CT   1   CHASE HP              J PEDIATR                       95   337 979
     2   CONGDON PJ            POSTGRAD MED J                  57   453 981
     3   PARK RW               GASTROENTEROLOGY                81  1143 981
     4   FRATES RC             AM J DIS CHILD                 135   719 981
     5   TURKEL SB             CLIN PERINATOL                   9   613 982
     6   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982
     7   FARRELL PM            J DENT CHILD                    50   385 983
     8   DWORKIN B             J PARENT ENTERAL NUTR           11    38 987

PN 76059
RN 00414 
AN 76256271
AU Warwick-W-J.  Hansen-L-G.  Sharp-H.
TI Absorption of vitamin A in patients with cystic fibrosis.
   Absorption is best with emulsified vitamin A alcohol.
SO Clin-Pediatr (Phila). 1976 Sep. 15(9). P 807-10.
MJ CYSTIC-FIBROSIS: me.  INTESTINAL-ABSORPTION.  VITAMIN-A: me.
MN ADOLESCENCE.  ADULT.  ALCOHOL-ETHYL: me.  CHILD.  CHILD-PRESCHOOL.
   CLINICAL-TRIALS.  COMPARATIVE-STUDY.  CYSTIC-FIBROSIS: dt.
   EMULSIONS.  FEMALE.  HUMAN.  INFANT.  MALE.  PALMITATES: me.
   VITAMIN-A-DEFICIENCY: dt.  VITAMIN-A: ad.  VITAMIN-A: bl.
AB Vitamin A absorption tests using vitamin A palmitate and alcohol
   separately in oil and oil-water emulsions were done on 43 patients
   with cystic fibrosis. Patients were given 7,000 units of vitamin A
   per kilogram of body weight with a fatty breakfast. Pancreatic
   enzymes were not given with the test meal and were withheld for five
   hours from start of test. Blood was drawn before administration of
   the vitamin and at three and five hours after administration. Serum
   vitamin A levels were estimated using the Carr-Price technique. The
   percentages of patients with normal vitamin A absorption were 85 with
   vitamin A alcohol in oil-water emulsion, 61 with vitamin A alcohol
   dissolved in oil, 64 with vitamin A palmitate in oil-water emulsion,
   and 19 with vitamin A palmitate in oil. The number of stools per day
   is an inverse indicator of retention time in the intestine.
   Absorption of fat soluble vitamins is always abnormal when a patient
   has four or more stools a day. The observations that cystic fibrosis
   patients with abnormal liver biopsies have poor absorption of vitamin
   A were not statistically significant. The question of the effect of
   cirrhosis in cystic fibrosis on vitamin A absorption remains
   unresolved.
RF 001   FITZGERALD O          GUT                              2   261 961
   002   FITZGERALD O          GUT                              3    74 962
   003   FITZGERALD O          GUT                              3   264 962
   004   CARR FH               BIOCHEM J                       20   497 926
   005   MAY CD                AM J DIS CHILD                  59  1167 940
   006   WALKER WA             PEDIATRICS                      40   946 967
   007   LEWIS JM              J PEDIATR                       31   496 947
   008   KAGAN BM              J CLIN INVEST                   29   141 950
   009   BARNES BC             J CLIN INVEST                   29   982 950
   010   FOX HJ                J LAB CLIN MED                  34  1140 949
   011   HAMRE CJ              AM J MED SCI                   220   183 950
CT   1   CHASE HP              J PEDIATR                       95   337 979
     2   PARK RW               GASTROENTEROLOGY                81  1143 981
     3   FARRELL PM            J DENT CHILD                    50   385 983
     4   VANBOVEN M            J AM ACAD DERMATOL              12   822 985
     5   RASMUSSEN M           J PEDIATR GASTROENTEROL NUTR     5   397 986

PN 76060
RN 00415 
AN 76234881
AU Weeke-B.  Flensborg-E-W.  Jacobsen-L.  Jorgensen-B-A.  Lykkegaard-E.
   Hoiby-N.
TI Immunochemical quantitation of 18 proteins in sera from patients
   with cystic fibrosis: concentrations correlated to class of
   fibroblast metachromasia, clinical and radiological lung symptoms.
SO Dan-Med-Bull. 1976 Jun. 23(3). P 155-60.
MJ BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: bl.  FIBROBLASTS: me.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  ENGLISH-ABSTRACT.
   FEMALE.  FLUORESCENT-ANTIBODY-TECHNIC.  HUMAN.
   IMMUNOELECTROPHORESIS.  LUNG-DISEASES: bl.  MALE.
EX Sera from 32 patients with cystic fibrosis classified according to
   fibroblast metachromasia into three classes have been analysed
   immunochemically for the concentrations of 18 serum proteins.  In
   addition, the clinical and radiological status of the lungs were
   evaluated, using two scoring systems.  Eleven of 16 serum proteins
   differed from the values of a thousand-donor serum pool.  The most
   pronounced differences from the control sera were elevated
   acute-phase proteins, notably haptoglobin, alpha1-antichymotrypsin,
   IgG, and IgA, and low serum albumin and alpha2-HS-glycoprotein.
   Patients from metachromatic class III presented the most pronounced
   rise in acute-phase proteins and, furthermore, significantly
   decreased complement C3 and IgM, IgG and IgA were normal in class III
   patients.  These differences from the control sera possibly reflect
   inflammatory tissue damage involving immune reactions.  The clinical
   score was positively correlated to the radiologic score, and both
   these scores were positively correlated to the concentrations of
   eight and seven, respectively, of the serum proteins, and negatively
   correlated to three of the serum proteins.  Based upon the
   correlations between the scores and the concentrations of some of the
   serum proteins, it is recommended that longitudinal prospective
   studies follow individual patients for the concentrations in serum of
   haptoglobin, albumin, IgA, IgG, C3, and, eventually, IgM and
   alpha1-antichymotrypsin.  The present results suggest that these
   serum proteins will yield valuable information as regards prognosis
   and therapy of the lung disease in CF.
RF 001   BELFRAGE S            ACTA MED SCAND SUPPL           173     5 963
   002   BERG T                ACTA PAEDIATR SCAND             58   513 969
   003   BROGAN TD             THORAX                          30    72 975
   004   BUCKLEY RH            J CLIN INVEST                   55   157 975
   005   CONOVER JH            LIFE SCI                        14   253 974
   006   CONOVER JH            LANCET                           2  1501 973
   007   CONOVER JH            LANCET                           1    47 975
   008   DANES BS              J EXP MED                      129   775 969
   009   DANES BS              AM J HUM GENET                  23   297 971
   010   DANES BS              J EXP MED                      137  1538 973
   011   HANN S                LANCET                           2   520 974
   012   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973
   013   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974
   014   HOIBY N               ACTA PAEDIATR SCAND             63   843 974
   015   HOIBY N               SCAND J RESPIR DIS              56    38 975
   016   LANGGARD H            ACTA PAEDIATR SCAND             57   255 968
   017   LIEBERMAN J           LANCET                           1  1230 974
   018   LUNDH B               ACTA UNIV LUND II               24     1 965
   019   LYKKEGAARD E          DAN MED BULL                    21   232 974
   020   LYKKEGAARD E          DAN MED BULL                    21   241 974
   021   LYKKEGAARD E          DAN MED BULL                    22   169 975
   022   LYKKEGAARD E          DAN MED BULL                    22   175 975
   023   LYKKEGAARD E          DAN MED BULL                    22   177 975
   024   MCFARLANE H           BR MED J                         1   423 975
   025   MULLER HE             DTSCH MED WSCHR                 93   120 968
   026   MINCHIN-CLARKE HG     THORAX                          25   423 970
   027   NIELSEN HG            CLIN CHIM ACTA                  36   133 972
   028   NORMAN AP             PROC EWGCF 2ND ANNU MTG                  971
   029   NYMAN M               SCAND J CLIN LAB INVEST SUPPL   39     5 959
   030   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   83   469 975
   031   SCHWARTZ RH           AM J DIS CHILD                 111   408 966
   032   STROBER W             PEDIATRICS                      43   416 969
   033   TANNER JM             ARCH DIS CHILD                  41   613 966
   034   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   035   WEEKE B               ACTA MED SCAND                 192   149 972
   036   WEEKE B               THESIS                                 1 973
   037   WEEKE B               SCAND J IMMUNOL SUPPL 1          2    37 973
   038   WEEKE B               SCAND J IMMUNOL SUPPL 2          1    48 973
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   TURNER MW             ARCH DIS CHILD                  53   631 978
     3   GOTZ M                EUR J PEDIATR                  127   133 978
     4   SCHIOTZ PO            MONOGR PAEDIATR                 10   131 979
     5   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     6   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
     7   FICK RB               CLIN CHEST MED                   2    91 981
     8   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   89   185 981
     9   MARGOLIES R           PEDIATR RES                     16   181 982
    10   BERNINGER RW          METABOLISM                      31   299 982
    11   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982
    12   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982
    13   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
    14   EMMETT M              PROC SOC EXP BIOL MED          184    74 987

PN 76061
RN 00416 
AN 77003984
AU Paulsen-E-P.  Koury-M.
TI Hemoglobin AIc levels in insulin-dependent and -independent diabetes
   mellitus.
SO Diabetes. 1976. 25(2 SUPPL). P 890-6.
MJ DIABETES-MELLITUS: bl.
MN ACIDOSIS-DIABETIC: bl.  ADOLESCENCE.  ADULT.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: bl.  DIABETES-MELLITUS: dt.
   DIABETES-MELLITUS-INSULIN-DEPENDENT: bl.
   DIABETES-MELLITUS-INSULIN-DEPENDENT: ci.  ERYTHROCYTES: me.  FEMALE.
   HUMAN.  INFANT.  INSULIN: tu.  MALE.  OBESITY-IN-DIABETES: bl.
   PREDNISONE: ae.  PREGNANCY-IN-DIABETES: bl.  PREGNANCY.
AB Unusual increases in the minor hemoglobin components (Hb AIa, b, c)
   known to be elevated in diabetes mellitus were found in states of
   relative or absolute insulinopenia: diabetic ketoacidosis, steroid-
   induced diabetes, insulin-dependent diabetes in cystic-fibrosis
   patients, and cystic fibrosis occurring in infants who have a marked
   suppression of insulin secretion. In ketoacidotic diabetics, it
   required at least a month for high Hb AI levels (16.9 +/- 2.6 per
   cent) to stabilize at nonacidotic levels (12.8 +/- 0.3 per cent),
   suggesting that decreases occur only as new red cells form under
   conditions less favorable to Hb AI synthesis. Abnormal amounts os Hb
   A and Hb AI resisted removal from diabetic red-cell membranes by low
   ionic buffers but yielded to hypotonic Tris buffer. Their removal
   resulted in simultaneous elution of peripheral and integral membrane
   proteins. It is suggested that Hb so firmly bound could reduce
   membrane elasticity and cell deformability, characteristics so vital
   to normal red cell movement through the microvasculature.
RF 001   ALLEN DW              J AM CHEM SOC                   80  1628 958
   002   HOLMQUIST WR          BIOCHEMISTRY                     5  2489 966
   003   BOOKCHIN RM           BIOCHEM BIOPHYS RES COMMUN      32    86 968
   004   BUNN HF               BIOCHEM BIOPHYS RES COMMUN      67   103 975
   005   BUNN HF               J CLIN INVEST                   49  1088 970
   006   HUISMAN TH            J LAB CLIN MED                  60   302 962
   007   RAHBAR S              BIOCHEM BIOPHYS RES COMMUN      36   838 969
   008   TRIVELLI LA           N ENGL J MED                   284   353 971
   009   PAULSEN EP            METABOLISM                      22   269 973
   010   DITZEL J              ACTA PAEDIATR SCAND             64   355 975
   011   DITZEL J              ACTA MED SCAND SUPPL           578    59 975
   012   KOENIG RJ             PROC NAT ACAD SCI USA           72  3687 975
   013   KOENIG RJ             DIABETES                        25     1 976
   014   DRABKIN DL            J BIOL CHEM                    164   703 946
   015   DODGE JT              ARCH BIOCHEM BIOPHYS           100   119 963
   016   LOWRY OH              J BIOL CHEM                    193   265 951
   017   PAULSEN EP            PEDIATR RES                      7   325 973
   018   MILNER AD             ARCH DIS CHILD                  44   351 969
   019   BEISSWENGER PJ        SCIENCE                        168   596 970
   020   NICOLSON GL           J CELL BIOL                     59   395 973
   021   MARFEY P              IN: JAMIESON GA                      309 969
   022   DITZEL J              IN: DITZEL J                         123 970
CT   1   ANON                  BR MED J                         1  1555 977
     2   PAULSEN EP            MED COLL VIRGINIA Q             13    26 977
     3   PALMBERG PF           DIABETES                        26   703 977
     4   NG RCK                GASTROENTEROLOGY                73   804 977
     5   DITZEL J              ACTA PAEDIATR SCAND SUPPL 270 1977   112 977
     6   ANON                  BR MED J                         1  1373 978
     7   DAVIS RE              MED J AUST                       1   530 978
     8   DITZEL J              BR MED J                         1   741 978
     9   MOSES RG              MED J AUST                       2   160 978
    10   BECCARIA L            AM J HEMATOL                     4   367 978
    11   JUHAN I               NOUV PRESSE MED                  7   759 978
    12   HANDELSMAN DJ         AUST NZ J MED                    8  R  1 978
    13   GONEN B               DIABETOLOGIA                    15     1 978
    14   ABRAHAM EC            DIABETES                        27   931 978
    15   DAVIS JE              DIABETES                        27   102 978
    16   DITZEL J              METABOLISM                      27   927 978
    17   GRAF RJ               DIABETES                        27   834 978
    18   MCMILLAN DE           DIABETES                        27   895 978
    19   RASKIN P              METABOLISM                      27   235 978
    20   WIDNESS JA            DIABETES                        27  1182 978
    21   MAQUART F             BIOMEDICINE EXPRESS             29   208 978
    22   DAUMERIEGOFFINET C    ACTA CLIN BELG                  33   240 978
    23   SCHROTER W            HELV PAEDIATR ACTA              33   535 978
    24   LESPERANCE FA         MED CLIN NORTH AM               62   767 978
    25   WIDNESS JA            BR J OBSTET GYNAECOL            85   812 978
    26   WIDNESS JA            J PEDIATR                       92     8 978
    27   FRASER DM             BR MED J                         1   979 979
    28   FRIEDMAN S            HEMOGLOBIN                       3   411 979
    29   BROWNLEE M            ATHEROSCLEROSIS REV              4    29 979
    30   JUHAN I               NOUV PRESSE MED                  8  4083 979
    31   MCDONALD JM           HUM PATHOL                      10   279 979
    32   ANGELI A              ACTA DIABETOL LAT               16   295 979
    33   BRESSLER R            DRUGS                           17   461 979
    34   MOLNAR GD             DIABETOLOGIA                    17     5 979
    35   DIX D                 CLIN CHEM                       25   877 979
    36   GRUBER CA             CLIN CHEM                       25  1970 979
    37   HAMBURGER S           J AM MED WOM ASSOC              34   109 979
    38   POLLAK A              BIOL NEONATE                    36   185 979
    39   DITZEL J              FED PROC                        38  2484 979
    40   GIACOMELLI F          LAB INVEST                      40   460 979
    41   FADEL HE              OBSTET GYNECOL                  54   322 979
    42   SPICER KM             J CLIN INVEST                   64    40 979
    43   LIND T                BR J OBSTET GYNAECOL            86   210 979
    44   KLUJBER L             EUR J PEDIATR                  132   289 979
    45   OSHAUGHNESSY R        AM J OBSTET GYNECOL            135   783 979
    46   BEYLOT M              LYON MED                       242   179 979
    47   DANEMAN D             DIABETOLOGIA                    19   423 980
    48   DAVIES DM             AUST NZ J OBSTET GYNAECOL       20   147 980
    49   HATRON PY             LILLE MED                       25   213 980
    50   STUART J              J CLIN PATHOL                   33   417 980
    51   GENEZ VS              TER ARKH                        52   142 980
    52   BYYNY RL              POSTGRAD MED                    68   191 980
    53   KJAERGAARD JJ         ACTA ENDOCRINOL                 94    25 980
    54   JOHNSON MW            CLIN CHIM ACTA                 104   319 980
    55   GOEBEL FD             MUNCH MED WOCHENSCHR           122  1731 980
    56   SCHROTER W            EUR J PEDIATR                  134    95 980
    57   WIDNESS JA            AM J OBSTET GYNECOL            136  1024 980
    58   BROOKS AP             BR MED J                       281   707 980
    59   OUGHTON J             HORM METAB RES                  11   112 981
    60   LANTZ B               HORM METAB RES                  13   660 981
    61   MONNIER LH            DIABETOLOGIA                    20    12 981
    62   ISOGAI Y              SCAND J CLIN LAB INVEST         41   171 981
    63   JUHAN I               SCAND J CLIN LAB INVEST         41   159 981
    64   BROWNLEE M            ANNU REV BIOCHEM                50   385 981
    65   SCHULTZ TA            AM J MED                        70   373 981
    66   GARNER A              J ROY SOC MED                   74   427 981
    67   DITZEL J              EUR J PEDIATR                  137   171 981
    68   GOEBEL FD             RES EXP MED                    179   133 981
    69   MANSANI FE            INT J BIOL RES PREGNANCY         3   180 982
    70   OKADA Y               DIABETOLOGIA                    22   212 982
    71   JUHANVAGUE I          NOUV REV FR HEMATOL             24   191 982
    72   ARNQVIST H            SCAND J CLIN LAB INVEST         42   265 982
    73   BACHEM MG             KLIN WSCHR                      60   497 982
    74   CARNEY RM             DIABETES CARE                    6   378 983
    75   JACQUES C             PRESSE MED                      12   673 983
    76   WORTH R               DIABETOLOGIA                    25   482 983
    77   NAKAYOSHI N           JAP J OPHTHALMOL                27   255 983
    78   KAMADA T              DIABETES                        32   585 983
    79   CZECH A               J CHRON DIS                     36   803 983
    80   GARLICK RL            J CLIN INVEST                   71  1062 983
    81   MAYER TK              CLIN CHIM ACTA                 127   147 983
    82   KAIBARA M             INT J GYNAECOL OBSTET           22   221 984
    83   GOMO ZAR              ANN CLIN BIOCHEM                22   362 985
    84   FEIGE A               Z GEBURTSHILFE PERINATOL       189    13 985
    85   PAGANO G              CLIN HEMORHEOL                   6   303 986
    86   DURRUTY P             REV MED CHIL                   114  1123 986
    87   STUART J              CLIN HEMORHEOL                   7   239 987

PN 76062
RN 00417 
AN 76235423
AU Rossipal-E.  Mlekusch-W.
TI Steatorrhea, a simple and rapid method of diagnosis.
SO Eur-J-Pediatr. 1976 Jul 12. 122(4). P 297-302.
MJ CELIAC-DISEASE: di.
MN ADOLESCENCE.  CELIAC-DISEASE: di.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: di.  FECES: an.  HUMAN.  INFANT.  LIPIDS: an.
   METHODS.PNEUMONIA: di.  RESPIRATORY-TRACT-INFECTIONS: di.
AB A simple and rapid method for the diagnosis of steatorrhea is
   described. The method is based on the assessment of the difference of
   specific gravity and lipophilic property between a normal stool and
   that in steatorrhea, using a benzene-NaBr system. The stool samples
   are dried, pulverized, and then investigated. Steatorrhea is defined
   either as a fat or more in a 24-hour sample. Stool samples of 71
   infants and children were examined. Among these were 23 healthy
   subjects, 10 with upper respiratory tract infections, and 6 with
   pneumonia. A further 31 children had celiac disease, 9 of them were
   on a gluten-free diet, and one child had cystic fibrosis. The
   procedure described renders single stool samples suitable for the
   assessment of steatorrhea. As a screening test the method proved to
   be rapid and accurate in the diagnosis of steatorrhea.
RF 001   VAN DE KAMER JH       J BIOL CHEM                    177   347 949
   002   ROSSIPAL E            KLIN PAEDIATR                  184   385 972
   003   SHMERLING DH          PEDIATRICS                      46   690 970
CT   1   BORKENSTEIN M         PAEDIATR PAEDOL                 13   145 978

PN 76063
RN 00418 
AN 76235422
AU Emrich-H-M.  Heitz-J.  Katz-S.  Thom-R.
TI Cystic fibrosis: normal volumes of red cells.  Model experiments on
   the pathomechanism of the disease.
SO Eur-J-Pediatr. 1976 Jul 12. 122(4). P 293-6.
MJ CYSTIC-FIBROSIS: bl.  ERYTHROCYTES.
MN CYSTIC-FIBROSIS: pp.  ERYTHROCYTES: de.  GRAMICIDINS: pd.  HUMAN.
   ION-EXCHANGE.  PERMEABILITY.  POTASSIUM: ph.  SODIUM: ph.  SWEAT.
   VALINOMYCIN: pd.
AB Normal values of mean cell volume (M.C.V.) and of distribution of
   single cell volumes (S.C.V.) have been observed in erythrocytes of
   patients with cystic fibrosis using an electronical particle-volume
   analyzer (sheath flow detector). From these results a strong defect
   in red cell salt transport seems improbable. Valinomucin induces
   shrinking (by increase of K+ permeability) and gramicidin D induces
   swelling (by increase of Na+ permeability) of normal erythrocytes.
   Addition of C.F. sweat to normal erythrocytes induces no volume
   change. From this result no influence of the "C.F. factor" on passive
   ion permeability is concluded.
RF 001   BALFE JW              SCIENCE                        162   689 968
   002   COLE CH               PEDIATR RES                      6   616 972
   003   EMRICH HM             Z NATURFORSCH                  24B  1144 969
   004   EMRICH HM             PEDIATR RES                      2   464 968
   005   FEIG SA               CLIN RES                        22  234A 974
   006   FEIG SA               PEDIATR RES                      8   594 974
   007   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   008   KAISER D              PEDIATR RES                      5   167 971
   009   MANGOS JA             SCIENCE                        158   135 967
   010   PRESSMAN BC           PROC NAT ACAD SCI USA           58  1949 967
   011   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   012   THOM R                TELEFUNKEN HOCHFREQUENZ TECHN            972
CT   1   GALEY WR              PEDIATR RES                     14  1269 980
     2   WARWICK WJ            AM J MED TECHNOLOGY             48   539 982

PN 76064
RN 00419 
AN 76235421
AU Nikolaejek-W-P.  Emrich-H-M.
TI ALPHA-Amylase activity in sweat and serum of patients with cystic
   fibrosis of the pancreas.
SO Eur-J-Pediatr. 1976 Jul 12. 122(4). P 289-91.
MJ AMYLASES: an.  CYSTIC-FIBROSIS: en.  SWEAT: en.
MN ADOLESCENCE.  AMYLASES: bl.  CHILD.  CHILD-PRESCHOOL.  HUMAN.
AB The hypothesis by Doggett and Harrison, according to which alpha-
   amylase is the pathogenic factor of the exocrinopathy in cystic
   fibrosis (C.F.), is investigated.No elevation of alpha-amylase in
   sweat and serum of C.F. patients, as compared with controls of
   similar age, is observed. It is concluded that the "C.F. factor"
   cannot be identified with alpha-amylase.
RF 001   DOGGETT RG            NATURE NEW BIOL                243   251 973
   002   EMRICH HM             PFLUEGERS ARCH                 290   298 966
   003   LOBECK CC             IN: STANBURY JB                     1605 972
   004   MANGOS JA             SCIENCE                        158   135 967
   005   MANGOS JA             PEDIATR RES                      2   378 968
   006   MANGOS JA             PEDIATR RES                      1   436 967
   007   RICHTERICH R          KLINISCHE CHEMIE THEORIE UND             968
CT   1   TAKACS O              ACTA PAEDIATR ACAD SCI HUNG     18    21 977
     2   DAVIDSON GP           PEDIATR RES                     12   967 978
     3   SCHRODER CP           EUR J PEDIATR                  128    49 978
     4   CASOLA L              CLIN CHIM ACTA                  94    83 979
     5   QUINTON PM            ANNU REV MED                    34   429 983

PN 76065
RN 00420 
AN 76235415
AU Knopfle-G.  Rottauwe-H-W.  Lehmann-F-G.
TI Serum alpha1-fetoprotein in cystic fibrosis.
SO Eur-J-Pediatr. 1976 Jul 12. 122(4). P 241-8.
MJ ALPHA-FETOPROTEINS: an.  CYSTIC-FIBROSIS: bl.  FETAL-PROTEINS: an.
MN ADULT.  CHILD.  CHILD-PRESCHOOL.  COMPARATIVE-STUDY.
   CYSTIC-FIBROSIS: fg.  FEMALE.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.
   MALE.  RADIOIMMUNOASSAY.
AB In 38 children and adolescents with cystic fibrosis, in 19 normal
   children and 62 healthy adults the serum alpha1-fetoprotein
   concentrations were measured by radioimmunoassay. In cystic fibrosis
   patients 97.5% and in normal children 95% of the alpha1-fetoprotein
   values were within the normal range for healthy adults (1--9 ng/ml).
   Critical judgement of the reported findings in literature and our own
   results demonstrate that the investigation of alpha1-fetoprotein in
   the serum cannot serve for detecting homozygotes of cystic fibrosis
   genes or heterozygote carriers.
RF 001   GITLIN D              J CLIN INVEST                   45  1826 966
   002   ADINOLFI M            DEVELOP MED CHILD NEUROL         9   609 967
   003   MARKLEIN G            Z KINDERHEILK                  113   327 972
   004   SEPPALA M             LANCET                           1   375 972
   005   VAN FURTH R           NATURE                         222  1296 969
   006   PURVES LR             S AFR MED J                     46  1290 972
   007   RUOSLAHTI E           INT J CANCER                     8   374 971
   008   RUOSLAHTI E           NATURE                         235   161 972
   009   MASSEYEFF R           IN: MASSEYEFF R                      313 974
   010   SEPPALA M             AM J OBSTET GYNECOL            112   208 972
   011   ABELEV GI             CANCER RES                      28  1344 968
   012   SMITH JB              AM J MED                        51   767 971
   013   RUOSLAHTI E           J NATL CANCER INST              49   623 972
   014   GASSNER M             SCHWEIZ MED WOCHENSCHR         102   465 972
   015   LEHMANN FG            KLIN WOCHENSCHR                 49   609 971
   016   RUOSLAHTI E           SCAND J GASTROENTEROL            8   197 973
   017   GEFFROY Y             PRESSE MED                      78  1107 970
   018   MASOPUST J            PROTIDES BIOL FLUIDS            18   239 971
   019   LEHMANN FG            INTERNIST (BERL)                13   332 972
   020   KOHN J                LANCET                           2   334 974
   021   ZELTZER PM            LANCET                           1   373 974
   022   BELANGER L            PATHOL BIOL (PARIS)             21   457 973
   023   BELANGER L            PATHOL BIOL (PARIS)             21   449 973
   024   WALDMANN TA           LANCET                           2  1112 972
   025   SELLER MJ             BR MED J                         2   524 974
   026   BROCK DJH             LANCET                           2   197 972
   027   ALLAN LD              LANCET                           2   522 973
   028   HARRIS R              LANCET                           1   429 974
   029   NEVIN NC              LANCET                           1  1383 973
   030   KJESSLER B            LANCET                           1   432 975
   031   SEPPALA M             AM J OBSTET GYNECOL            115    48 973
   032   CHANDRA RK            BR MED J                         1   714 975
   033   SMITH JA              BR MED J                         2   392 975
   034   WALLWORK JC           BR MED J                         2   392 975
   035   BROCK DJH             BR MED J                         2   392 975
   036   FITZSIMMONS JS        BR MED J                         3   544 975
   037   BELANGER L            BR MED J                         4   759 975
   038   KNOPFLE G             BR MED J                         4   459 975
   039   NISHI S               GANN MOGR CANCER RES            14    79 973
   040   ISHII M               GANN MOGR CANCER RES            14    89 973
   041   LEHMANN FG            CLIN CHIM ACTA                  33   197 971
   042   LEHMANN FG            Z KLIN CHEM KLIN BIOCHEM         9   309 971
   043   MANCINI G             COLLOQ PROTIDES BIOL FLUIDS     11   370 965
   044   SIZARET P             J BIOL STANDARDS                 3   201 975
   045   LEHMANN FG            Z KLIN CHEM KLIN BIOCHEM        11   339 973
   046   SACHS L               ANGEWANDTE STATISTIK                     974
   047   CRAIG JM              AM J DIS CHILD                  93   357 957
   048$  FEIGELSON J           PEDIATRIE                        8   417 972
   049   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   050   ROBERTS WC            AM J MED                        32   324 962
   051   SWIFT PN              PROC R SOC MED                  56   923 963
   052   WEBSTER R             ARCH DIS CHILD                  28   343 953
CT   1   KNOPFLE G             KLIN PAEDIATR                  189   207 977
     2   ADINOLFI M            ADV HUM GENET                    9   165 979

PN 76066
RN 00421 
AN 76140667
AU Lebenthal-E.  Antonowicz-I.  Shwachman-H.
TI Enterokinase and trypsin activities in pancreatic insufficiency and
   diseases of the small intestine.
SO Gastroenterology. 1976 Apr. 70(4). P 508-12.
MJ ENTEROPEPTIDASE: me.  INTESTINAL-DISEASES: en.
   INTESTINAL-MUCOSA:  en.  INTESTINE-SMALL: en.
   PANCREATIC-DISEASES: en.  PEPTIDE-PEPTIDOHYDROLASES: me.  TRYPSIN: me.
MN CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: en.  DIARRHEA: en.
   DISACCHARIDASES: df.  FOOD-HYPERSENSITIVITY: en.
   HYPOPROTEINEMIA:  en.  INFANT.  MALABSORPTION-SYNDROMES: en.
   MILK-PROTEINS: ae.  STREPTOKINASE: df.  TRYPSIN: df.
AB The interrelationship of enterokinase and trypsin activities were
   investigated in 133 infants and children with a variety of
   gastrointestinal and pancreatic disorders. Fourteen patients with
   diarrhea and grade II mucosal injury revealed a significant (P less
   than 0.01) reduction of enterokinase, trypsin, and disaccharidase
   activites as compared to 59 children with normal mucosa. Nine
   patients with cystic fibrosis and pancreatic insufficiency had normal
   mucosal enterokinase activity and elevated intraluminal enterokinase
   activity with very low or no trypsin activity. Patients with
   hypoproteinemia and gastrointestinal protein loss, associated with
   intestinal lymphangiectasia (4 patients) and intestinal lymphoid
   nodular hyperplasia (3 patients), had normal or insignificant
   decrease of enterokinase and trypsin activities. In patients with
   steatorrhea, a normal sweat test, normal intestinal mucosa, and
   absent trypsin activity, two entities were defined. One group (3
   patients) was diagnosed as Schwachman-Diamond syndrome with
   pancreatic insufficiency and normal mucosal and intraluminal
   enterokinase activity. The second group (2 patients) with absent
   mucosal and intraluminal enterokinase activity and normal lipase and
   amylase activities was diagnosed as congenital enterokinase
   deficiency.
RF 001   KUNITZ M              J GEN PHYSIOL                   22   429 939
   002   MAROUX S              J BIOL CHEM                    246  5031 971
   003   NORDSTROM C           BIOCHIM BIOPHYS ACTA           242   209 971
   004   HADORN B              LANCET                           1   812 969
   005   TARLOW MJ             ARCH DIS CHILD                  45   651 970
   006   HADORN B              SWED NUTR FOUND SYMP 11              107 973
   007   NIESSEN KH            KINDERHEILK                    121    49 973
   008   RUTGEERSTS L          TIJDSCHR GASTROENTEROL          15   379 972
   009   LEBENTHAL E           PEDIATRICS                      56   585 975
   010   HADORN B              GASTROENTEROLOGY                66   548 974
   011   WOODLEY JF            GUT                             13   900 972
   012   GOLDMAN AS            PEDIATRICS                      32   425 963
   013   WALDMANN TA           GASTROENTEROLOGY                50   422 966
   014   ANTONOWICZ I          PEDIATRICS                      49   847 972
   015   SHWACHMAN H           J PEDIATR                       65   645 964
   016   TOWNLEY RRW           PEDIATRICS                      36   911 965
   017   DAHLQVIST A           ANAL BIOCHEM                     7    18 964
   018   LOWRY OH              J BIOL CHEM                    193   265 951
   019   EGGSTEIN M            KLIN WOCHENSCHR                 33   879 955
   020   EGGERMONT E           ACTA GASTROENTEROL BELG         34   655 971
   021   NORDSTROM C           LANCET                           1   933 972
   022   TAKANO K              OKAJIMAS FOLIA ANAT JPN         48    15 971
CT   1   LEBENTHAL E           CLIN GASTROENTEROL               6   397 977
     2   LEBENTHAL E           PEDIATR RES                     11   282 977
     3   HERMONTAYLOR J        GUT                             18   259 977
     4   MORIN CL              PEDIATRICS                      60   114 977
     5   ANTONOWICZ I          GASTROENTEROLOGY                72  1299 977
     6   RINDERKNECHT H        AM J DIG DIS                    23   327 978
     7   FREEMAN HJ            ANNU REV MED                    29    99 978
     8   KWONG WKL             GASTROENTEROLOGY                74  1277 978
     9   THEIL KW              J AM VET MED ASSOC             173   548 978
    10   SCHMIDT E             CLIN BIOCHEM                    12   247 979
    11   SCHMIDT E             J CLIN CHEM CLIN BIOCHEM        17   693 979
    12   TSAGIKYAN TA          VOPR MED KHIM                   25   161 979
    13   BERG NO               ACTA PAEDIATR SCAND             68   275 979
    14   HATCH TF              J NUTR                         109  1874 979
    15   HERMAN RH             WEST J MED                     130    95 979
    16   BURKE V               J MED MICROBIOL                 13   103 980
    17   DOCKTER G             MONATSSCHR KINDERHEILKD        128   732 980
    18   NIESSEN KH            MONATSSCHR KINDERHEILKD        128   301 980
    19   LENTZE MJ             LANCET                           2   504 982
    20   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
    21   LEBENTHAL E           DIGESTION                       23    39 982
    22   LENTZE MJ             J PEDIATR GASTROENTEROL NUTR     2  S252 983
    23   BOSSMANN B            J CLIN CHEM CLIN BIOCHEM        21     1 983
    24   LOJDA Z               HISTOCHEMISTRY                  78   251 983
    25   GHISHAN FK            GASTROENTEROLOGY                85   727 983
    26   GREEN JR              J PEDIATR GASTROENTEROL NUTR     3   630 984
    27   KAI H                 J PEDIATR GASTROENTEROL NUTR     3   328 984
    28   HJELM M               CLIN BIOCHEM                    17   284 984
    29   BOSSMANN B            ACTA HISTOCHEM                  74   217 984
    30   MANN NS               GASTROENTEROLOGY                86   384 984
    31   DOCKTER G             MONATSSCHR KINDERHEILKD        132   589 984
    32   CALVIN RT             J PEDIATR GASTROENTEROL NUTR     4   949 985
    33   NEWMAN BM             AM J PHYSIOL                   250  G103 986

PN 76067
RN 00422 
AN 76165918
AU Stern-R-C.  Stevens-D-P.  Boat-T-F.  Doershuk-C-F.  Izant-R-J-Jr.
   Matthews-L-W.
TI Symptomatic hepatic disease in cystic fibrosis: incidence, course,
   and outcome of portal systemic hunting.
SO Gastroenterology. 1976 May. 70(5 PT.1). P 645-9.
MJ CYSTIC-FIBROSIS: co.  LIVER-DISEASES: et.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.
   ESOPHAGEAL-AND-GASTRIC-VARICES: et.  FEMALE.
   HEMORRHAGE-GASTROINTESTINAL: et.  HUMAN.  HYPERSPLENISM: et.
   HYPERTENSION-PORTAL: co, et, su.  INFANT.  LIVER-DISEASES: oc, su.
   MALE.  OHIO.  PORTACAVAL-SHUNT-SURGICAL.  SUPPORT-U-S-GOVT-P-H-S.
AB Fifteen (2.2%) of 693 patients with cystic fibrosis seen over an 18-
   year period developed clinical hepatic disease. In 13 patients all
   symptoms were secondary to portal hypertension. Ten had hypersplenism
   and 6 had variceal bleeding, including 3 who developed both
   conditions. All 5 patients who survived the initial episode of
   gastrointestinal bleeding underwent portal systemic shunting. A
   shunting procedure also was performed on 1 patients with
   hypersplenism but no variceal bleeding. No subsequent deterioration
   of intellectual function occurred in either the shunted or unshunted
   patients. Only 1 of the shunted patients showed progression of
   hepatic disease after surgery. These results suggest that portal
   systemic shunting is useful in the treatment of bleeding esophageal
   varices in cystic fibrosis. A sweat test to rule out cystic fibrosis
   should be included in the evaluation of any teenage or young adult
   patient with unexplained portal hypertension.
RF 001   FARBER S              ARCH PATHOL                     37   238 944
   002   WEBSTER R             ARCH DIS CHILD                  28   343 953
   003   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   004   CRAIG JM              AM J DIS CHILD                  93   357 957
   005   SLOTH K               ACTA PAEDIATR SCAND             61   380 972
   006   ROBERTS WC            AM J MED                        32   324 962
   007   OPPENHEIMER EH        J PEDIATR                       86   683 975
   008   TYSON KRT             J PEDIATR SURG                   3   271 968
   009   DANIELSON GK          JAMA                           195   217 966
   010   GRAND RJ              CLIN PEDIATR                     9   588 970
   011   WILROY RS JR          J PEDIATR                       68    67 966
   012   VALMAN HB             ARCH DIS CHILD                  46   805 971
   013   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   014   KATTWINKEL J          J PEDIATR                       82   234 973
   015   BOAT TF               CLIN PEDIATR                    13   505 974
   016   RESNICK RH            GASTROENTEROLOGY                67   843 974
   017   CONN HO               GASTROENTEROLOGY                67  1065 974
   018   KOPEL FB              GASTROENTEROLOGY                62   483 972
   019   DALE DC               J INFECT DIS SUPPL             130   143 974
   020   ZIEGLER EJ            J INFECT DIS SUPPL             130   145 974
CT   1   STERN RC              J PEDIATR                       89   406 976
     2   SCOTT J               AM J MED                        63   488 977
     3   STERN RC              ANN INTERN MED                  87   188 977
     4   ROY CC                N ENGL J MED                   297  1301 977
     5   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
     6   SANTAGNESE PAD        AM J MED                        66   121 979
     7   WOOD RE               SOUTH MED J                     72   189 979
     8   VANVROONHOVEN TJ      SURG GYNECOL OBSTET            149   559 979
     9   CUNNINGHAM DG         J COMPUT ASSIST TOMOGR           4   151 980
    10   ARBORGH B             SCAND J GASTROENTEROL           15    73 980
    11   MIELIVERGANI G        ARCH DIS CHILD                  55   696 980
    12   STERN RC              AM J DIS CHILD                 134   267 980
    13   PSACHAROPOULOS HT     LANCET                           2    78 981
    14   LAMBERT JR            GASTROENTEROLOGY                80   169 981
    15   PARK RW               GASTROENTEROLOGY                81  1143 981
    16   CLARKE M              BR MED J                       283  1263 981
    17   ROY CC                J PEDIATR GASTROENTEROL NUTR     1   469 982
    18   STERN RC              LANCET                           1  1401 982
    19   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
    20   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982
    21   DOHERTY DE            SOUTH MED J                     76  1580 983
    22   MATTHEWS LW           PEDIATR CLIN NORTH AM           31   133 984
    23   HUBBARD VS            SEM RESPIR MED                   6   299 985
    24   BERNARD O             CLIN GASTROENTEROL              14    33 985
    25   SCHRODER R            SCHWEIZ MED WOCHENSCHR         115   828 985
    26   STERN RC              J PEDIATR GASTROENTEROL NUTR     5    35 986
    27   HULTCRANTZ R          HEPATOLOGY                       6   881 986
    28   FEIST D               WIEN KLIN WOCHENSCHR            98   547 986
    29   KUMARISUBAIYA S       J PEDIATR GASTROENTEROL NUTR     6    71 987
    30   VARMA RR              SEM LIVER DIS                    7    59 987

PN 76068
RN 00423 
AN 76188462
AU Javitt-N-B.
TI Cholestasis in infancy.  Status report and conceptual approach.
SO Gastroenterology. 1976 Jun. 70(6). P 1172-81.
MJ CHOLESTASIS: th.
MN ALPHA-1-ANTITRYPSIN: df.  ANION-EXCHANGE-RESINS: tu.
   BACTERIAL-INFECTIONS: co.  BILE-DUCTS: ab.  BILE-DUCTS: su.
   BILE-DUCTS-INTRAHEPATIC: pp.  BILE: se.  CHOLESTASIS: pa, pp, su.
   CYSTIC-FIBROSIS: pp.  FEMALE.  HUMAN.  INFANT.  INFANT-NEWBORN.
   MALE.  PHENOBARBITAL: tu.  RECURRENCE.  SUPPORT-U-S-GOVT-P-H-S.
EX This review is concerned with the disturbances in bile flow that
   occur early in life.  Although cholestasis is defined
   physiologically, it can be considered to have morphological features.
   Morphological cholestasis is the presence of bile pigments in
   histopathological sections of the liver and is most easily recognized
   as bile plugs or thrombi in bile canaliculi.  Physiological
   cholestasis, a reduction in bile flow, is inferred from the finding
   of an elevated serum bile acid.  This inference is derived from the
   known positive correlation between canalicular bile flow and bile
   acid excretion that has been found to occur in all species this far
   examined, including man.  An increase in the amount of bile acid in
   plasma implies a reduction in the hepatic transport of the primary
   conjugated bile acids of man and therefore a decrease in associated
   canalicular bile flow.  Classifications of cholestatic syndromes,
   functional abnormalities, and therapy for cholestasis syndromes are
   discussed.
RF 001   SCHEUER P             LIVER BIOPSY INTERPRETATION           22 973
   002   SCHERSTEN T           EUR J CLIN INVEST                1   242 971
   003   KAPLOWITZ N           AM J MED                        54   725 973
   004   JAVITT NB             PEDIATR RES                      7   119 973
   005   SJOVALL K             CLIN CHIM ACTA                  13   207 966
   006   SANDBERG DH           PEDIATR RES                      4   262 970
   007   SANDBERG DH           J LIPID RES                      6   182 965
   008   ALI SS                CAN J BIOCHEM                   48  1054 970
   009   SCHWARZ HP            CLIN CHIM ACTA                  50   197 974
   010   WATKINS JB            N ENGL J MED                   288   431 973
   011   NORMAN A              ACTA PAEDIATR SCAND             62   161 973
   012   LANDING BH            IN: GALL EA                          480 972
   013   ROLLESTON HD          BR MED J                         1   758 901
   014   ODELL GB              IN: JAMES AE JR                      290 974
   015   LANDING BH            IN: BECKER FF                        821 975
   016   CRAIG JM              ARCH PATHOL                     54   321 952
   017   STRAUSS L             ARCH PATHOL                     86   317 968
   018   ALPERT LI             N ENGL J MED                   280    16 969
   019   BROUGH AJ             PEDIATRICS                      43   519 969
   020   BROUGH AJ             HUM PATHOL                       5   507 974
   022   JAVITT NB             POSTGRAD MED J                  50   354 974
   023   YEUNG CY              PEDIATRICS                      50   812 972
   024   JAVITT N              IN: GORESKY CA                       401 975
   025   SHARP HL              PEDIATR RES                      5   274 971
   026   BACK P                HOPPE SEYLERS Z PHYSIOL CHEM   354    83 973
   027   LAVY U                GASTROENTEROLOGY                65   556 973
   028   JAVITT NB             IN: PAUMGARTNER G                    355 973
   029   MAKINO I              LIPIDS                           8    47 973
   030   STIEHL A              EUR J CLIN INVEST                4    59 974
   031   RUDMAN D              J CLIN INVEST                   36   530 957
   032   CAREY JB JR           J CLIN INVEST                   37  1494 958
   033   WOOTON IDP            LANCET                           2  1049 959
   033   JAVITT NB             IN: MATERN S                         123 974
   034   LILLY JR              SURGERY                         75   664 974
   035   LEES W                ARCH DIS CHILD                  41   188 966
   036   LEE SS                ARCH SURG                       99    19 969
   037   WATTS DR              ARCH SURG                      108   592 974
   038   SHARP HL              J PEDIATR                       71   723 967
   039   AHRENS EH JR          PEDIATRICS                       8   628 951
   040   JAVITT NB             IN: SCHIFF L                         111 975
   041   GUTSTEIN S            ISR J MED SCI                    4    36 968
   042   CLAYTON RJ            AM J DIS CHILD                 117   112 969
   043   LINARELLI LG          J PEDIATR                       81   484 972
   044   JUBERG RC             PEDIATRICS                      38   819 966
   045   WATSON GH             ARCH DIS CHILD                  48   459 973
   046   ALAGILLE D            J PEDIATR                       86    63 975
   047   MILLARD M             J MAINE MED ASSOC               62   243 971
   048   EYSSEN H              BIOCHIM BIOPHYS ACTA           273   212 972
   049   WEBER A               PEDIATRICS                      50    73 972
   050   CAREY JB JR           J BIOL CHEM                    238   855 963
   051   NORMAN A              ACTA PAEDIATR SCAND             58    59 969
   052   NORMAN A              ACTA PAEDIATR SCAND             62   264 973
   053   HAAS L                ARCH DIS CHILD                  43   438 968
   054   HAMBOURG M            ANN PEDIATR (PARIS)             18   695 971
   055   LUDERS D              MONATSSCHR KINDERHEILKD        121   717 973
   056   TYGSTRUP N            ACTA MED SCAND                 185   523 969
   057   AAGENAES O            ARCH DIS CHILD                  43   646 968
   058   SIGSTAD H             ACTA MED SCAND                 188   213 970
   059   SHARP HL              J PEDIATR                       78   491 971
   060   DANKS DM              AUST PAEDIATR J                  1   193 965
   061   ESCOBEDO MB           CLIN PEDIATR                    13   656 974
   062   SEELER RA             ILL MED J                      143   347 973
   063   JEAN R                ARCH FR PEDIATR                 27   849 970
   064   VALMAN HB             ARCH DIS CHILD                  46   805 971
   065$  TAYLOR WF             AM J DIS CHILD                  46   805 971
   066   OPPENHEIMER EH        J PEDIATR                       86   683 975
   067   REID IS               ARCH DIS CHILD                  48   952 973
   068   PORTO SD              AM J DIS CHILD                 117   684 969
   069   LEVINE G              ARCH PATHOL                     95   267 973
   070   AKERS DR              SURGERY                         71   817 972
   071   HSIA DYY              METABOLISM                      16   419 967
   072   SCRIVER CR            AM J DIS CHILD                 113    41 967
   073   YU JS                 ARCH DIS CHILD                  46   306 971
   074   SHARP HL              J LAB CLIN MED                  73   934 969
   075   AAGENAES O            ACTA PAEDIATR SCAND             61   632 972
   075   JOHNSON AM            IN: BECKER FF                            974
   076   KATTAMIS C            PEDIATRICS                      54   157 974
   077   KATTAMIS C            ARCH DIS CHILD                  48   133 973
   078   GILLESPIE A           LANCET                           2  1081 970
   079   SCHWEITZER IL         GASTROENTEROLOGY                65   277 973
   080   TOLENTINO P           LANCET                           1   398 971
   081   VASSELLA F            AM J DIS CHILD                 123   300 972
   082   ALTSCHULER G          LANCET                           2  1206 973
   083   PORTER CA             BR MED J                         3   435 972
   084   ZELTZER PM            LANCET                           1   373 974
   085   MORRISSEY KP          SURGERY                         74   116 973
   086   SHARP HL              J PEDIATR                       70    46 967
   087   MAKSOUD JG            PEDIATRICS                      48   966 971
   088$  POLEY JR              J LAB CLIN MED                   3   325 973
   089   POLEY JR              J PEDIATR SURG                   7   660 972
   090   HARDISON WG           J LAB CLIN MED                  77   811 971
   091   PAUMGARTNER G         BULL NY ACAD MED                51   455 970
   092   GREIM H               GASTROENTEROLOGY                63   846 972
   093   EINARSSON K           CLIN SCI MOL MED                46   183 974
   094   HARKAVY M             IN: SALHANIK HA                       11 969
   095   LOTTSFELDT FI         N ENGL J MED                   269   186 963
   096   WEST RJ               ARCH DIS CHILD                  48   370 973
   097   SHARP HL              IN: GELLIS SS                        224 973
   098   COHEN BD              N ENGL J MED                   280  1362 969
   099   ERLINGER S            GASTROENTEROLOGY                66   281 974
   100   MACAROL V             J CLIN INVEST                   49  1714 970
   101   BARNHART J            IN: PAUMGARTNER G                    315 973
   102   STIEHL A              N ENGL J MED                   286   858 972
   103   SHARP HL              J PEDIATR                       81   116 972
   104   KROVETZ LJ            SURGERY                         47   468 960
   105   KROVETZ LJ            SURGERY                         47   453 960
   106   HAYES DM              J PEDIATR                       71   598 967
   107   LLANA-NAVAINO R       REV MED CHIR MAL FOIE           46   137 971
   108   THALER MM             AM J DIS CHILD                 116   262 968
   109   RAVITCH MM            MED TIMES                       95   586 967
   110   FONKALSRUD EW         AM SURGEON                      37   389 971
   111   KOOP CE               J PEDIATR SURG                  10   169 975
   112   LILLY J               PEDIATRICS                      55    12 975
   113   KASAI M               J PEDIATR SURG                  10   173 975
   114   GARDNER LI            N ENGL J MED                   290   406 974
   115   CAMPBELL DP           J PEDIATR SURG                   9   329 974
   116   MIYADA M              SURGERY                         76   234 974
   117   STERLING JA           INT SURG                        46   228 966
   118   ZACHERY RB            PRACTITIONER                   210   627 973
   119   DE LORIMIER AA        N ENGL J MED                   288  1284 973
   120   HAYES DM              SURG CLIN NORTH AM              53  1257 973
   121   ALAGILLE D            AM J DIS CHILD                 123   287 972
   122   LANDING BH            PROG PEDIATR SURG                6   113 974
CT   1   RODGERS BM            GASTROENTEROLOGY                71   710 976
     2   UTILI R               GASTROENTEROLOGY                71  1109 976
     3   JAVITT NB             CLIN GASTROENTEROL               6   219 977
     4   ROY CC                CLIN GASTROENTEROL               6   377 977
     5   WATKINS JB            CLIN GASTROENTEROL               6   201 977
     6   DELEZE G              HELV PAEDIATR ACTA              32    29 977
     7   LLOYDSTILL JD         PEDIATRICS                      59   626 977
     8   CHIPRUT R             GASTROENTEROLOGY                72   772 977
     9   MATHIS RK             J PEDIATR                       90   864 977
    10   SCHMEISSER W          SCHWEIZ MED WOCHENSCHR         107  1613 977
    11   EVANS J               BR J DERMATOL                   98   469 978
    12   ABERNATHY CO          MED HYPOTHESES                   5   641 979
    13   CALANDI C             MINERVA PEDIATR                 31  1357 979
    14   JAVITT NB             POSTGRAD MED                    65   120 979
    15   GOLDBERG DM           AM J CLIN PATHOL                71   557 979
    16   LLOYDSTILL JD         AM J CLIN PATHOL                71   444 979
    17   MANGINELLO FP         J PEDIATR                       94   296 979
    18   BRANSKI D             J CLIN GASTROENTEROL             2   251 980
    19   KAPLINSKY C           PEDIATRICS                      65   782 980
    20   DOCKTER G             MONATSSCHR KINDERHEILKD        128   326 980
    21   ROTTHAUWE HW          MONATSSCHR KINDERHEILKD        128   284 980
    22   FRANKEN P             ZENTRALBL VETERINARMED (A)      28   276 981
    23   FINNI K               BIOL NEONATE                    40   264 981
    24   BARNES S              J CLIN INVEST                   68   775 981
    25   KOCOSHIS SA           J PEDIATR                       99   436 981
    26   FINNI K               EUR J PEDIATR                  138    53 982
    27   SPIVAK W              J PEDIATR GASTROENTEROL NUTR     2   381 983
    28   WATKINS JB            J PEDIATR GASTROENTEROL NUTR     2   365 983
    29   GANGL A               ACTA MED AUSTRIACA              10   107 983
    30   TUCHWEBER B           TOXICOL LETT                    19   107 983
    31   WATSON S              CLIN PEDIATR                    22    30 983
    32   MATHIS U              GASTROENTEROLOGY                85   674 983
    33   LEWITTES M            HEPATOLOGY                       4   486 984
    34   WALSHE JM             SEM LIVER DIS                    4   252 984
    35   WEAVER LT             ACTA PAEDIATR SCAND             73   155 984
    36   BECKER M              EUR J PEDIATR                  143    41 984
    37   BOHLES H              KLIN PAEDIATR                  198   435 986
    38   BOHLES H              INFUSIONSTHER KLIN ERNAHR       14     3 987
    39   COX KL                PEDIATR RES                     21   170 987

PN 76069
RN 00424 
AN 76188872
AU Weber-A-M.  Roy-C-C.  Chartrand-L.  Lepage-G.  Dufour-O-L.
   Morin-C-L.  Lasalle-R.
TI Relationship between bile acid malabsorption and pancreatic
   insufficiency in cystic fibrosis.
SO Gut. 1976 Apr. 17(4). P 295-9. (REVIEW).
MJ BILE-ACIDS-AND-SALTS: me.  CYSTIC-FIBROSIS: pp.
   MALABSORPTION-SYNDROMES: me.  PANCREAS: pp.
MN ADOLESCENCE.  ADULT.  BICARBONATES: pd.  CHILD.  CHILD-PRESCHOOL.
   COMPARATIVE-STUDY.  CYSTIC-FIBROSIS: co, me.  FECES: an.  HUMAN.
   INFANT.  INTESTINAL-ABSORPTION: de.  LIPIDS: me.  REVIEW.
   TRIGLYCERIDES: pd.
AB Bile acid loss (mg/m2 24h) in the stools of 43 cystic fibrosis (CF)
   children with pancreatic insufficiency was 751-1 +/- 48-3, while that
   of six without clinical evidence of pancreatic disease (133-4 +/- 15-
   9) did not differ from values in 25 controls (109-8 +/- 9-8). There
   was a good correlation between the degree of bile acid (BA) and fat
   sequestration. Concomitant changes in bile acid and fat loss were
   observed in the one group of six patients studied on and off
   pancreatic enzymes as well as in a second group of seven children
   treated with pancreatic supplements and maintained on a normal diet
   followed by a low fat diet supplemented with medium chain
   triglycerides. Administration of NA bicarbonate led to a significant
   decrease in fat loss (15-8 +/- 2-7 leads to 10-3 +/- 1-9) without any
   simultaneous change in bile acid excretion (533-1 +/- 58-3 leads to
   500-4 +/- 58-6). Qualitative bile acid patterns in controls, in
   infants after an ileal resection, and in patients with CF or with
   coeliac disease showed that the percentage of primary BA followed
   closely the total amount excreted except in situations where
   antibiotics were administered. The exact mechanism for the increased
   loss of BA in CF is unknown. It is found in all age groups and is
   related to the presence and degree of pancreatic insufficiency. The
   possibility that unhydrolysed triglycerides may interfere with the
   intestinal absorption of bile acid needs further confirmation.
RF 001   AMMON HV              J CLIN INVEST                   53   205 974
   002   ANNEGERS JH           ARCH INTERN MED                 93     9 954
   003   BONIN A               J PEDIATR                       83   594 973
   004   BORGSTROM B           J LIPID RES                      8   598 967
   005   EASTWOOD MA           GUT                             13   845 972
   006   FIASSE R              GASTROENTERO 3RD ANN CONG ABS            974
   007   FLOCH MH              GASTROENTEROLOGY                61   228 971
   008   GO VLW                GASTROENTEROLOGY                58   638 970
   009   GRACEY M              ARCH DIS CHILD                  45   445 970
   010   HARO EN               CLIN RES                        12   207 964
   011   HEIZER WD             BULL JOHNS HOPKINS HOSP        116   261 965
   012   HOFMANN AF            GASTROENTEROLOGY                62   918 972
   013   HOLT PR               DISEASE A MONTH                  6    19 971
   014   KATTWINKEL J          PEDIATRICS                      50   133 972
   015   KUO PT                J CLIN INVEST                   44  1924 965
   016   MALLORY A             GASTROENTEROLOGY                64    26 973
   017   REDINGER RN           GASTROENTEROLOGY                64   610 973
   018   RICOUR C              ARCH FR PEDIATR                 29   668 972
   019   VAN DE KAMER JH       J BIOL CHEM                    177   347 949
   020   VEEGER W              N ENGL J MED                   267  1341 962
   021   WATKINS JB            GASTROENTEROLOGY                67   835 974
   022   WEBER AM              CLIN CHIM ACTA                  39   524 972
   023   WEBER AM              GASTROENTEROLOGY                68  1066 975
   024   WEBER AM              N ENGL J MED                   289  1001 973
CT   1   ROY CC                CLIN GASTROENTEROL               6   377 977
     2   AURICCHIO S           PEDIATR RES                     11   997 977
     3   LEFEBVRE D            EXPERIENTIA                     33   616 977
     4   LIPSON AH             ARCH DIS CHILD                  52   428 977
     5   SCOTT J               AM J MED                        63   488 977
     6   ROY CC                GASTROENTEROLOGY                72  1123 977
     7   KERN F                GASTROENTEROLOGY                73   631 977
     8   ROY CC                GASTROENTEROLOGY                73   631 977
     9   WATKINS JB            GASTROENTEROLOGY                73  1023 977
    10   ROY CC                N ENGL J MED                   297  1301 977
    11   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
    12   SMALLEY CA            ARCH DIS CHILD                  53   477 978
    13   CUMMINGS JH           J CLIN INVEST                   61   953 978
    14   STARKEY BJ            MONOGR PAEDIATR                 10    12 979
    15   ROY CC                LIPIDS                          14   811 979
    16   LOESCHKE K            INTERNIST                       20   369 979
    17   DUTTA SK              DIG DIS SCI                     24   529 979
    18   ROY  CC               AM J CLIN NUTR                  32  2404 979
    19   HARRIES JT            ARCH DIS CHILD                  54    19 979
    20   LLOYDSTILL JD         AM J CLIN PATHOL                71   444 979
    21   REGAN PT              GASTROENTEROLOGY                77   285 979
    22   MISCHLER EH           AM J DIS CHILD                 133   632 979
    23   ROY CC                PROC SOC EXP BIOL MED          161   105 979
    24   ROULET M              PEDIATR RES                     14  1360 980
    25   HUBBARD VS            AM J CLIN NUTR                  33  2281 980
    26   GORIUP U              HELV PAEDIATR ACTA              35   177 980
    27   EKLUND A              SCAND J CLIN LAB INVEST         40   595 980
    28   BOYLE BJ              GASTROENTEROLOGY                78   950 980
    29   BALISTRERI WF         J PEDIATR                       96   582 980
    30   PARK RW               GASTROENTEROLOGY                81  1143 981
    31   ROY CC                J PEDIATR GASTROENTEROL NUTR     1   469 982
    32   COLOMBO C             RIV ITAL PEDIATR                 8    77 982
    33   FONDACARO JD          PEDIATR RES                     16   494 982
    34   GRAHAM DY             DIG DIS SCI                     27   485 982
    35   HEUBI JE              GASTROENTEROLOGY                83   804 982
    36   HEUBI JE              GASTROENTEROLOGY                83  1156 982
    37   BALISTRERI WF         J PEDIATR GASTROENTEROL NUTR     2   105 983
    38   ISENBERG JN           J PEDIATR GASTROENTEROL NUTR     2   447 983
    39   ROY CC                J PEDIATR GASTROENTEROL NUTR     2   152 983
    40   COLOMBO C             DIG DIS SCI                     28   306 983
    41   COLOMBO C             J PEDIATR GASTROENTEROL NUTR     3   556 984
    42   GOTZ M                ATEMWEGS LUNGENKRANKH           10   594 984
    43   ZENTLERMUNRO PL       GUT                             25   500 984
    44   PERRY RS              CLIN PHARMACY                    4   161 985
    45   ROBB TA               GUT                             26  1246 985
    46   ZENTLERMUNRO PL       GUT                             26   892 985
    47   SETCHELL KDR          CLIN CHIM ACTA                 151   101 985
    48   SINAASAPPEL M         ACTA PAEDIATR SCAND SUPPL 317 1985    22 985
    49   WEBER AM              ACTA PAEDIATR SCAND SUPPL 317 1985     9 985
    50   WEIZMAN Z             GUT                             27  1043 986
    51   LEROY C               DIG DIS SCI                     31   911 986
    52   DUTTA SK              GASTROENTEROLOGY                91  1243 986

PN 76070
RN 00425 
AN 76236387
AU Desai-L-S.  Lazarus-H.  Morrissey-G-W.  Wulff-U-C.  Foley-G-E.
   Shwachman-H.
TI Differences in the frequency distribution of DNA and dry mass per
   cell in lymphocytes derived from cystic fibrosis patients.
SO Haematologica (Pavia). 1976 Jun. 61(2). P 157-69.
MJ BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: bl.  DNA: an.
   LYMPHOCYTES:  an.
MN ADOLESCENCE.  ADULT.  CELL-LINE.  CHILD.  FEMALE.  HUMAN.
   KARYOTYPING.  MALE.  MIDDLE-AGE.  SUPPORT-U-S-GOVT-P-H-S.
AB The DNA and dry mass content of lymphocytes of normal controls,
   heterozygotic and cystic fibrosis patients have been studied
   utilizing biophysical instrumentation.  The lymphocytes from CF had
   Feulgen-DNA mean values significantly lower than the normal
   controls.  DNA values for CF lymphocytes exhibited two
   sub-population values.  The mean dry mass (total protein) values
   exhibited greater intercellular variability among CF cells.  The dry
   mass:DNA ratio was higher in CF than in normal controls, and this
   ratio appeared to increase concomitantly with advance of disease.
RF 001   ANDERSEN DH           ANN NY ACAD SCI                 93   500 962
   002   ANTONOWICZ I          PEDIATR RES                      6   803 972
   003   ATKIN NB              BR J CANCER                     13   773 959
   004   ATKIN NB              BR J CANCER                     13   773 959
   005   BLUME RS              BLOOD                           33   821 969
   006   BOYUM A               SCAND J CLIN LAB INVEST SUPPL   97    77 968
   007   BURZYNSKI NJ          J DENT RES                      52   164 973
   008   CASPERSSON T          EXP CELL RES                    28   621 962
   009   CASPERSSON T          EXP CELL RES                    32   553 963
   010   CHOI KW               SCIENCE                        170    89 970
   011   CONOVER JH            PEDIATR RES                      7   224 973
   012   DANES BS              J EXP MED                      129   775 969
   013   DANES BS              J EXP MED                      123     1 966
   014   DANES BS              J EXP MED                      124  1181 966
   015   GARCIA AM             IN: WIED GL                      2       966
   016   DESAI LS              CHROMOSOMA                      38   329 972
   017   EAGLE H               SCIENCE                        130   432 959
   018   FOLEY GE              PROC SYMP FUND CANC RES 21ST          65 968
   019   FRANZER CS            EXP CELL RES                     4   316 953
   020   GAHRTON G             CANCER RES                      29  1076 969
   021   DEITCH AD             IN: WIED GL                      2       966
   022   INUI N                CYTOLOGIA                       35   280 970
   023   LAZARUS H             IN: ROTHBLAT GH                  2   170 972
   024   LEUCHTENBERGER C      IN: DANIELLI JF                  1   219 968
   025   LOMAKKA G             ACTA HISTOCHEM SUPPL             6    47 965
   026   LOMAKKA G             ACTA HISTOCHEM SUPPL             6   393 965
   027   MCCARTHY RE           EXP CELL RES                    43   564 966
   028   OBRIEN JS             FED PROC                        30   956 971
   029   SHEETER S             BIRTH DEF ORIG ART SER           9   138 973
   030   SHWACHMAN H           PEDIATRICS                      36   689 965
   031   SNEDECOR GW           STATISTICAL METHODS                      967
CT   1   JAKEL HP              BIOL ZENTRALBL                  98    55 979

PN 76071
RN 00426 
AN 76237304
AU Schaub-J.  Remberger-K.  Endres-W.  Bremer-H-J.
TI Galactosemia with endogenous production of galactose-1-phosphate and
   with cystic fibrosis-like appearance at autopsy.
SO Helv-Paediatr-Acta. 1976 Jun. 31(1). P 67-76.
MJ CYSTIC-FIBROSIS: co.  GALACTOSEMIA: bl.  LIVER-CIRRHOSIS: co.
MN AUTOPSY.  CASE-REPORT.  CYSTIC-FIBROSIS: pa.  ERYTHROCYTES: me.
   GALACTOSEMIA: co, dh.  HUMAN.  INFANT.  JEJUNUM: pa.
   LIVER-CIRRHOSIS: pa.  LIVER: pa.  MALE.  PANCREAS: pa.
AB In an infant with galactosemia high levels of galactose-1-phosphate
   in red blood cells and of blood galactose were observed under a
   "galactose-free'' diet. The child did not thrive and developed a
   liver cirrhosis. At the age of 5 months he died unexpectedly. Post
   mortem examination revealed in the pancreas and the small intestine
   changes suggestive of a cystic fibrosis. Since the exogenous
   administration of galactose by diet could be excluded the endogenous
   production of significant amounts of galactose-1-phosphate has to be
   considered.
RF 001   BREMER HJ             HELV PAEDIATR ACTA              27   525 972
   002   BRODEHL J             BEIHEFT ZUM ARCHIV FUR KINDER            969
   003   DONNELL GN            BIOCHEM MED                      1    29 967
   004   GITZELMANN R          PEDIATRICS                      36   231 965
   005   GITZELMANN R          PEDIATR RES                      3   279 969
   006   GITZELMANN R          BIOCHIM BIOPHYS ACTA           372   374 974
   007   GITZELMANN R          IN: HOMMES FA                         25 975
   009   HARRIS RC             PEDIATR RES ABST 78              1   220 967
   010   HSIA DYY              GALACTOSEMIA                             969
   011   KALCKAR HM            BIOCHIM BIOPHYS ACTA            20   262 956
   012   KAPLAN E              N ENGL J MED                   279    65 968
   013   KIRKMAN HN            J LAB CLIN MED                  56   161 960
   014   KISSANE JM            PATHOLOGY OF INFANCY AND CHIL        320 975
   015   POTTER EL             PATHOLOGY OF FETUS AND INFANT        142 962
   016   PROSSER R             ARCH DIS CHILD                  49   597 974
   017   SONNINO S             J BIOL CHEM                    241  1009 966
   018   SPACKMAN DH           ANAL CHEM                       30  1190 958
   019   TSUBOI KK             J BIOL CHEM                    244  1008 969
   020   ZIMMERMAN HM          PROGRESS IN NEUROPATHOLOGY               973

PN 76072
RN 00427 
AN 77206026
AU Wood-R-E.
TI Pseudomonas: the compromised host.
SO Hosp-Pract. 1976 Aug. 11(8). P 91-100.
MJ PSEUDOMONAS-INFECTIONS.
MN ANIMAL.  BLOOD-TRANSFUSION.  CHILD.  CYSTIC-FIBROSIS: co.  DOGS.
   GRANULOCYTES: tr.  CROSS-INFECTION.  HUMAN.  INFANT-NEWBORN.
   INFANT-NEWBORN-DISEASES.  INFANT-PREMATURE.  PSEUDOMONAS-AERUGINOSA.
   PSEUDOMONAS-INFECTIONS: co, th.  RESPIRATORY-TRACT-INFECTIONS.
   SKIN-DISEASES-INFECTIOUS.  TRANSPLANTATION-HOMOLOGOUS.
AB Although the incidence of pseudomonas infection is low in the total
   hospital population, certain conditions predispose to such
   infection, which can be life-threatening.  Patients with cystic
   fibrosis are a special group, since a majority have chronic
   pulmonary infections with pseudomonas, often of a mucoid variant
   rarely found in other patients.  Several approaches are being tried
   in CF patients, but none shows much promise thus far.
RF 000   FARMER JJ 3RD         HOSP PRACT                      11    63 976
   000   LIU PV                HOSP PRACT                      11   139 976
   001   REYNOLDS HY           ANN INTERN MED                  82   819 975
   002   YOUNG LS              CRC CRIT REV CLIN LAB SCI        3   291 972
   003   MOREHEAD CD           AM J DIS CHILD                 124   564 972
   004   HUANG NN              J PEDIATR                       59   512 961
   005   PENNINGTON JE         AM J MED                        55   155 973
   006   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   007   HALL JH               ARCH DERMATOL                   97   312 968
CT   1   THOMASSEN MJ          PEDIATR RES                     13  1085 979
     2   WOOD RE               SOUTH MED J                     72   189 979
     3   THOMASSEN MJ          PEDIATR RES                     14   715 980
     4   THOMASSEN MJ          INFECT IMMUN                    33   512 981
     5   SORDELLI DO           CLIN IMMUNOL IMMUNOPATHOL       22   153 982
     6   THOMASSEN MJ          INFECT IMMUN                    38   802 982
     7   WINNIE GB             INFECT IMMUN                    38  1088 982
     8   OFFREDOHEMMER C       ANN MICROBIOL (PARIS)         A134   281 983
     9   WOODS DE              REV INFECT DIS                   5  S715 983
    10   SCHILLER NL           PEDIATR RES                     17   747 983
    11   SORENSEN RU           EUR J RESPIR DIS                64   524 983
    12   KEREN G               J INFECT                         9    22 984
    13   NICAS TI              CAN J MICROBIOL                 31   387 985
    14   NICAS TI              J CLIN MICROBIOL                23   967 986
    15   WOODS DE              J CLIN MICROBIOL                24   260 986
    16   SOKOL PA              INFECT IMMUN                    51   896 986

PN 76073
RN 00428 
AN 77206023
AU Davidson-M.
TI GI problems in children: I.
SO Hosp-Pract. 1976 Aug. 11(8). P 47-55.
MJ INTESTINAL-DISEASES: di, th.
MN CELIAC-DISEASE: di, th.  CHILD.  CHILD-PRESCHOOL.
   COLITIS-ULCERATIVE: di, th.  CYSTIC-FIBROSIS: di, th.
   DISACCHARIDASES: df.  CROHN-DISEASE: di, th.  HUMAN.  INFANT.
   INFANT-NEWBORN.  INFANT-PREMATURE.
   LYMPHANGIECTASIS-INTESTINAL: di, th.
AB The first of two articles focuses on a number of malabsorptive
   disorders and on inflammatory bowel diseases as causes of persistent
   diarrhea.  Diagnosis and treatment of the different entities are
   detailed.
RF 001   DAVIDSON M            IN: BARNETT HL                           972
   002   SILVERBERG M          IN: BARNETT HL                           972
   003   DAVIDSON M            IN: BARNETT HL                           972
   004   ANDERSON CM           PEDIATRIC GASTROENTEROLOGY               975
   005   DAVIDSON M            J PEDIATR                       66   545 965
   006   SHWACHMAN H           IN: SLEISENGER MH                   1206 973
   007   DAVIDSON M            IN: SLEISENGER MH                        973
   008   DAVIDSON M            J PEDIATR                       69  1027 966
   009   SHINER M              LANCET                           1   136 975

PN 76074
RN 00429 
AN 76166525
AU Bedrossian-C-W.  Greenberg-S-D.  Singer-D-B.  Hansen-J-J.
   Rosenberg-H-S.
TI The lung in cystic fibrosis.  A quantitative study including
   prevalence of pathologic findings among different age groups.
SO Hum-Pathol. 1976 Mar. 7(2). P 195-204.
MJ CYSTIC-FIBROSIS: pa.  LUNG: pa.
MN ADOLESCENCE.  ADULT.  AGE-FACTORS.  BRONCHI: pa.  CHILD.
   CHILD-PRESCHOOL.  FEMALE.  HUMAN.  INFANT.  INFANT-NEWBORN.  MALE.
   MUCOUS-MEMBRANE: pa.  PULMONARY-EMPHYSEMA: pa.
AB The autopsies of 82 patients with cystic fibrosis were reviewed with
   respect to pathologic changes in the lungs and their respective
   prevalence among different age groups. Although bronchitis,
   mucopurulent plugging, and bronchopneumonia were almost universally
   present among children of all ages, epithelial metaplasia and
   bronchiectasis were rarer among infants and progressively more
   prevalent in older age groups. Emphysema was absent in patients under
   two years of age and affected 11 per cent of the patients two to six
   years of age and 40 per cent of the patients older than six years,
   but was never of a severe degree by the point count method. Pulmonary
   hemorrhage, although uncommon, was usually associated with prominent
   arterial vessels in walls of bronchiectatic airways. Quantitative
   assessment of bronchial glands revealed Reid indices significantly
   higher in patients with cystic fibrosis when compared to noncystic
   fibrosis patients, but there was no increase in these indices with
   the age of the patients. Glandular hypertrophy, predominance of
   mucous acini within glands, and goblet cell hyperplasia of the
   bronchial mucosa all suggest an explanation for the copious mucous
   secretion of patients with cystic fibrosis. However, it was not
   possible to ascertain whether these findings reflect a general
   exocrine defect of such patients or whether they were merely a
   response to chronic airway infection, even though the latter is a
   more plausible assumption.
RF 001   SHWACHMAN H           PEDIATRICS                      36   689 965
   002   TALAMO RC             MED TIMES                       97   139 969
   003   ADDINGTON WW          CHEST                           59   306 971
   004   REID L                MOD PROBL PEDIATR               10   195 967
   005   ESTERLY JR            JOHNS HOPKINS MED J            122    94 968
   006   GREENBERG SD          AM J CLIN PATHOL                41   658 964
   007   REID L                THORAX                          15   132 960
   008   FIELD WEH             BR J DIS CHEST                  62    11 968
   009   WENTWORTH P           THORAX                          23   582 968
   010   MATSUBA K             AM REV RESPIR DIS              105   908 972
   011   THURLBECK WM          THORAX                          19   436 964
   012   ESTERLY JR            THORAX                          23   670 968
   014   AUERBACH O            AM REV RESPIR DIS               82   640 960
   015   DI SANTAGNESE PA      N ENGL J MED                   277  1399 967
   016   LEVITSKY S            JAMA                           213   125 970
   017   SYMCHYCH PS           ARCH PATHOL                     92   409 971
   018   GOLDRING RM           J PEDIATR                       65   501 964

PN 76076
RN 00430 
AN 76215350
AU Benke-P-J.
TI Biochemistry of cystic fibrosis: an overview.  pp.  157-64.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976.
MJ CYSTIC-FIBROSIS: me.
MN CELLS-CULTURED.  CYSTIC-FIBROSIS: bl.  GLYCOPROTEINS: me.  IGG.
   MONOGRAPH.  MUCOPOLYSACCHARIDES: me.  SODIUM: me.
   SUPPORT-U-S-GOVT-NON-P-H-S.
EX Cystic fibrosis has been a difficult problem to solve.  One amino
   acid is not found in elevated concentrations in the urine, one
   abnormal sugar or polysaccharide is not found in secretions of the
   bronchial tree which causes pulmonary damage, and a unique material
   which inhibits sodium transport has not yet been identified in sweat.
   Instead of viewing the current state of CF research as chaotic,
   perhaps we should say in a positive way that the diversity of ideas
   stimulates thinking, and in the process of sorting out the primary
   defect, a wide spectrum of pathophysiologic changes will be
   recognized.  Recently a positive-charged polypeptide associated with
   immunoglobulin G has been identified which may be responsible for the
   ciliary dyskinesis effect of CF serum.  This material should
   demonstrate the same properties when bound to immunoglobulin G from
   control sera.  It would be interesting if it were identical with the
   basic protein recently found only in the serum and IgG fraction of CF
   patients and carriers.  Further work may identify how the polypeptide
   affects cell membrane surfaces, and whether a defective peptidase,
   perhaps an arginine esterase, fails to break down the polypeptide.  A
   unifying hypothesis could then emerge and tie biochemical and
   physiological findings together.
RF 001   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   002   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   004   GRIFFIN GD            PROC SOC EXP BIOL MED          137   438 971
   005   GIBBS GE              SCIENCE                        167   993 970
   006   MARCHI AG             HELV PAEDIATR ACTA              28   427 973
   007   BENKE PJ              N ENGL J MED                   284   731 971
   008   KRAUS I               PEDIATRICS                      47  1010 971
   009   ROSENLUND ML          NATURE                         251   719 974
   010   KUO PT                J CLIN INVEST                   44  1924 965
   011   EMERY AEH             LANCET                           2    80 975
   012   MCEVOY FA             LANCET                           2   236 975
   013   FITZPATRICK DF        NATURE NEW BIOL                242   113 973
   014   DUFFY MJ              NATURE NEW BIOL                246   151 973
   015   SMITH QT              NATURE NEW BIOL                240    56 972
   016   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   017   COHEN LF              PEDIATR RES                      9   312 975
   018   MCEVOY FA             PEDIATR RES                      9   721 975
   019   CAMPBELL RA           CLIN RES                        23  144A 975
   020   RENNERT OM            CLIN PEDIATR                    11   351 972
   021   RENNERT OM            PEDIATRICS                      50   485 972
   022   KLAGSBRUN M           PEDIATR RES                      8   205 974
   023   HODES ME              PEDIATR RES                      8   212 974
   024   BALFE JW              SCIENCE                        162   689 968
   025   LAPEY A               PEDIATR RES                      5   446 971
   026   FEIG SA               PEDIATR RES                      8   594 974
   027   MANGOS JA             IN: DI SANTAGNESE PA                 109 964
   028   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   029   MANGOS JA             PEDIATR RES                      1   436 967
   030   CONOVER JH            LANCET                           2  1501 973
   031   HANN S                LANCET                           2   520 974
   032   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   033   MAXFIELD M            J CLIN INVEST                   41   455 962
   034   FRIEDMANN T           J LAB CLIN MED                  70   404 967
   035   EYLAR E               GAP CONF REP CELL TISS CULT            8 971
   036   SINGER L              CLIN BIOCHEM                     7   146 974
   037   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   038   BUTTERWORTH J         CLIN CHIM ACTA                  56   159 974
   039   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   040   BOLTON WE             AM J HUM GENET                  27   394 975
   041   SOLOMONS CC           PEDIATRICS                      47   384 971
   042   KATTWINKEL J          PEDIATRICS                      50   133 972
   043   RAO GJS               SCIENCE                        177   610 972
   044   LIEBERMAN J           PEDIATR RES                      3   571 969
   045   TALAMO RC             PEDIATR RES                      6   430 972
   046   SPOCK A               PEDIATR RES                      1   173 967
   047   BOWMAN BH             SCIENCE                        164   325 969
   048   CHERRY JD             J PEDIATR                       79   937 971
   049   FARRELL PM            PEDIATR RES                      8   467 974
   050   SHAPIRO BL            PROC SOC EXP BIOL MED          144   181 973
   051   SHAPIRO BL            LANCET                           2  1020 974
   052   RAO GJS               PEDIATR RES                      8   684 974
   053   COBURN MD             AM REV RESPIR DIS              110   368 974
   054   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   055   DANES BS              LANCET                           1  1061 968
   056   TAYSI K               N ENGL J MED                   281  1108 969
   057   HOUCK JC              PROC SOC EXP BIOL MED          135   369 970
   058   SHAPIRO BL            BIOCHEM BIOPHYS RES COMMUN      39   816 970
   059   RAO GJS               J PEDIATR                       80   573 972
   060   ANTONOWICZ I          PEDIATR RES                      6   803 972
   061   BOHME B               HELV PAEDIATR ACTA              27   607 972
   062   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   063   CONOD EJ              PEDIATR RES                      9   724 975
   064   WILSON GB             CLIN CHIM ACTA                  49    79 973
   065   WILSON GB             PEDIATR RES                      9   635 975
   066   LOWE CU               SCIENCE                        153  1124 966
   067   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   068   NEUFELD EF            REPORT ON STAINING FOR METACH            972
   069   ROBERTSON JA          LANCET                           1  1256 974
   070   CAUDILL M             LANCET                           1    32 974
   071   WELCH DW              PEDIATR RES                      9   698 975
   072   WIESMANN UN           J PEDIATR                       77   685 970
   073   DANES BS              BIOCHEM GENET                   12   359 974
   074   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   075   CHOU L                PEDIATR RES                      9   312 975
   076   PALLAVICINI JC        J PEDIATR                       77   280 970
   077   BENKE PJ              LANCET                           1   182 972
   078   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   079   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   080   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   081   RAO GJS               PEDIATR RES                      9   739 975
CT   1   SCHAAP T              ISR J MED SCI                   14   201 978
     2   LAST JA               J LAB CLIN MED                  91   328 978
     3   HALLINAN F            MED HYPOTHESES                   7   793 981
     4   CAREY WF              MED J AUST                       2   528 983
     5   TRAVERS H             AM J OBSTET GYNECOL            146   338 983

PN 76077
RN 00431 
AN 76215349
AU Schaap-T.  Cohen-M-M.
TI A proposed model for the inheritance of cystic fibrosis.  pp.
   291-307.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976.
MJ CYSTIC-FIBROSIS: fg.  MODELS-BIOLOGICAL.
MN ALLELES.  CAUCASOID-RACE.  CONSANGUINITY.  GENE-FREQUENCY.  GENES.
   GENES-RECESSIVE.  GENOTYPE.  HETEROZYGOTE.  HUMAN.  MONGOLOID-RACE.
   MONOGRAPH.  MUTATION.  PEDIGREE.  POLYMORPHISM-GENETICS.
   SELECTION-GENETICS.  SEX-FACTORS.
EX To geneticists, cystic fibrosis, perhaps the most frequently
   encountered genetic disease among Caucasians of European origin,
   presents an enigmatic dilemma on various levels.  Those problem areas
   which complicate our understanding of this disease include methods of
   diagnosis, ascertainment, and analysis and interpretation of data.
   In spite of an apparently clear-cut mode of inheritance (autosomal
   recessive), several conceptual difficulties exist in the acceptance
   of this formal transmission pattern.  The most pressing problem of
   all, perhaps, is the population genetics of CF.  The fact that a
   lethal gene may be maintained at such elevated frequencies and
   restricted to given population groups represents a seemingly genetic
   paradox.  Our aim is to review some of the problems encountered in a
   genetic study of CF and to propose a theoretical model which may help
   in their elucidation.  Topics discussed include problems of
   diagnosis, ascertainment, and data analysis; family studies and
   inferences as to the mode of inheritance; population studies; and a
   proposed model for the inheritance of CF.  The main tenet of this
   model states that CF is determined by dominant alleles at two
   autosomal loci, with interaction between them.
RF 001   DANKS DM              ANN HUM GENET                   28   323 965
   001   CONOVER JH            LIFE SCI                        14   253 974
   002   ANDERSEN DH           AM J DIS CHILD                  72    62 946
   003   WRIGHT SW             AM J HUM GENET                  20   157 968
   003   RAO GJS               PEDIATR RES                      8   684 974
   004   BRUNECKY Z            J MED GENET                      9    33 972
   004   BLOMFIELD J           GUT                             14   558 973
   005   CROW JF               IN: NEEL JV                           23 965
   005   CONOVER JH            LANCET                           1  1194 973
   006   LOWE CU               AM J DIS CHILD                  78   349 949
   007   GOODMAN HO            AM J HUM GENET                   4    59 952
   008   BAUMANN T             HELV PAEDIATR ACTA SUPPL 8      13     1 958
   009   ROBERTS GBS           ANN HUM GENET                   24   127 960
   010   STEINBERG AG          AM J HUM GENET                  12   416 960
   011   SELANDER P            ACTA PAEDIATR SCAND             51    65 962
   012   KRAMM ER              AM J PUBLIC HEALTH              52  2041 962
   013   HOUSTEK J             REV MED LIEGE                   22   421 967
   014   MERRITT AD            J LAB CLIN MED                  60   998 962
   015   LEVIN S               IN: GOLDSCHMIDT E                    294 963
   016   HONEYMAN MS           AM J HUM GENET                  17   461 965
   017   PUGH RJ               ARCH DIS CHILD                  42   544 967
   018   HALL BD               J MED GENET                      5   262 968
   019   SULTZ HA              AM J PUBLIC HEALTH              58   491 968
   020   ANTONELLI M           FRACASTORO (VERONA)             63   207 970
   021   STEINBERG AG          AM J HUM GENET                   8   162 956
   022   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   023   BERNHEIM M            PEDIATRIE                       16    17 961
   024   REDDY CR              J TROP MED HYG                  73    59 970
   025   SALEM M               J MED LIBAN                     15    61 962
   026   HARRIS RL             PEDIATRICS                      41   733 968
   027   OPPENHEIMER EH        PEDIATRICS                      42   547 968
   028   YAMAMOTO T            SHONIKA RINSHO                  10  1003 957
   029   KOBAYASHI R           NIPON SHONIKAGAKKAI ZASSHI      65   597 961
   030   HAMAMOTO E            NIPON SHONIKAGAKKAI ZASSHI      65   502 961
   031   IKAI K                ACTA PAEDIATR JAP                7    23 965
   032   KADOWAKI H            ARCH JAP CHIRUG                 32   437 963
   033   KOMI N                BULL TOKYO MED DENT UNIV        13     1 966
   034   KANDAR HR             ANTISEPTIC                      68   563 971
   035   WANG CI               CF CLUB ABST                     9    57 968
   036   ZUELZER WW            PEDIATRICS                       4    53 949
   037   DI SANTAGNESE PA      ANN INTERN MED                  54   482 961
   038   PILEGGI A             DELAWARE MED J                  34    97 962
   039   KULCZYCKI LL          CLIN PEDIATR                     3   692 964
   040   SENECAL JJ            BULL MED AFRI OCCID FRANC       11    95 954
   041   GROVE SS              S AFR J LAB CLIN MED             5   113 959
   042   MACDOUGALL LG         LANCET                           2   409 962
   043   HEFFER ET             NY STATE J MED                  74  2355 974
   044   WRIGHT SW             AM J HUM GENET                  20   157 968
   045   BEARN AG              TRANS ASSOC AM PHYSICIANS       82   248 969
   046   DANES BS              AM J HUM GENET                  23   297 971
   047   KNUDSON AG JR         AM J HUM GENET                  19   388 967
   048   ANDERSON CM           MOD PROBL PEDIATR               10   381 967
   049   DODGE JA              LANCET                           1   572 975
   050   CRAWFURD MDA          HEREDITY                        29   126 972
   051   STUART AB             LANCET                           2  1521 974
   052   HALLETT WY            AM REV RESPIR DIS               92   714 965
CT   1   COX DW                PEDIATR CLIN NORTH AM           26   467 979
     2   MACDONALD MJ          DIABETES                        29   110 980
     3   ROMEO G               RIV ITAL PEDIATR                 7   201 981
     4   ROMEO G               EUR J PEDIATR                  137   119 981
     5   SING CF               AM J MED GENET                  13   179 982
     6   BUCHANAN KD           SCAND J GASTROENTEROL           18   155 983
     7   WOOD RE               SEM RESPIR MED                   5   336 984
     8   MATTHEWS LW           PEDIATR CLIN NORTH AM           31   133 984
     9   ROMEO G               AM J HUM GENET                  37   338 985
    10   FISHER JH             AM REV RESPIR DIS              132  1149 985
    11   STOLLINGER O          WIEN MED WOCHENSCHR            135   307 985
    12   BRAGANZA JM           MED HYPOTHESES                  20   233 986
    13   BOUE A                HUM GENET                       74   288 986

PN 76078
RN 00432 
AN 76215355
AU Talamo-R-C.  Stiehm-E-R.  Schwartz-R-H.
TI Immunologic aspects of cystic fibrosis.  pp.  195-217.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: im.
MN ALPHA-1-ANTITRYPSIN: me.  ANTIBODIES.  ASPERGILLOSIS: et.
   B-LYMPHOCYTES: im.  COMPLEMENT: me.  CYSTIC-FIBROSIS: co.
   FACTOR-XII.  HLA-ANTIGENS.  HUMAN.  HYPERSENSITIVITY: et.  IGA: me.
   IGD: me.  IGG: me.  IGM: me.  IMMUNE-COMPLEX-DISEASE.
   IMMUNOLOGIC-DEFICIENCY-SYNDROMES: co.  LUNG: pp.  MONOGRAPH.
   PANCREATIC-EXTRACTS: im.  PHAGOCYTOSIS.  PSEUDOMONAS-INFECTIONS: et.
   RESPIRATORY-TRACT-INFECTIONS: et.  REVIEW.
   STAPHYLOCOCCAL-INFECTIONS: et.  T-LYMPHOCYTES: im.
EX Because of the prominent role of infection in cystic fibrosis, and
   because of the genetic nature of both cystic fibrosis and specific
   immune defects, considerable effort has been expended in determining
   if there are hereditary immune defects in cystic fibrosis patients
   that render them susceptible to infection.  Against a congenital
   immune defect is the fact that the infections nearly always are
   localized to the lung with the same two organisms, rather than
   infections at multiple sites involving multiple organisms.  Specific
   immune mechanisms in the B and T cell systems are examined.
   Nonspecific host defense mechanisms include the complement system,
   phagocytosis, pulmonary clearance, the pulmonary barrier to the
   systemic spread of infection, protease inhibitors, and factor
   XIII-dependent systems.  Hypersensitivity states include allergy and
   atopy, allergic aspergillosis, immune complex disease, and
   hypersensitivity to pancreatic extracts.  The presence or absence of
   specific antigen components and the association of HL-A antigens are
   also discussed.
RF 001   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   559 974
   002   GREEN MN              AM J DIS CHILD                 100   365 960
   003   SCHWARTZ RH           AM J DIS CHILD                 111   408 966
   004   YOHE RM               ANN ALLERGY                     30   627 972
   005   COLLINS-WILLIAMS C    ANN ALLERGY                     25   177 967
   006   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   007   RACHELEFSKY GS        AM J DIS CHILD                 128   355 974
   008   SPITZ E               J ALLERGY CLIN IMMUNOL          49   337 972
   009   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
   010   FALCHUK ZM            PEDIATRICS                      51    49 973
   011   GUGLER EC             J PEDIATR                       73   548 968
   012   SOUTH MA              J PEDIATR                       71   645 967
   013   RULE AH               PEDIATRICS                      48   601 971
   014   HALBERT SP            PEDIATRICS                      26   792 960
   015   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973
   016   HALBERT SP            MOD PROBL PEDIATR               10   144 967
   017   SCHWARTZ RH           AM J DIS CHILD                 120   432 970
   018   HABBOUSHE C           PEDIATRICS                      48   973 971
   019   DIAZ F                J INFECT DIS                   121   269 970
   020   PENNINGTON JE         J INFECT DIS SUPPL             130   159 974
   021   MCFARLANE H           BR MED J                         1   423 975
   022   RENNERT OM            CLIN PEDIATR                    11   351 972
   023   HUNICKI VZ            KLIN WOCHENSCHR                 75   862 963
   024   AMMANN AJ             MEDICINE (BALTIMORE)            50   223 971
   025   BELTOAS E             J LANCET                        85   254 965
   026   BITAR J               J PEDIATR                       71   123 967
   027   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   028   CONOVER JH            LANCET                           2  1501 973
   029   HANN S                LANCET                           2   520 974
   030   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   031   SCANLIN TF JR         LANCET                           1  1382 975
   032   CONOVER JH            LIFE SCI                        14   253 974
   033   POLLEY MJ             GAP CONF REP CILIARY INHIBITO            973
   034   BOHME B               HELV PAEDIATR ACTA              27   607 972
   035   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   036   ROSSMAN CM            PEDIATR RES                      8   469 974
   037   WOOD RE               AM REV RESPIR DIS              111   733 975
   038   TALAMO RC             PEDIATRICS                      56    91 975
   039   SCHWARTZ RH           CF CLUB ABST                          19 972
   040   SHARP HL              IN: MANGOS JA                        229 973
   041   HOIBY N               ACTA PAEDIATR SCAND             63   843 974
   042   LIEBERMAN J           PEDIATR RES                      3   571 969
   043   RAO GJS               J PEDIATR                       80   573 972
   044   RAO GJS               SCIENCE                        177   610 972
   045   RAO GJS               PEDIATR RES                      8   684 974
   046   TALAMO RC             PEDIATR RES                      7  170A 972
   047   KOMP DM               CHEST                           58   501 970
   048   COOMBS RRA            IN: GELL PGH                         761 975
   049   VAN METRE TE JR       J ALLERGY CLIN IMMUNOL          31   141 960
   050   KULCZYCKI LL          JAMA                           175   358 961
   051   PEPYS J               J ROY COLL PHYSICIANS LOND       2    42 967
   052   HENDERSON AH          THORAX                          23   501 968
   053   MEARNS MB             THORAX                          20   385 965
   054   BATTEN JC             MOD PROBL PEDIATR               10   227 967
   055   ORES CN               CF CLUB ABST                    16    48 975
   056   MEARNS MB             LANCET                           1   538 967
   057   BURNS MW              LANCET                           1   270 968
   058   DOLAN TF JR           AM REV RESPIR DIS              110   812 974
   059   BERGNER A             PEDIATRICS                      55   814 975
   060   RAUNIO V              IN: DI SANTAGNESE PA                 339 964
   061   TALAMO RC             IN: DI SANTAGNESE PA                 356 964
   062   BLANC WA              IN: DI SANTAGNESE PA                 327 964
   063   URIEL J               IN: DI SANTAGNESE PA                 243 964
   064   LOWE CU               SCIENCE                        153  1124 966
   065   BROGLIO AL            CF CLUB ABST                             967
   066   SCHWARTZ RH           J LAB CLIN MED                  70   725 967
   067   GREEN MN              PEDIATRICS                      21   635 958
   068   GREENE EL             INT ARCH ALLERGY                40   184 971
   069   STEPHAN U             PEDIATRICS                      55    35 975
   070   BREWERTON DA          LANCET                           1   904 973
   071   MACKAY IR             LANCET                           2   793 972
   072   FALCHUK ZM            J CLIN INVEST                   51  1602 972
   073   WALFORD RL            HISTOCOMPATIBILITY TESTING           271 970
   074   POLYMENIDIS Z         LANCET                           2  1452 973
   075   VLADUTIU AO           IMMUNOGENETICS                   1   305 974
   076   PATTERSON PR          CF CLUB ABST                             975
   077   BACH FH               SCIENCE                        176  1024 972
CT   1   DISANTAGNESE PA       N ENGL J MED                   295   597 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   BUESCHER ES           J PEDIATR                       93   530 978
     4   SORENSEN RU           J PEDIATR                       93   201 978
     5   SEALE TW              J CLIN MICROBIOL                 9    72 979
     6   CHURCH JA             J PEDIATR                       95   272 979
     7   MCCARTHY MM           CLIN PEDIATR                    19   746 980
     8   FICK RB               J IMMUNOL METH                  38   103 980
     9   CHURCH JA             ANN ALLERGY                     45   217 980
    10   WILSON GB             J CLIN INVEST                   66  1010 980
    11   HARPER TB             LUNG                           157   219 980
    12   MATTHEWS WJ           N ENGL J MED                   302   245 980
    13   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    14   WELCH MJ              PEDIATRICS                      67   664 981
    15   MOSS RB               J PEDIATR                       99   215 981
    16   SORENSEN RU           AM REV RESPIR DIS              123    37 981
    17   DANIELE RP            AM REV RESPIR DIS              124   738 981
    18   VANGEFFEL R           IMMUNOL LETTERS                  5   155 982
    19   WILSON GB             MED HYPOTHESES                   8   527 982
    20   PUGASHETTI BK         J CLIN MICROBIOL                16   686 982
    21   GRAFT DF              AM REV RESPIR DIS              125   540 982
    22   HARPER TB             AM REV RESPIR DIS              126   540 982
    23   GUIDOTTI TL           AM J MED SCI                   283   157 982
    24   SORENSEN RU           EUR J RESPIR DIS                64   524 983
    25   FICK RB               J CLIN INVEST                   74   236 984
    26   AUERBACH HS           LANCET                           2   686 985
    27   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985

PN 76079
RN 00433 
AN 76215360
AU Denning-C-R.  Gluckson-M-M.  Mohr-I.
TI Psychological and social aspects of cystic fibrosis.  pp.  127-51.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS.
MN CYSTIC-FIBROSIS: fg, th.  DENIAL-PSYCHOLOGY.  FAMILY-PLANNING.
   GENETIC-COUNSELING.  HETEROZYGOTE.  HUMAN.  MASS-SCREENING.
   MONOGRAPH.  PSYCHOLOGY.  QUESTIONNAIRES.  REVIEW.
   SOCIOECONOMIC-FACTORS.  SOCIOLOGY.  STRESS-PSYCHOLOGICAL.
   UNITED-STATES.
EX Cystic fibrosis is a disease in which there are enormous and
   sometimes overwhelming psychological and social problems encountered
   by the patient and his family.  The present "state of the art" as it
   pertains to the psychological and social aspects of cystic fibrosis
   are examined.  Attitudes towards cystic fibrosis, implications of a
   genetic diagnosis, heterozygote screening, and projections for the
   future are discussed.
RF 001   ANDERSEN DH           CHILDREN                         7    11 960
   002   TURK J                PEDIATRICS                      34    67 964
   003   LAWLER RH             CAN MED ASSOC J                 94  1043 966
   004   SPOCK A               NC MED J                        27   426 966
   005   KULCZYCKI LL          CLIN PROC CHILD HOSP DC         25   320 969
   006   MCCOLLUM AT           J PEDIATR                       77   571 970
   007   TROPAUER A            AM J DIS CHILD                 119   424 970
   008   MEYEROWITZ JH         SOC SCI MED                      1   249 967
   009   PLESS IB              J PEDIATR                       79   351 971
   010   MATTSSON A            PEDIATRICS                      50   801 972
   011   GAYTON WF             AM J DIS CHILD                 126   856 973
   012   BEVERIDGE J           AUST PAEDIATR J                  9   214 973
   013   BURTON L              PRACTITIONER                   210   247 973
   014   ALLAN JL              AUST PAEDIATR J                 10   136 974
   015   MCCRAE WM             IN: APLEY J                      4   157 974
   016   WINDER A              IN: PATTERSON PR                         973
   017   ROSENLUND ML          ANN INTERN MED                  78   959 973
   018   FARKAS A              AM J ORTHOPSYCHIATRY            43   259 973
   019   PATTERSON PR          PSYCHOSOCIAL ASPECTS OF CF               973
   020   MANGOS JA             FUNDAMENTAL PROB CF AND RELAT            973
   021   SHWACHMAN H           PEDIATRICS                      36   689 965
   022   HECHT F               N ENGL J MED                   287   464 972
   023   STEINHAUER PD         PEDIATR CLIN NORTH AM           21   825 974
   024   EMERY AEH             BR MED J                         1   724 973
   025   LEONARD CO            N ENGL J MED                   287   433 972
   026   CARTER CO             LANCET                           1   281 971
   027   PEARN JH              J MED GENET                     10   129 973
   028   MYERS JK              DECADE LATER FOLLOW UP OF SOC        235 968
   029   ANON                  MONTHLY VITAL STAT REPORT USD   24     4 975
   030   KABACK MM             PROG MED GENET                  10   103 974
   031   WOOD RE               LANCET                           2  1452 973
   032   ANON                  GRANTS ADMIN MANUAL DHEW PUB             971
   033   SHIH VE               LAB TECH FOR DETECTION HEREDI            973
   034   LEVY HL               ADV HUM GENET                    4     1 973
   035   SHWACHMAN H           PEDIATRICS                      46   335 970
   036   GEORGE L              ARCH DIS CHILD                  46   139 971
   037   STEPHAN U             IN: MANGOS JA                        281 973
   038   WARWICK WJ            IN: MANGOS JA                            973
   039   STEPHAN U             PEDIATRICS                      55    35 975
   040   ANON                  GENETIC SCREENING PROG PRIN A            975
   041   ANON                  WHO TECH REP SER NO 401                  968
   042   WILSON JMG            PRINCIPLES PRACTICE SCREENING            968
   043   THORNER RM            PUBLIC HEALTH MONOGRAPH DHEW    10       967
   044   LAPPE M               N ENGL J MED                   286  1129 972
   045   INGLEFINGER FJ        N ENGL J MED                   287   465 972
   046   LUBS HA               IN: HILTON B                             973
   047   MOTULSKY AG           ISR J MED SCI                    9  1341 973
CT   1   FALKMAN C             ACTA PAEDIATR SCAND SUPPL 264 1977     7 977
     2   DROTAR D              PEDIATRICS                      67   338 981
     3   SINNEMA G             ACTA PAEDIATR SCAND             72   427 983
     4   MOLLERING M           KLIN PAEDIATR                  198   369 986

PN 76080
RN 00434 
AN 76215357
AU Esterly-J-R.  Oppenheimer-E-H.  Landing-B-H.
TI Pathology of cystic fibrosis.  pp.  115-24.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: pa.
MN ADRENAL-MEDULLA: pa.  BRONCHI: pa.  CYSTIC-FIBROSIS: co.
   DIABETES-MELLITUS: et.  DOWNS-SYNDROME: co.  EXOCRINE-GLANDS: pa.
   GENES.  HEMOPTYSIS: et.  HEMOSIDERIN: me.  HUMAN.
   KIDNEY-MEDULLA:  pa.  LIPOFUSCIN: me.  LUNG: pa.  MONOGRAPH.
   PANCREAS: pa.  REVIEW.  VITAMIN-A-DEFICIENCY: pa.
EX The varied morphologic lesions in cystic fibrosis each result from
   obstruction of one type or another, documented or presumed.  They are
   modified by the age of the individual, the severity and the
   conditions peculiar to each tissue.  These lesions, plus the
   functional changes in sweat electrolytes, membrane transport and
   serum factor affecting syncrony of cilia, represent the diverse
   actions of a genetic defect, the intermediate stages of which are as
   yet unknown.  Neither the diversity of abnormalities, their range in
   severity, nor differences in the age of onset argue convincingly for
   a trigger mechanism or acquire rather than inborn deficiency.
RF 001   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   002   FARBER S              ARCH PATHOL                     37   238 944
   003   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   004   OPPENHEIMER EH        J PEDIATR                       86   683 975
   005   DI SANTAGNESE PA      N ENGL J MED                   279   103 968
   006   LANDING BH            ARCH PATHOL                     88   569 969
   007   OPPENHEIMER EH        PERSPECT PEDIATR PATHOL          2   241 975
   008   FIELD WEH             BR J DIS CHEST                  62    11 968
   009   ESTERLY JR            THORAX                          23   670 968
   010   VAWTER GF             GAP CONF REP PATHOL OF CF              9 972
   011   LANDING BH            ANN NY ACAD SCI                 93   518 962
   012   TAYLOR BW             ARCH DIS CHILD                  49   133 974
   013   KOPITO L              PEDIATR RES                      6   427 972
   014   GLISSON F             RACHITIDE SIVE MORBO PUERI               650
   015   BLACKFAN KD           J PEDIATR                        3   679 933
   016   PETERSEN RA           AM J DIS CHILD                 116   662 968
   017   SMITH FR              J LAB CLIN MED                  80   423 972
   018   DE LUCA L             CANCER                          30  1326 972
   019   BLANC WA              PEDIATRICS                      22   494 958
   020   WALTERS TR            AM J DIS CHILD                 124   641 972
   022   KOMP DM               CHEST                           58   501 970
   023   TABOLIN VA            VOPR OKHR MATERIN DET           17    41 972
   024   BOLANDE RP            ARCH PATHOL                     95   172 973
   025   WANG CI               CF CLUB ABST                             968
   026   OPPENHEIMER EH        JOHNS HOPKINS MED J            131   351 972
   027   MILUNSKY A            PEDIATRICS                      42   501 968
   028   WANG CI               PEDIATRICS                      48   442 972
   029   OPPENHEIMER EH        BULL JOHNS HOPKINS HOSP        111     1 962
   030   GIBSON LE             J PEDIATR                       81   193 972
   031   OPPENHEIMER EH        IN: MCKUSICK VA                  7   108 972
   032   OPPENHEIMER EH        ARCH PATHOL                     96   149 973
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   GOTZ M                EUR J PEDIATR                  127   133 978
     3   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
     4   JALOWAYSKI AA         RESPIRATION                     43   249 982
     5   COALSON JJ            BR J EXP PATHOL                 66   205 985
     6   HOIBY N               ANNU REV MICROBIOL              40    29 986

PN 76081
RN 00435 
AN 76215363
AU Butcher-F-R.
TI Relevance of cyclic nucleotides and calcium to cystic fibrosis.  pp.
   243-58.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ ADENOSINE-CYCLIC-MONOPHOSPHATE: ph.  CALCIUM: ph.
   CYSTIC-FIBROSIS:  me.  GUANOSINE-CYCLIC-MONOPHOSPHATE: ph.
   PANCREAS: se.  SALIVARY-GLANDS: se.
MN ADENYL-CYCLASE: me.  AMYLASES: se.  ANIMAL.  CALCIUM: pd.
   CELLS-CULTURED.  CILIA: pp.  CYSTIC-FIBROSIS: pp.  GLYCOGEN: me.
   MICROTUBULES: pp.  MONOGRAPH.  PARASYMPATHOMIMETICS: pd.
   POTASSIUM:  me.  PROTEIN-KINASES: me.  RATS.  REVIEW.  SECRETIN: ph.
   SYMPATHOMIMETICS: pd.  SUPPORT-U-S-GOVT-P-H-S.
EX The general area of research at the biochemical and molecular levels
   related to cystic fibrosis has suffered from the lack of a suitable
   animal model.  Although some animal models have been proposed, these
   have not yet been tested.  In attempts to circumvent this problem
   several investigators have turned to cell culture techniques to study
   various aspects of cystic fibrosis.  These studies have included the
   use of red blood cells, lymphocytes, skin fibroblasts and cultured
   nasal polyps.  There are enough positive indications from this
   approach to indicate that it might be fruitful.  Consequently, a
   final aspect of this article will be a consideration of the use of
   cell cultures for future investigations into the possible metabolic
   lesions in cystic fibrosis.  Control of cyclic nucleotide levels in
   parotid, the role of calcium, microfilaments and microtubules in
   secretion, and the use of cell cultures as an approach to the study
   of biochemical defects in cystic fibrosis are discussed.
RF 001   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   001   DANES BS              J EXP MED                      136  1313 972
   002   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   002   MARTINEZ JR           PEDIATR RES                      9   463 975
   003   MARTINEZ JR           PEDIATR RES                      9   470 975
   003   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   004   BDOLAH A              BIOCHEM BIOPHYS RES COMMUN      18   452 965
   004   PALLAVICINI JC        J PEDIATR                       77   280 970
   005   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   005   BATZRI S              J BIOL CHEM                    248   361 973
   006   DANES BS              J EXP MED                      129   775 969
   006   MONNARD P             EUR J PHARMACOL                 23   306 973
   007   MALAMUD D             BIOCHIM BIOPHYS ACTA           279  3731 972
   007   KLAGSBRUN M           PEDIATR RES                      8   205 974
   008   QUISSELL DO           NATURE                         247   115 974
   008   DURHAM JP             BIOCHIM BIOPHYS ACTA           372   196 974
   009   BUTCHER FR            BIOCHIM BIOPHYS ACTA           392    82 975
   009   DUFFEY MJ             NATURE                         249    94 974
   010   BENZ L                BR J PHARMACOL                  46    66 972
   010   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   011   BARTMAN J             J PEDIATR                       76   430 970
   011   DESCHODT-LANCKMAN M   GASTROENTEROLOGY                68   318 975
   012   BAIG MM               J PEDIATR                       86    72 975
   012$  CASE RM               J PHYSIOL (LOND)               223       972
   013   BURGEU ASV            HANDBOOK OF PHYSIOLOGY               561 967
   013   GRIFFIN GD            PROC SOC EXP BIOL MED          137   438 971
   014   SCHULTZ G             PROC NAT ACAD SCI USA           70  3889 973
   014   CAUDILL M             LANCET                           1    32 974
   015   DUFFY MJ              CLIN CHIM ACTA                  49   397 973
   016   RASMUSSEN H           CRIT REV BIOCHEM                 1    95 972
   016   DUFFY MJ              CLIN CHIM ACTA                  50    97 974
   017   SELINGER Z            BIOCHIM BIOPHYS ACTA           203   335 970
   017   BOAT TF               AM REV RESPIR DIS              110   428 974
   018   HARFIELD B            CAN J PHYSIOL PHARMACOL          5   997 973
   018   DANES BS              BIOCHEM GENET                   12   359 974
   019   CONOVER JH            PEDIATR RES                      7   224 973
   019   FRANKS DJ             FEBS LETTERS                    42   267 974
   020   DOUGLAS WW            J PHYSIOL (LOND)               165   528 963
   021   SELINGER Z            J BIOL CHEM                    248   369 973
   022   SCHRAMM M             IN: CECCARELLI B                 2       974
   025   HEISLER S             BIOCHIM BIOPHYS ACTA           279   561 972
   026   KANNO T               J PHYSIOL (LOND)               226   353 972
   027   CASE RM               J PHYSIOL (LOND)               235    75 973
   028   MATTHEWS EK           J PHYSIOL (LOND)               234   689 973
   029   SELINGER Z            ANN NY ACAD SCI                185   395 971
   031   CHRISTOPHE J          IN: CECCARELLI B                 2       974
   032   SCHRAMM M             NATURE NEW BIOL                240   203 972
   033   BUTCHER FR            BIOCHEM BIOPHYS RES COMMUN      48    23 972
   034   BUTCHER FR            J CELL BIOL                     60   519 974
   035   WILLIAMS JA           FED PROC                        34  1324 975
   036   BAUDUIN H             J CELL BIOL                     66   165 975
   037   ALLISON AC            IN: CECCARELLI B                 2       974
   038   HSIE AW               PROC NAT ACAD SCI USA           68   358 971
   039   YAHARA I              PROC NAT ACAD SCI USA           72  1579 975
   040   BHISEY AN             EXP CELL RES                    64   419 971
   041   GOODMAN DBP           PROC NAT ACAD SCI USA           67   652 970
   042   SOIFER D              J NEUROCHEM                     24    21 975
   043   SLOBODA RD            PROC NAT ACAD SCI USA           72   177 975
   044   PIRAS R               PROC NAT ACAD SCI USA           72  1161 975
   045   SHELANSKI ML          PROC NAT ACAD SCI USA           70   765 973
   046   EDELMAN GM            PROC NAT ACAD SCI USA           70  1442 973
   047   ROSENBLITH JZ         PROC NAT ACAD SCI USA           70  1625 973
   048   OLIVER JM             NATURE                         253   471 975
   049   WOOD RE               AM REV RESPIR DIS              111   733 975
   050   BESLEY GTN            J MED GENET                      6   278 969
   051   DOGGETT RG            NATURE NEW BIOL                243   250 973
   052   ADSHEAD PC            ANN NY ACAD SCI                253   192 975
   053   ECKERT R              J PHYSIOL (LOND)               226   699 972
   054   CHERNICK WS           MOD PROBL PEDIATR               10   125 967
   056   PICKERING R           ARCH ORAL BIOL                  20   153 975
   057   ASPRAY DW             ANAL BIOCHEM                    66   353 975
   058   IGNARRO LJ            PROC NAT ACAD SCI USA           71  2027 974
   059   NEISSMAN G            NATURE NEW BIOL                231   131 971
   060   ZURIER RB             J CELL BIOL                     58    27 973
   061   SMITH RJ              PROC NAT ACAD SCI USA           72   108 975
   062   GOLDSTEIN IM          BIOCHEM BIOPHYS RES COMMUN      60   807 974
   063   ZURIER RB             PROC NAT ACAD SCI USA           70   844 973
   064   ZURIER RB             J CLIN INVEST                   53   297 974
   065   BARTMAN J             J PEDIATR                       76   430 970
   066   STAHL M               J PEDIATR                       84   821 974
   067   BERATIS NG            PEDIATR RES                      7   958 973
   068   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   069   BAIG MM               J PEDIATR                       86    72 975
   070   PALLAVICINI JC        J PEDIATR                       77   280 970
   071   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   072   PASTAN IH             ANNU REV BIOCHEM                44   491 975
   073   GRANNER DK            BIOCHEM BIOPHYS RES COMMUN      46  1516 972
   074   COFFINO P             J CELL PHYSIOL                  85   603 975
   075   MACKENZIE CW          J BIOL CHEM                    249  5755 974
CT   1   NEUTRA MR             GASTROENTEROLOGY                75   701 978
     2   THEOHARIDES TC        LIFE SCI                        27   703 980
     3   ROOMANS GM            ULTRASTRUCTURAL PATHOL           2    53 981
     4   SORSCHER EJ           LANCET                           1   368 982
     5   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983

PN 76082
RN 00436 
AN 76215362
AU Farrell-P-M.  Lundgren-D-W.
TI Recent observations concerning RNA methylation and polyamine
   metabolism in cystic fibrosis.  pp.  223-41.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976.
MJ CYSTIC-FIBROSIS: me.  POLYAMINES: me.  RNA: me.
MN ARGININE: an.  CELL-LINE.  ERYTHROCYTES: me.  FEMALE.  HUMAN.  MALE.
   MENSTRUATION.  METHYLATION.  MONOGRAPH.  PROGESTERONE: bl.
   PUTRESCINE: an.  RNA-RIBOSOMAL: me.  RNA-TRANSFER: me.  SEX-FACTORS.
   SPERMIDINE: bl.  SPERMINE: bl.  SWEAT: an.
EX Determination of fibroblast proliferation rates and RNA methylation
   patterns in our laboratory has revealed no alteration in cells from
   cystic fibrosis patients.  Blood polyamines are located predominantly
   in erythrocytes with low concentrations in plasma; sweat has likewise
   been shown to have a low content of spermidine and spermine.  Whole
   blood polyamine concentrations fluctuate from one individual to
   another and are especially variable in females subject to the
   hormonal changes of the menstrual cycle.  Because of the variability
   in the spermidine and spermine content of blood, it is useful to
   express such data on the basis of the spermidine/spermine ratio;
   however, results must be analyzed according to sex and, in the case
   of females, should be interpreted in relationship to the menstrual
   cycle.  Spermidine/spermine ratios are significantly elevated in
   whole blood extracts and isolated erythrocytes from male CF homo-
   and heterozygotes.
RF 001   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   002   VEGHELYI PV           AM J DIS CHILD                  90    28 955
   003   PARSA I               FED PROC                        31   166 972
   004   FLEISHER DS           J PEDIATR                       64   349 964
   005   RENNERT OM            PEDIATRICS                      50   485 972
   006   KERR SJ               ADV ENZYMOL                     36     1 972
   007   STARR JL              PHYSIOL REV                     49   623 969
   008   KLAGSBRUN M           J BIOL CHEM                    247  7443 972
   009   TABOR H               PHARMACOL REV                   16   245 964
   010   ROSENTHAL SM          PROC SOC EXP BIOL MED           80   432 952
   011   SEILER N              HOPPE SEYLERS Z PHYSIOL CHEM   354   589 973
   012   STEVENS L             ANN NY ACAD SCI                171   827 970
   013   STURMAN JA            PEDIATR RES                      8   231 974
   014   OKA T                 J BIOL CHEM                    249  7647 974
   015   RUSSELL DH            BIOCHEM J                      128  1109 972
   016   MUNRO GF              J BACTERIOL                    118   952 974
   017   IGARASHI K            BIOCHEM BIOPHYS RES COMMUN      64   897 975
   018   HEBY O                FEBS LETTERS                    50     1 975
   019   MARTON LJ             IN: RUSSELL DH                       367 973
   020   DENTON MD             IN: RUSSELL DH                       373 973
   021   NISHIOKA K            CLIN CHIM ACTA                  57   155 974
   022   MANGOS JA             AMINO ACID METABOLISM AND CF           7 971
   023   RENNERT OM            CLIN PEDIATR                    11   351 972
   024   RENNERT OM            IN: MANGOS JA                         41 973
   025   KLAGSBRUN M           IN: MANGOS JA                         53 973
   026   KLAGSBRUN M           PEDIATR RES                      8   205 974
   027   HODES ME              PEDIATR RES                      8   212 974
   028   LUNDGREN DW           CLIN CHIM ACTA                  62   357 975
   029   MUNRO GF              CF CLUB ABST                    16     7 975
   030   FARRELL PM            PROC SOC EXP BIOL MED          149   340 975
   031   WRIGHT SW             AM J HUM GENET                  20   157 968
   032   TODARO GJ             J CELL COMP PHYSIOL             62   257 963
   033   KLAGSBRUN M           J BIOL CHEM                    248  2612 973
   034   TABOR H               ANAL BIOCHEM                    55   457 973
   036   COHEN LF              PEDIATR RES                      9   312 975
   037   RABINOWITZ Y          BLOOD                           23   811 964
   039   GORDON RS             J APPL PHYSIOL                  31   713 971
   040   PALLAVICINI JC        J PEDIATR                       77   280 970
   041   BARNETT DR            TEX REP BIOL MED                31   691 973
   042   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   043   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   044   RUSSELL DH            ENDOCRINOLOGY                   88  1397 971
   045   ROSENTHAL SM          J PHARMACOL EXP THER           116   131 956
   046   BAKER AP              ARCH BIOCHEM BIOPHYS           165   597 974
   047   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   048   PETER WH              HOPPE SEYLERS Z PHYSIOL CHEM   354  1146 973
   049   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   050   COLE CH               PEDIATR RES                      6   616 972
   051   INOUE H               J BIOCHEM (TOKYO)               75   679 974
   052   MARTINEZ JR           PEDIATR RES                      9   463 975
   053   KNOECKI D             ARCH BIOCHEM BIOPHYS           169   192 975
CT   1   SCANLIN TF            CLIN CHEST MED                   1   424 980

PN 76083
RN 00437 
AN 76215365
AU Levison-H.  Godfrey-S.
TI Pulmonary aspects of cystic fibrosis.  pp.  3-24.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: pp.  RESPIRATION.
MN ADOLESCENCE.  AIRWAY-RESISTANCE.  CHILD.  CYSTIC-FIBROSIS: th.
   EXERTION.  FEMALE.  HELIUM.  HUMAN.  MALE.
   MAXIMAL-EXPIRATORY-FLOW-RATE.  MAXIMAL-EXPIRATORY-FLOW-VOLUME-CURVES.
   MONOGRAPH.  OXYGEN.  PHYSICAL-FITNESS.  PHYSICAL-THERAPY.
   PLETHYSMOGRAPHY-WHOLE-BODY.  REVIEW.  SEX-FACTORS.
   VENTILATION-PERFUSION-RATIO.
EX Defective mucociliary transport has been implicated in the
   pathogenesis of the lung disease in cystic fibrosis, based on
   several observations.  First, patients with the disease secrete more
   mucus than normal subjects, as indicated by gland hypertrophy, and
   frequently retain it in the lung.  Second, the mucus is said to have
   altered biochemical and rheological properties; however, although the
   physiochemical properties of mucus are altered in all lung diseases,
   little histochemical or rheological difference has been found in
   mucus from patients with CF and other hypersecretory conditions such
   as chronic bronchitis and bronchiectasis.  Third, a factor in the
   serum of CF patients inhibits normal ciliary activity in explain
   glands of ciliated epithelium; and infection, which damages human
   ciliated epithelium in culture, could further reduce mucociliary
   transport.  Measurement of pulmonary function in cystic fibrosis,
   physical fitness and response to exercise in cystic fibrosis, control
   of breathing in patients with cystic fibrosis, regional lung function
   in cystic fibrosis, and therapy of cystic fibrosis are discussed.
RF 001   ZUELZER WW            PEDIATRICS                       4    53 949
   002   REID L                MOD PROBL PEDIATR               10   195 967
   003   ESTERLY JR            JOHNS HOPKINS MED J            122    94 968
   004   MATTHEWS LW           AM REV RESPIR DIS               88   199 963
   005   POTTER JL             ANN NY ACAD SCI                106   692 963
   006   DENTON R              PEDIATRICS                      25   611 960
   007   LAMB D                BR J DIS CHEST                  66   239 972
   008   STURGESS JM           IN: LAWSON D PROC 5TH INT CF         368 969
   009   CHARMAN J             BIORHEOLOGY                      9   185 972
   010   FEATHER EA            BR J DIS CHEST                  64   192 970
   011   SPOCK A               PEDIATR RES                      1   173 967
   012   CONOVER JH            PEDIATR RES                      7   220 973
   013   CAMNER P              AM REV RESPIR DIS              108   131 973
   014   CAMNER P              IN: HERS JFP                         236 973
   015   SAKAKURA Y            ANN OTOL RHINOL LARYNGOL        82   203 973
   017   SANCHIS J             N ENGL J MED                   288   651 973
   018   THOMSON ML            N ENGL J MED                   289   749 974
   019   WOOD RE               AM REV RESPIR DIS              111   733 975
   020   MACKLEM PT            PHYSIOL REV                     51   368 971
   021   LAMARRE A             PEDIATRICS                      50   291 972
   022   COOPER DM             AM REV RESPIR DIS              109   519 974
   023   MCCARTHY DS           AM J MED                        52   747 972
   024   MANSELL A             AM REV RESPIR DIS              109   190 974
   025   HUTCHEON M            AM REV RESPIR DIS              110   458 974
   026   LAPIERRE JG           CAN PAED SOC ANN MTG ABST             61 975
   027   EMIRGIL C             AM J MED                        51   504 971
   028   DOERSHUK CF           AM REV RESPIR DIS              109   452 974
   029   PHELAN PD             ARCH DIS CHILD                  44   393 969
   031   GOLDRING RM           J PEDIATR                       65   501 964
   032   GODFREY S             EXERCISE TESTING IN CHILDREN             974
   033   GODFREY S             ARCH DIS CHILD                  46   144 971
   034   JONES NL              CLIN SCI                        31    39 966
   035   DAVIES CT             HUM BIOL                        44   195 972
   036   ANDERSON SD           BR J DIS CHEST                  69     1 975
   037   DAY G                 ARCH DIS CHILD                  48   355 973
   039   LLOYD-STILL JD        PEDIATRICS                      53   678 974
   040   COUNAHAN R            ARCH DIS CHILD                  50   477 975
   041   WHITELAW WA           RESPIR PHYSIOL                  23   181 975
   044   FEATHERBY EA          CAN MED ASSOC J                102   835 970
   045   CHANG N               AM REV RESPIR DIS              107   672 973
   046   MOTOYAMA EK           IN: MANGOS JA                        335 973
CT   1   BOWMAN BH             LIFE SCI                        19  1289 976
     2   WOOD RE               AM REV RESPIR DIS              113   833 976
     3   ORENSTEIN DM          AM J DIS CHILD                 131   973 977
     4   SEALE TW              J CLIN MICROBIOL                 9    72 979
     5   GUIDOTTI TL           RESPIRATION                     44   351 983
     6   WHEELER WB            J PEDIATR                      104   695 984
     7   EICHLER I             DTSCH MED WSCHR                111   896 986

PN 76084
RN 00438 
AN 76215361
AU Doershuk-C-F.  Wood-R-E.  Boat-T-F.
TI Pulmonary therapy for cystic fibrosis.  pp.  25-37.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: th.  EXERCISE-THERAPY.
   EXPECTORANTS: tu.  RESPIRATORY-THERAPY.
MN AEROSOLS.  AIRWAY-OBSTRUCTION: th.  ASPERGILLOSIS: dt.
   BREATHING-EXERCISES.  BRONCHODILATOR-AGENTS: tu.
   CYSTIC-FIBROSIS:  co, dt.  ENDOSCOPY.  HEMOPTYSIS: th.  HUMAN.
   IRRIGATION.  LUNG-DISEASES: dt, et.  LUNG: su.
   MONOGRAPH.PNEUMOTHORAX: dt.  PSEUDOMONAS-INFECTIONS: dt.  REVIEW.      
   SUPPORT-U-S-GOVT-P-H-S.  WATER.
EX This report summarizes selected aspects of pulmonary therapy for
   cystic fibrosis.  Since the results of chronic bronchopulmonary
   infection are the cause of death in most CF patients, improved
   patient survival patterns may possibly be attributed in large part to
   improvements in antibiotic therapy and increased therapeutic
   aggressiveness.  Mist tent therapy was defined and initiated in the
   1950s, but later studies of mist tent therapy have not shown
   beneficial response in many patients selected for study.
   Intermittent aerosol therapy continues to be employed by many
   physicians to deliver medication rather than bulk liquid to the
   bronchial mucosa.  Pulmonary endoscopy and lavage, expectorants,
   allergic aspergillosis, pneumothorax, lobectomy, and hemoptysis are
   also examined.
RF 001   MATTHEWS LW           J PEDIATR                       65   558 964
   002   MEARNS MB             ARCH DIS CHILD                  47     5 972
   003   DOERSHUK CF           ARCH DIS CHILD                  47   984 972
   004   ANON                  AM REV RESPIR DIS PART 2       110     1 974
   005   HUANG NN              J PEDIATR                       59   512 961
   006   IACOCCA VF            AM J DIS CHILD                 106   315 963
   007   MEARNS MB             ARCH DIS CHILD                  47   902 972
   008   MAY JR                ARCH DIS CHILD                  47   908 972
   009   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   010   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   011   WOOD RE               AM REV RESPIR DIS              111   733 975
   012   ESTERLY JR            JOHNS HOPKINS MED J            122    94 968
   013   BURNS MW              LANCET                           1   270 968
   014   HOIBY N               SCAND J RESPIR DIS              56    38 975
   015   LAWSON D              IN: WATT PJ                           69 970
   016   DOERSHUK CF           IN: GREEN M                          707 968
   017   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            971
   018   MARKS MI              J PEDIATR                       79   822 971
   019   HUANG NN              J PEDIATR                       78   338 971
   020   PENNINGTON JE         J INFECT DIS                   128    63 973
   022   KLASTERSKY J          CHEST                           61   117 972
   023   DENTON R              AM J DIS CHILD                  82   433 951
   024   DOERSHUK CF           PEDIATRICS                      41   723 968
   025   PARKS CR              J PEDIATR                       76   305 970
   026   MATTHEWS LW           PEDIATRICS                      39   176 967
   027   MOTOYAMA EK           PEDIATRICS                      50   299 972
   028   CHANG N               AM REV RESPIR DIS              107   672 973
   029   WOLFSDORF J           PEDIATRICS                      43   799 969
   030   BAU SK                PEDIATRICS                      48   605 971
   031   YEATES DB             AM REV RESPIR DIS              107   602 973
   032   ALDERSON PO           J PEDIATR                       84   479 974
   033   WEST JB               NATURE                         189   588 961
   034   MORROW PE             AM REV RESPIR DIS SUPPL        110    88 974
   035   PARKS CR              AM REV RESPIR DIS              104    99 971
   036   PARKS CR              AM REV RESPIR DIS              108   513 973
   037   GOLDBERG IS           ARCH INTERN MED                131    88 973
   038   KING MA               AM REV RESPIR DIS              110   740 974
   039   DULFANO MJ            AM REV RESPIR DIS              112   341 975
   040   LIFSCHITZ MI          AM REV RESPIR DIS              102   456 970
   041   DULFANO MJ            AM REV RESPIR DIS              107   130 973
   042   ROSENBLUTH M          ARCH DIS CHILD                  49   606 974
   043   ANON                  AM REV RESPIR DIS PART 2       110     7 974
   044   PHELAN PD             ARCH DIS CHILD                  44   393 969
   045   LANDAU LI             J PEDIATR                       82   863 973
   046   BARKER R              J PEDIATR                       80   396 972
   047   CARSON S              AM REV RESPIR DIS SUPPL         93    86 966
   048   LAKE KB               CHEST                           68    62 975
   049   MELLINS RB            AM REV RESPIR DIS SUPPL        110   137 974
   050   LORIN MI              AM J PHYS MED                   50   215 971
   051   MOTOYAMA EK           IN: MANGOS JA                        335 973
   052   SHARP JT              AM REV RESPIR DIS SUPPL        110   154 974
   053   SACKNER MA            AM REV RESPIR DIS              111    62 975
   054   CEZEAUX G JR          JAMA                           199    15 967
   055   KYLSTRA JA            AM REV RESPIR DIS              103   651 971
   056   ALTMAN RP             J PEDIATR SURG                   8   809 973
   057   FORBES J              LANCET                           2   767 957
   058   HIRSCH SR             CHEST                           63     9 973
   059   SCHWARTZ RH           AM J DIS CHILD                 120   432 970
   060   PEPYS J               AM REV RESPIR DIS               80   167 959
   061   SLAVIN RG             AM J MED                        47   306 969
   062   HENDERSON AH          THORAX                          23   501 968
   063   BOAT TF               JAMA                           209  1498 969
   064   LIFSCHITZ MI          AM J DIS CHILD                 116   633 968
   065   STOWE SM              AM REV RESPIR DIS              111   611 975
   066   KULCZYCKI LL          N ENGL J MED                   257   203 957
   067   DOERSHUK CF           ANESTH ANALG CLEVE              51   413 972
   068   GOTTLIEB LS           CHEST                           67   482 975
   069   FELLOWS KE            RADIOLOGY                      114   551 975

PN 76085
RN 00439 
AN 76215356
AU Boat-T-F.  Cheng-P-W.
TI Mucous glycoproteins.  pp.  165-77.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ BRONCHI: se.  CYSTIC-FIBROSIS: me.  GLYCOPROTEINS: se.  MUCUS: se.
   TRACHEA: se.
MN AMINO-ACIDS: an.  ATROPINE: pd.  BRONCHITIS.  CARBOHYDRATES: an.
   COMPARATIVE-STUDY.  EPINEPHRINE: pd.  GLYCOPROTEINS: an.  HUMAN.
   METHACHOLINE-COMPOUNDS: pd.  MONOGRAPH.  MUCUS: an.  MURAMIDASE: se.
   NOREPINEPHRINE: pd.  REVIEW.  TERBUTALINE: pd.
   SUPPORT-U-S-GOVT-P-H-S.
EX Early investigators employed histochemical, chemical and
   physiochemical techniques in an attempt to identify differences
   between cystic fibrosis and control mucous secretions.  Several
   mucous glycoprotein abnormalities were suggested by their studies.
   In retrospect, none of these studies achieved their goal of
   describing a fundamental mucous glycoprotein abnormality peculiar to
   CF.  Improved methods have been devised for the collection of mucous
   glycoproteins in human respiratory tract secretions and the study of
   their chemical and physical properties.  Therefore, it is now
   possible to make preliminary comparisons between human
   tracheobronchial mucous glycoproteins from CF and non-CF sources.
   General properties of mucous glycoproteins, human tracheobronchial
   mucous glycoproteins, comparison of CF and non-CF tracheobronchial
   mucous glycoprotein, and suggested directions for future studies of
   CF mucous secretions are discussed.
RF 001   DI SANTAGNESE PA      PEDIATRICS                      19   252 957
   002   DISCHE Z              PEDIATRICS                      24    74 959
   003   ROELFS RE             AM J DIS CHILD                 113   419 967
   004   CHERNICK WS           ANN NY ACAD SCI                106   698 963
   005   DISCHE Z              AM J DIS CHILD                 102   733 961
   006   PALLAVICINI JC        ANN NY ACAD SCI                106   330 963
   007   LEV R                 AM J PATHOL                     46    23 965
   008   LAMB D                BR J DIS CHEST                  66   239 972
   009   GUGLER EC             J PEDIATR                       71   585 967
   010   POTTER JL             ANN NY ACAD SCI                106   692 963
   011   BOAT TF               AM REV RESPIR DIS              110   428 974
   012   BOAT TF               PEDIATR RES                      8   531 974
   013   SPIRO RG              ADV PROT CHEM                   27   349 973
   014   GOTTSCHALK A          GLYCOPROTEINS THEIR COMPOSITI            972
   015   LLOYD KO              BIOCHEMISTRY                     7  2976 968
   016   ANDERSON B            ARCH BIOCHEM BIOPHYS           145   490 971
   017   LUNDBLAD A            ARCH BIOCHEM BIOPHYS           148   291 972
   018   ROVIS L               BIOCHEMISTRY                    12  5340 973
   019   ROVIS L               BIOCHEMISTRY                    12  5340 973
   020   GOODWIN SD            EUR J BIOCHEM                   47   371 974
   021   BISERTE G             EXP ANNU BIOCHIM MED            24    85 963
   022   HAVEZ R               CLIN CHIM ACTA                  17   281 967
   023   HAVEZ R               CLIN CHIM ACTA                  17   463 967
   024   HAVEZ R               IN: PEETERS H                   16   343 968
   025   DEGAND P              IN: PEETERS H                   16   361 968
   026   HAVEZ R               BULL SOC CHIM BIOL              51   245 969
   027   ROUSSEL P             CLIN CHIM ACTA                  36   315 972
   028   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   029   DEGAND P              BULL PHYSIOPATH RESPIR NANCY     9   199 973
   030   ROUSSEL P             J BIOL CHEM                    250  2114 975
   031   ROBERTS GP            EUR J BIOCHEM                   50   265 974
   032   BOAT TF               PEDIATR RES                      7   607 973
   033   WOOD RE               AM REV RESPIR DIS              111   733 975
   034   WAGNER BM             AM J DIS CHILD                  99    61 960
   035   BOAT TF               CHEST                           67   325 975
   036   SLOMIANY BL           J BIOL CHEM                    247  5062 972
   037   PECK HD               ADV ENZYMOL                     39   651 974
   038   KALINER M             N ENGL J MED                   289   277 973
   039   YEAGER H JR           CLIN RES                        23   34A 975
   040   FRIBERG S             AM REV RESPIR DIS              108  1010 973
   041   DULFANO MJ            AM REV RESPIR DIS              112   341 975
   042   OSSERMAN EF           J EXP MED                      124   921 966
   043   LOWRY OH              J BIOL CHEM                    193   265 951
CT   1   WOOD RE               AM REV RESPIR DIS              113   833 976
     2   SANTAGNESE PAD        N ENGL J MED                   295   481 976
     3   BOAT TF               PEDIATR RES                     11   977 977
     4   NEUTRA MR             LAB INVEST                      36   535 977
     5   WANNER A              AM REV RESPIR DIS              116    73 977
     6   BARTON AD             PROC SOC EXP BIOL MED          156     8 977
     7   LAST JA               J LAB CLIN MED                  91   328 978
     8   BOAT TF               ACS SYMPOSIUM SERIES          1978   108 978
     9   HOSLI P               MONOGR PAEDIATR                 10    90 979
    10   BOAT TF               FED PROC                        39  3067 980
    11   MATTHEWS WJ           N ENGL J MED                   302   245 980
    12   LIEBERMAN J           J LAB CLIN MED                  97   646 981
    13   TABAK LA              J ORAL PATHOL                   11     1 982
    14   MORIARTY CM           J MED                           13   257 982
    15   CHENG PW              J BIOL CHEM                    257  6251 982
    16   FRATES RC             PEDIATR RES                     17    30 983
    17   KNOWLES M             J CLIN INVEST                   71  1410 983
    18   KATZ S                CELL CALC                        5   421 984
    19   WINGERT WE            BIOCHEMISTRY                    23   690 984
    20   RAM BP                CRC CRIT REV BIOCHEM            17   257 985
    21   REDDY MS              J DENT RES                      64    33 985
    22   CHENG PW              BIOCHEM J                      227   405 985
    23   SMITH AC              CLIN GASTROENTEROL              15   815 986
    24   CHENG PW              CARBOHYD RES                   149   253 986

PN 76086
RN 00440 
AN 76215358
AU Mangos-J-A.  Bargman-G-J.  Martinez-J-R.  Rennert-O-M.
TI Physiology and pharmacology of secretion and cystic fibrosis.  A
   review of past developments and projections into the future.  pp.
   311-36.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: pp.  EXOCRINE-GLANDS: se.
MN ADENOSINE-TRIPHOSPHATE: me.  ANIMAL.  BODY-FLUIDS: se.  CALCIUM: me.
   CHLORIDES: me.  DISEASE-MODELS-ANIMAL.  EXOCRINE-GLANDS: ir.
   GLUCOSE: se.  HUMAN.  MEMBRANE-POTENTIALS.  MICE.  MONOGRAPH.
   NEURAL-TRANSMISSION.  NEUROSECRETION.  OSMOLAR-CONCENTRATION.
   PANCREAS: se.  POLYAMINES: ph.  POTASSIUM: me.  REVIEW.
   SALIVARY-GLANDS: se.  SODIUM: me.  SWEAT-GLANDS: se.  SWEAT: se.
   UREA: se.  WATER: me.
EX Cystic fibrosis is a recessively inherited metabolic disease which is
   characterized by a universal dysfunction in the exocrine glands of
   affected individuals.  This dysfunction results in abnormalities of
   the composition and/or the physiochemical behavior of the various
   exocrine gland products.  Although significant advances have been
   made in our understanding of exocrine gland physiology and
   pharmacology, many questions remain unanswered and significant gaps
   exist in our knowledge of exocrine gland function.  Perhaps
   clarification of these issues may lead to better understanding of the
   pathogenesis of cystic fibrosis and to development of better forms of
   therapy for the patients.  The purpose of this article is to review
   past and present developments in this area of biomedical research and
   to point out areas of exocrine gland physiology and pharmacology
   where more knowledge is needed in order to clarify the nature of a
   disease like cystic fibrosis.  Composition of the acinar fluid,
   secretory mechanisms, modification of ductal fluid, ionic dependence
   and energy requirements of the secretory process, calcium metabolism
   in exocrine glands, and exocrine gland dysfunction in cystic fibrosis
   are discussed.
RF 001   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   002   DI SANTAGNESE PA      N ENGL J MED                   277  1344 967
   003   LOBECK CC             IN: STANBURY JB                     1605 972
   005   MANGOS JA             IN: MANGOS JA                        221 973
   006   MARTINEZ JR           IN: DI SANTAGNESE PA                 129 966
   007   MARTINEZ JR           PFLUEGERS ARCH                 290   124 966
   008   MARTINEZ JR           PHYSIOLOGIST                    10   244 967
   009   MARTINEZ JE           IN: BOTELHO SY                        20 969
   010   MANGOS JA             PFLUEGERS ARCH                 291    99 966
   011   MANGOS JA             AM J PHYSIOL                   221   496 971
   012   MANGOS JA             AM J PHYSIOL                   225    18 973
   013   MANGOS JA             AM J PHYSIOL                   225   450 973
   014   MANGOS JA             PROC SOC EXP BIOL MED          146   321 974
   015   SCHULZ IJ             PFLUEGERS ARCH                 284   360 965
   016   SCHULZ IJ             J CLIN INVEST                   48  1470 969
   017   SCHULZ IJ             PFLUEGERS ARCH                 308   277 969
   018   YOUNG JA              PFLUEGERS ARCH                 291    85 966
   019   YOUNG JA              PFLUEGERS ARCH                 327   285 971
   020   PETERSEN OH           IN: GIEBISCH G                       207 971
   021   PETERSEN OH           PHIL TRANS R SOC LOND BIOL     262   307 971
   022   PETERSEN OH           IN: EMMELIN N                         21 972
   023   PETERSEN OH           ACTA PHYSIOL SCAND SUPPL 381           1 972
   024   SCRATCHERD T          GUT                             14   592 973
   025   SWANSON CH            J GEN PHYSIOL                   62   407 973
   026   PETERSEN OH           J MEMBR BIOL                    16   353 974
   027   MANGOS JA             AM J PHYSIOL                   218  1329 970
   028   MANGOS JA             AM J PHYSIOL                   224  1260 973
   029   MANGOS JA             AM J PHYSIOL                   225   683 973
   030   SCHNEYER CA           IN: THORN NA                          42 974
   031   GARRETT JR            IN: THORN NA                         487 974
   032   EMMELIN N             HANDBOOK OF PHYSIOLOGY           2       967
   033   BATZRI S              J BIOL CHEM                    248   361 973
   034   POHTO P               J ORAL THER PHARMACOL            4   467 968
   035   BATZRI S              J BIOL CHEM                    248   356 973
   037   MANGOS JA             AM J PHYSIOL                   229   553 975
   038   MANGOS JA             AM J PHYSIOL                   229   560 975
   039   MANGOS JA             AM J PHYSIOL                   229   566 975
   040   THOMAS JE             HANDBOOK OF PHYSIOLOGY           2   955 967
   041   TAUSSIG LM            J PEDIATR                       79  1034 971
   042   AMSTERDAM A           PROC NAT ACAD SCI USA           69  3028 973
   043   PETERSEN OH           EXPERIENTIA                     29   160 973
   044   PETERSEN OH           NATURE NEW BIOL                244    73 973
   045   PETERSEN OH           IN: USSING HH                        478 973
   046$  NISHIYAMA A           J PHYSIOL (LOND)               283   145 974
   047   NISHIYAMA A           IN: THORN NA                         216 974
   048   NISHIYAMA A           EXPERIENTIA                     29   161 973
   049   ROBISON GA            CYCLIC AMP                               971
   050   GOLDBERG ND           IN: WEISSMAN G                       185 975
   051   DOUGLAS WW            BR J PHARMACOL                  34   451 968
   052   RASMUSSEN H           SCIENCE                        170   404 970
   053   AMSTERDAM A           J CELL BIOL                     41   753 969
   054   JAMIESON JD           J CELL BIOL                     48   503 971
   055   KANNO T               IN: THORN NA                         278 974
   056   BYRT PN               BIOCHIM BIOPHYS ACTA           148   215 967
   057   DREISBACH RH          PROC SOC EXP BIOL MED          126   279 967
   058   SCHRAMM M             J BIOL CHEM                    245  3225 970
   059   PALADE GE             SCIENCE                        189   347 975
   060   LIEBOW C              AM J PHYSIOL                   226  1077 974
   061   LIEBOW C              SCIENCE                        189   472 975
   062   YOUNG JA              PFLUEGERS ARCH                 295   157 967
   063   YOUNG JA              PFLUEGERS ARCH                 319   185 970
   064   FIELD MJ              PFLUEGERS ARCH                 345   207 973
   065   SCHNEYER LH           AM J PHYSIOL                   215   664 968
   066   SCHNEYER LH           AM J PHYSIOL                   217  1324 969
   067   KNAUF H               IN: GEIBISH G                        198 970
   068   FIELD MJ              THESIS                                   972
   069   MARTIN CJ             PFLUEGERS ARCH                 327   303 971
   070   YOUNG JA              PFLUEGERS ARCH                 327   285 971
   071   MARTIN CJ             PFLUEGERS ARCH                 341   131 971
   072   MARTIN CJ             IN: THORN NA                         549 974
   073   MARTINEZ JR           EUR J PHARMACOL                 18   375 972
   074   DENNIS AR             PROC ARUST PHYSIOL PHARMACOL     4    45 973
   075   CASE RM               IN: BOTELHO SY                        39 969
   076   JANOWITZ HD           CIBA FOUND SYMP EXOCRINE PANC        115 962
   077   CASE RM               J PHYSIOL (LOND)               196   133 968
   078   WORMSLEY KG           GASTROENTEROLOGY                54   197 968
   079   MANGOS JA             AM J PHYSIOL                   224  1235 973
   080   PETERSEN OH           J PHYSIOL (LOND)               210   205 970
   081   DOUGLAS WW            J PHYSIOL (LOND)               165   528 963
   082   MARTINEZ JR           EXPERIENTIA                     28   167 972
   083   SELINGER Z            J BIOL CHEM                    248   369 973
   084   PETERSEN OH           J PHYSIOL (LOND)               208   431 970
   085   CASE RM               J PHYSIOL (LOND)               235    75 973
   086   MATTHEWS EJ           J PHYSIOL (LOND)               231   283 973
   087   BABAD H               EUR J BIOCHEM                    1    96 967
   088   FEINSTEIN H           EUR J BIOCHEM                   13   158 970
   089   RIDDERSTAP AS         AM J PHYSIOL                   216   547 969
   090   CASE RM               IN: THORN NA                         344 974
   091   WINDELER AS JR        ARCH ORAL BIOL                  11  1043 966
   092   DREISBACH RH          AM J PHYSIOL                   196   645 959
   093   NEILSEN SP            J PHYSIOL (LOND)               223   685 972
   094   DREISBACH RH          BIOCHEM J                       82    71 962
   095   DREISBACH RH          PROC SOC EXP BIOL MED          116   953 964
   096   SCHNEYER LH           AM J PHYSIOL                   226   821 974
   097   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   098   MANGOS JA             TEX REP BIOL MED                31   651 973
   099   MANGOS JA             SCIENCE                        158   135 967
   100   KAISER D              PEDIATR RES                      5   167 971
   101   HADORN B              CAN MED ASSOC J                 98   377 968
   102   JOHANSEN PG           LANCET                           1   455 968
   103   CHERNICK WS           J PEDIATR                       59   890 961
   104   CHERNICK WS           J PEDIATR                       65   694 964
   105   CHERNICK WS           ANN NY ACAD SCI                106   698 963
   106   CHERNICK WS           MOD PROBL PEDIATR               10   125 967
   107   BARBERO GJ            IN: DI SANTAGNESE PA                 208 964
   108   BARBERO GJ            CF CLUB ABST                           4 967
   109   MANDEL ID             AM J DIS CHILD                 113   431 967
   110   MANDEL ID             AM J DIS CHILD                 110   646 965
   111   MARMAR J              GASTROENTEROLOGY                50   551 966
   112   GUGLER EC             J PEDIATR                       71   585 967
   113   RUBIN LS              J PEDIATR                       63  1120 963
   114   MANGOS JA             PEDIATR RES                      1   436 967
   115   MANGOS JA             PEDIATR RES                      2   378 968
   116   TAYLOR A              PEDIATR RES                      8   861 974
   117   LUTZ RJ               IN: GABELNICK HL                     119 973
   118   LITT M                BIOCHEM BIOPHYS RES COMMUN      43   919 971
   119   BETTELHEIM FA         BIORHEOLOGY                      8   129 971
   120   LORIN MI              BIORHEOLOGY                      9    27 972
   121   KHAN MA               TEX REP BIOL MED                31   665 973
   122   SELYE HR              SCIENCE                        133    44 961
   123   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   124   MARTINEZ JR           PEDIATR RES                      9   470 975
   125   MARTINEZ JR           PEDIATR RES                      9   463 975
   126   IMMKEN L              CF CLUB ABST                    16     9 975
   127   PIVETTA OH            J HERED                         64   301 973
   131   SMITH T               BIOCHEM J                       84   292 962
   132   ELFERINK J            Z NATURFORSCH                   30   117 975
   133   FULLER D              BIOCHEM J                      150   557 975
   134   RUSSELL DH            GORDON RES CONF POLYAMINES               975
   135   PROCTOR MS            J INVEST DERMATOL               65   409 975
   136   CASE RM               IN: THORN NA                         344 974
   137   RASMUSSEN H           SCIENCE                        170   404 970
CT   1   DISANTAGNESE PA       N ENGL J MED                   295   534 976
     2   DANN LG               LANCET                           2   405 978
     3   HALLINAN F            MED HYPOTHESES                   7   793 981
     4   MANGOS JA             J DENT RES                      60    19 981
     5   ROOMANS GM            SCANN ELECTRON MICROSC        1982   229 982
     6   HARE ER               PEDIATR RES                     19   938 985
     7   SCHONI MH             PEDIATR RES                     19    47 985

PN 76087
RN 00441 
AN 76215364
AU Dearborn-D-G.
TI Water and electrolytes of exocrine secretions.  pp.  179-91.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ BICARBONATES: me.  CALCIUM: me.  CYSTIC-FIBROSIS: me.
   EXOCRINE-GLANDS: se.  SODIUM: me.  WATER: me.
MN BRONCHI: se.  ESCHERICHIA-COLI: me.  GLYCOPROTEINS: me.  HUMAN.
   MONOGRAPH.  MUCUS: se.  CHOLECYSTOKININ: pd.  POLYAMINES: me.
   REVIEW.  SECRETIN: pd.  SWEAT: se.  TRACHEA: se.
   SUPPORT-U-S-GOVT-P-H-S.
EX It has been recognized that the levels of water and electrolytes are
   deranged in many, if not all, of the exocrine secretions of cystic
   fibrosis patients.  The sodium and chloride levels in serous
   secretions from CF patients are elevated.  In contrast, the more
   protein-rich or mucoid, isotonic secretions (viz, from the pancreas
   and tracheobronchial mucus glands) are found to have sodium
   concentrations near normal or even somewhat decreased.  However,
   these secretions have significantly reduced water content.  The
   abnormalities in hypotonic secretions appear to rise from a decreased
   Na+ reabsorption in the ducts.  The low water content of the isotonic
   secretions of CF patients appears to result from decreased secretion
   of water and electrolytes.  Early studies on tracheobronchial
   secretions from CF patients led investigators to suggest that the
   primary defect may be a decrease in the levels of water and
   monovalent ions.  In an attempt to provide a unifying hypothesis, it
   has been suggested that an increased calcium concentration in the
   various exocrine secretions leads to a "hyperpermeability" of the
   mucus linings and thus to an excessive loss of water and small ions.
   The concentration of calcium in exocrine secretions appears to follow
   the concentration of proteins and especially the mucous
   glycoproteins.  It was suggested that calcium may be an important
   factor in the increased viscosity and insolubility of CF mucus.
   Organic ions are also potential perturbants of macromolecular
   structure.  In addition to a possible perturbant role, polyamines
   have a potential role in water and electrolyte transport.
RF 001   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   002   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   003   JOHANSEN PG           LANCET                           1   455 968
   004   MANGOS JA             PEDIATR RES                      1   436 967
   005   MANGOS JA             SCIENCE                        158   135 967
   006   MANGOS JA             PEDIATR RES                      2   378 968
   007   KAISER D              PEDIATR RES                      5   167 971
   008   MANGOS JA             TEX REP BIOL MED                31   651 973
   009   KAISER D              EUR J CLIN INVEST                4   261 974
   011   HADORN B              AUST PAEDIATR J                  4     8 968
   012   HADORN B              CAN MED ASSOC J                 98   377 968
   013   HADORN B              J PEDIATR                       73    39 968
   014   ZOPPI G               ACTA PAEDIATR SCAND             59   692 970
   015   CHERNICK WS           PEDIATRICS                      24   739 959
   016   CHERNICK WS           ANN NY ACAD SCI                106   698 963
   017   MATTHEWS LW           AM REV RESPIR DIS               88   199 963
   018   POTTER JL             AM REV RESPIR DIS               96    83 967
   019   KOPITO LE             FERTIL STERIL                   24   499 973
   020   KOPITO LE             FERTIL STERIL                   24   512 973
   021   GIBSON LE             PEDIATRICS                      48   695 971
   022   BOAT TF               PEDIATRICS                      50   343 972
   023   GOEBELL H             KLIN WOCHENSCHR                 48  1330 970
   024   BOTELHO SY            J PEDIATR                       83   601 973
   025   MANDEL ID             CLIN PEDIATR                     8   161 969
   026   ULLRICH KJ            IN: THORN NA                         423 974
   027   SELINGER Z            BIOCHIM BIOPHYS ACTA           203   326 970
   028   WALLACH D             EUR J BIOCHEM                   21   433 971
   029   BLOMFIELD J           ARCH DIS CHILD                  48   267 973
   030   WARNER RR             J CELL BIOL                     64    54 975
   032   SATIR B               J CELL BIOL                     56   153 973
   033   EMRICH HM             PEDIATR RES                      2   464 968
   034   WIESMANN UN           LANCET                           2   510 972
   035   GUGLER EC             J PEDIATR                       71   585 967
   036   BETTELHEIM FA         BIOCHIM BIOPHYS ACTA           236   702 971
   037   BOAT TF               PEDIATR RES                      8   531 974
   038   WARTON KL             BR MED J                         3   683 971
   039   KATCHALSKY A          BIOPHYS J SUPPL 9                4     9 964
   040   MANDEL ID             AM J DIS CHILD                 113   431 967
   041   RULE AH               FERTIL STERIL                   21   515 970
   042   LIAPPIS N             CLIN CHIM ACTA                  48   233 973
   043   LEWIS RW              LIPIDS                           6   859 971
   044   MCEVOY FA             PEDIATR RES                      9   721 975
   048   BAKER AP              ARCH BIOCHEM BIOPHYS           165   597 974
   049   ZELLER EA             IN: BOYER PD                     8   313 963
   051   MUNRO GF              J BIOL CHEM                    247  1272 972
   052   SEILER N              HOPPE SEYLERS Z PHYSIOL CHEM   354   589 973
   053   TABOR H               ADV ENZYMOL                     36   203 972
   054   JAKOWSKA S            CF AND RELATED HUMAN AND ANIM            970
   055   DI SANTAGNESE PA      ANN NY ACAD SCI                 93   555 962
   056   LOBECK CC             MOD PROBL PEDIATR               10    41 967
   057   DI SANTAGNESE PA      MOD PROBL PEDIATR               10    54 967
   058   GIBBS GE              IN: MCINTOSH R                       145 960
   059   PAUNIER L             PEDIATRICS                      52   446 973
   060   CHAUNCEY HH           ARCH ORAL BIOL                   7   707 962
   061   WOTMAN S              ARCH ORAL BIOL                  16   663 971
   062   BLOMFIELD J           AUST PAEDIATR J                 10    75 974
   063   MANDEL ID             AM J DIS CHILD                 110   646 965
   064   CHERNICK WS           J PEDIATR                       59   890 961
   065   SHWACHMAN H           ANN NY ACAD SCI                 93   600 962
   066   DI SANTAGNESE PA      PEDIATRICS                      22   507 958
   067   BRAND-AURABAN A       J INVEST DERMATOL               58    14 972
   068   STOLL E               HELV PAEDIATR ACTA              25   234 970
   069   KOPITO L              J PEDIATR                       68   313 966
CT   1   WOOD RE               AM REV RESPIR DIS              113   833 976
     2   BOAT TF               ACS SYMPOSIUM SERIES          1978   108 978
     3   SEALE TW              PEDIATR RES                     14  1398 980
     4   WILL PC               PEDIATR RES                     14  1245 980
     5   BOAT TF               FED PROC                        39  3067 980
     6   WELCH MJ              PEDIATRICS                      67   664 981
     7   KNOWLES M             N ENGL J MED                   305  1489 981
     8   SORSCHER EJ           LANCET                           1   368 982
     9   SEALE TW              ANN CLIN LAB SCI                12   415 982
    10   BOGART BI             PEDIATR RES                     16   223 982
    11   KNOWLES M             J CLIN INVEST                   71  1410 983
    12   CHACE KV              CLIN CHIM ACTA                 132   143 983
    13   QUINTON PM            N ENGL J MED                   308  1185 983
    14   DEARBORN DG           N ENGL J MED                   309   796 983
    15   BOUCHER RC            PEDIATR RES                     18  1336 984
    16   CROWTHER RS           BIORHEOLOGY                     21   253 984
    17   KNOWLES MR            PEDIATR RES                     19   676 985
    18   COLLIE G              IN VITRO CELL DEVEL BIOL        21   597 985
    19   KNOWLES MR            CLIN CHEST MED                   7   285 986
    20   BOUCHER RC            J CLIN INVEST                   78  1245 986
    21   FEIGAL RJ             ANN NY ACAD SCI                488    82 986

PN 76088
RN 00442 
AN 76215359
AU Lederberg-S.
TI Polypeptide mediators of cystic fibrosis.  pp.  259-71.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: me.  PEPTIDES: me.
MN ANIMAL.  BIOLOGICAL-ASSAY.  BLOOD-PROTEINS: an, me.  CELLS-CULTURED.
   COMPLEMENT-3: me.  COMPLEMENT-5: me.  DISEASE-MODELS-ANIMAL.
   HETEROZYGOTE.  HUMAN.  IGG.  MODELS-BIOLOGICAL.  MOLECULAR-WEIGHT.
   MONOGRAPH.  PEPTIDES: an.  PROTEINURIA.  RATS.  REVIEW.  SALIVA: me.
EX Although complex models involving multiple loci may be plausible, the
   high frequency of cystic fibrosis in Caucasians is probably best
   explained by selective advantage for the heterozygote carrier.  In
   short, an analogy of cystic fibrosis with hemoglobin S sickle cell
   anemia may be greater than with Tay-Sachs disease in terms of
   molecular mechanisms.  Protein and polypeptide differences have been
   reported for the humoral fluids of cystic fibrosis patients and their
   heterozygotic relatives in connected with selected bioassay systems.
   These directions relate to a model here proposed for the intermediate
   stages of the physiology of cystic fibrosis, which builds on a large
   body of elegant experimental work.  The basic tenet is that the cells
   of cystic fibrosis heterozygotes and normal individuals are in a
   stimulatory loop.  Chronic reserpine treatment exaggerates in the
   normal rat a loop similar to the one exaggerated by genetic
   differences in the human, elevating to pathological levels an
   otherwise normal process.
RF 001   STEINBERG AG          AM J HUM GENET                   8   162 956
   002   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   003   LOBECK CC             IN: STANBURY JB                     1605 972
   004   MANGOS JA             FUNDAMENTAL PROB CF AND RELAT            973
   005   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   006   COHEN SS              INTRODUCTION TO POLYAMINES               971
   007   LEDERBERG S           GAP CONF REP STRAT GEN DIS            15 972
   008   RENNERT OM            IN: MANGOS JA                         41 973
   010   MUNRO GF              CF CLUB ABST                    16     7 975
   011   BDOLAH A              BIOCHEM BIOPHYS RES COMMUN      18   452 965
   012   CECCARELLI B          ADV CYTOPHARMACOLOGY             2       974
   013   RUSSELL DH            PROC NAT ACAD SCI USA           72  1482 975
   014   HSIE AW               PROC NAT ACAD SCI USA           68   358 971
   015   WHITFIELD JF          IN VITRO                         8   257 973
   016   RASMUSSEN H           CRIT REV BIOCHEM                 1    95 972
   017   SCHULTZ G             PROC NAT ACAD SCI USA           70  3889 973
   018   DANKS DM              ANN HUM GENET                   28   323 965
   019   KNUDSON AG JR         AM J HUM GENET                  19   388 967
   020   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   021   DI SANTAGNESE PA      ANN NY ACAD SCI                 93   555 962
   022   SPOCK A               PEDIATR RES                      1   173 967
   023   BOWMAN BH             SCIENCE                        164   325 969
   024   BESLEY GTN            J MED GENET                      6   278 969
   025   DANES BS              J EXP MED                      136  1313 972
   026   SCHMOYER IR           LIFE SCI PART 2                 11  1037 972
   027   CONOVER JH            PEDIATR RES                      7   220 973
   028   MANGOS JA             SCIENCE                        158   135 967
   029   MANGOS JA             PEDIATR RES                      1   436 967
   030   KAISER D              PEDIATR RES                      5   167 971
   031   KAISER D              LANCET                           1  1003 970
   032   BOWMAN BH             SCIENCE                        167   871 970
   033   BARNETT DR            TEX REP BIOL MED                31   709 973
   034   HERZBERG V            J CLIN INVEST                   52  2732 973
   035   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   036   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   037   BARNETT DR            TEX REP BIOL MED                31   703 973
   038   DANES BS              J EXP MED                      137  1538 973
   039   BARNETT DR            TEX REP BIOL MED                31   691 973
   040   BARNETT DR            TEX REP BIOL MED                31   697 973
   041   DOGGETT RG            CF CLUB ABST                          41 971
   042   MCNEELY CM            CF CLUB ABST                    16     6 975
   043   MANGOS JA             PEDIATR RES                      2   378 968
   044   POLLEY MJ             J MED GENET                     11   249 974
   045   CONOVER JH            PEDIATR RES                      7   224 973
   046   BERATIS NG            PEDIATR RES                      7   958 973
   047   CONOVER JH            LIFE SCI                        14   253 974
   048   CONOVER JH            CLIN RES                        21   531 973
   049   CONOVER JH            LANCET                           1  1194 973
   050   CONOVER JH            LANCET                           2  1501 973
   051   LIEBERMAN J           LANCET                           1  1230 974
   052   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   053   HANN S                LANCET                           2   520 974
   054   CONOVER JH            LANCET                           1    47 975
   055   CONOVER JH            PEDIATR RES                      9   394 975
   056   RAO GJS               J PEDIATR                       80   573 972
   057   RAO GJS               PEDIATR RES                      8   684 974
   058   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   059   LIEBERMAN J           PEDIATR RES                      3   571 969
   060   RAO GJS               SCIENCE                        177   610 972
   061   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   062   ADSHEAD PC            ANN NY ACAD SCI                253   192 975
   063   KATCHALSKY A          BIOPHYS J SUPPL 9                4     9 964
   064   QUINTON PM            J CELL BIOL                     56   787 973
   065   KRAUS I               PEDIATRICS                      47  1010 971
   066   ANTONOWICZ I          PEDIATR RES                      6   803 972
   067   ESTENSEN RD           NATURE                         248   347 974
   068   GOLDSTEIN IM          BIOCHEM BIOPHYS RES COMMUN      60   807 974
   069   BARTMAN J             J PEDIATR                       76   430 970
   070   AMSTERDAM A           J CELL BIOL                     41   753 969
   071   PICKERING R           ARCH ORAL BIOL                  20   153 975
CT   1   DISANTAGNESE PA       N ENGL J MED                   295   534 976
     2   WANNER A              AM REV RESPIR DIS              116    73 977

PN 76089
RN 00443 
AN 76215354
AU Barbero-G-J.  Shwachman-H.  Grand-R.  Woodruff-C.
TI Gastrointestinal and nutritional manifestations of cystic fibrosis.
   pp.  83-111.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: co.  GASTROINTESTINAL-DISEASES: et.
   NUTRITION-DISORDERS: et.
MN AMINO-ACIDS: me.  BODY-COMPOSITION.  CYSTIC-FIBROSIS: dh.
   DIABETES-MELLITUS: et.  DIETARY-FATS: me.  GALLBLADDER: pa.
   GASTROINTESTINAL-MOTILITY.  GROWTH.  HUMAN.  INTESTINAL-ABSORPTION.
   INTESTINAL-OBSTRUCTION: et.  INTUSSUSCEPTION: et.
   LACTOSE-INTOLERANCE: et.  LIVER-CIRRHOSIS: et.  MONOGRAPH.
   NITROGEN:  me.  PANCREATIC-DISEASES: et.  REVIEW.
   TRIGLYCERIDES: me.  VITAMINS:  me.
EX The purpose of this paper is to summarize the present state of our
   knowledge of the gastrointestinal manifestations and absorption and
   metabolism of nutrients in patients with cystic fibrosis.  The
   gastrointestinal manifestations include pancreatic exocrine
   insufficiency, pancreatic calcification and stones, diabetes, liver
   and gall bladder abnormalities, intestinal obstruction, and
   complications of malabsorption.  Nutritional aspects of cystic
   fibrosis include growth retardation and body composition, fat and
   nitrogen absorption, amino acid absorption, medium-chain triglyceride
   absorption, and deficiency of fat-soluble vitamins.  The critical
   questions for projection into the future fall into three categories:
   intestinal absorption, gastrointestinal function and experimental
   design.
RF 001   SHWACHMAN H           ADV PEDIATR                      7   249 955
   002   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   003   FARBER S              ARCH PATHOL                     37   238 944
   004   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   005   SHWACHMAN H           PEDIATR CLIN NORTH AM            1   389 954
   006   SHINER M              LANCET                           1    17 956
   007   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   009   COZZETTO FJ           PEDIATRICS                      32   228 963
   011   DI SANTAGNESE PA      GASTROENTEROLOGY                40    64 961
   012   GRAND RJ              CLIN PEDIATR                     9   588 970
   013   KOPEL FB              GASTROENTEROLOGY                62   483 972
   014   BERK RN               RADIOLOGY                      106   377 973
   015   TUCKER AS             AM J ROENTG RAD THER NUCL MED   89  1048 963
   016   MADDOCK CL            AM J DIS CHILD                  66   370 943
   017   SHWACHMAN H           PEDIATRICS                      55    86 975
   018   HADORN B              J PEDIATR                       73    39 968
   019   SHWACHMAN H           AM J DIS CHILD                  92   347 956
   020   JOHANSEN PG           LANCET                           1   455 968
   022   BEARDMORE M           BR MED J                         2  1383 966
   023   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   024   HANDWERGER S          N ENGL J MED                   281   451 969
   025   ROSAN RC              AM J DIS CHILD                 104   625 962
   026   ROSAN RC              METABOLISM                      12   553 963
   027   CRAIG JM              AM J DIS CHILD                  93   357 957
   028   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   029   OPPENHEIMER EH        J PEDIATR                       86   683 975
   030   KATTWINKEL J          J PEDIATR                       82   234 973
   031   LEBENTHAL E           GASTROENTEROLOGY                67   807 974
   032   GREEN MN              AM J DIS CHILD                 100   365 960
   033   FEIGELSON J           ACTA PAEDIATR SCAND             61   337 972
   034   TYSON KRT             J PEDIATR SURG                   3   271 968
   035   ESTERLY JR            BULL JOHNS HOPKINS HOSP        110   247 962
   036   FEIGELSON J           ACTA PAEDIATR SCAND             59   539 970
   037   WEBER AM              N ENGL J MED                   289  1001 973
   038   WATKINS JB            GASTROENTEROLOGY                68  1087 975
   039   PARKINS RA            LANCET                           2   851 963
   040   SHWACHMAN H           N ENGL J MED                   286  1300 972
   041   HOLSCLAW DS           J PEDIATR SURG                   9   867 974
   042   ALTERMAN K            AM J DIS CHILD                 101   210 961
   043   DONNISON AB           PEDIATRICS                      37   833 966
   044   HOLSCLAW DS           AM J DIS CHILD                 109   101 965
   045   NEUHAUSER EBD         AM J ROENTG RAD THER            51   421 944
   046   BERNSTEIN JG          AM J DIS CHILD                  99   804 960
   047   OPPENHEIMER EH        PEDIATR RES                      7   339 973
   048   NOBLETT HR            J PEDIATR SURG                   4   190 969
   049   WAGGET J              J PEDIATR                       77   407 970
   050   KOPITO L              J PEDIATR                       68   313 966
   051   GREEN MN              PEDIATRICS                      21   635 958
   052   GREEN MN              PEDIATRICS                      41   989 968
   053   STEPHAN U             PEDIATRE                        10    63 974
   054   STEPHAN U             PEDIATRICS                      55    35 975
   055   BROWN PM              N ENGL J MED                   263   544 960
   056   HUNTON DB             GASTROENTEROLOGY                50    99 966
   057   LILLIBRIDGE CB        J PEDIATR                       71   887 967
   058   GRACEY M              ARCH DIS CHILD                  44   404 969
   059   MULLINS F             JAMA                           192   741 965
   060   ANDERSON CM           PEDIATRIC GASTROENTEROLOGY               975
   061   HOLSCLAW DS           PEDIATRICS                      48    51 971
   062   KULCZYCKI LL          N ENGL J MED                   259   409 958
   063   SHAHIDI NT            J PEDIATR                       59   533 961
   064   PITTMAN FE            AM J DIS CHILD                 108   360 964
   065   FLEISHER DS           J PEDIATR                       64   349 964
   066   DOLAN TF JR           CLIN PEDIATR                     9   295 970
   067   TORSTENSON OL         PEDIATRICS                      45   857 970
   068   ANTONOWICZ I          PEDIATRICS                      42   492 968
   069   GIBBONS ISE           ARCH DIS CHILD                  44    63 969
   070   LEBENTHAL E           AM J CLIN NUTR                  28   595 975
   071   ANTONOWICZ I          PEDIATRICS                      49   847 972
   072   LLOYD-STILL JD        PEDIATRICS                      53   678 974
   073   SHWACHMAN H           PEDIATRICS                      46     3 970
   074   LLOYD-STILL JD        PEDIATRICS                      54   306 974
   075   LAPEY A               J PEDIATR                       84   328 974
   076   DOOLEY RR             J PEDIATR                       74    95 969
   078   SHOHL AT              J PEDIATR                       23   267 943
   079   ANDERSEN DH           AM J DIS CHILD                  69   221 945
   080   CHUNG AW              PEDIATRICS                       7   491 951
   081   ROSS CAC              ARCH DIS CHILD                  30   316 955
   082   HARRIS R              ARCH DIS CHILD                  30   424 955
   083   JENSEN SB             ACTA PAEDIATR SCAND             45    70 956
   084   SHMERLING DH          PEDIATRICS                      46   690 970
   086   NIESSEN KH            KLIN PAEDIATR                  185   271 973
   087   KATTWINKEL J          PEDIATRICS                      50   133 972
   088   SOONG CS              GASTROENTEROLOGY                63   748 972
   089   GIARDINI O            N ENGL J MED                   286  1059 972
   090   DEREN JJ              N ENGL J MED                   288   949 973
   091   TONZ O                MOD PROBL PEDIATR               10   259 967
   092   WEISS S               ARCH KINDERHEILK               174   254 966
   093   ROMANO C              LANCET                           1   657 966
   094   WEST CD               AM J DIS CHILD                  72   251 946
   095   CHRISTENSEN HN        J CLIN INVEST                   28   319 949
   096   GOULD BS              AM J DIS CHILD                  91   584 956
   097   ANFANGER H            AM J DIS CHILD                  77   425 949
   098   MORIN CL              BIOMEDICINE EXPRESS             19   133 973
   099   SEAKINS JWT           IN: LAWSON D PROC 5TH INT CF         275 969
   100   FERNANDES JH          J CLIN INVEST                   41   488 962
   101   HUANG NN              IN: SENIOR JR                        207 968
   102   GRACEY M              IN: LAWSON D PROC 5TH INT CF         288 969
   103   UNDERWOOD BA          PEDIATR RES                      6    26 972
   104   SMITH FR              J LAB CLIN MED                  80   423 972
   105   KATTWINKEL J          J PEDIATR                       82   234 973
   106   MULLER DPR            BIOCHEM J                      112   28P 969
   107   UNDERWOOD BA          ANN NY ACAD SCI                203   237 972
   108   BLANC WA              PEDIATRICS                      22   494 958
   109   DARBY CW              ARCH DIS CHILD                  48    72 973
   110   FARRELL PM            ACTA PAEDIATR SCAND             64   150 975
   111   HARRIES JT            ARCH DIS CHILD                  46   341 971
   112   DOLAN TF JR           J PEDIATR                       77   515 970
   113   WALTERS TR            AM J DIS CHILD                 124   641 972
   114   LUKENS JN             AM J DIS CHILD                 124   639 972
   115   ALLAN JD              AM J DIS CHILD                 126    22 973
   116   BERRY HK              AM J DIS CHILD                 129   165 975
   117   SHERMAN JO            J PEDIATR                       86   518 975
   118   FILLER RM             N ENGL J MED                   281   589 969
CT   1   BOWMAN BH             LIFE SCI                        19  1289 976
     2   SUPER M               S AFR MED J                     52   991 977
     3   KAISER D              AKTUEL ERNAHRUNGSMED             4    26 979
     4   BENDIG DW             J PEDIATR                      100   536 982
     5   MISCHLER EH           AM J DIS CHILD                 136  1060 982
     6   SUPER M               LANCET                           2  1200 983
     7   JEFFREY I             J CLIN PATHOL                   36  1292 983
     8   WELKON CJ             AM J DIS CHILD                 139   805 985

PN 76090
RN 00444 
AN 76215353
AU Bowman-B-H.
TI Factors related to cystic fibrosis.  pp.  277-84.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS.  PROTEINS.
MN ANIMAL.  BIOLOGICAL-ASSAY.  CELLS-CULTURED.  CILIA.  COMPLEMENT-1.
   COMPLEMENT-3.  CYSTIC-FIBROSIS: bl, fg, ur.  DOGS.  GENES.
   GLYCOPROTEINS.  HUMAN.  IMMUNOGLOBULINS.  MEMBRANE-POTENTIALS.
   MOLECULAR-WEIGHT.  MONOGRAPH.  REVIEW.  SALIVA.
EX A variety of bioassays have identified molecules circulating in
   cystic fibrosis genotypes and synthesized in vitro by cultured cells
   from these genotypes by functional disturbances observed in the
   assays employed.  Preliminary characterizations of these factors are
   in general agreement and the properties include a small molecular
   weight polypeptide within the range of 4000 to 10000 MW, a
   heat-labile protein having a cationic charge, and a protein present
   in saliva, serum, urine (and perhaps sweat) which is synthesized in
   vitro by fibroblasts, short-term lymphocytes and long-term lymphoid
   lines.  The relationship of the factor or factors to the pathogenesis
   of cystic fibrosis is presently unknown, but its presence in cystic
   fibrosis genotypes appears to be related to the basic defect.
RF 001   MANGOS JA             SCIENCE                        158   135 967
   002   MANGOS JA             PEDIATR RES                      1   436 967
   003   MANGOS JA             TEX REP BIOL MED                31   651 973
   004   SPOCK A               PEDIATR RES                      1   173 967
   005   BESLEY GTN            J MED GENET                      6   278 969
   006   BOWMAN BH             SCIENCE                        164   325 969
   007   BOWMAN BH             SCIENCE                        167   871 970
   008   DANES BS              J EXP MED                      136  1313 972
   009   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   010   MCNEELY CM            CF CLUB ABST                    16     6 975
   011   CONOVER JH            PEDIATR RES                      7   220 973
   012   CONOVER JH            PEDIATR RES                      7   224 973
   013   BERATIS NG            PEDIATR RES                      7   958 973
   014   BOWMAN BH             CLIN GENET                       4   461 973
   015   SCHMOYER IR           LIFE SCI PART 2                 11  1037 972
   016   BARNETT DR            TEX REP BIOL MED                31   709 973
   017   HERZBERG V            J CLIN INVEST                   52  2732 973
   018   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   019   CONOVER JH            LIFE SCI                        14   253 974
   020   BARNETT DR            TEX REP BIOL MED                31   703 973
   021   DANES BS              J EXP MED                      137  1538 973
   022   BARNETT DR            TEX REP BIOL MED                31   697 973
   023   WILSON GB             CLIN CHIM ACTA                  49    79 973
   024   LITT M                BIOCHEM BIOPHYS RES COMMUN      43   919 971
   025   BOWMAN BH             FED PROC                        31   842 972
   026   KAHN MA               TEX REP BIOL MED                31   665 973
   027   COHEN FL              J MED GENET                     11   253 974
   028   WILSON GB             LIFE SCI                        15   551 974
   029   POLLEY MJ             J MED GENET                     11   249 974
CT   1   WILSON GB             PEDIATR RES                     11   317 977
     2   IMPERO JE             PEDIATR RES                     12   108 978
     3   SEALE TW              J CLIN MICROBIOL                 9    72 979
     4   WILSON GB             MED HYPOTHESES                   8   527 982
     5   SEALE TW              ANN CLIN LAB SCI                12   415 982

PN 76091
RN 00445 
AN 76215352
AU Nadler-H-L.
TI Enzyme studies.  pp.  285-90.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: en.  ESTERASES: me.
   PEPTIDE-PEPTIDOHYDROLASES:  me.
MN ARGININE.  ESTERASES: df.  KALLIKREIN: me.  MONOGRAPH.
   PAROTID-GLAND: en.  REVIEW.  SALIVA: en.  TRYPSIN-INHIBITORS: pd.
EX It has been reported that saliva and serum of patients contain
   macromolecular "factors" which are presumably cationic and inhibit
   transport of electrolytes, induce dyskinesis or degranulate
   sensitized polymorphonuclear leukocytes and contain polypeptide
   moieties.  The difference between levels of trypsin-like activity of
   mixed saliva of patients with cystic fibrosis and controls has been
   confirmed.  A number of studies have been carried out in order to
   determine if a deficiency of proteolytic activity might account for
   the presence of cystic fibrosis serum factors.  It was presumed that
   the observed partial deficiency of arginine esterase activity might
   well represent the total deficiency of one of several arginine
   esterases assayed under the experimental conditions.  Although it was
   postulated that the deficiency of arginine esterase activity is
   related to the elevation of the levels of polypeptide or protein
   "factors", the hydrolysis of peptide bands by activated plasma could
   not be demonstrated, probably due to the limitations of the methods
   employed.  The deficiency of plasma arginine esterase in cystic
   fibrosis has been questioned and confirmed in another laboratory.
RF 001   MANGOS JA             SCIENCE                        158   135 967
   002   MANGOS JA             PEDIATR RES                      1   436 967
   003   SPOCK A               PEDIATR RES                      1   173 967
   004   BOWMAN BH             SCIENCE                        164   325 969
   005   BOWMAN BH             SCIENCE                        167   871 970
   007   DOGGETT RG            TEX REP BIOL MED                31   685 973
   008   MANGOS JA             PEDIATR RES                      2   378 968
   009   RAO GJS               J PEDIATR                       80   573 972
   010   RAO GJS               SCIENCE                        177   610 972
   011   SCHONI M              EUR J CLIN INVEST                5   153 975
   012   TAYLOR A              PEDIATR RES                      8   861 974
   013   RAO GJS               PEDIATR RES                      8   684 974
   014   RAO GJS               PEDIATR RES                      9   739 975
   015   COLMAN RW             J CLIN INVEST                   48    23 969
   016   COLMAN RW             PROG HEMATOL                     7   255 971
   017   BARRETT AJ            BIOCHEM J                      131   809 973
   018   GLOVER G              J BIOL CHEM                    246  4594 971
   019   GROSKOPF WR           J BIOL CHEM                    244   359 969
   020   CHASE T JR            BIOCHEMISTRY                     8  2212 969
   021   TALAMO RC             PEDIATR RES                      6   430 972
   022   LIEBERMAN J           PEDIATR RES                      3   571 969
   023   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   024   COBURN MD             AM REV RESPIR DIS              110   368 974
   025   CONOVER JH            LIFE SCI                        14   253 974
   026   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
CT   1   HALLINAN F            MED HYPOTHESES                   7   793 981
     2   DANDONA P             THORAX                          36    60 981
     3   WILSON GB             MED HYPOTHESES                   8   527 982

PN 76092
RN 00446 
AN 76215351
AU Liebman-J.  Lucas-R-V.  Moss-A.  Rosenthal-A.
TI Cor pulmonale and related cardiovascular effects of cystic fibrosis.
   pp.  41-80.
SO In: Mangos JA, Talamo RC, ed. Cystic fibrosis: projections into the
   future. New York, Stratton, 1976. WI 820 C9995 1976. (REVIEW).
MJ CYSTIC-FIBROSIS: co.  PULMONARY-HEART-DISEASE: et.
MN ADOLESCENCE.  ADULT.  CHILD.  DIGOXIN: tu.  DIURETICS: tu.
   ECHOCARDIOGRAPHY.  FUROSEMIDE: tu.  HEART-ENLARGEMENT: et.
   HEART:  pp.  HUMAN.  MONOGRAPH.  MYOCARDIAL-CONTRACTION.
   MYOCARDIUM: pa.  OXYGEN-INHALATION-THERAPY.  OXYGEN: bl.  PROGNOSIS.
   PULMONARY-HEART-DISEASE: di, th.  RESPIRATION.  REVIEW.
   TOLAZOLINE:  tu.  VASCULAR-RESISTANCE.  VECTORCARDIOGRAPHY.
EX Cor pulmonale was defined by a committee of the World Health
   Organization as "right ventricular hypertrophy, secondary to disease
   of the lung parenchyma or pulmonary vasculature, or due to
   abnormalities of pulmonary function."  It has been estimated that 70%
   of children dying with cystic fibrosis have cor pulmonale, though as
   children live longer, the number may be higher.  Clinical diagnosis,
   management, prognosis, echocardiography, echocardiography as a
   measure of left ventricular dysfunction, and a study of 94 ambulatory
   and hospitalized cystic fibrosis patients are discussed.  The study
   establishes that in patients with cystic fibrosis, left ventricular
   dysfunction and hypertrophy occur and are related to increasing
   severity of pulmonary involvement.
RF 001   ANON                  CIRCULATION                     27   594 963
   002   FISHMAN AP            HOSP PRACT                       6   101 971
   003   SIASSI B              J PEDIATR                       78   794 971
   004   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   005   MOSS AJ               J PEDIATR                       67   797 965
   006   FERRER MI             BULL NY ACAD MED                41   942 965
   007   LIEBMAN J             CIRCULATION                     35   552 967
   008   LIEBMAN J             IN: MOSS AJ                          183 968
   009   LIEBMAN J             CHEST                           63   218 973
   010   HAYES CJ              PEDIATRICS                      52   561 973
   011   WILLIAMS JF JR        AM J CARDIOL                    16   534 965
   012   CROWELL JW            AM J PHYSIOL                   206   313 964
   013   HERNANDEZ A           AM J DIS CHILD                 115   576 968
   014   MOSS AJ               J PEDIATR                       86   295 975
   015   WHITMAN V             PEDIATRICS                      55    83 975
   016   CAMPBELL EJM          LANCET                           1  1184 960
   017   NOBLE MIM             LANCET                           2   257 966
   019   GOLDRING RM           J PEDIATR                       65   501 964
   020   KELMINSON LL          PEDIATRICS                      39    24 967
   021   FISHER BJ             CF CLUB ABST                             971
   022   FISHER BJ             PROC AM PEDIATR SOC ANNU MTG         299 971
   026   SAKAMOTO T            JAPAN HEART J                   15   360 974
   027   HIRSCHFELD S          CIRCULATION                     51   304 975
   028   HIRSCHFELD S          CIRCULATION                     52   641 975
   029   BISHOP JM             MED CLIN NORTH AM               57   771 973
   030   FISHMAN AP            N ENGL J MED                   285   402 971
   031   FRANK MJ              CIRCULATION                     47   798 973
   032   DAVIES H              CHEST                           58     8 970
   033   WILLIAMS JF JR        J CLIN INVEST                   47  1143 968
   034   RAO BS                AM J MED                        45   229 968
   035   BAUM GL               N ENGL J MED                   285   361 971
   036   BLAND JW JR           AM J CARDIOL                    23   830 969
   037   LUKE MJ               PEDIATRICS                      37   762 966
   038   BARNES GL             AUST PAEDIATR J                  6    81 970
   039   OPPENHEIMER EH        JOHNS HOPKINS MED J            133   252 973
   040   HOLMAN RL             PEDIATRICS                      24    34 959
   041   WEISSLER AM           AM HEART J                      62   367 961
   042   WEISSLER AM           AM J CARDIOL                    23   577 969
   043   WEISSLER AM           AM J CARDIOL                    15   153 965
   044   WEISSLER AM           AM J MED SCI                   259     4 970
   045   LEVY AM               CIRCULATION                     46   816 972
   046   GOLDE D               CIRCULATION                     42  1029 970
   047   HARRIS LC             AM J CARDIOL                    14   448 964
   048   MARTIN CE             CIRCULATION                     44   419 971
   049   GARRARD CL JR         CIRCULATION                     42   455 970
   050   WALLACE AG            CIRC RES                        12   611 963
   051   WEISSLER AM           CIRCULATION                     37   149 968
   052   WEISSLER AM           AM J CARDIOL                    17   768 966
   053   FEIGENBAUM H          ECHOCARDIOGRAPHY                         972
   054   FEIGENBAUM H          ARCH INTERN MED                129   461 972
   055   GIBSON DG             BR HEART J                      35   128 973
   056   FORTUIN NJ            CIRCULATION                     44   575 971
   057   MURRAY JA             AM J CARDIOL                    30   252 972
   058   ABBASI AS             N ENGL J MED                   289   118 973
   059   COOK CD               J PEDIATR                       59   710 961
   060   MURRAY AB             J PEDIATR                       62   186 963
   061   GOODMAN DJ            AM J CARDIOL                    33   438 974
   062   GRAHAM TP JR          PEDIATR CLIN NORTH AM           18  1109 971
   063   MARSHALL RJ           CARDIAC FUNCTION IN HEALTH AN            968
   064   TAJIK AJ              CIRCULATION                     46    36 972
   065   ZAKY A                CIRCULATION                     37   789 968
   066   POPP RL               CIRCULATION                     49   428 974
   067   ZIMMERMAN HA          DIS CHEST                       20   286 951
   068   KELLY DT              CIRCULATION                     44   403 971
   069   ALPERT JS             CIRCULATION                     50   317 974
   070   FLUCK DC              BR HEART J                      28    92 966
   071   MICHELSON N           DIS CHEST                       38   435 960
   072   BOWDEN DH             AM J MED                        38   226 965
   073   ROWLATT UF            PEDIATR CLIN NORTH AM           10   499 963
   074   DUCHAK JM JR          AM J CARDIOL                    29   628 972
   075   MCLAURIN LP           CIRCULATION                     48   801 973
CT   1   WOOD RE               AM REV RESPIR DIS              113   833 976
     2   HIRSCHFELD SS         CHEST                           75   351 979
     3   CHIPPS BE             J PEDIATR                       95   379 979
     4   MATTHAY RA            BR HEART J                      43   474 980
     5   MORIN DP              PEDIATRICS                      65    44 980
     6   STERN RC              AM J DIS CHILD                 134   267 980
     7   FOWLER RS             J ELECTROCARDIOL                14   319 981
     8   MATTHAY RA            MED CLIN NORTH AM               65   489 981
     9   JACOBSTEIN MD         CHEST                           80   399 981
    10   NEWTH CJL             AM REV RESPIR DIS              124   463 981
    11   MOSS AJ               PEDIATRICS                      70   728 982
    12   GOODING CA            J PEDIATR                      105   384 984
    13   BENSON LN             AM REV RESPIR DIS              130   987 984
    14   CANNY GJ              AM REV RESPIR DIS              130   822 984
    15   STANBROOK HS          AM REV RESPIR DIS              130    81 984
    16   GEGGEL RL             AM REV RESPIR DIS              131   531 985
    17   RUTISHAUSER M         WIEN KLIN WOCHENSCHR            98   728 986

PN 76093
RN 00447 
AN 76236895
AU Hann-S.  Holsclaw-D-S.
TI Interactions of Pseudomonas aeruginosa with immunoglobulins and
   complement in sputum.
SO Infect-Immun. 1976 Jul. 14(1). P 114-7.
MJ COMPLEMENT-3.  COMPLEMENT.  CYSTIC-FIBROSIS: im.  IMMUNOGLOBULINS.
   PSEUDOMONAS-AERUGINOSA: im.  SPUTUM: im.
MN ADOLESCENCE.  ADULT.  ANTIGEN-ANTIBODY-REACTIONS.  CHILD.
   CHILD-PRESCHOOL.  COMPLEMENT-3: an.  COMPLEMENT: an.
   CYSTIC-FIBROSIS: mi.  FEMALE.  HUMAN.  IGA: an.  IGG: an.  IGM: an.
   IMMUNOGLOBULINS: an.  MALE.  SPUTUM: mi.
AB The interactions of Pseudomonas aeruginosa with humoral factors in
   the sputum of patients with cystic fibrosis were investigated by
   using an indirect immunofluorescent technique. Fluorescein-
   conjugated, monovalent antiserum specific to heavy chains of human
   immunoglobulin A (IgA), IgG, or IgM and to complement C3 were used.
   All strains of P. aeruginosa recovered from the sputum specimens of
   patients with cystic fibrosis were found to be coated with antibodies
   of IgA, IgG, and IgM classes and with C3. The specificity of the
   antibody coating was determined. The fluorescence was most intense
   with IgA and was followed in intensity by IgG, IgM, and C3. No
   difference was noted between rough and mucoid strains of P.
   aeruginosa. When the subcultured P. aeruginosa was incubated with the
   sputum eluates, a similar pattern of fluorescence was demonstrated,
   indicating that these humoral factors are present in the sputum and
   that the coating process can take place in the lower respiratory
   tract of the patients. By single radial immunodiffusion, significant
   quantities of the humoral factors in the sputum eluates were
   detected. These findings suggest that P. aeruginosa is opsonized in
   sputum of patients with cystic fibrosis.
RF 001   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   002   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   003   BOYDEN SV             IN: WOLSTENHOLME GEW                 190 976
   004   GOTZE O               J EXP MED                      134   90S 971
   005   GREEN GM              N ENGL J MED                   276   421 967
   006   GREEN GM              J CLIN INVEST                   43   769 964
   007   GUGLER EC             J PEDIATR                       73   548 968
   008   HUANG NN              J PEDIATR                       59   512 961
   009   IACOCCA VF            AM J DIS CHILD                 106   315 963
   010   ISHIZAKA T            J IMMUNOL                       97   716 966
   011   JOHNSTON RB JR        J EXP MED                      129  1275 969
   012   MARCER V              RIV CLIN PEDIATR                83   135 970
   013   OREN R                J CELL BIOL                     17   486 963
   014   REYNOLDS HY           GAP CONF REP PSEUDOMON IN CF           7 974
   015   SMITH MR              PROC NAT ACAD SCI USA           63  1151 969
   016   SOUTH MA              J PEDIATR                       71   645 967
   017   THOMAS V              N ENGL J MED                   290   588 974
   018   WILLIAMS RC JR        IMMUNOLOGY                      17   249 969
   019   WINKELSTEIN JA        J PEDIATR                       82   747 973
   020   YOUNG LS              J INFECT DIS                   126   257 972
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   SORENSEN RU           INFECT IMMUN                    18   735 977
     3   SORENSEN RU           J PEDIATR                       93   201 978
     4   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87   229 979
     5   SHAW JO               LAB INVEST                      42   547 980
     6   HOMMA JY              JAP J EXP MED                   50   149 980
     7   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
     8   KOLB WP               AM REV RESPIR DIS              123   226 981
     9   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982
    10   OLIVER AM             J CLIN LAB IMMUNOL              10   221 983
    11   SCHILLER NL           PEDIATR RES                     17   747 983
    12   SORENSEN RU           EUR J RESPIR DIS                64   524 983
    13   PIER GB               J INFECT DIS                   150   223 984
    14   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985
    15   PIEDRA P              J PEDIATR                      108   817 986

PN 76094
RN 00448 
AN 76238105
AU Tavormina-J-B.  Kastner-L-S.  Slater-P-M.  Watt-S-L.
TI Chronically ill children.  A psychologically and emotionally deviant
   population?.
SO J-Abnorm-Child-Psychol. 1976. 4(2). P 99-110.
MJ ADAPTATION-PSYCHOLOGICAL.  CHRONIC-DISEASE.  SOCIAL-ADJUSTMENT.
MN ACHIEVEMENT.  ADOLESCENCE.  ADULT.  ASTHMA: co.
   CHILD-BEHAVIOR-DISORDERS: co.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: co.  DEFENSE-MECHANISMS.  DEPENDENCY-PSYCHOLOGY.
   DIABETES-MELLITUS-INSULIN-DEPENDENT: co.  FEMALE.
   HEARING-DISORDERS:  co.  HUMAN.  INTERNAL-EXTERNAL-CONTROL.  MALE.
   PERSONAL-SATISFACTION.  PERSONALITY-INVENTORY.  PROJECTIVE-TECHNICS.
   SELF-CONCEPT.  SEX-FACTORS.  SOCIAL-DESIRABILITY.
AB The study evaluated the psychosocial functioning levels of a group of
   chronically ill (diabetic, asthmatic, cystic fibrotic, and hearing-
   impaired) children across a battery of standardized personality
   instruments. The assessments were performed to provide a rigorous
   test of the popular hypothesis that chronically ill children are
   especially vulnerable to psychopatholgy. In contrast to this
   sterotype, results across measures demonstrated the normalcy rather
   than the deviance of these children. Although exceptions were noted,
   the children's functional strengths and coping abilities noticeably
   outweighed their weaknesses.
RF 001   BAKWIN H              BEHAVIOR DISORDERS IN CHILDRE            972
   002   DILLER L              IN: WOLMAN BB                            972
   003   EYSENCK SBG           JR EYSENCK PERSONAL INVENTOR             963
   004   FARBER B              SOCIOMETRY                      20   117 957
   005   FARBER B              CHILD DEVELOPMENT               24       959
   006   GAYTON WF             AM J DIS CHILD                 126   856 973
   008   GREEN M               IN: GREEN M                              965
   009   KNOWLES HC JR         MED CLIN NORTH AM               55  1007 971
   010   LANYON RI             J CONSULT CLIN PSYCHOL          35     1 970
   011   LOUGHLIN WC           AM J DIS CHILD                  68    13 944
   012   MATTSSON A            PEDIATRICS                      50   801 972
   013   MATTSSON A            J AM ACAD CHILD PSYCHIAT        11   558 972
   014   NOWICKI S JR          J CONSULT CLIN PSYCHOL          40   148 973
   015   PIERS EV              PIERS HARRIS CHILDRENS SELF C            967
   016   PURCELL K             IN: WOLMAN BB                            972
   017   RAINER JD             ADV PSYCHOSOMATIC MED            3   167 963
   018   SINES JO              MANUAL FOR THE MISSOURI CHILD            971
   019   SWIFT CR              PSYCHOSOM MED                   29   555 967
   020   WERRY JS              IN: QUAY HC                              972
   021   WINER BJ              STATISTICAL PRIN IN EXP              101 962
CT   1   BEDELL JR             J PSYCHOSOM RES                 21   237 977
     2   GAYTON WF             PEDIATRICS                      59   888 977
     3   SULLIVAN BJ           PSYCHOSOM MED                   41   127 979
     4   KELLERMAN J           J PEDIATR                       97   126 980
     5   DONALD MW             J NEUROL NEUROSURG PSYCHIAT     44   641 981
     6   DROTAR D              PEDIATRICS                      67   338 981
     7   LEWIS BL              J PEDIATR                      101   636 982
     8   STEINHAUSEN HC        J AM ACAD CHILD PSYCHIAT        22   559 983
     9   SINNEMA G             ACTA PAEDIATR SCAND             72   427 983
    10   CERRETO MC            PEDIATR CLIN NORTH AM           31   689 984
    11   PLESS IB              PEDIATR CLIN NORTH AM           31    33 984
    12   VIEWEG BW             J CLIN PSYCHOL                  40  1382 984
    13   VERMA A               J NEUROL NEUROSURG PSYCHIAT     47   414 984
    14   SLIJPER FME           PROG BRAIN RES                  61   417 984
    15   LEWISTON NJ           SEM RESPIR MED                   6   321 985
    16   BRESLAU N             J AM ACAD CHILD PSYCHIAT        24    87 985
    17   GRAHAM P              DEVELOP MED CHILD NEUROL        27   389 985
    18   FIELDING D            J PSYCHOSOM RES                 29   457 985
    19   SIMMONS RJ            PSYCHOSOM MED                   47   111 985
    20   HELLER A              AM J DIS CHILD                 139   257 985
    21   CARRGREGG MRC         MED J AUST                     143   503 985
    22   KOVACS M              DIABETES CARE                    9   472 986
    23   JAMISON RN            J CHRON DIS                     39   609 986
    24   COWEN L               PEDIATRICS                      77   745 986
    25   NOLAN T               J PEDIATR                      109   201 986

PN 76095
RN 00449 
AN 76190785
AU Carson-J-A.  Gormican-A.
TI Disease-medication relationships in altered taste sensitivity.
SO J-Am-Diet-Assoc. 1976 Jun. 68(06). P 550-3.
MJ DRUG-THERAPY: ae.  NUTRITION.  TASTE-DISORDERS: et.
MN ANESTHETICS: pd.  ANOREXIA: et.  DYSAUTONOMIA-FAMILIAL: co.
   CYSTIC-FIBROSIS: co.  DEFICIENCY-DISEASES: co.
   ENDOCRINE-DISEASES:  co.  HUMAN.  KIDNEY-DISEASES: co.  NEOPLASMS: co.
   NERVOUS-SYSTEM-DISEASES: co.  NUTRITION: de.  SJOGRENS-SYNDROME: co.
   TASTE: de.  WOUNDS-AND-INJURIES: co.
EX Reviewing evidence of abnormal taste acuity elicits several factors
   which can change a patient's taste acuity.  Consideration of his
   diagnosis, his nutritional status, and the treatment he is receiving
   or has received can offer further understanding of his perceptions of
   food.  Future studies will furnish more information about how the
   patient's ability to taste and smell may be altered and thus affect
   his attitude toward food.
RF 001   RUBINI ME             AM J CLIN NUTR                  27   223 974
   002   PANGBORN RM           IN: KARE MR                              967
   003   HENKIN RL             BORDENS NUTR REV                28    71 967
   004   GREEN RF              SCHIZOPHRENIA                    2    70 970
   005   GREEN RF              JAMA                           218  1303 971
   006   HODGES RE             IN: WHITE PL                             972
   007   COHEN IK              JAMA                           223   915 973
   008   HAMBIDGE KM           PEDIATR RES                      6   868 972
   009   HENKIN RI             PROC NAT ACAD SCI USA           62    30 969
   010   ANON                  POSTGRAD MED                    53    30 973
   011$  HENKIN RI             JAMA                           223   914 971
   012   KING ER               VA MED                          98   652 971
   013   FLETCHER GH           RADIATION THERAPY IN THE MANA            962
   014   TEWFIK HH             PRESENTATION DIET THERAPY USA            973
   015   MACCARTHY-LEVENTHAL F LANCET                           2  1138 959
   016   BONANNI G             NUNT RADIOL                     31   383 965
   017   KALMUS H              J LARYNGOL OTOL                 73   180 959
   018   HANSEN D              WEGNEISER FUR DIE FACHAERZTLI   18   133 970
   019   CONGER AD             RADIAT RES                      37    31 969
   020   HENKIN RI             J CLIN INVEST                   42   727 963
   021   HENKIN RI             J CLIN ENDOCRINOL METAB         27  1436 967
   022   HENKIN RI             J CLIN ENDOCRINOL METAB         28   624 968
   023   WEISS VALBRANCA G     RIV CLIN MED                     5    46 946
   024   SCHAUPP H             ARCH KLIN EXP OHR NAS KEHLK H  195   179 969
   025   SCHELLING JL          LANCET                           1   508 965
   026   DEWYS WD              ANN NY ACAD SCI                230   427 974
   027   ABASOV IT             SOV MED                         25    47 961
   028   SIMON JA              MASTERS RESEARCH REPORT                  974
   029   HENKIN RI             IN: BOSMA JF                             967
   030   HENKIN RI             NATURE                         227   965 970
   032   HENKIN RI             ANN INTERN MED                  76   375 972
   033   HENKIN RI             SCIENCE                        138  1107 962
   034   HENKIN RI             IN: BOSMA JF                             970
   035   BRANDENBURG JH        FACIAL NERVE PARALYSIS (TAPE)            973
   036   KALMUS H              CHEMICAL SENSES IN HEALTH                960
   037   SUMNER D              BRAIN                           90   187 967
   038   GROSSMAN SP           IN: HERXHEIMER A                         968
   039   MATA F                J NEUROPSYCH                     4   315 963
   040   FOGAN L               ANN INTERN MED                  74   795 971
   041   HENKIN RI             LANCET                           2  1268 967
   042   DUFFIELD JE           BR MED J                         1   491 973
   043$  SCOTT PJ              NZ MED J                        59   296 970
   044   SHAFAR J              LANCET                           1    83 965
   045   RABE F                MED WELT                        16   711 970
   046   HALLMAN BL            JAMA                           152   322 953
   047   SCHNEEBURG NG         JAMA                           149  1091 952
CT   1   BURLESON WR           AM J HOSP PHARM                 35   584 978
     2   MATTES RD             AM J CLIN NUTR                  41   672 985

PN 76096
RN 00450 
AN 76190784
AU Rickard-K.  Brady-M-S.  Hempel-J.  Gresham-E.
TI Care of children with conditions characterized by high nutritional
   risks.
SO J-Am-Diet-Assoc. 1976 Jun. 68(06). P 546-50.
MJ CYSTIC-FIBROSIS: dh.  HEART-DEFECTS-CONGENITAL: dh.
   SPINA-BIFIDA:  dh.
MN CHILD-NUTRITION.  CHILD.  CHILD-PRESCHOOL.  DIET-SODIUM-RESTRICTED.
   DIETARY-FATS.  DIETARY-PROTEINS.  ENZYMES: tu.  HEALTH-EDUCATION.
   HUMAN.  INFANT.  INFANT-NEWBORN.  PATIENTS: ed.  POTASSIUM.  SODIUM.
   VITAMINS: tu.  WATER-ELECTROLYTE-BALANCE.  PATIENT-EDUCATION.
EX A key to any successful preventive nutritional program is long-term
   follow up, reinforcement, and early intervention when necessary.  The
   dietitian must evaluate the effectiveness of her approach through
   careful monitoring of various parameters of growth, such as length,
   weight, head circumference, and skinfold measurements.  It is
   essential that she be aware of the advantages, limitations, and
   complications of any dietary program.  We have described only three
   examples of complex nutritional problems encountered in the intensive
   care nursery.  There are many more equally challenging and
   frustrating medical and surgical disorders which demand the expertise
   of the dietitian for successful management.  The dietitian of the
   future cannot rely on knowledge alone, but must utilize considerable
   ingenuity and creativity in managing these complicated nutritional
   enigmas if acceptance and effectiveness are to be maintained.
RF 001   RICKARD K             J AM DIET ASSOC                 66   592 975
   002   FOMON SJ              IN: FOMON SJ                         472 974
   003   BERGMANN KE           IN: FOMON SJ                             974
   004   FOMON SJ              INFANT NUTRITION                         974
   005   ROOK GD               BR HEART J                      35    87 973
   006   SELVARAJ RJ           AM J CLIN NUTR                  25   166 972
   007   KOPEL FB              GASTROENTEROLOGY                62   483 972
   008   WEIHOFEN DM           J AM DIET ASSOC                 54   206 969
   009   ANTONOWICZ I          PEDIATRICS                      42   492 968
   010   HUANG NN              IN: SENIOR JR                        207 968

PN 76097
RN 00451 
AN 76259953
AU Govan-J-R.
TI Antibiotic therapy and cystic fibrosis: increased resistance of
   mucoid Pseudomonas aeruginosa to carbenicillin.
SO J-Antimicrob-Chemother. 1976 Jun. 2(2). P 215-7.
MJ ANTIBIOTICS: tu.  CARBENICILLIN: pd.  CYSTIC-FIBROSIS: dt.
   PSEUDOMONAS-AERUGINOSA: de.
MN CYSTIC-FIBROSIS: mi.  DRUG-RESISTANCE-MICROBIAL.  HUMAN.
EX The present communication reports the effect of the bacterial mucus
   on the activity of antibodies on strains of P. aeruginosa.  Mucoid
   variants of P. aeruginosa obtained from the non-mucoid strains PAO
   381 and PAT 404 by selection for phenotypic resistance to the
   virulent phage E 79 were more resistant to carbenicillin than the
   non-mucoid parent strains.  Mucoid P. aeruginosa strains isolated
   from two CF patients were more resistant to carbenicillin than
   non-mucoid strains isolated from the same samples of sputum.  When
   the experiments already described were repeated with oxytetracycline,
   in contrast to our experience with carbenicillin, mucoid strains were
   found to be more sensitive than non-mucoid strains.  To prove the
   hypothesis that mucoid strains can be selected in vivo by
   carbenicillin therapy it will be necessary to show that the level of
   carbenicillin in CF secretions is less than the minimum inhibitory
   concentrations of mucoid strains but greater than that of non-mucoid
   strains.  We are now investigating additional CF isolates in
   conjunction with the range of antibiotics used in chemotherapy of CF
   patients.
RF 001   BURNS MW              LANCET                           1   270 968
   002   DOGGETT RG            APPL MICROBIOL                  18   936 969
   003   DOGGETT RG            J PEDIATR                       68   215 966
   004   GOVAN JRW             J MED MICROBIOL                  8   513 975
   005   MARKS MI              J PEDIATR                       79   822 971
   006   WILLIAMS RJ           J MED MICROBIOL                  6   409 973
   007   ZIERDT CH             J BACTERIOL                     87  1003 964
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   BROWN MRW             J ANTIMICROB CHEMOTHER           3   198 977
     3   JONES SE              J PHARMACY PHARMACOL            29  P 69 977
     4   GOVAN JRW             J ANTIMICROB CHEMOTHER           4   233 978
     5   MARKOWITZ SM          INFECT IMMUN                    22   530 978
     6   HOLLOWAY BW           MICROBIOL REV                   43    73 979
     7   BRANSON D             AM J MED TECHNOLOGY             45   405 979
     8   GOVAN JRW             J GEN MICROBIOL                110   229 979
     9   SAVITSKAYA KI         ZH MIKROBIO EPIDEMIO IMMUNOBI 1979    96 979
    10   MARKOWITZ SM          J ANTIMICROB CHEMOTHER           6   251 980
    11   MARTIN AJ             ARCH DIS CHILD                  55   604 980
    12   CHOPRA I              ADV MICROB PHYSIOL              23   183 982
    13   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
    14   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
    15   OMBAKA EA             REV INFECT DIS                   5  S880 983
    16   HOOGKAMPKORSTANJE JAA J ANTIMICROB CHEMOTHER          12   175 983
    17   ANWAR H               FEMS MICROBIOL LETTERS          16   247 983
    18   TURNOWSKY F           FEMS MICROBIOL LETTERS          17   243 983
    19   ANWAR H               BIOCHIM BIOPHYS ACTA           761   119 983
    20   TANNENBAUM CS         ANTIMICROB AGENTS CHEMOTHER     25   673 984
    21   MODAI J               SEM HOP PARIS                   61  2325 985
    22   WOODS DE              J INFECT DIS                   151   581 985
    23   DERETIC V             J BACTERIOL                    165   510 986

PN 76098
RN 00452 
AN 76259939
AU Raeburn-J-A.
TI Antibiotic management of cystic fibrosis.
SO J-Antimicrob-Chemother. 1976 Jun. 2(2). P 107-9.
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: co.
   RESPIRATORY-TRACT-INFECTIONS:  dt.
MN RESPIRATORY-TRACT-INFECTIONS: co, mi.
EX Cystic fibrosis is the most common autosomal recessive disorder in
   Great Britain, Central Europe and North America and it affects 1 in
   2000 live born children.  Does the antibiotic treatment in cystic
   fibrosis differ from the treatment of respiratory infection in other
   conditions?  The cystic fibrosis patient not only suffers progressive
   deterioration in respiratory function; he often has dangerous
   complicating conditions culminating in super-infection by highly
   resistant organisms.  The basic principle of antibiotic therapy must
   be rigidly applied in cystic fibrosis.  The first principle is to
   identify the pathogen and its susceptibility to antibiotics.  The
   second principle is to ensure that the chosen antibiotic reaches the
   site of infection.  The third principle is that the antibiotic
   therapy ought to complement the immunological defences of the
   patient.  A fourth principle is that no therapy must be given
   without first deciding upon the criteria which will be acceptable as
   indicating clinical improvement.
RF 001   BEARN AG              CLIN GASTROENTEROL               2   515 973
   002   BRUMFITT W            J ANTIMICROB CHEMOTHER           1   163 975
   003   DIAZ F                J INFECT DIS                   121   269 970
   004   FORBES IJ             AUST NZ J MED                    2   160 971
   005   FORSGREN A            IN: BRENT L                          345 974
   006   LAWSON D              IN: WATT PJ                           69 970
   007   LEHRER RI             J CLIN INVEST                   50  2498 971
   008   MAY JR                CHEMOTHERAPY OF CHRONIC BRONC            972
   009   MAY JR                ARCH DIS CHILD                  47   908 972
   010   MCCRAE WM             IN: APLEY J                      4   157 974
   011   MCCRAE WM             SCOTT MED J                     19   187 974
   013   MEARNS MB             IN: MANGOS JA                        345 973
   014   RAEBURN JA            POSTGRAD MED J                  47   366 971
   015   RAEBURN JA            SCAND J INFECT DIS               5   135 973
   016   RAEBURN JA            IN: DAIKOS GK                    2   730 974
   017   SOLBERG CO            LANCET                           2   727 972
CT   1   RAEBURN JA            PROC NUTR SOC                   36    77 977
     2   GOVAN JRW             J ANTIMICROB CHEMOTHER           4   233 978
     3   GRAY JA               SCOTT MED J                     24   141 979
     4   MICHALSEN H           CHEMOTHERAPY                    26   135 980
     5   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
     6   HODSON ME             BR J DIS CHEST                  77    71 983

PN 76099
RN 00453 
AN 76167755
AU Barranco-S-C.  Bolton-W-E.  Haenelt-B-R.  Abell-C-W.
TI Differences in the incorporation of thymidine into DNA of normal and
   cystic fibrosis fibroblasts in vitro.
SO J-Cell-Physiol. 1976 May. 88(1). P 33-41.
MJ CYSTIC-FIBROSIS: me.  DNA: bi.  THYMIDINE: me.
MN BROMODEOXYURIDINE: pd.  CADMIUM.  CELL-DIVISION.  CELL-LINE.
   COMPARATIVE-STUDY.  GENOTYPE.  KINETICS.  THYMIDINE-KINASE: me.
   THYMINE-NUCLEOTIDES: bi.  URIDINE: me.
AB Although similar fractions of cells were in the S phase of the cell
   cycle, normal human skin fibroblasts were shown to incorporate more
   than twice the 3HTdR into their DNA in vitro than did cells obtained
   from individuals with cystic fibrosis (CF). Obligate heterozygotes
   incorporated an intermediate amount of the DNA precursor. Studied
   were initiated to determine the basis of the differential
   incorporation of 3HTdR among the genotypes. An analog of thymidine,
   BUdR, produced varied effects on the growth kinetics of the three
   genotypes. The growth of cells in BUdR resulted in a 50% increase in
   the population doubling times of all three genotypes, and caused the
   cell morphology to change from a spindle shape to one in which the
   cells became broadened and flat, with numerous cytoplasmic
   projections extending for distances of several cell diameters. The
   activities of thymidine kinase and the participation of the exogenous
   and de novo pathways in the synthesis of TMP were found to be
   approximately the same in all three genotypes. The data suggest that
   an alteration in the transport of thymidine into the cells may
   account for the differences in TdR incorporation into DNA, and this
   may be associated with other changes in cystic fibrosis that are
   apparently membrane associated.
RF 001   BARRANCO SC           CANCER RES                      33   691 973
   002   BOLTON WE             AM J HUM GENET                  27   394 975
   003   BUKOVSKY J            CANCER RES                      25   358 965
   004   DANES BS              AM J HUM GENET                  25   323 973
   005   FURLONG N             ANAL BIOCHEM                     5   515 963
   006   HAHN GM               EXP CELL RES                    49   285 968
   007   HOWARD A              HEREDITY SUPPL                   6   261 953
   008   HUMPHREY RM           DNA STRAND SCISSION AND REJOI        570 970
   009   MATALON R             LANCET                           2   838 969
   010   MENDELSOHN ML         J NATL CANCER INST              28  1015 962
   011   SHWACHMAN H           MOD PROBL PEDIATR               10   158 967
   012   STUBBLEFIELD E        EXP CELL RES                    48   652 967
   013   TOBEY RA              J CELL BIOL                     46   151 970
   014   TOLIVER A             EXP CELL RES                    53   506 968
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   YOKOYAMA M            PEDIATR RES                     11   765 977
     3   GROSS S               CLIN CHEM                       23   299 977
     4   BARRANCO SC           J NATL CANCER INST              59  1685 977
     5   EPSTEIN J             PROC NAT ACAD SCI USA           74  1676 977
     6   KATZ S                RES COMMUN CHEM PATH PHARM      19   491 978
     7   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     8   ROSCHER AA            PEDIATR RES                     14   261 980
     9   KATZ S                CLIN CHIM ACTA                 100   245 980
    10   THOMPSON KVA          GERONTOLOGY                     29    97 983

PN 76100
RN 00454 
AN 77071904
AU Tannenbaum-P-J.  Posner-A-S.  Mandel-I-D.
TI Formation of calcium phosphates in saliva and dental plaque.
SO J-Dent-Res. 1976 Nov-Dec. 55(6). P 997-1000.
MJ CALCIUM-PHOSPHATES: an.  DENTAL-PLAQUE: an.  HYDROXYAPATITES: an.
   SALIVA: an.
MN ADOLESCENCE.  ADULT.  ASTHMA: me.  CALCIUM-CARBONATE: an.  CHILD.
   CYSTIC-FIBROSIS: me.  DENTAL-CALCULUS: an.  HUMAN.
   SUPPORT-U-S-GOVT-P-H-S.
AB This is an X-ray diffraction study of the mineral phases in saliva
   and early dental plaque. The salivas studied came from patients with
   cystic fibrosis (CF), those with asthma, and heavy and light calculus
   formers. One-week old plaque was studied from individuals who are
   heavy, moderate, and light calculus formers.
RF 001   CHERNICK WS           J PEDIATR                       59   890 961
   002   MANDEL ID             CLIN PEDIATR                     8   161 969
   003   BLOMFIELD J           ARCH DIS CHILD                  48   267 973
   004   GUGLER EC             J PEDIATR                       71   585 967
   005   BOAT TF               PEDIATR RES                      8   531 974
   006   WARTON KL             BR MED J                         3   570 971
   007   BLOMFIELD J           ARCH ORAL BIOL                  19  1153 974
   008   BERTHOLD H            DTSCH ZAHNAERNTZL Z             25     7 970
   009   JENSEN TA             J DENT RES                      33   741 973
   010   KAUFMAN HW            CALC TISS RES                   11    97 973
   011   LEGEROS RI            J DENT RES                      53    45 974
   012   SCHROEDER HE          ARCH ORAL BIOL                  11     1 966
   013   ROWLES SL             IN: BLACKWOOD HJJ                    176 973
   014   MANDEL ID             J PERIODONT RES                  9   211 974
   015   ROWLES SL             DENT PRACTIT DENT RES           15     2 964
   016   WESTERDEN EM          J DENT RES                      37   749 958
   017   HAY DI                ARCH ORAL BIOL                  12   937 967
CT   1   DRIESSENS FCM         J BIOL BUCCALE                   8   239 980
     2   MANDEL ID             CRC CRIT REV CLIN LAB SCI       12   321 980

PN 76101
RN 00455 
AN 77071903
AU Jagels-A-E.  Sweeney-E-A.
TI Oral health of patients with cystic fibrosis and their siblings.
SO J-Dent-Res. 1976 Nov-Dec. 55(6). P 991-6.
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: dt.  ORAL-HEALTH.
   PANCREATIN:  tu.
MN CHILD.  CHILD-PRESCHOOL.  COMPARATIVE-STUDY.  DENTAL-CARIES: et.
   FEMALE.  HUMAN.  MALE.  ORAL-HYGIENE.  TETRACYCLINE: ae.
   TOOTH-DISCOLORATION: et.  SUPPORT-U-S-GOVT-P-H-S.
AB Caries prevalence, oral hygiene index, submandibular gland
   hypertrophy, occlusion, dental hypoplasia, and staining of permanent
   teeth were evaluated in 63 patients with cystic fibrosis (CF) who
   were maintained on a regimen of broad-spectrum antibiotics and oral
   pancreatin, and the findings were compared with those of their near-
   aged siblings. Gland hypertrophy and dental staining were increased
   in patients with CF whereas caries was significantly decreased. No
   other significant differences were found.
RF 001   SHWACHMAN H           PEDIATRICS                      46   335 970
   002   SHWACHMAN H           PEDIATR CLIN NORTH AM            3   295 956
   003   SHWACHMAN H           ANTIBIOT ANN                         692 958
   004   ZEGARELLI EV          ORAL SURG                       24    62 967
   005   YULE A                AUST DENT J                     15   519 970
   006   SWALLOW JN            ARCH DIS CHILD                  42   311 967
   007   SHWACHMAN H           MOD PROBL PEDIATR               10   158 967
   008   KNUTSON J             PUBLIC HEALTH REP               59   253 944
   009   GRUEBBEL A            J DENT RES                      23   163 944
   010   GREENE JC             JADA                            68    25 964
   011   HANDELMAN S           J ORAL THER                      2   338 966
   012   LITTLETON N           JADA                            68   520 964
   013   WELLS H               AM J PHYSIOL                   208   877 965
   014   SWEENEY EA            J DENT RES                      44   973 964
   015   MANGOS JA             J PEDIATR                       74   823 969
   016   BAUMHAMMERS A         ARCH ORAL BIOL                  13   353 968
   017   JENSEN AL             JADA                            59   923 959
   018   ENNEVER J             J PERIODONTOL                   32   331 961
   019   PORTER PJ             ANTIMICROB AGENTS CHEMOTHER      5   668 965
CT   1   FISCHER EG            J PEDIATR                       95   385 979
     2   PRIMOSCH RE           ORAL SURG                       50   301 980
     3   MAHANEY MC            ARCH ORAL BIOL                  31   363 986

PN 76102
RN 00456 
AN 77208522
AU Baylis-J-M.
TI Experiences in a paediatric gastroenterology clinic.
SO J-Hum-Nutr. 1976 Oct. 30(5). P 327-32.
MJ DIETETICS.  GASTROINTESTINAL-DISEASES: dh.
MN CARBOHYDRATE-METABOLISM-INBORN-ERRORS: dh.  CELIAC-DISEASE: dh.
   CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: dh.  ENGLAND.  FEMALE.
   GASTROINTESTINAL-DISEASES: et.  GLUTEN: ae.
   OUTPATIENT-CLINICS-HOSPITAL.  HUMAN.  MILK: ae.  PEDIATRICS.
EX The Paediatric Gastroenterology Clinic at this hospital was started
   to follow children with gastroenterological problems after discharge
   from hospital and in particular to monitor their clinical and dietary
   progress.  Other dietitians who see an opening for this work in their
   hospitals may find our experiences to be of interest.  Gluten-free
   diets, cow's milk free diets, sugar intolerance, cystic fibrosis, and
   non-specific cases are discussed.
RF 001   BAKER PG              BR MED J                         1   486 975
   002   CUNNINGHAM K          NUTRITION                       27    23 973
   003   FRANCIS DEM           DIETS FOR SICK CHILDREN                  974
   004   KUITUNEN P            ARCH DIS CHILD                  50   351 975
   005   TANNER JM             IN: HOLZER A                             958

PN 76103
RN 00457 
AN 77007715
AU Wright-P-F.  Khaw-K-T.  Oxman-M-N.  Shwachman-H.
TI Evaluation of the safety of amantadine-HC1 and the role of
   respiratory viral infections in children with cystic fibrosis.
SO J-Infect-Dis. 1976 Aug. 134(2). P 144-9.
MJ AMANTADINE: tu.  CYSTIC-FIBROSIS: co.  INFLUENZA: pc.
   RESPIRATORY-TRACT-INFECTIONS: pc.  VIRUS-DISEASES: pc.
MN ADOLESCENCE.  ADULT.  AMANTADINE: ae.  CHILD.  CHILD-PRESCHOOL.
   CLINICAL-TRIALS.  FEMALE.  HUMAN.  INFANT.  MALE.  PLACEBOS.
   RESPIRATORY-TRACT-INFECTIONS: et.  SUPPORT-U-S-GOVT-P-H-S.
   VIRUS-DISEASES: et.
AB Amantadine-HC1, an antiviral drug clinically effective against most
   strains of influenza A virus, was evaluated in a double-blind trial
   in 153 children with cystic fibrosis during the initial appearance of
   influenza A/England/42 virus in the New England area. Infection with
   this variant strain of influenza virus did not reach epidemic
   proportions during the study, so that the effectiveness of amantadine
   in this study population could not be fully assessed. However, the
   potential symptomatic and biochemical toxicity of amantadine was
   carefully monitored in a pediatric population. Serologic screening by
   complement fixation tests indicated that respiratory viruses may be
   important pathogens in exacerbations of respiratory disease in
   patients with cystic fibrosis.
RF 001   DAVIES WL             SCIENCE                        144   862 964
   002   TOGO Y                JAMA                           203  1089 968
   003   SMORODINSTSEV AA      JAMA                           213  1448 970
   004   WINGFIELD WL          N ENGL J MED                   281   579 969
   005   ANON                  AAP COMMITTEE INFECT DIS REPT        140 974
   006   QUILLIGAN JJ JR       J PEDIATR                       69   572 969
   007   ANON                  RECOMMENDED METHOD FOR THE US            971
   008   SEVER JL              J IMMUNOL                       88   320 962
   009   BIANDRATE P           J CHROMATOGR                    74    31 972
   010   ANON                  INFLUENZA RESPIRATORY DISEASE            974
   011   KATTWINKEL J          J PEDIATR                       82   234 973
   012   BLEIDNER WE           J PHARMACOL EXP THER           150   484 965
   013   MCLAREN C             LANCET                           1  1157 973
   014   CHANOCK RM            JAMA                           176   647 961
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   TERMEULEN V           MONATSSCHR KINDERHEILKD        127   367 979
     3   GLEZEN WP             REV INFECT DIS                   2   408 980
     4   BECKER Y              PROG MED VIROL                  26     1 980
     5   FISHAUT M             AM J DIS CHILD                 134   321 980
     6   FEIGELSON J           NOUV PRESSE MED                 10   955 981
     7   HALL CB               AM J MED                        70   670 981
     8   PETERSEN NT           ACTA PAEDIATR SCAND             70   623 981
     9   GLEZEN WP             PEDIATR RES                     17  1029 983
    10   AMBROSINI PJ          J CLIN PSYCHOPHARMACOL           4   223 984
    11   EFTHIMIOU J           THORAX                          39   150 984
    12   WANG EEL              N ENGL J MED                   311  1653 984
    13   MISCHLER EH           SEM RESPIR MED                   6   271 985
    14   SHIELDS WD            NEUROLOGY                       35   579 985
    15   FRIEND PA             J INFECT                        13    55 986
    16   STROOBANT J           J ROY SOC MED                   79    19 986
    17   WANG EEL              PEDIATR INFECT DIS J             6   256 987
    18   THOMPSON J            J MED VIROL                     21   249 987

PN 76104
RN 00458 
AN 77007743
AU Crozier-D-N.  Khan-S-R.
TI Tobramycin in treatment of infections due to Pseudomonas aeruginosa
   in patients with cystic fibrosis.
SO J-Infect-Dis. 1976 Aug. 134 Suppl. P S187-90.
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: co.  PSEUDOMONAS-INFECTIONS: dt.
   TOBRAMYCIN: tu.
MN ADOLESCENCE.  ADULT.  CHILD.  CHRONIC-DISEASE.  FEMALE.  HUMAN.
   LUNG-DISEASES: dt.  MALE.  PSEUDOMONAS-AERUGINOSA.
   PSEUDOMONAS-INFECTIONS: co.  TOBRAMYCIN: pd.
AB The effectiveness and safety of tobramycin against infections due to
   Pseudomonas aeruginosa in patients with cystic fibrosis were studied
   in 15 patients with moderate-to-severe exacerbation of chronic
   pulmonary infection. Seventeen courses of treatment were given.
   Tobramycin (5-7.5 mg/kg per day) was administered intravenously in
   three divided doses per day (seven to 21 days). All specimens of
   sputum yielded moderate-to-heavy growth of P. aeruginosa; all
   isolates were inhibited by 4 mug of tobramycin/ml, and in seven cases
   isolates were not inhibited by 4 mug of gentamicin/ml. The mean
   levels of tobramycin in the blood were 4.4 mug/ml 0.5-1 hr and 0.8
   mug/ml 7.5-8 hr after administration. All patients received an
   antistaphylococcal agent before, during, and after therapy. All
   patients except for two received 750 mg of carbenicillin/kg per day
   intravenously in six divided doses and 1 g of carbenicillin in a mask
   for inhalation three times a day. Both clinical and radiological
   improvement was noted in all patients. The white blood cell count,
   which was elevated in seven patients, returned to normal, and levels
   of blood gases improved. P. aeruginosa was eliminated from the sputum
   in five cases. No adverse side effects were noted.
RF 001   PRESTON DA            ANTIMICROB AGENTS CHEMOTHER     11   322 971
   002   ANON                  TOBRAMYCIN PRODUCT MONOGRAPH             975
CT   1   NEU HC                MED J AUST                       2    13 977
     2   CIPOLLE RJ            THER DRUG MONITOR                2   359 980
     3   MARTIN AJ             ARCH DIS CHILD                  55   604 980
     4   HYATT AC              J PEDIATR                       99   307 981
     5   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
     6   HOOGKAMPKORSTANJE JAA J ANTIMICROB CHEMOTHER          12   175 983
     7   MENDELMAN PM          AM REV RESPIR DIS              132   761 985
     8   PEDERSEN SS           ANTIMICROB AGENTS CHEMOTHER     31   594 987

PN 76105
RN 00459 
AN 77007744
AU McCrae-W-M.  Raeburn-J-A.  Hanson-E-J.
TI Tobramycin therapy of infections due to Pseudomonas aeruginosa in
   patients with cystic fibrosis: effect of dosage and concentration of
   antibiotic in sputum.
SO J-Infect-Dis. 1976 Aug. 134 Suppl. P S191-3.
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: co.  PSEUDOMONAS-INFECTIONS: dt.
   SPUTUM: me.  TOBRAMYCIN: tu.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  HUMAN.  INFANT.
   PSEUDOMONAS-INFECTIONS: co.  TOBRAMYCIN: ad, me.
AB Established respiratory infections with mucoid Pseudomonas aeruginosa
   in patients suffering from cystic fibrosis were treated with
   conventional as well as larger doses of tobramycin. The infection was
   eradicated in four of the 17 patients treated, but the duration of
   follow-up study of one patient was short. It appeared that treatment
   was most successful in those patients in whom the highest peak
   concentrations of tobramycin in sputum were obtained. No side effects
   were noted, even when tobramycin was given in large doses for two
   weeks.
RF 001   WARWICK WJ            IN: LAWSON D PROC 5TH INT CF         320 969
   002   MCCRAE WM             IN: APLEY J                      4   157 974
   003   WOOD RE               GAP CONF REP PSEUDOMON IN CF           4 974
   004   MARKS MI              J PEDIATR                       79   822 971
   005   HUANG NN              J PEDIATR                       78   338 971
   006   HAWLEY HB             CURR THER RES                   16   414 974
   007   RAEBURN JA            POSTGRAD MED J                  47   366 971
   008   RAEBURN JA            SCAND J INFECT DIS               5   135 973
CT   1   NEU HC                MED J AUST                       2    13 977
     2   GOVAN JRW             J ANTIMICROB CHEMOTHER           4   233 978
     3   NEU HC                INFECTION                        8  S 62 980
     4   MARTIN AJ             ARCH DIS CHILD                  55   604 980
     5   WIENTZEN R            AM J DIS CHILD                 134  1134 980
     6   THYS JP               J ANTIMICROB CHEMOTHER           8    29 981
     7   MOMBELLI G            ANTIMICROB AGENTS CHEMOTHER     19    72 981
     8   VAKOUTIS J            AM J HOSP PHARM                 38  1477 981
     9   MOMBELLI G            SCHWEIZ MED WOCHENSCHR         111   123 981
    10   MALMBORG AS           SCAND J INFECT DIS            1981    64 981
    11   RIFF L                SEM PERINATOL                    6   155 982
    12   LEVY J                J ANTIMICROB CHEMOTHER          10   227 982
    13   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
    14   HODSON ME             BR J DIS CHEST                  77    71 983
    15   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984
    16   KUHN RJ               CLIN PHARMACY                    4   555 985
    17   CHRYSTYN H            J CLIN HOSP PHARM               10   219 985
    18   FRASER GL             DRUG INTEL CLIN PHARM           19   757 985
    19   CONWAY SP             ACTA PAEDIATR SCAND             74   107 985
    20   HORREVORTS AM         CHEST                           88   260 985
    21   MOMBELLI G            SCHWEIZ MED WOCHENSCHR         115    93 985
    22   MENDELMAN PM          AM REV RESPIR DIS              132   761 985
    23   MARLIN GE             AM REV RESPIR DIS              134  1209 986
    24   PEDERSEN SS           ANTIMICROB AGENTS CHEMOTHER     31   594 987

PN 76106
RN 00460 
AN 77007745
AU Parry-M-F.  Neu-H-C.
TI Tobramycin and ticarcillin therapy for exacerbations of pulmonary
   disease in patients with cystic fibrosis.
SO J-Infect-Dis. 1976 Aug. 134 Suppl. P S194-7.
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: co.  LUNG-DISEASES: dt.
   PENICILLINS: tu.  PSEUDOMONAS-INFECTIONS: dt.  TICARCILLIN: tu.
   TOBRAMYCIN: tu.
MN ADOLESCENCE.  ADULT.  CHILD.  DRUG-THERAPY-COMBINATION.  FEMALE.
   HUMAN.  MALE.  PSEUDOMONAS-AERUGINOSA: de.  TICARCILLIN: pd.
   TOBRAMYCIN: pd.
AB Patients who had cystic fibrosis and acute infectious exacerbations
   of pulmonary disease produced by Pseudomonas aeruginosa were treated
   with a combination of tobramycin and ticarcillin. P. aeruginosa
   recovered from patients was inhibited by lower concentrations of both
   of these drugs than of gentamicin or carbenicillin. Thirteen courses
   of treatment were administered to 11 patients (mean, 14.4 days). A
   favorable response was seen in 11 of 12 completed courses of
   treatment. Improvement was associated with decreases in white blood
   cell count, temperature, and sedimentation rate. Adverse reactions
   were uncommon. Although P. aeruginosa was not eradicated from the
   sputum, the clinical results suggest that the combination of
   tobramycin and ticarcillin may be particularly useful for treatment
   of acute exacerbations of pulmonary disease in patients with cystic
   fibrosis from whom P. aeruginosa is isolated.
RF 001   MAY JR                ARCH DIS CHILD                  47   908 972
   002   HUANG NN              J PEDIATR                       78   338 971
   003   MARKS MI              J PEDIATR                       79   822 971
   004   KLASTERSKY J          CLIN PHARMACOL THER             14   104 973
   005   HAWLEY HB             CURR THER RES                   16   414 974
   006   NEU HC                ANTIMICROB AGENTS CHEMOTHER     10   385 970
   008   BAUER AW              AM J CLIN PATHOL                45   493 966
   009   NEU HC                APPL MICROBIOL                  21    66 971
   010   SHWACHMAN H           AM J DIS CHILD                  96     6 958
CT   1   CIPOLLE RJ            THER DRUG MONITOR                2   359 980
     2   NEU HC                INFECTION                        8  S 62 980
     3   PRINCE AS             J PEDIATR                       97   148 980
     4   HYATT AC              J PEDIATR                       99   307 981
     5   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
     6   SZAFF M               ACTA PAEDIATR SCAND             72   651 983
     7   FRASER GL             DRUG INTEL CLIN PHARM           19   757 985
     8   CONWAY SP             ACTA PAEDIATR SCAND             74   107 985
     9   HORREVORTS AM         CHEST                           88   260 985
    10   JEWETT CV             J PEDIATR                      106   669 985

PN 76107
RN 00461 
AN 76216212
AU Lorin-M-I.  Gaerlan-P-F.  Mandel-I-D.  Denning-C-R.
TI Composition of nasal secretion in patients with cystic fibrosis.
SO J-Lab-Clin-Med. 1976 Jul. 88(1). P 114-7.
MJ CYSTIC-FIBROSIS: me.  MUCUS: an.  NASAL-MUCOSA: se.
MN ADOLESCENCE.  ADULT.  ALBUMINS: an.  CHILD.  HUMAN.  IGA: an.
   IGG:  an.  PHOSPHATES: an.  POTASSIUM: an.  PROTEINS: an.  SODIUM: an.
   SUPPORT-U-S-GOVT-P-H-S.
AB Quantitative examination of nasal secretion in patients with cystic
   fibrosis revealed a significantly greater than normal concentration
   of calcium, a finding in keeping with the hypothesized importance of
   this ion in the pathophysiology of the disease.
RF 001   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   002   SHWACHMAN H           IN: KENDIG EL JR                 1   524 972
   003   GIBSON LE             PEDIATRICS                      23   545 959
   004   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   005   EMRICH HM             MOD PROBL PEDIATR               10    58 967
   006   GUGLER EC             MOD PROBL PEDIATR               10    95 967
   007   MANDEL ID             AM J DIS CHILD                 113   431 967
   008   WOTMAN S              ARCH ORAL BIOL                  16   663 971
   009   GUGLER EC             J PEDIATR                       71   585 967
   010   GIBSON LE             PEDIATRICS                      48   695 971
   011   CHERNICK WS           PEDIATRICS                      24   739 959
   012   MATTHEWS LW           AM REV RESPIR DIS               88   199 963
   013   TREMBLE GE            LARYNGOSCOPE                    59   639 949
   014   LORIN MI              J LAB CLIN MED                  80   275 972
   015   CHEN PS               ANAL CHEM                       28  1756 956
   016   FOLIN O               J BIOL CHEM                     73   627 927
   017   HEIDELBERGER M        SCIENCE                         97   405 943
   018   MANCINI G             IMMUNOCHEMISTRY                  2   235 965
   019   GRIFO S               PRACT OTORHINOLARYNGOL          33   394 971

PN 76108
RN 00462 
AN 76096193
AU Wolf-R-O.  Taussig-L-M.  Ross-M-E.  Wood-R-E.
TI Quantitative evaluation of serum pancreatic isoamylases in cystic
   fibrosis.
SO J-Lab-Clin-Med. 1976 Jan. 87(1). P 164-8.
MJ CYSTIC-FIBROSIS: en.  GLYCOSIDE-HYDROLASES: bl.  ISOAMYLASE: bl.
   PANCREAS: en.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: bl, co.  HUMAN.  INFANT.  INFANT-NEWBORN.
   ISOAMYLASE: an.  PANCREATIC-DISEASES: en, co, bl.  SALIVARY-GLANDS: en.
AB The amylase in sera of 20 patients with cystic fibrosis of the
   pancreas (CFP), 17 of whom had pancreatic insufficiency (PI), and of
   34 normal control subjects was separated into its pancreatic and
   salivary components and quantitated. Electrophoretic separation was
   achieved on polyacrylamide disc gels with subsequent sectioning of
   the gel columns. The amylase content in international units per liter
   (IU/L.) was obtained for each section by the insoluble blue starch
   substrate method. The mean total serum amylase of the CFP patients
   with PI was significantly lower than the control group. A highly
   significant decrease was found when the pancreatic isoamylase was
   considered alone. The salivary isoamylase level remained essentially
   the same. Three patients with CFP but without PI demonstrated higher
   than normal pancreatic amylase values in the serum. These patients
   may be in an early stage of a progressive involvement of the pancreas
   in which there is an increased release of amylase. This method of
   electrophoretic separation and quantitation of the serum amylase is
   sensitive and efficient and allows the simultaneous processing of
   multiple specimens. The results obtained agree with previously
   published ratios of serum isoamylases. Our method should be valuable
   in the study of other diseases of the exocrine pancreas and salivary
   glands.
RF 001   TAUSSIG LM            PEDIATRICS                      54   229 974
   002   WOLF RO               AM J CLIN PATHOL                54   214 970
   003   ROSS ME               J LAB CLIN MED                  83   750 974
   004   WOLF RO               AM J CLIN PATHOL                49   871 968
   005   FRIDHANDLER L         CLIN CHEM                       18  1493 972
   006   KAMARYT J             CESK PEDIATR                    25    78 970
   008   MELNYCK A             CAN J MED TECHNOL               35     8 973
CT   1   WOLF RO               AM J CLIN PATHOL                65  1022 976
     2   MERRITT AD            ADV HUM GENET                    8   135 977
     3   OTSUKI M              EUR J PEDIATR                  125   175 977
     4   DAVIDSON GP           PEDIATR RES                     12   967 978
     5   GILLARD BK            PEDIATR RES                     12   868 978
     6   HUBBARD VS            J PEDIATR                       92   685 978
     7   FORSTNER GG           PEDIATR RES                     13  1077 979
     8   WOLF RO               PEDIATR RES                     13  1076 979
     9   GILLARD BK            CLIN CHEM                       25  1919 979
    10   WOOD RE               SOUTH MED J                     72   189 979
    11   GILLARD BK            PEDIATR RES                     14  1168 980
    12   WOLF RO               PEDIATR RES                     14   968 980
    13   TARNOKY AL            J ROY SOC MED                   73    73 980
    14   PARK RW               GASTROENTEROLOGY                81  1143 981
    15   TOBIN MJ              IR J MED SCI                   150   325 981
    16   STERN RC              LANCET                           1  1401 982
    17   TSIANOS EB            LANCET                           1   856 982
    18   BROWN RC              J CLIN PATHOL                   35   547 982
    19   STERN RC              GASTROENTEROLOGY                82   707 982
    20   TSIANOS EB            CLIN CHIM ACTA                 124    13 982
    21   MASARYK TJ            DIG DIS SCI                     28   874 983
    22   MATTHEWS LW           PEDIATR CLIN NORTH AM           31   133 984
    23   GILLARD BK            AM J DIS CHILD                 138   577 984
    24   MAILLIE AJ            SCAND J GASTROENTEROL           21   941 986
    25   WOLF RO               CLIN CHEM                       32   296 986

PN 76109
RN 00463 
AN 76263347
AU Barton-A-D.  Ryder-K.  Lourenco-R-V.  Dralle-W.  Weiss-S-G.
TI Inflammatory reaction and airway damage in cystic fibrosis.
SO J-Lab-Clin-Med. 1976 Sep. 88(3). P 423-6.
MJ BRONCHIECTASIS: pa.  BRONCHITIS: pa.  CYSTIC-FIBROSIS: pa.
MN BRONCHI: pa.  CHRONIC-DISEASE.  DNA: an.  EPITHELIUM: pa.
   GAMMA-GLUTAMYLTRANSFERASE: an.  HUMAN.  LEUKOCYTES: pa.  SPUTUM: an.
   SUPPORT-U-S-GOVT-P-H-S.
AB In cystic fibrosis there is chronic infection and inflammatory
   reaction in the airways, accompanied by destruction and shedding of
   airway epithelium. Leukocytes migrate into the airways and some
   disintegrate, liberating deoxyribonucleoprotein that is incorporated
   into the gel structure of the bronchial mucus. We compared the status
   of these processes in cystic fibrosis with that in chronic bronchitis
   and bronchiectasis, by examining the sputum raised from the lower
   airways. Measurements also were made on sputum induced in normal
   subjects. The results indicate that migration of leukocytes into the
   airways and shedding of damaged airway epithelium were minimal in the
   normal subjects; they were significant in the patients with chronic
   bronchitis, higher in those with bronchiectasis, and still higher in
   those with cystic fibrosis. The large increases found in the total
   content of DNA and solids in the cystic fibrosis sputum were due to
   increases in the insoluble fraction containing the whole leukocytes
   and particulate debris that remained when the sputum mucus gel was
   solubilized with mercaptoethanol. Despite the large increases in the
   total content of DNA and solids, the contents of mucus gel components
   and of deoxyribonucleoprotein from disintegrated leukocytes actually
   present in the mucus gel structure of the cystic fibrosis sputum were
   not significantly higher than in the sputum from the patients with
   chronic bronchitis or brochiectasis.
RF 001   PECORA DV             N ENGL J MED                   258    71 958
   002   WHITE JR              IN: COPLEY A                         259 960
   003   ANON                  AM REV RESPIR DIS               85   762 962
   004   DI SANTAGNESE PA      IN: VAUGHAN VC III                   903 975
   005   HAVEZ R               CLIN CHIM ACTA                  17   281 967
   006   BURTON K              BIOCHEM J                       62   315 956
   007   BARTON AD             PROC SOC EXP BIOL MED          146    99 974
   008   PUCHELLE E            BULL PHYSIOPATH RESPIR NANCY     9   237 973
   009   LOPATA M              AM REV RESPIR DIS              110   730 974
   010   HAVEZ R               EXP ANNU BIOCHIM MED            32   121 973
   011   MACKAY M              EXP CELL RES                    49   533 968
   012   CHERNICK WS           PEDIATRICS                      24   739 959
   013   MATTHEWS LW           AM REV RESPIR DIS               88   199 963
   014   GLENNER GG            J HISTOCHEM CYTOCHEM            10   481 962
   015   CROFTON J             RESPIRATORY DISEASES                     969
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   WANNER A              AM REV RESPIR DIS              116    73 977
     3   BARTON AD             PROC SOC EXP BIOL MED          156     8 977
     4   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     5   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
     6   WILSON GB             J CLIN INVEST                   68   171 981
     7   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982
     8   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
     9   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985

PN 76110
RN 00464 
AN 77121095
AU Goodchild-M-C.  Edwards-J-H.  Glenn-K-P.  Grindey-C.  Harris-R.
   Mackintosh-P.  Wentzel-J.
TI A search for linkage in cystic fibrosis.
SO J-Med-Genet. 1976 Dec. 13(6). P 417-9.
MJ CYSTIC-FIBROSIS: fg.  LINKAGE-GENETICS.
MN CHILD.  HUMAN.
AB Linkage between the locus for cystic fibrosis and other genetic
   markers was explored in 40 families from Birmingham and 20 from
   Manchester. No strong evidence was found for linkage with any of the
   markers examined. There was evidence against close linkage with ABO,
   HLA, and Rh.
RF 001   CARTER CO             IN: BODIAN M                          49 952
   002$  CHAUTARD-FREIRE-MAIA  ANN HUM GENET                   38   191 974
   003   DANKS DM              ANN HUM GENET                   28   323 965
   004   EDWARDS JH            CLIN GENET                       3   371 972
   005   EDWARDS JH            HISTOCOMPATIBILITY TESTING               972
   006   FELLOUS M             C R ACAD SCI (D)(PARIS)        272  3356 971
   007   GOODCHILD MC          ARCH DIS CHILD                  48   684 973
   008   LAMM LU               ANN HUM GENET                   38   383 975
   009   MORTON NE             AM J HUM GENET                   7   277 955
   010   POLYMENIDIS Z         LANCET                           2  1452 973
   011   STEINBERG AG          AM J HUM GENET                   8   177 956
   012   STEINBERG AG          AM J HUM GENET                   8   162 956
   013   TERASAKI PI           NATURE                         204   998 964
   014   WRIGHT SW             AM J HUM GENET                  20   157 968
CT   1   SAFWENBERG J          TISSUE ANTIGENS                 10   287 977
     2   HERROD HG             J PEDIATR                       94   676 979
     3   TACIEREUGSTER H       HELV PAEDIATR ACTA              35    31 980
     4   BOWMAN BH             HUM HERED                       31   248 981
     5   EDWARDS JH            LANCET                           1  1020 984
     6   ANON                  LANCET                           2   249 985
     7   EIBERG H              CLIN GENET                      27   206 985
     8   EIBERG H              CLIN GENET                      28   265 985
     9   POVEY S               CYTOGENET CELL GENET            40    67 985
    10   SCAMBLER  P           HUM GENET                       69   250 985
    11   RUSH PJ               SEM ARTHRITIS RHEUM             15   213 986
    12   MOSS RB               MONOGR ALLERGY                  19   202 986
    13   SCHMIEGELOW K         CLIN GENET                      29   374 986
    14   FARRALL M             AM J HUM GENET                  38    75 986
    15   SCAMBLER PJ           AM J HUM GENET                  38   567 986
    16   SCAMBLER  PJ          CYTOGENET CELL GENET            41    62 986

PN 76111
RN 00465 
AN 76145694
TI Report of the committe for a study for evaluation of testing for
   cystic fibrosis.
SO J-Pediatr. 1976 Apr. 88(4 Pt 2). P 711-50. (REVIEW).
MJ CYSTIC-FIBROSIS: di.
MN ADULT.  CHILD.  CYSTIC-FIBROSIS: fg, me.  DUODENUM: an.  FEMALE.
   FINANCING-GOVERNMENT.  FINANCING-ORGANIZED.  GENETIC-COUNSELING.
   HUMAN.  INFANT-NEWBORN.  METHODS.  MUCINS: me.  MUCOUS-MEMBRANE: me.
   PANCREAS: me.  PANCREATIC-JUICE: an.  PREGNANCY.  PRENATAL-DIAGNOSIS.
   PROTEINS: me.  RESEARCH.  REVIEW.  SODIUM-CHLORIDE: an.
   SWEAT-GLANDS: me.  SWEAT: an.  SUPPORT-U-S-GOVT-P-H-S.
   UNITED-STATES.
EX The Committee for a Study for Evaluation of Testing for Cystic
   Fibrosis was established in August 1974 to assess the reliability of
   the data on cystic fibrosis "factors" in serum and exocrine
   secretions and in cell culture; evaluate the role of the cystic
   fibrosis "factors" in the detection of the heterozygote and in the
   diagnosis of cystic fibrosis in the homozygote in utero, during the
   neonatal period, and thereafter; evaluate the various screening tests
   for the diagnosis of cystic fibrosis in the newborn infant that have
   been proposed in this country and abroad, about which there is
   considerable controversy; and evaluate the sweat test, which as
   currently performed leads to diagnostic errors, both positive and
   negative.  Section 1 of this report presents what is known about the
   clinical aspects of cystic fibrosis; Section 2 summarizes the diverse
   facets of research in cystic fibrosis, including the sources of its
   support; and Section 3 is a critical analysis of the state of the art
   for testing for cystic fibrosis.  Section 4 comprises the Committee's
   recommendations, which it is hoped will be of use to both clinicians
   and researchers in the various settings where cystic fibrosis is
   diagnosed, treated, and studied.
RF 001   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   002   HALLETT WY            AM REV RESPIR DIS               92   714 965
   003   KNUDSON AG JR         AM J HUM GENET                  19   388 967
   005   CORNET JM             IN: BARNETT HL                      1208 972
   006   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   007   SHWACHMAN H           PEDIATRICS                      36   689 965
   008   DI SANTAGNESE PA      MOD PROBL PEDIATR               10   135 967
   009   SHWACHMAN H           PEDIATRICS                      46   335 970
   010   SHWACHMAN H           HOSP PRACT                       9   143 974
   011   ANON                  CF FND 1973 REP SURVI STUD PA            975
   012   DISCHE Z              PEDIATRICS                      24    74 959
   013   JOHANSEN PG           BIOCHEM J                       87    63 963
   014   KOPITO LE             FERTIL STERIL                   24   512 973
   015   BOAT TF               AM REV RESPIR DIS              110   428 974
   016   SPOCK A               PEDIATR RES                      1   173 967
   017   SANCHIS J             N ENGL J MED                   288   651 973
   018   ROSSMAN CM            PEDIATR RES                      8   469 974
   019   QUINLAN MF            AM REV RESPIR DIS               99    13 969
   020   YEATES DB             J APPL PHYSIOL                  39   487 975
   022   SACKNER MA            J APPL PHYSIOL                  34   495 973
   023   SANTA CRUZ R          AM REV RESPIR DIS              109   458 974
   024   WOOD RE               AM REV RESPIR DIS              111   733 975
   025   MANGOS JA             PEDIATR RES                      1   436 967
   026   SCHULZ IJ             J CLIN INVEST                   48  1470 969
   027   SIMOPOULOS AP         PEDIATR RES                      5   626 971
   028   MANGOS JA             TEX REP BIOL MED                31   651 973
   029   DI SANTAGNESE PA      IN: DOWNEY JA                         25 974
   030   LEWISTON NJ           CF CLUB ABST                    15    59 974
   031   COHEN FL              J MED GENET                     11   253 974
   032   SMOLLER M             AM J DIS CHILD                  98   277 959
   033   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   034   DANES BS              J EXP MED                      129   775 969
   035   DANES BS              LANCET                           2   765 973
   036   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   038   TAUSSIG LM            LANCET                           1  1367 972
   039   KAISER D              LANCET                           1  1003 970
   040   KAISER D              PEDIATR RES                      5   167 971
   041   BROWN GA              LANCET                           2   639 971
   042   LOBECK CC             IN: STANBURY JB                     1605 972
   043   KAISER D              IN: MANGOS JA                        247 973
   044   TAYLOR A              PEDIATR RES                      8   861 974
   045   LOCKHART LH           TEX REP BIOL MED                31   631 973
   046   CONOVER JH            PEDIATR RES                      7   220 973
   047   CONOVER JH            PEDIATR RES                      7   224 973
   048   BERATIS NG            PEDIATR RES                      7   958 973
   049   CONOVER JH            LIFE SCI                        14   253 974
   050   MANGOS JA             PEDIATR RES                      2   378 968
   051   MANGOS JA             IN: MANGOS JA                        221 973
   052   DOGGETT RG            TEX REP BIOL MED                31   685 973
   054   DANES BS              J EXP MED                      136  1313 972
   055   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   056   SCANLIN TF JR         LANCET                           1  1382 975
   057   POLLEY MJ             J MED GENET                     11   249 974
   059   RAO GJS               J PEDIATR                       80   573 972
   060   RAO GJS               SCIENCE                        177   610 972
   061   RAO GJS               PEDIATR RES                      8   684 974
   063   HATHAWAY WE           BLOOD                           26   521 965
   064   HATTERSLEY PG         BR J HAEMATOL                   18   411 970
   066   WILSON GB             CF CLUB ABST                    15     1 974
   067   WILSON GB             PEDIATR RES                      9   635 975
   068   RENNERT OM            PEDIATRICS                      50   485 972
   069   RENNERT OM            IN: MANGOS JA                         41 973
   070   LUNDGREN DW           CF CLUB ABST                    15     2 974
   071   KLAGSBRUN M           IN: MANGOS JA                         53 973
   072   HODES ME              PEDIATR RES                      8   212 974
   073   MCEVOY FA             PEDIATR RES                      9   721 975
   074   COHEN LF              PEDIATR RES                      9   312 975
   075   SCHWERT GW            BIOCHIM BIOPHYS ACTA            16   570 955
   076   HADORN B              J PEDIATR                       73    39 968
   077   LAPEY A               J PEDIATR                       84   328 974
   078   SLEGERS JFG           PFLUEGERS ARCH                 279   265 964
   079   SCHULZ IJ             PFLUEGERS ARCH                 284   360 965
   080   DI SANTAGNESE PA      ANN NY ACAD SCI                 93   555 962
   081   SHWACHMAN H           MOD PROBL PEDIATR               10   158 967
   082   ANON                  GAP CONF REP PROB SWEAT TESTI            975
   083   KOPITO L              PEDIATRICS                      43   794 969
   085   SHWACHMAN H           PEDIATRICS                      32    85 963
   086   SHWACHMAN H           J PEDIATR                       66   432 965
   087   WARWICK WJ            CF CLUB ABST                    16    58 975
   088   BRIMBLECOMBE FSW      LANCET                           2  1428 973
   089   BRAY PT               ARCH DIS CHILD                  48   825 973
   090   GRAND RJ              J PEDIATR                       70   357 967
   091   NADLER HL             LANCET                           2    84 969
   092   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   093   BOLTON WE             AM J HUM GENET                  27   394 975
   094   FARRELL PM            PROC SOC EXP BIOL MED          149   340 975
   095   ANON                  GENETIC SCREENING PROG PRIN A            975
   096   WARWICK WJ            IN: LAWSON D PROC 5TH INT CF         320 969
   097   GEORGE L              ARCH DIS CHILD                  46   139 971
   098   KULCZYCKI LL          AM J DIS CHILD                 127    64 974
   099   WILSON JMG            PUBLIC HEALTH PAPERS            34       968
   100   KOPITO L              N ENGL J MED                   272   504 965
   101   SHWACHMAN H           N ENGL J MED                   255   999 956
   102   KULCZYCKI LL          AM J DIS CHILD                 100   174 960
   103   KOLLBERG H            ACTA PAEDIATR SCAND             63   411 974
   104   HELLSING K            SCAND J CLIN LAB INVEST         33   333 974
   105   STEPHAN U             PEDIATRICS                      55    35 975
   106   LEVY HL               IN: MANGOS JA                        261 973
   107   GREEN MN              PEDIATRICS                      21   635 958
   108   WISER WC              PEDIATRICS                      33   115 964
   109   GREEN MN              PEDIATRICS                      41   989 968
   110   PROSSER R             ARCH DIS CHILD                  49   597 974
   111   KOLLBERG H            ACTA PAEDIATR SCAND             64   477 975
   114   GIAMMONA ST           AM REV RESPIR DIS              102   834 970
   115   ANON                  NIH APPROPR FY 1972 REPORT            34 972
   116   GIBSON LE             PEDIATRICS                      23   545 959
CT   1   RYLEY HC              LANCET                           2   365 976
     2   SANTAGNESE PAD        N ENGL J MED                   295   481 976
     3   TENKATE LP            INT J EPIDEMIOL                  6    23 977
     4   THOMAS JM             PEDIATR RES                     11  1148 977
     5   THOMAS JM             PEDIATR RES                     11   138 977
     6   GOTZ M                PAEDIATR PAEDOL                 12   413 977
     7   ANDORSKY M            AM J DIG DIS                    22    56 977
     8   BRAY PT               CLIN CHIM ACTA                  80   333 977
     9   DESAI N               J PEDIATR                       91   447 977
    10   LYRENE RK             J PEDIATR                       91   681 977
    11   ANON                  LANCET                           2  1032 978
    12   WILSON GB             PEDIATR RES                     12   801 978
    13   BARNES GL             AUST PAEDIATR J                 14    78 978
    14   WARWICK WJ            CLIN CHEM                       24  2050 978
    15   HOLTZMAN NA           PEDIATR CLIN NORTH AM           25   411 978
    16   MILLER WA             SOUTH MED J                     71   201 978
    17   BRESLOW JL            SCIENCE                        201   180 978
    18   SANTAGNESE PAD        AM J MED                        66   121 979
    19   WARWICK WJ            AM J CLIN PATHOL                72   142 979
    20   DAVIDSON AGF          N ENGL J MED                   300  1164 979
    21   DAVIS PB              AM J MED                        69   643 980
    22   RYLEY HC              J CLIN PATHOL                   34   906 981
    23   RYLEY HC              J CLIN PATHOL                   34   179 981
    24   PARK RW               GASTROENTEROLOGY                81  1143 981
    25   SCHWACHMAN H          J PEDIATR                       98   576 981
    26   BRESLOW JL            N ENGL J MED                   304     1 981
    27   LITTLEFIELD JW        N ENGL J MED                   304    44 981
    28   KNOWLES M             N ENGL J MED                   305  1489 981
    29   SORSCHER EJ           LANCET                           1   368 982
    30   STERN RC              LANCET                           1  1401 982
    31   SEALE TW              ANN CLIN LAB SCI                12   415 982
    32   WIESEMANN HG          MONATSSCHR KINDERHEILKD        130    96 982
    33   BONFORTE RJ           LANCET                           1    71 983
    34   WEBSTER HL            CRC CRIT REV CLIN LAB SCI       18   313 983
    35   COURY AJ              CLIN CHEM                       29  1593 983
    36   HANSEN RC             ARCH DERMATOL                  119    51 983
    37   BONFORTE RJ           AM REV RESPIR DIS              127   392 983
    38   DAVIS PB              AM REV RESPIR DIS              128    34 983
    39   MASOERO G             AM J DIS CHILD                 137   167 983
    40   BOUCHER RC            LUNG                           161     1 983
    41   FRANCKX J             HELV PAEDIATR ACTA              39   347 984
    42   DAVIS PB              CHEST                           85   802 984
    43   SCHONI MH             J PEDIATR                      104   691 984
    44   WARWICK WJ            CLIN CHEM                       32   850 986
    45   LITTLEWOOD JM         J ROY SOC MED                   79    55 986
    46   ROBERTS DD            ARCH BIOCHEM BIOPHYS           245   292 986

PN 76112
RN 00466 
AN 76122145
AU Morin-C-L.  Roy-C-C.  Lasalle-R.  Bonin-A.
TI Small bowel mucosal dysfunction in patients with cystic fibrosis.
SO J-Pediatr. 1976 Feb. 88(2). P 213-6.
MJ CYSTIC-FIBROSIS: co.  INTESTINAL-MUCOSA: me.  INTESTINE-SMALL: me.
   MALABSORPTION-SYNDROMES: et.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  CYCLOLEUCINE: me.
   CYSTIC-FIBROSIS: me, en.  DIPEPTIDASES: me.  DISACCHARIDASES: me.
   HUMAN.  INTESTINAL-MUCOSA: en.  INTESTINE-SMALL: en.  LYSINE: me.
   MALABSORPTION-SYNDROMES: me, en.  PHENYLALANINE: me.
   CELIAC-DISEASE:  me, en.
AB Jejunal biopsies were obtained from 37 children with cystic fibrosis,
   16 with gluten-induced enteropathy, and 18 control subjects for the
   following studies: (1) disaccharidase activity, (2) L-ALA-L-Phe
   hydrolase activity, and (3) intestinal uptake of three 14C-labeled
   amino acids. Values were significantly reduced in the three
   determinations in patients with gluten-induced enteropathy as
   compared to control subjects. Lactase and L-ALA-L-Phe hydrolase
   activities were significantly reduced (p less than 0.01) in CF
   patients as compared to control subjects. Definite hypolactasia was
   also observed in 23% of the children with CF. Uptake of lysine was
   normal in CF patients whereas that of phenylalanine and cycloleucine
   was reduced as compared to control subjects. This study suggests an
   intestinal component to the malabsorption of patients with CF.
RF 001   WEBER AM              N ENGL J MED                   289  1001 973
   002   DEREN JJ              N ENGL J MED                   288   949 973
   003   REEMTSMA K            PEDIATRICS                      22   525 958
   004   GIBBONS ISE           LANCET                           1   877 967
   005   ANTONOWICZ I          PEDIATRICS                      42   492 968
   006   LAPEY A               J PEDIATR                       84   328 974
   007   JENSEN SB             ACTA PAEDIATR SCAND             45    70 956
   008   HAINES RD             JAMA                           180  1000 962
   009   SHWACHMAN H           J PEDIATR                       65   645 964
   010   DAHLQVIST A           ANAL BIOCHEM                     7    18 964
   011   HEIZER WD             J CLIN INVEST                   48   210 969
   012   LOWRY OH              J BIOL CHEM                    193   265 951
   013   MORIN CL              J CLIN INVEST                   50  1961 971
   014   THIER SO              J CLIN INVEST                   44   442 965
   015   WINER BJ              STATISTICAL PRIN IN EXP              101 962
   016   WELSH JD              ARCH INTERN MED                120   261 967
   017   NEWCOMER AD           GASTROENTEROLOGY                66   754 974
   018   PLOTKIN GR            N ENGL J MED                   271  1037 964
   019   ARTHUR AB             ARCH DIS CHILD                  41   519 966
   020   DAHLQVIST A           ACTA PAEDIATR SCAND             59   621 970
   021   BERG NO               GASTROENTEROLOGY                59   575 970
   022   DOUGLAS AP            LANCET                           2   491 968
   023   DOUGLAS AP            GUT                             11    15 970
   024   SILK DBA              GUT                             15     1 974
   025   CRAFT IL              GUT                              9   425 968
   026   SCHEDL HP             J CLIN INVEST                   47   417 968
   027   BAYLESS TM            AM J CLIN NUTR                  22   181 969
   028   BEDINE MS             GASTROENTEROLOGY                65   735 973
   029   HEIZER WD             BIOCHIM BIOPHYS ACTA           185   409 969
   030   HEIZER WD             BIOCHIM BIOPHYS ACTA           264   450 972
   031   MATTHEWS DM           GUT                              6   411 965
   032   FREYE HB              J PEDIATR                       64   575 964
   033   DISCHE Z              PEDIATRICS                      24    74 959
CT   1   BUTS JP               UNION MED CAN                  105  1660 976
     2   ROY CC                CLIN GASTROENTEROL               6   377 977
     3   MORIN CL              PEDIATRICS                      60   114 977
     4   MORIN CL              LANCET                           1  1102 979
     5   KAISER D              AKTUEL ERNAHRUNGSMED             4    26 979
     6   HARRIES JT            ARCH DIS CHILD                  54    19 979
     7   BERG NO               ACTA PAEDIATR SCAND             68   275 979
     8   COX KL                J PEDIATR                       94   488 979
     9   ANDRIA G              PEDIATR RES                     14   812 980
    10   MITCHELL EA           AUST PAEDIATR J                 17    89 981
    11   DEBIEVILLE F          ACTA PAEDIATR SCAND             70    33 981
    12   PARK RW               GASTROENTEROLOGY                81  1143 981
    13   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
    14   FONDACARO JD          PEDIATR RES                     16   494 982
    15   AURICCHIO S           J PEDIATR GASTROENTEROL NUTR     2  S304 983
    16   MILLA PJ              GUT                             24   818 983
    17   COLOMBO C             J PEDIATR GASTROENTEROL NUTR     3   556 984
    18   FONDACARO JD          LIFE SCI                        35  1431 984
    19   BERTRAND JM           J PEDIATR                      104    41 984
    20   FRASE LL              GASTROENTEROLOGY                88   478 985
    21   EGGERMONT E           ACTA PAEDIATR SCAND SUPPL 317 1985    16 985
    22   MOORE MC              AM J CLIN NUTR                  44    33 986
    23   PENNY DJ              ARCH DIS CHILD                  61  1127 986
    24   RUBINSTEIN S          PEDIATRICS                      78   473 986
    25   DODGE JA              J ROY SOC MED                   79    27 986

PN 76113
RN 00467 
AN 76122172
AU Boyle-I-R.  di-SantAgnese-P-A.  Sack-S.  Millican-F.  Kulczycki-L-L.
TI Emotional adjustment of adolescents and young adults with cystic
   fibrosis.
SO J-Pediatr. 1976 Feb. 88(2). P 318-26.
MJ CYSTIC-FIBROSIS.  EMOTIONS.  STRESS-PSYCHOLOGICAL.
MN ACTIVITIES-OF-DAILY-LIVING.  ADOLESCENCE.  ADULT.  ATTITUDE-TO-DEATH.
   ATTITUDE.  BODY-IMAGE.  COMMUNICATION.  FEMALE.  HUMAN.
   INTELLIGENCE.  INTERPERSONAL-RELATIONS.  MALE.  PARENTS.
   SEX-MATURATION.
AB Twenty-seven adolescents and young adults with cystic fibrosis were
   studied to evaluate the phychological impact of this chronic illness.
   At first glance, most patients appeared to function adequately on a
   daily basis. However, four sources of psychological stress, leading
   to emotional disturbance, were identified: altered physical
   appearance causing distorted body images and denial of sexuality,
   strained interpersonal relationships resulting in isolation and
   mental strain, conflicts in upbringing, and increased awareness of
   the future and of death. Guidelines for the physician treating these
   young adults and their families include: (1) encouragement for
   greater involvement by the patient's father; (2) assisting the mother
   to find outside interests and to allow more independence to the
   patient; (3) stressing communication about cystic fibrosis within the
   home; (4) emphasizing outside activity for each patient; (5) repeated
   discussions of the patient's concerns while emphasizing his
   strengths; (6) anticipation of problems, specific to cystic fibrosis,
   such as sterility in males; and (7) encouragement of interpatient
   communication.
RF 001   MEYEROWITZ JH         SOC SCI MED                      1   249 967
   002   TURK J                PEDIATRICS                      34    67 964
   003   TROPAUER A            AM J DIS CHILD                 119   424 970
   004   MCCOLLUM AT           J PEDIATR                       77   571 970
   005   KULCZYCKI LL          CLIN PROC CHILD HOSP DC         25   320 969
   006   LAWLER RH             CAN MED ASSOC J                 94  1043 966
   007   CYTRYN L              IN: ANTHONY EJ                        37 973
   008   SPOCK A               NC MED J                        27   426 966
   009   PATTERSON PR          PSYCHOSOCIAL ASPECTS OF CF               973
   010   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   011   TAUSSIG LM            J PEDIATR                       82   380 973
   013   PINKERTON P           DEVELOP MED CHILD NEUROL        12   207 970
   014   MURAWSKI B            DIABETES                        19   259 970
   015   KAUFMAN RV            PEDIATRICS                      48   123 971
   016   CAMPBELL WA           J UROL                         104   930 970
   017   KURTZ R               J CLIN PSYCHOL                  26   149 970
   018   BERNSTEIN DM          AM J PSYCHIATRY                127  1189 971
   019   ABRAM HS              AM J PSYCHIATRY                127  1199 971
   021   AGLE DP               MODERN TREATMENT                 5   111 968
   022   BROWNE JW             AM J ORTHOPSYCHIATRY            30   730 960
   023   MATTSSON A            AM J PSYCHIATRY                122  1349 966
CT   1   HERROD HG             J PEDIATR                       91   276 977
     2   GOLDBERG RT           ARCH PHYS MED REHABIL           60   369 979
     3   STRAUSS GD            AM J DIS CHILD                 133   301 979
     4   ZELTZER L             J PEDIATR                       97   132 980
     5   HUBBARD VS            AM J DIS CHILD                 134   317 980
     6   STRAUSS GD            J CHRON DIS                     34   141 981
     7   BYWATER EM            ARCH DIS CHILD                  56   538 981
     8   DROTAR D              PEDIATRICS                      67   338 981
     9   PARSONS HG            J PEDIATR GASTROENTEROL NUTR     2    44 983
    10   STEINHAUSEN HC        J AM ACAD CHILD PSYCHIAT        22   559 983
    11   FIRTH M               DEVELOP MED CHILD NEUROL        25   466 983
    12   WELLS AL              J FOOD NUTR                     41    65 984
    13   COWEN L               PSYCHOSOM MED                   46   363 984
    14   DEWET B               S AFR MED J                     65   526 984
    15   LANDON C              AM J DIS CHILD                 138   388 984
    16   SIMMONS RJ            PSYCHOSOM MED                   47   111 985
    17   GOLDBERG RT           ARCH PHYS MED REHABIL           66   492 985
    18   KADEN GG              AM J DIS CHILD                 139   995 985
    19   PUMARIEGA AJ          J AM ACAD CHILD PSYCHIAT        25   269 986
    20   FITZPATRICK C         DEVELOP MED CHILD NEUROL        28   589 986
    21   FITZPATRICK C         DEVELOP MED CHILD NEUROL        28   596 986
    22   NOLAN T               PEDIATRICS                      77   229 986
    23   MEARNS MB             J ROY SOC MED                   79    51 986
    24   NOLAN T               J PEDIATR                      109   201 986
    25   MOLLERING M           KLIN PAEDIATR                  198   369 986

PN 76114
RN 00468 
AN 76193175
AU Oppenheimer-E-H.  Schwartz-A.
TI Easy bruisability and terminal coma in a "normal" 5-month-old infant.
SO J-Pediatr. 1976 Jun. 88(6). P 1049-53.
MJ CEREBRAL-HEMORRHAGE: pa.  CYSTIC-FIBROSIS: pa.
MN CASE-REPORT.  CEREBRAL-HEMORRHAGE: et.  COMA.  HUMAN.  INFANT.  MALE.
   VITAMIN-K-DEFICIENCY: co.
EX The patient was a 5-month-old white male admitted in coma via
   transferral from another hospital.  Clinical discussion argues that
   this child had acquired coagulopathy due to vitamin K deficiency and
   that this was secondary to the fat malabsorption that occurs in
   cystic fibrosis.  The left third nerve palsy and contralateral
   hemiparesis in a patient with rapid neurologic deterioration suggest
   a mass lesion in the left cerebral hemisphere with uncal herniation.
   Pathologic discussion also suggests intracranial hemorrhage, massive
   on left, accompanied by cystic fibrosis with severe pancreatic
   lesions and bleeding disorder, probably due to vitamin K deficiency.
RF 001   BAEHNER RL            N ENGL J MED                   275   524 966
   002   MOSESSON MW           N ENGL J MED                   278   815 968
   003   COOPER HA             MAYO CLIN PROC                  46   521 971
   004   NAMMACHER MA          J PEDIATR                       76   549 970
   005   DAM H                 ACTA MED SCAND                 112   210 942
   006   GOLDMAN HI            PEDIATRICS                      44   745 969
   007   MOSS MH               AM J DIS CHILD                 117   540 969
   008   WALTERS TR            AM J DIS CHILD                 124   641 972
   009   TORSTENSON OL         PEDIATRICS                      45   857 970
   010   DOLAN TF JR           J PEDIATR                       77   515 970
   011   KOMP DM               CHEST                           58   501 970
   012   DANNAWI N             CLIN RES                        22   84A 974
CT   1   CARPENTIERI U         SOUTH MED J                     71   854 978
     2   CABALLERO FM          PEDIATRICS                      65   161 980
     3   ROSENSTEIN BJ         PEDIATRICS                      73   877 984
     4   LANE PA               J PEDIATR                      106   351 985

PN 76115
RN 00469 
AN 76216936
AU Laraya-Cuasay-L-R.  Cundy-K-R.  Huang-N-N.
TI Pseudomonas carrier rates of patients with cystic fibrosis and of
   members of their families.
SO J-Pediatr. 1976 Jul. 89(1). P 23-6.
MJ CARRIER-STATE: mi.  CYSTIC-FIBROSIS: mi.  PSEUDOMONAS-INFECTIONS.
MN ADOLESCENCE.  ANTIBIOTICS: pd.  ANTIBODIES-BACTERIAL: an.  CHILD.
   CHILD-PRESCHOOL.  FEMALE.  HUMAN.  INFANT.  MALE.  NOSE: mi.
   PSEUDOMONAS-AERUGINOSA: de, ip.  PSEUDOMONAS-INFECTIONS: co, fg.
   PYOCINS.  SEROTYPING.  SKIN: mi.  SUPPORT-U-S-GOVT-P-H-S.
AB The majority (86.6%) of patients with cystic fibrosis were found to
   be carriers of Pseudomonas aeruginosa. None of them, however, carried
   P. aeruginosa in their nares. In contrast, none of the non-CF family
   members of the patients with CF were carriers of P. aeruginosa. For
   example, only 4 of 468 cultures from skin, throat, and nares of the
   family members were positive for P. aeruginosa. Isolations of P.
   aeruginosa from the same CF patients were often of the same pyocine
   type. No specific pyocine type of P. aeruginosa was predominant in
   patients with CF. Isolations of P. aeruginosa from siblings with CF
   may or may not be of the same pyocine type as that of the family
   proband. Colonization of a patient with CF by P. aeruginosa is not a
   threat to the non-CF members of the family.
RF 001   HUANG NN              J PEDIATR                       59   512 961
   002   HUANG NN              J PEDIATR                       62    36 963
   003   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969
   004   HUANG NN              J PEDIATR                       78   338 971
   005   FARMER JJ 3RD         PROC AM SOC MICROBIOL ANN MTG  261   123 972
   006   FARMER JJ 3RD         APPL MICROBIOL                  18   760 969
   007   SCHLICHTER JG         AM HEART J                      34   209 947
   008   HUANG NN              CF CLUB ABST                    11    19 970
   009   DIAZ F                J INFECT DIS                   121   269 970
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   STERN RC              JAMA                           239  2676 978
     3   BEAUDRY PH            J PEDIATR                       97   144 980
     4   STERN RC              LANCET                           1  1401 982
     5   BAKER NR              CURRENT MICROBIOL                7    35 982
     6   SPEERT DP             J PEDIATR                      101   227 982
     7   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
     8   ZIMAKOFF J            J HOSP INFECT                    4    31 983
     9   HASTIE AT             INFECT IMMUN                    40   506 983
    10   KESTEL FG             KLIN PAEDIATR                  195   330 983
    11   BUCKMIRE FLA          MICROBIOS                       41    49 984
    12   DUNNE WM              MICROBIOS                       43   193 985
    13   MARCUS H              INFECT IMMUN                    47   723 985
    14   DUNNE WM              APPL ENVIRON MICROBIOL          50   562 985
    15   LUZAR MA              INFECT IMMUN                    50   572 985
    16   LUZAR MA              INFECT IMMUN                    50   577 985
    17   LINDEMANN RA          J DENT RES                      64    54 985
    18   MCCARTHY VP           PEDIATR INFECT DIS               5   256 986
    19   PADGETT PJ            CURRENT MICROBIOL               14   187 986
    20   HINGLEY ST            INFECT IMMUN                    51   254 986
    21   PEDERSEN SS           ACTA PAEDIATR SCAND             75   840 986
    22   HARDY KA              J PEDIATR                      109    51 986
    23   DUNNE WM              DIAGN MICROBIOL INFECT DIS       6   165 987
    24   SPEERT DP             J HOSP INFECT                    9    11 987
    25   OGLE JW               J INFECT DIS                   155   119 987

PN 76116
RN 00470 
AN 76096876
AU Papp-Z.  Karsai-T.  Gyurkovits-K.
TI Letter: Protein level in the meconium of a homozygotic and a
   heterozygotic infant with cystic fibrosis.
SO J-Pediatr. 1976 Jan. 88(1). P 151.
MJ CYSTIC-FIBROSIS: me.  MECONIUM: an.  PROTEINS: an.
MN COMPARATIVE-STUDY.  CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.  HOMOZYGOTE.
   HUMAN.  INFANT-NEWBORN.  MALE.
EX In our patient, the second child of a married couple heterozygous for
   cystic fibrosis , the meconium protein content was higher than that
   of controls.  He has no symptoms of cystic fibrosis.  The
   determination of sodium and chloride ions in the sweat excluded
   homozygosity; the bromide test led us to conclude the child to be a
   heterozygote.  In our patient the protein content of the meconium,
   the majority of which was albumin, was two- to threefold that of the
   controls.  This elevated protein content, however, was not
   characteristic of homozygosity.  Our results lead us to conclude that
   a high protein content of meconium does not unconditionally indicate
   the homozygotic state for cystic fibrosis.  It would appear that
   heterozygosity for cystic fibrosis is not completely without
   abnormality.  Our findings perhaps explain "false positive" results
   recorded in the literature.  High-protein content in the meconium may
   be useful in the identification of heterozygotes too.
RF 001   BUCHANAN DJ           PEDIATRICS                       9   304 952
   002   SCHUTT WH             ARCH DIS CHILD                  43   178 968
   003   GREEN MN              PEDIATRICS                      41   989 968
   004   PROSSER R             ARCH DIS CHILD                  49   597 974
   005   KOLLBERG H            ARCH DIS CHILD                  47   836 972
   006   BULL FE               ARCH DIS CHILD                  49   602 974
CT   1   PAPP Z                CLIN GENET                      11   431 977

PN 76117
RN 00471 
AN 76263960
AU Cohen-L-F.  Farrell-P-M.  Lundgren-D-W.  di-SantAgnese-P-A.
TI Electrolyte values of sweat obtained by local and whole body
   collection methods in cystic fibrosis patients.
SO J-Pediatr. 1976 Sep. 89(3). P 430-3.
MJ CHLORIDES: an.  CYSTIC-FIBROSIS: me.  SODIUM: an.  SWEAT: an.
MN ADULT.  HUMAN.  MALE.
EX The composition of sweat and its relationship to the condition and
   site of collection are of interest in environmental physiology,
   dermatology, and the study of cystic fibrosis.  This study was
   undertaken to compare the concentrations of sodium and chloride in
   whole body sweat of normal control patients and of CF patients
   obtained by thermal stimulation with samples collected locally by
   pilocarpine iontophoresis.  Electrolyte concentrations in whole body
   sweat samples correlated in a highly significant fashion with sodium
   and chloride values found in arm patch sweat.  Patients with CF,
   however, showed significantly higher sodium and chloride
   concentrations in arm patch sweat and whole body sweat, and increased
   sodium excretion rates.
RF 001   SCHULZ IJ             J CLIN INVEST                   48  1470 969
   002   MANGOS JA             PEDIATR RES                      1   436 967
   003   KAISER D              PEDIATR RES                      5   167 971
   004$  LADILL WSS            J PHYSIOL (LOND)               107   465 948
   005   GORDON RS             J APPL PHYSIOL                  31   713 971
   006   GOCHBERG SH           PEDIATRICS                      18   701 956
   007   SIBINGA MS            J APPL PHYSIOL                  18  1226 963
   008   CAGE GW               J CLIN INVEST                   45  1373 966
CT   1   WEBSTER HL            CRC CRIT REV CLIN LAB SCI       18   313 983
     2   HEELEY AF             CLIN CHEM                       29  2011 983
     3   FELLMANN N            EUR J APP PHYSI OCCUP PHYSIOL   54   511 985

PN 76118
RN 00472 
AN 76263954
AU Stern-R-C.  Boat-T-F.  Doershuk-C-F.  Tucker-A-S.  Primiano-F-P-Jr.
   Matthews-L-W.
TI Course of cystic fibrosis in 95 patients.
SO J-Pediatr. 1976 Sep. 89(3). P 406-11.
MJ CYSTIC-FIBROSIS: di.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: co.  FEMALE.
   FOLLOW-UP-STUDIES.  HUMAN.  LUNG-DISEASES: co.  MALE.
   SUPPORT-U-S-GOVT-NON-P-H-S.
AB The course of 95 patients with cystic fibrosis is presented.
   Survivors have a mean follow-up period of over 14 years (minimum: 13
   years). Of 45 patients diagnosed prior to extensive irreversible
   pulmonary involvement, only one has died and none is disabled. In
   contrast, of the other 50 patients diagnosed after substantial
   irreversible pulmonary disease was present, 26 have died. Mortality
   and morbidity has been greater in females. Possible factors
   contributing to the improving prognosis include early diagnosis,
   aggressive management with comprehensive care, easy access to
   specialized care, and improved antimicrobial therapy.
RF 001   DOERSHUK CF           J PEDIATR                       65   677 964
   002   MATTHEWS LW           J PEDIATR                       65   558 964
   003   SHWACHMAN H           AM J DIS CHILD                  96   615 958
   004   HUANG NN              AM J DIS CHILD                 120   289 970
   005   LAWSON D              ARCH DIS CHILD                  47     1 972
   006   MEARNS MB             ARCH DIS CHILD                  47   251 972
   007   MATTHEWS LW           IN: MANGOS JA                        303 973
   008   WARWICK WJ            IN: LAWSON D PROC 5TH INT CF         320 969
   009   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   010   GELLIS SS             YEARBOOK OF PEDIATRICS               289 971
   011   GELLIS SS             YEARBOOK OF PEDIATRICS               176 972
   012   GELLIS SS             YEARBOOK OF PEDIATRICS               168 973
   013   WARWICK WJ            STATISTICAL ANALYSIS OF NATIO            974
   014   CUTLER SJ             J CHRON DIS                      8   699 958
   015   STOWE SM              AM REV RESPIR DIS              111   611 975
   016   STERN RC              GASTROENTEROLOGY                70   645 976
   017   RACHELEFSKY GS        AM J DIS CHILD                 128   355 974
CT   1   STERN RC              J PEDIATR                       89   412 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   LUCK SR               J THORAC CARDIOVASC SURG        74   834 977
     4   STERN RC              ANN INTERN MED                  87   188 977
     5   KNOKE JD              PEDIATR RES                     12   676 978
     6   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
     7   ZAPLETAL A            BULL EUR PHYSIOPATH RESP        15   575 979
     8   GURWITZ D             PEDIATR CLIN NORTH AM           26   603 979
     9   FRYDMAN MI            J CHRON DIS                     32   211 979
    10   RYLEY HC              ARCH DIS CHILD                  54    92 979
    11   SANTAGNESE PAD        AM J MED                        66   121 979
    12   WEISMAN Y             J PEDIATR                       95   416 979
    13   PIEPSZ A              J NUCL MED                      21   909 980
    14   MULLERWIEFEL DE       MONATSSCHR KINDERHEILKD        128   692 980
    15   MOSHANG T             AM J DIS CHILD                 134  1139 980
    16   STERN RC              AM J DIS CHILD                 134   267 980
    17   PASSERO MA            CLIN PEDIATR                    20   264 981
    18   PEDERSEN PS           ACTA PAEDIATR SCAND             70   507 981
    19   LAMBERT JR            GASTROENTEROLOGY                80   169 981
    20   REITER EO             AM J DIS CHILD                 135   422 981
    21   REITER EO             CLIN ENDOCRINOL                 16   127 982
    22   KISTLER I             HELV PAEDIATR ACTA              36   495 982
    23   HELLSING K            ACTA PAEDIATR SCAND             71   827 982
    24   REDDING GJ            AM REV RESPIR DIS              126    31 982
    25   TUMMLER B             MONATSSCHR KINDERHEILKD        130   157 982
    26   FRATES RC             AM J DIS CHILD                 136   279 982
    27   WARWICK WJ            ACTA PAEDIATR SCAND SUPPL 301 1982    27 982
    28   PARSONS HG            J PEDIATR GASTROENTEROL NUTR     2    44 983
    29   PEDERZINI F           RIV ITAL PEDIATR                 9   445 983
    30   ANON                  LANCET                           1   663 984
    31   SATEGNAGUIDETTI C     GASTROENTEROL CLIN BIOL          8   141 984
    32   PHELAN P              ARCH DIS CHILD                  59    71 984
    33   LEWIS MI              S AFR MED J                     65   641 984
    34   SEALE TW              ANN CLIN LAB SCI                15   152 985
    35   CONWAY SP             ACTA PAEDIATR SCAND             74   107 985
    36   DUHAMEL JF            ARCH FR PEDIATR                 43   229 986
    37   MAHANEY MC            HUM BIOL                        58   445 986
    38   PEDERSEN SS           ACTA PAEDIATR SCAND             75   840 986
    39   LITTLEWOOD JM         J ROY SOC MED                   79    55 986
    40   KATZ JN               J PEDIATR                      108   352 986

PN 76119
RN 00473 
AN 76263955
AU Stern-R-C.  Doershuk-C-F.  Boat-T-F.  Tucker-A-S.  Primiano-F-P-Jr.
   Matthews-L-W.
TI Course of cystic fibrosis in black patients.
SO J-Pediatr. 1976 Sep. 89(3). P 412-7.
MJ CYSTIC-FIBROSIS: di.  NEGROID-RACE.
MN CHILD.  CHILD-PRESCHOOL.  FEMALE.  FOLLOW-UP-STUDIES.  HUMAN.
   INFANT.  MALE.  RESPIRATORY-FUNCTION-TESTS.
   SUPPORT-U-S-GOVT-NON-P-H-S.
AB Seventeen black patients showed typical sweat gland,
   gastrointestinal, and pulmonary manifestations of cystic fibrosis.
   There was an unusually high incidence of meconium ileus equivalent
   (35%). Three infant siblings of patients in this study had died of
   cystic fibrosis prior to referral of a family member to this center.
   One patient died at age four years after emotional problems
   interfered with the treatment program; status asthmaticus played a
   major role in his terminal respiratory failure. The remainder of the
   patients have had substantially less morbidity from pulmonary disease
   than a comparable, much larger group of white patients. Only one
   patient, age 28, who is married and employed full-time has severe
   pulmonary involvement as assessed by pulmonary function studies and
   chest roentgenogram. The 16 surviving patients have a mean age of 13
   1/2 years after a mean follow-up period of 10 years. If black
   patients with cystic fibrosis survive infancy, they then, as a group,
   may have a relatively good prognosis.
RF 001   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            971
   002   STEINBERG AG          AM J HUM GENET                  12   416 960
   003   KULCZYCKI LL          AM J DIS CHILD                 127    64 974
   004   DI SANTAGNESE PA      ANN INTERN MED                  54   482 961
   005   PILEGGI A             DELAWARE MED J                  34    97 962
   006   MACDOUGALL LG         LANCET                           2   409 962
   007   LEVIN SE              S AFR MED J                     41   482 967
   009   OPPENHEIMER EH        PEDIATRICS                      42   547 968
   010   KULCZYCKI LL          CLIN PEDIATR                     3   692 964
   011   SENECAL JJ            BULL MED AFRI OCCID FRANC       11    95 954
   012   MATTHEWS LW           J PEDIATR                       65   558 964
   014   DUBOIS AB             J CLIN INVEST                   35   322 956
   015   DUBOIS AB             J CLIN INVEST                   35   322 956
   016   SHWACHMAN H           AM J DIS CHILD                  96   615 958
   017   CUTLER SJ             J CHRON DIS                      8   699 958
   018   STERN RC              J PEDIATR                       89   406 976
   019   ROBERTS GBS           ANN HUM GENET                   24   127 960
   020   SHWACHMAN H           N ENGL J MED                   286  1300 972
   021   DOLAN TF JR           CLIN PEDIATR                    14   862 975
CT   1   HEFFER ET             J PEDIATR                       90   324 977
     2   FLANIGAN RC           J PEDIATR SURG                  13   435 978
     3   ZAPLETAL A            BULL EUR PHYSIOPATH RESP        14   265 978
     4   KULCZYCKI LL          J PEDIATR                       92   855 978
     5   LOPEZCORELLA E        PATOLOGIA (MEXICO CITY)         18   167 980
     6   ROSENSTEIN BJ         AM J DIS CHILD                 134    72 980
     7   TABACHNIK NF          SURG GYNECOL OBSTET            152   837 981
     8   ROSENBERG E           KLIN PAEDIATR                  195   323 983
     9   ROSENSTEIN BJ         AM J DIS CHILD                 140   966 986

PN 76120
RN 00474 
AN 77008518
AU Anthony-Di-Sant-Agnese-P.  Blanc-W-A.
TI Infarction of the common bile duct in an infant after surfical
   exploration for jaundice: a possible cause of extrahepatic biliary
   atresia.
SO J-Pediatr-Surg. 1976 Aug. 11(4). P 543-5.
MJ BILIARY-TRACT-DISEASES: et.  COMMON-BILE-DUCT: bs.  INFARCTION: et.
   CHOLESTASIS: su.  SURGERY-OPERATIVE: ae.
MN BILIARY-TRACT: pa.  CASE-REPORT.  CHOLANGITIS: co.
   CYSTIC-FIBROSIS:  co.  HEPATIC-DUCT-COMMON: pa.  HUMAN.  INFANT.
   CHOLESTASIS: co.  MALE.
AB An infant explored for obstructive jaundice died 6 days
   postoperatively and was found to have extensive infarction of the
   common duct. This would have gone undetected had the patient survived
   and without careful sampling at autopsy. The incidence of this
   unsuspected complication is unknown. Surgical infarction may be one
   cause of fibrosis and secondary atresia of the extra-hepatic bile
   ducts.
RF 001   LANDING BH            PROG PEDIATR SURG                6   113 974
   002   GELLIS SS             PEDIATRICS                      55     8 975
   003   KOOP CE               PEDIATRICS                      55     8 975
   004   LOUW JH               J PEDIATR SURG                   1     8 966
   005   CAMERON GR            J PATHOL BACTERIOL              35   769 932
   006   BENNETT DE            PEDIATRICS                      33   735 964
   007   SHORTER RB            MAYO CLIN PROC                  36   148 961
   008   HOLDER TM             AM J SURG                      107   458 964
   009   BRENT RL              J PEDIATR                       61   111 962
   010   THALER MM             AM J DIS CHILD                 116   262 968
   011   GELLIS SS             AM J DIS CHILD                  88   285 954
   012   NORRIS WT             AM J SURG                       94   321 957
   013   SANTULLI TV           PEDIATRICS                      26    27 960
CT   1   SCHWEIZER P           MONATSSCHR KINDERHEILKD        128   292 980
     2   TODANI T              Z KINDERCHIRURGIE               38   400 983

PN 76121
RN 00475 
AN 76171335
AU Holsclaw-D-S.  Habboushe-C.
TI Occult appendiceal abscess complicating cystic fibrosis.
SO J-Pediatr-Surg. 1976 Apr. 11(2). P 217-21.
MJ ABSCESS: co.  APPENDICITIS: co.  CYSTIC-FIBROSIS: co.
MN ADOLESCENCE.  APPENDICITIS: di, su.  CASE-REPORT.  CHILD.
   CHILD-PRESCHOOL.  HUMAN.  MALE.
AB Three case histories illustrate the diagnostic dilemma encountered
   whenever a patient with CF who is receiving antibiotics is evaluated
   for abdominal pain. Although acute appendicitis with perforation and
   abscess formation is not a common complication of CF, it occurs more
   frequently than is generally appreciated. The large number of
   abdominal situations in CF which can cause pain confused with but not
   typical of acute appendicitis. The true underlying condition is
   further masked by the concurrent use of antibiotics for pulmonary
   infection. A higher index of suspicion is needed to rule out acute
   appendicitis in a patient with cystic fibrosis and abdominal pain. A
   greater awaremess of the possibility of occult appendiceal abscess
   may help to avoid this complication.
RF 001   GRAND RJ              CLIN PEDIATR                     9   588 970
   002   KOPEL FB              GASTROENTEROLOGY                62   483 972
   003   HOLSCLAW DS           J PEDIATR SURG                   9   867 974
   004   SNYDER WH JR          PEDIATRICS                      34    72 964
   005   HOLSCLAW DS           PEDIATRICS                      48    51 971
   006   SHWACHMAN H           PEDIATRICS                      55    86 975
   008   DI SANTAGNESE PA      ANN INTERN MED                  50  1321 959
   009   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   010   HOLGERSEN LD          AM J DIS CHILD                 122   288 971
   011   WILKINSON RH          AM J DIS CHILD                 118   687 969
   012   HATTEN  LE            SOUTH MED J                     66   803 973
   013   STORER EH             IN: SCHWARTZ S                      1021 969
   014   GONGAWARE RD          J PEDIATR SURG                   8    33 973
   015   BELL MJ               AM J DIS CHILD                 129   138 975
   016   SHANDLING B           J PEDIATR SURG                   9    79 974
   017   SHWACHMAN H           N ENGL J MED                   286  1300 972
CT   1   OESTREICH AE          J PEDIATR SURG                  17   191 982
     2   ROSENBERG E           KLIN PAEDIATR                  195   323 983
     3   MCCARTHY VP           GASTROENTEROLOGY                86   564 984
     4   GEORGE DH             HUM PATHOL                      18    75 987

PN 76122
RN 00476 
AN 76097309
AU Carter-R-A.
TI The value of screening in paediatrics.
SO J-R-Coll-Physicians-Lond. 1976 Jan. 10(2). P 153-60.
MJ MASS-SCREENING.  PEDIATRICS.
MN ALPHA-FETOPROTEINS: df.  ALPHA-1-ANTITRYPSIN: df.
   AMINO-ACID-METABOLISM-INBORN-ERRORS: di.  CYSTIC-FIBROSIS: di.
   EVALUATION-STUDIES.  GALACTOSEMIA: di.
   GLUCOSEPHOSPHATE-DEHYDROGENASE-DEFICIENCY: di.  HARTNUP-DISEASE: di.
   HIP-DISLOCATION-CONGENITAL: di.  HOMOCYSTINURIA: di.  HUMAN.
   HYPOTHYROIDISM: cn.  INFANT.  INFANT-NEWBORN.
   MAPLE-SYRUP-URINE-DISEASE: di.  PHENYLKETONURIA: di.
EX Population screening is the carrying out of some test or procedure on
   every individual within a population defined by such limits as
   geography, administration, race, sex or age.  At risk screening is
   the carrying out of such a test or procedure on a person or persons
   for whom there already exists some medical reason to suppose that the
   findings may be positive.  This review of conditions for which
   population screening may be considered is not exhaustive, but it
   serves to show the central dilemma in this field, which is that,
   apart from congenital dislocation of the hip, phenylketonuria and
   possibly homocystinuria, none seems to show quite strong enough a
   case to be considered worthwhile screening for on its own.
RF 001   ABULID J              J CLIN ENDOCRINOL METAB         39   263 974
   002   BARNES ND             ARCH DIS CHILD                  50   497 975
   003   ANON                  BR MED J                         3   489 971
   004   ANON                  BR MED J                         1   527 974
   005   BROCK DJH             LANCET                           2   923 973
   006   BROCK DJH             LANCET                           2   197 972
   007   DACOU-VOUTETAKIS C    ARCH DIS CHILD                  48   826 973
   008   DEALL AM              BR MED J                         3   639 971
   009   DICKSON LG            CLIN CHEM                       19   301 973
   010   DOW PA                AM J CLIN PATHOL                61   333 974
   011   ENDRE L               LANCET                           1   631 974
   012   GUTHRIE R             US DHEW CHILDRENS BUREAU PUBL            965
   013   HARRIS R              LANCET                           1   429 974
   014   HAWCROFT J            HEALTH TRENDS                    6    72 974
   015   HOLLAND WW            LANCET                           2  1494 974
   016   HOLT KS               LANCET                           2  1057 974
   017   HOLTON JB             ANN CLIN BIOCHEM                 9   118 972
   018   KLEIN AH              LANCET                           2    77 974
   019   KLEIN A               PEDIATR RES                      5   399 971
   021   LAURENCE KM           LANCET                           2   939 974
   022   LEEK AE               LANCET                           1   876 974
   023   LEEK AE               LANCET                           2  1151 974
   024   LEEK AE               LANCET                           1   385 973
   025   LINDSAY G             ANN CLIN BIOCHEM                 9   115 972
   026   ANON                  BR MED J                         4     7 968
   027   MITTMAN C             CHEST                           60   214 971
   028   RAINE DN              ANN CLIN BIOCHEM                 6    29 969
   029   RAINE DN              BR MED J                         2   329 972
   030   RAINE DN              BR MED J                         3     7 972
   032   RAINE DN              LANCET                           2   996 974
   033   RAINE DN              TREATMENT OF INHERITED ME                975
   034   SCRIVER CR            LANCET                           2   230 964
   035   SEAKINS JWT           TREATMENT OF INBORN ERRORS OF            973
   036   SELLER MJ             LANCET                           1   428 974
   037   SIMILA S              ARCH DIS CHILD                  50   565 975
   038   STEPHAN U             LANCET                           1   367 975
   039   SUN T                 AM J CLIN PATHOL                62   725 974
   040   THAMBIPILLAI S        AM J CLIN PATHOL                63   836 975
   041   UDDIN DE              JAMA                           227  1408 974
   042   WALD NJ               LANCET                           1   765 974
   043   WHITBY LG             LANCET                           2   819 974
   044   ANON                  SCREENING FOR INBORN ERRORS O            968
CT   1   CHALMERS RA           ANN CLIN BIOCHEM                14   149 977
     2   SMILKSTEIN G          J MED EDUC                      53   766 978
     3   NELSON JH             WEST J MED                     129   243 978

PN 76123
RN 00477 
AN 76122997
AU Blanck-R-R.  Mendoza-E-M.
TI Fertility in a man with cystic fibrosis.
SO JAMA. 1976 Mar 29. 235(13). P 1364.
MJ CYSTIC-FIBROSIS.  FERTILITY.
MN ADULT.  CASE-REPORT.  CYSTIC-FIBROSIS: co.  HUMAN.  LUNG: pp.  MALE.
   PANCREAS: pp.  RESPIRATORY-FUNCTION-TESTS.  SEMEN: an.
   SPERM-MOTILITY.  INFERTILITY-MALE: et.
EX Our patient had well-compensated and late-appearing cystic fibrosis
   manifested by moderately decreased exercise, tolerance and a normal
   semen analysis, and he had presumably fathered one child.  It is
   important to again emphasize the physician's obligation to determine
   fertility in any male cystic fibrosis patient, particularly with
   late-onset of symptoms, and to provide appropriate genetic
   counseling.
RF 001   ROSENLUND ML          ANN INTERN MED                  78   959 973
   002   KAPLAN E              N ENGL J MED                   279    65 968
   003   DENNING CR            PEDIATRICS                      41     7 968
   004   FEIGELSON J           ARCH FR PEDIATR                 26   937 969
   005   TAUSSIG LM            N ENGL J MED                   287   586 972
   006   SHWACHMAN H           PEDIATRICS                      32    85 963

PN 76124
RN 00478 
AN 76122937
AU Lober-C-W.  Seigler-H-F.  Spock-A.
TI Cystic fibrosis in a black woman.
SO JAMA. 1976 Mar 15. 235(11). P 1140-1.
MJ CYSTIC-FIBROSIS: oc.  NEGROID-RACE.
MN ADULT.  AGE-FACTORS.  CASE-REPORT.  CYSTIC-FIBROSIS: di.
   FECES-IMPACTED: di.  FEMALE.  HEMOPTYSIS: di.  HUMAN.
   INTESTINE-LARGE: ra.  RECTAL-PROLAPSE: di.
EX This article reports a case of a 22-year-old unmarried black woman
   with cystic fibrosis.  There is only one report in the literature of
   cystic fibrosis in a black person over 20 years old.  Due in part to
   the deficiency of pancreatic exocrine secretions and the production
   of a copious amount of highly viscous mucus by gastrointestinal
   glands, patients with cystic fibrosis are prone to recurrent
   intestinal obstruction, intussusception, and volvulus, as well as
   abdominal pain and masses.  Shwachman and Holsclaw firmly state that
   the diagnosis of cystic fibrosis may be made on the histologic
   appearance of the appendix.
RF 001   KULCZYCKI LL          AM J DIS CHILD                 127    64 974
   002   DI SANTAGNESE PA      ANN INTERN MED                  54   482 961
   003   SENECAL JJ            BULL MED AFRI OCCID FRANC       11    95 954
   004   GROVE SS              S AFR J LAB CLIN MED             5   113 959
   005   MACDOUGALL LG         LANCET                           2   409 962
   006   LEVIN SE              S AFR MED J                     41   482 967
   007   ZUELZER WW            PEDIATRICS                       4    53 949
   008   PILEGGI A             DELAWARE MED J                  34    97 962
   009   OPPENHEIMER EH        PEDIATRICS                      42   547 968
   010   HEFFER ET             NY STATE J MED                  74  2355 974
   011   BROWN PM              N ENGL J MED                   263   544 960
   012   BECK AR               GASTROENTEROLOGIA              106    84 966
   013   MURTHY MSN            OHIO STATE MED J                69   768 973
   014   HOLSCLAW DS           J PEDIATR SURG                   9   867 974
   015   DOLAN TF JR           CLIN PEDIATR                    14   862 975
   016   SHWACHMAN H           N ENGL J MED                   286  1300 972

PN 76125
RN 00479 
AN 77031958
AU Reynolds-H-Y.  Di-SantAgnese-P-A.  Zierdt-C-H.
TI Mucoid Pseudomonas aeruginosa.  A sign of cystic fibrosis in young
   adults with chronic pulmonary disease?.
SO JAMA. 1976 Nov 8. 236(19). P 2190-2.
MJ CYSTIC-FIBROSIS: di.  LUNG-DISEASES: di.  PSEUDOMONAS-AERUGINOSA: ip.
   PSEUDOMONAS-INFECTIONS: di.
MN ADOLESCENCE.  ADULT.  AGE-FACTORS.  CASE-REPORT.  CHILD.
   CHRONIC-DISEASE.  FEMALE.  FOLLOW-UP-STUDIES.  HUMAN.  MALE.
   SPUTUM:  mi.
AB Two adult patients with cystic fibrosis had late onset of symptoms
   with principal involvement only of the lungs. The absence of other
   typical features of cystic fibrosis confused the diagnosis. Recovery
   of mucoid Pseudomonas aeruginosa from sputum cultures helped to
   establish the diagnosis in these patients, because these mucoid
   isolates are rarely obtained from subjects who do not have cystic
   fibrosis. Recent findings, which have identified the mucoid isolates
   as predominantly a single strain of P aeruginosa and have documented
   its widespread carriage in the United States by patients with cystic
   fibrosis, point to an interesting epidemiologic relationship between
   this bacterium and this disease.
RF 001   CETIN ET              J BACTERIOL                     89  1432 965
   002   DOGGETT RG            LANCET                           1   236 971
   003   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   004   GIBSON LE             PEDIATRICS                      23   545 959
   005   FISHER MW             J BACTERIOL                     98   835 969
   006   HOMMA JY              JAPAN J EXP MED                 41    89 971
   007   ZIERDT CH             J CLIN MICROBIOL                 1   521 975
   008   ZIERDT CH             J BACTERIOL                     87  1003 964
   009   REYNOLDS HY           ANN INTERN MED                  82   819 975
   010   DI SANTAGNESE PA      AM FAM PHYSICIAN                 7   102 973
   011   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   012   ELSTON HR             AM J CLIN PATHOL                48   519 967
   013   ANDERSON CM           ARCH DIS CHILD                  35   581 960
   014   GIBSON LE             CLIN PEDIATR                    12   450 973
   015   BOAT TF               PATIENT CARE                         120 975
CT   1   MARKOWITZ SM          INFECT IMMUN                    22   530 978
     2   KULCZYCKI LL          JAMA                           240    30 978
     3   SANTAGNESE PAD        AM J MED                        66   121 979
     4   MARRIE TJ             J INFECT DIS                   139   357 979
     5   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
     6   MARKOWITZ SM          J ANTIMICROB CHEMOTHER           6   251 980
     7   DAVIS PB              PEDIATR RES                     14    83 980
     8   FICK RB               CLIN CHEST MED                   2    91 981
     9   REYNOLDS HY           CLIN CHEST MED                   2   103 981
    10   CARLONE S             MICROBIOLOGICA                   4   215 981
    11   OHMAN DE              INFECT IMMUN                    33   142 981
    12   MASHIMO K             JAP J EXP MED                   51   271 981
    13   MARKS MI              J PEDIATR                       98   173 981
    14   MACONE AB             N ENGL J MED                   304  1445 981
    15   PUGASHETTI BK         J CLIN MICROBIOL                16   686 982
    16   RIVERA M              AM REV RESPIR DIS              126   833 982
    17   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982
    18   FICK RB               BULL EUR PHYSIOPATH RESP        19   151 983
    19   JOHNSON SR            OBSTET GYNECOL                  61  S  2 983
    20   BOUCHER RC            LUNG                           161     1 983
    21   FLOURNOY DJ           METH FIND EXP CLIN PHARMACOL     6   487 984
    22   KILBOURN JP           CURRENT MICROBIOL               11    19 984
    23   BOSSO JA              DRUG INTEL CLIN PHARM           18   825 984
    24   PIER GB               J IMMUNOL                      133   734 984
    25   MCCARTHY VP           ARCH INTERN MED                144   408 984
    26   ORENSTEIN DM          SEM RESPIR MED                   6   252 985
    27   REYNOLDS HY           DISEASE A MONTH                 31     1 985
    28   ROTH RM               SOUTH MED J                     78   573 985
    29   WOODS DE              J INFECT DIS                   151   581 985
    30   MCCARTHY VP           PEDIATR INFECT DIS               5   256 986
    31   WOODS DE              CLIN INVEST MED                  9   108 986
    32   PEDERSEN SS           J ANTIMICROB CHEMOTHER          17   505 986
    33   STUTTS MJ             AM REV RESPIR DIS              134    17 986

PN 76126
RN 00480 
AN 76172577
AU Nikolajek-W-P.  Emrich-H-M.
TI pH of sweat of patients with cystic fibrosis.
SO Klin-Wochenschr. 1976 Mar 15. 54(6). P 287-8.
MJ CYSTIC-FIBROSIS: me.  SWEAT: an.
MN BICARBONATES: me.  HUMAN.  HYDROGEN-ION-CONCENTRATION.  SWEATING.
AB pH of the sweat from patients with cystic fibrosis and in controls
   was measured as a function of the sweat-rate using a fluorescence-pH-
   indicator (umbelliferone). In both populations sweat is acid at low
   sweat-rates and alkaline at high ones. The results do not favour an
   abnormality of the ductal H+-secretion as the pathomechanism of
   cystic fibrosis.
RF 001   EMRICH HM             PFLUEGERS ARCH                 290   311 966
   002   EMRICH HM             PEDIATR RES                      2   464 968
   003   KAISER D              PFLUEGERS ARCH                 349    63 974
   004   KAISER D              MED WELT                        25   243 974
   005   GRUNHAGEN HH          Z NATURFORSCH                  25B   373 970
   006   EMRICH HM             PFLUEGERS ARCH                 290   298 966
   007   SPOCK A               PEDIATR RES                      1   173 967
   008   MANGOS JA             SCIENCE                        158   135 967
CT   1   BIJMAN J              PEDIATR RES                     21    79 987
     2   BIJMAN J              PFLUGERS ARCH                  408   505 987

PN 76127
RN 00481 
AN 77054785
AU Czegledy-Nagy-E.  Sturgess-J-M.
TI Cystic fibrosis: effects of serum factors on mucus secretion.
SO Lab-Invest. 1976 Dec. 35(6). P 588-95.
MJ CYSTIC-FIBROSIS: pp.
MN ANIMAL.  CILIA: pa.  CYSTIC-FIBROSIS: bl, pa.  HUMAN.  RABBITS.
   TRACHEA: pa, ul.
AB The effects of serum from children with cystic fibrosis and from
   normal children on the mucus-secreting, ciliated epithelium have been
   investigated in vitro using explanted tissue from rabbit lung. By
   optical and scanning electron microscopy, a sequence of structural
   changes is observed after incubation with cystic fibrosis serum; this
   sequence does not occur with normal serum. The earliest changes
   involve swelling of the goblet cells, with subsequent discharge of
   mucus onto the epithelial surface. This is followed by disruption of
   the normally rapid and synchronized ciliary activity. Mucus gradually
   extends over the surface entangling cilia. Finally, some shedding of
   ciliated cells occurs from the epithelium. These findings suggest
   that factors in cystic fibrosis serum cause discharge of mucus
   leading to a disturbance of the normal ciliary activity in the rabbit
   lung. It is postulated that such changes result in dysfunction of the
   mucociliary clearance mechanism and that this dysfunction may be a
   contributory factor to the pathogenesis of lung disease.
RF 001   ADSHEAD PC            ANN NY ACAD SCI                253   192 975
   002   BARNETT DR            TEX REP BIOL MED                31   703 973
   003   BOWMAN BH             IN: MANGOS JA                         29 973
   004   BOWMAN BH             SCIENCE                        164   325 969
   005   CONOVER JH            PEDIATR RES                      7   220 973
   006   CONOVER JH            LANCET                           1  1194 973
   007   CONOVER JH            LIFE SCI                        14   253 974
   008   CRAWFURD MDA          IN: LAWSON D PROC 5TH INT CF          42 969
   009   CZEGLEDY-NAGY E       PROC MICROSC SOC CAN             2    76 975
   010   FORSTNER GG           CAN MED ASSOC J                113   550 975
   011   KILBURN KH            AM REV RESPIR DIS               98   449 968
   012   RAO GJS               PEDIATR RES                      8   684 974
   013   SANCHIS J             N ENGL J MED                   289   749 974
   014   SPOCK A               PEDIATR RES                      1   173 967
   015   STANNERS CP           NATURE NEW BIOL                230    52 971
   017   YEATES DB             ARCH DIS CHILD                  51    28 976
CT   1   SCHWACHMAN H          N ENGL J MED                   296  1519 977
     2   FORSTNER JF           DIGESTION                       17   234 978
     3   NAGY EC               PEDIATR RES                     13   729 979
     4   STURGESS JM           PEDIATR CLIN NORTH AM           26   481 979
     5   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     6   NICOSIA SV            SCIENCE                        206   698 979
     7   KENNEDY JR            PEDIATR RES                     14  1173 980
     8   KURLANDSKY LE         PEDIATR RES                     14  1263 980
     9   BATTISTA SP           ARCH ENVIRON HEALTH             35   239 980
    10   PEATFIELD AC          THORAX                          35   232 980
    11   BOWMAN BH             FED PROC                        39  3195 980
    12   WILSON GB             J CLIN INVEST                   66  1010 980
    13   FLEMING N             EXPERIENTIA                     37   139 981
    14   SPECIAN RD            AM J ANAT                      160   461 981
    15   BERGAN T              SCAND J INFECT DIS            1981     7 981
    16   MORIARTY CM           J MED                           13   257 982
    17   BOAT TF               PEDIATR RES                     16   792 982
    18   REID L                ADV EXP MED BIOL               144   369 982
    19   ROOMANS GM            SCANN ELECTRON MICROSC        1982   229 982
    20   CEDER O               ULTRASTRUCTURAL PATHOL           4   305 983
    21   VONEULER AM           ULTRASTRUCTURAL PATHOL           5    37 983
    22   QUISSELL DO           PEDIATR RES                     17   899 983
    23   RUTLAND J             AM REV RESPIR DIS              128  1030 983
    24   MCPHERSON MA          CLIN CHIM ACTA                 135   181 983
    25   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983
    26   WOOTEN MW             J CELL PHYSIOL                 121   490 984
    27   VONEULER AM           LIFE SCI                        37  2399 985
    28   VONEULER AM           EXP MOL PATH                    43   142 985

PN 76128
RN 00482 
AN 76148660
AU Antonowicz-I.  Ishida-S.  Shwachman-H.
TI Letter: Screening for cystic fibrosis.
SO Lancet. 1976 Apr 3. 1(7962). P 746-7.
MJ CYSTIC-FIBROSIS: di.  INFANT-NEWBORN-DISEASES: di.
MN ALBUMINS: du.  COMPARATIVE-STUDY.  FALSE-POSITIVE-REACTIONS.  HUMAN.
   INFANT-NEWBORN.  LACTOSE: du.  MECONIUM: an.  PROTEINS: an.
   SWEAT:  an.
EX Screening for cystic fibrosis (C.F.) in the newborn has been in vogue
   since the introduction of a rapid simple test based in the presence
   of albumin in the meconium of C.F. babies.  False-positive tests have
   been observed in prematurity or when the specimen is contaminated
   with blood.  We have reduced the number of false positives by
   additional studies on the meconium, including detection of lactase.
   Lactase activity can be detected in meconium from babies with C.F.
   but not in meconium for healthy babies.  In testing 200 normal
   meconiums with a negative albumin test we noted 3 positive tests for
   lactase.  These 3 patients did not have C.F.  These false-positive
   lactase tests could be distinguished by the addition of distilled
   water to the meconium instead of lactose.  This simple test may
   provide an additional or alternative method for detection of C.F. in
   a screening programme.  When this test is used in addition to the
   albumin test the number of false-positive albumin tests will be
   reduced.
RF 001   STEPHAN U             PEDIATRICS                      55    35 975
   002   ANTONOWICZ I          PEDIATRICS                      56   782 975
   003   SHWACHMAN H           ANN NY ACAD SCI                 93   600 962
CT   1   RYLEY HC              LANCET                           2   365 976
     2   GRIFFITHS AD          ARCH DIS CHILD                  51   901 976
     3   RYLEY HC              MONOGR PAEDIATR                 10   151 979
     4   STEPHAN U             MONOGR PAEDIATR                 10    41 979
     5   BERRY HK              AM J DIS CHILD                 134   930 980
     6   MASTELLA G            RIV ITAL PEDIATR                 7   581 981
     7   MACHILL G             BIOL ZENTRALBL                 100   449 981
     8   DODGE JA              ARCH DIS CHILD                  57   774 982
     9   NAYLOR EW             SEM PERINATOL                    9   232 985

PN 76129
RN 00483 
AN 76266330
AU Ryley-H-C.  Neale-L-M.  Bray-P-T.
TI Letter: False-negative meconium tests for cystic fibrosis.
SO Lancet. 1976 Aug 14. 2(7981). P 365-6.
MJ CYSTIC-FIBROSIS: di.  MECONIUM: an.
MN EVALUATION-STUDIES.  FALSE-NEGATIVE-REACTIONS.  HUMAN.
   INFANT-NEWBORN.
EX Two reviews have questioned the value of meconium tests for the
   routine screening of cystic fibrosis because of the high proportion
   of false-positive and (perhaps more importantly) false-negative
   results.  We wish to report our findings on false-negative results.
   We are evaluating various methods of meconium screening including the
   Boehringer Mannheim test strip, a semiquantitative test for proteins,
   electroimmunoassay of albumin, and estimation of the
   albumin/alpha1-antirypsin ratio.  The figures are too small to draw
   any conclusions between the apparent relationship of false-negative
   results and a family history of the disease, but we feel that the
   results illustrate that little reliance should be put on a negative
   meconium test.  This is not to say that the meconium test is
   valueless.  In our study, at least 40% of infants with cystic
   fibrosis had a positive meconium-test result but did not have
   meconium ileus and thus the possibility of cystic fibrosis in these
   infants was recognised within a few days after birth and usually well
   before definitive clinical signs of the disease were manifest.
RF 001   BRIMBLECOMBE FSW      LANCET                           2  1428 973
   002   ANON                  J PEDIATR                       88   711 976
   003   ANTONOWICZ I          LANCET                           1   746 976
   004   RYLEY HC              CLIN CHIM ACTA                  64   117 975
   005   STEPHAN U             PEDIATRICS                      55    35 975
CT   1   GRUTTNER R            MONATSSCHR KINDERHEILKD        133    54 985

PN 76130
RN 00484 
AN 77076041
AU Conover-J-H.  Conod-E-J.  Gaerlan-P-F.  Bogart-B-I.
TI Calcium flux and cystic fibrosis [letter].
SO Lancet. 1976 Dec 18. 2(7999). P 1362-3.
MJ CALCIUM: me.  CYSTIC-FIBROSIS: me.
MN A-23187: pd.  ANIMAL.  BIOLOGICAL-ASSAY.
   CELL-MEMBRANE-PERMEABILITY:  de.  CILIA: ph.  HUMAN.  RABBITS.
   TISSUE-CULTURE.  TRACHEA: pa.
EX In an effort to determine whether increased permeability to calcium
   ions could explain the cystic fibrosis-serum ciliary dyskensia factor
   response in the tracheal test system, we selectively increased the
   membrane permeability of the tracheal epithelium to calcium ions by
   adding calcium ionophore A23187 to the tracheal culture medium.
   These studies determined that calcium ionophore A23187 in culture
   medium produced a change in mucociliary function in the tracheal test
   system indistinguishable from that promoted by C.F. sera.  These
   investigations, which are now being extended to include the
   ultrastructural alterations induced in the epithelium of the rabbit
   tracheal bioassay system, point to an important role for calcium as a
   cofactor in the production of the C.D.F. response generated by the
   C.F sera.  The C.F. serum substance seems to act at the
   cellular-membrane level, promoting membrane-permeability changes (at
   least with respect to calcium) in the rabbit tracheal test system.
   Such a mechanism would not necessarily result in a net physiological
   imbalance of calcium in the rabbit tracheal system but only local
   changes in calcium concentration that would subsequently alter
   secretion and microtubular function.  Since C.F. serum, like sweat
   and saliva from these same patients, can promote ionic fluxes,
   perhaps there is a common factor in all these body-fluids which is
   related to the basic defect in C.F.  It is tempting to speculate that
   such a factor produces a membrane-associated phenomenon that may be
   generally representative of the in-vivo C.F. disorder and as such may
   reflect the nature of the cellular and glandular abnormalities of the
   disease.
RF 001   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   002   MANGOS JA             PEDIATR RES                      1   436 967
   003   MANGOS JA             SCIENCE                        158   135 967
   004   WOTMAN S              ARCH ORAL BIOL                  16   663 971
   005   CONOVER JH            PEDIATR RES                      7   220 973
   006   COCHRANE DE           PROC NAT ACAD SCI USA           71   408 974
   007   SATIR P               SCIENCE                        190   586 975
CT   1   KENNEDY JR            PEDIATR RES                     14  1173 980
     2   KATZ S                CELL CALC                        5   421 984

PN 76131
RN 00485 
AN 76195104
AU McFarlane-H.  Allan-J-D.
TI Letter: Cystic fibrosis heterozygosity in pathogenesis of allergy.
SO Lancet. 1976 Jun 5. 1(7971). P 1241.
MJ CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.  HYPERSENSITIVITY: et.
MN ADULT.  CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: et.  HUMAN.
   HYPERSENSITIVITY: di, fg.  IGE: an.
EX The article by Dr Warner and colleagues may be of great significance
   to our understanding of the aetiology and pathogenesis of cystic
   fibrosis (C.F.), and accords with our observations that allergic
   symptoms and positive skin tests are more common in C.F. homozygotes
   than in healthy controls.  Apart from the fact that 59% of our C.F.
   homozygotes gave a positive skin test to one or more of 40 different
   classes of Bencard antigens, the main one being Aspergillus
   fumigatus, at least 85% of the C.F. heterozygotes had a strong
   positive history of allergy, of which the mother and her maternal
   progenitors, followed by the siblings, accounted for most.  Further
   studies are required to establish the relationship, if any, between
   the gene responsible for the allergic manifestation in the population
   and the C.F. phenotype.
RF 001   WARNER JO             LANCET                           1   990 976
   002   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   003   ALLAN JD              CLIN ALLERGY                     5   255 975
   004   MCFARLANE H           BR MED J                         1   423 975
   005   GIBBONS A             BR MED J                         1   120 976
CT   1   GYURKOVITS K          LANCET                           1   203 977
     2   MCFARLANE H           CLIN ALLERGY                     7   279 977
     3   SILVERMAN M           ARCH DIS CHILD                  53   873 978
     4   CARSWELL F            MONOGR PAEDIATR                 10   144 979
     5   CARSWELL F            CLIN EXP IMMUNOL                35   141 979
     6   TACIEREUGSTER H       HELV PAEDIATR ACTA              35    31 980
     7   MOSS RB               AM REV RESPIR DIS              121    23 980
     8   CLARKE CW             BR J DIS CHEST                  75    15 981
     9   WILSON GB             MED HYPOTHESES                   8   527 982

PN 76132
RN 00486 
AN 78070537
AU Bentley-D.  Moore-A.  Shwachman-H.
TI Finger Clubbing: A quantitative survey by analysis of the
   shadowgraph.
SO Lancet. 1976 Jul 24. 2(7978). P 164-7.
MJ NAILS.  OSTEOARTHROPATHY-SECONDARY-HYPERTROPHIC: di.
MN ADOLESCENCE.  ADULT.  ASTHMA: co.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: co.  HEART-DEFECTS-CONGENITAL: co.  HUMAN.  METHODS.
   SUPPORT-U-S-GOVT-P-H-S.
AB Finger-clubbing has been measured from the magnified silhouette of
   the right index finger (shadowgram) in 125 subjects, comprising
   children and young adults. The profile and hyponychial angles were
   both found to be good discriminators of clubbing and to be
   independent of age and sex. The normal profile angle was 168.3
   degrees +/- 3.6 and the mean normal hyponychial angle was 180.1
   degrees +/- 4.2. Patients with cystic fibrosis and cyanotic
   congenital heart-disease were found to have grossly elevated values
   of these angles. Some asthmatics were found to have a moderate degree
   of clubbing with significantly elevated values of these angles. The
   shadowgram proved a convenient objective method for recording the
   degree and progress of fingerclubbing in clinical practice.
RF 001   TROUSSEAU A           CONNAISSANCES MED CHIR               351 833
   002   ADAMS F               IN: GENUINE WORKS OF HIPP        1   249 849
   003   LOVIBOND JL           LANCET                           1   363 938
   004   LOVELL RRH            CLIN SCI                         9   299 950
   005   BIGLER FC             AM J PATHOL                     34   237 958
   006   CUDKOWICZ L           BR J TUBERC DIS CHEST           51    14 957
   007   STAVEM P              LANCET                           2     7 959
   008   CARROLL DG            TRANS AM CLIN CLIMAT ASSOC      83   198 972
   009   NEUFELD O             OHIO STATE MED J                48   834 952
   010   MELLINS RB            CIRCULATION                     33   143 966
   011   REGAN GM              LANCET                           1   530 967
   012   WARING WW             AM REV RESPIR DIS              104   166 971
   013   BENTLEY D             BR MED J                         3    43 970
   014   SLY RM                ANN ALLERGY                     30   575 972
   015   PYKE DA               LANCET                           2   352 954
   016   WARING WW             CF CLUB ABST                             967
CT   1   SINNIAH D             J PEDIATR                       92   597 978
     2   KITIS G               BR MED J                         2   825 979
     3   SINNIAH D             ARCH DIS CHILD                  54   145 979
     4   ROTHSCHILD BM         AM J GASTROENTEROL              73   503 980
     5   BLUMSOHN D            HEART LUNG                      10  1069 981
     6   SHNEERSON JM          BR J DIS CHEST                  75    75 981
     7   PITTSTUCKER TJ        ARCH DIS CHILD                  61   576 986

PN 76133
RN 00487 
AN 76173255
AU Lipson-A.
TI Letter: Infecting dose of Salmonella.
SO Lancet. 1976 May 1. 1(7966). P 969.
MJ SALMONELLA: py.
MN CYSTIC-FIBROSIS: dt.  DRUG-CONTAMINATION.  GASTROENTERITIS: mi.
   CROSS-INFECTION: mi.  HUMAN.  INFANT.  PANCREATIN: ae.
   SALMONELLA-INFECTIONS: mi.
EX An outbreak of salmonellosis in patients consuming pancreatin in the
   U.K. prompted a study at this hospital which included determination
   of the infecting dose in children with cystic fibrosis known to have
   contracted a S. schwarzengrund enteritis from contaminated porcine
   powdered pancreatin.  We found that infection was especially
   prevalent in very young cystic-fibrosis patients who were receiving
   broad-spectrum antibiotic treatment for chest infection.  All had
   their pancreatin added to meals immediately before consumption.
   Susceptibility to most infections depends on many factors and
   variables.  It is necessary to take into account such things as age
   and condition of the patient when discussing the actual number of
   organisms causing an infection.
RF 000   DAOUST JY             LANCET                           1   866 976
   004   ROWE B                BR MED J                         4    51 975
   006   LANG DJ               N ENGL J MED                   276   829 967
   007   MCCULLOUGH NB         J INFECT DIS                    88   276 951
   008   MCCULLOUGH NB         J INFECT DIS                    89   209 951
   009   MCCULLOUGH NB         J INFECT DIS                    89   259 951
   010   HORNICK RB            N ENGL J MED                   288   686 973
   011   BOHNHOFF M            J INFECT DIS                   111   117 962
   012   BENNETT IL            ANNU REV MED                    10     1 959
CT   1   CRAUN GF              J WATER POLLUT CONTROL FED      49  1268 977
     2   DICKINSON RJ          SCOTT MED J                     23    23 978
     3   TURNBULL PCB          CLIN GASTROENTEROL               8   663 979
     4   SILLIKER JH           J FOOD PROTECT                  43   307 980
     5   PALMER SR             LANCET                           1   881 981
     6   BLASER MJ             REV INFECT DIS                   4  1096 982
     7   SCOTT E               J HYG LOND                      89   279 982
     8   LEE A                 ADV MICROB ECOL                  8   115 985

PN 76134
RN 00488 
AN 76173321
AU Warner-J-O.  Norman-A-P.  Soothill-J-F.
TI Cystic fibrosis heterozygosity in the pathogenesis of allergy.
SO Lancet. 1976 May 8. 1(7967). P 990-1.
MJ CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.  HYPERSENSITIVITY: et.
MN ALLERGENS: du.  COMPARATIVE-STUDY.  FEMALE.  HOMOZYGOTE.  HUMAN.
   HYPERSENSITIVITY: di, fg.  MALE.  SKIN-TESTS.
AB 47% of cystic fibrosis (C.F.) heterozygotes had positive prick skin
   tests of 1 or more of 9 antigens and 53% had histories of allergic
   disease, both occurring significantly more often than in a control
   group. Since 1 in 20 of the population are C.F. carriers, this would
   contribute to allergy in the community.
RF 001   TAYLOR B              LANCET                           2   111 973
   002   MEARNS MB             LANCET                           1   538 967
   003   WARREN CPW            CLIN ALLERGY                     5     1 975
   004   ALLAN JD              CLIN ALLERGY                     5   255 975
   006   BLAIR H               CLIN ALLERGY                     4   389 974
   007   COUNAHAN R            ARCH DIS CHILD                  50   477 975
   008   SMITH JM              MED CLIN NORTH AM               48     3 974
   009   SPOCK A               PEDIATR RES                      1   173 967
   010   BESLEY GTN            J MED GENET                      6   278 969
   011   CAPLIN I              ANN ALLERGY                     31   320 973
CT   1   GYURKOVITS K          LANCET                           1   203 977
     2   MCFARLANE H           CLIN ALLERGY                     7   279 977
     3   RAEBURN JA            PROC NUTR SOC                   36    77 977
     4   WILLCOX HNA           IMMUNOGENETICS                   6   209 978
     5   SILVERMAN M           ARCH DIS CHILD                  53   873 978
     6   TURNER MW             ARCH DIS CHILD                  53   631 978
     7   PRICE JF              CLIN ALLERGY                     9   563 979
     8   CARSWELL F            MONOGR PAEDIATR                 10   144 979
     9   CARSWELL F            CLIN EXP IMMUNOL                35   141 979
    10   ZAMBIE MF             ANN ALLERGY                     42   290 979
    11   VANASPEREN PP         AUST PAEDIATR J                 16    53 980
    12   HODSON ME             THORAX                          35   801 980
    13   ORMEROD LP            THORAX                          35   768 980
    14   SKOV PS               ALLERGY                         35    23 980
    15   TACIEREUGSTER H       HELV PAEDIATR ACTA              35    31 980
    16   TOBIN MJ              THORAX                          35   807 980
    17   WANG A                ARCH DIS CHILD                  55   130 980
    18   HOLZER FJ             ARCH DIS CHILD                  56   455 981
    19   CLARKE CW             BR J DIS CHEST                  75    15 981
    20   ZETTERSTROM O         BR MED J                       283  1215 981
    21   MANKU MS              PROSTAGLANDINS LEUKOTR MED       9   615 982
    22   ZETTERSTROM O         J ALLERGY CLIN IMMUNOL          75   594 985

PN 76135
RN 00489 
AN 77010669
TI The later years of cystic fibrosis [editorial].
SO Lancet. 1976 Sep 18. 2(7986). P 614-5.
MJ CYSTIC-FIBROSIS.
MN ADOLESCENCE.  ADULT.  CHILD.  CHRONIC-DISEASE.
   CYSTIC-FIBROSIS: co, th.  FOLLOW-UP-STUDIES.  HUMAN.
EX According to Schwachman and Holsclaw, a cystic-fibrosis child who
   does not present with meconium ileus and who receives optimum care
   now has an 80% chance of reaching adulthood.  The main feature
   needing continuous medical care in the older CF patient is
   persisting, and often progressive, chest disease.  CF patients often
   owe their lives to paediatrician and to parents who have persevered
   with an arduous and exacting treatment regimen.  Now that such
   patients are reaching adult life, we must continue to offer the best
   possible support.
RF 013   SHWACHMAN H           N ENGL J MED                   281   500 969
   014   SHWACHMAN H           PEDIATRICS                      36   689 965
   015   SHWACHMAN H           CF CLUB ABST                    13       974
   016   GRACEY M              AUSTRALAS ANN MED               18    91 969
   017   MITCHELL-HEGGS PF     Q J MED                         45   479 976
   018   PROSSER R             ARCH DIS CHILD                  49   597 974
   019   STEPHAN U             PEDIATRICS                      55    35 975
   020   ANDERSON CM           CF A MANUAL OF DIAGNOSIS AND             976

PN 76136
RN 00490 
AN 77055460
AU Bowman-B-H.
TI Current biochemical approaches in cystic fibrosis research.
SO Life-Sci. 1976 Nov 1. 19(9). P 1289-96. (REVIEW).
MJ CYSTIC-FIBROSIS.
MN BIOLOGICAL-TRANSPORT.  CILIA: ph.  CYSTIC-FIBROSIS: co, fg, me.
   GASTROINTESTINAL-DISEASES: et.  GLYCOPROTEINS: bi.  HETEROZYGOTE.
   HOMOZYGOTE.  HUMAN.  IONS.  LUNG-DISEASES: et.  MUCUS: me.
   POLYAMINES: me.  PROTEINS: me.  REVIEW.  SODIUM: me.  SULFATES: me.
   SWEAT: an.  SUPPORT-U-S-GOVT-P-H-S.
EX The clinical abnormalities in cystic fibrosis can be categorized into
   three headings: pulmonary disease, digestive disorders, and ion
   transport abnormalities.  Research directions in cystic fibrosis have
   evolved from observations of the characteristic malfunctions inherent
   in the disease.  These include defects in mucociliary function,
   mucous secretion, membrane transport and glycoprotein biosynthesis.
   Drawing from what is known about the bases of other inherited
   diseases, one could predict that cystic fibrosis results from an
   abnormal functional protein, as in sickle cell anemia; an enzyme
   deficiency, as in phenylketonuria; or a deficiency of a normal
   inhibitor, as in hereditary angioedema.
RF 001   STEINBERG AG          AM J HUM GENET                  12   416 960
   002   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   003   LEVISON H             IN: MANGOS JA                          3 976
   004   BARBERO GJ            IN: MANGOS JA                         83 976
   005A  FANCONI G             WIEN MED WOCHENSCHR             86   753 936
   005B  ANDERSEN DH           AM J DIS CHILD                  56   344 938
   006   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   007   MANGOS JA             PEDIATR RES                      1   436 967
   008   HIRSCHHORN K          IN: MANGOS JA                         11 973
   009   KNUDSON AG JR         AM J HUM GENET                  19   388 967
   011   SPOCK A               PEDIATR RES                      1   173 967
   012   BOWMAN BH             SCIENCE                        167   871 970
   013   MCCOMBS ML            CLIN GENET                       1   171 970
   014   BARNETT DR            TEX REP BIOL MED                31   703 973
   015   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   016   BARNETT DR            TEX REP BIOL MED                31   697 973
   017   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   018   BERATIS NG            PEDIATR RES                      7   958 973
   019   BESLEY GTN            J MED GENET                      6   278 969
   020   CONOVER JH            PEDIATR RES                      7   224 973
   021   DANES BS              J EXP MED                      136  1313 972
   022   DANES BS              J EXP MED                      137  1538 973
   023   MANGOS JA             PEDIATR RES                      1   436 967
   024   MANGOS JA             TEX REP BIOL MED                31   651 973
   025   LITT M                BIOCHEM BIOPHYS RES COMMUN      43   919 971
   026   BOWMAN BH             IN: MANGOS JA                         29 973
   027   WOOD RE               AM REV RESPIR DIS              111   733 975
   029   DANES BS              AM J HUM GENET                  25   323 973
   031   RAO GJS               PEDIATR RES                      9   739 975
   032   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   033   CONOD EJ              PEDIATR RES                      9   724 975
   035   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   036   COHEN LF              PEDIATR RES                      9   312 975
   037   DANES BS              J EXP MED                      129   775 969
   038   DANES BS              J EXP MED                      136  1313 972
   039   CONOVER JH            LANCET                           1  1194 973
   040   BOAT TF               AM REV RESPIR DIS              110   428 974
   041   BALFE JW              SCIENCE                        162   689 968
   042   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   043   LAPEY A               PEDIATR RES                      5   446 971
   044   COLE CH               PEDIATR RES                      6   616 972
   045   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   046   WILSON GB             CLIN CHIM ACTA                  49    79 973
CT   1   GABRIDGE MG           PEDIATR RES                     13    31 979
     2   AFZELIUS BA           INT REV EXP PATHOL              19     1 979
     3   EKLUND A              SCAND J CLIN LAB INVEST         40   595 980
     4   MALER T               BIOCHIM BIOPHYS ACTA           598     1 980
     5   BERG U                ACTA PAEDIATR SCAND             71   833 982
     6   ARVIDSSON A           ACTA PAEDIATR SCAND             72   293 983
     7   RUDICK VL             J CELL PHYSIOL                 118    67 984
     8   GIBSON RA             J PEDIATR GASTROENTEROL NUTR     5   408 986

PN 76137
RN 00491 
AN 77034202
TI Screening for cystic fibrosis--further thoughts [editorial].
SO Med-J-Aust. 1976 Aug 7. 2(6). P 194-5.
MJ CYSTIC-FIBROSIS: oc.  INFANT-NEWBORN-DISEASES: oc.
   MASS-SCREENING.
MN ALBUMINS: an.  ENZYME-TESTS.  HUMAN.  INFANT-NEWBORN.  MECONIUM:  an.
EX Screening of the newborn for genetically determined diseases is one
   thing when sought by parents who know they are likely to pass a
   defective gene to their offspring; it is another thing altogether to
   apply screening tests to all newborns, irrespective of individual
   risks.  In Australia, in the foreseeable future, the best hope for
   infants and children born with cystic fibrosis lies in the
   application of the proven sweat test technique whenever any of the
   numerous presenting features of the disease crops up.
RF 001   ROBINSON PG           ARCH DIS CHILD                  51   301 976
   002   ROBINSON PG           MED J AUST                       1   901 976

PN 76138
RN 00492 
AN 76174003
TI Screening newborn infants for cystic fibrosis.
SO Med-Lett-Drugs-Ther. 1976 Apr. 18(8). P 35-6.
MJ CYSTIC-FIBROSIS: di.
MN CYSTIC-FIBROSIS: fg.  FALSE-NEGATIVE-REACTIONS.
   FALSE-POSITIVE-REACTIONS.  GENETIC-COUNSELING.  HUMAN.
   INFANT-NEWBORN.  MECONIUM: an.  PROGNOSIS.
EX The Boehringer Mannheim test meconium strip advertised for detection
   of cystic fibrosis was, like many other diagnostic aids, marketed
   before its reliability was proven.  The test is positive in many
   infants who do not have cystic fibrosis, and may be negative in those
   who have the disease.  It is therefore unacceptable for routine
   screening of newborn infants for cystic fibrosis.
RF 001   NOLAN AJ              CAN MED ASSOC J                114   142 976
   002   BRIMBLECOMBE FSW      LANCET                           2  1428 973
   003   ANTONOWICZ I          PEDIATRICS                      56   782 975
   004   STEPHAN U             PEDIATRICS                      55    35 975
   005   ANON                  J PEDIATR                       88   711 976

PN 76139
RN 00493 
AN 76149472
AU Rennert-O-M.
TI RNA methylation and polyamine metabolism in cystic fibrosis.
SO Minerva-Pediatr. 1976 Jan 28. 28(2). P 62-8.
MJ CYSTIC-FIBROSIS: me.  POLYAMINES: me.  RNA: me.
MN ANIMAL.  CATTLE.  DOGS.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.
   METHYLATION.  PREGNANCY.  RATS.
EX The autosomal recessively inherited disorder cystic fibrosis is
   clinically identified in patients by the pathognomonic finding of
   increased electrolyte content in the exocrine secretion sweat.  Two
   other observations merit mention.  First, the demonstration by Magos
   of the existence of a factor in CF sweat which interfered with
   reabsorption of sodium in the rat parotid.  Secondly is the existence
   of a CF serum component which interfered with ciliary rhythm in organ
   culture systems.  Our investigations in cystic fibrosis have been
   oriented towards the establishment of a possible pedigree of causes
   which will unite all these observations and secondly to develop a
   possible method for heterozygote detection.  Cystic fibrosis RNA is
   relatively undermethylated in comparison with contrast cultures.  In
   addition, CF heterozygote fibroblast cultures also appear
   undermethylated.  Our interpretation of these data do not imply a
   primary defect of RNA methylases in cystic fibrosis but rather
   suggested a defect elsewhere in biochemical sequences involving
   methionine.

PN 76140
RN 00494 
AN 76174070
AU Martinez-J-R.
TI Recent advances in research on cystic fibrosis.
SO Mo-Med. 1976 Apr. 73(4). P 173-8.
MJ CYSTIC-FIBROSIS.
MN ANIMAL.  CYSTIC-FIBROSIS: et, me.  EXOCRINE-GLANDS: se.  RATS.
   RESEARCH.
EX Advances have been made in two areas of cystic fibrosis research at
   the University of Missouri School of Medicine.  First, investigations
   have improved understanding of the normal mechanisms that underline
   the production of exocrine secretions.  The second involves recent
   observations relating to important efforts to develop methods for
   heterozygote detection.  The author concludes that efforts should be
   made to shift emphasis in research from qualitative bioassays to more
   reliable detection systems.
RF 001   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   002   MARTINEZ JR           PEDIATR RES                      9   463 975
   003   MARTINEZ JR           PEDIATR RES                      9   470 975
   004   IMMKEN L              CF CLUB ABST                    16     9 975
   006   ADSHEAD PC            ANN NY ACAD SCI                253   192 975
   007   SPOCK A               PEDIATR RES                      1   173 967
   008   CONOVER JH            PEDIATR RES                      7   224 973
   009   DOGGETT RG            TEX REP BIOL MED                31   685 973
   010   MANGOS JA             PEDIATR RES                      1   436 967
   011   MANGOS JA             TEX REP BIOL MED                31   651 973
   012   FARRELL PM            PEDIATR RES                     10   127 976
   013   CHEUNG ATW            PEDIATR RES                     10   144 976
   014   RENNERT OM            IN: MANGOS JA                         41 973
CT   1   WILSON GB             MED HYPOTHESES                   8   527 982

PN 76141
RN 00495 
AN 78071429
AU Buchwald-M.  Mapleson-J-L.
TI Adenosine 3':5'-cyclic AMP in fibroblasts from patients with cystic
   fibrosis and its relationship to secretion.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 165-74.
MJ ADENOSINE-CYCLIC-MONOPHOSPHATE: bi.  CYSTIC-FIBROSIS: me.
MN ADENOSINE-CYCLIC-MONOPHOSPHATE: an.  ADOLESCENCE.  ADULT.
   CELLS-CULTURED.  CHILD.  FEMALE.  FIBROBLASTS: de, me.  HUMAN.
   INFANT.  ISOPROTERENOL: pd.  MALE.
EX Because of the known involvement of cyclic AMP in the control of
   secretion in exocrine and other mammalian cells, we have studied
   cyclic AMP metabolism in cultured cystic fibrosis cells in the hopes
   of demonstrating such an abnormality.  A detailed comparison of 5 CF
   and 5 control strains showed that the CF cells synthesized 3 times
   more intracellular cyclic AMP than controls.  In this paper, we
   present data on an additional 10 CF and 10 control strains.
   Measurement of intracellular cyclic AMP did not provide the same
   clear-cut differences between the CF and control strains, as we had
   previously observed.  The CF strains synthesized more cyclic AMP than
   controls but the difference was not as large as in our earlier study
   and there is considerable overlap between the two groups.  It is not
   clear why these two studies should have yielded such disparate
   results.
RF 001   LOBECK CC             IN: STANBURY JB                     1605 972
   002   WOOD RE               AM REV RESPIR DIS              113   833 976
   003   DI SANTAGNESE PA      N ENGL J MED                   295   481 976
   004   CHANGUS JE            ARCH PATHOL LAB MED            100     7 976
   005   BUTCHER FR            IN: MANGOS JA                        243 976
   006   DANES BS              LANCET                           1  1061 968
   007   DANES BS              J EXP MED                      129   775 969
   008   DANES BS              NATURE                         222   685 969
   009   DANES BS              J EXP MED                      136  1313 972
   010   CONOVER JH            PEDIATR RES                      7   224 973
   011   BERATIS NG            PEDIATR RES                      7   958 973
   012   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   013   STURGESS JM           BR J EXP PATHOL                 54   388 973
   014   MARTINEZ JR           PEDIATR RES                      9   463 975
   015   MARTINEZ JR           PEDIATR RES                      9   470 975
   016   RASMUSSEN H           SCIENCE                        170   404 970
   017   BERRIDGE MJ           ADV CYCLIC NUCLEO RES            6     1 975
   018   BUCHWALD M            PROC NAT ACAD SCI USA           73  2899 976
   019   GOLDSTEIN S           DIABETES                        18   545 969
   020   STANNERS CP           NATURE NEW BIOL                230    52 971
   021   AMSTERDAM A           J CELL BIOL                     63  1037 974
   022   MANGOS JA             AM J PHYSIOL                   229   553 975
   023   MCKUSICK VA           ANNU REV GENET                   7   435 974
   024   LAYMAN DL             PROC NAT ACAD SCI USA           68   454 971
   025   MATALON R             PROC NAT ACAD SCI USA           56  1310 966
   026   SEAR CHJ              BIOCHEM BIOPHYS RES COMMUN      71   379 976
   027   HOUCK JC              PROC SOC EXP BIOL MED          135   369 970
   028   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   029   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969
   030   DANES BS              BIOCHEM GENET                   12   359 974
   031   WIESMANN UN           J PEDIATR                       77   685 970
   032   WELCH DW              PEDIATR RES                      9   698 975
   033   PETERS HD             POL J PHARMACOL PHARM           26    41 974
   034   PALADE GE             SCIENCE                        189   347 975
   035   GOGGINS JF            J BIOL CHEM                    247  5759 972
   036   MANNER G              CONN TISS RES                    2   167 974
   037   KOYAMA H              J CELL PHYSIOL                  87   189 976
   038   LORANS G              EUR J BIOCHEM                   50   563 975

PN 76142
RN 00496 
AN 78071428
AU Lamblin-G.  Lafitte-J-J.  Lhermitte-M.  Degand-P.  Roussel-P.
TI Mucins from cystic fibrosis sputum.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 153-64.
MJ CYSTIC-FIBROSIS: pp.  MUCINS: an.  SPUTUM: an.
MN ADULT.  BRONCHIECTASIS: pp.  BRONCHITIS: pp.  CHILD.
   CHRONIC-DISEASE.  GLYCOPEPTIDES: an.  HUMAN.  MUCUS: an.
EX A biochemical study of bronchial mucins in sputum from patients with
   cystic fibrosis was undertaken in order to determine their chemical
   features and to compare them with bronchial mucins secreted in other
   physiological or pathological conditions.  The mucins studied in the
   present work were obtained from the insoluble and fibrillar part of
   sputum.  If bronchial mucins are the main glycoproteins in the
   fibrillar mucus, these data suggest that there is a high proportion
   of acidic mucins within the bronchial secretions from CF patients.
   The predominance of acidic mucins may not be a specific feature of CF
   since the sputum from the 2 patients with other diseases had a
   similar mucin distribution.  As far as CF is concerned, it is
   presently impossible to state whether the bronchial mucins represent
   normal mucins of the child or structurally abnormal molecules.
RF 001   WAREMBOURG H          PROC COLLOQUE INT PATHOLOGI          181 968
   002   GOERKE J              BIOCHIM BIOPHYS ACTA           344   241 974
   003   BISERTE G             EXP ANNU BIOCHIM MED            24    85 963
   004   MASSON PL             BIOCHIM BIOPHYS ACTA           111   466 965
   005   RYLEY HC              BIOCHIM BIOPHYS ACTA           271   300 972
   006   HAVEZ R               EXP ANNU BIOCHIM MED            32   121 973
   007   BROGAN TD             BIOCHEM J                       71   125 959
   008   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   009   LAMBLIN G             BIOCHIM BIOPHYS ACTA           322   372 973
   010   ROUSSEL P             J BIOL CHEM                    250  2114 975
   011   POTTER JL             ANN NY ACAD SCI                106   692 963
   012   ROVIS L               BIOCHEMISTRY                    12  5340 973
   013   BAIG MM               J BIOL CHEM                    247  6111 972
   014   CARLSON DM            J BIOL CHEM                    243   616 968
   015   KABAT EA              BIOCHEMISTRY                     4  1632 965
   016   ROVIS L               BIOCHEMISTRY                    12  5340 973
   017   ROBERTS GP            EUR J BIOCHEM                   50   265 974
   018   LAFITTE JJ            C R ACAD SCI (PARIS)           281  1901 975
   019   LHERMITTE M           BIOCHIMIE                       58   367 976
   020   BAKER AP              BIOCHEM MED                     14    42 975
   021   LAMB D                COLLOQ INT PATHOL THORAC LILL        143 968
   022   LEV R                 AM J PATHOL                     46    23 965
   023   REID L                MOD PROBL PEDIATR               10   195 967
   024   DEMAILLE J            BULL SOC CHIM FRANCE          1965  3506 965
CT   1   SPICER SS             ENVIRON HEALTH PERSPECT         55   193 984

PN 76143
RN 00497 
AN 78071427
AU Boat-T-F.  Cheng-P-W.  Wood-R-E.
TI Tracheobronchial mucus secretion in vivo and in vitro by epithelial
   tissues from cystic fibrosis and control subjects.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 141-52.
MJ BRONCHI: se.  CYSTIC-FIBROSIS: pp.  MUCUS: se.  TRACHEA: se.
MN ADOLESCENCE.  ADULT.  BRONCHITIS: pp.  CHRONIC-DISEASE.
   EPITHELIUM:  se.  FEMALE.  GLYCOPROTEINS: an.  HUMAN.  IN-VITRO.
   ORGAN-CULTURE.  SPUTUM: an.
EX This paper reviews some of our efforts to compare mucous
   glycoproteins from the tracheobronchial tract of cystic fibrosis
   patients with those of control subjects.  We have used secretions
   from several sources, including sputum, bronchial washings obtained
   with the aid of the fiberoptic bronchoscope, tracheobronchial
   aspirates through endotracheal or tracheostomy tubes and, finally,
   secretions discharged by human tracheobronchial epithelial explants.
   Solubilization and fractionation of secretions; properties of the
   major mucous glycoprotein components; composition of major components
   from non-infected, bronchitic and CF lungs; and organ culture of
   human tracheobronchial epithelium are discussed.
RF 001   LITT M                BIORHEOLOGY                     11   111 974
   002   DI SANTAGNESE PA      N ENGL J MED                   295   481 976
   003   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   004   BROGAN TD             BR J EXP PATHOL                 41   288 960
   005   HAVEZ R               CLIN CHIM ACTA                  17   281 967
   006   BOAT TF               AM REV RESPIR DIS              110   428 974
   007   BOAT TF               ARCH BIOCHEM BIOPHYS           117    95 976
   008   BOAT TF               IN: MANGOS JA                        165 976
   009   SPIRO RG              ADV PROT CHEM                   27   349 973
   010   SPRINGER GF           PROC NAT ACAD SCI USA           64   635 969
   011   HOORN B               ACTA PATH MICROBIOL SCAND     S183       966
   012   BOAT TF               PEDIATR RES                      7   607 973
   013   BOAT TF               CHEST                           67   325 975
   014   SEGAL MS              ASTHMA ALLERGY                   2    17 975
   015   WARREN L              J BIOL CHEM                    234  1971 959
   016   ANTONOPOULOS CA       ACTA CHEM SCAND                 16  1521 962

PN 76144
RN 00498 
AN 78071426
AU Sturgess-J-M.
TI Bronchial mucus secretion in cystic fibrosis.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 129-40.
MJ BRONCHI: se.  CYSTIC-FIBROSIS: pp.  MUCUS: se.
MN ANIMAL.  BRONCHI: ul.  CHILD.  CHRONIC-DISEASE.  CYSTIC-FIBROSIS: bl.
   HUMAN.  IN-VITRO.  INFANT-NEWBORN.  LUNG-DISEASES: pp.
   MICROSCOPY-ELECTRON-SCANNING.  MUCOUS-MEMBRANE: de, se.
   ORGAN-CULTURE.  RATS.
EX Mucus is the primary aetiological factor in the development of
   pulmonary disease in cystic fibrosis.  Biochemical studies on
   bronchial secretions have not yet confirmed any qualitative
   difference in composition or in the nature of the glycoproteins, the
   major component of secretion.  With the lack of any clear evidence of
   a basic abnormality in the nature of mucus, attention has been
   directed to the possible defect in the control of mucus secretion.
   This encompasses alteration in the normal regulation of the autonomic
   nervous system or to its stimulation either at the cellular or
   intracellular control level.  In recent years, attention has focused
   on the presence of ciliotoxic factors in serum of children with
   cystic fibrosis, and their possible role in the pathophysiology of
   cystic fibrosis.  Control of mucus secretion, submucosal glands,
   goblet cells, experimental models of lung disease in cystic fibrosis,
   the role of serum factors in mucus secretion, and the mucus blanket
   in chronic lung disease are discussed.
RF 001   REID L                MOD PROBL PEDIATR               10   195 967
   002   OPPENHEIMER EH        PERSPECT PEDIATR PATHOL          2   241 975
   003   MELLINS RB            PEDIATRICS                      44   315 969
   004   FARBER S              ARCH PATHOL                     37   238 944
   005   STURGESS JM           IN: LAWSON D PROC 5TH INT CF         368 969
   006   YEATES DB             ARCH DIS CHILD                  51    28 976
   007   SPOCK A               PEDIATR RES                      1   173 967
   008   MEYRICK B             THORAX                          24   729 969
   009   REID L                IN: LIEBOW AA                         87 968
   010   BRANTIGAN OC          AM REV RESPIR DIS               80   194 959
   011   STURGESS JM           BR J EXP PATHOL                 54   388 973
   012   HAVEZ R               CLIN CHIM ACTA                  17   281 967
   013   STURGESS J            EXP MOL PATH                    16   362 972
   014   STURGESS JM           CLIN SCI                        43   533 972
   015   BOAT TF               CHEST                           67   325 975
   016   DE HALLER R           IN: EMERY JL                          94 969
   017   FLOREY HW             BR J EXP PATHOL                 13   269 932
   018   BOYD EM               CAN MED ASSOC J                 82   821 960
   019   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   020   MANGOS JA             PEDIATR RES                      1   436 967
   021   MARTINEZ JR           PEDIATR RES                      9   463 975
   022   HOLZEL A              LANCET                           1   822 962
   023   DI SANTAGNESE PA      N ENGL J MED                   295   481 976
   024   JOHANSEN PG           LANCET                           1   455 968
   025   FORSTNER JF           PEDIATR RES                     10   609 976
   027   BOWMAN BH             SCIENCE                        167   871 970
   028   CONOVER JH            LIFE SCI                        14   253 974
   029   SCHMOYER IR           LIFE SCI PART 2                 11  1037 972
   030   FORSTNER GG           CAN MED ASSOC J                113   550 975
   031   RAO GJS               PEDIATR RES                      9   739 975
   032   CONOVER JH            LANCET                           2  1501 973
   033   CZEGLEDY-NAGY E       LAB INVEST                      35   588 976
   035   HERZBERG V            J CLIN INVEST                   52  2732 973
   036   MCFARLANE H           BR MED J                         1   423 975
   037   STURGESS JM           AM REV RESPIR DIS              115   819 977
   039   EBERT RV              AM REV RESPIR DIS              112   491 975
CT   1   SPICER SS             ENVIRON HEALTH PERSPECT         55   193 984

PN 76145
RN 00499 
AN 78071425
AU Lopez-Vidriero-M-T.  Reid-L.
TI Pathophysiology of mucus secretion in cystic fibrosis.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 120-8.
MJ BRONCHI: se.  CYSTIC-FIBROSIS: pp.  MUCUS: se.
MN ADOLESCENCE.  ADULT.  BRONCHI: pa.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: pa.  GLYCOPROTEINS: se.  HUMAN.  IN-VITRO.  INFANT.
   INFANT-NEWBORN.  ORGAN-CULTURE.  SPUTUM: an.  TRACHEA: se.
AB Abnormality of mucus secretion, either biochemical or physical, has
   long been claimed to be the primary cause of pulmonary complications
   - obstruction and infection - in patients suffering from cystic
   fibrosis  (CF).  This review will draw in large measure on the
   experience of Prof. L. Reid and her research team who over the last
   15 years have studied mucus-secreting structures and their
   secretions in the normal and diseased lung from various angles:
   development, structure and ultrastructure, histochemistry organ
   culture, biochemical analysis and rheological characterization.
RF 001   TAPPAN V              ANN NY ACAD SCI                106   722 963
   002   REID L                ADV INTERN MED                  12   256 964
   003   MEYRICK B             THORAX                          24   729 969
   004   LAMB D                J PATHOL                        98   213 969
   005   JONES R               HISTOCHEM J                      5    19 973
   006   JONES R               HISTOCHEM J                      5    19 973
   007   LAMB D                HISTOCHEM J                      4    91 972
   008   LAMB D                BR J DIS CHEST                  66   239 972
   009   REID L                MOD PROBL PEDIATR               10   195 967
   010   LAMB D                BR J DIS CHEST                  66   239 972
   011   LEV R                 AM J PATHOL                     46    23 965
   012   STURGESS J            EXP MOL PATH                    16   362 972
   013   MEYRICK B             J CELL BIOL                     67   320 975
   014   REID L                IN: BALLS M                          463 976
   015   STURGESS JM           CLIN SCI                        43   533 972
   017   KEAL EE               THESIS                                   970
   018   MEARNS MB             ARCH DIS CHILD                  43   528 968
   019   LOPEZ-VIDRIERO MT     THESIS                                   976
   020   STURGESS J            RHEOL ACTA                      10    36 971
   021   CHARMAN J             BIORHEOLOGY                      9   185 972
   022   MITCHELL-HEGGS PF     BIORHEOLOGY                     11   417 974
CT   1   SPICER SS             ENVIRON HEALTH PERSPECT         55   193 984

PN 76146
RN 00500 
AN 78071422
AU Carlson-D-M.
TI Mucous glycoproteins.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 1-10.
MJ CYSTIC-FIBROSIS: me.  GLYCOPROTEINS: an.  MUCUS: an.
MN AMINO-ACIDS: an.  ANIMAL.  GLYCOPROTEINS: bi.  HUMAN.  MAMMALS.
   OLIGOSACCHARIDES: an, bi.  SWINE.
EX While there is widespread acceptance that mucous glycoprotein
   production is correlated with the pathogenesis of cystic fibrosis, as
   yet relatively little is known about the chemistry and control of
   synthesis and secretion of these heteromacromolecules.  This
   presentation describes briefly the chemistry and biosynthesis of
   glycoproteins in general, but is focused on the mucous glycoproteins.
   The chemistry of glycoproteins, carbohydrate to amino acid linkages,
   carbohydrate structural analysis, biosynthesis, and regulation are
   discussed.
RF 001   JAKOWSKA S            CF AND RELATED HUMAN AND ANIM            970
   002   ROSEMAN S             CHEM PHYS LIPIDS                 5   270 970
   003   SCHACHTER H           IN: HOROWITZ MI                          975
   004   JENTOFT N             IN: MARTONOSI A                  2   343 976
   005   KORNFELD R            ANNU REV BIOCHEM                45   217 976
   006   NUENKE RH             J BIOL CHEM                    236  2452 961
   007   JOHANSEN PG           BIOCHEM J                       78   518 961
   008   SPIRO RG              ADV PROT CHEM                   27   349 973
   009   ANDERSON B            ARCH BIOCHEM BIOPHYS           148   304 972
   010   SPIRO RG              J BIOL CHEM                    249  5704 974
   011$  BAHL OP               J BIOL CHEM                    244   575 972
   012   ARIMA T               J BIOL CHEM                    247  1825 972
   013   THOMAS DB             J BIOL CHEM                    244  5943 969
   014   CLAMP JR              IN: GOTTSCHALK A                     612 972
   015   CARLSON DM            J BIOL CHEM                    243   616 968
   016   IYER RN               ARCH BIOCHEM BIOPHYS           142   101 971
   017   LEHMAN D              FED PROC FED AM SOC EXP BIOL    33  1497 974
   018   CHOI HV               J BIOL CHEM                    249   932 974
   019   CARLSON DM            ANAL BIOCHEM                    20   195 967
   020   BELLA A JR            J CHROMATOGR                    51   314 970
   021   BHATTI T              BIOCHIM BIOPHYS ACTA           222   339 970
   022   BAIG MM               J BIOL CHEM                    247  6111 972
   023   SWELLEY CC            J AM CHEM SOC                   85  2497 963
   024   HAKOMORI S            J BIOCHEM (TOKYO)               55   205 964
   025   LINDBERG B            METHODS ENZYMOL                 28   178 972
   026   CARLSON DM            IN: ROSSI E                          304 968
   027   CARLSON DM            J BIOL CHEM                    248  5742 973
   028   MCGUIRE EJ            IN: AMINOFF D                        461 970
   029   MONTGOMERY R          IN: GOTTSCHALK A                     518 972
   030   SCHACHTER H           J BIOL CHEM                    246  5321 971
   031   ROVIS L               BIOCHEMISTRY                    12  5340 973
   032   GINSBURG V            ADV ENZYMOL                     26    35 964
   033   RUTTER WJ             J CELL PHYSIOL SUPPL            72     1 968
   034   PICTET RL             HANDBOOK OF PHYSIOLOGY SECT 7    1    25 972
   035   CARLSON DM            ARCH BIOCHEM BIOPHYS           152   605 973
   036   RONZIO RA             ARCH BIOCHEM BIOPHYS           159   777 973
   037   TURKINGTON RW         J BIOL CHEM                    246  1814 971

PN 76147
RN 00501 
AN 78071432
AU Newhouse-M-T.  Rossman-C-M.  Dolovich-J.  Dolovich-M-B.  Wilson-W-M.
TI Impairment of mucociliary transport in cystic fibrosis.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 190-8.
MJ CILIA: ph.  CYSTIC-FIBROSIS: pp.  MUCUS: ph.
MN HUMAN.  IGG.  IN-VITRO.  INFLAMMATION: pp.  NASAL-MUCOSA: pp.
   RESPIRATORY-SYSTEM: pp.
EX Over the past few years, studies from various laboratories have
   suggested the presence of a factor(s) in cystic fibrosis serum
   causing widespread in vitro abnormalities of components of the lung
   defence mechanism particularly with respect to macrophage
   dysfunction, quantitative and qualitative alterations in mucus, and
   ciliary motility.  The possible in vivo role of ciliary dysfunction
   in the pathogenesis of the disease is of particular clinical
   interest.  Since an in vitro ciliary dyskinesia factor had been
   previously demonstrated and pulmonary complications are the hallmark
   of CF, yet clearance in most of our clinically stable CF subjects was
   relatively well maintained, this suggested to us that a mucociliary
   transport abnormality might be present intermittently.  In order to
   explore this further, we designed nasal mucociliary clearance studies
   to determine whether CF serum might exhibit MCT inhibition in vivo.
   From these studies, we concluded that there was a substance(s) in CF
   serum which had the capacity to slow MCT.  Whether this effect is on
   the cilia themselves or via overproduction of normal or abnormal
   mucus is not known.
RF 001   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   002   YEATES DB             ARCH DIS CHILD                  51    28 976
   003   GIBSON LE             LANCET                           2   189 970
   004   SPOCK A               PEDIATR RES                      1   173 967
   005   BOWMAN BH             SCIENCE                        164   325 969
   006   BESLEY GTN            J MED GENET                      6   278 969
   007   WOOD RE               LANCET                           2  1452 973
   008   CHRISTENSEN J         IN: LAWSON D PROC 5TH INT CF          49 969
   009   CHERRY JD             J PEDIATR                       79   937 971
   010   SANCHIS J             N ENGL J MED                   288   651 973
   011   WOOD RE               AM REV RESPIR DIS              111   733 975
   012   NEWHOUSE M            IN: MANGOS JA                        319 973
   013   SANCHIS J             J APPL PHYSIOL                  33   757 972
   014   SANCHIS J             BULL PHYSIOPATH RESPIR NANCY     9   325 973
   015   ROSSMAN CM            J PEDIATR                       90   579 977
   016   PROCTOR DF            IN: DAVIES CN                    2    25 967
   017   BOWMAN BH             SCIENCE                        167   871 970
   018   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   019   DANES BS              J EXP MED                      137  1538 973
   020   ISHIZAKA K            J IMMUNOL                      100   554 968
   021   WANNER A              CHEST                           61   287 972
   022   KARTAGENER M          BEITR KLIN TUBERK               83   489 933
   023   CAMNER P              AM REV RESPIR DIS              112   807 975
   024   AFZELIUS BA           SCIENCE                        193   317 976

PN 76148
RN 00502 
AN 78071433
AU Aspin-N.  Wong-J-W.  Yeates-D-B.  Levison-H.
TI Mucociliary clearance in cystic fibrosis.
SO Mod-Probl-Paediatr. 1976 Oct 24-27. 19. P 199-206.
MJ CILIA: ph.  CYSTIC-FIBROSIS: pp.  MUCUS: ph.
MN ADULT.  AEROSOLS.  ANIMAL.  HUMAN.  POSTURE.  RABBITS.
   RADIOACTIVE-TRACERS.  RESPIRATORY-SYSTEM: pp.
   SCINTILLATION-COUNTING.  TRACHEA: pp.
EX If we are to fully understand the factors which control mucociliary
   clearance throughout the human lung and the interrelationships
   between clearance and disease, it will be necessary to measure
   mucociliary clearance rates in airways at all levels within the lung.
   During the past few years, technical means have been sought whereby
   the rates of mucus clearance within individual airways can be
   measured.  In this laboratory, we have developed a relatively
   noninvasive technique for measuring mucociliary tracheal transport
   rates.  We measured MTTRs in 20 patients with cystic fibrosis.  The
   MTTRs did not correlate well with the degree of pulmonary disease in
   these patients.  The measurements of MTTR would suggest that a
   deranged mucociliary clearance mechanism is not a necessary condition
   for patients with CF.  We have also been interested in evaluating the
   effectiveness of the therapy used in the treatment of CF.
RF 001   ASMUNDSSON T          AM REV RESPIR DIS              102   388 970
   002   SADE J                AM REV RESPIR DIS              102    48 970
   003   ALBERT RE             ARCH INTERN MED                131   115 973
   004   PROCTOR DF            AM REV RESPIR DIS              115    97 977
   005   SACKNER MA            J APPL PHYSIOL                  34   495 973
   006   WOOD RE               AM REV RESPIR DIS              111   733 975
   007   FRIEDMAN M            AM REV RESPIR DIS              115    67 977
   008   YEATES DB             J APPL PHYSIOL                  39   487 975
   009   YEATES DB             ARCH DIS CHILD                  51    28 976
CT   1   PASSERO MA            CLIN PEDIATR                    20   264 981

PN 76149
RN 00503 
AN 76242808
AU Di-SantAgnese-P-A.  Davis-P-B.
TI Research in cystic fibrosis (first of three parts).
SO N-Engl-J-Med. 1976 Aug 26. 295(9). P 481-5. (REVIEW).
MJ CYSTIC-FIBROSIS.
MN CAUCASOID-RACE.  CYSTIC-FIBROSIS: fg, me.  EXOCRINE-GLANDS: se.
   GENES-RECESSIVE.  GLYCOPROTEINS: me, ur.  GLYCOSAMINOGLYCANS: me.
   HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.  RESEARCH.  REVIEW.
   SUPPORT-U-S-GOVT-P-H-S.  VISCOSITY.
EX This review describes the major directions in cystic fibrosis
   research in the last nine years.  There have been no further reports
   of cystic fibrosis in native African Negroes.  It has been generally
   accepted that cystic fibrosis follows simple autosomal recessive
   transmission.  It is difficult, however, to explain maintenance of a
   lethal gene at such high frequency.  Nothing is known of the
   chromosomal localization of the trait.  At present there is no simple
   and reliable method of heterozygote detection.  The secretions of
   patients with cystic fibrosis are often not copious but exhibit a
   peculiar rheologic property.  Several groups have emphasized
   decreased water content of cystic fibrosis secretions in the
   pathogenesis of the disease.  There is no consistent abnormality of
   glycoproteins or glycosaminoglycans to explain why mucus secretions
   precipitate and obstruct the organ passages.
RF 001   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   002   DI SANTAGNESE PA      IN: VAUGHAN VC III                   903 975
   003   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   004   LOBECK CC             IN: STANBURY JB                     1605 972
   005   OPPENHEIMER EH        PERSPECT PEDIATR PATHOL          2   241 975
   006   SHWACHMAN H           IN: KENDIG EL JR                 1   524 972
   007   DI SANTAGNESE PA      IN: DOWNEY JA                         25 974
   008   WOOD RE               AM REV RESPIR DIS              113   833 976
   009   ANTONELLI M           FRACASTORO (VERONA)             63   207 970
   010   KULCZYCKI LL          AM J DIS CHILD                 127    64 974
   011   WRIGHT SW             AM J HUM GENET                  20   157 968
   012   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   013   HIRSCHHORN K          IN: MANGOS JA                        275 976
   014   LAPEY A               J PEDIATR                       84   328 974
   015   DANES BS              J EXP MED                      129   775 969
   016   DANES BS              J EXP MED                      136  1313 972
   017   POLYMENIDIS Z         LANCET                           2  1452 973
   018   SCHWARTZ RH           PEDIATR RES                      9   299 975
   019   BOCHKOVA DN           GENETICS                        11   154 975
   020   ANON                  J PEDIATR                       88   711 976
   021   BETTELHEIM FA         BIORHEOLOGY                      8   129 971
   022   LORIN MI              BIORHEOLOGY                      9    27 972
   023   LIEBERMAN J           AM REV RESPIR DIS               97   654 968
   024   KHAN MA               TEX REP BIOL MED                31   665 973
   025   HADORN B              CAN MED ASSOC J                 98   377 968
   026   KOPITO LE             FERTIL STERIL                   24   512 973
   027   JOHANSEN PG           LANCET                           1   455 968
   028   GIBSON LE             PEDIATRICS                      48   695 971
   029   WOTMAN S              ARCH ORAL BIOL                  16   663 971
   030   WIESMANN UN           LANCET                           2   510 972
   031   FORSTNER JF           PEDIATR RES                     10   609 976
   032   BOAT TF               PEDIATR RES                      8   531 974
   033   BETTELHEIM FA         BIOCHIM BIOPHYS ACTA           236   702 971
   034   BOAT TF               AM REV RESPIR DIS              110   428 974
   035   REID L                MOD PROBL PEDIATR               10   195 967
   036   ROUSSEL P             J BIOL CHEM                    250  2114 975
   037   BROGAN TD             THORAX                          30    72 975
   038   CLEAVE AJ             BIOCHIM BIOPHYS ACTA           285   208 972
   039   STEVENSON FK          CLIN CHIM ACTA                  23   441 969
   040   CROSBY P              HISTOCHEM J                      3   223 971
   041   BAIG MM               J PEDIATR                       86    72 975
   042   CHANGUS JE            AM J PATHOL                     80   317 975
   043   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   044   BAKER AP              BIOCHEM MED                     10   387 974
   045   LUNDGREN DW           CLIN CHIM ACTA                  62   357 975
   046   BAKER AP              ARCH BIOCHEM BIOPHYS           165   597 974
   047   SINGER L              CLIN BIOCHEM                     7   146 974
   048   BUTTERWORTH J         CLIN CHIM ACTA                  56   159 974
   049   MENGUY R              GASTROENTEROLOGY                59   257 970
   050   BOAT TF               IN: MANGOS JA                        165 976
   051   WILSON RG             CLIN CHIM ACTA                  36   189 972
   052   LANGGARD H            ACTA PAEDIATR SCAND             57   255 968
   053   CONSTANTOPOULOS G     J PEDIATR                       78   806 971
CT   1   POLONOVSKI C          PEDIATRE                        12   379 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   ANON                  BR MED J                         1   596 977
     4   SUPER M               LANCET                           2  1288 977
     5   HUNT LA               J SUPRAMOL STRUCT                7   213 977
     6   THOMAS JM             PEDIATR RES                     11  1148 977
     7   NEUTRA MR             LAB INVEST                      36   535 977
     8   HOSLI P               BIOCHEM BIOPHYS RES COMMUN      79   741 977
     9   SCANLIN TF            BIOCHEM BIOPHYS RES COMMUN      79   869 977
    10   BRAY PT               CLIN CHIM ACTA                  80   333 977
    11   HERROD HG             J PEDIATR                       91   276 977
    12   LIEBERMAN J           AM REV RESPIR DIS              116  1047 977
    13   DOERING KM            EUR J PEDIATR                  126   185 977
    14   HODSON ME             BR MED J                         1   971 978
    15   ANON                  LANCET                           2  1032 978
    16   FIGARELLA C           GASTROENTEROL CLIN BIOL          2   343 978
    17   OWEN E                J MOL MED                        3   203 978
    18   DAVIS PB              PEDIATR RES                     12   703 978
    19   IMPERO JE             PEDIATR RES                     12   108 978
    20   BOIS E                CLIN GENET                      14    73 978
    21   SCHAAP T              ISR J MED SCI                   14   201 978
    22   PEARSON RD            HEALTH LAB SCI                  15    32 978
    23   MARKOWITZ SM          INFECT IMMUN                    22   530 978
    24   RAO GJS               ENZYME                          23   314 978
    25   PURKISS P             CLIN CHEM                       24   714 978
    26   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
    27   HARRIES JT            BR MED BULL                     34    75 978
    28   HOSLI P               HUM GENET                       41   169 978
    29   KOLLBERG H            SCAND J RESPIR DIS              59   297 978
    30   NEUTRA MR             GASTROENTEROLOGY                75   701 978
    31   WILSON GB             J LAB CLIN MED                  92   463 978
    32   VAUGHAN WJ            SCIENCE                        199   783 978
    33   BRESLOW JL            SCIENCE                        201   180 978
    34   RAO GJS               BIOCHIM BIOPHYS ACTA           541   435 978
    35   HOSLI P               LANCET                           2   543 979
    36   SHIER WT              MED HYPOTHESES                   5   661 979
    37   SEALE TW              J CLIN MICROBIOL                 9    72 979
    38   DISANTAGNESE PA       MONOGR PAEDIATR                 10    66 979
    39   FEIGAL RJ             PEDIATR RES                     13   764 979
    40   GABRIDGE MG           PEDIATR RES                     13    31 979
    41   PEARSON RD            PEDIATR RES                     13   834 979
    42   PIVETTA OH            PEDIATR RES                     13  1160 979
    43   RUSSELL DH            PEDIATR RES                     13  1137 979
    44   WILL PC               PEDIATR RES                     13  1129 979
    45   LAM LFH               LIFE SCI                        24  2483 979
    46   SORDELLI DO           LIFE SCI                        24  2003 979
    47   COX DW                PEDIATR CLIN NORTH AM           26   467 979
    48   STURGESS JM           PEDIATR CLIN NORTH AM           26   481 979
    49   TUCKER RD             IEEE TRANS BIOMED ENG           26   607 979
    50   BROOKS FP             MAYO CLIN PROC                  54   475 979
    51   SANTAGNESE PAD        AM J MED                        66   121 979
    52   KOLLBERG H            ACTA PAEDIATR SCAND             68   639 979
    53   WOOD RE               SOUTH MED J                     72   189 979
    54   SHAPIRO BL            PROC NAT ACAD SCI USA           76  2979 979
    55   SCANLIN TF            CLIN CHIM ACTA                  91   197 979
    56   CHASE HP              J PEDIATR                       95   337 979
    57   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    58   HOSLI P               FEBS LETTERS                   104   271 979
    59   LEPRAT R              ANN MICROBIOL (PARIS)         B131   209 980
    60   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
    61   SCANLIN TF            CLIN CHEST MED                   1   424 980
    62   IANNACCONE G          PEDIATR RADIOL                   9    85 980
    63   BUCHWALD M            ADV CYCLIC NUCLEO RES           12   243 980
    64   MANDEL ID             CRC CRIT REV CLIN LAB SCI       12   321 980
    65   DAVIS PB              PEDIATR RES                     14    83 980
    66   GILLARD BK            PEDIATR RES                     14  1168 980
    67   WILL PC               PEDIATR RES                     14  1245 980
    68   LASZLO A              ACTA PAEDIATR ACAD SCI HUNG     21    69 980
    69   CHASE HP              METABOLISM                      29   365 980
    70   PRIMOSCH RE           ORAL SURG                       50   301 980
    71   GLORIABOTTINI F       HUM GENET                       54    79 980
    72   LLOYDSTILL JD         PEDIATRICS                      65  1010 980
    73   WILSON GB             J CLIN INVEST                   66  1010 980
    74   ADRIAN TE             GASTROENTEROLOGY                79   460 980
    75   DAVIS PB              J LAB CLIN MED                  96    75 980
    76   DUFFY MJ              CLIN CHIM ACTA                 103   233 980
    77   FODER B               CLIN CHIM ACTA                 104   187 980
    78   MALER T               FEBS LETTERS                   121   153 980
    79   WILLI UV              AM J ROENTGENOL                134  1005 980
    80   BALTIMORE RS          J INFECT DIS                   141   238 980
    81   ROSENSTEIN BJ         JOHNS HOPKINS MED J            147   188 980
    82   TABACHNIK NF          J PHARMACOL EXP THER           214   246 980
    83   DAVIS PB              N ENGL J MED                   302  1453 980
    84   MATTHEWS WJ           N ENGL J MED                   302   245 980
    85   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    86   FICK RB               CLIN CHEST MED                   2    91 981
    87   REYNOLDS HY           CLIN CHEST MED                   2   103 981
    88   STEGMAYR B            ULTRASTRUCTURAL PATHOL           2   357 981
    89   ANTONELLI M           RIV ITAL PEDIATR                 7   769 981
    90   BANCHINI G            PEDIATR RES                     15  1073 981
    91   BENYOSEPH Y           PEDIATR RES                     15   839 981
    92   IMPERO JE             PEDIATR RES                     15   940 981
    93   SANDERSON MJ          PEDIATR RES                     15   219 981
    94   SORENSEN RU           PEDIATR RES                     15    14 981
    95   RUDIN DO              BIOL PSYCHIAT                   16   373 981
    96   PIVETTA OH            LIFE SCI                        28  2207 981
    97   CAVALIER SJ           NEUROLOGY                       31   714 981
    98   FERNANDES PB          INFECT IMMUN                    33   527 981
    99   LLOYDSTILL JD         AM J CLIN NUTR                  34     1 981
   100   RUTLAND J             THORAX                          36   654 981
   101   ANON                  NUTR REV                        39    14 981
   102   CONGDON PJ            POSTGRAD MED J                  57   453 981
   103   FICK RB               J CLIN INVEST                   68   899 981
   104   WILSON GB             J CLIN INVEST                   68   171 981
   105   TEGNER H              ACTA PAEDIATR SCAND             70   629 981
   106   REZNIK VM             PROC NAT ACAD SCI USA           78  7143 981
   107   MARKS MI              J PEDIATR                       98   173 981
   108   LLOYDSTILL JD         J PEDIATR                       99   580 981
   109   JAKEL HP              BIOL ZENTRALBL                 100   273 981
   110   LEMANSKE RF           AM REV RESPIR DIS              123   622 981
   111   TABACHNIK NF          SURG GYNECOL OBSTET            152   837 981
   112   ROSCHER AA            J PHARMACOL EXP THER           216   419 981
   113   BYLUND DB             J PHARMACOL EXP THER           218   134 981
   114   MALER T               J BIOL CHEM                    256  1420 981
   115   BRESLOW JL            N ENGL J MED                   304     1 981
   116   SORSCHER EJ           LANCET                           1   368 982
   117   STERN RC              LANCET                           1  1401 982
   118   HOOGENRAAD TU         NEUROOPHTHALMOL                  2   267 982
   119   PALING MR             SKELETAL RADIOL                  8    63 982
   120   AONO M                IRCS MED SCI BIOCHEM            10   159 982
   121   TABAK LA              J ORAL PATHOL                   11     1 982
   122   FIGARELLA C           EUR J CLIN INVEST               12   145 982
   123   MORIARTY CM           J MED                           13   257 982
   124   BLITZER MG            PEDIATR RES                     16   203 982
   125   BOGART BI             PEDIATR RES                     16   223 982
   126   PATTON CJ             PEDIATR RES                     16  1035 982
   127   MITCHELL EA           AUST PAEDIATR J                 18    40 982
   128   MATSON JA             J REPROD MED                    27   373 982
   129   SHAPIRO BL            AM J HUM GENET                  34   846 982
   130   OHMAN DE              INFECT IMMUN                    37   662 982
   131   SLOMIANY BL           J DENT RES                      61  1163 982
   132   KOLLBERG H            EUR J RESPIR DIS                63   101 982
   133   MOSS AJ               PEDIATRICS                      70   728 982
   134   KOLLBERG H            ACTA PAEDIATR SCAND             71   197 982
   135   HUBBARD VS            J AM DIET ASSOC                 80   127 982
   136   KEMP T                ARCH INT PHYSIOL BIOCHIM        90  B123 982
   137   SNYDER CE             CARBOHYD RES                   105    87 982
   138   STURGESS J            AM J PATHOL                    106   303 982
   139   TSCHOLAKOFF D         FORTSCHR GEB RONTG NUKL        137    18 982
   140   KRAEMER R             EUR J PEDIATR                  138   172 982
   141   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982
   142   KATZ SM               JAMA                           248  2284 982
   143   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
   144   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
   145   SHAWKER TH            J ULTRASOUND MED                 2   439 983
   146   ZAMMARCHI E           RIV ITAL PEDIATR                 9   505 983
   147   NEU HC                J ANTIMICROB CHEMOTHER          11     1 983
   148   CERQUETTI MC          IMMUNOL COMMUN                  12   375 983
   149   HARD R                TISSUE CELL                     15   217 983
   150   CARMAGNOL F           PEDIATR RES                     17   181 983
   151   FRATES RC             PEDIATR RES                     17    30 983
   152   MARMON L              J PEDIATR SURG                  18   811 983
   153   FICK RB               BULL EUR PHYSIOPATH RESP        19   151 983
   154   CEDER O               CLIN GENET                      23   298 983
   155   DAVIS PB              J CHRON DIS                     36   269 983
   156   NEWHOUSE MT           EUR J RESPIR DIS                64   151 983
   157   PEDERSEN M            EUR J RESPIR DIS                64   118 983
   158   NEVE J                ACTA PAEDIATR SCAND             72   437 983
   159   ALLEN JM              GASTROENTEROLOGY                85  1379 983
   160   RUDICK VL             J CELL PHYSIOL                 115   143 983
   161   BARDON A              CLIN CHIM ACTA                 133   311 983
   162   ROSENBERG E           KLIN PAEDIATR                  195   323 983
   163   SLOMIANY A            J BIOL CHEM                    258  8535 983
   164   MINER C               J PHYSIOL (LOND)               338  P 63 983
   165   SHAPIRA E             ANN NY ACAD SCI                421   352 983
   166   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983
   167   SEYMOUR CA            BIOESSAYS                        1    38 984
   168   ANDERSON CM           J PEDIATR GASTROENTEROL NUTR     3    15 984
   169   VLADUTIU GD           IRCS MED SCI BIOCHEM            12   515 984
   170   BERGHOUT AGRV         PEDIATR RES                     18  1017 984
   171   BOYD RL               PEDIATR RES                     18  1028 984
   172   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984
   173   WILSON GB             CLIN GENET                      26   331 984
   174   MCCLURE HM            ADV VET SCI COMP MED            28   267 984
   175   TAWARA K              RES COMMUN CHEM PATH PHARM      43   515 984
   176   ALBAZZAZ FJ           RESPIRATION                     46    88 984
   177   HODSON ME             POSTGRAD MED J                  60   225 984
   178   BARDON A              ACTA PAEDIATR SCAND             73   263 984
   179   SATO K                J CLIN INVEST                   73  1763 984
   180   MCNEILL WF            AM J CLIN PATHOL                81   742 984
   181   DAVIS PB              CHEST                           85   802 984
   182   WAUTERS J             ARCH INT PHYSIOL BIOCHIM        92  B115 984
   183   RUDICK VL             J CELL PHYSIOL                 118    67 984
   184   WOOTEN MW             J CELL PHYSIOL                 121   490 984
   185   GILLARD BK            AM J DIS CHILD                 138   577 984
   186   RICE DH               WEST J MED                     140   238 984
   187   HANCOCK REW           J INFECT DIS                   149   220 984
   188   BRADY RC              EXP CELL RES                   150   141 984
   189   GOLDBERG JB           J BACTERIOL                    158  1115 984
   190   SATO K                AM J PHYSIOL                   247  R646 984
   191   SWOBODNIK W           J CLIN ULTRASOUND               13   469 985
   192   CASSANO WF            MED HYPOTHESES                  18    51 985
   193   WOOTEN MW             IN VITRO CELL DEVEL BIOL        21   207 985
   194   REYNOLDS HY           DISEASE A MONTH                 31     1 985
   195   DUNNE WM              MICROBIOS                       43   193 985
   196   JACQUOT J             INFECT IMMUN                    47   555 985
   197   DUNNE WM              APPL ENVIRON MICROBIOL          50   562 985
   198   TABLAN OC             J PEDIATR                      107   382 985
   199   HILL DJS              MED J AUST                     143   230 985
   200   FICK RB               J INFECT DIS                   151   589 985
   201   BRADY RC              AM J PHYSIOL                   248  G 54 985
   202   COLE DEC              J CHROMATOGR                   337   267 985
   203   MUALLEM S             BIOCHIM BIOPHYS ACTA           819   143 985
   204   GIBSON RA             J PEDIATR GASTROENTEROL NUTR     5   408 986
   205   BRIDGES MA            PEDIATR RES                     20   356 986
   206   REGELMANN WE          PEDIATR RES                     20   619 986
   207   RUPP GM               MED HYPOTHESES                  20   245 986
   208   PORTER WH             CLIN CHEM                       32   652 986
   209   SULLIVAN MM           CHEST                           90   239 986
   210   HUNSINGER RN          CLIN CHIM ACTA                 156   165 986
   211   BATTINO M             FEBS LETTERS                   199   155 986
   212   DASGUPTA MK           J CLIN IMMUNOL                   7    51 987
   213   DAVIS PB              J DENT RES                      66   667 987
   214   TANDLER B             J DENT RES                      66   398 987
   215   GEDSCHOLD J           HUM GENET                       75   277 987

PN 76150
RN 00504 
AN 76242767
AU di-SantAgnese-P-A.  Davis-P-B.
TI Research in cystic fibrosis (second of three parts).
SO N-Engl-J-Med. 1976 Sep 2. 295(10). P 534-41. (REVIEW).
MJ CYSTIC-FIBROSIS: me.
MN ANIMAL.  BIOLOGICAL-TRANSPORT.  CELL-MEMBRANE: me.  CHLORIDES: me.
   CILIA: ph.  COMPLEMENT-3.  CYSTIC-FIBROSIS: bl, pa.  FEMALE.
   GLYCOSAMINOGLYCANS: me.  HUMAN.  IGG: me.  LYSOSOMES: en.  MALE.
   METHYLATION.  POLYAMINES: bl.  PROTEIN-BINDING.  REVIEW.  RNA: me.
   SALIVA: an.  SODIUM: me.  SUBCELLULAR-FRACTIONS: en.
   SWEAT-GLANDS:  me.  TISSUE-CULTURE.  TOXINS: ip.
EX Tissue-culture studies involving metachromasia, glycosaminoglycans,
   RNA methylation, cell membranes, and ciliatoxic activity in medium
   are described.  Although not fulfilling the hopes of a quick route to
   discovery of the basic defect in this disease that were raised by the
   first findings, the study of fibroblasts in cystic fibrosis has given
   important information.  The evidence at present indicates that
   lysosomes and probably other intracellular organelles are normal in
   morphology and function in cystic fibrosis.  Several humoral
   abnormalities have been found in cystic fibrosis: those that
   influence ciliary activity in experimental models; those that affect
   membrane transport; and the abnormality in polyamine distribution.
   A number of abnormal humoral factors have been found in cystic
   fibrosis.  The limitations in their interpretation are serious: the
   assays used to delineate these abnormalities are often not
   universally reproducible, some because of their inherent variability
   and others because they are technically forbidding.  Therefore,
   unified definition of the so-called "cystic fibrosis factors" is not
   possible at present.
RF 054   DANES BS              LANCET                           1  1061 968
   055   BEARN AG              N ENGL J MED                   282   102 970
   056   TAYSI K               N ENGL J MED                   281  1108 969
   057   KRAUS I               PEDIATRICS                      47  1010 971
   058   MILUNSKY A            N ENGL J MED                   281  1128 969
   059   ANON                  SUBCOMMITTEE ON METACHROMASIA            972
   060   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   061   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969
   062   WIESMANN UN           J PEDIATR                       77   685 970
   063   WELCH DW              PEDIATR RES                      9   698 975
   064   RENNERT OM            IN: MANGOS JA                         41 973
   065   KLAGSBRUN M           IN: MANGOS JA                         53 973
   066   KLAGSBRUN M           PEDIATR RES                      8   205 974
   067   HODES ME              PEDIATR RES                      8   212 974
   068   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   069   QUISSELL DO           NATURE                         247   115 974
   070   BENKE PJ              LANCET                           1   182 972
   071   CHOU L                PEDIATR RES                     10   176 976
   072   DAVIS PB              PEDIATR RES                     10   364 976
   073   BERATIS NG            PEDIATR RES                      7   958 973
   074   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   075   HOUCK JC              PROC SOC EXP BIOL MED          135   369 970
   076   SIMOPOULOS AP         PEDIATR RES                      6   355 972
   077   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   078   BOLTON WE             AM J HUM GENET                  27   394 975
   079   FARRELL PM            PROC SOC EXP BIOL MED          149   340 975
   080   PALLAVICINI JC        J PEDIATR                       77   280 970
   081   STEELE MW             INT RES COMMUN SYST              2  1614 974
   082   SPICER SS             CF CLUB ABST                             976
   083   FARRELL PM            ACTA PAEDIATR SCAND             64   150 975
   084   BARTMAN J             J PEDIATR                       76   430 970
   085   ANTONOWICZ I          PEDIATR RES                      6   803 972
   086   BUTTERWORTH J         CLIN CHIM ACTA                  41   367 972
   087   BUTTERWORTH J         CLIN CHIM ACTA                  40   139 972
   088   WILSON RG             CLIN CHIM ACTA                  36   113 972
   089   MARCHI AG             HELV PAEDIATR ACTA              28   427 973
   090   GIBBS GE              SCIENCE                        167   993 970
   091   GRIFFIN GD            PROC SOC EXP BIOL MED          137   438 971
   092   GIBBS GE              J INVEST DERMATOL               51   200 968
   093   EVANS BW              AM J DIS CHILD                 127   660 974
   094   BENKE PJ              N ENGL J MED                   284   731 971
   095   FILLIAT M             PATHOL BIOL (PARIS)             21    13 973
   096   RUSSELL SB            J MED GENET                      8   441 971
   097   SLY WS                J PEDIATR                       82   249 973
   098   SHAPIRO BL            LANCET                           2  1020 974
   099   SHAPIRO BL            PROC SOC EXP BIOL MED          144   181 973
   100   SHAPIRO BL            BIOCHEM BIOPHYS RES COMMUN      39   816 970
   101   SPOCK A               PEDIATR RES                      1   173 967
   102   BOWMAN BH             SCIENCE                        164   325 969
   103   BESLEY GTN            J MED GENET                      6   278 969
   104   COHEN FL              J MED GENET                     11   253 974
   105   CHERRY JD             J PEDIATR                       79   937 971
   106   PUSSELT H             Z KINDERHEILK                  100    93 971
   107   CHRISTENSEN J         IN: LAWSON D PROC 5TH INT CF          49 969
   108   CONOVER JH            LANCET                           1  1194 973
   109   SCHMOYER IR           LIFE SCI PART 2                 11  1037 972
   110   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   111   BARNETT DR            TEX REP BIOL MED                31   709 973
   112   DANES BS              J EXP MED                      137  1538 973
   113$  BERATIS NG            PEDIATR RES                      8   687 974
   114   HERZBERG V            J CLIN INVEST                   52  2732 973
   115   POLLEY MJ             J MED GENET                     11   249 974
   116   CONOVER JH            LANCET                           2  1501 973
   117   RAO GJS               PEDIATR RES                      8   684 974
   118   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   119   LEDERBERG S           IN: MANGOS JA                        259 976
   120   WOOD RE               LANCET                           2  1452 973
   121   FARRELL PM            PEDIATR RES                     10   127 976
   122   CONOD EJ              PEDIATR RES                      9   724 975
   123   WILSON GB             PEDIATR RES                      9   635 975
   124   MANGOS JA             PEDIATR RES                      1   436 967
   125   MANGOS JA             PEDIATR RES                      2   378 968
   126   KAISER D              PEDIATR RES                      5   167 971
   127   TAYLOR A              PEDIATR RES                      8   861 974
   128   MANGOS JA             TEX REP BIOL MED                31   651 973
   129   TAUSSIG LM            LANCET                           1  1367 972
   130   SCHULZ IJ             J CLIN INVEST                   48  1470 969
   131   MANGOS JA             IN: MANGOS JA                        311 976
   132   ARAKI H               PEDIATR RES                      9   932 975
   133   MORIN CL              BIOMEDICINE EXPRESS             19   133 973
   134   BROWN GA              LANCET                           2   639 971
   135   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   136   OKA T                 J BIOL CHEM                    249  7647 974
   137   LUNDGREN DW           PROC SOC EXP BIOL MED          152    81 976
   138   RUSSELL DH            CANCER RES                      31  1555 971
   139   COHEN LF              PEDIATR RES                      9   312 975
   140   MCEVOY FA             PEDIATR RES                      9   721 975
   141   MUNRO GF              CF CLUB ABST                    16     7 975
   142   PETER WH              HOPPE SEYLERS Z PHYSIOL CHEM   354  1146 973
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   THOMAS JM             PEDIATR RES                     11  1148 977
     3   WILSON GB             PEDIATR RES                     11   986 977
     4   WILSON GB             PEDIATR RES                     11   317 977
     5   NEUTRA MR             LAB INVEST                      36   535 977
     6   SCANLIN TF            BIOCHEM BIOPHYS RES COMMUN      79   869 977
     7   LIEBERMAN J           AM REV RESPIR DIS              116  1047 977
     8   DOERING KM            EUR J PEDIATR                  126   185 977
     9   WILSON GB             NATURE                         266   463 977
    10   HODSON ME             BR MED J                         1   971 978
    11   FIGARELLA C           GASTROENTEROL CLIN BIOL          2   343 978
    12   OWEN E                J MOL MED                        3   203 978
    13   DAVIS PB              PEDIATR RES                     12   703 978
    14   IMPERO JE             PEDIATR RES                     12   108 978
    15   PEARSON RD            HEALTH LAB SCI                  15    32 978
    16   MARKOWITZ SM          INFECT IMMUN                    22   530 978
    17   RAO GJS               ENZYME                          23   314 978
    18   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
    19   NEUTRA MR             GASTROENTEROLOGY                75   701 978
    20   WIEDERHOLD ML         BRAIN RES                      156   369 978
    21   BRESLOW JL            SCIENCE                        201   180 978
    22   HOSLI P               LANCET                           2   543 979
    23   SEALE TW              J CLIN MICROBIOL                 9    72 979
    24   DISANTAGNESE PA       MONOGR PAEDIATR                 10    66 979
    25   GABRIDGE MG           PEDIATR RES                     13    31 979
    26   THOMASSEN MJ          PEDIATR RES                     13  1085 979
    27   LAM LFH               LIFE SCI                        24  2483 979
    28   SORDELLI DO           LIFE SCI                        24  2003 979
    29   COX DW                PEDIATR CLIN NORTH AM           26   467 979
    30   STURGESS JM           PEDIATR CLIN NORTH AM           26   481 979
    31   BROOKS FP             MAYO CLIN PROC                  54   475 979
    32   SANTAGNESE PAD        AM J MED                        66   121 979
    33   KOLLBERG H            ACTA PAEDIATR SCAND             68   639 979
    34   WOOD RE               SOUTH MED J                     72   189 979
    35   SHAPIRO BL            PROC NAT ACAD SCI USA           76  2979 979
    36   SCANLIN TF            CLIN CHIM ACTA                  91   197 979
    37   CHASE HP              J PEDIATR                       95   337 979
    38   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    39   HOSLI P               FEBS LETTERS                   104   271 979
    40   LEPRAT R              ANN MICROBIOL (PARIS)         B131   209 980
    41   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
    42   SCANLIN TF            CLIN CHEST MED                   1   424 980
    43   IANNACCONE G          PEDIATR RADIOL                   9    85 980
    44   BUCHWALD M            ADV CYCLIC NUCLEO RES           12   243 980
    45   DAVIS PB              PEDIATR RES                     14    83 980
    46   DAVIS PB              PEDIATR RES                     14   863 980
    47   GILLARD BK            PEDIATR RES                     14  1168 980
    48   WILL PC               PEDIATR RES                     14  1245 980
    49   PRIMOSCH RE           ORAL SURG                       50   301 980
    50   GLORIABOTTINI F       HUM GENET                       54    79 980
    51   WILSON GB             J CLIN INVEST                   66  1010 980
    52   DAVIS PB              J LAB CLIN MED                  96    75 980
    53   ROSENSTEIN BJ         JOHNS HOPKINS MED J            147   188 980
    54   DAVIS PB              N ENGL J MED                   302  1453 980
    55   MATTHEWS WJ           N ENGL J MED                   302   245 980
    56   MALER T               BIOCHIM BIOPHYS ACTA           598     1 980
    57   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    58   FICK RB               CLIN CHEST MED                   2    91 981
    59   REYNOLDS HY           CLIN CHEST MED                   2   103 981
    60   STEGMAYR B            ULTRASTRUCTURAL PATHOL           2   357 981
    61   ANTONELLI M           RIV ITAL PEDIATR                 7   769 981
    62   BANCHINI G            PEDIATR RES                     15  1073 981
    63   IMPERO JE             PEDIATR RES                     15   940 981
    64   SANDERSON MJ          PEDIATR RES                     15   219 981
    65   FERNANDES PB          INFECT IMMUN                    33   527 981
    66   ANON                  NUTR REV                        39    14 981
    67   FICK RB               J CLIN INVEST                   68   899 981
    68   WILSON GB             J CLIN INVEST                   68   171 981
    69   TEGNER H              ACTA PAEDIATR SCAND             70   629 981
    70   LIEBERMAN J           J LAB CLIN MED                  97   646 981
    71   MARKS MI              J PEDIATR                       98   173 981
    72   LLOYDSTILL JD         J PEDIATR                       99   580 981
    73   JAKEL HP              BIOL ZENTRALBL                 100   273 981
    74   LEMANSKE RF           AM REV RESPIR DIS              123   622 981
    75   ROSCHER AA            J PHARMACOL EXP THER           216   419 981
    76   BYLUND DB             J PHARMACOL EXP THER           218   134 981
    77   BRESLOW JL            N ENGL J MED                   304     1 981
    78   SORSCHER EJ           LANCET                           1   368 982
    79   STERN RC              LANCET                           1  1401 982
    80   HOOGENRAAD TU         NEUROOPHTHALMOL                  2   267 982
    81   TABAK LA              J ORAL PATHOL                   11     1 982
    82   BLITZER MG            PEDIATR RES                     16   203 982
    83   PATTON CJ             PEDIATR RES                     16  1035 982
    84   MITCHELL EA           AUST PAEDIATR J                 18    40 982
    85   SHAPIRO BL            AM J HUM GENET                  34   846 982
    86   OHMAN DE              INFECT IMMUN                    37   662 982
    87   SLOMIANY BL           J DENT RES                      61  1163 982
    88   KOLLBERG H            EUR J RESPIR DIS                63   101 982
    89   KOLLBERG H            ACTA PAEDIATR SCAND             71   197 982
    90   HUBBARD VS            J AM DIET ASSOC                 80   127 982
    91   KEMP T                ARCH INT PHYSIOL BIOCHIM        90  B123 982
    92   STURGESS J            AM J PATHOL                    106   303 982
    93   KRAEMER R             EUR J PEDIATR                  138   172 982
    94   KATZ SM               JAMA                           248  2284 982
    95   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
    96   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
    97   NEU HC                J ANTIMICROB CHEMOTHER          11     1 983
    98   CERQUETTI MC          IMMUNOL COMMUN                  12   375 983
    99   HARD R                TISSUE CELL                     15   217 983
   100   FRATES RC             PEDIATR RES                     17    30 983
   101   BUCHANAN KD           SCAND J GASTROENTEROL           18   155 983
   102   FICK RB               BULL EUR PHYSIOPATH RESP        19   151 983
   103   CEDER O               CLIN GENET                      23   298 983
   104   DAVIS PB              J CHRON DIS                     36   269 983
   105   NEVE J                ACTA PAEDIATR SCAND             72   437 983
   106   BARDON A              CLIN CHIM ACTA                 133   311 983
   107   ROSENBERG E           KLIN PAEDIATR                  195   323 983
   108   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983
   109   ANDERSON CM           J PEDIATR GASTROENTEROL NUTR     3    15 984
   110   VLADUTIU GD           IRCS MED SCI BIOCHEM            12   515 984
   111   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984
   112   WILSON GB             CLIN GENET                      26   331 984
   113   MCCLURE HM            ADV VET SCI COMP MED            28   267 984
   114   MESHULAM T            CLIN IMMUNOL IMMUNOPATHOL       32   151 984
   115   TAWARA K              RES COMMUN CHEM PATH PHARM      43   515 984
   116   HODSON ME             POSTGRAD MED J                  60   225 984
   117   BARDON A              ACTA PAEDIATR SCAND             73   263 984
   118   SATO K                J CLIN INVEST                   73  1763 984
   119   MCNEILL WF            AM J CLIN PATHOL                81   742 984
   120   DAVIS PB              CHEST                           85   802 984
   121   GILLARD BK            AM J DIS CHILD                 138   577 984
   122   HANCOCK REW           J INFECT DIS                   149   220 984
   123   GOLDBERG JB           J BACTERIOL                    158  1115 984
   124   SATO K                AM J PHYSIOL                   247  R646 984
   125   CASSANO WF            MED HYPOTHESES                  18    51 985
   126   REYNOLDS HY           DISEASE A MONTH                 31     1 985
   127   JACQUOT J             INFECT IMMUN                    47   555 985
   128   FRASE LL              GASTROENTEROLOGY                88   478 985
   129   TABLAN OC             J PEDIATR                      107   382 985
   130   FICK RB               J INFECT DIS                   151   589 985
   131   MUALLEM S             BIOCHIM BIOPHYS ACTA           819   143 985
   132   BRIDGES MA            PEDIATR RES                     20   356 986
   133   RUPP GM               MED HYPOTHESES                  20   245 986
   134   SULLIVAN MM           CHEST                           90   239 986
   135   DASGUPTA MK           J CLIN IMMUNOL                   7    51 987
   136   DAVIS PB              J DENT RES                      66   667 987
   137   TANDLER B             J DENT RES                      66   398 987
   138   GEDSCHOLD J           HUM GENET                       75   277 987
   139   EMMETT M              PROC SOC EXP BIOL MED          184    74 987

PN 76151
RN 00505 
AN 76242784
AU di-SantAgnese-P-A.  Davis-P-B.
TI Research in cystic fibrosis (third of three parts).
SO N-Engl-J-Med. 1976 Sep 9. 295(11). P 597-602. (REVIEW).
MJ CYSTIC-FIBROSIS: me.
MN ALPHA-FETOPROTEINS: me.  ANIMAL.  CILIA: pp.
   CYSTIC-FIBROSIS: di, im, mi, pp.  ELECTROLYTES: me.
   ENDOCRINE-GLANDS: pp.  FEMALE.  HETEROZYGOTE.  HUMAN.  INFECTION: im.
   KALLIKREIN: me.  KININS: me.  MUCUS: se.  PEPTIDE-HYDROLASES: ai.
   PREGNANCY.  PRENATAL-DIAGNOSIS.  PSEUDOMONAS-AERUGINOSA: ip.
   RESPIRATORY-SYSTEM: mi.  REVIEW.  SALIVARY-GLANDS: me.  SODIUM: me.
   STAPHYLOCOCCUS-AUREUS: ip.  TEARS:  me.  TRACHEA: pp.
EX Recent autonomic nervous system studies in cystic fibrosis are
   outlined.  Miscellaneous observations regarding salivary and tear
   glands, calcium, the kallikrein-kinin system, protease inhibitor,
   alpha-fetoprotein, and endocrine glands are discussed.  Because more
   than 90 per cent of patients with cystic fibrosis die of progressive
   pulmonary involvement, complicated by infection with Staphylococcus
   aureus or Pseudomonas aeruginosa (or both), the question of
   immunologic deficit is frequently raised.  Extensive investigations
   have shown the immune system in cystic fibrosis to be intact.
   Studies regarding pulmonary ciliary clearance and bacteriology are
   also outlined.  Despite extensive investigations, the basic defect of
   cystic fibrosis is still unknown.  What then is the explanation of
   the two defects in homozygotes that lead to most clinical
   manifestations - the sweat electrolyte defect and the abnormality in
   physiochemical behavior of mucous secretions?  The former is
   satisfactorily explained by a sodium-reabsorption-inhibitory factor
   present in sweat and saliva of patients.  As for the mucous-secretion
   abnormality, the effect of the increasing calcium concentration in
   decreasing the solubility of glycoproteins suggests that this
   mechanism might be responsible for the precipitation and obstruction
   of organ passages, which gives rise to most symptoms in cystic
   fibrosis.  Although there is an excellent diagnostic test for
   homozygotes (sweat test), one cannot rely on any of the present
   biologic assays for determination of heterozygosity or antenatal
   diagnosis.
RF 143   BOLANDE RP            ARCH PATHOL                     95   172 973
   144   STURGESS JM           BR J EXP PATHOL                 54   388 973
   145   MARTINEZ JR           PEDIATR RES                      9   463 975
   146   MARTINEZ JR           PEDIATR RES                      9   470 975
   147   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   148   BUCHWALD M            AM J HUM GENET                  27   22A 975
   149   WIESMANN UN           J PEDIATR                       76   444 970
   150   BLOMFIELD J           ARCH DIS CHILD                  48   267 973
   151   BOTELHO SY            J PEDIATR                       83   601 973
   152   SIMOPOULOS AP         PROC AM PEDIATR SOC ANNU MTG         201 971
   153   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   154   SMITH QT              NATURE NEW BIOL                240    56 972
   155   DUFFY MJ              NATURE NEW BIOL                246   151 973
   156   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   157   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   158   RAO GJS               J PEDIATR                       80   573 972
   159   RAO GJS               SCIENCE                        177   610 972
   160   COBURN MD             AM REV RESPIR DIS              110   368 974
   161   LIEBERMAN J           PEDIATR RES                      3   571 969
   162   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   163   TALAMO RC             PEDIATR RES                      6   430 972
   164   WEISS AS              J CLIN INVEST                   53   622 974
   165   SCHWARTZ RH           CF CLUB ABST                          19 972
   166   SHARP HL              IN: MANGOS JA                        229 973
   167   TALAMO RC             PEDIATRICS                      56    91 975
   168   SCHWARTZ RH           PEDIATR RES                      9   299 975
   169   TALAMO RC             IN: MANGOS JA                        195 976
   170   CHANDRA RK            BR MED J                         1   714 975
   171   SMITH JA              BR MED J                         2   392 975
   172   WALLWORK JC           BR MED J                         2   392 975
   173   BROCK DJH             BR MED J                         2   392 975
   174   DOLAN TF JR           J PEDIATR                       79   684 971
   175   ROSEN SW              J CLIN ENDOCRINOL METAB         32   410 971
   176   HANDWERGER S          N ENGL J MED                   281   451 969
   177   SIMOPOULOS AP         PEDIATR RES                      5   626 971
   178   MURAD F               J CLIN ENDOCRINOL METAB         40   552 975
   179   ROSAN RC              AM J DIS CHILD                 104   625 962
   180   WILMSHURST EG         PEDIATRICS                      55    75 975
   181   MILUNSKY A            AM J DIS CHILD                 121    15 971
   182   KJELLMAN NIM          ARCH DIS CHILD                  50   205 975
   183   STAHL M               J PEDIATR                       84   821 974
   184   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   559 974
   185   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   186   SCHWARTZ RH           AM J DIS CHILD                 120   432 970
   187   PENNINGTON JE         AM J MED                        58   629 975
   188   DI SANTAGNESE PA      DIS CHEST                       27   654 955
   189   MCFARLANE H           BR MED J                         1   423 975
   190   GUGLER EC             J PEDIATR                       73   548 968
   191   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
   192   FALCHUK ZM            PEDIATRICS                      51    49 973
   193   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   194   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   195   ROSSMAN CM            PEDIATR RES                      8   469 974
   196   SANCHIS J             N ENGL J MED                   288   651 973
   197   ASPIN NA              PEDIATR RES                      9   393 975
   198   WOOD RE               AM REV RESPIR DIS              111   733 975
   199   MAY JR                ARCH DIS CHILD                  47   908 972
   200   ZIERDT CH             J CLIN MICROBIOL                 1   521 975
   201   DOGGETT RG            APPL MICROBIOL                  18   936 969
   202   CONOVER JH            LIFE SCI                        14   253 974
CT   1   POLONOVSKI C          PEDIATRE                        12   379 976
     2   AZIZI F               N ENGL J MED                   295  1381 976
     3   RAMIREZ P             N ENGL J MED                   295  1381 976
     4   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     5   ANON                  BR MED J                         1   596 977
     6   THOMAS JM             PEDIATR RES                     11  1148 977
     7   LONGNECKER DS         ENVIRON HEALTH PERSPECT         20   105 977
     8   SCANLIN TF            BIOCHEM BIOPHYS RES COMMUN      79   869 977
     9   LIEBERMAN J           AM REV RESPIR DIS              116  1047 977
    10   DOERING KM            EUR J PEDIATR                  126   185 977
    11   FIGARELLA C           GASTROENTEROL CLIN BIOL          2   343 978
    12   OWEN E                J MOL MED                        3   203 978
    13   DAVIS PB              PEDIATR RES                     12   703 978
    14   IMPERO JE             PEDIATR RES                     12   108 978
    15   PEARSON RD            HEALTH LAB SCI                  15    32 978
    16   MARKOWITZ SM          INFECT IMMUN                    22   530 978
    17   RAO GJS               ENZYME                          23   314 978
    18   SCHWARZ HP            HELV PAEDIATR ACTA              33   351 978
    19   KOLLBERG H            SCAND J RESPIR DIS              59   297 978
    20   NEUTRA MR             GASTROENTEROLOGY                75   701 978
    21   VAUGHAN WJ            SCIENCE                        199   783 978
    22   BRESLOW JL            SCIENCE                        201   180 978
    23   RAO GJS               BIOCHIM BIOPHYS ACTA           541   435 978
    24   HOSLI P               LANCET                           2   543 979
    25   SEALE TW              J CLIN MICROBIOL                 9    72 979
    26   DISANTAGNESE PA       MONOGR PAEDIATR                 10    66 979
    27   GABRIDGE MG           PEDIATR RES                     13    31 979
    28   THOMASSEN MJ          PEDIATR RES                     13  1085 979
    29   LAM LFH               LIFE SCI                        24  2483 979
    30   SORDELLI DO           LIFE SCI                        24  2003 979
    31   COX DW                PEDIATR CLIN NORTH AM           26   467 979
    32   STURGESS JM           PEDIATR CLIN NORTH AM           26   481 979
    33   BROOKS FP             MAYO CLIN PROC                  54   475 979
    34   SANTAGNESE PAD        AM J MED                        66   121 979
    35   KOLLBERG H            ACTA PAEDIATR SCAND             68   639 979
    36   WOOD RE               SOUTH MED J                     72   189 979
    37   SHAPIRO BL            PROC NAT ACAD SCI USA           76  2979 979
    38   SCANLIN TF            CLIN CHIM ACTA                  91   197 979
    39   CHASE HP              J PEDIATR                       95   337 979
    40   WEISMAN Y             J PEDIATR                       95   416 979
    41   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    42   HOSLI P               FEBS LETTERS                   104   271 979
    43   LEPRAT R              ANN MICROBIOL (PARIS)         B131   209 980
    44   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
    45   SCANLIN TF            CLIN CHEST MED                   1   424 980
    46   IANNACCONE G          PEDIATR RADIOL                   9    85 980
    47   BUCHWALD M            ADV CYCLIC NUCLEO RES           12   243 980
    48   CASSINO RJJ           PEDIATR RES                     14  1212 980
    49   DAVIS PB              PEDIATR RES                     14    83 980
    50   GILLARD BK            PEDIATR RES                     14  1168 980
    51   WILL PC               PEDIATR RES                     14  1245 980
    52   WOODS DE              INFECT IMMUN                    30   694 980
    53   PRIMOSCH RE           ORAL SURG                       50   301 980
    54   SHIMAMOTO K           J CLIN ENDOCRINOL METAB         51   840 980
    55   GLORIABOTTINI F       HUM GENET                       54    79 980
    56   WILSON GB             J CLIN INVEST                   66  1010 980
    57   DAVIS PB              J LAB CLIN MED                  96    75 980
    58   ROSENSTEIN BJ         JOHNS HOPKINS MED J            147   188 980
    59   BYLUND DB             NATURE                         285   229 980
    60   DAVIS PB              N ENGL J MED                   302  1453 980
    61   MATTHEWS WJ           N ENGL J MED                   302   245 980
    62   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    63   FICK RB               CLIN CHEST MED                   2    91 981
    64   REYNOLDS HY           CLIN CHEST MED                   2   103 981
    65   ANTONELLI M           RIV ITAL PEDIATR                 7   769 981
    66   BANCHINI G            PEDIATR RES                     15  1073 981
    67   IMPERO JE             PEDIATR RES                     15   940 981
    68   SANDERSON MJ          PEDIATR RES                     15   219 981
    69   PIVETTA OH            LIFE SCI                        28  2207 981
    70   FERNANDES PB          INFECT IMMUN                    33   527 981
    71   OHMAN DE              INFECT IMMUN                    33   142 981
    72   THOMASSEN MJ          INFECT IMMUN                    33   512 981
    73   ANON                  NUTR REV                        39    14 981
    74   FICK RB               J CLIN INVEST                   68   899 981
    75   WILSON GB             J CLIN INVEST                   68   171 981
    76   TEGNER H              ACTA PAEDIATR SCAND             70   629 981
    77   CLARKE CW             BR J DIS CHEST                  75    15 981
    78   JACOBS WH             AM J GASTROENTEROL              76   342 981
    79   LIEBERMAN J           J LAB CLIN MED                  97   646 981
    80   MARKS MI              J PEDIATR                       98   173 981
    81   LLOYDSTILL JD         J PEDIATR                       99   580 981
    82   JAKEL HP              BIOL ZENTRALBL                 100   273 981
    83   LEMANSKE RF           AM REV RESPIR DIS              123   622 981
    84   SORENSEN RU           AM REV RESPIR DIS              123    37 981
    85   ROSCHER AA            J PHARMACOL EXP THER           216   419 981
    86   BYLUND DB             J PHARMACOL EXP THER           218   134 981
    87   BRESLOW JL            N ENGL J MED                   304     1 981
    88   VANGEFFEL R           ANN IMMUNOL (PARIS)           D133   293 982
    89   SORSCHER EJ           LANCET                           1   368 982
    90   STERN RC              LANCET                           1  1401 982
    91   HOOGENRAAD TU         NEUROOPHTHALMOL                  2   267 982
    92   VANGEFFEL R           IMMUNOL LETTERS                  5   155 982
    93   PALING MR             SKELETAL RADIOL                  8    63 982
    94   TABAK LA              J ORAL PATHOL                   11     1 982
    95   MORIARTY CM           J MED                           13   257 982
    96   JAGGER KS             J CLIN MICROBIOL                15  1054 982
    97   BLITZER MG            PEDIATR RES                     16   203 982
    98   PATTON CJ             PEDIATR RES                     16  1035 982
    99   MITCHELL EA           AUST PAEDIATR J                 18    40 982
   100   SHAPIRO BL            AM J HUM GENET                  34   846 982
   101   BOYCE JR              INFECT IMMUN                    37   695 982
   102   OHMAN DE              INFECT IMMUN                    37   662 982
   103   WINNIE GB             INFECT IMMUN                    38  1088 982
   104   DODGE JA              ARCH DIS CHILD                  57   774 982
   105   KOLLBERG H            EUR J RESPIR DIS                63   101 982
   106   KOLLBERG H            ACTA PAEDIATR SCAND             71   197 982
   107   HUBBARD VS            J AM DIET ASSOC                 80   127 982
   108   KEMP T                ARCH INT PHYSIOL BIOCHIM        90  B123 982
   109   STURGESS J            AM J PATHOL                    106   303 982
   110   KRAEMER R             EUR J PEDIATR                  138   172 982
   111   ROSENSTEIN BJ         JOHNS HOPKINS MED J            150   113 982
   112   KATZ SM               JAMA                           248  2284 982
   113   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
   114   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
   115   NEU HC                J ANTIMICROB CHEMOTHER          11     1 983
   116   CERQUETTI MC          IMMUNOL COMMUN                  12   375 983
   117   HARD R                TISSUE CELL                     15   217 983
   118   FRATES RC             PEDIATR RES                     17    30 983
   119   JAGGER KN             J CLIN MICROBIOL                17    55 983
   120   SCHILLER NL           PEDIATR RES                     17   747 983
   121   FICK RB               BULL EUR PHYSIOPATH RESP        19   151 983
   122   CEDER O               CLIN GENET                      23   298 983
   123   DAVIS PB              J CHRON DIS                     36   269 983
   124   NEVE J                ACTA PAEDIATR SCAND             72   437 983
   125   BARDON A              CLIN CHIM ACTA                 133   311 983
   126   HANNE LF              J BACTERIOL                    154   383 983
   127   ROSENBERG E           KLIN PAEDIATR                  195   323 983
   128   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983
   129   ANDERSON CM           J PEDIATR GASTROENTEROL NUTR     3    15 984
   130   SHAWKER TH            J ULTRASOUND MED                 3   267 984
   131   VLADUTIU GD           IRCS MED SCI BIOCHEM            12   515 984
   132   RABKIN CS             ANN NEUROL                      15   608 984
   133   BOYD RL               PEDIATR RES                     18  1028 984
   134   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984
   135   SPEERT DP             PEDIATR RES                     18   431 984
   136   ANWAR H               FEMS MICROBIOL LETTERS          24   235 984
   137   MCCLURE HM            ADV VET SCI COMP MED            28   267 984
   138   TAWARA K              RES COMMUN CHEM PATH PHARM      43   515 984
   139   HODSON ME             POSTGRAD MED J                  60   225 984
   140   BARDON A              ACTA PAEDIATR SCAND             73   263 984
   141   SATO K                J CLIN INVEST                   73  1763 984
   142   MCNEILL WF            AM J CLIN PATHOL                81   742 984
   143   DAVIS PB              CHEST                           85   802 984
   144   GILLARD BK            AM J DIS CHILD                 138   577 984
   145   HANCOCK REW           J INFECT DIS                   149   220 984
   146   GOLDBERG JB           J BACTERIOL                    158  1115 984
   147   SATO K                AM J PHYSIOL                   247  R646 984
   148   CASSANO WF            MED HYPOTHESES                  18    51 985
   149   MITCHELL EA           AUST PAEDIATR J                 21   127 985
   150   REYNOLDS HY           DISEASE A MONTH                 31     1 985
   151   JACQUOT J             INFECT IMMUN                    47   555 985
   152   LUZAR MA              INFECT IMMUN                    50   577 985
   153   LUZAR MA              INFECT IMMUN                    50   572 985
   154   FRIEDMAN HZ           GASTROENTEROLOGY                88   808 985
   155   TABLAN OC             J PEDIATR                      107   382 985
   156   MENDELMAN PM          AM REV RESPIR DIS              132   761 985
   157   FICK RB               J INFECT DIS                   151   589 985
   158   MUALLEM S             BIOCHIM BIOPHYS ACTA           819   143 985
   159   BRIDGES MA            PEDIATR RES                     20   356 986
   160   RUPP GM               MED HYPOTHESES                  20   245 986
   161   KUZEMKO JA            J ROY SOC MED                   79     2 986
   162   SULLIVAN MM           CHEST                           90   239 986
   163   DASGUPTA MK           J CLIN IMMUNOL                   7    51 987
   164   DAVIS PB              J DENT RES                      66   667 987
   165   TANDLER B             J DENT RES                      66   398 987
   166   GEDSCHOLD J           HUM GENET                       75   277 987
   167   EMMETT M              PROC SOC EXP BIOL MED          184    74 987

PN 76152
RN 00506 
AN 76220253
AU Stapleton-F-B.  Kennedy-J.  Nousia-Arvanitakis-S.  Linshaw-M-A.
TI Hyperuricosuria due to high-dose pancreatic extract therapy in
   cystic fibrosis.
SO N-Engl-J-Med. 1976 Jul 29. 295(5). P 246-8.
MJ CYSTIC-FIBROSIS: dt.  URIC-ACID: ur.
MN ADMINISTRATION-ORAL.  CASE-REPORT.  CHILD-PRESCHOOL.  HUMAN.  MALE.
   PANCREATIC-EXTRACTS: ad, ae, tu.  PANCREATIN: ad.  PURINES: ae, an.
   URINATION-DISORDERS: et.
AB Dysuria, uric acid crystalluria and hyperuricosuria developed in a
   child with cystic fibrosis and normal serum uric acid.
   Hyperuricosuria in this patient and two other children was directly
   related to ingestion of large amounts of pancreatic extract. In these
   three children, reducing pancreatic extract dosage by 85 percent
   lowered their purine intake by 307, 225, and 148 mg, respectively;
   urinary uric acid excretion decreased by 245, 239, and 158 mg.
   Overmedication resulted from parents' decisions to increase enzyme
   dosages. In our cystic fibrosis clinic, 15 of 32 patients screened at
   random were taking higher than the prescribed dose of pancreatic
   enzymes, and 14 of these 15 children were hyperuricosuric. On the
   basis of this information, we suggest that the minimal effective dose
   of pancreatic extract should be determined and adhered to for each
   child with cystic fibrosis to avoid potential renal injury from
   hyperuricosuria.
RF 001   ANON                  BR MED J                         2   161 970
   002   GRIEBSCH A            ADV EXP MED BIOL               41B   443 974
   003   EMERSON BT            NEPHRON                         14    62 975
   004   SCHNEIDER WC          J BIOL CHEM                    161   293 945
   005   WEBB JM               J BIOL CHEM                    230  1023 958
   006   UCHIDA T              IN: CANTONI GL                         3 966
   007   WILSON DM             KIDNEY INT                       4   331 974
   008   SEEGMILLER JE         IN: COHEN AS                         265 967
   009   MICHENER WM           AM J DIS CHILD                 113   195 967
   010   ROBSON AM             J PEDIATR                       79    42 971
   011   LITTMAN A             N ENGL J MED                   281   201 969
   012   MEYERS A              AM J DIS CHILD                 129  1011 975
CT   1   ANON                  LANCET                           2    73 977
     2   NOUSIAARVANITAKIS S   J PEDIATR                       90   302 977
     3   DIMAGNO EP            N ENGL J MED                   296  1318 977
     4   GAHL WA               N ENGL J MED                   297  1349 977
     5   CLAIN JE              S AFR MED J                     53   582 978
     6   NOUSIAARVANITAKIS S   J PEDIATR                       92   734 978
     7   STAPLETON FB          J PEDIATR                       92   911 978
     8   DAVIDSON GP           J PEDIATR                       93   976 978
     9   WOOD RE               SOUTH MED J                     72   189 979
    10   NEWMAN AJ             J PEDIATR                       94   594 979
    11   FORSTNER GG           J PEDIATR                       95   331 979
    12   GAHL WA               J PEDIATR                       95   330 979
    13   ROBB TA               LANCET                           2   544 980
    14   SACK J                ISR J MED SCI                   16   417 980
    15   NIESSEN KH            MONATSSCHR KINDERHEILKD        128   301 980
    16   SAGRANSKY DM          AM J DIS CHILD                 134   319 980
    17   GOW R                 LANCET                           2  1071 981
    18   CHO YW                J CLIN PHARMACOL                21   224 981
    19   PARK RW               GASTROENTEROLOGY                81  1143 981
    20   TOLCKMITT W           KLIN PAEDIATR                  193   365 981
    21   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
    22   MITCHELL EA           AUST PAEDIATR J                 18   114 982
    23   SHAW DW               NZ MED J                        95   424 982
    24   MISCHLER EH           AM J DIS CHILD                 136  1060 982
    25   MCGUIRE S             IR J MED SCI                   151   253 982
    26   GRENDELL JH           CLIN GASTROENTEROL              12   551 983
    27   SORKIN EM             DRUG INTEL CLIN PHARM           17   110 983
    28   DELUMLEY L            ARCH FR PEDIATR                 40   723 983
    29   STAPLETON FB          J PEDIATR                      102    88 983
    30   LANKISCH PG           CLIN GASTROENTEROL              13   985 984
    31   CHEN YT               N ENGL J MED                   311   128 984
    32   PERRY RS              CLIN PHARMACY                    4   161 985
    33   SPINO M               J PEDIATR                      107    64 985
    34   RUSH PJ               SEM ARTHRITIS RHEUM             15   213 986
    35   DAUDON M              ANN BIOL CLIN                   44    25 986
    36   RUBINSTEIN S          PEDIATRICS                      78   473 986
    37   PHILLIPS BM           J ROY SOC MED                   79    44 986

PN 76153
RN 00507 
AN 76196171
TI Letter: Cystic fibrosis: description and genetics.
SO N-Engl-J-Med. 1976 Jul 22. 295(4). P 231.
MJ CYSTIC-FIBROSIS.
MN CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.  HUMAN.
EX It is regrettable that the excellent article by Bowman and Mangos on
   cystic fibrosis should be marred by a minor, yet unfortunately
   common, error.  The risks of producing a child with cystic fibrosis
   in Table 1 would have been essentially correct if they had been
   stated in fractional terms.  They are, however, stated in odds forms,
   and therefore understatements of the true risks.  The risk when both
   parents are known to be heterozygous, for example, is stated as 1:4.
   This would mean that the second alternative has four times as much
   likelihood of occurring as the first, and it is clearly not true.
   When both parents are heterozygous the odds are three times as likely
   that the child will be normal as affected.  This is usually stated as
   a risk of 1/4, or 1:3, that the child will be affected.
RF 001   BOWMAN BH             N ENGL J MED                   294   937 976

PN 76154
RN 00508 
AN 77034612
TI Cystic fibrosis: thyroid function and alpha fetoprotein [letter].
SO N-Engl-J-Med. 1976 Dec 9. 295(24). P 1381-2.
MJ ALPHA-FETOPROTEINS.  CYSTIC-FIBROSIS: pp.  THYROID-GLAND: pp.
MN ADOLESCENCE.  ADULT.  CHILD.  CYSTIC-FIBROSIS: bl.  FEMALE.  HUMAN.
   MALE.
EX Our recent studies showed normal serum thyroxine but lower serum
   total and free tri-iodothyronine and higher serum thyrotropin
   concentration in children with cystic fibrosis than in controls
   matched for age and sex.  Furthermore, administration of iodides to
   children with cystic fibrosis resulted in goiter decrease in serum
   thyroxine and increase in serum thyrotropin concentration.  Our
   studies point to multiple derangement in thyroid hormone economy in
   children with cystic fibrosis.  Peripheral deiodination of thyroxine
   to tri-iodothyronine may be defective, probably as a result of a
   state of malnutrition.  An intrinsic abnormality may also be present
   in the thyroid gland.  Iodide, which is frequently used in this
   disease, may enhance this defect, occasionally producing
   hypothyroidism.  Therefore, the thyroid, like other organs of
   endodermal origin (lung and pancreas), may be involved in cystic
   fibrosis.  Thyroid function should be examined in all children with
   cystic fibrosis, and if iodides are administered, replacement doses
   of thyroid hormones should also be given to prevent hypothyroidism.
   - A recent review of cystic fibrosis referred to the report by
   Chandra et al. that the serum level of alpha fetoprotein (AFP) is
   increased in patients with cystic fibrosis (CF) or heterozygotes who
   bear the CF gene.  The report of Chandra et al. had prompted us to
   assess the level of AFP in cystic fibrosis, and we wish to record
   here briefly our negative observations.  On the whole, these results
   suggest that AFP is not increased in cystic fibrosis. - We thought
   that the complications of therapy with iodides or other agents was
   beyond the scope of our review, and thus we did not discuss the very
   interesting observations of the high rate of goiter after iodide
   therapy in CF patients.  Whether this phenomenon indicates a
   subclinical thyroid defect related to CF per se or is a secondary
   effect of chronic illness in youth is still unsettled.
RF 001   DOLAN TF JR           J PEDIATR                       79   684 971
   001   DI SANTAGNESE PA      N ENGL J MED                   295   597 976
   001   DI SANTAGNESE PA      N ENGL J MED                   295   597 976
   002   DOLAN TF JR           J PEDIATR                       79   684 971
   002   AZIZI F               TRANS ASSOC AM PHYSICIANS       87   111 974
   002   CHANDRA RK            BR MED J                         1   714 975
   003   FALLIERS CJ           J ALLERGY                       38   183 966
   003   AZIZI F               TRANS ASSOC AM PHYSICIANS       87   111 974
   003   BAUMGARTIN A          CLIN IMMUNOL IMMUNOPATHOL        6    42 976
   004   HOLTER H              LANCET                           2   184 975
   005   WALLWORK JC           BR MED J                         2   392 975
   006   BROCK DJH             BR MED J                         2   392 975
   007   FITZSIMMONS JS        BR MED J                         3   544 975
   008   SMITH JA              BR MED J                         2   392 975
CT   1   SACK J                ISR J MED SCI                   19    17 983

PN 76155
RN 00509 
AN 76149940
AU Zegers-B-J.  Maertzdorf-W-J.  Van-Loghem-E.  Mul-N-A.  Stoop-J-W.
   Van-Der-Laag-J.  Vossen-J-J.  Ballieux-R-E.
TI Kappa-chain deficiency.  An immunoglobulin disorder.
SO N-Engl-J-Med. 1976 May 6. 294(19). P 1026-30.
MJ ANTI-ANTIBODIES: an.  DYSGAMMAGLOBULINEMIA: im.  IGA: an.
   IMMUNOGLOBULINS-KAPPA-CHAIN.  IMMUNOGLOBULINS-LIGHT-CHAIN.
   IMMUNOLOGIC-DEFICIENCY-SYNDROMES: im.
MN ANTIBODY-FORMATION.  ANTIBODY-SPECIFICITY.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: co, fg, im.
   DIABETES-MELLITUS-INSULIN-DEPENDENT:  co.
   DYSGAMMAGLOBULINEMIA: co, fg.  HUMAN.  IGG: ip.  IGM: ip.
   IMMUNOELECTROPHORESIS.  LINKAGE-GENETICS.
   MALABSORPTION-SYNDROMES:  co.  MALE.  PHENOTYPE.
AB Since kappa-chain deficiency is an unusual condition, we studied the
   clinical and laboratory findings in a patient with this deficiency.
   The patient had cystic fibrosis with concurrent malabsorption,
   diabetes mellitus and IgA deficiency. The serum levels of IgM and IgG
   were 0.85 and 7.22 mg per milliliter, respectively. Kappa type IgM
   and IgG was not present in serum and external secretions; gamma, mu
   and lambda chains were probably polyclonal in character. Antibodies
   against kappa chains were not detected in either the patient or the
   mother. Plasma cells containing kappa-type immunoglobulins were
   absent in jejunum samples and bone marrow; kappa-chainbearing B
   lymphocytes could not be detected in blood and bone marrow. The serum
   of one of the patient's sisters contained trace amounts of kappa-type
   immunoglobulins. The patient displays a complete absence of kappa-
   type immunoglobulins, probably owing to a genetic defect.
RF 001   HOBBS JR              ADV CLIN CHEM                   14   219 971
   002   NATVIG JB             ADV IMMUNOL                     16    59 973
   003?  SELIGMANN M           REV FR ETUD CLIN BIOL           12   604 967
   004   BERNIER GM            BLOOD                           40   795 972
   005   BARANDUN S            BLOOD                           47    79 976
   007   MAERTZDORF W          EUR J CLIN INVEST                2   294 972
   008   VAN DER GIESSEN M     CLIN EXP IMMUNOL                21   501 975
   009   VAN LOGHEM E          IN: WEIR DM                            1 973
   010   MUL NAJ               EUR J CLIN INVEST                5    63 975
   011   HIJMANS W             CLIN EXP IMMUNOL                 4   457 969
   012   VOSSEN JM             ANN NY ACAD SCI                254   262 975
   013   HIJMANS W             IN: PEETERS H                        181 973
   014   ROSAN RC              AM J DIS CHILD                 104   625 962
   015   PENNY R               J PEDIATR                       78   512 971
   016   VYAS GN               CLIN GENET                       1    45 970
   017   NADORP JHS            EUR J CLIN INVEST                3   317 973
   018   BALLIEUX RE           ADV EXP MED BIOL                45   423 973
   019   LAWTON AR             CONTEMP TOP IMMUNOBIOL           3   193 974
   020   VAN LOGHEM E          EUR J IMMUNOL                    4    57 974
   021   HOOD L                IN: STERZL J                         283 970
   022   NUSSENZWEIG V         J EXP MED                      126   727 967
   023   CAPRA JD              PROC NAT ACAD SCI USA           69    40 972
   024   FRANKLIN EC           J IMMUNOL                      107  1527 971
CT   1   SOLOMON A             SCAND J IMMUNOL                  5   685 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   VANTHIEL DH           ANN INTERN MED                  86    10 977
     4   COIFFIER B            LYON MED                       237   399 977
     5   COOPER MD             SPRINGER SEMIN IMMUNOPATHOL      1   265 978
     6   SMITH WI              DIABETES                        27  1092 978
     7   HENDRICKX GFM         ACTA PAEDIATR SCAND             68   187 979
     8   MILLER ME             AM J HEMATOL                     8   333 980
     9   HODDINOTT S           DIABETOLOGIA                    23   326 982
    10   VANLOGHEM E           J CLIN INVEST                   72  1918 983
    11   ROSEN FS              N ENGL J MED                   311   300 984
    12   WEDGWOOD RJ           CLIN IMMUNOL ALLERGY             5   301 985
    13   STAVNEZER J           NUCLEIC ACIDS RES               13  3495 985
    14   STAVNEZERNORDGREN J   SCIENCE                        230   458 985
    15   OLIVIERO S            J IMMUNOGENET                   13     3 986
    16   MOSS RB               MONOGR ALLERGY                  19   202 986
    17   MONTECUCCO C          ARTHRITIS RHEUM                 29  1532 986
    18   RENCKENS ALJM         CLIN CHEM                       32  2147 986
    19   BUCKLEY RH            CLIN IMMUNOL IMMUNOPATHOL       40    13 986
    20   MONTECUCCO C          HAEMATOLOGICA                   71   237 986

PN 76156
RN 00510 
AN 76149897
AU Bowman-B-H.  Mangos-J-A.
TI Current concepts in genetics.  Cystic fibrosis.
SO N-Engl-J-Med. 1976 Apr 22. 294(17). P 937-8.
MJ CYSTIC-FIBROSIS: fg.
MN ALBUMINS: an.  CYSTIC-FIBROSIS: di.  FEMALE.  FETAL-DISEASES: di.
   GENETIC-COUNSELING.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.
   INFANT-NEWBORN.  INFANT-NEWBORN-DISEASES: di.  MECONIUM: an.
   PREGNANCY.  PRENATAL-DIAGNOSIS.  RATS.  SUPPORT-U-S-GOVT-P-H-S.
EX Cystic fibrosis has attracted the attention of biomedical
   investigators because it is the most prevalent chronic disease
   inherited in Caucasian children.  Carriers of the gene leading to
   cystic fibrosis occur quite frequently in the Caucasian population.
   A major aim in research on cystic fibrosis is the development of a
   test that will offer reliable detection of the heterozygote and of
   the fetus with cystic fibrosis.  Considerable numbers of patients
   with this disease are not diagnosed until after death.  The therapy
   of patients with cystic fibrosis is still symptomatic and includes
   appropriate diet (or diets), pancreatic enzyme and vitamin
   supplementation, treatment of chronic obstructive pulmonary
   involvement and chronic infections by antibiotics, physical therapy
   and inhalation therapy, psychoemotional support, and vocational
   rehabilitation.
RF 001   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   002   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   003   BOWMAN BH             TEX REP BIOL MED                31   611 973
CT   1   THOMAS JM             PEDIATR RES                     11  1148 977
     2   YOKOYAMA M            PEDIATR RES                     11   765 977
     3   LONGNECKER DS         ENVIRON HEALTH PERSPECT         20   105 977
     4   HARTUNG J             SOC BIOL                        24   192 977
     5   EVENSON MA            ANAL CHEM                       49  R 16 977
     6   FINLEY PR             AM J CLIN PATHOL                69   615 978
     7   STRAUSS GD            AM J DIS CHILD                 133   301 979
     8   STRAUSS GD            J CHRON DIS                     34   141 981
     9   MCNEELY MC            PEDIATR RES                     16    21 982
    10   LONGNECKER DS         AM J PATHOL                    107   103 982
    11   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984
    12   NAYLOR SL             AM J HUM GENET                  39   707 986

PN 76157
RN 00511 
AN 77011660
AU Newhouse-M.  Sanchis-J.  Bienenstock-J.
TI Lung defense mechanisms (first of two parts).
SO N-Engl-J-Med. 1976 Oct 28. 295(18). P 990-8. (REVIEW).
MJ LUNG: ph.
MN AIRWAY-OBSTRUCTION: pp.  ANIMAL.  BRONCHI: ph, se.  BRONCHITIS: pp.
   CILIA: ph, ul.  COMPLEMENT: ph.  COUGH: pp.  CYSTIC-FIBROSIS: pp.
   EXOCRINE-GLANDS: ph.  FILTRATION.  HUMAN.  LUNG: im, me, pp, ul.
   MOTION.  MUCUS: ph.  PARTICLE-SIZE.  REFLEX.  RESPIRATION.
   RESPIRATORY-AIRFLOW.  REVIEW.  SMOKING: pp.  TRACHEA: me, se.
EX One of the most important functions of the lung, aside from its role
   in gas exchange and metabolism, is the provision of an essential
   biologic barrier between man and his environment.  Of fundamental
   importance is the way in which the airways and lung parenchyma
   prevent entry of and neutralize or remove injurious agents, tasks
   performed so efficiently that the lung is normally sterile from the
   first bronchial division to terminal lung units.  Inhaled particles
   may be deposited in the respiratory tract as a result of impaction,
   sedimentation, Brownian motion, turbulent diffusion, and, to a
   minimal degree, electrostatic forces.  Particles deposited between
   the posterior two thirds of the nasal cavity and the nasopharynx and
   from the larynx to the terminal bronchioles land on airways lined by
   mucus-covered, ciliated epithelium and are removed by means of
   mucociliary transport mechanisms.  The structure of the mucociliary
   transport system, physical aspects of mucus, nonspecific soluble
   factors in airways secretions, and cilia and mucociliary transport
   are discussed.
RF 001   BOUHUYS A             PHYSIOLOGY ENVIRONMENT AND LU            974
   002   HATCH TF              PULMONARY DEPOSITION AND RETE            964
   003   OWEN PR               IN: WOLSTENHOLME GEW                     969
   004   WEHNER AP             CHEST                           60   468 971
   005   LANDAHL HD            BULL MATH BIOPHYS               12   161 950
   006   MOORMAN WJ            ARCH ENVIRON HEALTH             26   153 973
   007   LANDAHL HD            ARCH IND HYG                     1    36 950
   008   STRANDBERG LG         ARCH ENVIRON HEALTH              9   160 964
   009   SPEIZER FE            ARCH ENVIRON HEALTH             12   725 966
   010   VAUGHAN TR            ARCH ENVIRON HEALTH             19    45 969
   011   PROCTOR DF            IN: DAVIES CN                    2    25 967
   012   PROCTOR DF            IN: FENN WO                      1   309 964
   013   MORROW PE             HEALTH PHYS                      2   366 960
   014   HOFFMAN RA            J APPL PHYSIOL                  38   955 975
   015   SCHROTER RC           RESPIR PHYSIOL                   7   341 969
   016   LANDAHL HD            BULL MATH BIOPHYS               12    43 950
   017   MUIR DCF              ANN OCCUP HYG                   10   161 967
   018   COFFIN DL             ANN OCCUP HYG                   15   219 972
   019   AMDUR MO              ARCH ENVIRON HEALTH             16   460 968
   020   BOREN HG              ENVIRON RES                      1   178 967
   021   BOREN HG              ARCH ENVIRON HEALTH              8   119 964
   022   WILKENING MH          REV SCI INSTRUM                 23    13 952
   023   MCJILTON C            SCIENCE                        182   503 973
   024   AMDUR MO              ARCH ENVIRON HEALTH             16   460 968
   025   AMDUR MO              ARCH ENVIRON HEALTH             23   459 971
   026   DALHAMN T             AIR WATER POLLUT                 7   517 963
   027   DALHAMN T             AIR WATER POLLUT                 7   531 963
   028   MERCER TT             AEROSOL SCI                      1     9 970
   029   MORROW PE             IN: BOUHUYS A                        299 970
   030   TIMBRELL V            IN: MERCER TT                            972
   031   BEECKMANS JM          INT J ENVIRON STUD               1    31 970
   032   NADEL JA              J APPL PHYSIOL                  17   861 962
   033   NADEL JA              J APPL PHYSIOL                  20   164 965
   034   ZUSKIN E              N ENGL J MED                   290   660 974
   035   WIDDICOMBE JG         J APPL PHYSIOL                  17   613 962
   036   NADEL JA              ARCH ENVIRON HEALTH             16   171 968
   037   OLSEN CR              J APPL PHYSIOL                  20   202 965
   038   NADEL JA              ARCH ENVIRON HEALTH              7   179 963
   039   GOUGH J               INDIAN MED SURG                  6   285 960
   040   ROSS BB               J APPL PHYSIOL                   8   264 955
   041   NEWHOUSE M            IN: MANGOS JA                        319 973
   042   LOUDEN RG             AM REV RESPIR DIS               96   666 967
   043   WHITTENBERGER JL      TRANS NAT TUBERC ASS 48TH MTG            952
   044   JONES JG              CLIN SCI                        37   343 969
   045   JONES JG              BR J ANAESTH                    42   280 970
   046   WELLS WF              AIRBORNE CONTAGION AND AIR HY            955
   047   SANCHIS J             J APPL PHYSIOL                  33   757 972
   048   RHODIN JAG            AM REV RESPIR DIS SUPPL 3       93     1 966
   049   BUCHER U              THORAX                          16   219 961
   050   MATSUBA K             AM REV RESPIR DIS              107   552 973
   051   REID LM               THORAX                          10   199 955
   052   SLEIGH MA             INT REV CYTOL                   25    31 969
   053   SATIR P               SCI AM                         231    44 974
   054   KINOSITA H            PHYSIOL REV                     47    53 967
   055   KILBURN KH            AM REV RESPIR DIS               98   449 968
   056   REID L                THORAX                          15   132 960
   057   NIEWOEHNER DE         N ENGL J MED                   291   755 974
   058   MEYRICK B             THORAX                          24   729 969
   059   CHARMAN J             BIORHEOLOGY                      9   185 972
   060   DULFANO MJ            AM REV RESPIR DIS              112   341 975
   061   BANG BG               ANN NY ACAD SCI                106   625 963
   062   GUDBJERG CE           ACTA RADIOL                     42   269 954
   063   ANON                  BULL PHYSIOPATH RESPIR NANCY     9   471 973
   064   BOYD EM               RESPIRATORY TRACT FLUID                  972
   065   YEAGER H JR           AM J MED                        50   493 971
   066   DULFANO MJ            SPUTUM FUNDAMENTALS AND CLINI            974
   067   CHERNICK WS           PEDIATRICS                      24   739 959
   068   DENTON R              AM REV RESPIR DIS               98   380 968
   069   MEYER FA              BULL PHYSIOPATH RESPIR NANCY     9   259 973
   070   DULFANO MJ            AM REV RESPIR DIS              104    88 971
   071   GIBSON LE             LANCET                           2   189 970
   072   LUCAS AM              ARCH OTOLARYNGOL                20   518 934
   073   BANG BG               PROC SOC EXP BIOL MED          106   516 961
   074   SPICER SS             IN: DULFANO MJ                        22 973
   075   RYLANDER R            ARCH INTERN MED                126   496 970
   076   WEIBEL ER             MORPHOMETRY OF THE HUMAN LUNG            963
   077   NEGUS V               BR MED J                         2   723 961
   078   REYNOLDS HY           J LAB CLIN MED                  84   559 974
   079   LAURELL CB            SCAND J CLIN LAB INVEST         15   132 963
   080   ERIKSSON S            ACTA MED SCAND SUPPL           432     1 965
   081   TALAMO RC             N ENGL J MED                   278   345 968
   082   TALAMO RC             J ALLERGY CLIN IMMUNOL          48   240 971
   083   WARD PA               J CLIN INVEST                   52   516 973
   084   TOURVILLE DR          J EXP MED                      129   411 969
   085   MASSON PL             PROTIDES BIOL FLUIDS            16   633 968
   086   MASSON PL             J EXP MED                      130   643 969
   087   ORAM JD               BIOCHIM BIOPHYS ACTA           170   351 968
   088   BULLEN JJ             BR MED J                         1    69 972
   089   TOMASI TB JR          ADV IMMUNOL                      9     1 968
   090   WHEELOCK EF           ADV IMMUNOL                     16   123 973
   091   SADE J                AM REV RESPIR DIS              102    48 970
   092   SLEIGH MA             AM REV RESPIR DIS               93    16 966
   093   ASMUNDSSON T          AM REV RESPIR DIS              102   388 970
   094   LUCHSINGER PC         AM REV RESPIR DIS               97  1046 968
   095   DALHAMN T             ACTA PHYSIOL SCAND SUPPL 36          123 956
   096   HILDING AC            TRANS AM ACAD OPHTHALMOL OTOL   65   475 961
   097   DADAIAN JH            AM REV RESPIR DIS              103   808 971
   098   GOSSELIN RE           AM REV RESPIR DIS               93    41 966
   099   LAURENZI GA           J OCCUP MED                     15   175 973
   100   LAURENZI GA           AM REV RESPIR DIS              103   800 971
   101   BARCLAY AE            J PHYSIOL (LOND)                90   482 937
   102   HILDING AC            ARCH ENVIRON HEALTH              6    61 963
   103   YEATES DB             J APPL PHYSIOL                  39   487 975
   104   WOOD RE               AM REV RESPIR DIS              111   733 975
   105   HILDING AC            AM J PHYSIOL                   191   404 957
   106   REASOR MJ             FED PROC ABST NO 898            33   365 974
   107   SANCHIS J             IN: WALTON WH                            972
   108   SANCHIS J             N ENGL J MED                   288   651 973
   109   CAMNER P              ARCH ENVIRON HEALTH             26   294 973
   110   BOOKER DV             NATURE                         215    30 967
   111   MARIN MG              J APPL PHYSIOL                  27   385 969
   112   LAURENZI GA           N ENGL J MED                   279   333 968
   113   SACKNER MA            ANN INTERN MED                  82    40 975
   114   DALHAMN T             ARCH OTOLARYNGOL                70   166 959
   115   FALK HL               J NATL CANCER INST              23   999 959
   116   WANNER A              ARCH ENVIRON HEALTH             27   370 973
   117   SAKAKURA Y            PROC SOC EXP BIOL MED          140   870 972
   118   ALBERT RE             ARCH ENVIRON HEALTH             18   738 969
   119   LOURENCO RV           J CLIN INVEST                   50  1411 971
   120   CAMNER P              ARCH ENVIRON HEALTH             26    90 973
   121   CAMNER P              ARCH ENVIRON HEALTH             25    60 972
   122   WESTERGAARD O         ARCH KLIN EXP OHR NAS KEHLK H  203   179 973
   123   CAMNER P              ARCH ENVIRON HEALTH             23   421 971
   124   YEATES DB             J APPL PHYSIOL                  39   487 975
   125   DALHAMN T             BR J IND MED                    13   110 956
   126   FRENCH JG             ARCH ENVIRON HEALTH             27   129 973
   127   CARNOW BW             JAMA                           214   894 970
   128   LAWTHER PJ            THORAX                          25   525 970
   129   HOLMA B               ACTA MED SCAND SUPPL           473     1 967
   130   GIORDANO AM JR        ARCH ENVIRON HEALTH             25   443 972
   131   KILBURN KH            ARCH ENVIRON HEALTH             14    77 967
   132   BALLANGER JJ          PROC ASPEN EMPHYSEM CONF 11TH            968
   133   DALHAMN T             ACTA PHYSIOL SCAND              58   287 963
   134   HIRSCH JA             ARCH ENVIRON HEALTH             30   249 975
   135   ANDERSEN I            ARCH ENVIRON HEALTH             28    31 974
   136   WOLFF RK              ARCH ENVIRON HEALTH             30   521 975
   137   WOLFF RK              FED PROC ABST NO 951            34   387 975
   138   ROSSMAN CM            PEDIATR RES                      8   469 974
   139   WANNER A              FED PROC ABST NO 1169           34   427 975
   140   LANDA JF              J APPL PHYSIOL                  38   946 975
   141   SANTA CRUZ R          AM REV RESPIR DIS              109   458 974
   142   REASOR MJ             FED PROC ABST NO 898            33   365 974
   143   CAMNER P              ARCH ENVIRON HEALTH             29   220 974
   144   GREEN GM              J CLIN INVEST                   43   769 964
   145   LAURENZI GA           AM REV RESPIR DIS SUPPL 3       93   134 966
   146   SELLERS TF            J EXP MED                      114   237 961
   147   HERS JFP              AM REV RESPIR DIS SUPPL 3       93   162 966
   148   CAMNER P              AM REV RESPIR DIS              108   131 973
   149   JARSTRAND C           AM REV RESPIR DIS              110   415 974
   150   SCHWARZMANN SW        ARCH INTERN MED                127  1037 971
   151   CAMNER P              AM REV RESPIR DIS              112   807 975
CT   1   NEWHOUSE M            N ENGL J MED                   295  1486 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   ANON                  BR MED J                         1  1179 977
     4   JUNOD AF              BULL EUR PHYSIOPATH RESP        13   729 977
     5   VOISIN C              BULL EUR PHYSIOPATH RESP        13     3 977
     6   DANNENBERG AM         J RETICULOENDOTHEL SOC          22   273 977
     7   LAFORCE FM            ANESTHESIOLOGY                  47   195 977
     8   BRIGGS DD             MED CLIN NORTH AM               61  1163 977
     9   TILSON MD             SURGERY                         82   130 977
    10   BREEZE RG             AM REV RESPIR DIS              116   705 977
    11   FOURNIER G            LYON MED                       238    59 977
    12   COIL JA               INFECT IMMUN                    21   412 978
    13   DEMARIA TF            INFECT IMMUN                    21   114 978
    14   DOMINGUEZDEVILLOTA E  ACTA ANAESTHESIOL SCAND         22   227 978
    15   REASOR MJ             J APPL PHYSIOL                  45   190 978
    16   NEWHOUSE MT           CHEST                           73   936 978
    17   RUFFIN RE             CHEST                           73   501 978
    18   HARVEY RP             AM REV RESPIR DIS              117   695 978
    19   MCLEOD E              AM REV RESPIR DIS              118   561 978
    20   REYNOLDS HY           LUNG                           155   225 978
    21   BATEMAN JRM           LANCET                           1   294 979
    22   REYNOLDS HY           NOUV PRESSE MED                  8  2057 979
    23   KUTZ SA               ENVIRON RES                     19   405 979
    24   NEWTH CJL             PEDIATR CLIN NORTH AM           26   617 979
    25   MARCUCCI F            MINERVA PEDIATR                 31  1379 979
    26   CHOPRA SK             THORAX                          34   493 979
    27   DONALDSON SS          CANCER                          43  2036 979
    28   DICKERMAN JD          BLOOD                           54   354 979
    29   COOPER JM             AUST J EXP BIOL MED SCI         57   279 979
    30   REYNOLDS HY           CHEST                           75   239 979
    31   TISI GM               AM REV RESPIR DIS              119   293 979
    32   GONG H                AM REV RESPIR DIS              120   821 979
    33   DUNNILL MS            J PATHOL                       128   221 979
    34   ETIEVANT M            ANN IMMUNOL (PARIS)           D131    13 980
    35   COGGINS CRE           TOXICOLOGY                      16    83 980
    36   COIL JA               J SURG RES                      28    18 980
    37   ZANENLIM OG           J CLIN PATHOL                   33   474 980
    38   NIELSEN H             ANAESTHESIA                     35   703 980
    39   WALKER RD             AM J VET RES                    41  1015 980
    40   REYES MP              MED CLIN NORTH AM               64   363 980
    41   BERRY EM              LANCET                           1  1159 981
    42   BOUCHER RC            CLIN CHEST MED                   2   377 981
    43   CHANANA AD            J RETICULOENDOTHEL SOC          29   127 981
    44   HEBERT JC             J SURG RES                      31   337 981
    45   HESSE H               ARZNEIMITTEL FORSCH DRUG RES  31-1   716 981
    46   RUSSELLJONES GJ       INT ARCH ALLERGY APPL IMMUNOL   66   316 981
    47   COLLINS FM            VET IMMUNOL IMMUNOPATHOL         3     5 982
    48   BIENENSTOCK J         BULL EUR PHYSIOPATH RESP        18   153 982
    49   NIJHUISHEDDES JMA     EUR J RESPIR DIS                63   249 982
    50   NAKHOSTEEN JA         DTSCH MED WSCHR                107  1713 982
    51   HEIDBRINK PJ          AM REV RESPIR DIS              125   517 982
    52   WILKIE BN             J AM VET MED ASSOC             181  1074 982
    53   CHRETIEN J            SCHWEIZ MED WOCHENSCHR                36 983
    54   CLAYPOOL WD           SURV SYNTH PATHOL RES            2    34 983
    55   GILMOUR IJ            UROL CLIN NORTH AM              10    65 983
    56   HEBERT JC             J TRAUMA                        23     1 983
    57   CADIEUX A             ENVIRON HEALTH PERSPECT         51   287 983
    58   JAY SJ                MED CLIN NORTH AM               67  1251 983
    59   LARSEN GL             CHEST                           83  S  1 983
    60   LEUENBERGER P         SCHWEIZ MED WOCHENSCHR         113  1006 983
    61   ALBLAS ABV            AM REV RESPIR DIS              128   276 983
    62   CHRISTENSEN TG        SURV SYNTH PATHOL RES            3   201 984
    63   ELLENBERGER MA        VET IMMUNOL IMMUNOPATHOL         7   315 984
    64   GAUNT PN              INT ANESTHESIOL CLIN            22   113 984
    65   BIENENSTOCK J         ANNU REV MED                    35    49 984
    66   LAFORCE FM            INFECT IMMUN                    45   692 984
    67   PANCIERA RJ           AM J VET RES                    45  2538 984
    68   RUSSELLJONES GJ       AUST J EXP BIOL MED SCI         62     1 984
    69   PENNINGTON JE         AM J MED                        76    34 984
    70   HERROD HG             SOUTH MED J                     77  1007 984
    71   ZIMMERLI W            SCHWEIZ MED WOCHENSCHR         114  1074 984
    72   SHENNIB H             ARCH SURG                      119   274 984
    73   MCKIERNAN BC          J AM VET MED ASSOC             185  1155 984
    74   WINCHESTER JW         NUCL INSTR METH PHYS RES (B)   231   360 984
    75   LIGGITT HD            VET CLIN NORTH AM F ANI PRACT    1   347 985
    76   LEVISON ME            REV INFECT DIS                   7  S656 985
    77   PRUETER JC            VET CLIN NORTH AM S ANI PRACT   15  1085 985
    78   REYNOLDS HY           DISEASE A MONTH                 31     1 985
    79   TRIGO E               AM J VET RES                    46  1098 985
    80   TOEWS GB              INFECT IMMUN                    48   343 985
    81   HARADA RN             CHEST                           87   247 985
    82   SONE S                BIOCHIM BIOPHYS ACTA           823   227 985
    83   WANNER A              CLIN CHEST MED                   7   247 986
    84   NAIR P                J HOSP INFECT                    8    96 986
    85   KOHLER D              ATEMWEGS LUNGENKRANKH           12   358 986
    86   STRATTON CW           HEART LUNG                      15   226 986
    87   MARIN MG              PHARMACOL REV                   38   273 986
    88   TAYLOR RG             THORAX                          41   295 986
    89   OHMANN HB             INFECT IMMUN                    51   344 986
    90   REISER J              ARCH DIS CHILD                  61    88 986
    91   WOLFF RK              ENVIRON HEALTH PERSPECT         66   223 986
    92   LAFORCE FM            J INFECT DIS                   154   959 986
    93   HEILMANN P            J VET MED (B)                   34   126 987

PN 76158
RN 00512 
AN 77057479
AU Norman-A-P.
TI Cystic fibrosis.
SO Nurs-Times. 1976 Nov 18. 72(46). P 1804-6.
MJ CYSTIC-FIBROSIS.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: co, di.  GROWTH-DISORDERS: et.  HUMAN.  INFANT.
   INFANT-NEWBORN.  MECONIUM.
AB Gone are the days when it was thought that the prognosis was
   hopeless - at least three quarters of these children should live
   past the age of 19, especially now that the disease can be diagnosed
   at birth.  The diagnosis and treatment of cystic fibrosis are
   explained.

PN 76159
RN 00513 
AN 76243160
TI Immunologic mechanisms in cystic fibrosis.
SO Nutr-Rev. 1976 Jul. 34(7). P 210-1. (REVIEW).
MJ CYSTIC-FIBROSIS: im.  IMMUNITY.  LUNG-DISEASES: et.
MN ANTIBODY-FORMATION.  ANTIGENS-BACTERIAL.  BACTERIAL-INFECTIONS: et.
   CELL-MIGRATION-INHIBITION.  HUMAN.  IMMUNITY-CELLULAR.
   LUNG-DISEASES-OBSTRUCTIVE: et.  MACROPHAGES: im.
   MUCOUS-MEMBRANE:  im.  PHAGOCYTOSIS.  REVIEW.  SPUTUM: im.
AB Patients with cystic fibrosis appear to have normal immunocompetence
   although they are unusually susceptible to infections of the lung.
RF 001   SCHWARTZ RH           AM J DIS CHILD                 111   408 966
   002   OLIVIERI M            PEDIATRIA (NAPOLI)              81   453 973
   003   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   004   SOUTH MA              J PEDIATR                       71   645 967
   005   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
   006   FALCHUK ZM            PEDIATRICS                      51    49 973
   007   OGRADY LR             CF CLUB ABST                          16 975
   008   HANN S                CF CLUB ABST                          47 974
   009   HILL HR               J PEDIATR                       84    55 974
   010   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   011   HANN S                CF CLUB ABST                          24 975
   012   GIBBONS A             BR MED J                         1   120 976
   013   MCFARLANE H           BR MED J                         1   423 975
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985

PN 76160
RN 00514 
AN 76268238
AU Robinson-P-G.  Elliott-R-B.  Fraser-J.
TI Cystic fibrosis in New Zealand: incidence and mortality data.
SO NZ-Med-J. 1976 Apr 28. 83(562). P 268-70.
MJ CYSTIC-FIBROSIS: oc.
MN CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: mo.  ETHNIC-GROUPS.
   HOSPITALIZATION.  HUMAN.  INFANT.  INTESTINAL-OBSTRUCTION: mo.
   MECONIUM.  NEW-ZEALAND.  RESIDENCE-CHARACTERISTICS.
AB The incidence of and mortality from cystic fibrosis in New Zealand
   for the years 1965-1971 have been reviewed. Data were obtained from
   hospital admission and death records. All of the 171 cases were of
   European parentage except for one part-Maori child. The minimum
   incidence of cystic fibrosis in the European population (one in 3185
   live births) is comparable with that in other populations of similar
   background but somewhat lower than that derived by Becroft (1968).
   The data show that, during the period of the survey, approximately 30
   percent of cystic fibrosis suffereres died at less than 12 months of
   age.
RF 001   ANTONELLI M           FRACASTORO (VERONA)             63   207 970
   002   BECROFT DMO           NZ MED J                        68   113 968
   003   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   004   DONNISON AB           PEDIATRICS                      37   833 966
   005   MERRITT AD            J LAB CLIN MED                  60   998 962
   006   ROBINSON PG           NZ MED J                        79  1024 974
   007   SELANDER P            ACTA PAEDIATR SCAND             51    65 962
   008   WRIGHT SW             AM J HUM GENET                  20   157 968
CT   1   CROSSLEY JR           LANCET                           2  1093 977
     2   WESLEY AW             NZ MED J                        98   321 985

PN 76161
RN 00515 
AN 77035343
AU Mandel-I-D.  Wotman-S.
TI The salivary secretions in health and disease.
SO Oral-Sci-Rev. 1976. (8). P 25-47. (REVIEW).
MJ SALIVA: se.  SECRETORY-RATE: de.
MN AMYLASES: an.  BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: pp.
   DENTAL-CARIES: pc.  DIGITALIS-GLYCOSIDES: pd.  ELECTROLYTES: an.
   GLYCOPROTEINS: an.  HUMAN.  HYPERTENSION: pp.  IGA-SECRETORY: an.
   MOUTH-DISEASES: pc.  MURAMIDASE: an.  PAROTID-GLAND: ir.
   PHYSICAL-STIMULATION.  REVIEW.  SALIVA: an, en, ph, re.
   SALIVARY-GLAND-DISEASES: me.  SALIVARY-PROTEINS: an.
   SPECIMEN-HANDLING.  SUBMANDIBULAR-GLAND: ir.
AB The potential usefulness of analysis of the salivary secretions in
   diagnosis and prognosis is beginning to be explored in depth. The
   preliminary work already undertaken indicates that modern methods
   applied to this secretion may provide information that is different
   from that obtained in other body fluids. Saliva is collected at the
   point of its manufacture and, therefore, is unaffected by collection
   or storage in the body. It is the product both of protein synthesis
   within the glands and of most of the known water and electrolyte
   exchange mechanisms. Salivary composition is affected by both
   autonomic and hormonal stimuli. As the specific influence of each of
   these factors is better understood, studies of this fluid will
   provide important clues to the understanding of disease and the
   evaluation of therapy. There are few places in the body where it is
   possible directly, utilizing a non-invasive technique, to examine the
   product of a large number of important biological processes. It is
   obvious that careful handling of collection and analytic techniques
   are essential if these secretions are to be utilized. Future
   investigations in clinical situations should take full advantage of
   the strong base of knowledge of the physiology of these glands.
   Development of this field depends on careful clinical investigations
   designed to make full use of our current knowledge.
RF 001   ABELSON DC            J ORAL MED                      29    41 974
   002   ABELSON DC            J DENT RES SPEC ISS A A389      54       975
   003$  BAIG MM               J IMMUNOL                       11  1826 973
   004   BELLANTI JA           PHAGOCYTIC CELL IN HOST                  975
   005   GAERLAN PF            CF CLUB ABST                          40 974
   006   BERTRAM U             ACTA ALLERGOL                   19   458 964
   007   BERTRAM U             ACTA ODONT SCAND SUPPL          25    49 967
   008   BERNFELD P            METHODS ENZYMOL                  1   149 955
   009   BLAIR-WEST JR         HANDBOOK OF PHYSIOLOGY           2       967
   010   BLATT IM              ANN OTOL RHINOL LARYNGOL        67   595 958
   011   BLATT IM              TRANS AM ACAD OPHTHALMOL OTOL   66   723 962
   012   BLOCK PL              NY STATE DENT J                 28   116 962
   013   BLOMFIELD J           ARCH DIS CHILD                  48   267 973
   014   BOCHNER F             ARCH NEUROL                     31    57 974
   015   BOGDONOFF MD          J PSYCHOSOM RES                  5   170 961
   016   BOLTE HD              VERH DTSCH GES INN MED                   973
   017   BRANDTZAEG P          ACTA PATH MICROBIOL SCAND       79   189 971
   018   BRANDTZAEG P          ARCH ORAL BIOL                  16  1295 971
   019   BRANDTZAEG P          IMMUNOLOGY                      26  1101 974
   020   BRANDTZAEG P          SCAND J HAEMATOL SUPPL          12     1 970
   021   BROWN CC              PSYCHOPHYSIOL                    7    66 970
   022   BRUNNER HR            N ENGL J MED                   286   441 972
   023   CALDWELL RC           BIOCHIM BIOPHYS ACTA           101   157 965
   024   CARAWAY WT            AM J CLIN PATHOL                32    97 959
   025   CHAUNCEY HH           J DENT RES                      33   321 954
   026   CHANEY AL             CLIN CHEM                        8   130 962
   027   CHEN PS               ANAL CHEM                       28  1756 956
   028   CHISHOLM DM           BR DENT J                      135   393 973
   029   CONN JW               J LAB CLIN MED                  45     6 955
   030   DAWES C               J DENT RES                      49  1263 970
   031   DAWES C               J PHYSIOL (LOND)               220   529 972
   032   ELLISON SA            HANDBOOK OF PHYSIOLOGY               531 967
   033   ERICSSON Y            ACTA ODONT SCAND                17   131 959
   034   GIBSON LE             CLIN PEDIATR                    12   450 973
   035   GIBSON LE             GAP CONF REP PROB SWEAT TESTI            975
   036   GOLDMAN AS            J PEDIATR                       82  1082 973
   037   GOW BS                J DENT RES                      44   885 965
   038   HAMMER SM             AM COLL CARDIOL                          973
   039   HAWKINS GR            J DENT RES                      42   105 963
   040   HAYES CJ              PROC AM PEDIATR SOC ANNU MTG             974
   041   HENKIN RI             J APPL PHYSIOL                  22   316 967
   042   HENKIN RI             JAMA                           217     4 971
   043   HENKIN RI             ANN INTERN MED                  76   375 972
   044   HILTON SM             J PHYSIOL (LOND)               134   471 956
   045   HOEPRICH P            ANTIMICROB AGENTS CHEMOTHER      5   330 974
   046   IRIBE K               J NIHON UNIV SCH DENT           11    34 969
   047   JENKINS GN            IN: WOLSTENHOLME GEW                 192 965
   048   JENKINS GN            ARCH ORAL BIOL                  11  1203 966
   049   JOSELOW M             ARCH ENVIRON HEALTH             17    35 968
   050   JUSKO WJ              RES COMMUN CHEM PATH PHARM      10   189 975
   051   KABAT EA              EXPERIMENTAL IMMUNOCHEMISTRY             961
   052   KAHN N                IADR PROGRAM ABST                    169 969
   053   KOYSOOKO R            CLIN PHARMACOL THER             15   454 974
   054   KRAUS FW              ARCH ORAL BIOL                  16   781 971
   055   KRAKOWA P             POL MED J                        5   895 966
   056   KULLANDER S           ACTA ENDOCRINOL                 48   329 965
   057   KUTSCHER AH           NY STATE J MED                  68    28 968
   058   LASHLEY KS            J EXP PSYCHOL                    1   461 916
   059   LAULER D              N ENGL J MED                   267  1136 962
   060   MANDEL ID             PROC SOC EXP BIOL MED          115   959 964
   061   MANDEL ID             AM J DIS CHILD                 113   431 967
   062   MANDEL ID             J PERIODONTOL                   38   310 967
   063   MANDEL ID             ARCH ORAL BIOL                  14  1433 969
   064   MANDEL ID             CLIN PEDIATR                     8   161 969
   065   MANDEL ID             IN: GRANT DA                          99 972
   066   MANDEL ID             J DENT RES PRG ABST 672         52       973
   067   MANDEL ID             IN: MERGENHAGEN S                        973
   068   MANDEL ID             J DENT RES                      53   246 974
   069   MANDEL ID             J PERIODONT RES                  9   211 974
   070   MARDER MZ             J DENT RES SPEC ISS A A391      54       975
   071   MCDONALD RC           THESIS                                   950
   072   MERGENHAGEN S         COMPARATIVE IMMUNOLOGY OF                973
   073   MORRISON M            IN: PERSON P                             968
   074   MULROW PJ             IN: WESSON LG                  465   520 969
   075   OEMRAWSINGH I         ARCH ORAL BIOL                  19   615 974
   076   OPPENHEIM FG          HELV ODONT ACTA                 16    22 972
   077   OPPENHEIM F           IADR ABST 52                             973
   078   RAUCH S               IN: GORLIN R                             970
   079   SCHNEYER LH           J DENT RES                      34   257 955
   080   SHANNON IL            ACTA ENDOCRINOL                 46   393 964
   081   SHANNON IL            N ENGL J MED                   271    37 964
   082   SHANNON IL            J DENT RES                      51     6 972
   083   SHANNON IL            SALIVA COMPOSITION AND                   974
   084   SIEGEL IA             J PHARMACOL EXP THER           187   518 973
   085   SMITH TW              J CLIN INVEST                   49  2377 970
   086   STROMINGER JL         SCIENCE                        156   213 967
   087   SWANSON M             CIRCULATION                     47   736 973
   088   TARBET WJ             IADR ABST 92                             968
   089   TAUBMAN M             SALIVARY RES GRP IADR                152 973
   090   TOMASI TB JR          ADV IMMUNOL                      9     1 968
   091   TRUELOVE EL           J DENT RES                      46  1400 967
   092   VOLKER JF             J DENT RES                      25     9 947
   093   WARD R                LANCET                           2   726 972
   094   WEINSTEIN E           ARCH ORAL BIOL                  17   375 972
   095   WOLF RD               ARCH ORAL BIOL                  16  1357 971
   096   WOTMAN S              J DENT RES SPEC ISS A A52       54       975
   097   WOTMAN S              J ORAL THER                      3   239 967
   098   WOTMAN S              ARCH INTERN MED                124   477 969
   099   WOTMAN S              ARCH INTERN MED                126   248 970
   100   WOTMAN S              N ENGL J MED                   285   871 971
   101   WOTMAN S              J APPL PHYSIOL                  35   322 973
   102   WOTMAN S              IADR ABST 673                            973
   103   WOTMAN S              POSTGRAD MED                    53    73 973
   104   WOTMAN S              J PERIODONTOL                   44   278 973
   105   ZALL KM               ANAL CHEM                       28  1165 956
   106   ZENGO AN              ARCH ORAL BIOL                  16   557 971
CT   1   KLOCK B               SCAND J DENT RES                85    56 977
     2   TAMARIN A             J ORAL PATHOL                    8   293 979
     3   SKURK A               ARCH ORAL BIOL                  24   739 979
     4   GERMAINE GR           INFECT IMMUN                    26   991 979
     5   KLOCK B               SCAND J DENT RES                87   129 979
     6   GABAY EL              J ORAL REHABIL                   7   435 980
     7   MANDEL ID             J ORAL PATHOL                    9    92 980
     8   MANDEL ID             CRC CRIT REV CLIN LAB SCI       12   321 980
     9   SLOMIANY BL           ARCH ORAL BIOL                  25   749 980
    10   EPSTEIN SR            J PERIODONTOL                   51   336 980
    11   IZUTSU K              J DENT RES                      59  1192 980
    12   TWETMAN S             SWED DENT J                      5     9 981
    13   ITO H                 MECH AGEING DEV                 15   177 981
    14   MORMANN JE            CARIES RES                      15   166 981
    15   ECKERSALL PD          ARCH ORAL BIOL                  26   727 981
    16   BAUM BJ               LIFE SCI                        29  1143 981
    17   COLE MF               INFECT IMMUN                    31   998 981
    18   GERMAINE GR           INFECT IMMUN                    31   598 981
    19   SPIELMAN A            ORAL SURG                       51   144 981
    20   SMITH QT              J PERIODONTOL                   52   673 981
    21   BAUM BJ               J DENT RES                      60  1292 981
    22   KUYATT BL             J DENT RES                      60   936 981
    23   ITO H                 BIOCHEM BIOPHYS RES COMMUN      98   275 981
    24   BAUM BJ               J BIOL CHEM                    256  9731 981
    25   EDGAR WM              J ORAL PATHOL                   11   252 982
    26   JONEJA JM             ARCH ORAL BIOL                  27    51 982
    27   MARTINEZ JR           ARCH ORAL BIOL                  27   443 982
    28   SLOMIANY BL           ARCH ORAL BIOL                  27   803 982
    29   KARLSSON A            J TROP PEDIATR                  28   230 982
    30   BAUM BJ               J GERONTOL                      37   392 982
    31   EDGAR WM              J DENT RES                      61  1126 982
    32   SLOMIANY BL           J DENT RES                      61  1163 982
    33   DONATSKY O            SCAND J DENT RES                90   157 982
    34   STENBERG T            SCAND J DENT RES                90   472 982
    35   SLOMIANY BL           ARCH ORAL BIOL                  28   711 983
    36   WIESENFELD D          AUST DENT J                     28    87 983
    37   DISTLER W             J DENT RES                      62    87 983
    38   ROLLA G               SCAND J DENT RES                91   186 983
    39   OHLSSON M             HOPPE SEYLERS Z PHYSIOL CHEM   364  1323 983
    40   MARSHALL T            ELECTROPHORESIS                  5   245 984
    41   CROSSNER CG           SWED DENT J                      8   271 984
    42   OSTERBERG T           J ORAL REHABIL                  11   157 984
    43   STUCHELL RN           OTOL CLIN NORTH AM              17   697 984
    44   BENARYEH H            J PSYCHIATR RES                 18   299 984
    45   OHURA K               J PERIODONT RES                 19    21 984
    46   BENARYEH H            ISR J MED SCI                   20   197 984
    47   BORGEAT F             PSYCHOPHYSIOL                   21   690 984
    48   HEFT MW               J DENT RES                      63  1182 984
    49   OGLESBEE LH           CLIN CHIM ACTA                 143   135 984
    50   BENARYEH H            GERODONTOLOGY                    4    77 985
    51   MORGAN BLG            J ORAL PATHOL                   14    37 985
    52   SLOMIANY BL           PROG LIPID RES                  24   311 985
    53   RUDNEY JD             ARCH ORAL BIOL                  30   765 985
    54   LAIBLE NJ             INFECT IMMUN                    48   720 985
    55   RUDNEY JD             INFECT IMMUN                    49   469 985
    56   YOSHIDA Y             ORAL SURG                       59   426 985
    57   LORBER M              JAMA                           253   778 985
    58   SCOTT J               GERODONTOLOGY                    5   149 986
    59   HAKANSSON B           J ORAL REHABIL                  13   235 986
    60   RAVALD N              J CLIN PERIODONTOL              13   758 986
    61   AHLQWIST M            COMMUNITY DENT ORAL EPIDEMIOL   14   358 986
    62   YONTCHEV E            INT J ORAL MAXILLOFAC SURG      15   687 986
    63   JENZANO JW            ARCH ORAL BIOL                  31   627 986
    64   SLOMIANY BL           ARCH ORAL BIOL                  31   463 986
    65   PASTER BJ             INFECT IMMUN                    52   378 986
    66   FOX PC                ORAL SURG                       61   243 986
    67   HANDELMAN SL          ORAL SURG                       62    26 986
    68   AGUIRRE A             ARCH ORAL BIOL                  32   297 987
    69   EDGERTON M            J PROSTHET DENT                 57    57 987
    70   SCHUBERT MM           J DENT RES                      66   680 987

PN 76162
RN 00516 
AN 77124688
AU Sturgess-J-M.  Moscarello-M-A.
TI Alterations in the Golgi complex and glycoprotein biosynthesis in
   normal and diseased tissues.
SO Pathobiol-Annu. 1976. 6. P 1-29. (REVIEW).
MJ GLYCOPROTEINS: bi.  GOLGI-APPARATUS: me.
MN ADOLESCENCE.  ADULT.  ANIMAL.  CHILD.  CHILD-PRESCHOOL.
   CYCLOHEXIMIDE: pd.  CYSTIC-FIBROSIS: me, pa.
   ENDOPLASMIC-RETICULUM:  me.  FREEZE-FRACTURING.
   GOLGI-APPARATUS: de, ul.  HUMAN.  LIVER-DISEASES: me.
   LIVER-DISEASES: pa.  LIVER: me, pa.  MICROSCOPY-ELECTRON.
   NEPHROSIS: me, pa.  RATS.  REVIEW.
EX The Golgi complex has an important role in the regulation and normal
   development of the cell, contributing to anabolic functions including
   the assembly and secretion of macromolecules and to catabolic
   functions, in the synthesis of lysosomes.  The central role of the
   Golgi complex in the biosynthesis of glycoproteins has been
   demonstrated.  The purpose of this review is to focus attention on
   the structural and functional correlation of the Golgi complex in the
   liver, in relation to its involvement in disease.  The hepatic
   parenchymal cell has been used widely as a model to study
   biosynthetic, absorptive and secretory functions of epithelial cell
   types.  The studies are grouped under five broad headings: structural
   organization; development and differentiation; ultrastructural
   changes in pathologic conditions; alterations in glycoprotein
   biosynthesis; and alterations in glycosyltransferases.
RF 001   DEDUVE C              ANNU REV PHYSIOL                28   435 966
   002   CARO LG               J CELL BIOL                     20   473 964
   003   JAMIESON JD           PROC NAT ACAD SCI USA           55   424 966
   004   MAHLEY RW             J LIPID RES                     10   433 969
   005   HAMILTON RL           LAB INVEST                      16   305 967
   006   NEUTRA M              J CELL BIOL                     30   119 966
   007   SJOSTRAND FS          IN: DALTON AJ                            968
   008   PALADE GE             IN: HAYASHI T                         64 959
   009   WHALEY WG             SCIENCE                        175   596 972
   010   SCHACHTER H           J BIOL CHEM                    245  1090 970
   011   EYLAR EH              J THEOR BIOL                    10    89 966
   012   COOK GMW              FED PROC                        23   274 964
   013   COOK GMW              BIOCHIM BIOPHYS ACTA           101    57 965
   014   WALDENSTROM J         ACTA MED SCAND                 117   216 944
   015   SCHULTZE HE           NATURFORSCH                    10B   463 955
   016   PETERKOFSKY A         J IMMUNOL                       76   237 956
   017   ROWE DS               BIOCHEM J                       67   435 957
   018   SPIRO RG              N ENGL J MED                   281   991 969
   019   SCHACHTER H           IN: FISHMAN WH                   3     2 973
   020   SPIRO RG              J BIOL CHEM                    235  2860 960
   021   LEWIN PK              EXP MOL PATH                     8    21 968
   022   SARCIONE EJ           CANCER RES                      27  2025 967
   023   KUHLENSCHMIDT MS      LAB INVEST                      31   413 974
   024   HUDGIN RL             CAN J BIOCHEM                   49    61 971
   025   ITO S                 J CELL BIOL                     27   475 965
   026   RAMBOURG A            INT REV CYTOL                   31    87 971
   027   STURGESS JM           J MEMBR BIOL                    12   367 973
   028   BEAMS HW              INT REV CYTOL                   23   209 968
   029   NORTHCOTE DH          ENDEAVOR                        30    26 971
   030   MORRE DJ              IN: REINERT J                            971
   031   CUNNINGHAM WP         IN: LASKIN AI                            974
   032   CUNNINGHAM WP         J CELL BIOL                     63  1018 974
   033   STURGESS JM           PROC INT CONG ELECTR MICR            194 974
   034   CLAUDE A              J CELL BIOL                     47   745 970
   035   BRUNI C               AM J PATHOL                     46   691 965
   036   ZEIGEL RF             J CELL BIOL                     15    45 962
   037   MOSCARELLO MA         BIOCHIM BIOPHYS ACTA           320   123 972
   038   STAEHELIN LA          J CELL SCI                       7   787 970
   039   HEREWARD FW           J CELL SCI                      13   621 973
   040   BRANTON D             PHIL TRANS R SOC LOND BIOL     261   133 971
   042   STURGESS JM           J CELL BIOL                     55   524 972
   043   ROHR HP               LAB INVEST                      24   128 971
   045   WEIBEL ER             J CELL BIOL                     42    68 969
   046   WIENER J              J CELL BIOL                     37    47 968
   047   STAUBLI W             J CELL BIOL                     42    92 969
   048   RIEDE UN              VIRCHOWS ARCH CELL PATHOL        9    16 971
   049   BOLENDER RP           J CELL BIOL                     56   746 973
   051   FLICKINGER CJ         J ULTRASTRUCT RES               27   344 969
   052   KOHN RR               PRINCIPLES OF MAMMALIAN A                971
   053   STURGESS JM           LAB INVEST                      31     6 974
   054   BALIS JU              OVERDRUK TYDSCHRIFR GASTORO E    7   133 964
   055   SALLNER G             J CELL BIOL                     30    73 966
   056   CHIU HF               LAB INVEST                      30   305 974
   057   DALLNER G             J CELL BIOL                     30    97 966
   058   BROWN RM JR           J CELL BIOL                     41   109 969
   059   TRUMP BF              IN: LAVIA MF                             975
   060   STEINER JW            INT REV EXP PATH                 3    65 964
   061   TRUMP BF              IN: RICHTER GW                        84 971
   062   SVBODA D              CANCER RES                      28  1703 968
   063   JEZEQUEL AM           GUT                             15   737 974
   064   THIERY JP             REV INT HEPATOL                 12   207 962
   065   SCHAFFNER F           GASTROENTEROLOGY                37   565 959
   066   ORLANDI F             ACTA HEPATO SPLENOL              9   155 962
   067   ORLANDI F             ANN NEUROL PSICHIE ANN DESPID   55     1 961
   068   SCHAFFNER F           IN: MARTINI GA                           962
   069   BIEMPICA L            LAB INVEST                      24   110 971
   070   DAVID H               Z ZELLFORSCH MIKROSK ANAT       53   857 961
   071   SALOMON JC            BULL ASSOC FRANC CANCER         53   139 962
   072   OBERLING C            ANN ANAT PATHOL                  1   401 956
   073   REYNOLDS ES           J CELL BIOL                     19   139 963
   075   STURGESS JM           LAB INVEST                      31     6 974
   076   ARCASOY M             AM J PATHOL                     52   841 968
   077   JEZEQUEL AM           ANN ANAT PATHOL                  3   512 958
   078   HRUBAN Z              J ULTRASTRUCT RES                8   236 963
   079   SHINOZUKA H           LAB INVEST                      18    72 968
   080   DAVID H               BEITR PATHOL ANAT              134   463 966
   081   STEINER JW            AM J PATHOL                     43   677 963
   082   CAMAIN R              ANN ANAT PATHOL                  4   220 959
   083   WEISBLUM B            J CELL BIOL                     12   313 962
   084   DAVID H               ACTA BIOL MED GER                4   159 960
   085   JEZEQUEL AM           PROG LIVER DIS                   2   303 966
   086   OZAKI Y               ACTA SCHOL MED UNIV KYOTO       33   159 956
   087   HARKIN JC             AM J PATHOL                     34   559 958
   088   KOVACS E              CAN J BIOCHEM                   48    39 970
   089   MOSCARELLO MA         BIOCHIM BIOPHYS ACTA           127   373 966
   090   HRUBAN Z              LAB INVEST                      14    70 965
   091   MOLLENHAUER HH        EXP MOL PATH                    11   113 969
   092   MICHAEL AF            LAB INVEST                      11   266 962
   093   FISHER ER             AM J PATHOL                     52   869 968
   094   SALOMON MI            ARCH INTERN MED                115   704 967
   095   NEUHAUS DW            EXP MOL PATH                     2   183 973
   096   HORNE CHW             CLIN SCI                        42   743 972
   097   SHIBATA S             LAB INVEST                      27   457 972
   098   PIERCE GB             LAB INVEST                      21    27 969
   099   ROY AK                J HISTOCHEM CYTOCHEM            20    89 972
   100   ROSENMANN E           BEITR PATHOL ANAT              149   227 973
   101   DERR RF               PROC SOC EXP BIOL MED          125   248 967
   102   KUHN R                NATURWISSENSCHAFTEN             35   125 948
   103   MOSCARELLO MA         CAN J BIOCHEM                   45   136 967
   104   DARKEN MA             PHARMACOL REV                   16   223 964
   105   REID IM               LAB INVEST                      23   119 970
   106   SPIRO RG              J BIOL CHEM                    241  1271 966
   107   HERSCOVICS A          BIOCHEM J                      112   709 969
   109   AKERBLOM HK           HORM METAB RES                   4    15 972
   110   DARCY DA              BR J EXP PATHOL                 46   155 965
   111   DARCY DA              BR J EXP PATHOL                 49   614 968
   112   DARCY DA              BR J EXP PATHOL                 48   608 967
   113   JAMIESON JC           CAN J BIOCHEM                   53   401 975
   114   TRELOAR M             J BIOL CHEM                    249  6628 974
   115   KIM YS                J CLIN INVEST                   51  2033 972
   116   MOOKERJEA S           CAN J BIOCHEM                   50   738 972
   117   SCHACHTER H           BIOCHEM BIOPHYS RES COMMUN      45  1011 971
   118   NOVIKOFF AB           FED PROC                        21  1130 962
   119   ESSNER E              J CELL BIOL                     15   289 962
   120   WEISBLUM B            J CELL BIOL                     12   313 962
   121   WHALEY WG             IN: LOCKE M                              964
   122   ASHTON FE             CAN J BIOCHEM                   48   841 970
   123   KRAMER MF             J CELL BIOL                     52   147 972
   124   JAMIESON JD           J CELL BIOL                     39   580 968
   125   ORRENIUS S            J CELL BIOL                     28   181 966
   126   MOOKERJEA S           CAN J BIOCHEM                   45   825 967
   127   NEUHAUS DW            PROC SOC EXP BIOL MED          117   244 964
   128   HRUBAN Z              LAB INVEST                      27    62 972
   129   D LA IGLESIA FA       LAB INVEST                      30   539 974
CT   1   BROADWELL RD          J CELL BIOL                     90   474 981
     2   AKISAKA T             HISTOCHEMISTRY                  76   539 982

PN 76163
RN 00517 
AN 76243687
AU Cahill-L-T.
TI Impairment of natural defenses- II: Endogenous causes: diseases,
   malignancies, malnutrition, organ transplants.
SO Pediatr-Ann. 1976 Jul. 5(7). P 457-64.
MJ IMMUNOLOGIC-DEFICIENCY-SYNDROMES.  INFECTION: et.
MN ADRENAL-GLAND-DISEASES: co.  ANEMIA-SICKLE-CELL: co.  CHILD.
   CYSTIC-FIBROSIS: co.  GRAFT-REJECTION: co.  HUMAN.
   IMMUNOSUPPRESSION: ae.  NEOPLASMS: co.  NUTRITION-DISORDERS: co.
   TRANSPLANTATION-HOMOLOGOUS: ae.  UREMIA: co.
EX This article provides evidence that opportunistic infection can be
   expected in chronically debilitated, immunosuppressed persons.  The
   onset of an infectious disease in these patients can be sudden or
   insidious with few prodromal signs.  Anorexia, malaise, fever, and
   vomiting are nonspecific symptoms that these children may manifest
   because of their primary illness or its treatment.  Any insult to
   natural defense barriers may cause serious infections in the
   compromised host.  An infected wound from an insect bite, easily
   controlled by local measures in a healthy person, may become a focus
   for septicemia in a child with leukemia.  Despite the diagnosis and
   appropriate treatment of the specific infection, the
   immunosuppressed person is still subject to overwhelming infection by
   resistant opportunistic organisms until the natural defense
   mechanisms are restored.  An awareness of the vulnerability of the
   compromised host is the key to effective diagnosis and management of
   the various complications of infectious disease.
RF 001   SONG YS               AM J PATHOL                     33   331 957
   002   PEARSON HA            N ENGL J MED                   281   923 969
   003   ERAKLIS AJ            N ENGL J MED                   276  1225 967
   004   RAVRY M               ANN INTERN MED                  77    11 972
   005   ROWLEY DA             J IMMUNOL                       65   515 950
   006   SASLOW S              N ENGL J MED                   261   120 959
   007   ROBINSON MG           N ENGL J MED                   274  1006 966
   008   BARRETT-CONNOR E      MEDICINE (BALTIMORE)            50    97 971
   009   HOOK EW               N ENGL J MED                   257   403 957
   010   RUBIN HM              AM J DIS CHILD                 116    83 968
   011   SHULMAN ST            N ENGL J MED                   287   164 972
   012   WILFERT CM            PEDIATRICS                      42   840 968
   013   LANG PA               TEX REP BIOL MED                24   107 966
   014   KIRKPATRICK CH        J EXP MED                      119   727 964
   015   MING PL               FED PROC                        27   432 968
   016   COHN ZA               BACT REV                        24    96 960
   017   WUEPPER KD            CLIN EXP IMMUNOL                 2    71 967
   018   CHIGREN RA            LANCET                           2   688 967
   020   MILLER ME             J PEDIATR                       81   979 972
   021   VAN OSS CJ            INFECT IMMUN                     4    54 971
   022   VEJLSGAARD R          ACTA MED SCAND                 193   337 973
   023   BAKER RD              DIABETES                         9   143 960
   024   MARTIN FP             J PEDIATR                       44   437 954
   025   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969
   026   SPOCK A               PEDIATR RES                      1   173 967
   027   BOWMAN BH             SCIENCE                        164   325 969
   028   CONOVER JH            LANCET                           1  1194 973
   029   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   030   STRAUSS RR            CANCER RES                      30   480 970
   031   HOLLAND JF            BLOOD                           37   499 971
   032   ARMSTRONG D           MED CLIN NORTH AM               55     3 971
   033   LOURIA DB             ANN INTERN MED                  67   261 967
   034   SINCORICS JG          CANCER                          25   663 970
   035   GOOCH WM              CANCER                          28   984 971
   036   WOLLMAN MR            J PEDIATR                       86   376 975
   037   WILBUR JR             CANCER                          36   765 975
   038   CLAMAN HN             N ENGL J MED                   287   388 972
   039   CLINE MJ              SCIENCE                        153  1135 966
   040   FAUVE RM              J EXP MED                      125   807 967
   041   RINEHART JJ           N ENGL J MED                   292   236 975
   042   BOGGS DR              AM J PATHOL                     44   763 964
   043   MAKMAN MH             J BIOL CHEM                    243  1485 968
   044   HUGHES WT             CANCER                          36  2004 975
   045   BRAZINSKY JH          JAMA                           209  1527 969
   046   HUGHES WT             PEDIATR CLIN NORTH AM           21   583 974
   047   WELLER TH             N ENGL J MED                   285   203 971
   048   OLDING LB             J EXP MED                      141   561 975
   049   FEIGIN RD             J PEDIATR                       87   677 975
   050   SCRIMSHAW NS          AM J MED SCI                   237   367 959
   051   KLAINER AS            AM J MED SCI                   258   431 968
   052   JOSE DG               LANCET                           1   263 976

PN 76164
RN 00518 
AN 76175338
AU Suberman-R-I.
TI Constipation in children.
SO Pediatr-Ann. 1976 Jan. 5(1). P 32-48.
MJ CONSTIPATION: et.
MN ABNORMALITIES: ra.  ANUS-IMPERFORATE: ra.  ASCARIASIS: ra.  CHILD.
   COLON: ra.  COLONIC-DISEASES: ra.  CONSTIPATION: ra.
   CYSTIC-FIBROSIS: ra.  FEMALE.  GASTROINTESTINAL-MOTILITY.  HUMAN.
   INFANT-NEWBORN.  INFANT-NEWBORN-DISEASES: et.
   INTESTINAL-OBSTRUCTION: ra.  MALE.  MEGACOLON: ra.
   PSYCHOPHYSIOLOGIC-DISORDERS.  URETERAL-DISEASES: ra.
EX Although constipation is not well defined, when it is brought to the
   attention of a physician, it should raise certain questions.  In a
   newborn, is obstipation due to Hirschsprung's disease, meconium
   ileus, or intermittent volvulus?  Is obstipation in a child with a
   mass in the cecum due to cystic fibrosis - i.e., meconium ileus
   equivalent?  Has the formula been mixed correctly?  Does the patient
   have spinal defects?  Has the child been on medications?  Is the
   child constipated for psychogenic reasons?  All of us who deal with
   children should consider all of these entities in each of our
   patients, so as not to miss those several diseases with grave but
   preventable consequences.
RF 001   BERDON WE             RADIOLOGY                       90   466 968
   002   GANS SL               J PEDIATR SURG                   5   511 970
   003   THOMPSON W            RADIOLOGY                      113   693 974
   004   BERDON WE             AM J ROENTG RAD THER NUCL MED   93   432 965
   005   SHEY WL               AM J ROENTG RAD THER NUCL MED  112   105 971
   006   THOMAS CG JR          ANN SURG                       171   796 970
   007   BERDON WE             RADIOLOGY                       96   375 970
   008   NOBLETT HR            J PEDIATR SURG                   4   190 969
   009   GROSSMAN H            AM J ROENTG RAD THER NUCL MED   97   227 966
   010   SWISCHUK LE           AM J ROENTG RAD THER NUCL MED  103   339 968
   011   FRIEDLAND GW          RADIOLOGY                      103   159 972
   012   BURKE EC              AM J DIS CHILD                 117   668 969
   013   GROSSMAN H            IN: KAUFMAN HJ                           970
   014   CULP WC               RADIOLOGY                      115     9 975
   015   GARRARD SD            PEDIATRICS                      10   479 952
   016   KOTTMEIR PK           PEDIATRICS                      36   572 965

PN 76165
RN 00519 
AN 76197001
AU Rosenthal-A.  Tucker-C-R.  Williams-R-G.  Khaw-K-T.  Strieder-D.
   Shwachman-H.
TI Echocardiographic assessment of cor pulmonale in cystic fibrosis.
SO Pediatr-Clin-North-Am. 1976 May. 23(2). P 327-44.
MJ CYSTIC-FIBROSIS: co.  ECHOCARDIOGRAPHY.
   PULMONARY-HEART-DISEASE:  di.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  ELECTROCARDIOGRAPHY.
   FEMALE.  HUMAN.  LUNG-VOLUME-MEASUREMENTS.  MALE.
   PULMONARY-HEART-DISEASE: et.
AB The early clinical recognition and assessment of cor pulmonale are
   frequently difficult. To evaluate the usefulness of echocardiographic
   measurement of right ventricular dimension and septal motion in
   assessing cor pulmonale, we studied 94 patients with cystic fibrosis
   of varying severity. There was a significant relationship between
   increasing right ventricular dimension index (RVDI) and (1)
   decreasing clinical score, vital capacity, forced expiratory volume
   in one second (FEV1), and maximal midexpiratory flow rate (MMFR); and
   (2) increasing residual volume and thoracic gas volume. There was no
   correlation between right ventricular dimension index and PaO2. These
   findings were supported by electrocardiogram and pathologic evidence
   of right ventricular involvement. Abnormal septal motion was observed
   more frequently in patients with severe obstructive airway disease as
   measured by decreased vital capacity, FEV1, and MMFR. The data show
   that there is echocardiographic evidence of mild right ventricular
   enlargement and/or hypertrophy much earlier in the course of cystic
   fibrosis than previously suspected and that the echocardiogram is a
   useful tool in the evaluation of cor pulmonale in patients with
   cystic fibrosis.
RF 001   BEIER FR              AM REV RESPIR DIS               94   430 966
   002   BISHOP JM             MED CLIN NORTH AM               57   771 973
   003   COOK CD               PEDIATRICS                      24   181 959
   004   DIAMOND MA            CIRCULATION                     43   129 971
   005   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   006   DORNHORST AC          LANCET                           1   746 952
   007   FEATHERBY EA          AM REV RESPIR DIS              102   737 970
   008   FEIGENBAUM H          ECHOCARDIOGRAPHY                         972
   009   FRANKLIN DL           CIRC RES                        10    17 962
   010   GOLDRING RM           J PEDIATR                       65   501 964
   011   GOODMAN DJ            AM J CARDIOL                    33   438 974
   012   HIRSCHFELD S          CIRCULATION                     52   641 975
   013   JOHNSON DH            PEDIATR RES                      8   350 974
   014   KEANE JF              PEDIATR RES                      8   351 974
   015   LAMARRE A             PEDIATRICS                      50   291 972
   016   LANGE RL              CIRCULATION                     33   763 966
   017   LIEBMAN J             CIRCULATION                     35   552 967
   018   LIEBMAN J             CHEST                           63   218 973
   019   LIEBMAN J             IN: MANGOS JA                         41 976
   020   MCCANN WD             JAMA                           221  1243 972
   021   MCDONALD IG           BR HEART J                      34  1137 972
   022   MEYER RA              PROG CARDIOVASC DIS             15   341 973
   023   MOSS AJ               J PEDIATR                       67   797 965
   024   NANDA NC              CIRCULATION                     50   575 974
   025   REILLY BJ             RADIOLOGY                       98   281 971
   026   ROWLATT UF            PEDIATR CLIN NORTH AM           10   499 963
   027   ROYCE SW              PEDIATRICS                       8   255 951
   028   RUSHKIN J             CIRCULATION                     48    79 973
   029   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   030   SIASSI B              J PEDIATR                       78   794 971
   031   SPECTOR WS            HANDBOOK OF BIOLOGIC DATA            162 956
   032   STROBER W             PEDIATRICS                      43   416 969
   033   SYMCHYCH PS           ARCH PATHOL                     92   409 971
   034   TAJIK AJ              CIRCULATION                     46    36 972
   035   THOMAS AJ             BR HEART J                      34   653 972
   036   WAYMAN AE             CIRCULATION                     50   905 974
   037   ANON                  WHO TECH REP SER NO 213                  961
CT   1   ROSENTHAL A           PEDIATRICS                      59   919 977
     2   RYSSING E             ACTA PAEDIATR SCAND             66   753 977
     3   SANTAGNESE PAD        AM J MED                        66   121 979
     4   ALLEN HD              CHEST                           75   428 979
     5   HIRSCHFELD SS         CHEST                           75   351 979
     6   CHIPPS BE             J PEDIATR                       95   379 979
     7   MATTHAY RA            BR HEART J                      43   474 980
     8   TANG SC               CHIN MED J                      93   779 980
     9   LESTER LA             J PEDIATR                       97   742 980
    10   FRANCIS PWJ           AM J DIS CHILD                 134   734 980
    11   FOWLER RS             J ELECTROCARDIOL                14   319 981
    12   RABINOVITCH M         BR HEART J                      45   198 981
    13   BERGER HJ             AM J CARDIOL                    47   950 981
    14   MATTHAY RA            MED CLIN NORTH AM               65   489 981
    15   JACOBSTEIN MD         CHEST                           80   399 981
    16   NEWTH CJL             AM REV RESPIR DIS              124   463 981
    17   MOSS AJ               PEDIATRICS                      70   728 982
    18   COATES AL             CHEST                           82   543 982
    19   JOHNSON SR            OBSTET GYNECOL                  61  S  2 983
    20   GOODING CA            J PEDIATR                      105   384 984
    21   BENSON LN             AM REV RESPIR DIS              130   987 984
    22   MICHAEL JR            AM REV RESPIR DIS              130   516 984
    23   LESTER LA             SEM RESPIR MED                   6   285 985
    24   PANIDIS IP            J AM COLL CARDIOL                6   701 985

PN 76166
RN 00520 
AN 76197021
AU Allars-H-M.  Cockayne-D-J.  Blomfield-J.  Rush-A-R.  Van-Lennep-E-W.
   Brown-J-M.
TI Colloid and crystal formation in parotid saliva of cystic fibrosis
   patients and non-cystic fibrosis subjects.  II.  Electron microscopy
   and electrophoresis.
SO Pediatr-Res. 1976 Jun. 10(6). P 584-94.
MJ COLLOIDS: me.  CRYSTALLIZATION.  CYSTIC-FIBROSIS: me.
   PAROTID-GLAND:  me.  SALIVA: me.
MN ADOLESCENCE.  ADULT.  CALCIUM-PHOSPHATES: me.  CHILD.  COLD.
   EDTA:  pd.  ELECTROPHORESIS-POLYACRYLAMIDE-GEL.  GUANIDINES: pd.
   HUMAN.  MICROSCOPY-ELECTRON.  PAROTID-GLAND: pa.  SALIVA: de.
   NEPHELOMETRY-AND-TURBIDIMETRY.  UREA: pd.
AB Centrifuged pellets of turbid parotid saliva from cystic fibrosis
   (CF) patients and non-CF subjects, obtained from saliva kept at 2
   degrees for 10 min, had the electron microscope appearance of
   amorphous, round particles, and were thought to be colloidal
   aggregates of organic material. Drops of turbid saliva, from samples
   incubated for 2 hr at 2 degrees or 37 degrees, additionally contained
   discrete, electron-dense crystals having well defined angular
   morphology: usually cubic, retangular, or approximately hexagonal.
   The inhibitors, urea, guanidine hydrochloride, and EDTA, resulted in
   no crystals being observed. Selected area electron diffraction from
   individual crystals showed predominantly hexagonal, rectangular
   patterns could be indexed as coming from hydroxyapitite. A transition
   from the hexagonal to the rectangular pattern and back to the
   hexagonal pattern could be obtained from individual crystals tilted
   in the electron microscope. The square diffraction pattern may be
   from octa-calcium or brushite. Polyacrylamide gel disc
   electrophoresis of the parotid saliva indicated that the sparingly
   soluble proteins in the 2 degree and 37 degree pellets comprised
   proline-rich proteins and a calcium-precipitable, trichloroacetic
   acid (TCA)-precipitable phosphoprotein, which fluoresced with amido
   schwarz and Coomassie brilliant blue G250.
RF 001   ALLARS HM             PEDIATR RES                     10   578 976
   002   AZEN EA               SCIENCE                        180  1067 973
   003   BEEVERS CA            ACTA CRYSTAL                    11   273 958
   004   BLOMFIELD J           AUST PAEDIATR J                 10    75 974
   005   BLOMFIELD J           GUT                             14   558 973
   006   BLOMFIELD J           PEDIATR RES                     10   574 976
   007   BLOMFIELD J           ARCH ORAL BIOL                  19  1153 974
   008   BLOMFIELD J           ARCH DIS CHILD                  48   267 973
   009   BOAT TF               PEDIATR RES                      8   531 974
   010   BROWN WE              J AM CHEM SOC                   79  5318 957
   011   BROWN WE              NATURE                         196  1050 962
   012   CANCRO LP             PROC IADR 48TH GENERAL MTG               970
   013   DAVIS BJ              ANN NY ACAD SCI                121   404 964
   014   EANES ED              CALC TISS RES                   12   143 973
   015   FRANCIS MD            CALC TISS RES                    6   335 971
   016   FRONDEL C             AM MINERAL                      26   145 941
   017   FUREDI-MILHOFER H     CALC TISS RES                    8   142 971
   018   HAY DI                ARCH ORAL BIOL                  18  1517 973
   019   HAY DI                ARCH ORAL BIOL                  18  1517 973
   020   JOHANSEN PG           LANCET                           1   455 968
   021   KAMIYA M              SEIKAGAKU                       45   327 973
   022   KARNOVSKY MJ          J CELL BIOL                     27  137A 965
   023   LARSEN S              EXPERIENTIA                     27   483 971
   024   LEACH SA              J DENT RES                      53   310 974
   025   MAYO JW               ARCH BIOCHEM BIOPHYS           161   134 974
   026   MCKENZIE HA           ADV PROT CHEM                   22    55 967
   027   MEYER JL              CALC TISS RES                   10    91 972
   028   NOBLE RW              J AM CHEM SOC                   87  2236 965
   029   NYLEN MU              J CELL BIOL                     18   109 963
   030   PALLAVICINI JC        ATTACHMENT FOR THE BUCHLER AP            964
   031   POSNER AS             PHYSIOL REV                     49   760 969
   032   REISNER AH            ANAL BIOCHEM                    64   509 975
   033   RIVA A                ANAT REC                       176   149 973
   034   SCHROEDER HE          HELV ODONT ACTA                  9    73 965
   035   SHACKLEFORD JM        J HISTOCHEM CYTOCHEM            12   512 964
   036   STEVE-BOCCIARELLI D   J MICROSC                       16    21 973
   037   TERMINE JD            CALC TISS RES                   10   171 972
   038   TERMINE JD            ARCH BIOCHEM BIOPHYS           140   307 970
   039   WARTON KL             BR MED J                         3   570 971
   040   WAUGH DF              J AM CHEM SOC                   87  2246 965
   041   WOTMAN S              J PERIODONTOL                   44   278 973
   042   YOUNG RA              ARCH ORAL BIOL                  11   699 966
CT   1   ALLARS HM             PEDIATR RES                     10   578 976
     2   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     3   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983

PN 76167
RN 00521 
AN 76268606
AU Shapira-E.  Rao-G-J.  Wessel-H-U.  Nadler-N-L.
TI Absence of an alpha two-macroglobulin-protease complex in cystic
   fibrosis.
SO Pediatr-Res. 1976 Sep. 10(9). P 812-7.
MJ ALPHA-MACROGLOBULINS: df.  ARGININE: bl.  CYSTIC-FIBROSIS: en.
   ESTERASES: bl.
MN HUMAN.  HYDROLYSIS.  IMMUNE-SERA.  IMMUNOELECTROPHORESIS.
   IMMUNOLOGIC-TECHNICS.  RABBITS: im.
AB The present study using immunologic methodology confirms previous
   observations from this laboratory of an absence of a protease
   component with arginine esterase activity in plasma of patients with
   cystic fibrosis. In this study, the pooled plasma from control
   individuals was activated and partially purified after adsorption on
   columns of soybean trypsin inhibitor conjugated to Sepharose 4B
   followed by elution with benzamidine. The fraction was further
   purified by isoelectrofocusing on polyacrylamide gels. Proteins
   around the pI range of 5.5 were eluted and utilized to prepare an
   antiserum. Immunoelectrophoresis of activated plasma samples from
   control subjects and patients with cystic fibrosis was performed
   utilizing the antiserum. In controls, four precipitin arcs with
   residual esterase activity were observed, whereas only three were
   seen in plasma from patients with cystic fibrosis. Double gel
   diffusion experiments using specific antisera ruled out the presence
   of trypsin, chymotrypsin, plasminogen, prothrombin, C1 esterase,
   alpha one-trypsin inhibitor, and inter-alpha-trypsin inhibitor in the
   concentrated benzamidine eluate. The antisera to alpha two-
   macroglobulin gave an immunoprecipitate which was readily stained for
   proteolytic activity. On immunoelectrophoresis, the alpha two-
   macroglobulin precipitin band corresponded to the band absent in
   plasma of patients with cystic fibrosis. In contrast, the alpha two-
   macroglobulin levels were similar in plasma of control subjects and
   patients with cystic fibrosis. Using the antiserum to the protein
   fractith proteolytic activity could be demonstrated in control
   plasma. One specific enzyme-active "rocket" was absent in plasma of
   patients with cystic fibrosis. In a double blind study of 15 control
   samples and 15 samples from patients with cystic fibrosis, a specific
   "rocket" was shown to be present in 13 control samples and absent in
   14 cystic fibrosis samples. alpha two-Macroglobulin was determined by
   both an immunologic procedure and by its trypsin binding (trypsin
   protein esterase concentration). The ratio of the immunologic assay
   to the biologic activity assay was 90 for the normal plasma samples
   and only 65 for cystic fibrosis samples.
RF 001   AXEN R                NATURE                         214  1302 967
   002   BAGDASARIAN A         J CLIN INVEST                   54  1444 974
   003   BARRETT AJ            BIOCHEM J                      133   709 973
   004   BOWMAN BH             SCIENCE                        164   325 969
   005   CONOVER JH            PEDIATR RES                      7   220 973
   006   ERLANGER BF           ARCH BIOCHEM BIOPHYS            95   271 961
   007   GANROT PO             CLIN CHIM ACTA                  14   493 966
   008   HAMBERG U             EUR J BIOCHEM                   40   439 973
   009   HARPEL PC             J EXP MED                      138   508 973
   010   KABAT EA              EXPERIMENTAL IMMUNOCHEMISTRY             961
   011   KAUZMANN W            J AM CHEM SOC                   75  5154 953
   012   LAURELL CB            ANAL BIOCHEM                    15    45 966
   013   LEVY HB               PROC SOC EXP BIOL MED          103   250 960
   014   LOWRY OH              J BIOL CHEM                    193   265 951
   015   MANCINI G             IMMUNOCHEMISTRY                  2   235 965
   016   MANGOS JA             PEDIATR RES                      1   436 967
   017   OUCHTERLONY O         ACTA PATH MICROBIOL SCAND       25   186 948
   018   RAO GJS               J PEDIATR                       80   573 972
   019   RAO GJS               PEDIATR RES                      8   684 974
   020   RAO GJS               PEDIATR RES                      9   739 975
   021   RAO GJS               SCIENCE                        177   610 972
   022   SHAPIRA E             J LAB CLIN MED                  77   877 971
   024   SHAPIRA E             ISR J MED SCI                   10  1086 974
   025   SPOCK A               PEDIATR RES                      1   173 967
   026   WILSON GB             PEDIATR RES                     10    87 976
CT   1   RAO GJS               PEDIATR RES                     11   981 977
     2   WILSON GB             PEDIATR RES                     11   317 977
     3   SHAPIRA E             CLIN CHIM ACTA                  78   359 977
     4   SHAPIRA E             J BIOL CHEM                    252  7923 977
     5   WILSON GB             NATURE                         266   463 977
     6   SCHAAP T              ISR J MED SCI                   14   201 978
     7   RAO GJS               ENZYME                          23   314 978
     8   PEARSON RD            PEDIATR RES                     13   834 979
     9   ROMEO G               PEDIATR RES                     13  1030 979
    10   VANLEUVEN F           PEDIATR RES                     13  1384 979
    11   DAVIS PB              PEDIATR RES                     14    83 980
    12   WALSH MMJ             PEDIATR RES                     14   353 980
    13   SHAPIRA E             BIOCHEM BIOPHYS RES COMMUN      93    50 980
    14   ROMEO G               J LAB CLIN MED                  95   116 980
    15   SCHIDLOW DV           AM REV RESPIR DIS              121    31 980
    16   NELLES LP             BIOCHIM BIOPHYS ACTA           623    46 980
    17   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    18   HULTBERG B            CLIN CHIM ACTA                 112   167 981
    19   COX KL                J PEDIATR GASTROENTEROL NUTR     1   345 982
    20   BURY AF               IRCS MED SCI BIOCHEM            10   255 982
    21   BURY AF               PEDIATR RES                     16   613 982
    22   ROBERTS RC            PEDIATR RES                     16   416 982
    23   BRIDGES MA            CLIN CHIM ACTA                 118    33 982
    24   VEREMEENKO KN         UKR BIOKHIM ZH                  55   218 983
    25   BRIDGES MA            ANN NY ACAD SCI                421   360 983
    26   SHAPIRA E             ANN NY ACAD SCI                421   352 983
    27   EAGER KB              PEDIATR RES                     18   999 984

PN 76168
RN 00522 
AN 76243782
AU Kopito-L-E.  Shwachman-H.
TI The pancreas in cystic fibrosis: chemical composition and
   comparative morphology.
SO Pediatr-Res. 1976 Aug. 10(8). P 742-9.
MJ CYSTIC-FIBROSIS: pa.  PANCREAS: pa.
MN ADOLESCENCE.  ADULT.  CALCIUM: me.  CHILD.  CHILD-PRESCHOOL.
   COPPER:  me.  FATTY-ACIDS: me.  FEMALE.  HISTOCYTOCHEMISTRY.  HUMAN.
   INFANT.  INFANT-NEWBORN.  INFANT-NEWBORN-DISEASES: me.  MAGNESIUM: me.
   MALE.  ORGAN-WEIGHT.  PANCREAS: me.  PANCREATIC-DUCTS: me, pa.
   WATER-ELECTROLYTE-IMBALANCE: me.  ZINC: me.
AB Sections of pancreas from 16 individuals who died with cystic
   fibrosis (CF) were classified by morphometric criteria into four
   categories in increasing order of pancreatic involvement. The
   concentration of acini, islets, main ducts, lobular ducts, connective
   tissue, and fat was compared with control levels. The results show
   that in the least involved pancreases, from neonates who died under 5
   months of age, acini were reduced to 33% of control levels and the
   following were increased: islets, to 410%, lobular ducts, to 250%;
   and main ducts, to 1700% of controls. With increasing severity of the
   pancreatic disease the acini were further reduced to 5% and lobular
   ducts to 37% of control levels, respectively. Main ducts increased by
   19-fold, and fatty infiltration accounted for more than 25% of the
   fresh weight of the pancreas in 9 of the 16 specimens. Comparative
   biochemical studies of 35 fibrocystic pancreases were quantitatively
   related to the severity of the pancreatic involvement as follows.
   Water and volatile matter, normally accounting for 80 +/-% of the
   weight of the fresh pancreas, was reduced to less than 30% in the
   most affected organs. The concentration of zinc diminished from near
   normal mean levels of 193 mugZn/g dry pancreas to 10% of this amount
   in the severely involved pancreas. Elevated concentrations of
   calcium, amounting to over 10 times control level, were found in
   obstructed ductal structures. Calcium was depleted from pancreatic
   sections adjacent to the obstructions. The following biochemical
   indicators were significantly different in their mean levels in the
   35 fibrocystic pancreases when compared with the 17 controls: (P less
   than or equal to 0.001) fat, water, zinc, calcium, copper, magnesium,
   potassium, and sodium (P less than or equal to 0.01).
RF 001   ALLEN RA              AM J PATHOL                     31   337 955
   002   BLANC WA              GAP CONF REP PATHOL OF CF                972
   003   BLOMFIELD J           GUT                             14   558 973
   004   BUSCH H               YALE J BIOL MED                 29   596 957
   005   CHERNICK WS           ANN NY ACAD SCI                106   698 963
   006   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   007   DONNISON AB           PEDIATRICS                      37   833 966
   008   FORSTNER JF           CLIN RES                        21  1033 973
   009   HADORN B              CAN MED ASSOC J                 98   377 968
   010   HSU JM                SCIENCE                        153   882 966
   011$  KLEINER IS            BIOCHEMISTRY                             962
   012   KOPITO L              ATOM ABSORP SPECTRO CLIN CHE     3       970
   013   KOPITO L              J PEDIATR                       68   313 966
   014   KOPITO LE             FERTIL STERIL                   24   512 973
   015   RASMUSSEN H           SCIENCE                        170   404 970
   016   RULE AH               FERTIL STERIL                   21   515 970
   017   SHWACHMAN H           AM J DIS CHILD                  92   347 956
   018   SHWACHMAN H           IN: SLEISENGER MH                   1206 973
   019   TING KAI LI           IN: PRASAD AS                            966
   020   VALLEE BL             IN: ANSON ML                    10       955
CT   1   SCHWACHMAN H          N ENGL J MED                   296  1519 977
     2   ROLLA G               ACTA PATH MICROBIOL SCAND (A)   86    83 978
     3   ROMEO G               NATURE                         274   909 978
     4   SANTAGNESE PAD        AM J MED                        66   121 979
     5   IMRIE JR              AM J PATHOL                     95   697 979
     6   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     7   IANNACCONE G          PEDIATR RADIOL                   9    85 980
     8   GILLARD BK            PEDIATR RES                     14  1168 980
     9   LOPEZCORELLA E        PATOLOGIA (MEXICO CITY)         18   167 980
    10   LLOYDSTILL JD         PEDIATRICS                      65  1010 980
    11   SPEHLROBBERECHT M     ANN RADIOL (PARIS)              24    49 981
    12   CAVALIER SJ           NEUROLOGY                       31   714 981
    13   LAMBERT JR            GASTROENTEROLOGY                80   169 981
    14   PARK RW               GASTROENTEROLOGY                81  1143 981
    15   SCHONI M              SCHWEIZ MED WOCHENSCHR         111   658 981
    16   ROOMANS GM            ULTRASTRUCTURAL PATHOL           3   285 982
    17   MASOERO G             AM J DIS CHILD                 137   167 983
    18   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983
    19   GOSDEN CM             LANCET                           2   541 984
    20   KATZ S                CELL CALC                        5   421 984
    21   IANNUCCI A            HUM PATHOL                      15   278 984
    22   GILLARD BK            AM J DIS CHILD                 138   577 984
    23   NEAL JL               EVOLUTIONARY THEORY              7   153 985
    24   GRAHAM N              CLIN RADIOL                     36   199 985
    25   BOLLBACH R            EUR J PEDIATR                  144   167 985
    26   DURIE PR              PEDIATR RES                     20   209 986
    27   ABDULKARIM FW         ARCH PATHOL LAB MED            110   602 986
    28   DAVIS PB              J DENT RES                      66   667 987

PN 76169
RN 00523 
AN 76221607
AU Gahl-W-A.  Changus-J-E.  Pitot-H-C.
TI The effect of spermidine and spermine on proliferation in vitro of
   fibroblasts from normal and cystic fibrosis patients.
SO Pediatr-Res. 1976 May. 10(5). P 531-5.
MJ CELL-DIVISION: de.  CYSTIC-FIBROSIS: pa.  SPERMIDINE: pd.
   SPERMINE:  pd.
MN DEPRESSION-CHEMICAL.  FIBROBLASTS: cy, de, gd.  HUMAN.
   SUPPORT-U-S-GOVT-P-H-S.
AB The effects of spermidine and spermine at varying concentrations upon
   the replicative ability of human fibroblasts in cell culture have
   been studied. The average concentrations of spermidine causing a 50%
   inhibition of prolifertion (ID50) after 3 days of growth for three
   normal cell strains and three strains derived from patients with
   cystic fibrosis (CF) were 4.4 X 10(-6) +/- 1.2 M and 6.2 X 10(-6) +/-
   2.1 M, respectively. The values for spermine were 2.0 X 10(-6) +/-
   0.5 M for normal and 2.2 X 10(-6) +/- 0.1 M for fibroblasts from
   cystic fibrosis patients. No significant difference between the
   replicative ability of normal and CF cell strains was seen over a
   wide range of polyamine concentrations employed for a period of up to
   3 days.
RF 001   ALARCON RA            ARCH BIOCHEM BIOPHYS           106   240 964
   002   ALARCON RA            ARCH BIOCHEM BIOPHYS           137   365 970
   003   ALARCON RA            J THEOR BIOL                    37   159 972
   004   ALARCON RA            ARCH BIOCHEM BIOPHYS            94   540 961
   005   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   006   BACHRACH U            BIOCHIM BIOPHYS ACTA           134   174 967
   007   BLASCHKO H            J PHYSIOL (LOND)               145   124 959
   009   COHEN SS              INTRODUCTION TO POLYAMINES               971
   010   COHEN LF              PEDIATR RES                      9   312 975
   011   DYKSTRA WG            SCIENCE                        149   428 965
   012   GIBSON LE             PEDIATRICS                      23   545 959
   013   GOLDSTEIN J           EXP CELL RES                    37   494 965
   014   HAM RG                BIOCHEM BIOPHYS RES COMMUN      14    34 964
   015   HAM RG                IN VITRO                        10   119 974
   016   HERBST EJ             ANN NY ACAD SCI                171   691 970
   017   HIGGINS ML            J CELL PHYSIOL                  74   149 969
   018   HIRSCH JG             J EXP MED                       97   345 953
   019   HIRSCH JG             J EXP MED                       95   191 952
   020   JANNE J               ACTA PHYSIOL SCAND SUPPL 300           1 967
   021   KIMES BW              BIOCHIM BIOPHYS ACTA           228   223 971
   022   LOBECK CC             IN: STANBURY JB                     1605 972
   023   LUNDGREN DW           CF CLUB ABST                    15     2 974
   024   MAGER J               BIOCHIM BIOPHYS ACTA            36   529 959
   025   MUNRO GF              CF CLUB ABST                    16     7 975
   026   OTSUKA H              J CELL SCI                       9    71 971
   027   POHJANPELTO P         EXP CELL RES                    80   137 973
   028   POHJANPELTO P         NATURE NEW BIOL                235   247 972
   030   RENNERT OM            IN: MANGOS JA                         41 973
   031   ROZANSKY R            J GEN MICROBIOL                 10    11 954
   032   RUSSELL DH            IN: RUSSELL DH                         1 973
   033   RUSSELL DH            CANCER RES                      31   248 971
   034   TABOR CW              J BIOL CHEM                    239  2194 964
   035   TABOR CW              J BIOL CHEM                    208   645 954
   036   TABOR H               PHARMACOL REV                   16   245 964
CT   1   LIVINGSTON JN         J BIOL CHEM                    252   560 977
     2   GAHL WA               CHEMBIOL INTERACT               22    91 978
     3   GAHL WA               IN VITRO                        15   252 979
     4   CLO C                 BIOCHEM J                      182   641 979
     5   SEALE TW              ARCH BIOCHEM BIOPHYS           198   164 979
     6   WEBBER MM             CELL BIOL INT REP                4   185 980
     7   GAHL WA               PEDIATR RES                     14   118 980
     8   SWANSON TL            IN VITRO                        16   761 980
     9   JENSEN PKA            IN VITRO                        18   867 982
    10   HENLE KJ              CANCER RES                      46   175 986

PN 76170
RN 00524 
AN 76197011
AU Wu-J-T.  Herbst-J-J.  Bray-P-F.
TI Elevated plasma levels of carcinoembryonic antigen in cystic
   fibrosis.
SO Pediatr-Res. 1976 Apr. 10(4). P 235-8.
MJ CARCINOEMBRYONIC-ANTIGEN: an.  CYSTIC-FIBROSIS: im.
MN CHILD.  CYSTIC-FIBROSIS: bl, ur.  HUMAN.  SALIVA: im.  SALIVATION.
   SUPPORT-U-S-GOVT-P-H-S.
AB Elevated levels of plasma CEA were found in patients with cystic
   fibrosis. The elevations were well correlated with the Shwachman
   scores of the patients. Parallel changes of the levels of plasma CEA
   and clinical conditions of four patients were also observed in the
   follow-up studies. Close clinical examination indicated that the
   elevated plasma CEA of cystic fibrosis patients may be derived from
   sputum which is produced in abnormal amounts. This hypothesis is
   further supported by the very high content and the chromatographic
   profile of the CEA activity of sputum from patients with cystic
   fibrosis.
RF 001   BOAT TF               PEDIATR RES                      8   531 974
   002   BOWMAN BH             AM J HUM GENET                  25   16A 973
   003   GOLD P                J NATL CANCER INST              45   219 970
   004   GOLD P                J EXP MED                      121   439 965
   005   HANSEN HJ             HUM PATHOL                       5   139 974
   006   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   007   LAURENCE DJR          BR MED J                         3   605 972
   008   LOGERFO P             N ENGL J MED                   285   138 971
   009   MARTIN F              J NATL CANCER INST              50  1375 974
   010   ROGALSKY VY           BULL EXP BIOL                   12    64 971
   011   ROGALSKY VY           LANCET                           1  1322 973
   012   ROGALSKY VY           LANCET                           2   729 974
   013   ROUSSEL P             CLIN CHIM ACTA                  36   315 972
   014   ROUSSEL P             J BIOL CHEM                    250  2114 975
   015   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   016   THOMSON MP            PROC NAT ACAD SCI USA           64   161 969
   018   WU JT                 J NATL CANCER INST              53  1589 974
CT   1   EGAN ML               CANCER                          40   458 977
     2   ALHADEFF JA           CLIN GENET                      14   189 978
     3   MACSWEEN JM           PEDIATR RES                     14   187 980
     4   MULDER H              ANTICANCER RES                   3   247 983
     5   WU JT                 CLIN CHEM                       29  2049 983
     6   WU JT                 CLIN CHIM ACTA                 130    47 983

PN 76171
RN 00525 
AN 76197015
AU Shapiro-B-L.  Smith-Q-T.  Warwick-W-J.
TI Letter: Serum glutathione reductase and cystic fibrosis.
SO Pediatr-Res. 1976 Apr. 10(4). P 250.
MJ CYSTIC-FIBROSIS: bl.  GLUTATHIONE-REDUCTASE: bl.
MN HUMAN.
EX We have obtained additional data which support the specificity of the
   reported serum glutathione reductase (GR) changes in cystic fibrosis
   (CF).  As in previous series, mean GR in CF was 20% greater than in
   controls (P < 0.005).  No difference was found between CF and
   controls for either lactate dehydrogenase (LDH) or glutamic-pyruvic
   transaminase (GPT).  It appears that some underlying process or
   processes such as leakage into serum from cellular damage as
   reflected in raised LDH and GPT might lead to raised GR as
   demonstrated by positive correlations in controls.  The absence of a
   positive correlation between these enzymes and GR in the CF sample as
   well as normal values for LDH and GPT in CF suggests that the raised
   serum GR in CF is not attributable to tissue leakage from damaged
   cells secondary to the disease.
RF 001   SHAPIRO BL            PEDIATR RES                      9   885 975

PN 76172
RN 00526 
AN 76197019
AU Blomfield-J.  Rush-A-R.  Allars-H-M.  Brown-J-M.
TI Parotid gland function in children with cystic fibrosis and child
   control subjects.
SO Pediatr-Res. 1976 Jun. 10(6). P 574-8.
MJ CYSTIC-FIBROSIS: pp.  PAROTID-GLAND: pp.
MN ADOLESCENCE.  AMYLASES: an.  CALCIUM: an.  CHILD.  CHILD-PRESCHOOL.
   CITRATES: pd.  FEMALE.  HUMAN.  MALE.  PAROTID-GLAND: de.
   PHOSPHATES: an.  POTASSIUM: an.  SALIVA: an.  SALIVATION.
   SODIUM:  an.  STIMULATION-CHEMICAL.
AB Parotid saliva was collected from 22 children with cystic fibrosis
   (CF) and 21 control children. Stimulation was by 0.1 ml 5% citric
   acid on the tongue every 15 sec over a period of 10 min, and samples
   were collected for 2-min intervals. Stimulated saliva showed a lag
   period of low amylase release, and an activated period of higher
   amylase release. The major difference between CF and child control
   parotid saliva was in the elevated calcium concentrations in CF
   subjects. Flow rate and amylase, although higher in the CF group,
   were not raised to a statistically significant level. There were
   higher mean values for sodium and inorganic phosphate in CF children
   but statistical significance was minimal. Potassium values were
   almost identical in CF and control saliva. In the activated parotid
   saliva samples of both control and CF subjects there were positive
   correlations between flow rate and calcium, flow rate and sodium,
   anylase and calcium, and sodium and calcium, and negative
   correlations between sodium and potassium. The parotid function test
   has no value as a diagnostic test for cystic fibrosis, as even
   calcium values show too much overlap with control saliva to be of
   diagnostic worth.
RF 001   ALLARS HM             PEDIATR RES                     10   578 976
   002   ALLARS HM             PEDIATR RES                     10   584 976
   003   BLOMFIELD J           AUST PAEDIATR J                 10    75 974
   004   BLOMFIELD J           CF CLUB ABST                    15    29 974
   006   CHAUNCEY HH           ARCH ORAL BIOL                   7   707 962
   007   CHEN PS               ANAL CHEM                       28  1756 956
   008   DAWES C               CARIES RES                       1   333 967
   009   DAWES C               ARCH ORAL BIOL                  14   277 969
   010   GOEBELL H             GUT                             13   477 972
   011   GOW BS                J DENT RES                      44   885 965
   012   JOHNSTON WH           ARCH DIS CHILD                  31   477 956
   013   KUTSCHER AH           AM J DIS CHILD                 110   643 965
   014   LAWSON D              ARCH DIS CHILD                  44   715 969
   015   MANDEL ID             AM J DIS CHILD                 113   431 967
   016   MANDEL ID             AM J DIS CHILD                 110   646 965
   017   MANGOS JA             PEDIATR RES                      1   436 967
   018   MARMAR J              GASTROENTEROLOGY                50   551 966
   019   MATTHEWS EK           J PHYSIOL (LOND)               234   689 973
   020   SAGGERS BA            ARCH DIS CHILD                  42   187 967
   021   SCHNEYER LH           PHYSIOL REV                     52   720 972
   022   SHACKLEFORD JM        J HISTOCHEM CYTOCHEM            12   512 964
   023   WALLACH D             EUR J BIOCHEM                   21   433 971
   024   WIESMANN UN           J PEDIATR                       76   444 970
   025   WOTMAN S              ARCH ORAL BIOL                  16   663 971
   026   WOTMAN S              J PERIODONTOL                   44   278 973
CT   1   ALLARS HM             PEDIATR RES                     10   578 976
     2   ALLARS HM             PEDIATR RES                     10   584 976
     3   GILLARD BK            PEDIATR RES                     12   868 978
     4   SETSER ME             LAB INVEST                      41   256 979
     5   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     6   FEIGAL RJ             NATURE                         278   276 979
     7   WOOD JH               METH FIND EXP CLIN PHARMACOL     4   255 982
     8   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983
     9   KATZ S                CELL CALC                        5   421 984
    10   ROOMANS GM            ANN NY ACAD SCI                428   121 984
    11   MUALLEM S             BIOCHIM BIOPHYS ACTA           819   143 985

PN 76173
RN 00527 
AN 76197020
AU Allars-H-M.  Blomfield-J.  Rush-A-R.  Brown-J-M.
TI Colloid and crystal formation in parotid saliva of cystic fibrosis
   patients and non-cystic fibrosis subjects.  I. Physicochemistry.
SO Pediatr-Res. 1976 Jun. 10(6). P 578-84.
MJ COLLOIDS: me.  CRYSTALLIZATION.  CYSTIC-FIBROSIS: me.
   PAROTID-GLAND:  me.  SALIVA: me.
MN ADOLESCENCE.  ADULT.  CALCIUM: me.  CHEMISTRY-PHYSICAL.  CHILD.
   COLD.  EDTA: pd.  GUANIDINES: pd.  HEATING.  HUMAN.  PHOSPHATES: me.
   PROTEINS: me.  SALIVA: de.  NEPHELOMETRY-AND-TURBIDIMETRY.  UREA: pd.
AB Two types of turbidity were found in parotid saliva from both cystic
   fibrosis (CF) patients and non-CF subjects. On cooling saliva, a
   rapidly forming, reversible, cold-dependent turbidity appeared in
   increasing amounts with decreasing temperature and increasing protein
   concentration. At 37 degrees, a slowly forming, stable turbidity
   appeared in increased amounts in parotid saliva samples containing
   increased amounts of calcium. The 2 degree centrifuged pellet
   consisted predominantly of protein, whereas the 37 degree pellet
   contained calcium, inorganic phosphate, and protein. The cold-
   dependent turbidity at 2 degrees was not inhibited by EDTA, but 37
   degrees turbidity was dramatically inhibited. Urea and guanidine
   hydrochloride reduced 2 degree turbidity, and, to a lesser extent,
   inhibited 37 degree turbidity. The tendency towards higher levels of
   protein, amylase, and calcium in CF compared with child control
   parotid saliva (4, 6) causes a greater incidence and degree of
   turbidity formation in saliva of CF patients. In this paper only the
   nature of the turbidity has been investigated, not its relative
   occurrence in each group of subjects.
RF 001   ALLAN J               DIGESTION                       11   428 974
   002   ALLARS HM             PEDIATR RES                     10   584 976
   003   AZEN EA               SCIENCE                        180  1067 973
   004   BLOMFIELD J           AUST PAEDIATR J                 10    75 974
   005   BLOMFIELD J           GUT                             14   558 973
   006   BLOMFIELD J           PEDIATR RES                     10   574 976
   008   BLOMFIELD J           ARCH ORAL BIOL                  19  1153 974
   009   BOAT TF               PEDIATR RES                      8   531 974
   010   BOURSNELL JC          J REPROD FERTIL                 36    91 974
   011   CANCRO LP             IADR ABST                            107 970
   012   CHEN PS               ANAL CHEM                       28  1756 956
   013   DAWES C               CARIES RES                       1   333 967
   014   DAWES C               ARCH ORAL BIOL                  14   277 969
   015   EGGSTEIN M            KLIN WOCHENSCHR                 33   879 955
   016   GOW BS                J DENT RES                      44   885 965
   017   GRON P                ARCH ORAL BIOL                  18  1365 973
   018   GRON P                ARCH ORAL BIOL                  18  1385 973
   019   HAY DI                ARCH ORAL BIOL                  18  1517 973
   020   JOHANSEN PG           LANCET                           1   455 968
   021   LOWRY OH              J BIOL CHEM                    193   265 951
   022   MCKENZIE HA           ADV PROT CHEM                   22    55 967
   023   NOBLE RW              J AM CHEM SOC                   87  2236 965
   024   OAKENFULL DG          PROC AUST BIOCHEM SOC            7    20 974
   025   OPPENHEIMER EH        J PEDIATR                       75   806 969
   026   ROBERTS TK            J REPROD FERTIL                 35   595 973
   027   RULE AH               FERTIL STERIL                   21   515 970
   028   SHACKLEFORD JM        J HISTOCHEM CYTOCHEM            12   512 964
   029   TERMINE JD            CALC TISS RES                   15    81 974
   030   TISCORNIA O           DIGESTION                       11   172 974
   031   WAUGH DF              J AM CHEM SOC                   87  2246 965
   032   WOTMAN S              J PERIODONTOL                   44   278 973
CT   1   ALLARS HM             PEDIATR RES                     10   584 976
     2   GILLARD BK            CLIN CHEM                       23  2279 977
     3   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     4   FEIGAL RJ             NATURE                         278   276 979
     5   MUALLEM S             BIOCHIM BIOPHYS ACTA           819   143 985

PN 76174
RN 00528 
AN 76127229
AU Chou-L.  Nadler-H.
TI Absence of a serum factor in patients with cystic fibrosis.
SO Pediatr-Res. 1976 Mar. 10(3). P 176-8.
MJ CYSTIC-FIBROSIS: bl.
MN CELL-MEMBRANE: me.  CELLS-CULTURED.  CHILD.  COMPARATIVE-STUDY.
   CYSTIC-FIBROSIS: me.  FIBROBLASTS: me.  FUCOSE: me.  HUMAN.
   SKIN:  me.
AB A serum factor was demonstrated in normal individuals which (1)
   enhances the incorporation of L-[3H]fucose into cultured human skin
   fibroblasts, (2) is nondialyzable, (3) is heat labile at 50 degrees,
   (4) is present in the noneuglobulin fraction, and (5) appears to be
   deficient in serum from patients with cystic fibrosis. The specific
   activity of L-[3H]fucose incorporated into skin fibroblasts from
   normal individuals in the presence of serum from 12 control subjects
   was 3,337 +/- 168 cpm/mg protein in contrast to 2,294 +/- 172, the
   activity obtained either in the presence of serum from 10 age-matched
   patients with cystic fibrosis or in the absence of serum. These
   differences were significant at P less than 0.001. In comparison, no
   significant difference was detected in the amount of L-[3H]fucose
   incorporated into skin fibroblasts derived from normal individuals
   and patients with cystic fibrosis. The plasma membrane of cultured
   skin fibroblasts derived from patients with cystic fibrosis appears
   to be grossly unaltered in its protein and L-fucose labeling pattern.
RF 001$  ATKINSON PH           J BIOL CHEM                    210  5162 971
   002   BAIG MM               J PEDIATR                       86    72 975
   003   BESLEY GTN            J MED GENET                      6   278 969
   004   BOSMANN HB            ARCH BIOCHEM BIOPHYS           130   573 969
   005   BOWMAN BH             SCIENCE                        164   325 969
   006   BROWN GA              LANCET                           2   639 971
   008   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   009   FAIRBANKS G           BIOCHEMISTRY                    10  2606 971
   010   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   011   KAISER D              PEDIATR RES                      5   167 971
   012   LOWRY OH              J BIOL CHEM                    193   265 951
   013   MANGOS JA             PEDIATR RES                      1   436 967
   014   NADLER HL             NATURE                         213  1261 967
   015   NAITOH Y              SCIENCE                        166  1633 969
   016   SPOCK A               PEDIATR RES                      1   173 967
   017   WARREN L              IN: DAVIS BD                             967
CT   1   DISANTAGNESE PA       N ENGL J MED                   295   534 976
     2   BANCHINI G            PEDIATR RES                     15  1073 981

PN 76175
RN 00529 
AN 77057102
AU Smith-Q-T.  Hamilton-M-J.  Shapiro-B-L.
TI Simple technique for detection of cystic fibrosis heterozygotes and
   homozygotes.
SO Pediatr-Res. 1976 Dec. 10(12). P 999-1000.
MJ CYSTIC-FIBROSIS: di.
MN BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: bl.
   ELECTROPHORESIS-POLYACRYLAMIDE-GEL.  HETEROZYGOTE.  HOMOZYGOTE.
   HUMAN.  ISOELECTRIC-FOCUSING.  STAINS-AND-STAINING.
EX We examined serum proteins from 18 CF subjects and 14 control
   individuals.  We were unable to detect any consistent differences
   between the stained serum protein patterns of the CF and the control
   subjects.  These patterns show greater resolution of proteins than
   those previously published, but, in contrast, no consistent
   differences between CF and control subjects.  In addition, we have
   modified the published methods with procedures which would enhance
   the likelihood of electrophoretic detection of an abnormal protein
   with the reported properties.  A portion of the samples analyzed by
   the published procedures also were analyzed by each of these
   modifications.  None of the modified procedures showed consistent
   differences between serum proteins from the CF and the control
   subjects.  No explanation is readily apparent for the difference
   between results of Thomas et al. and our own results on the one hand
   and the previously reported results on the other.  We attempted to
   rigorously reproduce the isoelectric focusing techniques given in the
   literature.  However, isoelectric focusing in polyacrylamide gel can
   be affected by small technical differences and, thus, factors
   essential to reproducing the techniques may not have been evident in
   the published procedure.
RF 001   ALTLAND K             HUMANGENETIK                    28   207 975
   002   THOMAS JM             CF CLUB ABST                    17    19 976
   003   WILLIAMSON AR         IN: WEIR DM                              973
   004   WILSON GB             PEDIATR RES                      9   635 975
   005   WILSON GB             CLIN CHIM ACTA                  49    79 973
CT   1   WILSON GB             PEDIATR RES                     10  1001 976
     2   THOMAS JM             PEDIATR RES                     11  1148 977
     3   WILSON GB             PEDIATR RES                     11   139 977
     4   WILSON GB             PEDIATR RES                     11   986 977
     5   SCHOLEY J             PEDIATR RES                     12   800 978
     6   WILSON GB             PEDIATR RES                     12   801 978
     7   TULLY GW              PEDIATR RES                     13  1078 979
     8   WILSON GB             PEDIATR RES                     13  1079 979
     9   MANSON JC             LANCET                           1   330 980
    10   NEVIN GB              HUM GENET                       56   387 981
    11   HALLINAN FM           CLIN CHIM ACTA                 117   103 981
    12   BULLOCK S             CLIN GENET                      21   336 982
    13   BURY AF               CLIN CHIM ACTA                 118    45 982
    14   ANON                  LANCET                           2   249 985
    15   JAMIESON A            HUM GENET                       70   168 985
    16   GETLIFFE KA           J INHERIT METAB DIS              9   348 986

PN 76176
RN 00530 
AN 76101892
AU Wilson-G-B.  Fudenberg-H-H.
TI Studies on cystic fibrosis using isoelectric focusing.  II.
   Demonstration of deficient proteolytic cleavage of
   alpha2-macroglobulin in cystic fibrosis plasma.
SO Pediatr-Res. 1976 Feb. 10(2). P 87-96.
MJ ALPHA-MACROGLOBULINS: me.  CYSTIC-FIBROSIS: bl.
   PEPTIDE-HYDROLASES:  df.
MN ALPHA-MACROGLOBULINS: ip, an, df.  ARGINASE: df, bl.
   BLOOD-PROTEINS:  ip.  HUMAN.  ISOELECTRIC-FOCUSING.
   PEPTIDE-HYDROLASES: bl.  PROTEIN-BINDING.  TRYPSIN: bl.
AB A protein with an isoelectric point (pI) of 5.48 was found to be
   deficient in plasma from most cystic fibrosis (CF) homozygotes and
   obligate heterozygote carriers of CF as compared with normal control
   plasma. Purification of the protein with a pI of 5.48 from normal
   plasma was performed using ammonium sulfate precipitation, DEAE-
   cellulose and CM-cellulose chromatography, Sephadex G-200- gel
   filtration, starch block electrophoresis, and Sepharose 4B gel
   filtration. The purified protein migrated as a single band on
   polyacrylamide gel electrophoresis, and displayed a single arc on
   immunoelectrophoresis against polyvalent antiserum to whole human
   serum. Results from various techniques used in its characterization
   indicate that this protein is a fragment of alpha2-macroglobulin
   (alpha2M) which is derived from alpha2M by proteolytic cleavage of
   intact alpha2M subunits. Quantitation of alpha2M levels in plasma
   indicated no significant differences between levels of alpha2M in CF
   homozygote, obligate heterozygote carrier, or normal control plasma
   samples. Quantitation of arginine esterase activity in plasma treated
   with cloroform and ellagic acid indicated that both the total
   arginine esterase activity and that fraction of arginine esterase
   activity inhibited by soybean trypsin inhibitor (SBTI) were decreased
   in most CF homozygote and obligate heterozygote plasma samples
   relative to normal control values. The results of this study indicate
   that plasma samples from CF homozygotes and obligate heterozygote
   carriers for CF show deficient proteolytic cleavage of alpha2M as
   compared with normal control plasma, and suggest that a structural
   abnormality in alpha2M or a deficiency in plasma proteolytic activity
   may be responsible for this deficiency in proteolysis.
RF 001   BARNETT DR            PEDIATR RES                      8   687 974
   002   BARNETT DR            TEX REP BIOL MED                31   703 973
   003   BARRETT AJ            BIOCHEM J                      133   709 973
   004   BERATIS NG            PEDIATR RES                      7   958 973
   005   BOWMAN BH             IN: MANGOS JA                         29 973
   006   BOWMAN BH             CLIN GENET                       4   461 973
   007   BOWMAN BH             SCIENCE                        167   871 970
   008   COHEN LF              PEDIATR RES                      9   312 975
   009   COLMAN RW             J CLIN INVEST                   48    23 969
   010   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   011   CONOVER JH            PEDIATR RES                      7   220 973
   012   CONOVER JH            LANCET                           1    47 975
   013   CONOVER JH            LIFE SCI                        14   253 974
   014   DAVIS BJ              ANN NY ACAD SCI                121   404 964
   015   FAIRBANKS G           BIOCHEMISTRY                    10  2606 971
   016   GANROT PO             CLIN CHIM ACTA                  13   518 966
   017   GANROT PO             CLIN CHIM ACTA                  13   597 966
   018   GANROT PO             CLIN CHIM ACTA                  16   328 967
   019   GANROT PO             ACTA CHEM SCAND                 21   595 967
   020   HARPEL PC             J EXP MED                      132   329 970
   021   HARPEL PC             J EXP MED                      138   508 973
   022   HIRSCHHORN K          IN: MANGOS JA                         11 973
   023   JONES JM              BIOCHEM J                      127   187 972
   024   KAPLAN AP             MICROVASC RES                    8    97 974
   025   KUNKEL HG             IN: BIER M                           225 959
   026   LANCHANTIN GF         PROC SOC EXP BIOL MED          121   444 966
   027   LASKOWSKI M           IN: BOYER PD                     3   375 971
   028   LIEBERMAN J           LANCET                           1  1230 974
   029   LIEBERMAN J           CF CLUB ABST                          44 975
   030   LOWRY OH              J BIOL CHEM                    193   265 951
   031   MANGOS JA             PEDIATR RES                      2   378 968
   032   MARGOLIS J            J PHYSIOL (LOND)               151   238 960
   033   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   034   MCCONNELL DJ          J CLIN INVEST                   51  1611 972
   035   MOLENAAR J            J IMMUNOL                      112  1444 974
   036   MUNRO GF              CF CLUB ABST                    16     7 975
   037   OUCHTERLONY O         IN: WEIR DM                          191 973
   038   RAO GJS               PEDIATR RES                      8   684 974
   039   RAO GJS               SCIENCE                        177   610 972
   040   RATNOFF OD            ADV IMMUNOL                     10   145 969
   041   RATNOFF OD            IN: GOOD RA                          135 971
   042   RAYMOND S             ANN NY ACAD SCI                121   350 964
   043   RENNERT OM            IN: MANGOS JA                         41 973
   044   SAUNDERS R            J CLIN INVEST                   50  2376 971
   045   SIEGELMAN AM          ARCH BIOCHEM BIOPHYS            97   159 962
   046   STEINBACH M           REV FR ETUD CLIN BIOL           13   179 968
   047   STEINBACH M           BIOCHIM BIOPHYS ACTA           154   228 968
   048   WILSON GB             THESIS                                   974
   050   WILSON GB             PEDIATR RES                      9   635 975
   051   WILSON GB             LIFE SCI                        15   551 974
   052   WILSON GB             CLIN CHIM ACTA                  49    79 973
   053   CAUDILL M             LANCET                           2   307 973
CT   1   SHAPIRA E             PEDIATR RES                     10   812 976
     2   WILSON GB             PEDIATR RES                     10  1001 976
     3   LEDERBERG S           AM J HUM GENET                  28   597 976
     4   WILSON GB             TEX REP BIOL MED                34    51 976
     5   FORSTNER G            CLIN CHIM ACTA                  70   459 976
     6   SHAPIRA E             BIOCHEM BIOPHYS RES COMMUN      71   864 976
     7   RAO GJS               PEDIATR RES                     11   981 977
     8   WILSON GB             PEDIATR RES                     11   139 977
     9   WILSON GB             PEDIATR RES                     11   317 977
    10   ARNAUD P              J IMMUNOL METH                  16   221 977
    11   CHAN KYH              CLIN CHIM ACTA                  74    71 977
    12   SHAPIRA E             CLIN CHIM ACTA                  78   359 977
    13   GOLDSMITH GH          J LAB CLIN MED                  89   131 977
    14   SHAPIRA E             J BIOL CHEM                    252  7923 977
    15   WILSON GB             NATURE                         266   463 977
    16   WILSON GB             PEDIATR RES                     12   801 978
    17   ALHADEFF JA           CLIN GENET                      14   189 978
    18   RAO GJS               ENZYME                          23   314 978
    19   VIRCA GD              ANAL BIOCHEM                    89   274 978
    20   WILSON GB             J LAB CLIN MED                  92   463 978
    21   ROMEO G               NATURE                         274   909 978
    22   PEARSON RD            PEDIATR RES                     13   834 979
    23   ROMEO G               PEDIATR RES                     13  1030 979
    24   VANLEUVEN F           PEDIATR RES                     13  1384 979
    25   WILSON GB             PEDIATR RES                     13  1079 979
    26   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    27   KURECKI T             ANAL BIOCHEM                    99   415 979
    28   BARRETT AJ            BIOCHEM J                      181   401 979
    29   SCANLIN TF            CLIN CHEST MED                   1   424 980
    30   DAVIS PB              PEDIATR RES                     14    83 980
    31   SHAPIRA E             BIOCHEM BIOPHYS RES COMMUN      93    50 980
    32   ROMEO G               J LAB CLIN MED                  95   116 980
    33   BURDON MG             CLIN CHIM ACTA                 100   225 980
    34   PARSONS M             CLIN CHIM ACTA                 100   215 980
    35   SCHIDLOW DV           AM REV RESPIR DIS              121    31 980
    36   NELLES LP             BIOCHIM BIOPHYS ACTA           623    46 980
    37   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    38   WILSON GB             J CLIN INVEST                   68   171 981
    39   VANLEUVEN F           J BIOL CHEM                    256  9016 981
    40   OWENSWILLIAMS L       J PEDIATR GASTROENTEROL NUTR     1   567 982
    41   WILSON GB             MED HYPOTHESES                   8   527 982
    42   BURY AF               IRCS MED SCI BIOCHEM            10   255 982
    43   BLITZER MG            PEDIATR RES                     16   203 982
    44   BURY AF               PEDIATR RES                     16   613 982
    45   ROBERTS RC            PEDIATR RES                     16   416 982
    46   BRIDGES MA            CLIN CHIM ACTA                 118    33 982
    47   BRIDGES MA            CLIN CHIM ACTA                 118    21 982
    48   TUMMLER B             CLIN CHIM ACTA                 125   219 982
    49   BACK SA               BIOCHEM MED                     30    34 983
    50   BACK SA               J CHROMATOGR                   278    43 983
    51   BRIDGES MA            ANN NY ACAD SCI                421   360 983
    52   SHAPIRA E             ANN NY ACAD SCI                421   352 983
    53   WILSON GB             ANN NY ACAD SCI                421   404 983
    54   HJELM M               CLIN BIOCHEM                    17   284 984
    55   EAGER KB              PEDIATR RES                     18   999 984
    56   MARYNEN P             BIOCHIM BIOPHYS ACTA           799   187 984
    57   GOLDSTEIN W           AM REV RESPIR DIS              134    49 986

PN 76177
RN 00531 
AN 76101889
AU Cheung-A-T.  Jahn-T-L.
TI High speed cinemicrographic studies on rabbit tracheal (ciliated)
   epithelia: cytolytic effect of cystic fibrosis serum on tracheal
   epithelial cells.
SO Pediatr-Res. 1976 Feb. 10(2). P 144-47.
MJ CILIA: ph.  CYSTIC-FIBROSIS: bl.  TRACHEA: cy.
MN ANIMAL.  CELL-MOVEMENT.  EPITHELIUM: cy.  MOTION-PICTURES.
   PHOTOMICROGRAPHY.  RABBITS.  TRACHEA: ph.  EPITHELIUM: cy.
AB High speed cinemicrographs are made on the ciliary activity of rabbit
   tracheal cilia with the aid of Nomarski optics. The detailed nature
   of the ciliary beat pattern is determined from slow motion analysis
   of the high speed cinemicrographs (1-3). Such documented forms of
   ciliary beat pattern and the physiologic state of the tracheal
   epithelia are utilized as basic reference controls to investigate the
   physiologic effects of cystic fibrosis serum on ciliated epithelia
   and the cystic fibrosis tracheal mucus stagnation phenomenon. Careful
   analyses of the high speed cinemicrographs reveal that cystic
   fibrosis serum has no effect on the rhythm and beat pattern of rabbit
   tracheal cilia. However, it is shown in controlled procedures that
   cystic fibrosis serum has a cytolytic effect on the tracheal
   epithelial cells and also at the cell junctions. Ciliary dyskinesis,
   as described in previous reports (6-9), is actually a secondary
   effect of cytolysis and cell destruction.
RF 001   CHEUNG ATW            DISSERTATION                             973
   006   CONOVER JH            PEDIATR RES                      7   220 973
   007   KOPEL FB              CF CLUB ABST                          32 972
   008   SPOCK A               PEDIATR RES                      1   173 967
   009   SPOCK A               MOD PROBL PEDIATR               10   200 967
CT   1   MARTINEZ JR           MO MED                          73   173 976
     2   WILSON GB             PEDIATR RES                     11   143 977
     3   BOGART BI             PEDIATR RES                     12    15 978
     4   GABRIDGE MG           PEDIATR RES                     13    31 979
     5   VERDUGO P             PEDIATR RES                     13   131 979
     6   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     7   BOROVIKOVA TM         TER ARKH                        52   125 980
     8   TEGNER H              ACTA PAEDIATR SCAND             70   629 981
     9   MARUYAMA I            JAP J PHARMACOL                 32   237 982
    10   RUTLAND J             AM REV RESPIR DIS              128  1030 983
    11   CHEUNG ATW            J MED PRIMATOL                  15    37 986
    12   HENNESSY SJ           J APPL PHYSIOL                  60  2109 986

PN 76178
RN 00532 
AN 76101886
AU Farrell-P-M.  Fox-G-N.  Spicer-S-S.
TI Determination and characterization of ciliary ATPase in the presence
   of serum from cystic fibrosis patients.
SO Pediatr-Res. 1976 Feb. 10(2). P 127-35.
MJ ADENOSINE-TRIPHOSPHATE: me.  CILIA: en.  CYSTIC-FIBROSIS: en.
   EPITHELIUM: en.  EPITHELIUM: cy.
MN ADENOSINE-TRIPHOSPHATASE: me.  ANIMAL.  CHROMATOGRAPHY: mt.
   CYSTIC-FIBROSIS: bl.  ELECTROLYTES: pd.  HUMAN.  HYDROLYSIS.
   IN-VITRO.  MICROSCOPY-ELECTRON.  OYSTERS: an.  RABBITS.
AB The purpose of this investigation was twofold: (1) to identify and
   characterize the enzymatic ATP hydrolysis system of epithelial cilia,
   and (2) to develop a quantitative, biochemical test for the
   ciliotoxic cystic fibrosis (CF) factor based on inhibition of ATP
   utilization by ciliary preparations. Our rationale for selecting this
   system for CF factor analysis relates to the tight and essential
   mechanochemical coupling of functioning cilia. Using rabbit tracheal
   epithelium as the source, a high molecular weight (greater than
   200,000) ATPase was identified, partially purified, and extensively
   characterized. The properties of this protein were similar to those
   observed in previous studies of others with flagellar and ciliary
   dynein (the motility-associated ATPase) isolated from microorganisms.
   Analysis of the pH profile revealed a broad range of high enzymatic
   activity between 6.5 and 9. Studies with potential cation activators
   showed that the enzyme is activated equally by either Ca2+ or Mg2+ in
   equimolar concentrations. No activation occurred in the presence of
   Zn2+, Na+, H+, or Na+ plus K+ and the effect of Mg2+ or Ca2+ was not
   inhibited by Na+, K+, or Na+ plus K+. The enzyme hydrolyzed Mg2+-
   containing solutions of UTP, CTP, and ADP at 51-54% the rate of ATP
   dephosphorylation, whereas Mg-deoxy-ATP was hydrolyzed 79% as
   effectively as ATP. Using a newly devised, analytical technique with
   [gamma-32P]ATP as the substrate, the ATP hydrolysis of various
   ciliary preparations from rabbit trachea and oyster gill (including
   motile suspensions) was monitored in the presence of sera from CF
   homo- and heterozygotes. Reproducible rates of ATP dephosphorylation
   averaging 27 nmol/min/mg protein were demonstrable with homogenates
   of ciliated epithelium. None of the test systems evaluated, however,
   were capable of demonstrating CF-related differences in ATPase
   activity or ATP utilization. Although these attemps have been
   unsuccessful thus far, the approach described in this report provides
   an example of an objective, quantitative, biochemical assessment of
   ciliary function.
RF 001   AIELLO EL             PHYSIOL ZOOL                    23   120 960
   002   BARGMAN GJ            PEDIATR RES                      8   464 974
   003   BESLEY GTN            J MED GENET                      6   278 969
   004   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   005   BOWMAN BH             SCIENCE                        164   325 969
   006   BROKAW CJ             SCIENCE                        156    76 967
   007   BROKAW CJ             ARCH BIOCHEM BIOPHYS           125   770 968
   008   BROKAW CJ             ARCH BIOCHEM BIOPHYS           142    91 971
   009   CHERRY JD             J PEDIATR                       79   937 971
   010   CHEUNG ATW            CF CLUB ABST                    14    28 973
   011   COLE CH               PEDIATR RES                      6   616 972
   012   CONOVER JH            PEDIATR RES                      7   220 973
   013   CONOVER JH            PEDIATR RES                      7   224 973
   014   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   015   ECKERT R              SCIENCE                        176   473 972
   016   EISENBERG E           J BIOL CHEM                    245  2451 970
   017   FAIRBANKS G           BIOCHEMISTRY                    10  2606 971
   018   FISKE CH              J BIOL CHEM                     66   375 925
   019   GRAY J                PROC R SOC LOND BIOL            96    95 924
   020   GIBBONS IR            J BIOL CHEM                    241  5500 966
   021   GIBBONS IR            J CELL BIOL                     54   365 972
   022   GIBBONS BH            J CELL BIOL                     54    75 972
   023   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   024   KINOSITA H            PHYSIOL REV                     47    53 967
   025   LOWRY OH              J BIOL CHEM                    193   265 951
   026   MANGOS JA             PEDIATR RES                      1   436 967
   027   MANGOS JA             GAP CONF REP CILIARY INHIBITO          2 973
   028   POSSELT HG            Z KINDERHEILK                  110    93 971
   029   SKOU JC               PHYSIOL REV                     45   596 965
   030   SPOCK A               PEDIATR RES                      1   173 967
   031   TAYLOR A              PEDIATR RES                      8   861 974
   032   WARNER FD             ADV CELL MOL BIOL                2   193 972
   033   WACHSTEIN M           J HISTOCHEM CYTOCHEM             8   387 960
   034   WATANABE T            BIOCHEM BIOPHYS RES COMMUN      52   195 973
   035   WETZEL MG             J CELL BIOL                     30   299 966
   036   WOOD RE               LANCET                           2  1452 973
CT   1   MARTINEZ JR           MO MED                          73   173 976
     2   WOOD RE               AM REV RESPIR DIS              113   833 976
     3   DISANTAGNESE PA       N ENGL J MED                   295   534 976
     4   BOGART BI             PEDIATR RES                     12    15 978
     5   KURLANDSKY LE         PEDIATR RES                     14  1263 980
     6   MALER T               BIOCHIM BIOPHYS ACTA           598     1 980

PN 76179
RN 00533 
AN 76197024
AU Forstner-J-F.  Forstner-G-G.
TI Effects of calcium on intestinal mucin: implications for cystic
   fibrosis.
SO Pediatr-Res. 1976 Jun. 10(6). P 609-13.
MJ CALCIUM: pd.  CYSTIC-FIBROSIS: me.  INTESTINAL-SECRETIONS: de.
   MUCINS: me.
MN ANIMAL.  ELECTROPHORESIS-POLYACRYLAMIDE-GEL.  RATS.  SOLUBILITY.
   ULTRACENTRIFUGATION.  VISCOSITY.
AB A major feature of the disease cystic fibrosis is the excessive
   concentration of mucus within ducts and glands of mucous-producing
   organs. Some mucous secretions also show an elevation in calcium
   concentration. Using purified rat intestinal goblet cell mucin as a
   model mucin, we have investigated the effect of millimolar additions
   (1-25 mM) of CaCl2 on the physical properties of the mucin.
   Isotonicity of incubation media was preserved in order to mimic in
   vivo conditions. CaCl2 (8-15mM) caused a 15-33% decrease in
   viscosity, no change in electrophoretic mobility in acrylamide gels,
   and a 20-30% decrease in solubility of the mucin. Solubility changes
   were reversed by the addition of EDTA (20 mM) to incubations.
   Insolubility was also produced in incubations of mucin with a mixture
   of soluble intestinal contents (NaCl washings). These findings
   strongly suggest that the mucin became smaller and more dense as
   calcium was added, a process most probably achieved by loss of
   intramolecular water.
RF 001   ALLEN A               GUT                             13   666 972
   002   BARTOLINI A           J MEMBR BIOL                    13   283 973
   003   BELLA A JR            ARCH BIOCHEM BIOPHYS           150   679 972
   004   BETTELHEIM FA         BIOCHIM BIOPHYS ACTA           236   702 971
   005   BOAT TF               PEDIATR RES                      8   531 974
   006   BUDDECKE E            IN: GOTTSCHALK A                         966
   007   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   008   FORSTNER JF           BIOCHIM BIOPHYS ACTA           386   283 975
   009   FORSTNER JF           CAN J BIOCHEM                   51  1154 973
   010   FORSTNER JF           BIOCHEM J                      124   563 971
   011   FORSTNER JF           J CELL SCI                      12   585 973
   012   GIBSON LE             PEDIATRICS                      48   695 971
   013   GUGLER EC             J PEDIATR                       71   585 967
   014   JAKOWSKA S            CF AND RELATED HUMAN AND ANIM            970
   015   JOOS RW               PROC SOC EXP BIOL MED          124  1268 967
   016   NEGUS V               PROC R SOC MED                  60    75 967
   017   PIGMAN W              ANN ANAT PATHOL                 17   227 972
   018   ROBERTS GP            EUR J BIOCHEM                   50   265 974
   019   ROUSSEL P             J BIOL CHEM                    250  2114 975
   020   TAYLOR M              LARYNGOSCOPE                    84   612 974
   021   WARNER RR             J CELL BIOL                     64    54 975
   022   WARTON KL             BR MED J                         3   570 971
CT   1   SANTAGNESE PAD        N ENGL J MED                   295   481 976
     2   RAO GJS               PEDIATR RES                     11   981 977
     3   WOOD DL               PEDIATR RES                     11   827 977
     4   NEUTRA MR             LAB INVEST                      36   535 977
     5   KATZ S                PEDIATR RES                     12  1033 978
     6   ALHADEFF JA           CLIN GENET                      14   189 978
     7   FORSTNER JF           DIGESTION                       17   234 978
     8   KATZ S                RES COMMUN CHEM PATH PHARM      19   491 978
     9   NAKAMURA J            CHEM PHARMACEUT BULL            26   857 978
    10   NEUTRA MR             GASTROENTEROLOGY                75   701 978
    11   LIST SJ               BIOCHEM J                      175   565 978
    12   BOAT TF               ACS SYMPOSIUM SERIES          1978   108 978
    13   MARRIOTT C            BIORHEOLOGY                     16   331 979
    14   SHAPIRO BL            PROC NAT ACAD SCI USA           76  2979 979
    15   SCANLIN TF            CLIN CHEST MED                   1   424 980
    16   DAVIS PB              PEDIATR RES                     14    83 980
    17   KATZ S                CLIN CHIM ACTA                 100   245 980
    18   LAMONT JT             BIOCHIM BIOPHYS ACTA           629   553 980
    19   HALLINAN F            MED HYPOTHESES                   7   793 981
    20   HUTH SW               ARCH OPHTHALMOL                 99  1628 981
    21   TABAK LA              J ORAL PATHOL                   11     1 982
    22   MURAKAMI T            CHEM PHARMACEUT BULL            30   659 982
    23   FORSTNER G            ADV EXP MED BIOL               144   199 982
    24   MARRIOTT C            ADV EXP MED BIOL               144    89 982
    25   ZENTLERMUNRO PL       BR MED J                       287   501 983
    26   KATZ S                CELL CALC                        5   421 984
    27   KARLSSON S            J MED GENET                     21   441 984
    28   ALBAZZAZ FJ           RESPIRATION                     46    88 984
    29   ALBAZZAZ FJ           J APPL PHYSIOL                  59  1191 985
    30   MULLER RM             SCANN ELECTRON MICROSC        1985  1583 985
    31   ALBAZZAZ FJ           CLIN CHEST MED                   7   259 986
    32   SMITH AC              CLIN GASTROENTEROL              15   815 986
    33   RUBINSTEIN S          PEDIATRICS                      78   473 986
    34   FEIGAL RJ             ANN NY ACAD SCI                488    82 986

PN 76180
RN 00534 
AN 77057091
AU Wilson-G-B.  Arnaud-P.  Monsher-M-T.  Fudenberg-H-H.
TI Detection of cystic fibrosis protein by electrofocusing.
SO Pediatr-Res. 1976 Dec. 10(12). P 1001-2.
MJ BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: bl.  ISOELECTRIC-FOCUSING.
MN HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.  ISOELECTRIC-FOCUSING: mt.
EX Detection of cystic fibrosis protein (CFP) using out method involves
   rather exacting requirements for the collection of serum samples and
   their subsequent analysis by electrofocusing.  Minor variations in
   the methods described for sample collection and storage may cause
   degradation and loss of CFP and this by itself could lead to
   erroneous results since many CF samples would appear to be CFP
   negative, making it impossible to observe a consistent difference
   between a group of CF samples and normal control samples by
   electrofocusing.  From the results presented by Thomas et al. and
   Figure 1 of the letter by Smith et al., it is obvious that neither
   group has reproduced the protein handling patterns presented in
   either of our previous reports.  The pH gradients are not the same,
   the location of the sample pads relative to the anode are not the
   same, and the protein banding patterns are totally different.  We
   question the validity of the techniques used, claims of having
   reproduced our method for detecting CFP, or supposed improvements
   designed to enhance the detection of CFP.
RF 001   ALTLAND K             HUMANGENETIK                    28   207 975
   002   AWDEH ZL              NATURE                         219    66 968
   003   CONOVER JH            PEDIATR RES                      7   220 973
   004   SMITH QT              PEDIATR RES                     10   999 976
   005   THOMAS JM             CF CLUB ABST                    17    19 976
   006   WILLIAMSON AR         IN: WEIR DM                              973
   007   WILSON GB             PEDIATR RES                     10    87 976
   008   WILSON GB             PEDIATR RES                      9   635 975
   009   WILSON GB             CLIN CHIM ACTA                  49    79 973
   010   WILSON GB             CLIN RES                        24   295 976
CT   1   THOMAS JM             PEDIATR RES                     11  1148 977
     2   WILSON GB             PEDIATR RES                     11   986 977
     3   WILSON GB             PEDIATR RES                     11   317 977
     4   WILSON GB             PEDIATR RES                     11   139 977
     5   WILSON GB             NATURE                         266   463 977
     6   SCHOLEY J             PEDIATR RES                     12   800 978
     7   WILSON GB             PEDIATR RES                     12   801 978
     8   JAMIESON A            HUM GENET                       70   168 985

PN 76181
RN 00535 
AN 77035582
AU Gillard-B-K.  Feig-S-A.  Harrison-G-M.  Nelson-T-E.
TI Cystic fibrosis: enzymatic detection of a ciliostatic factor.
SO Pediatr-Res. 1976 Nov. 10(11). P 907-10.
MJ AMYLASES.  CYSTIC-FIBROSIS: en.  GLUCOSYLTRANSFERASES: ai.
   GLYCOGEN-DEBRANCHING-ENZYME: ai.
MN AMYLASES: ai, me.  DIALYSIS.  HUMAN.  POLYAMINES: pd.  SALIVA: an, en.
AB The ciliostatic cystic fibrosis (CF) factor has been investigated in
   order to develop an enzymatic assay for its detection. In saliva,
   this factor is associated with alpha-amylase. Removal or addition of
   the factor by dialysis does not affect the alpha-amylase catalytic
   activity of CF or control (normal) saliva. Crude preparations of the
   dialyzable factor from CF saliva are ciliostatic. Alpha-Amylase-
   catalyzed starch hydrolysis from both CF and control saliva was found
   to be insensitive to hydroxyalkylamine inhibitors so this method
   could not be used to detect differences in CF and control amylase.
   Since another carbohydrase, mammalian debranching enzyme, is much
   more sensitive to inhibition, the effect of the isolated crude factor
   on this enzyme was determined. The mean values for percentage of
   inhibition of debranching enzyme activity by fractions obtained from
   saliva of CF patients, obligate heterozygotes, and control subjects
   are: 32% (27 samples), 13% (21 samples), and 6% (11 samples),
   respectively. Fifteen of the CF values exceed the maximum 13%
   inhibition observed for controls. Indeed, five samples almost
   completely inhibited debranching enzyme. This inhibitory action
   provides the basis of an enzymatic assay for the detection of the
   ciliostatic CF factor.
RF 001   CAUDILL M             LANCET                           2   307 973
   002   BISHOP SH             CF CLUB ABST                    14    25 973
   003   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   004   BOWMAN BH             SCIENCE                        164   325 969
   005   ANON                  GAP CONF REP CILIARY INHIBITO          2 973
   006   DANES BS              CLIN GENET                       7   128 975
   007   DANES BS              J EXP MED                      136  1313 972
   008   DANES BS              CLIN GENET                       8    85 975
   009   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   010   DOGGETT RG            TEX REP BIOL MED                31   685 973
   011   DOGGETT RG            NATURE NEW BIOL                243   251 973
   012   FISHER EH             BIOCHEM PREP                     8    27 961
   014   KAISER D              LANCET                           1  1003 970
   015   LOWRY OH              J BIOL CHEM                    193   265 951
   016   MANGOS JA             SCIENCE                        158   135 967
   017   MANGOS JA             PEDIATR RES                      1   436 967
   018   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   019   MCNEELY CM            CF CLUB ABST                    16     6 975
   020   MILLER GL             ANAL CHEM                       31   964 959
   021   NELSON TE             CF CLUB ABST                           7 974
   022   NELSON TE             FED PROC                        33  1311 974
   023   NELSON TE             BIOCHEMISTRY                     8  1419 969
   024   REESE ET              CARBOHYD RES                    18   381 971
   025   ROBYT JF              IN: RADLEY JA                        431 968
   026   SPOCK A               PEDIATR RES                      1   173 967
   027   WATTS TE              ANAL BIOCHEM                    49   479 972
CT   1   GILLARD BK            BIOCHEMISTRY                    16  3978 977
     2   GILLARD BK            CLIN CHEM                       23  2279 977
     3   GILLARD BK            PEDIATR RES                     12   868 978
     4   IMPERO JE             PEDIATR RES                     12   108 978
     5   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     6   MANDEL ID             CRC CRIT REV CLIN LAB SCI       12   321 980
     7   SEALE TW              PEDIATR RES                     14  1398 980
     8   IMPERO JE             PEDIATR RES                     15   940 981
     9   SEALE TW              ANN CLIN LAB SCI                12   415 982
    10   VONEULER AM           ULTRASTRUCTURAL PATHOL           5    37 983

PN 76182
RN 00536 
AN 76197029
AU Thompson-F-E.  Quissell-D-O.  Williams-C-H.  Martinez-J-R.
TI The chronically reserpinized rat as a possible animal model for
   cystic fibrosis.  IV.  The protein composition of pulmonary lavage
   fluid.
SO Pediatr-Res. 1976 Jun. 10(6). P 632-5.
MJ CYSTIC-FIBROSIS: ci.  DISEASE-MODELS-ANIMAL.  PROTEINS: me.
   PULMONARY-SURFACTANT: me.  RESERPINE.
MN ADULT.  ANIMAL.  CHILD.  CHRONIC-DISEASE.  CYSTIC-FIBROSIS: me.
   GLYCOPROTEINS: me.  HUMAN.  IRRIGATION.  MALE.  MIDDLE-AGE.
   MOLECULAR-WEIGHT.  RATS.
AB Lung lavage samples obtained from patients with cystic fibrosis (CF)
   had significantly higher levels of total protein per ml lavage fluid
   (0.49 vs. 0.30 mg/ml). A significant increase in the absolute and
   relative amounts of a low molecular weight glycoprotein (15,000 mol
   wt) was noted in lavage specimens from CF patients. Reserpine-treated
   rats also showed a significant increase in the total protein
   recovered in the lung lavage fluid with a 233% increase in the
   absolute and relative amounts of a low molecular weight glycoprotein
   (15,000 mol wt). Thus, reserpine induced changes in the secretions of
   the lung of the rat which are similar to those observed in samples
   obtained from the lung of CF patients.
RF 001   ANDERSEN DH           ANN NY ACAD SCI                 93   500 962
   002   BARBERO GJ            IN: DI SANTAGNESE PA                 208 964
   003   CHAKRIN LW            AM REV RESPIR DIS              108    69 973
   004   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   005   DI SANTAGNESE PA      N ENGL J MED                   277  1344 967
   006   DI SANTAGNESE PA      N ENGL J MED                   277  1399 967
   007   FENNER C              ANAL BIOCHEM                    63   595 975
   008   FAIRBANKS G           BIOCHEMISTRY                    10  2606 971
   009   IMMKEN L              CF CLUB ABST                    16     9 975
   010   LOWRY OH              J BIOL CHEM                    193   265 951
   011   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   012   MARTINEZ JR           PEDIATR RES                      9   463 975
   013   MARTINEZ JR           PEDIATR RES                      9   470 975
   014   RAMIREZ RJ            DIS CHEST                       50   581 966
   015   WEBER K               J BIOL CHEM                    244  4406 969
   016   WILLIAMS CH           CLIN RES                        23  533A 975
CT   1   DAVIS PB              PEDIATR RES                     12   703 978
     2   PERLMUTTER J          PEDIATR RES                     12   188 978
     3   SIMSON JAV            LAB INVEST                      39   157 978
     4   MARTINEZ JR           PEDIATR RES                     13  1156 979
     5   MAWHINNEY TP          PEDIATR RES                     13   760 979
     6   SORDELLI DO           LIFE SCI                        24  2003 979
     7   SETSER ME             EXP MOL PATH                    31   413 979
     8   SETSER ME             LAB INVEST                      41   256 979
     9   MAWHINNEY TP          PEDIATR RES                     14   872 980
    10   MORTON D              PEDIATR RES                     14    18 980
    11   MCCURDY RE            PEDIATR RES                     15  1308 981
    12   SNIDER GL             MED CLIN NORTH AM               65   647 981
    13   FORSTNER J            AM J PHYSIOL                   241  G443 981
    14   CUTLER LS             VIRCHOWS ARCH PATHOL ANAT HIS  392   185 981
    15   SHIFFMAN ML           PEDIATR RES                     16   104 982
    16   MODRZAKOWSKI MC       CAN J MICROBIOL                 29  1339 983
    17   WERLIN SL             EXP MOL PATH                    39    24 983
    18   BOYD RL               PEDIATR RES                     18  1028 984

PN 76183
RN 00537 
AN 76151240
TI Airline travel for children with chronic pulmonary disease.
SO Pediatrics. 1976 Mar. 57(3). P 408-10.
MJ AEROSPACE-MEDICINE.  CYSTIC-FIBROSIS.  LUNG-DISEASES-OBSTRUCTIVE.
MN ALTITUDE.  ATMOSPHERIC-PRESSURE.  CARBON-DIOXIDE: bl.  CHILD.
   CHRONIC-DISEASE.  HUMAN.  OXYGEN: bl.
AB Air travel for children with chronic pulmonary disease is usually
   safe, but the potential hazards must be considered.  The high
   altitude, obviously, is that which provides the potential problem.
   Before specifically relating the problem to the children, a few
   words are in order concerning airline procedures and policies.
RF 001   ANON                  ARCH ENVIRON HEALTH              2   124 961
   002   ALTMAN PL             HANDBOOK OF RESPIRATION AND C            971
   003   HURTADO A             J APPL PHYSIOL                   1   304 948
   004   LENFANT C             N ENGL J MED                   284  1298 971
CT   1   FRATES RC             AM J DIS CHILD                 131   687 977
     2   CISSIK JH             AVIAT SPACE ENVIRON MED         52   312 981
     3   WALDMAN JD            J AM COLL CARDIOL                2  1158 983
     4   GONG H                AM REV RESPIR DIS              130   980 984
     5   DESMOND KJ            CAN MED ASSOC J                131   325 984

PN 76184
RN 00538 
AN 76175387
AU Chase-H-P.
TI Fatty acids, prostaglandins, and cystic fibrosis.
SO Pediatrics. 1976 Apr. 57(4). P 441-2.
MJ CYSTIC-FIBROSIS: dt.  FATTY-ACIDS: tu.  PROSTAGLANDINS: bi.
MN CYSTIC-FIBROSIS: me.  HUMAN.
EX The papers by Elliott and by Campbell et al. suggest a new approach
   toward etiology, pathophysiology, and therapy in patients with cystic
   fibrosis.  As in Elliott's original report of the effects of
   intravenous fatty acid therapy for CF, the patients in the present
   report fared remarkably well, particularly in regard to weight gain.
   The paper of Campbell et al. suggests that oxygen does not simply
   diffuse across membranes, but that instead its transport is
   influenced by the fatty acid composition of the membrane.  Elliott's
   suggestion that the disarranged fatty acid metabolism may be related
   to altered prostaglandin production is attractive.  These studies do
   not prove whether fatty acid and/or prostaglandin alterations are
   secondary to intestinal fat malabsorption or are related to the
   primary metabolic defect in CF.
RF 001   ELLIOTT RB            PEDIATRICS                      57   474 976
   002   CAMPBELL IM           PEDIATRICS                      57   480 976
   003   ELLIOTT RB            ARCH DIS CHILD                  50    76 975
   004   HOPKINS DT            PROC SOC EXP BIOL MED          114    82 963
   005   ANON                  NUTR REV                        32    19 974
   006   BUCHWALD M            AM J HUM GENET                  27   22A 975
CT   1   BARNESS LA            PEDIATRICS                      58   638 976
     2   SANJURJO P            LANCET                           1   752 977
     3   ALLUE X               PEDIATRICS                      61   924 978
     4   HAMDI I               MONOGR PAEDIATR                 10    84 979
     5   RUDIN DO              MED HYPOTHESES                   8    17 982
     6   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
     7   CRAIGSCHMIDT MC       AM J CLIN NUTR                  44   816 986

PN 76185
RN 00539 
AN 76175395
AU Campbell-I-M.  Crozier-D-N.  Caton-R-B.
TI Abnormal fatty acid composition and impaired oxygen supply in cystic
   fibrosis patients.
SO Pediatrics. 1976 Apr. 57(4). P 480-6.
MJ CYSTIC-FIBROSIS: me.  FATTY-ACIDS: me.  OXYGEN: bl.
MN CELL-MEMBRANE: ph.  CYSTIC-FIBROSIS: bl.  ERYTHROCYTES: ul.
   HEMOGLOBINS: me.  HUMAN.  LINOLEIC-ACIDS: me.  LUNG: pp.
   OLEIC-ACIDS: me.  OXYHEMOGLOBINS: bi.  PALMITATES: me.
AB Impaired oxygen supply and deteriorating health, in cystic fibrosis
   patients, correlates with abnormal changes in the fatty acid
   composition of blood lipids. As the proportion of oleates increases
   and that of linoleates decreases, erythrocyte membrane interference
   with the formation of intracellular oxyhemoglobin increases and
   arterial oxygen pressure decreases. The physical-chemical basis for
   these changes seems to be that oleic and linoleic acid differ in
   their ability to undergo reversible oxygenation in response to
   changes in oxygen pressure. The oxygen complex of linoleic acid
   dissociates at relatively high pressures, whereas that of oleic
   dissociates only at low pressures. Accordingly, excessive
   substitution of oleic for linoleic acid in membrane lipids would be
   expected to decrease the intracellular oxygen pressure to a level
   where hemoglobin oxygenation and any other oxygen-requiring processes
   would be impaired.
RF 001   KUO PT                J PEDIATR                       60   394 962
   002   UNDERWOOD BA          ANN NY ACAD SCI                203   237 972
   003   ROSENLUND ML          NATURE                         251   719 974
   004   CAMPBELL IM           CF CLUB ABST                    16       974
   005   CAMPBELL IM           LIPIDS                           9   916 974
   006   SHWACHMAN H           AM J DIS CHILD                  96     6 958
   007   KUKSIS A              LIPIDS                           2   217 967
   008   GODINEZ RI            J LIPID RES                     14   138 973
   009   QUARFORDT SH          LIPIDS                           8   522 973
   010   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   011   DEBEER JJ             EUR J BIOCHEM                   47   591 974
   012   HOLLEY RW             PROC NAT ACAD SCI USA           71  3976 974
   013   ELLIOTT RB            AUST PAEDIATR J                  8   217 972
   014   ELLIOTT RB            PEDIATR RES                      7   427 973
   015   ELLIOTT RB            ARCH DIS CHILD                  50    76 975
   016   PRESS M               LANCET                           1   597 974
CT   1   CHASE HP              PEDIATRICS                      57   441 976
     2   HUBBARD VS            LANCET                           2  1302 977
     3   DAVIS PB              PEDIATR RES                     12   703 978
     4   BONTA IL              BIOCHEM PHARMACOL               27  1611 978
     5   NEUTRA MR             GASTROENTEROLOGY                75   701 978
     6   LEMEN RJ              AM REV RESPIR DIS              117   639 978
     7   CAMPBELL IM           CAN J BIOCHEM                   57  1099 979
     8   CHASE HP              PEDIATRICS                      64   207 979
     9   WOOD RE               SOUTH MED J                     72   189 979
    10   RIORDAN JR            BIOCHIM BIOPHYS ACTA           574    39 979
    11   GALEY WR              PEDIATR RES                     14  1269 980
    12   ROGIERS V             PEDIATR RES                     14  1088 980
    13   HUBBARD VS            AM J CLIN NUTR                  33  2281 980
    14   COATES AL             ACTA PAEDIATR SCAND             69   353 980
    15   DAVIS PB              J LAB CLIN MED                  96    75 980
    16   HUBBARD VS            CLIN CHIM ACTA                 102   115 980
    17   OLLEY PM              AM J DIS CHILD                 134   688 980
    18   MALER T               BIOCHIM BIOPHYS ACTA           598     1 980
    19   HOLMAN RT             AM J CLIN NUTR                  34  1534 981
    20   LLOYDSTILL JD         AM J CLIN NUTR                  34     1 981
    21   PARK RW               GASTROENTEROLOGY                81  1143 981
    22   ALLING C              EUR J PEDIATR                  137   197 981
    23   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
    24   GASKIN K              J PEDIATR                      100   857 982
    25   MATKOVICS B           CLIN CHIM ACTA                 125    59 982
    26   HUBBARD VS            EUR J PEDIATR                  141    68 983
    27   GIBSON RA             J PEDIATR GASTROENTEROL NUTR     5   408 986
    28   CRAIGSCHMIDT MC       AM J CLIN NUTR                  44   816 986
    29   CAMPBELL IM           LANCET                           2   107 987
    30   HUBBARD VS            LIPIDS                          22   424 987

PN 76186
RN 00540 
AN 76175394
AU Elliott-R-B.
TI A therapeutic trial of fatty acid supplementation in cystic fibrosis.
SO Pediatrics. 1976 Apr. 57(4). P 474-9.
MJ CYSTIC-FIBROSIS: dt.  FATTY-ACIDS: tu.
MN BODY-WEIGHT.  CHYMOTRYPSIN: me.  CYSTIC-FIBROSIS: en.  FECES: en.
   HUMAN.  INFANT.  LINOLEIC-ACIDS: tu.  SODIUM: me.  SWEAT: me.
   TRYPSIN: me.
AB Seven children with cystic fibrosis (CF) have been treated for at
   least one year with intravenously administered soya oil emulsion. In
   all, an improvement of at least one biochemical abnormality in
   character with the disease appeared. The children's clinical course
   remains benign. This course is remarkably better than that of other
   children with CF treated without Intralipid in Auckland in the same
   period, though a placebo effect cannot be discounted. It is
   postulated that intravenous supplementation with essential fatty acid
   in CF may in turn partially correct an error of metabolism of
   prostaglandins present in the disease.
RF 001   ELLIOTT RB            ARCH DIS CHILD                  50    76 975
   002   KUO PT                J PEDIATR                       60   394 962
   003   CAREN R               J CLIN ENDOCRINOL METAB         26   470 966
   005   GIBSON LE             PEDIATRICS                      23   545 959
   006   SCHWARTZ IL           J CLIN INVEST                   35   114 956
   007   ROBINSON PG           CLIN CHIM ACTA                  62   225 975
   008   HAVERBACK BJ          GASTROENTEROLOGY                44   588 963
   009   MORRISON WR           J LIPID RES                      5   600 964
   010   SHWACHMAN H           PEDIATRICS                      46   335 970
   011   AHLUWALIA B           J NUTR                          92   205 967
   012   HOPKINS DT            PROC SOC EXP BIOL MED          114    82 963
   013   ELLIOTT RB            PEDIATR RES                      7   427 974
   014   ROBINSON GA           ANNU REV BIOCHEM                37   149 968
   015   HANSEN AE             J NUTR                          66   565 958
   016   SAMUELS CE            PROSTAGLANDINS                  10   617 975
CT   1   CHASE HP              PEDIATRICS                      57   441 976
     2   SANJURJO P            LANCET                           1   752 977
     3   CROSSLEY JR           LANCET                           2  1093 977
     4   HUBBARD VS            LANCET                           2  1302 977
     5   MCNIFF BL             AM J HOSP PHARM                 34  1080 977
     6   ROSENLUND ML          PEDIATRICS                      59   428 977
     7   CHASE HP              LANCET                           2   236 978
     8   DAVIDSON GP           AUST PAEDIATR J                 14    80 978
     9   PHELAN PD             AUST PAEDIATR J                 14    61 978
    10   BONTA IL              BIOCHEM PHARMACOL               27  1611 978
    11   ALLUE X               PEDIATRICS                      61   924 978
    12   NEUTRA MR             GASTROENTEROLOGY                75   701 978
    13   HUNT CE               J PEDIATR                       92   603 978
    14   LEMEN RJ              AM REV RESPIR DIS              117   639 978
    15   VAUGHAN WJ            SCIENCE                        199   783 978
    16   FRIEDMAN Z            SEM PERINATOL                    3   341 979
    17   BERG U                MONOGR PAEDIATR                 10     1 979
    18   CHASE HP              PEDIATRICS                      64   207 979
    19   LLOYDSTILL JD         PEDIATRICS                      64    50 979
    20   WOOD RE               SOUTH MED J                     72   189 979
    21   CHASE HP              J PEDIATR                       95   337 979
    22   RIORDAN JR            BIOCHIM BIOPHYS ACTA           574    39 979
    23   KARP RJ               CLIN CHEST MED                   1   375 980
    24   ROGIERS V             PEDIATR RES                     14  1088 980
    25   HUBBARD VS            AM J CLIN NUTR                  33  2281 980
    26   COATES AL             ACTA PAEDIATR SCAND             69   353 980
    27   FRIEDMAN Z            AM J DIS CHILD                 134   397 980
    28   OLLEY PM              AM J DIS CHILD                 134   688 980
    29   MALER T               BIOCHIM BIOPHYS ACTA           598     1 980
    30   LLOYDSTILL JD         AM J CLIN NUTR                  34     1 981
    31   RIVERS JPW            BR MED BULL                     37    59 981
    32   ALLING C              EUR J PEDIATR                  137   197 981
    33   LEVI N                RIV ITAL PEDIATR                 8   695 982
    34   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
    35   GASKIN K              J PEDIATR                      100   857 982
    36   HARPER TB             AM REV RESPIR DIS              126   540 982
    37   KUSOFFSKY E           J PEDIATR GASTROENTEROL NUTR     2   434 983
    38   MERRITT RJ            ADV NUTR RES                     5    77 983
    39   ROGIERS V             EUR J PEDIATR                  141    39 983
    40   LESTER LA             J PARENT ENTERAL NUTR           10   289 986
    41   MISCHLER EH           PEDIATR RES                     20    36 986
    42   GILLJAM H             SCAND J CLIN LAB INVEST         46   511 986

PN 76187
RN 00541 
AN 76243835
AU Katz-A-J.  Falchuk-Z-M.  Schwachman-H.
TI The coexistence of cystic fibrosis and celiac disease.
SO Pediatrics. 1976 May. 57(5). P 715-21.
MJ CELIAC-DISEASE: co.  CYSTIC-FIBROSIS: co.
MN ADOLESCENCE.  ALKALINE-PHOSPHATASE: me.  CASE-REPORT.
   CELIAC-DISEASE: fg, pa.  CHILD.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS:  fg, pa.  DUODENUM: pa.  FEMALE.  GLIADIN: me.
   HISTOCOMPATIBILITY-TESTING.  HLA-ANTIGENS.  HUMAN.  MALE.
   ORGAN-CULTURE.  SUPPORT-U-S-GOVT-P-H-S.
AB Two patients with cystic fibrosis (CF) who subsequently developed
   celiac disease (CD) are described. Since organ culture of intestinal
   mucosa has been used to establish an in vitro model for the study of
   CD, we utilized this opportunity to determine whether duodenal mucosa
   obtained from each of these two patients and their immediate families
   differed in its organ culture behavior from mucosa obtained from
   patients with CD alone. Additionally, as specific HL-A types are
   associated with CD, we used HL-A typing to determine whether the two
   patients with CF-CD differed genetically from patients with CD alone.
   One of our patients was HL-A8, the most common type associated with
   CD; the other was HL-A12, as are many of the non-HL-A8 celiac
   patients. The response in organ culture of the mucosa of these two
   patients was the same as the response in organ culture of the mucosa
   from patients with CD alone. These and other data suggest that CD
   occurring in patients with CF is no different than CD occurring
   alone.
RF 001   GEE S                 ST BART HOSP REP                24    17 881
   002   SHWACHMAN H           PEDIATR CLIN NORTH AM            1   389 954
   003   GOODCHILD MC          ARCH DIS CHILD                  48   684 973
   004   SHWACHMAN H           CF CLUB ABST                     4    23 963
   005   HIDE DW               ARCH DIS CHILD                  44   533 969
   006   TAYLOR BW             ARCH DIS CHILD                  48   692 973
   007   NORDIO S              MINERVA MED                           33 967
   008   FRANKLIN JP           AM J DIG DIS                    19   149 974
   009   BRANDBORG LL          GASTROENTEROLOGY                37     1 959
   010   CROSBY WH             AM J DIG DIS                     2   236 957
   011   FALCHUK ZM            J CLIN INVEST                   51  1602 972
   012   MITTAL KK             TRANSPLANTATION                  6   913 968
   013   FALCHUK ZM            J CLIN INVEST                   53   487 974
   014   BROWNING TH           J CLIN INVEST                   48  1423 969
   015   FRAZER AC             LANCET                           2   252 959
   016   DAHLQVIST A           ANAL BIOCHEM                    22    99 968
   017   BESSEY OA             J BIOL CHEM                    164   321 946
   018   LOWRY OH              J BIOL CHEM                    193   265 951
   019   DE GRUCHY GC          CLINICAL HAEMATOLOGY IN MEDIC            970
   020   ANDERSEN DH           ANN NY ACAD SCI                 93   500 962
   021   TRIER JS              N ENGL J MED                   283  1245 970
   022   FALCHUK ZM            IN: HEKKENS WTJM                         974
   023   MOOG F                ANN NY ACAD SCI                166   447 969
   024   STROBER W             LANCET                           2   459 974
   025   NELSON DL             CLIN RES                        22  695A 974
   026   FERGUSON R            GUT                             15   834 974
   027   MACDONALD WC          N ENGL J MED                   272   448 965
   028   ANTONOWICZ I          PEDIATRICS                      42   492 968
   029   ANTONOWICZ I          PEDIATRICS                      49   847 972
CT   1   SAFWENBERG J          TISSUE ANTIGENS                 10   287 977
     2   BERG NO               ACTA PAEDIATR SCAND             68   275 979
     3   PARK RW               GASTROENTEROLOGY                81  1143 981
     4   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
     5   FERGUSON A            HUM NUTR CLIN NUTR             40C   255 986
     6   RUDDY RM              CLIN PEDIATR                    26    83 987

PN 76188
RN 00542 
AN 76101935
AU Solomons-C.
TI Letter: Questions regarding arginine hydrochloride inhalation.
SO Pediatrics. 1976 Jan. 57(1). P 166.
MJ ARGININE: ad.  CYSTIC-FIBROSIS: dt.
MN ARGININE: tu.  HUMAN.
EX With regard to the recent study of Dietzsch et al. on the use of
   arginine hydrochloride inhalation in cystic fibrosis patients, I wish
   to point out that these investigators acted irresponsibly in exposing
   their patients for an appreciable period (seven weeks) to a
   preparation which is known to be irritating.  I would suggest that
   the deleterious effects seen by Dietzsch et al. are due to their
   inattention to experimental detail and lack of communication with
   other investigators. - Dietzsch et al. give the impression in their
   article that all arginine solution are detrimental to the lung.  We
   wish to point out that L-arginine hydrochloride buffered with a
   sodium solution is irritative to the airway of cystic fibrosis
   patients.  However, no comparison studies were done with L-arginine
   buffered with free base. - The fate of these children with cystic
   fibrosis depends on the quality of the inhalation treatment.  This
   means if you replace a good mucolytic drug with a better one you step
   by step approach the ideal mucolytic solution.  We think it to be
   unethical to use other, less effective, drugs or solutions in a
   control group (e.g., saline or distilled water).  We did not state
   that arginine solutions are "irritative" or that arginine treatment
   is "dangerous."  The N-acetylcysteine solution, which was
   successfully used before the treatment of our patients, was buffered
   with sodium hydroxide to a pH of 7.0.  The quantity of sodium which
   was administered during each inhalation amounts to only 0.04 mval of
   sodium so that an injurious pharmacological effect can be excluded.
   Both drugs were well tolerated and had no "deleterious" effects.
RF 001   DIETZSCH HJ           PEDIATRICS                      55    96 975
   002   SOLOMONS CC           PEDIATRICS                      47   384 971

PN 76189
RN 00543 
AN 77035665
AU Shapiro-G-G.  Bamman-J.  Kanarek-P.  Bierman-C-W.
TI The paradoxical effect of adrenergic and methylxanthine drugs in
   cystic fibrosis.
SO Pediatrics. 1976 Nov. 58(5). P 740-3.
MJ CYSTIC-FIBROSIS: dt.  ISOPROTERENOL: tu.  THEOPHYLLINE: tu.
MN ADMINISTRATION-ORAL.  ADOLESCENCE.  ADULT.  AEROSOLS.  CHILD.
   CLINICAL-TRIALS.  COMPARATIVE-STUDY.
   DOSE-RESPONSE-RELATIONSHIP-DRUG.  HUMAN.  ISOPROTERENOL: ad, ae.
   RESPIRATORY-AIRFLOW: de.  RESPIRATORY-FUNCTION-TESTS.
   THEOPHYLLINE:  ad, ae.
AB This study examined the effect of aerosolized isoproterenol and oral
   theophylline on pulmonary function in cystic fibrosis (CF) to
   determine how often these drugs are beneficial and whether there is a
   correlation between response to isoproterenol and response to oral
   theophylline. After obtaining baseline pulmonary function tests
   before and after isoproterenol aerosol, 12 patients with CF were put
   on a double-blind trial of high-dosage theophylline (10 mg/kg three
   times per day) or placebo for four weeks and were then switched to
   the alternate regimen for the next four weeks. Patients had weekly
   evaluations of pulmonary function and plasma theophylline
   determinations. Gastrointestinal side effects were common with
   theophylline. The responses to aerosolized bronchodilators were
   inconsistent from week to week. After aerosolized bronchodilator,
   five of 12 patients had an average increase of 10% or more in FEF45%-
   55% and FEF70%-80%. While taking oral theophylline, five patients had
   a 10% or more decrease in FEF 45%-55% and six patients had a decrease
   in FEF70%-80%. We conclude that there was no concordance between
   response to isoproterenol and theophylline, and that adrenergic and
   methylxanthine drugs must be used with caution in patients with CF.
RF 001   FEATHERBY EA          CAN MED ASSOC J                102   835 970
   002   ZAPLETAL A            PEDIATRICS                      48    64 971
   003   LANDAU LI             J PEDIATR                       82   863 973
   004   COOPERMAN EM          CAN MED ASSOC J                105   580 971
   005   FREEDMAN BJ           THORAX                          26    46 971
   006   BUTTS WC              J LAB CLIN MED                  84   451 974
   007   WEINBERGER MM         J PEDIATR                       84   421 974
   008   SILVERMAN A           PEDIATR CLIN GASTROENTEROL               971
   009   BIERMAN CW            ASTHMA IN CHILDHOOD CURRENT T            975
   010   POLGAR G              PULMONARY FUNCTION TESTING IN            971
CT   1   LARSEN GL             AM REV RESPIR DIS              119   399 979
     2   ROSCHER AA            PEDIATR RES                     14   261 980
     3   LARSEN GL             AM J DIS CHILD                 134  1143 980
     4   GEORGITIS JW          ANN ALLERGY                     48   175 982
     5   HOWARTH PH            ADVER DRUG REAC ACUT POIS REV    2    25 983
     6   HENDELES L            PHARMACOTHERAPY                  3     2 983
     7   DAVIS PB              J CHRON DIS                     36   269 983
     8   VALET SB              ANN ALLERGY                     50   161 983
     9   GODFREY S             PEDIATRICS                      72   517 983
    10   DAVIS PB              J PEDIATR                      102   177 983
    11   WEINBERGER M          J ALLERGY CLIN IMMUNOL          73   525 984
    12   DAVIS PB              CHEST                           85   802 984
    13   KUHN RJ               CLIN PHARMACY                    4   555 985
    14   MISCHLER EH           SEM RESPIR MED                   6   271 985
    15   GODFREY S             ARCH DIS CHILD                  60   997 985
    16   HORDVIK NL            AM REV RESPIR DIS              131   889 985
    17   ZACH MS               AM REV RESPIR DIS              131   537 985
    18   DARGA LL              PEDIATR PULMONOL                 2    82 986
    19   KNOWLES MR            CLIN CHEST MED                   7   285 986
    20   SEALE TW              PHARMACOL BIOCHEM BEHAV         24  1333 986

PN 76190
RN 00544 
AN 76268646
AU Beveridge-J.
TI Letter: Intralipid and cystic fibrosis.
SO Pediatrics. 1976 Sep. 58(3). P 465.
MJ CYSTIC-FIBROSIS: dh.  INFANT-FOOD.
MN ELECTROLYTES: me.  HUMAN.  INFANT-NEWBORN.  SWEAT: me.
EX Stimulated by Professor R. B. Elliott of Auckland,Australia, we have
   administered Intralipid regularly to a small number of babies in the
   last two years.  The volume used has been 10 ml of the 10% solution
   per kilogram of body weight.  This volume is administered every three
   weeks, the infusion taking approximately three hours.  The four
   entrants in the trial are all doing well clinically.
CT   1   HUBBARD VS            LANCET                           2  1302 977
     2   LLOYDSTILL JD         PEDIATRICS                      64    50 979
     3   ROGIERS V             PEDIATR RES                     14  1088 980
     4   HUBBARD VS            AM J CLIN NUTR                  33  2281 980
     5   MISCHLER EH           PEDIATR RES                     20    36 986

PN 76192
RN 00545 
AN 77012878
AU Hardwick-D-F.  Dimmick-J-E.
TI Metabolic cirrhoses of infancy and early childhood.
SO Perspect-Pediatr-Pathol. 1976. 3. P 103-44. (REVIEW).
MJ LIVER-CIRRHOSIS: pa.  METABOLISM-INBORN-ERRORS: pa.
MN AMINO-ACID-METABOLISM-INBORN-ERRORS: pa.  CYSTIC-FIBROSIS: pa.
   CYSTINOSIS.  FRUCTOSE-INTOLERANCE: me, pa.  GALACTOSEMIA: di, pa.
   GENETICS-MEDICAL.  GLYCOGENOSIS-4: pa.
   HEPATOLENTICULAR-DEGENERATION: pa.  HUMAN.  IATROGENIC-DISEASE.
   INFANT.  INFANT-NEWBORN.  KIDNEY-POLYCYSTIC: di.
   LIPID-METABOLISM-INBORN-ERRORS: pa.  LIVER-CIRRHOSIS: cn.  LIVER: pa.
   MUCOPOLYSACCHARIDOSIS: pa.  NIEMANN-PICK-DISEASE: pa.  REVIEW.
   TYROSINE: me.
EX Cirrhosis of the liver in infancy and early childhood is not a common
   phenomenon.  However, because of the attendant morbidity and frequent
   mortality, it represents a significant diagnostic and therapeutic
   problem in this age group.  This review will present briefly the
   metabolic cirrhoses of infancy, discuss currently proposed
   pathogenetic mechanisms and outline diagnostic techniques that may
   aid the pathologist in his approach to the problem of metabolic
   cirrhosis of the very young.  Hereditary tyrosinemia, galactosemia,
   hereditary fructose intolerance, alpha1-antitrypsin deficiency,
   glycogenesis type IV (amylopectinosis), fibrocystic disease of the
   pancreas, Niemann-Pick disease, Gaucher's disease,
   mucopolysaccharidosis (Hurler-Hunter syndrome), Wolman's disease,
   hemochromatosis, Wilson's disease, cystinosis, the cerebrohepatorenal
   syndrome of Zellweger, Indian childhood cirrhosis, infantile
   polycystic disease of the liver and kidneys, congenital hepatic
   fibrosis, iatrogenic metabolic cirrhoses, and idiopathic congenital
   cirrhosis are discussed.
RF 001   FORBES JG             TRANS PATHOL SOC LOND           57   347 906
   002   POYNTON FJ            ARCH DIS CHILD                   1     1 926
   003   HARRELL GT            AM J DIS CHILD                  59  1301 940
   004   KELLER PD             J PEDIATR                       34   588 949
   005   CRAIG JM              AM J DIS CHILD                  90   299 955
   006   PEACE R               ARCH PATHOL                     61   107 956
   007   LANDING BH            ANN NY ACAD SCI                111   399 963
   008   GALL EA               AM J CLIN PATHOL                26  1398 956
   009   JONES E               SOUTH MED J                     60    57 967
   010   JONES EL              MISS MED                        66   724 969
   011   BUIST NRM             IN: NYHAN WL                         160 974
   012   KENNAWAY NG           PEDIATR RES                      5   287 971
   013   MEDES G               BIOCHEM J                       26   917 932
   014   WOOLF LI              IN: GJESSING LR                          966
   015   SCRIVER CR            AM J DIS CHILD                 113    41 967
   016   GJESSING LR           LANCET                           2  1132 965
   017   FLOYD JS              J CLIN INVEST                   45  1487 966
   018   HARDWICK DF           IN: BROWN H                              974
   019   HARDWICK DF           METABOLISM                      19   381 970
   020   PERRY TL              PEDIATRICS                      36   236 965
   021   GAULL GE              PEDIATR RES                      4   337 970
   022   PERRY TL              J MENT DEFIC RES                11   246 967
   023   SHINOZUKA H           AM J PATHOL                     64   241 967
   024   COX R                 LAB INVEST                      29    54 973
   025   GENTZ J               ACTA PAEDIATR SCAND             58   383 969
   026   JEVTIC MM             AM J CLIN PATHOL                61   413 974
   027   PARTINGTON MW         CAN MED ASSOC J                 97  1059 967
   028   GENTZ J               SCAND J CLIN LAB INVEST         29   115 972
   029   GARROD AE             LANCET                           2     1 908
   030   HSIA DYY              J PEDIATR                       59   872 961
   031   BELL LS               ARCH PATHOL                     49   393 950
   032   SMETANA HF            AM J CLIN PATHOL                38     3 962
   033   SUZUKI A              ARCH PATHOL                     82   602 966
   034   SHIH VE               N ENGL J MED                   284   753 971
   035   BEUTLER E             J LAB CLIN MED                  68   646 966
   036   GITZELMANN R          PEDIATR RES                      1    14 967
   037   SEGAL S               IN: HSIA DYY                             969
   038   BAKER L               J PEDIATR                       68   551 966
   039   SCHAPIRA F            BIOCHEM BIOPHYS RES COMMUN      33   451 969
   040   NG WG                 ANN HUM GENET                   37     1 973
   041   SIDBURY JB JR         HELV PAEDIATR ACTA              14   317 959
   042   SIDBURY JB JR         IN: HSIA DYY                             969
   043   NADLER HL             IN: HSIA DYY                         127 969
   044   HILL HZ               SCIENCE                        179  1136 973
   045   FROESCH ER            IN: STANBURY JB                      131 972
   046   SCHWARTZ R            J CLIN INVEST                   43   333 964
   047   JEUNE M               PEDIATRIE                       16   605 961
   048   PERHEENTUPA J         ANN PEDIATR (PARIS)              8   221 962
   049   LEVIN B               AM J MED                        45   826 968
   050   MAENPAA PH            SCIENCE                        161  1253 968
   051   RAIVIO KD             BIOCHEM PHARMACOL               18  2625 969
   052   GOLDBATT PJ           LAB INVEST                      23   378 970
   053   PHILLIPS MJ           AM J MED                        44   910 968
   054   YU DT                 LAB INVEST                      31    85 974
   055   LAURELL CB            SCAND J CLIN LAB INVEST         15   132 963
   056   SHARP HL              J LAB CLIN MED                  73   934 969
   057   GANROT PO             SCAND J CLIN LAB INVEST         19   205 967
   058   TALAMO RC             J PEDIATR                       79    20 971
   059   GLASGOW JFT           AM J MED                        54   181 973
   060   ALPER CA              PEDIATRICS                      46   937 970
   061   JOHNSON AM            PEDIATRICS                      46   921 970
   062   AAGENAES O            ACTA PAEDIATR SCAND             61   632 972
   063   PORTER CA             BR MED J                         3   435 972
   064   AAGENAES O            POSTGRAD MED J                  50   365 974
   065   COTTRALL K            POSTGRAD MED J                  50   376 974
   066   WILKINSON EJ          J PEDIATR                       85   159 974
   067   FAGERHOL MK           CLIN CHIM ACTA                  16   199 967
   068   KUEPPERS F            AM J HUM GENET                  25   677 973
   069   FAGERHOL MK           ACTA PATH MICROBIOL SCAND       70   421 967
   070   COOK PJL              POSTGRAD MED J                  50   362 974
   071   DELELLIS RA           ARCH PATHOL                     94   308 972
   072   BELL OF               NATURE                         243   410 973
   073   KUHLENSCHMIDT MS      LAB INVEST                      31   413 974
   074   ERIKSSON S            N ENGL J MED                   292   176 975
   075   ERIKSSON S            N ENGL J MED                   292   925 975
   076   GANS H                IN: MITTMAN C                            972
   077   HUG G                 IN: GALL EA                              973
   078   MCADAMS AJ            HUM PATHOL                       5   463 974
   079   ANDERSEN DH           LAB INVEST                       5    11 956
   080   SIDBURY JB JR         BULL JOHNS HOPKINS HOSP        111   157 962
   081   HOLLEMAN LWJ          LAB INVEST                      15   357 966
   082   REED GB               LAB INVEST                      19   546 968
   083   SCHOCHET SS           ARCH PATHOL                     90   354 970
   084   CORI GT               HARVEY LECTURES                 48   145 953
   085   BROWN BI              PROC NAT ACAD SCI USA           56   725 966
   086   SIDBURY JB JR         PEDIATRICS                      27   103 961
   087   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   088   CRAIG JM              AM J DIS CHILD                  93   357 957
   089   OPPENHEIMER EH        J PEDIATR                       86   683 975
   090   CLAIREAUX AE          ARCH DIS CHILD                  31    22 956
   091   BERNSTEIN JG          AM J DIS CHILD                  99   804 960
   092   OPPENHEIMER EH        ARCH PATHOL                     96   149 973
   093   COOPER HS             JOHNS HOPKINS MED J            135   268 974
   094   FARBER S              ARCH PATHOL                     37   238 944
   095   VALMAN HB             ARCH DIS CHILD                  46   805 971
   096   LANDING BH            IN: GALL EA                              973
   097   WEBSTER R             ARCH DIS CHILD                  28   343 953
   098   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   099   CROCKER AC            MEDICINE (BALTIMORE)            37     1 958
   100   BLOOM W               AM J PATHOL                      1   595 925
   101   PICK L                AM J MED SCI                   185   601 933
   102   IVEMARK BI            ACTA PAEDIATR SCAND             52   391 963
   103   FREDRICKSON DS        IN: STANBURY JB                      783 972
   104   LANDING BH            PROG PEDIATR SURG                6   113 974
   105   LANDING BH            AM J PATHOL                     33     1 957
   106   BERNSTEIN JG          J PEDIATR                       55   577 959
   107   DRUKKER A             PEDIATRICS                      45  1017 970
   108   GINSBURG SJ           J PEDIATR                       82  1046 973
   109   SCHNEIDER EL          J PEDIATR                       81  1134 972
   110   RODGERS CL            PEDIATRICS                       7    53 951
   111   JAVETT SN             J PEDIATR                       68   810 966
   112   PICK L                AM J MED SCI                   185   453 933
   113   STRAUS R              AM J CLIN PATHOL                17   761 947
   114   STRAUSS L             AM J PATHOL                     24   855 948
   115   LINDSAY S             AM J DIS CHILD                  76   239 948
   116   HENDERSON JL          ARCH DIS CHILD                  27   230 952
   117   HAUST MD              J HISTOCHEM CYTOCHEM             9    79 961
   118   SCHWARZ H             CAN MED ASSOC J                 66   375 952
   119   ABRAMOV A             AM J DIS CHILD                  91   282 956
   120   WOLMAN M              PEDIATRICS                      28   742 961
   121   CROCKER AC            PEDIATRICS                      35   627 965
   122   MARSHALL WC           ARCH DIS CHILD                  44   331 969
   123   LOUGH J               ARCH PATHOL                     89   103 970
   124   PATRICK AD            NATURE                         222  1067 969
   125   PERKIN KW             AM J MED                        39   118 965
   126   FEINBERG R            J CLIN PATHOL                   33   480 960
   127   WILSON SAK            BRAIN                           34  2925 912
   128   LEVI AJ               LANCET                           2   575 967
   129   STRICKLAND GT         Q J MED                         42   619 973
   130   ANDERSON PJ           AM J PATHOL                     36   483 960
   131   MCINTYRE N            N ENGL J MED                   276   439 967
   132   REED GB               ARCH PATHOL                     93   249 972
   134   STILL WJS             ARCH DIS CHILD                  30   354 955
   135   BICKEL H              ACTA PAEDIATR SCAND SUPPL       90     1 952
   136   KING WB JR            STANFORD MED BULL               10   162 962
   137   PASSARGE E            J PEDIATR                       71   691 967
   138   PUNNETT HH            J PEDIATR                       73   602 968
   139   SMITH DW              J PEDIATR                       67   617 965
   140   JAN JE                AM J DIS CHILD                 119   274 970
   141   PATTON RG             AM J DIS CHILD                 124   840 972
   142   DANKS DM              J PEDIATR                       86   382 975
   143   VITALE L              N ENGL J MED                   280   642 969
   144   GOLDFISCHER S         SCIENCE                        182    62 973
   145   VOLPE JJ              ACTA NEUROPATH (BERL)           20   175 972
   146   BERNSTEIN J           BIRTH DEF ORIG ART SER          10    35 974
   147   SINGH A               LANCET                           1   587 961
   148   SMETANA HF            PEDIATRICS                      28   107 961
   149   NATAK NC              INDIAN J MED RES                60   246 972
   150   KERR DNS              Q J MED                         30    91 961
   151   MURRAY-LYON IM        GASTROENTEROLOGY                64   653 973
   152   BLYTH H               J MED GENET                      8   257 971
   153   LIEBERMAN E           MEDICINE (BALTIMORE)            50   277 971
   154   IVEMARK BI            ACTA PAEDIATR SCAND             48     1 959
   155   PARTIN JC             GASTROENTEROLOGY                67   107 974
   156   PEDEN VH              J PEDIATR                       78   180 971
   157   WIGGER JH             CITED IN: J PEDIATR             81   145 972
   158   DRISCOLL JM JR        J PEDIATR                       81   145 972
   159   ROGER R               J PEDIATR                       86   264 975
   160   THALER MM             PEDIATRICS                      33   721 964
   161   ALPERT LI             N ENGL J MED                   280    16 969
   162   STRAUSS L             BILIARY TRACT ANOMALIES THE R            972
   163   KURNICK H             HUM PATHOL                       5   223 974
   164   HARDWICK DF           AM J PATHOL                     62    56 971
   165   COEN R                AM J DIS CHILD                 119   383 970
   166   WEINBERG AG           AM J DIS CHILD                 119   290 970
   167   SHIRAKI K             AM J DIS CHILD                 119   315 970
   168   POPPER H              GASTROENTEROLOGY                 4   315 975
   169   RAPPAPORT AM          MICROVASC RES                    6   212 973
CT   1   FISCH RO              J PEDIATR                       93   592 978
     2   RUSHTON DI            DIAGN HISTOPATHOL                4    17 981
     3   MOWAT AP              CLIN GASTROENTEROL              11   171 982
     4   SPIVAK W              J PEDIATR GASTROENTEROL NUTR     2   381 983
     5   DENNEHY PH            J PEDIATR                      106   161 985
     6   BLISARD KS            HUM PATHOL                      17   376 986
     7   AGAMANOLIS DP         NEUROLOGY                       36   674 986
     8   ZIMMERMANN A          ARCH PATHOL LAB MED            110   136 986

PN 76193
RN 00546 
AN 76269924
AU Tecklin-J-S.  Holsclaw-D-S-Jr.
TI Bronchial drainage with aerosol medications in cystic fibrosis.
SO Phys-Ther. 1976 Sep. 56(9). P 999-1003.
MJ ACETYLCYSTEINE: tu.  CYSTIC-FIBROSIS: th.  DRAINAGE.
   ISOPROTERENOL:  tu.
MN ADOLESCENCE.  ADULT.  AEROSOLS.  BRONCHI: de, se.  CHILD.
   DRUG-EVALUATION.  DRUG-THERAPY-COMBINATION.  HUMAN.
   RESPIRATORY-FUNCTION-TESTS.  SUPPORT-U-S-GOVT-P-H-S.
AB Examined in this study are the immediate effects of bronchial
   drainage preceded by the inhalation of aerosol solutions of a
   mucolytic agent, a bronchodilator, and their combination upon four
   measures of pulmonary function in 20 patients with cystic fibrosis.
   On three separate occasions, pulmonary function was tested preceding
   and following treatments consisting of one of the above three aerosol
   solutions followed by bronchial drainage. The order of solutions used
   was random and each subject received one treatment with each
   solution. The greatest overall improvement in function was seen with
   the bronchodilator and bronchial drainage. The combination of the
   bronchodilator/mucolytic agents and bronchial drainage was the next
   most effective technique. The mucolytic agent, when used alone with
   bronchial drainage, decreased function. Comparison of the pulmonary
   function scores indicated a significant difference among the three
   treatments.
RF 001   ANON                  AM REV RESPIR DIS PART 2       110     1 974
   002   TECKLIN JS            PHYS THER                       55  1081 975
   003   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            971
   004   LORIN MI              AM J PHYS MED                   50   215 971
   005   MOTOYAMA EK           IN: MANGOS JA                        335 973
   006   REAS HW               J PEDIATR                       65   542 964
   007   STAMM SJ              DIS CHEST                       47   414 965
   008   FEATHERBY EA          CAN MED ASSOC J                102   835 970
   009   CHANG N               AM REV RESPIR DIS              106   867 972
   010   ALLEN GW              AM REV RESPIR DIS              104    61 971
   011   MITCHELL M            AM REV RESPIR DIS               96   685 967
   012   HIRSCH SR             THORAX                          25   737 970
CT   1   TECKLIN JS            AM REV RESPIR DIS              114  1038 976
     2   DREISIN RB            J LAB CLIN MED                  93   674 979
     3   TABACHNIK E           AM REV RESPIR DIS              122    97 980

PN 76194
RN 00547 
AN 76176175
AU Mattimore-J-M.
TI Differentiating the cause of wheezing in infants.
SO Postgrad-Med. 1976 Apr. 59(4). P 116-22.
MJ AUSCULTATION.  LUNG-NEOPLASMS: di.  RESPIRATION.
MN AORTA-THORACIC: ab.  BRONCHI.  ESOPHAGEAL-ACHALASIA: di.
   CASE-REPORT.  CYSTIC-FIBROSIS: di.  CYSTS: cn, di.
   DIAGNOSIS-DIFFERENTIAL.  ESOPHAGEAL-NEOPLASMS: di.  ESOPHAGUS.
   FEMALE.  FOREIGN-BODIES: di.  HEART-DEFECTS-CONGENITAL: di.  HUMAN.
   INFANT.  INFANT-NEWBORN.  LIPOMA: di.  LUNG-NEOPLASMS: cn.  MALE.
   RESPIRATORY-HYPERSENSITIVITY: di.  RESPIRATORY-TRACT-DISEASES: di.
   RESPIRATORY-TRACT-INFECTIONS: di.  TRACHEOESOPHAGEAL-FISTULA: di.
   VIRUS-DISEASES: di.
EX It cannot be emphasized too strongly that all infants who wheeze do
   not have asthma.  Because of the life-threatening consequences of
   failure to detect some of the clinical entities that present with
   wheezing, the clinician should thoroughly investigate the infant who
   wheezes.  Cases illustrating some causes of wheezing, additional
   causes of wheezing, and approaches to diagnosis are discussed.
RF 001   GERRARD JW            ACTA PAEDIATR SCAND SUPPL      234     1 973
   002   MCINTOSH K            J PEDIATR                       82   578 973
   003   HOGG JC               N ENGL J MED                   282  1283 970
   004   HILMAN BC             ANN ALLERGY                     25   622 967
   005   DEES SC               JAMA                           175   365 961
   006   MUSTARD WT            IN: BENSON CD                    1       962
   007   BROOKS JW             IN: KENDIG EL JR                 1       972
   008   SHAHIDI NT            J PEDIATR                       59   533 961
   009   VAN METRE TE JR       J ALLERGY CLIN IMMUNOL          31   141 960
   010   AMMANN AJ             RECURRENT INFECTION IN HYPERS            975
   011   KATZ RM               N ENGL J MED                   288   233 973
   012   LANG WR               BR MED J                         1    73 969
   013   BECROFT DMO           J CLIN PATHOL                   24    72 971
   014   CUMMING GR            J PEDIATR                       78   250 971
   015   POLMAR SH             PEDIATRICS                      50   279 972

PN 76195
RN 00548 
AN 76269694
AU Buchwald-M.
TI Abnormal levels of 3':5'-cyclic AMP in isoproterenol-stimulated
   fibroblasts from patients with cystic fibrosis.
SO Proc-Natl-Acad-Sci-USA. 1976 Aug. 73(8). P 2899-903.
MJ ADENOSINE-CYCLIC-MONOPHOSPHATE: me.  CYSTIC-FIBROSIS: me.
   ISOPROTERENOL: pd.  SKIN: me.
MN AGE-FACTORS.  CELL-DIVISION.  CELLS-CULTURED.
   DOSE-RESPONSE-RELATIONSHIP-DRUG.  FIBROBLASTS.  HUMAN.
   RECEPTORS-ADRENERGIC.  TIME-FACTORS.
AB To determine if the abnormalities of exocrine secretion
   characteristic of cystic fibrosis could be investigated in vitro, I
   studied the synthesis of 3':5'-cyclic AMP after isoproterenol
   stimulation in skin fibroblasts derived from patients with cystic
   fibrosis and from normal individuals. Comparison of normal and cystic
   fibrosis cells showed that the latter had 2- to 5-fold greater levels
   of intracellular cyclic AMP after stimulation with isoproterenol. The
   difference between the strains was observed at every stage of the
   culture cycle and was specific to stimulation by beta-adrenergic
   agonists. It could not be accounted for by different dose- or time-
   response curves nor by leakage of cyclic AMP into the medium. The
   increased sensitivity to catecholamines may reflect an intrinsic
   genetic property of cystic fibrosis cells, and it may be feasible to
   use this system to study the biochemical basis of the genetic defect
   in cystic fibrosis.
RF 001   MCKUSICK VA           MENDELIAN INHERIT IN MAN                 975
   002   DANES BS              J EXP MED                      129   775 969
   003   DANES BS              J EXP MED                      136  1313 972
   004   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   005   BERATIS NG            PEDIATR RES                      7   958 973
   006   CONOVER JH            PEDIATR RES                      7   224 973
   007   SPOCK A               PEDIATR RES                      1   173 967
   008   BOWMAN BH             SCIENCE                        164   325 969
   009   ANTONOWICZ I          PEDIATR RES                      6   803 972
   010   BUTTERWORTH J         CLIN CHIM ACTA                  40   139 972
   011   PALLAVICINI JC        J PEDIATR                       77   280 970
   012   DANES BS              BIOCHEM GENET                   12   359 974
   013   BARTMAN J             J PEDIATR                       76   430 970
   014   CHERNICK WS           J PEDIATR                       65   694 964
   015   BLOMFIELD J           GUT                             14   558 973
   016   BLOMFIELD J           AUST PAEDIATR J                 10    75 974
   017   BARBERO GJ            IN: DI SANTAGNESE PA                 208 964
   018   SEIFERT G             IN: SCHNEYER LH                          967
   019   MARTINEZ JR           PEDIATR RES                      9   470 975
   020   SCHRAMM M             IN: MANGOS JA                        215 973
   021   ROBISON GA            CYCLIC AMP                               971
   022   RAO GJS               NATURE NEW BIOL                232   253 971
   023   FRANKLIN TJ           NATURE NEW BIOL                246   119 973
   024   HASLAM RJ             BIOCHEM J                      144   253 974
   025   KELLY LA              J BIOL CHEM                    249  3098 974
   026   MANGANIELLO VC        BIOCHIM BIOPHYS ACTA           362   509 974
   027   FRANKLIN TJ           MOL PHARMACOL                   11   485 975
   028   GOLDSTEIN S           DIABETES                        18   545 969
   029   STANNERS CP           NATURE NEW BIOL                230    52 971
   030   GILMAN AG             PROC NAT ACAD SCI USA           67   305 970
   031   GILMAN AG             J BIOL CHEM                    248  6610 973
   032   SHEPPARD H            BIOCHEM PHARMACOL               20  2128 971
   033   LOWRY OH              J BIOL CHEM                    193   265 951
   034   FURCHGOTT RF          FED PROC                        29  1352 970
CT   1   DAVIDSON GP           J CLIN INVEST                   60  1402 977
     2   EPSTEIN J             PROC NAT ACAD SCI USA           74  1676 977
     3   EPSTEIN J             SOMATIC CELL GENET               4   451 978
     4   DAVIS PB              PEDIATR RES                     12   703 978
     5   WRIGHT RK             PEDIATR RES                     12   830 978
     6   ERICKSON RP           AM J HUM GENET                  30  A 28 978
     7   ROSCHER A             MONOGR PAEDIATR                 10    77 979
     8   HOSLI P               CLIN GENET                      15   487 979
     9   GNEGY ME              AM J HUM GENET                  31  A 48 979
    10   PECKER F              CLIN SCI                        57   313 979
    11   JAKEL HP              BIOL ZENTRALBL                  98    55 979
    12   KURZ JB               SCIENCE                        206  1317 979
    13   BUCHWALD M            ADV CYCLIC NUCLEO RES           12   243 980
    14   DAVIS PB              PEDIATR RES                     14   863 980
    15   ROSCHER AA            PEDIATR RES                     14   261 980
    16   AITKEN DA             J MED GENET                     17   187 980
    17   KURZ JB               PEDIATR RES                     15  1328 981
    18   GNEGY ME              BIOCHEM MED                     26   294 981
    19   MARKOVAC J            BIOCHEM MED                     26   299 981
    20   GALANT SP             J CLIN INVEST                   68   253 981
    21   MCSWIGAN JD           PROC NAT ACAD SCI USA           78  7670 981
    22   MAPLESON JL           J CELL PHYSIOL                 109   215 981
    23   ROSCHER AA            J PHARMACOL EXP THER           216   419 981
    24   CEDER O               SCANN ELECTRON MICROSC        1982   723 982
    25   BUCHWALD M            CLIN BIOCHEM                    17   143 984
    26   VOLICER L             NEUROBIOL AGING                  6    35 985
    27   KOPELMAN H            N ENGL J MED                   312   329 985
    28   HONEGGER UE           BIOCHEM PHARMACOL               35  1899 986

PN 76196
RN 00549 
AN 76198413
AU Seeff-L-B.  Zimmerman-H-J.
TI Relationship between hepatic and pancreatic disease.
SO Prog-Liver-Dis. 1976. 5. P 590-608. (REVIEW).
MJ LIVER-DISEASES: co.  PANCREATIC-DISEASES: co.
MN ASCITES: et.  CYSTIC-FIBROSIS: co.  DIABETES-MELLITUS: co.
   DRUG-THERAPY: ae.  GRANULOMA: co.  HEMOCHROMATOSIS: co.
   HEPATITIS-A:  co.  HUMAN.  KWASHIORKOR: co.  LIVER-CIRRHOSIS: co, et.
   LIVER-DISEASES: et.  MYCOSES: co.  PANCREATIC-DISEASES: et.
   PANCREATITIS: co.  PARASITIC-DISEASES: co.  REVIEW.
   VIRUS-DISEASES:  co.
AB A voluminous literature has dealt with the variety of pathologic
   entities that may effect the liver and the pancreas.  Much of it
   includes poorly or vaguely documented observations.  Only a few
   facets have been subjected to experimental study.  Despite the
   resultant difficulty in unraveling reported and inferred
   relationships between the two organs, the available information has
   been analyzed according to the following arbitrary categorization:
   (1) involvement of the liver in pancreatic disease, (2) involvement
   of the pancreas in hepatic disease, (3) involvement of both organs
   in systemic disease.
RF 001   STEIGMANN F           AM J GASTROENTEROL              33   454 960
   002   MORRELL MT            BR J SURG                       57   814 970
   003   LLOYD-JONES W         ANN SURG                       176   163 972
   004   COMFORT MW            GASTROENTEROLOGY                21    54 952
   005   MCELROY R             AM J MED                        52   228 972
   006   LOBECK CC             IN: STANBURY JB                     1300 966
   007   CRAIG JM              AM J DIS CHILD                  93   357 957
   008   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   009   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   010   FARBER S              ARCH PATHOL                     37   238 944
   011   WEBSTER R             ARCH DIS CHILD                  28   343 953
   012   GATZIMOS CD           AM J DIS CHILD                  89   182 955
   013   FEIGELSON J           ACTA PAEDIATR SCAND             59   539 970
   014   KATTWINKEL J          J PEDIATR                       82   234 973
   015   ANDERSON C            ARCH DIS CHILD                  31    31 956
   016   STEIN AA              ANN SURG                       157   516 963
   017   LONGNECKER DS         ARCH PATHOL                     80   148 965
   018   TRUHART H             PATHOLOGIE PT 1                          902
   019   ELOESSER L            MITT GRENZGEB D MED U CHIR      18   195 907
   020   SCHILLER W            SURG GYNECOL OBSTET             72    70 941
   021   MACKENZIE WC          ANN R COLL SURG ENGL            15   220 954
   022   SUSSMAN HM            AM J GASTROENTEROL              50   315 968
   023   COMFORT MW            GASTROENTEROLOGY                 6   239 946
   024   PHILLIPS AM           ARCH INTERN MED                 93   337 954
   025   SANES J               ARCH INTERN MED                 85   980 950
   026   FISHER ER             SURGERY                         37   213 955
   027   DOS REIS L            ARCH SURG                       87   604 963
   028   ANDERSON MC           ARCH SURG                       92   664 966
   029   KITAMURA O            AM J SURG                      126   379 973
   030   RUSH B JR             SURGERY                         31   349 952
   031   THAL AP               AM J SURG                      105   708 963
   032$  LUKASH WM             JAMA                           191   927 966
   033   FOULK WT              GASTROENTEROLOGY                35   375 958
   034   BUTLER ML             SOUTH MED J                     66   700 973
   035   WEINSTEIN BR          ANN INTERN MED                  58   245 963
   036   FRIEDEN JH            ARCH SURG                       90   422 965
   037   LEGER L               NOUV PRESSE MED                 33  2159 972
   038   EDMONDSON HA          AM J PATHOL                     26    37 950
   039   WOLDMAN EE            JAMA                           169  1281 959
   040   COLE WH               SURGERY                          8    19 940
   041   OWOR R                AFR J MED SCI                    3   205 972
   042   MASIH B               NY STATE J MED                  71  2312 971
   043   SUMMERSKILL WHJ       LANCET                           2   686 959
   044   TYGSTRUP N            ACTA MED SCAND                 185   523 969
   045   SALAZAR FA            MED ANN DC                      43   533 974
   046   YALE CE               JAMA                           217   317 971
   047   SUTTON JP             ARCH SURG                      100   623 970
   048   LONGSTRETH GF         ANN INTERN MED                  75   903 971
   049   RIGNAULT D            SURGERY                         63   571 968
   050   GREGORY PB            GASTROENTEROLOGY                62   436 972
   051   BRAGANZA JM           CLIN GASTROENTEROL               1   219 972
   052   DONOWITZ M            MEDICINE (BALTIMORE)            53   183 974
   053   CREUTZFELDT W         IN: POPPER H                     3   371 970
   054   VON MERING J          ARCH J EXP PATHOL PHARMACOL     26   371 889
   055   ALLAN FN              BR J EXP PATHOL                  5    75 924
   056   HERSHEY JM            AM J PHYSIOL                    98    74 931
   057   BEST CH               J PHYSIOL (LOND)                79    94 933
   058   DRAGSTEDT LR          AM J PHYSIOL                   117   175 936
   059   CLOWES GHA JR         AM J PHYSIOL                   165   628 951
   060   ZIMMERMAN HJ          J LAB CLIN MED                  36   922 950
   061   LUCAS CC              IN: HOLMAN RT                   10     1 967
   062   YOUNG FG              LANCET                           2   372 937
   064   MAURIAC P             PARIS MED                        2   525 935
   065   ZIMMERMAN HJ          J LAB CLIN MED                  36   912 950
   066   DROLLER H             BR MED J                         1   623 945
   067   WELLER E              DTSCH MED WSCHR                 74  1223 949
   068   SHERWIN R             N ENGL J MED                   290   239 974
   069   ZIMMERMAN HJ          IN: SAMTER M                         340 972
   070   ERBER WF              GUT                             13   996 972
   071   LISNEY AA             PROC R SOC MED                  37   165 943
   072   JOSKE RA              ROY MELBOURNE HOSP CLIN REP     25    20 955
   073   ACHORD JL             JAMA                           205   129 968
   074   HAM JM                AM J DIG DIS                    18  1079 973
   075   GEOKAS MC             CALIF MED                      117     1 972
   076   PARBHOO SP            GUT                             14   428 973
   077   WANDS JR              JOHNS HOPKINS MED J            133   156 973
   078   FRANZINI C            J CLIN PATHOL                   18   775 965
   079   LAVERDANT C           ANN MED INTERNE PARIS          122   343 971
   080   CONRAD ME             AM J GASTROENTEROL              42    47 964
   081   RAKE MO               LANCET                           1   533 970
   082   CRANDALL LA           ARCH NEUROL PSYCHIATR           27   367 932
   083   JOHNSON TA            ARCH INTERN MED                 66    62 940
   085   STINSON JC JR         AM J CLIN PATHOL                22   117 952
   086   NETIK J               BULL MEM ECOLE NAT MED PHARM     5   412 957
   087   STEIGMANN F           AM J GASTROENTEROL              38    40 962
   088   SOBEL JH              GASTROENTEROLOGY                45   341 963
   089   BUTT EM               AM J CLIN PATHOL                42   437 964
   090   VAN GOIDSENHOVEN GE   AM J DIG DIS                     8   160 963
   091   ZIEVE L               AM J DIG DIS                    12   303 967
   092   FERRI S               RIV GASTROENTEROL               20   244 968
   093   DAVIS AE              MED J AUST                       1   508 969
   094   GOEBELL H             DTSCH MED WSCHR                 95   808 970
   095   WILLIAMS CN           CAN MED ASSOC J                105  1143 971
   096   SARLES H              GASTROENTEROLOGY                66   604 974
   097   SOLOMON N             AM J DIG DIS                    19   253 974
   098   MYHRE J               J LAB CLIN MED                  34  1671 949
   099   WISLOSKI LR           N ENGL J MED                   275   322 966
   100   TILNEY NL             N ENGL J MED                   274  1051 966
   101   PAPPENHEIMER AM       J EXP MED                       94    45 951
   102   OBRIEN PK             BR MED J                         2  1529 965
   103   CRAIGHEAD JE          AM J PATHOL                     48   375 966
   104   PLATT H               VIROLOGY                         9   484 959
   105   SERRANO-RIOS M        DIGESTION                        2   262 969
   106   MOTT CB               AM J DIG DIS                    17   583 972
   107   LOUW JH               BR J SURG                       53   510 966
   108   KLATSKIN G            YALE J BIOL MED                 23   207 950
   109   CHAUN H               AM J DIG DIS                    17   725 972
   110   CALVIN C              PRESSE MED                      79  2230 971
   111   NIDUS BD              ANN INTERN MED                  63   663 965
   112   BARRETT PVD           N ENGL J MED                   268    36 963
   113   BLOCK MB              N ENGL J MED                   282   380 970
   114   GUERRA M              JAMA                           200   552 967
   115   PINCUS IJ             IN: BOCKUS HL                        960 965
   116   CORNISH AL            N ENGL J MED                   265   673 961
   117   NOGUEIRA JR           GASTROENTEROLOGY                62  1040 972
   118   FARBER E              PROC SOC EXP BIOL MED           74   838 950
   119   SCHRIER RW            JAMA                           194   564 965
   120   ZUBROD CG             PEDIATRICS                      45   555 970
   121   WHALLEY PJ            JAMA                           189   357 964
   122   VILLA-TREVINO S       J BIOL CHEM                    238  1757 963
   123   HATFIELD AK           AM J DIG DIS                    17   167 972
   124   DAVIES JNP            LANCET                           1   317 948
   125   TROISIER              BULL SOC ANAT PARIS             44   231 871
   126   GRACE ND              GASTROENTEROLOGY                64  1257 974
   127   SHELCON JH            HEMOCHROMATOSIS                          935
   128   POWELL LW             GASTROENTEROLOGY                64   889 973
   129   POWELL LW             NATURE                         250   333 974
   130   MACDONALD RG          HEMOCHROMATOSIS AND HEMOSIDER            964
   131   PURTILO DT            CANCER                          32   458 973
   132   BECKER D              N ENGL J MED                   263   367 960
   133   DYMOCK IW             AM J MED                        52   203 972
   134   CHARLTON RW           BR MED J                         2  1427 964
   135   TAPPER EJ             AM J MED SCI                   255    46 968
   136   BALCERZAK SP          GASTROENTEROLOGY                53   257 967
   137   CONN HO               GASTROENTEROLOGY                62    61 972
   138   KOFF RS               GASTROENTEROLOGY                63   834 972
   139   POUNDER RE            PROC R SOC MED                  67   323 974
   140   WILK PJ               AM J GASTROENTEROL              60   273 973
   141   LONGMIRE WP           AM J SURG                      125   661 972
CT   1   GRANT DAW             BIOCHEM J                      198   315 981
     2   BATMAN PA             HISTOPATHOLOGY                   9   237 985
     3   CASTELLANO G          REV ESP ENFERM APAR DIG         68    67 985
     4   GRANT D               INT J PANCREATOL                 1   167 986

PN 76197
RN 00550 
AN 76245035
AU Mitchell-Heggs-P.  Mearns-M.  Batten-J-C.
TI Cystic fibrosis in adolescents and adults.
SO Q-J-Med. 1976 Jul. 45(179). P 479-504.
MJ CYSTIC-FIBROSIS: pp.
MN ADOLESCENCE.  ADULT.  ASPERGILLUS: ip.  CYSTIC-FIBROSIS: co.  FEMALE.
   GASTROINTESTINAL-DISEASES: co.  GROWTH.  HUMAN.  LUNG-DISEASES: co.
   MALE.  PSEUDOMONAS-AERUGINOSA: ip.  PUBERTY.  RESPIRATION.
   SODIUM:  an.  SPUTUM: mi.  STAPHYLOCOCCUS: ip.  SWEAT: an.
AB Forty-five patients (25 male and 20 female) over 12 years of age with
   cystic fibrosis have been studied clinically, radiologically and
   physiologically. Their mean age at the first visit was 17 years; they
   were followed for a mean period of 4 years and attended at least
   every six months. The first symptom which developed before the age of
   five in 42 of the 45 patients was respiratory. Thirty-two of the 45
   patients had severe lung disease (Group III) at the start of the
   study of the seven patients died during the study. Cough and sputum
   were almost universal, 23 had haemoptyses and eight pneumothoraces.
   Staphylococcus pyogenes, Haemophilus influenzae and Pseudomonas
   aeruginosa were the common pathogens isolated from sputum and the
   increasing prevalence of the latter was again confirmed. Acquisition
   of the mucoid strain of pseudomonas signified poor prognosis.
   Established infection was never eradicated. Forty-three patients had
   evidence of pancreatic insufficiency; in all but one patient the
   symptoms were mild and five patients abandoned dietary restriction
   and pancreatin without ill effect. Seven patients had symptoms of
   partial bowel obstruction (meconium ileus equivalent) but only one
   required surgical relief. The liver was enlarged in seven patients
   and the spleen was felt in three. Three patients had diabetes
   mellitus. The influence of cystic fibrosis on growth and development
   is reported--the growth spurt is late in the majority but growth
   failure is not confined to those with severe lung infection or
   malabsorption and in these circumstances remains unexplained. Mean
   weight was low in relation to height and puberty was delayed in both
   sexes.
RF 001   ANDERSEN DH           AM J DIS CHILD                  56   344 938
   002   ANDERSEN DH           J CHRON DIS                      7    58 958
   003   ANDERSON CM           ARCH DIS CHILD                  35   581 960
   004   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   005   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   006   ANON                  BR MED J                         4   310 974
   007   BURNS MW              LANCET                           1   270 968
   008   BURTON L              PRACTITIONER                   210   247 973
   009   CATTANEO SM           J THORAC CARDIOVASC SURG        66   467 973
   010   CROFTON J             RESPIRATORY DISEASES                     969
   011   DANES BS              J EXP MED                      129   775 969
   012   DENNING CR            PEDIATRICS                      41     7 968
   013   DI SANTAGNESE PA      PEDIATRICS                      18   387 956
   014   DI SANTAGNESE PA      ANN INTERN MED                  50  1321 959
   015   FEATHERBY EA          IN: LAWSON D PROC 5TH INT CF         232 969
   016   FEIGELSON J           ACTA PAEDIATR SCAND             59   539 970
   017   FEIGELSON J           NOUV PRESSE MED                  1  1899 972
   018   GODFREY S             ARCH DIS CHILD                  46   144 971
   019   GRACEY M              ARCH DIS CHILD                  44   404 969
   020   GRACEY M              AUSTRALAS ANN MED               18    91 969
   021   GRAND RJ              JAMA                           195   993 966
   022   GOODCHILD MC          ARCH DIS CHILD                  48   684 973
   023   GREEN OC              J CLIN ENDOCRINOL METAB         27  1059 967
   024   HODSON CJ             CLIN RADIOL                     13    54 962
   025   HOLSCLAW DS           J PEDIATR                       76   829 970
   026   HUANG NN              PEDIATR RES                      7   428 973
   027   KAPLAN E              N ENGL J MED                   279    65 968
   028   KATTWINKEL J          JAMA                           226   557 973
   029   KREISSL T             Z KINDERHEILK                  113    93 972
   030   LANDAU LI             J PEDIATR                       82   863 973
   031   LAPEY A               J PEDIATR                       84   328 974
   032   LIFSCHITZ MI          AM J DIS CHILD                 116   633 968
   033   MARSHALL WA           ARCH DIS CHILD                  45    13 970
   034   MAY JR                ARCH DIS CHILD                  47   908 972
   035   MCCARTHY DS           IN: LAWSON D PROC 5TH INT CF         194 969
   036   MCCRAE WM             SCOTT MED J                     19   187 974
   037   MCINTOSH R            ACTA PAEDIATR SCAND SUPPL 100   43   469 954
   038   MCPARTLIN JF          BR J SURG                       60   707 973
   039   MEARNS MB             LANCET                           1   538 967
   040   MEARNS MB             ARCH DIS CHILD                  47   902 972
   041   MEARNS MB             THORAX                          28   537 973
   042   MEARNS MB             IN: MANGOS JA                        345 973
   043   MILNER AD             ARCH DIS CHILD                  44   351 969
   044   MITCHELL-HEGGS PF     THORAX                          25   165 970
   045   NATH AP               THORAX                          29   223 974
   046   REID L                IN: MANGOS JA                        195 973
   047   ROSAN RC              AM J DIS CHILD                 104   625 962
   048   ROSS CAC              ARCH DIS CHILD                  30   428 955
   049   ROVSING H             ACTA RADIOL DIAGN STOCKH        14   588 973
   050   SIEGENTHALER P        JAMA                           186  1178 963
   051   SHWACHMAN H           PEDIATRICS                      36   689 965
   052   SPROUL A              J PEDIATR                       65   664 964
   053   TANNER JM             STANDARDS FOR SKELETAL AGE               972
   054   TANNER JM             ARCH DIS CHILD                  41   454 966
   055   TAYLOR BW             ARCH DIS CHILD                  48   692 973
   056   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   057   WARREN CPW            CLIN ALLERGY                     5     1 975
   058   WARWICK WJ            IN: LAWSON D PROC 5TH INT CF         320 969
CT   1   ANON                  LANCET                           2   614 976
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   SEATON A              SCOTT MED J                     22    99 977
     4   RAEBURN JA            PROC NUTR SOC                   36    77 977
     5   SAKULA A              BR J DIS CHEST                  71   295 977
     6   OWEN E                J MOL MED                        3    49 978
     7   STERN RC              AM REV RESPIR DIS              118   821 978
     8   ANON                  BR MED J                         2   626 979
     9   GURWITZ D             PEDIATR CLIN NORTH AM           26   603 979
    10   SANTAGNESE PAD        AM J MED                        66   121 979
    11   ALLAN JL              MED J AUST                       1   600 980
    12   HOLSCLAW DS           CLIN CHEST MED                   1   407 980
    13   HODSON ME             THORAX                          35   801 980
    14   ORMEROD LP            THORAX                          35   768 980
    15   BRUETON MJ            ARCH DIS CHILD                  55   348 980
    16   FICK RB               CLIN CHEST MED                   2    91 981
    17   CHO YW                J CLIN PHARMACOL                21   224 981
    18   CONGDEN PJ            ARCH DIS CHILD                  56   708 981
    19   SCHWARTZ RH           J ALLERGY CLIN IMMUNOL          68   290 981
    20   JACOBS WH             AM J GASTROENTEROL              76   342 981
    21   REITER EO             AM J DIS CHILD                 135   422 981
    22   REITER EO             CLIN ENDOCRINOL                 16   127 982
    23   PARSONS HG            J PEDIATR GASTROENTEROL NUTR     2    44 983
    24   SHAWKER TH            J ULTRASOUND MED                 2   439 983
    25   NEVILLE E             THORAX                          38   929 983
    26   GUIDOTTI TL           RESPIRATION                     44   351 983
    27   HODSON ME             POSTGRAD MED J                  60   225 984
    28   PRESSLER T            ACTA PAEDIATR SCAND             73   541 984
    29   LESTER LA             SEM RESPIR MED                   6   285 985
    30   SEALE TW              ANN CLIN LAB SCI                15   152 985
    31   HANLY JG              Q J MED                         56   377 985
    32   BERKIN KE             EUR J RESPIR DIS                67   103 985
    33   GOTZ M                MONATSSCHR KINDERHEILKD        133   718 985
    34   HUGHES RL             ACTA PAEDIATR SCAND SUPPL 317 1985    42 985
    35   PREECE MA             CLIN ENDOCRINOL METAB           15   453 986
    36   MAHANEY MC            ARCH ORAL BIOL                  31   363 986
    37   MAHANEY MC            HUM BIOL                        58   445 986
    38   STEAD RJ              CLIN ENDOCRINOL                 26   187 987

PN 76198
RN 00551 
AN 77150040
AU Dillman-D-E.
TI Cystic fibrosis: a new challenge for the patient-care team.
SO Respir-Ther. 1976 May-Jun. 6(3). P 25-7.
MJ CYSTIC-FIBROSIS: th.  RESPIRATORY-THERAPY.  PATIENT-CARE-TEAM.
MN HUMAN.
AB To date, most cases of cystic fibrosis have been treated in
   pediatric hospitals.  With changes and advances in treatment,
   patients who were once considered terminally ill are now living into
   adulthood.  The stresses that result from chronic illness are
   considered herein from the standpoint of the social caseworker, who
   plans a crucial role on the patient-care team.  New problems
   regarding the personal development of the patient are presented,
   with particular emphasis on the role of a CF patient as a parent.
   The role of the respiratory therapist in the care of such patients
   is unique.  This is due to the extensiveness of patient contact,
   both verbal and physical, and to the primary threat that pulmonary
   disease poses to the patient with CF.  The therapist's ability to
   cope with the problem, while aiding the family and patient to do the
   same, becomes crucial to the child's rehabilitation.  The
   requirements for fulfilling this role are educational and
   developmental in nature, and should be pursued as a model for future
   patient care.

PN 76199
RN 00552 
AN 77015073
AU Paster-S-B.
TI Nasal polyposis and sinusitis in cystic fibrosis.
SO Rocky-Mt-Med-J. 1976 Sep-Oct. 73(5). P 261-3.
MJ CYSTIC-FIBROSIS: co.  NASAL-POLYPS: co.  NOSE-NEOPLASMS: co.
   SINUSITIS: co.
MN ADOLESCENCE.  ADULT.  CASE-REPORT.  CHILD.  HUMAN.  MALE.
AB Cystic fibrosis is now appearing in milder form or partial
   expression of the disease.  The occurrence of nasal polyposis and
   sinusitis in patients with abnormal chest x-rays may be the clue to
   its diagnosis.
RF 001   SCHWARTZ EE           AM J ROENTG RAD THER NUCL MED  122   708 974
   002   CROZIER DN            PEDIATR CLIN NORTH AM           21   935 974
   003   SHWACHMAN H           PEDIATRICS                      30   389 962
   004   ANON                  J PEDIATR                       88   711 976
   005   DI SANTAGNESE PA      PEDIATRICS                      12   549 953
   006   ANON                  J PEDIATR                       88   711 976
CT   1   DAVID TJ              J ROY SOC MED                   79    23 986

PN 76200
RN 00553 
AN 77038213
AU Wilson-G-B.  Burdash-N-M.  Arnaud-P.  Monsher-M-T.  Fudenberg-H-H.
TI Carcinoembryonic antigen and cystic fibrosis protein in blood from
   cystic fibrosis homozygotes and heterozygote carriers.
SO Scand-J-Immunol. 1976. 5(6-7). P 829-36.
MJ CARCINOEMBRYONIC-ANTIGEN.  CYSTIC-FIBROSIS: im.
MN ADOLESCENCE.  ADULT.  BLOOD-PROTEINS: an.  BLOOD-SPECIMEN-COLLECTION.
   CARCINOEMBRYONIC-ANTIGEN: an.  CARRIER-PROTEINS: an.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: bl, fg.
   GASTROINTESTINAL-NEOPLASMS: im.  GEL-DIFFUSION-TESTS.  HETEROZYGOTE.
   HOMOZYGOTE.  HUMAN.  ISOELECTRIC-FOCUSING.  RADIOIMMUNOASSAY.
   SUPPORT-U-S-GOVT-P-H-S.
AB Carcinoembryonic antigen (CEA) activity was measured by
   radioimmunoassay in blood from cystic fibrosis (CF) homozygotes,
   heterozygote carriers of CF, normal healthy controls, and other
   patient controls with carcinomas involving gastrointestinal organs.
   All samples were also screened by electrofocusing for cystic fibrosis
   protein (CFP), a metabolic marker previously shown to be associated
   with the CF gene. Significantly increased levels of CEA activity were
   found in all CFP-positive groups; however, with one exception all
   patient controls with marked increases in CEA activity were CFP-
   negative. Immunodiffusion of perchloric acid extracts of CEA-like
   material from heterozygote carrier blood indicated that the CEA-like
   material, which was elevated in homozygotes and heterozygotes for CF,
   showed only partial identity with two separate CEA preparations
   obtained from colon carcinomas and was not identical to either A, B,
   or O(H) blood group substances. This glycoprotein material did,
   however, react with three different anti-CEA antisera. Our finding of
   an abnormally increased glycoprotein in cystic fibrosis, taken
   together with previous reports demonstrating abnormalities in the
   carbohydrate portion of glycoproteins found in various  exocrine
   secretions in CF, further suggests that the primary defect in this
   disease is manifested partly as a defect in glycoprotein metabolism.
   This defect may result from an abnormality in one or more of the
   glycosyltransferases, possibly caused by a more primary defect in
   polyamine metabolism.
RF 001   ANDERSEN DH           ANN NY ACAD SCI                 93   500 962
   002   BANJO C               CANCER RES                      34  2114 974
   003   BIRD GWG              J MED GENET                     12   174 975
   004   BOAT TF               PEDIATR RES                      8   531 974
   005   BURTIN P              CANCER RES                      33  3299 973
   006   CONOVER JH            PEDIATR RES                      7   220 973
   007   DARCY DA              BR J CANCER                     28   147 973
   008   DAVIDSON AG           LANCET                           2  1393 973
   009   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   010   DISCHE Z              PEDIATRICS                      24    74 959
   011   CAUDILL M             LANCET                           2   307 973
   012   ESTERLY NB            AM J DIS CHILD                 123   200 972
   013   GOLD P                J EXP MED                      121   439 965
   014   GOLD P                J EXP MED                      122   467 965
   015   HANSEN HJ             HUM PATHOL                       5   139 974
   016   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   017   LEV R                 AM J PATHOL                     46    23 965
   018   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   019   MACH JP               IMMUNOCHEMISTRY                  9  1031 972
   020   MACSWEEN JM           BR J CANCER                     26   356 972
   021   MANDEL ID             AM J DIS CHILD                 113   431 967
   022   MANGIAROTTI-MARCHI MA MED CHIR DIG                     3   141 974
   023   MANGOS JA             SCIENCE                        158   135 967
   024   MANGOS JA             PEDIATR RES                      1   436 967
   025   MARTIN F              INT J CANCER                     6   352 970
   026   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   027   NEVILLE AM            INT J CANCER                    14     1 974
   028   POTTER JL             ANN NY ACAD SCI                106   692 963
   029   RENNERT OM            ANN CLIN LAB SCI                 3     1 973
   030   ROELFS RE             AM J DIS CHILD                 113   419 967
   031   ROGALSKY VY           LANCET                           1  1322 973
   032   ROUSSEL P             J BIOL CHEM                    250  2114 975
   033   SHWACHMAN H           IN: KENDIG EL JR                     541 967
   034   VONKLEIST S           PROC NAT ACAD SCI USA           69  2492 972
   036   WILSON GB             PEDIATR RES                      9   635 975
   037   WOOD RE               AM REV RESPIR DIS              113   833 976
   038   ZANCHECK Z            N ENGL J MED                   286    83 972
CT   1   WILSON GB             PEDIATR RES                     11   986 977
     2   WILSON GB             NATURE                         266   463 977
     3   WILSON GB             PEDIATR RES                     12   801 978
     4   ALHADEFF JA           CLIN GENET                      14   189 978
     5   MACSWEEN JM           PEDIATR RES                     14   187 980
     6   WILSON GB             CLIN GENET                      26   331 984

PN 76201
RN 00554 
AN 76199237
AU Hoiby-N.  Hoff-G-E.  Jensen-K.  Lund-E.
TI Serological types of Diplococcus pneumoniae isolated from the
   respiratory tract of children with cystic fibrosis and children with
   other diseases.
SO Scand-J-Respir-Dis. 1976. 57(1). P 37-40.
MJ CYSTIC-FIBROSIS: mi.  RESPIRATORY-SYSTEM: mi.
   STREPTOCOCCUS-PNEUMONIAE.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  FEMALE.  HUMAN.  INFANT.
   MALE.  SEROTYPING.  SPUTUM: mi.  STREPTOCOCCUS-PNEUMONIAE: ip.
AB The distribution of serological types of D. pneumoniae was
   investigated in 40 strains isolated from 26 children with cystic
   fibrosis and 57 strains isolated from 39 children with other
   diseases. All strains were isolated from sputum or tracheal
   secretion. The strains from cystic fibrosis patients belonged to 14
   different serological types, the most prevalent were 19F, 19A and 3.
   The strains from the other group of children belonged to 20 different
   serological types, the most prevalent were 23F, 19F and 11A. The
   differences between the two groups of patients as to the prevalences
   of types were small, and it is concluded that no special serological
   types of D. pneumoniae are associated with cystic fibrosis.
RF 001   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974
   002   HOIBY N               SCAND J RESPIR DIS              56    38 975
   003   LUND E                BULL WHO                        23     5 960
   004   LUND E                INT J SYSTEM BACT               20   321 970
   006   MAY JR                CHEMOTHERAPY OF CHRONIC BRONC            968
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   HOIBY N               SCAND J RESPIR DIS              58    65 977
     3   BRANSON D             AM J MED TECHNOLOGY             45   224 979
     4   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982
     5   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
     6   FRIEND PA             J INFECT                        13    55 986

PN 76202
RN 00555 
AN 77038272
AU Hoiby-N.  Kilian-M.
TI Haemophilus from the lower respiratory tract of patients with cystic
   fibrosis.
SO Scand-J-Respir-Dis. 1976. 57(3). P 103-7.
MJ CYSTIC-FIBROSIS: mi.  HAEMOPHILUS.  RESPIRATORY-SYSTEM: mi.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  FEMALE.
   HAEMOPHILUS-INFLUENZAE: ip.  HAEMOPHILUS: cl, ip.  HUMAN.
   LARYNX:  mi.  MALE.  SPUTUM: mi.
AB Fifty-six non-haemolytic Haemophilus strains were isolated during
   current bacteriological examinations from material from the lower
   respiratory tract of 39 patients with cystic fibrosis during a 6-
   month period. Except for six strains which belonged to Haemophilus
   parainfluenzae, all strains were identified as Haemophilus
   influenzae. Biotype I of H. influenzae was the predominating taxon
   (38%) and was especially related to patients with recurrent or
   prolonged colonization. Only two strains were capsulated. An
   unexpectedly high percentage of the strains produced lysine
   decarboxylase. The significance of this property in the pathogenesis
   of the respiratory tract colonization is discussed.
RF 001   DENNY FW              J INFECT DIS                   129    93 974
   002   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962
   003   HOLDAWAY MD           LANCET                           1   358 967
   004   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974
   005   HOIBY N               SCAND J RESPIR DIS              56    38 975
   006   KILBOURN JP           LANCET                           2   439 969
   007   KILIAN M              ACTA PATH MICROBIOL SCAND       80   571 972
   008   KILIAN M              J GEN MICROBIOL                 93     9 976
   009   MAY JR                CHEMOTHERAPY OF CHRONIC BRONC            968
   010   MAY JR                ARCH DIS CHILD                  47   908 972
   011   MEARNS MB             ARCH DIS CHILD                  47   902 972
   012   SAGGERS BA            J CLIN PATHOL                   23   262 970
   013   WHITE A               PRINCIPLES OF BIOCHEMISTRY               964
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   HOIBY N               SCAND J RESPIR DIS              58    65 977
     3   OILL PA               ARCH INTERN MED                139   985 979
     4   CHAD ZH               PEDIATRICS                      66     9 980
     5   IVANOVA NM            TER ARKH                        53   131 981
     6   LISTON TE             SOUTH MED J                     75   753 982
     7   TILLER FW             ZENTRALBL BAKT MIKROB HYG (A)  253   236 982
     8   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982
     9   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
    10   KILBOURN JP           AM REV RESPIR DIS              128  1093 983
    11   PRESSLER T            ACTA PAEDIATR SCAND             73   541 984
    12   NELSON JD             J PEDIATR                      106  1030 985
    13   LEVY J                ANTIMICROB AGENTS CHEMOTHER     29   474 986

PN 76203
RN 00556 
AN 76246160
AU McCrae-W-M.
TI Treatment of pseudomonas infections in cystic fibrosis using
   tobramycin.
SO Scott-Med-J. 1976 Apr. 21(2). P 68-9.
MJ ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: co.  PSEUDOMONAS-INFECTIONS: dt.
   TOBRAMYCIN: tu.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  HUMAN.  INFANT.
   TOBRAMYCIN:  ad.
EX It was decided to treat all seventeen cystic fibrosis patients under
   our care who were known to have active infection with mucoid strains
   of Pseudomonas, using large intravenous doses of tobramycin.  By the
   objective observations made, results were not so satisfactory.
   Changes in white blood cell count and erythrocyte sedimentation rate
   seemed often to conflict with clinical impression of improvement.
   However, there was closer agreement between subjective judgements,
   weight gain and respiratory function changes.  Eradication of
   Pseudomonas from the sputum was achieved in four cases, although the
   duration of follow-up in one was very short.
RF 001   HAWLEY HB             CURR THER RES                   16   414 974
   002   HUANG NN              J PEDIATR                       78   338 971
   003   MARKS MI              J PEDIATR                       79   822 971
   004   RAEBURN JA            POSTGRAD MED J                  47   366 971
   005   RAEBURN JA            SCAND J INFECT DIS               5   135 973
CT   1   BROGDEN RN            DRUGS                           12   166 976
     2   FRIIS B               SCAND J INFECT DIS              11   211 979
     3   HOWIE AD              SCOTT MED J                     24   193 979
     4   HODSON ME             BR J DIS CHEST                  77    71 983

PN 76204
RN 00557 
AN 77215997
AU Begleiter-M-L.  Burry-V-F.  Harris-D-J.
TI Prevalence of divorce among parents of children with cystic fibrosis
   and other chronic diseases.
SO Soc-Biol. 1976 Fall. 23(3). P 260-4.
MJ CHRONIC-DISEASE.  CYSTIC-FIBROSIS.  DIVORCE.
MN ATTITUDE-TO-HEALTH.  CHILD.  HUMAN.  MISSOURI.
   PARENT-CHILD-RELATIONS.
AB Data on the prevalence of divorce and separation among parents of
   children with cystic fibrosis and other chronic diseases indicate
   that marital breakdown is no more prevalent among these couples than
   it is in a general population.  For couples who attended genetic
   counseling clinics or had children with spina bifida or leukemia,
   the divorce rate is lower than the United States national average.
   For parents of children with cystic fibrosis, the divorce rate is
   the same as the national average.  The high recurrence risk for
   cystic fibrosis may deter many parents from further reproduction.
   We speculate that the inability to plan more children may be the
   factor responsible for the higher prevalence among these parents
   compared to those of children with other chronic diseases.
RF 001   ALLAN JL              AUST PAEDIATR J                 10   136 974
   002   CARTER CO             LANCET                           1   281 971
   003   EMERY AEH             BR MED J                         1   724 973
   004   FREESTON BM           DEVELOP MED CHILD NEUROL        13   456 971
   005   FRIEDMAN SB           PEDIATRICS                      32   610 963
   006   GLUCKSON MM           AM J HUM GENET                  27   39A 975
   007   HAMOVITCH MB          PARENT AND THE FATALLY IL                964
   008   HARE EH               BR MED J                         2   757 966
   009   MCCOLLUM AT           J PEDIATR                       77   571 970
   010   MCCRAE WM             LANCET                           2   141 973
   011   OAKLEY GR             NC MED J                        27   186 966
   012   REYNOLDS BD           CLIN GENET                       5   177 974
   013   SORENSON JR           AAAS SYMPOSIUM                           972
   014   STEHBENS JA           J CLIN PSYCHOL                  30   394 974
   015   TURK J                PEDIATRICS                      34    67 964
   016   ANON                  CENSUS OF POPULATION MARITAL             970
   017   WALKER JH             DEVELOP MED CHILD NEUROL        13   462 971
CT   1   HARTUNG J             SOC BIOL                        24   192 977
     2   LANSKY SB             PEDIATRICS                      62   184 978
     3   SILBERT AR            PEDIATRICS                      69   747 982
     4   DEWET B               S AFR MED J                     65   526 984
     5   THELIN T              ACTA PSYCHIATR SCAND            71   636 985

PN 76205
RN 00558 
AN 77127511
AU Levitt-R-G.  Forrest-J-V.  Sagel-S-S.
TI Roentgenographic recognition of bronchoceles.
SO South-Med-J. 1976 Dec. 69(12). P 1556-8.
MJ BRONCHIECTASIS: ra.
MN ADOLESCENCE.  ADULT.  ASPERGILLOSIS: co.  ASPERGILLUS-FUMIGATUS.
   ASTHMA: co.  BRONCHI: ab.  BRONCHIAL-NEOPLASMS: co.
   BRONCHIECTASIS:  et.  BRONCHOGRAPHY.  CHILD-PRESCHOOL.
   CYSTIC-FIBROSIS: co.  DIAGNOSIS-DIFFERENTIAL.  FEMALE.  HUMAN.  MALE.
   XENON-RADIOISOTOPES:  du.
AB Bronchoceles often have characteristic plain film, tomographic, and
   bronchographic appearances, and they may trap air. Roentgenographic
   recognition of bronchoceles can allow them to be distinguished from
   neoplasms and sometimes help avoid unnecessary surgery.
RF 001   LEMIRE P              AM J ROENTG RAD THER NUCL MED  110   687 970
   002   MCCARTHY C            CLIN RADIOL                     21   366 970
   003   WARING WW             PEDIATRICS                      39   166 967
   004   TALNER L              AM J ROENTG RAD THER NUCL MED  110   675 970
   005   GENEREUX GP           J CAN ASSOC RADIOL              22    71 971
   006   FENNESSY J            RADIOL CLIN NORTH AM            11   371 973
   007   REES DO               CLIN RADIOL                     21    62 970
   008   WADDELL J             THORAX                          20   214 965
   009   HUTCHESON J           AM J CLIN PATHOL                33   427 960
   010   FRASER RG             DIAGNOSIS OF DISEASES OF CHES            970
   011   SLAVIN RG             J ALLERGY                       46   150 970
CT   1   ARONBERG DJ           AM J ROENTGENOL                132    23 979

PN 76206
RN 00559 
AN 77127499
AU Lober-C-W.
TI Manifestations of cystic fibrosis in adults [letter].
SO South-Med-J. 1976 Nov. 69(11). P 1525.
MJ CYSTIC-FIBROSIS: fg.
MN CYSTIC-FIBROSIS: di.  HUMAN.
EX Cystic fibrosis (CF) is a recessive autosomal genetic disease in
   which exocrine glands secrete highly viscous mucus.  Variable genetic
   penetrance ("organ sparing") results in a broad spectrum of clinical
   presentations.  The diagnosis of CF is usually established by the
   presence of chronic obstructive lung disease and/or gastrointestinal
   dysfunction, together with elevated levels of sweat electrolytes
   (chloride > 60 mEq/liter), markedly diminished duodenal pancreatic
   enzyme concentrations, or pathologic changes in tissue.  Family
   history may occasionally be helpful.  The metabolic basis of CF is
   unknown.  The classic stereotype of the CF patient is an infant with
   a chronic cough, diarrhea, and growth failure.  Improved medical care
   is enabling many of these patients to reach adulthood, and increased
   diagnostic suspicion is resulting in identification of the disease in
   more adults.  Based upon analysis of over 11,000 cases of CF reported
   during the year 1974 by 119 Cystic Fibrosis Centers, the National
   Cystic Fibrosis Foundation estimated that the probability of an
   individual with CF surviving to age 20 was approximately 39%.
   Although most of these adults are currently under the care of
   pediatricians, the development of medical, psychiatric, surgical, or
   obstetric complications may necessitate the involvement of other
   professionals.  A joint study of cystic fibrosis in adults conducted
   by Duke Medical Center and the NIH has shown that the majority of
   affected adults, including those diagnosed early in life, are married
   and work full- or part-time.  Many manifest few if any symptoms until
   relatively late in life.  Since this study was retrospective, the
   reported frequencies of the clinical findings tend to underestimate,
   in all instances, the actual incidence in the population studied.
   The reported incidence of CF in the United States has been
   conservatively estimated at 1:2,000 live births.  If all adults with
   clubbing, infertility, and other symptoms were evaluated for CF, the
   true incidence would certainly be higher.
RF 001   ANON                  CF FND 1974 REP SURVI STUD PA            976
   002   LOBER CW              PROC AM COLL CHEST 40TH AN MT            974
   003   DI SANTAGNESE PA      IN: DOWNEY JA                         25 974

PN 76207
RN 00560 
AN 77060022
AU Litt-M.  Khan-M-A.
TI Detection of cystic fibrosis heterozygotes using the zeta potential
   reduction method.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 151-4.
MJ CYSTIC-FIBROSIS: di.  SALIVA: an.
MN ADULT.  CHILD.  COMPARATIVE-STUDY.  CYSTIC-FIBROSIS: fg.  GENES.
   HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.  METHODS.
AB Parotid saliva samples from cystic fibrosis homozygotes,
   heterozygotes and normal individuals were tested by the zeta
   potential technique for secretion factor in a double-blind
   experiment. There was no overlap between zeta potential reduction of
   the control group and the cystic fibrosis test groups, indicating
   that the zeta potential test may be detecting a unique component in
   saliva of cystic fibrosis genotypes.
RF 001   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   002   CONOVER JH            PEDIATR RES                      7   220 973
   003   KHAN MA               TEX REP BIOL MED                31   665 973
   004   LITT M                BIOCHEM BIOPHYS RES COMMUN      43   919 971
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976

PN 76208
RN 00561 
AN 77060026
AU Novak-R-A.  Abell-C-W.
TI L-fucose metabolism in cystic fibrosis fibroblasts.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 199-207.
MJ CYSTIC-FIBROSIS: me.  FUCOSE: me.
MN CHROMATOGRAPHY.  COMPARATIVE-STUDY.  FIBROBLASTS: me.
   GLYCOPEPTIDES:  me.  HUMAN.  MOLECULAR-WEIGHT.  SUPPORT-U-S-GOVT-P-H-S.
AB The capacity of skin fibroblasts from cystic fibrosis (CF) and non-CF
   individuals to incorporate exogenous L-fucose into various metabolic
   pools was compared. Incorporation into intracellular acid-soluble
   pools and extracellular glycopeptides was measured by a dual-label co-
   chromatographic technique, whereas total macromolecular incorporation
   was measured by a single-label procedure. Although CF and normal
   fibroblasts incorporate exogenous fucose into intracellular acid-
   soluble and high molecular weight compounds in a similar manner, CF
   cells appear to be characterized by an increased incorporation of
   label into low molecular weight extracellular glycopeptides.
RF 001   BAUER U               ANN PAEDIATR                   194   236 960
   002   BOLTON WE             AM J HUM GENET                  27   394 975
   003   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   004   CHERNICK WS           ANN NY ACAD SCI                106   698 963
   005   DANES BS              J EXP MED                      129   775 969
   006   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969
   007   DI SANTAGNESE PA      PEDIATRICS                      19   252 957
   008   DISCHE Z              AM J DIS CHILD                 102   733 961
   009   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   010   JOHANSEN PG           ANN NY ACAD SCI                106   755 963
   011   JOHANSEN PG           BIOCHEM J                       87    63 963
   012   KAUFMAN RL            EXP CELL RES                    50   127 968
   013   LOBECK CC             IN: STANBURY JB                     1605 972
   014   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   015   PALLAVICINI JC        ANN NY ACAD SCI                106   330 963
   016   POTTER JL             ANN NY ACAD SCI                106   692 963
   017   ROBERTS RM            J CELL BIOL                     59    86 973
   020   TRUJILLO JL           BIOCHIM BIOPHYS ACTA           230   610 971
   021   WIESMANN UN           J PEDIATR                       77   685 970

PN 76209
RN 00562 
AN 77060025
AU Rennert-O-M.  Frias-J.  Shukla-J-B.
TI Polyamine metabolism in cystic fibrosis.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 187-97.
MJ CYSTIC-FIBROSIS: me.  POLYAMINES: me.
MN ANIMAL.  ELECTROLYTES: bl.  HAMSTERS.  SPERMIDINE: bl.
   SUPPORT-U-S-GOVT-P-H-S.
AB Increased blood levels of spermidine and an increased
   spermidine/spermine ratio is documented in 31 patients with cystic
   fibrosis (CF). Some 29 percent of CF patients overlap with the
   control group. An abnormality of urinary free polyamines or their
   metabolic derivatives related to electrolyte transport, serum
   ciliostatic factors, and the autonomic nervous system are elaborated
   upon.
RF 001   NOUSIA-ARVANITAKIS S  CF CLUB ABST                           5 972
   002   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   003   BARBERO GJ            IN: DI SANTAGNESE PA                     966
   004   BARNETT DR            TEX REP BIOL MED                31   691 973
   005   BARNETT DR            TEX REP BIOL MED                31   703 973
   006   BOQUIST L             LAB INVEST                      21    96 969
   007   BOWMAN BH             SCIENCE                        164   325 969
   008   BYUS C                GORDON RES CONF POLYAMINES               975
   009   COHEN LF              PEDIATR RES                      9   334 975
   010   DOGGETT RG            NATURE NEW BIOL                243   251 973
   011   DOGGETT RG            TEX REP BIOL MED                31   685 973
   012   ELFERINK J            Z NATURFORSCH                   30   117 975
   013   FARRELL PM            CF CLUB ABST                             974
   014   FLEISHER DS           J PEDIATR                       64   341 964
   015   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   016   INOUE H               J BIOCHEM (TOKYO)               75   679 974
   017   KAISER D              PEDIATR RES                      5   167 971
   018   KOSSOROTOW A          BIOCHEM J                      144    21 974
   019   MANGOS JA             SCIENCE                        158   135 967
   020   MANGOS JA             IN: LAWSON D PROC 5TH INT CF          25 969
   021   MARTINEZ JR           PEDIATR RES                      9   463 975
   022   MARTINEZ JR           PEDIATR RES                      9   470 975
   023   MILLS J               MOL PHARMACOL                    2   311 966
   025   PARSA I               FED PROC                        31   166 972
   027   RENNERT OM            IN: MANGOS JA                         41 973
   030   SEILER N              J CHROMATOGR                    63    97 971
   031   SMITH T               BIOCHEM J                       84   292 962
   032   SPOCK A               PEDIATR RES                      1   173 967
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   MIALE TD              MED PEDIATR ONCOL                3   209 977
     3   WRIGHT RK             PEDIATR RES                     12   830 978
     4   DUNZENDORFER U        CANCER RES                      38  2321 978
     5   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     6   DESSER H              ZENTRALBL VETERINARMED (A)      27    45 980
     7   THEOHARIDES TC        LIFE SCI                        27   703 980
     8   DESSER H              ONCOLOGY                        37   376 980
     9   RENNERT OM            CLIN CHIM ACTA                 103   375 980
    10   KIMBERLY MM           ANAL CHEM                       53   789 981
    11   DESSER H              ADV POLYAMINE RES                4    49 982
    12   CASTI A               J ENDOCRINOLOGICAL INVEST        5   263 982
    13   DESSER H              ONKOLOGIE                        5    36 982
    14   EKSTROM J             ACTA PHYSIOL SCAND             119   287 983
    15   CHAYEN R              CELL BIOCHEM FUNCT               2    15 984
    16   SCALABRINO G          MECH AGEING DEV                 26   149 984
    17   PALES JL              SCAND J HAEMATOL                32   241 984

PN 76210
RN 00563 
AN 77060024
AU Arvanitakis-S.  Mangos-J.  Mcsherry-N-R.  Rennert-O.
TI Effect of polyamines and cystic fibrosis serum on glucose transport.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 175-86.
MJ CYSTIC-FIBROSIS: bl.  GLUCOSE: me.  POLYAMINES: pd.
MN ADULT.  ANIMAL.  CHILD.  EPITHELIUM: me.  FEMALE.  HETEROZYGOTE.
   HOMOZYGOTE.  HUMAN.  IN-VITRO.  JEJUNUM: me.  MALE.  RATS.
   SPERMIDINE: pd.
AB The effect of plasma or serum from homozygotes and heterozygotes for
   the cystic fibrosis (CF) gene on the active uptake of 3-0-14C-methyl-
   D-glucose (3-0-14C-MDG) by rat jejunal epithelium was studied.
   Furthermore, the role of the polyamine, spermidine, and its products
   of metabolic degradation on glucose transport were investigated, and
   a relationship to the pathogenesis of membrane dysfunction in cystic
   fibrosis was postulated. Glucose transport in everted rat jejunal
   rings was used in the study. Results were expressed as 3-0-14C-MDG
   concentration ratio between the intracellular (ICF) and the
   extracellular fluid spaces (ECF) of the jejunal rings at the end of a
   60 min incubation period. The mean ratio obtained from incubations of
   the rat jejunal rings in medium consisting of Krebs-Ringer-
   bicarbonate buffer and the labeled sugar was considered as 100%
   uptake. When plasma or serum, with or without spermidine, was mixed
   with the medium in a volume ratio of 1:3, a decrease in the active
   uptake of 3-0-14C-MDG was observed, expressed as percent inhibition.
   Percent inhibition of 3-0-14C-MDG uptake obtained when the rat
   jejunal rings were incubated in normal plasma was compared to that
   obtained with plasma from cystic fibrosis genotypes. It was found
   that: 1) plasma from 25 homozygous children had greater inhibitory
   effect on glucose uptake than plasma from 26 normal children; 2)
   plasma from 9 heterozygous women had greater inhibitory effect than
   that from 6 normal women; 3) the inhibitory effect of plasma from 3
   homozygous children was not influenced by dialysis; 4) the inhibitory
   effects of paired plasma and serum samples from 9 homozygotes were
   comparable; 5) spermidine added to the incubating electrolyte
   solution did not affect glucose transport; 6) the addition of
   spermidine to reaction mixtures containing normal plasma potentiated
   the inhibitory effect; and 7) mixing and incubation of fresh bovine
   serum with reaction mixtures containing plasma from homozygotes
   decreased the inhibitory effect. The predominant inhibitory effect of
   plasma or serum from homozygotes and heterozygotes for the CF gene
   appears to be related to a nondialyzeable molecule(s). It does not
   seem to reflect the presence of high plasma glucose levels in cystic
   fibrosis nor to be the result of competitive inhibition between
   sugars. It does not seem to be the result of sodium or other
   electrolyte differences. A similar inhibitory effect is acquired by
   normal plasma after the addition of spermidine. On the other hand,
   plasma from CF homozygotes loses its inhibitory effect after
   incubation with fresh bovine serum. These findings may indicate that
   products of metabolic degradation of spermidine are responsible for
   the inhibitory effect of glucose transport and suggest the
   possibility of a role in abnormal polyamine metabolism in the
   pathogenesis of cystic fibrosis.
RF 001   BACHRACH U            J GEN VIROL                     13   415 971
   002   BOWMAN BH             SCIENCE                        164   325 969
   003   BOWMAN BH             SCIENCE                        167   871 970
   004   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   005   BREMER HJ             CLIN CHIM ACTA                  32   407 971
   006   BROWN GA              LANCET                           2   639 971
   007   CRANE RK              ABSORPTION OF SUGARS HANDBOOK    3       968
   008   DESJEUX JF            EUROPEAN SOC PEDIAT RES MTG              970
   009   MCEWEN C              J BIOL CHEM                    240  2003 965
   010   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   011   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   012   KAISER D              PEDIATR RES                      5   167 971
   013   KIMES BW              BIOCHIM BIOPHYS ACTA           228   223 971
   014   KREMZNER LT           BIOCHEM PHARMACOL               19  2541 970
   015   LOWRY OH              J BIOL CHEM                    193   265 951
   016   MANGOS JA             SCIENCE                        158   135 967
   017   MANGOS JA             PEDIATR RES                      1   436 967
   018   MANGOS JA             PEDIATR RES                      2   378 968
   019   OLSEN WA              J CLIN INVEST                   49    96 970
   020   PEGG AE               BIOCHIM BIOPHYS ACTA           232   630 971
   021   RAO GJS               J PEDIATR                       80   573 972
   022   RAO GJS               SCIENCE                        177   610 972
   023   RAINA A               PROC NAT ACAD SCI USA           55  1587 966
   024   RENNERT OM            CLIN PEDIATR                    11   351 972
   025   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      46  1923 972
   026   SPOCK A               PEDIATR RES                      1   173 967
   027   TABOR H               PHARMACOL REV                   16   245 964
   028   TABOR CW              J BIOL CHEM                    239  2194 964
   029   WALTER V              CLIN RES                        19   204 971
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   WRIGHT RK             PEDIATR RES                     12   830 978
     3   WILL PC               PEDIATR RES                     13  1129 979
     4   THEOHARIDES TC        LIFE SCI                        27   703 980
     5   SHIPE JR              CRC CRIT REV CLIN LAB SCI       16     1 981
     6   KIMBERLY MM           ANAL CHEM                       53   789 981
     7   SCALABRINO G          ADV CANCER RES                  36     1 982
     8   GENEDANI S            LIFE SCI                        38  1293 986

PN 76211
RN 00564 
AN 77060023
AU Baur-P-S.  Brinkley-B-R.  Bowman-B-H.
TI Effects of cystic fibrosis serum ciliary inhibitor on oyster gill
   ultrastructure: analysis by scanning and transmission electron
   microscopy.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 155-74.
MJ BLOOD-PROTEINS.  CILIA: ul.  CYSTIC-FIBROSIS: bl.  MODELS-BIOLOGICAL.
   OYSTERS: ul.
MN ANIMAL.  CELLS-CULTURED.  CILIA: ph.  CYSTIC-FIBROSIS: me.
   GILLS:  ul.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.
   MICROSCOPY-ELECTRON-SCANNING.
AB Ultrastructural analysis including scanning and transmission electron
   microscopic studies (SEM and TEM) were carried out on oyster gill
   tissue after exposure either to serum fractions from individuals
   homozygous or heterozygous for cystic fibrosis (CF), to comparable
   serum fractions from normal individuals, or to sea water. In 4 of the
   experiments examined topologically (SEM), the CF sera (either
   heterozygous or homozygous) stimulated the production of mucus that
   was found in close association with the cilia. The association of
   excessive mucus with the cell surface could be responsible, in part,
   for the well-known inhibition of ciliary activity by a factor in CF
   serum. In 3 additional SEM experiments involving shorter treatment
   times, very little difference could be observed between homozygous
   CF, heterozygous CF, and normal serum-fraction-treated oyster
   tissues. In parallel experiments, ultrathin sections of gill tissue
   were examined by means of TEM. Those samples that were responsive, as
   determined by TEM, displayed several characteristic features,
   including enlarged and partially exuded goblet cells, altered mucus
   structure along with twisted and matted cilia. An overall swelling of
   the gill filament was also observed in the responsive tissues. From
   TEM analysis no detectable alteration in fine structure was apparent
   in gill tissues that were treated with sera from heterozygous or
   normal individuals.
RF 001   ADSHEAD PC            ANN NY ACAD SCI                253   192 975
   002   ANDERSON TF           NY ACAD SCI SER II              13   130 951
   003   BESLEY GTN            J MED GENET                      6   278 969
   004   BARNETT DR            TEX REP BIOL MED                31   691 973
   005   BOWMAN BH             TEX REP BIOL MED                31   611 973
   006   BOWMAN BH             IN: MANGOS JA                         29 973
   007   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   008   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   009   BOWMAN BH             SCIENCE                        164   325 969
   010   BOWMAN BH             SCIENCE                        167   871 970
   011   CHERRY JD             J PEDIATR                       79   937 971
   012   CONOVER JH            PEDIATR RES                      7   220 973
   013   GALSTOFF PS           FISHERY BULL                    64     1 964
   014   LUFT JH               J BIOPHYS BIOCHEM CYTOL          9   409 961
   015   SPOCK A               PEDIATR RES                      1   173 967
CT   1   WARD JB               TEX REP BIOL MED                34    11 976
     2   BOWMAN BH             CLIN GENET                      12   333 977
     3   FORSTNER JF           DIGESTION                       17   234 978
     4   GABRIDGE MG           PEDIATR RES                     13    31 979
     5   NAGY EC               PEDIATR RES                     13   729 979
     6   BOWMAN BH             TEX REP BIOL MED                38    47 979
     7   KENNEDY JR            PEDIATR RES                     14  1173 980
     8   BOWMAN BH             FED PROC                        39  3195 980
     9   SANDERSON MJ          PEDIATR RES                     15   219 981
    10   TEGNER H              ACTA PAEDIATR SCAND             70   629 981
    11   MCPHERSON MA          CLIN CHIM ACTA                 135   181 983
    12   ROOMANS GM            SCANN ELECTRON MICROSC        1983   697 983
    13   WOOTEN MW             J CELL PHYSIOL                 121   490 984

PN 76212
RN 00565 
AN 77060027
AU Carson-S-D.  Harper-B-L.  Barnett-D-R.  Kurosky-A.  Lankford-B-J.
   Bowman-B-H.
TI Electrophoretic studies of the cystic fibrosis ciliary inhibitor and
   its interaction with immunoglobulin G.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 210-9.
MJ BLOOD-PROTEINS: me.  CILIA: ph.  CYSTIC-FIBROSIS: bl.  IGG: me.
MN CYSTIC-FIBROSIS: me.  ELECTROPHORESIS-POLYACRYLAMIDE-GEL.
   FIBROBLASTS: me.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.
   MOLECULAR-WEIGHT.  SUPPORT-U-S-GOVT-P-H-S.
AB The cystic fibrosis ciliary inhibitor (CFCI) has been partially
   purified from serum and plasma of cystic fibrosis (CF) homozygotes
   and heterozygotes, and from media of cultured fibroblasts derived
   from cystic fibrosis genotypes. Characterization and comparison of
   fractions containing the CFCI were carried out by polyacrylamide gel
   electrophoresis. Gel electrophoresis confirmed previous molecular
   weight estimations of 4,500 to 11,000 for the CFCI and provided an
   estimate of the number of proteins present in the fractions. Low
   molecular weight proteins from serum and media were combined with IgG
   preparations. No specific binding to IgG by the media fraction
   containing the CFCI could be demonstrated by the techniques employed.
   There was decreased binding of the low molecular weight serum
   fraction containing CFCI to native IgG molecules from cystic fibrosis
   patients as compared to IgG from normal individuals. However, IgG
   from CF individuals demonstrated increased binding of the cfci-
   containing low molecular weight serum fraction after gel filtration
   in the presence of guanidinium chloride. This suggests: 1) that very
   low concentrations of CFCI are present in media fractions; and 2)
   that native CF IgG cannot bind the low molecular weight CFCI
   fractions to the same degree as native IgG from normals or CF IgG
   that has been dissociated from non-covalently bound components.
RF 001   BARNETT DR            TEX REP BIOL MED                31   703 973
   002   BARNETT DR            TEX REP BIOL MED                31   709 973
   003   BOLTON WE             AM J HUM GENET                  27   394 975
   004   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   005   BOWMAN BH             SCIENCE                        164   325 969
   006   BOWMAN BH             SCIENCE                        167   871 970
   007$  CUATRECASAS P         PROC NAT ACAD SCI USA           70   485 970
   008   CUATRECASAS P         PROC NAT ACAD SCI USA           61   636 968
   009   DANES BS              J EXP MED                      136  1313 972
   010   DANES BS              J EXP MED                      137  1538 973
   011   HARPER BL             TEX REP BIOL MED                34    73 976
   012   JOUSTRA M             PROTIDES BIOL FLUIDS            17   511 969
   013   PALACIOS R            J BIOL CHEM                    247  2316 972
   014   PANYIM S              ARCH BIOCHEM BIOPHYS           130   337 969
   015   SWANK RT              ANAL BIOCHEM                    39   462 971

PN 76213
RN 00566 
AN 77060021
AU Danes-B-S.
TI Expression of the cystic fibrosis genotype in cultured somatic cells.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 135-50.
MJ CYSTIC-FIBROSIS: fg.
MN CELL-MEMBRANE: me.  CELLS-CULTURED.  CYSTIC-FIBROSIS: me, pa.
   FIBROBLASTS: me.  GENOTYPE.  HEPARIN: me.  HETEROZYGOTE.  HOMOZYGOTE.
   HUMAN.  HYBRID-CELLS.  LEUKOCYTES: me.  LYSOSOMES: me.
   MUCOPOLYSACCHARIDES: me.  PINOCYTOSIS.  STAINS-AND-STAINING.
AB Observations on the characteristics of the cell with the cystic
   fibrosis (CF) genotype in culture are reviewed. Although numerous and
   diverse abnormalities have been described, none were specific for the
   CF gene. The relevance of each of these abnormalities to the clinical
   syndrome known as CF is discussed, emphasizing that the value thus
   far of such cell culture research has been to learn how the CF gene
   influences cellular function.
RF 001   BAIG MM               J PEDIATR                       86    72 975
   002   BARKA T               HISTOCHEMISTRY THEORY PRACTIC         84 963
   003   BARNETT DR            TEX REP BIOL MED                31   691 973
   004   BARNETT DR            PEDIATR RES                      8   687 974
   005   BARNETT DR            TEX REP BIOL MED                31   697 973
   006   BARNETT DR            TEX REP BIOL MED                31   703 973
   007   BARNETT DR            TEX REP BIOL MED                31   709 973
   008   BARTMAN J             J PEDIATR                       76   430 970
   009   BEARN AG              TRANS ASSOC AM PHYSICIANS       82   248 969
   010   BERATIS NG            PEDIATR RES                      7   958 973
   010A  BOLTON WE             AM J HUM GENET                  27   394 975
   011   BOWMAN BH             IN: MANGOS JA                         29 973
   012   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   013   BOWMAN BH             CLIN GENET                       4   461 973
   014   BOWMAN BH             SCIENCE                        164   325 969
   015   BOWMAN BH             SCIENCE                        167   871 970
   016   BOWMAN BH             AM J HUM GENET                  25   16A 973
   017   CAUDILL M             LANCET                           1    32 974
   018   CHOU L                PEDIATR RES                      9   312 975
   019   CONOVER JH            PEDIATR RES                      7   224 973
   020   CONOVER JH            PEDIATR RES                      7   220 973
   021   CONOVER JH            LANCET                           2  1501 973
   022   CONOVER JH            LANCET                           1  1194 973
   023   CONOVER JH            LIFE SCI                        14   253 974
   024   DANES BS              IN: LAWSON D PROC 5TH INT CF          67 969
   025   DANES BS              BIRTH DEF ORIG ART SER           8   114 972
   026   DANES BS              LANCET                           2   765 973
   027   DANES BS              LANCET                           2   655 974
   028   DANES BS              CLIN GENET                       7   128 975
   029   DANES BS              IN: KELLY S                          297 976
   031   DANES BS              BIOCHEM GENET                   12   359 974
   032   DANES BS              J EXP MED                      129   775 969
   033   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969
   034   DANES BS              J EXP MED                      136  1313 972
   035   DANES BS              CLIN GENET                       8    85 975
   036   DANES BS              J EXP MED                      137  1538 973
   037   DEMARS R              NAT CANCER INST MONOGRAPH       13   181 964
   038   DI FERRANTE N         CONNECT TISSUE RES               1    93 972
   039   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   040   DOGGETT RG            NATURE NEW BIOL                243   251 973
   041   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   042   FRATANTONI JC         PROC NAT ACAD SCI USA           60   699 968
   043   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   045   KLAGSBRUN M           PEDIATR RES                      8   205 974
   046   KRAUS I               PEDIATRICS                      47  1010 971
   047   LIE SO                PROC NAT ACAD SCI USA           69  2361 972
   048   MCMANUS SP            J MED GENET                     11   216 974
   049   MATALON R             PROC NAT ACAD SCI USA           56  1310 966
   050   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   051   MILUNSKY A            N ENGL J MED                   281  1128 969
   052   NADLER HL             LANCET                           2    84 969
   054   PALLAVICINI JC        J PEDIATR                       77   280 970
   055   POLLEY MJ             J MED GENET                     11   249 974
   056   RAFF EC               J CELL PHYSIOL                  74   235 969
   057   RENNERT OM            CLIN PEDIATR                    11   351 972
   058   RENNERT OM            PEDIATRICS                      50   485 972
   059   ROBERTSON JA          LANCET                           1  1256 974
   060   RUSSELL SB            J MED GENET                      8   441 971
   061   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   062   HOUCK JC              PROC SOC EXP BIOL MED          135   369 970
   063   SPOCK A               PEDIATR RES                      1   173 967
   064   SYLVEN B              ACTA HISTOCHEM SUPPL             1    79 958
   065   TAYSI K               N ENGL J MED                   281  1108 969
   066   WIESMANN UN           J PEDIATR                       77   685 970
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   DANES BS              CLIN GENET                      13   327 978
     3   WILSON GB             J LAB CLIN MED                  92   463 978
     4   WILSON GB             PEDIATR RES                     13  1079 979
     5   JAKEL HP              BIOL ZENTRALBL                  98    55 979
     6   BUCHWALD M            ADV CYCLIC NUCLEO RES           12   243 980
     7   WILSON GB             J CLIN INVEST                   66  1010 980
     8   TEGNER H              ACTA PAEDIATR SCAND             70   629 981

PN 76214
RN 00567 
AN 77060020
AU Baur-P-S.  Bolton-W-E.  Barranco-S-C.
TI Electron microscopy and microchemical analysis of cystic fibrosis
   diploid fibroblasts in vitro.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 114-34.
MJ CYSTIC-FIBROSIS: pa.
MN ADULT.  ANIMAL.  CALCIUM: an.  CELL-DIVISION.  CELL-LINE.
   CELLS-CULTURED.  CHILD.  CYSTIC-FIBROSIS: me.  CYTOPLASM: ul.
   DIPLOIDY.  FEMALE.  FIBROBLASTS: ul.  HETEROZYGOTE.  HOMOZYGOTE.
   HUMAN.  INFANT.  MALE.  SULFUR: an.  SUPPORT-U-S-GOVT-P-H-S.
AB Fibroblasts derived from cystic fibrosis homozygotes and
   heterozygotes were compared to normal fibroblasts topologically,
   ultrastructurally, and microchemically. Topological examinations, by
   means of scanning electron microscopy (SEM) revealed no significant
   differences between the 3 genotypes surveyed. The cells were
   generally flattened and/or fusiform structures that were more or less
   devoid of surface details. However, the dividing cells, in all of the
   populations surveyed, were found to have a more or less spherical
   configuration involving a highly complicated surface. The surface
   manifestations included blebs, ridges, and microvilli. Representative
   samples of the cells in all stages of growth, lag phase, exponential
   phase, and plateau phase, were surveyed in this study.
   Ultrastructurally, the fibroblasts of the 3 genotypes were found to
   have similar cytological detail. Highly infolded nuclei, distinct
   organelle components, and surface details, also seen in the SEM
   study, were observed. Numerous bundles of microfilaments were noted
   within the cytoplasm. Metachromatic granules were observed in cells
   from all 3 genotypes. Microchemical analysis, by means of energy
   dispersive X-ray analysis, demonstrated slight but recognizable
   differences in the elemental composition of the 3 genotypes. Of
   notable interest were the peak intensities of calcium and sulfur. The
   CF homozygous cells presented higher values for both of the elements
   when compared to the values observed in the CF heterozygous and
   normal cell populations. Although consistent differences could be
   observed in the CF genotypes when compared to the non-CF cells, no
   attempt was made to quantitate the concentrations of each of the
   elements within the cells.
RF 001   ANDERSON TF           NY ACAD SCI SER II              13   130 951
   002   BARNETT DR            TEX REP BIOL MED                31   691 973
   003   BARTMAN J             J PEDIATR                       76   430 970
   004   BEARN AG              N ENGL J MED                   282   102 970
   005   BRADDOCK LI           CF CLUB ABST                          31 970
   006   BOLTON WE             AM J HUM GENET                  27   394 975
   007   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   008   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   009   BOWMAN BH             SCIENCE                        167   871 970
   010   BOYDE A               EXP CELL RES                    71   313 972
   011   CHERNICK WS           MOD PROBL PEDIATR               10   125 967
   012   DANES BS              LANCET                           2   765 973
   013   DUNN MJ               BIOCHIM BIOPHYS ACTA           352    96 974
   014   EVERHART LP           J CELL BIOL                     60   442 974
   015   GIBSON LE             PEDIATRICS                      48   695 971
   016   GOLDBLOOM RG          PEDIATRICS                      48   693 971
   017   GUGLER EC             J PEDIATR                       71   585 967
   018   HODGES GM             J CELL SCI                      11   233 972
   019   KAMENSKY E            AM J PATHOL                     73    59 973
   020   LIM R                 SCIENCE                        185    63 974
   021   LUFT JH               J BIOPHYS BIOCHEM CYTOL          9   409 961
   022   PAWELETZ N            CYTOBIOLOGIE                     8   228 974
   023   PORTER KR             J CELL BIOL                     57   815 973
   024   PORTER KR             J CELL BIOL                     59   633 973
   025   PORTER KR             CELL                             2   145 974
   026   WARTON KL             BR MED J                         3   570 971

PN 76215
RN 00568 
AN 77060019
AU Ward-J-B-Jr.
TI Cultured cells in cystic fibrosis research: A review.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 11-36. (REVIEW).
MJ CYSTIC-FIBROSIS: pa.
MN ADENOSINE-CYCLIC-MONOPHOSPHATE: me.  ANIMAL.  BIOLOGICAL-TRANSPORT.
   BODY-FLUIDS: an.  CELL-DIVISION.  CELL-MEMBRANE: me.  CELLS-CULTURED.
   CILIA.  COLLAGEN: me.  CYSTIC-FIBROSIS: bl, me.  ELECTROLYTES: me.
   FIBROBLASTS.  GLUCOSYLTRANSFERASES: me.  GLYCOGEN: me.  HUMAN.
   LYSOSOMES: en.  MUCOPOLYSACCHARIDES: me.  OYSTERS.  PROTEINS: me.
   RABBITS.  REVIEW.  RNA-TRANSFER-METHYLTRANSFERASES: me.
   SUPPORT-U-S-GOVT-P-H-S.
AB Cystic fibrosis (CF) is a common inherited disorder which is
   characterized by the production of exocrine secretions with elevated
   ion content and abnormally viscous mucus. Over the last few years
   cells obtained from the peripheral blood or cultured from tissues of
   cystic fibrosis patients have been used increasingly in the study of
   the disease. Investigations of the following properties of cystic
   fibrosis cells are reviewed: morphology, ultrastructure, growth
   kinetics, cellular metachromasia, the production of ciliary
   inhibitors, cellular composition, plasma membrane composition, the
   transport of inorganic ions and small organic molecules, lysosomal
   enzyme content, and RNA methylation. Studies of the effects on
   cultured cells and erythrocyte membranes of factors in CF cell
   culture medium and biological fluids from CF patients are discussed.
RF 001   ANTONOWICZ I          PEDIATR RES                      6   803 972
   002   BAFALLUY E            LANCET                           1   973 971
   003   BAIG MM               J PEDIATR                       86    72 975
   004   BALFE JW              SCIENCE                        162   689 968
   005   BARNETT DR            TEX REP BIOL MED                31   691 973
   006   BARNETT DR            TEX REP BIOL MED                31   697 973
   007   BARNETT DR            TEX REP BIOL MED                31   703 973
   008   BARTMAN J             J PEDIATR                       76   430 970
   009   BAUR PS               TEX REP BIOL MED                34   155 976
   010   BENKE PJ              LANCET                           1   182 972
   011   BENKE PJ              PROC SOC EXP BIOL MED          137  1283 971
   012   BERATIS NG            PEDIATR RES                      7   958 973
   013   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971
   014   BOLTON WE             AM J HUM GENET                  27   394 975
   014A  BOLTON WE             TEX REP BIOL MED                34    97 976
   015   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   016   BOWMAN BH             LANCET                           1   404 974
   017   BOWMAN BH             CLIN GENET                       4   461 973
   018   BOWMAN BH             SCIENCE                        164   325 969
   019   BOWMAN BH             SCIENCE                        167   871 970
   020   BOXERBAUM B           AM REV RESPIR DIS              108   777 973
   021   BUCHWALD M            AM J HUM GENET                  27   22A 975
   022   BUTTERWORTH J         CLIN CHIM ACTA                  40   139 972
   023   CHANGUS JE            AM J PATHOL                     80   317 975
   024   COLE CH               PEDIATR RES                      6   616 972
   025   COLE CH               PEDIATR RES                      9   763 975
   026   CONOD EJ              PEDIATR RES                      9   724 975
   027   CONOVER JH            PEDIATR RES                      7   224 973
   028   DANES BS              IN: LAWSON D PROC 5TH INT CF          67 969
   029   DANES BS              LANCET                           2   765 973
   030   DANES BS              LANCET                           1  1061 968
   031   DANES BS              J EXP MED                      129   775 969
   032   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969
   033   DANES BS              J EXP MED                      136  1313 972
   034   DANES BS              CLIN GENET                       8    85 975
   035   DANES BS              J EXP MED                      137  1538 973
   036   DANES BS              AM J HUM GENET                  23   297 971
   037   DANES BS              NATURE                         222   685 969
   038   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   039   DUFFY MJ              CLIN CHIM ACTA                  50    97 974
   040   DUNHAM ET             J CLIN INVEST                   49  1804 970
   042   FARRELL PM            PROC SOC EXP BIOL MED          149   340 975
   043   FEIG SA               PEDIATR RES                      8   594 974
   044   FITZPATRICK DF        NATURE NEW BIOL                235   173 972
   045   FLETCHER DS           CLIN CHIM ACTA                  44     5 973
   046   ANON                  GAP CONF REP CELL TISS CULT            6 971
   047   GIBBS GE              SCIENCE                        167   993 970
   048   GRIFFIN GD            PROC SOC EXP BIOL MED          137   438 971
   049   HADDEN JW             PROC SOC EXP BIOL MED          142   577 973
   050   HODES ME              PEDIATR RES                      8   212 974
   051   HOFFMAN JF            AM J MED                        41   666 966
   052   HORTON CR             BIOCHEM BIOPHYS RES COMMUN      40   505 970
   053   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   054   HOUCK JC              PROC SOC EXP BIOL MED          135   369 970
   055   JACOBSON CB           CF CLUB ABST                          23 974
   056   KLAGSBRUN M           IN: MANGOS JA                         53 973
   057   KLAGSBRUN M           PEDIATR RES                      8   205 974
   058   KRAUS I               PEDIATRICS                      47  1010 971
   059   LAPEY A               PEDIATR RES                      5   446 971
   060   LIE SO                PROC NAT ACAD SCI USA           69  2361 972
   061   LOBECK CC             PROC INT CONF RES PATHOG 3RD         107 966
   062   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   063   MANGOS JA             TEX REP BIOL MED                31   651 973
   064   MANGOS JA             SCIENCE                        158   135 967
   065   MARCHI AG             HELV PAEDIATR ACTA              28   427 973
   066   MCMANUS SP            IR J MED SCI                   143   227 974
   067   MATALON R             LANCET                           2   838 969
   068   MATALON R             BIOCHEM BIOPHYS RES COMMUN      33   954 968
   069   MCEVOY FA             CLIN CHIM ACTA                  54   195 974
   070   MILUNSKY A            N ENGL J MED                   281  1128 969
   071   NADLER HL             J PEDIATR                       74   823 969
   072   NADLER HL             LANCET                           2    84 969
   073   NEUFELD EF            REPORT ON STAINING FOR METACH            972
   074   PALLAVICINI JC        J PEDIATR                       77   280 970
   075   POST RL               J BIOL CHEM                    235  1796 960
   076   QUISSELL DO           NATURE                         247   115 974
   077   RAFF EC               J CELL PHYSIOL                  74   235 969
   078   REED GB               J PATHOL                       101   251 970
   079   RENNERT OM            CLIN PEDIATR                    11   351 972
   080   RENNERT OM            IN: MANGOS JA                         41 973
   081   RENNERT OM            PEDIATRICS                      50   485 972
   082   ROBERTSON JA          LANCET                           1  1256 974
   083   RUSSELL SB            J MED GENET                      8   441 971
   084   SCHATZMANN HJ         J PHYSIOL (LOND)               201   369 969
   085   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   086   SPOCK A               PEDIATR RES                      1   173 967
   087   STEELE MW             PEDIATR RES                      5   393 971
   088   TAUSSIG LM            LANCET                           1  1367 972
   089   TAYSI K               N ENGL J MED                   281  1108 969
   090   WELCH DW              PEDIATR RES                      9   698 975
   091   WIESMANN UN           J PEDIATR                       77   685 970
CT   1   WARD JB               TEX REP BIOL MED                34    83 976
     2   ANON                  BR MED J                         1   596 977
     3   HOSLI P               MONOGR PAEDIATR                 10    90 979
     4   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983

PN 76216
RN 00569 
AN 77060018
AU Mayo-B-J.  Klebe-R-J.  Lankford-B-J.  Morris-N-R.  Barnett-D-R.
   Bowman-B-H.
TI Somatic cell genetic studies of cystic fibrosis.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 107-11.
MJ CYSTIC-FIBROSIS: fg.
MN ANIMAL.  BLOOD-PROTEINS: ip.  CELL-LINE.  CILIA: ph.  CLONE-CELLS.
   CULTURE-MEDIA.  CYSTIC-FIBROSIS: me.  ELECTROPHORESIS-STARCH-GEL.
   GLUCOSEPHOSPHATE-DEHYDROGENASE: an.  HUMAN.  HYBRID-CELLS: en.  MICE.
   OYSTERS.  SUPPORT-U-S-GOVT-P-H-S.
AB The expression of the gene coding for the cystic fibrosis ciliary
   inhibitor has been examined in somatic cell hybrid clonal lines.
   Hybrids were produced by the fusion of cultured skin fibroblasts from
   cystic fibrosis patients with mouse RAG and LM (TK-) cell lines. The
   ciliary inhibitor was detected by the oyster ciliary assay in several
   primary hybrid clones but not detected in others, indicating the
   segregation of an associated nuclear gene.
RF 001   BOLTON WE             AM J HUM GENET                  27   394 975
   002   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   003   BOWMAN BH             SCIENCE                        164   325 969
   004   CONOVER JH            PEDIATR RES                      7   224 973
   005   DANES BS              AM J HUM GENET                  25   323 973
   006   DAVIDSON RL           NATURE                         205  1170 965
   007   KIT S                 EXP CELL RES                    31   297 963
   008   KLEBE RJ              J CELL BIOL                     45    74 970
   009   LITTLEFIELD JW        SCIENCE                        145   709 964
   010   NICHOLS EA            J HISTOCHEM CYTOCHEM            21  1066 973
   011   NYHAN WL              PEDIATR RES                      1     5 967
   012   PUCK RR               J EXP MED                      103   273 956
   013   WEISS MC              PROC NAT ACAD SCI USA           58  1104 967
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   BOAT TF               ACS SYMPOSIUM SERIES          1978   108 978

PN 76217
RN 00570 
AN 77060017
AU Bowman-B-H.  Barnett-D-R.
TI Introduction: Current investigations and theories on the genetic
   defect in cystic fibrosis.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 1-9. (REVIEW).
MJ CYSTIC-FIBROSIS: fg.
MN ANIMAL.  CILIA: ph.  CYSTIC-FIBROSIS: en, me.  GENES.  HUMAN.
   MUCUS:  ph.  RABBITS.  REVIEW.  SUPPORT-U-S-GOVT-P-H-S.
EX Recent research in cystic fibrosis has suggested at least two
   theories regarding the genetic defect underlying this prevalent
   disease: that a mutant gene in cystic fibrosis genotypes is
   responsible for the synthesis of an altered protein that interferes
   with membrane transport and mucociliary activity; and that a mutant
   gene in cystic fibrosis genotypes is responsible for an enzyme
   deficiency leading to the presence of undegraded metabolites that
   interfere with membrane transport.  Circulating factors in cystic
   fibrosis and their effects on membrane transport and mucociliary
   systems are discussed, as are the search for an enzymatic deficiency
   and investigations of altered metabolic pathways.  Comparison of
   somatic cells from cystic fibrosis and normal genotypes is also
   outlined.
RF 001   ARVANITAKIS S         TEX REP BIOL MED                34   175 976
   002   NOUSIA-ARVANITAKIS S  PEDIATR RES                      7   336 973
   003   BALFE JW              SCIENCE                        162   689 968
   004   BARGMAN GJ            TEX REP BIOL MED                34    37 976
   005   BARNETT DR            TEX REP BIOL MED                31   703 973
   006   BARRANCO SC           J CELL PHYSIOL                  88    33 976
   007   BAUR PS               TEX REP BIOL MED                34   155 976
   008   BAUR PS               TEX REP BIOL MED                34   155 976
   009   BERATIS NG            PEDIATR RES                      7   958 973
   010   BOLTON WE             TEX REP BIOL MED                34    97 976
   011   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   012   BOWMAN BH             RECENT ADVANCES IN CF RESEARC   12       976
   013   BOWMAN BH             LANCET                           1   404 974
   014   BOWMAN BH             FED PROC                        31   842 972
   015   BUCHWALD M            AM J HUM GENET                  27   22A 975
   016   CARSON SD             TEX REP BIOL MED                34   209 976
   017   COHEN LF              PEDIATR RES                      9   334 975
   018   COLE CH               PEDIATR RES                      9   763 975
   019   CONOD EJ              PEDIATR RES                      9   724 975
   020   CONOVER JH            LANCET                           2  1501 973
   021   CONOVER JH            TEX REP BIOL MED                34    45 976
   022   CONOVER JH            PEDIATR RES                      7   224 973
   023   DANES BS              TEX REP BIOL MED                34   135 976
   024   DANES BS              J EXP MED                      136  1313 972
   025   DANES BS              J EXP MED                      137  1538 973
   027   GRISHAM CM            BIOCHEMISTRY                    12  2635 973
   028   GURD JW               BIOCHEM J                      122   43P 971
   029   HARPER BL             TEX REP BIOL MED                34    73 976
   030   LIEBERMAN J           AM REV RESPIR DIS              109   399 974
   031   LITT M                TEX REP BIOL MED                34   151 976
   032   MANGOS JA             SCIENCE                        158   135 967
   033   MAYO BJ               TEX REP BIOL MED                34   107 976
   034   NEWHOUSE M            IN: MANGOS JA                        319 973
   035   NOVAK RA              TEX REP BIOL MED                34   199 976
   036   RAO GJS               PEDIATR RES                      9   739 975
   037   RENNERT OM            TEX REP BIOL MED                34   187 976
   039   SANCHIS J             N ENGL J MED                   288   651 973
   040   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   041   SPOCK A               PEDIATR RES                      1   173 967
   042   BOWMAN BH             TEX REP BIOL MED                31   611 973
   043   TOWNES PL             AM J HUM GENET                  27   91A 975
   044   WARD JB JR            TEX REP BIOL MED                34    11 976
   045   WIDNELL CC            PROC NAT ACAD SCI USA           61  1050 968
   046   WILSON GB             TEX REP BIOL MED                34    51 976
   047   WOOD RE               AM REV RESPIR DIS              111   733 975
CT   1   ANON                  BR MED J                         1   596 977
     2   KOLLBERG H            ACTA PAEDIATR SCAND             68   639 979
     3   THOMAS JM             CLIN CHIM ACTA                 111   199 981

PN 76218
RN 00571 
AN 77060028
AU Bargman-G-J.
TI Larval brine shrimp (Nauplii): a potentially useful model to study
   cystic fibrosis.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 37-43.
MJ CYSTIC-FIBROSIS: me.  MODELS-BIOLOGICAL.  SHRIMP: me.
MN ANIMAL.  CYSTIC-FIBROSIS: fg.  ELECTROLYTES: me.
   EXOCRINE-GLANDS:  me.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.  LARVA.
   OXYGEN-CONSUMPTION.  SALIVA: me.
AB One of the most consistent characteristics of cystic fibrosis is the
   abnormal handling of electrolytes by exocrine glands. The present
   study has examined the possibility that diminished respiratory energy
   formation is a primary biochemical error responsible for this
   abnormality. Using oxygen consumption of intact larval brine shrimp,
   quantitative differences have been observed from reaction of mixed
   mouth saliva between CF heterozygotes and CF homozygotes. In
   addition, information demonstrating a correlation between a
   biochemical abnormality and disease severity was observed. The
   differences observed in inhibition by saliva from both CF homozygotes
   and obligate heterozygotes may occur as the result of 1) interference
   with electron transfer from organic fuel molecules to molecular
   oxygen or 2) interference with the mechanism responsible for
   generating the biochemical reducing power necessary for multiple
   biosynthetic reactions.
RF 001   DANES BS              J EXP MED                      129   775 969
   002   CONOVER JH            LANCET                           1  1122 973
   003   LOBECK CC             IN: STANBURY JB                     1605 972
   004   BARGMAN GJ            PEDIATR RES                      8   464 974
   005   CONTE FP              J COMP PHYSIOL                  80   239 972
   006   CONTE FP              J COMP PHYSIOL                  82   277 973
   007   EWING RD              J COMP PHYSIOL                  88   217 974
   008   EWING RD              J COMP PHYSIOL                  80   247 972
   009   HOOTMAN SR            J COMP PHYSIOL                  79    97 972
   010   SHAPIRO SS            BIOMETRICS                      21  1030 965
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   GABRIDGE MG           PEDIATR RES                     13    31 979
     3   JAKEL HP              BIOL ZENTRALBL                  98    55 979

PN 76219
RN 00572 
AN 77060029
AU Conover-J-H.  Conod-E-J.  Hirschhorn-K.
TI On the nature of the defect in cystic fibrosis.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 45-50.
MJ CYSTIC-FIBROSIS: bl.
MN AMNIOTIC-FLUID: me.  ANAPHYLATOXINS: me.  ANIMAL.  BIOLOGICAL-ASSAY.
   CILIA: ph.  COMPLEMENT-3: an.  CYSTIC-FIBROSIS: en, fg.
   FIBROBLASTS:  me.  HUMAN.  IGG: me.  LEUKOCYTES: me.  LYMPHOCYTES: me.
   RABBITS.  SUPPORT-U-S-GOVT-P-H-S.
AB Sera and lymphocyte culture media derived from cystic fibrosis (CF)-
   affected and carrier subjects contain ciliary dyskinesia factor (CDF)
   detected by our rabbit tracheal bioassay. In addition, we also find
   CDF in fibroblast media from these same donors and in amniotic fluid
   cell media derived from CF carrier or affected fetuses. In these
   latter instances, the media were inactive in the bioassay, but became
   active when mixed with purified IgG. In all instances, CDF activity
   was eliminated by the addition of anti-IgG. We have separated a low
   molecular weight fraction, between 1,000 and 10,000 M.W., from CF
   sera and culture media which is inactive in the bioassay until IgG is
   added. Presumptive and indirect evidence indicates that this fraction
   behaves similarly to the complement derived anaphylatoxin C3a. In
   addition, we have found activity in sera from CF patients and, to a
   lesser extent, carriers that induces degranulation of cytochalasin-B-
   treated human polymorphonuclear leukocytes. Since this activity
   appears to be in a different molecular species from that containing
   CDF, we postulate that the primary defect in CF is the deficiency of
   an enzyme whose substrates include a family of membrane-active
   molecules.
RF 001   BERATIS NG            PEDIATR RES                      7   958 973
   002   BLOMFIELD J           GUT                             14   558 973
   004   CONOVER JH            PEDIATR RES                      7   220 973
   005   CONOVER JH            PEDIATR RES                      7   224 973
   006   CONOVER JH            LANCET                           1  1194 973
   007   CONOVER JH            LANCET                           2  1501 973
   008   CONOVER JH            LIFE SCI                        14   253 974
   009   DANKS DM              ANN HUM GENET                   28   323 965
   010   DAVIS AT              PROC SOC EXP BIOL MED          137   161 971
   011   GOLDSTEIN IM          J IMMUNOL                      111    33 973
   012   LOBECK CC             IN: STANBURY JB                     1605 972
   013   MANGOS JA             PEDIATR RES                      1   436 967
   014   MCCOMBS ML            CLIN GENET                       1   171 970
   015   RAO GJS               SCIENCE                        177   610 972
   016   SPOCK A               PEDIATR RES                      1   173 967
   017   VALLOTA EH            J EXP MED                      137  1109 973
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   BOGART BI             PEDIATR RES                     12    15 978
     3   STRAUSS RG            HELV PAEDIATR ACTA              34   429 979
     4   SCHONI M              SCHWEIZ MED WOCHENSCHR         111   658 981
     5   WILSON GB             MED HYPOTHESES                   8   527 982
     6   WOOTEN MW             IN VITRO CELL DEVEL BIOL        21   207 985

PN 76220
RN 00573 
AN 77060030
AU Wilson-G-B.  Fudenberg-H-H.
TI Further purification and characterization of serum proteins used to
   detect cystic fibrosis genotypes by isoelectric focusing.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 51-71.
MJ BLOOD-PROTEINS: ip.  CYSTIC-FIBROSIS: bl.  ISOELECTRIC-FOCUSING.
MN ADOLESCENCE.  ADULT.  CHILD.  CHILD-PRESCHOOL.  CHROMATOGRAPHY-GEL.
   CYSTIC-FIBROSIS: fg.  FEMALE.  GENOTYPE.  HUMAN.  INFANT.  MALE.
   MOLECULAR-WEIGHT.  SUPPORT-U-S-GOVT-P-H-S.
AB Sera from cystic fibrosis (CF) homozygotes and obligate heterozygotes
   contain a CF factor (gamma CF factor) not found by isoelectric
   focusing in thin-layer polyacrylamide gels in most normal control
   sera. In addition, sera from most obligate heterozygotes lack another
   protein (bland B, C, or D) that is commonly found in sera from most
   normal and cystic fibrosis individuals. A standardized, biophysical
   assay is described that employs isoelectric focusing for the
   detection of both CF homozygotes and heterozygotes based on the
   analysis of whole serum for the presence of the gamma CF factor and
   bands B, C, and D. Results of analyzing sera from selected CF
   patients by isoelectric focusing indicated that there is a general
   correlation between the amount of the gamma CF factor and the
   clinical severity of the disease. Partial purification and
   characterization of the gamma CF factor and protein bands B, C,  and
   D was accomplished by using DEAE-cellulose chromatography, Sephadex G-
   200 gel filtration, sequential molecular filtration through a series
   of Amicon Diaflo ultrafiltration membranes, affinity chromatography,
   and cellulose acetate electrophoresis. The gamma CF factor is a
   cationic protein with a pI of 8.46+/-0.05, has gamma electrophoretic
   mobility, a molecular weight between 3,500 and 10,000, and apparently
   exists in CF serum in 2 forms (free in solution and complexed to
   IgG). Bands B, C, and D are cationic proteins with pI values of 7.85
   to 8.10, have gamma electrophoretic mobility and a molecular weight
   of approximately 100,000-150,000.
RF 001   BARNETT DR            PEDIATR RES                      8   687 974
   002   BARNETT DR            TEX REP BIOL MED                31   703 973
   003   BERATIS NG            PEDIATR RES                      7   958 973
   004   BOWMAN BH             IN: MANGOS JA                         29 973
   005   BOWMAN BH             CLIN GENET                       4   461 973
   006   BOWMAN BH             SCIENCE                        167   871 970
   007   CONOVER JH            PEDIATR RES                      7   220 973
   008   CONOVER JH            LANCET                           1    47 975
   009   CONOVER JH            LANCET                           1  1194 973
   010   CONOVER JH            LIFE SCI                        14   253 974
   011   GRAIG LC              IN: WILLIAMS CA                  2   119 968
   012   CUATRECASAS P         PROC NAT ACAD SCI USA           61   636 968
   013   DANES BS              J EXP MED                      137  1538 973
   014   EDER J                J IMMUNOL METH                   2    67 972
   015   FAHEY JL              J IMMUNOL                       94    84 965
   016   FUCHS S               IN: WEIR DM                            1 973
   017   GIBSON LE             PEDIATRICS                      23   545 959
   018   LOCKHART LH           TEX REP BIOL MED                31   631 973
   019   MANCINI G             IMMUNOCHEMISTRY                  2   235 965
   020   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      46  1923 972
   021   SHWACHMAN H           IN: KENDIG EL JR                     541 967
   022   SPOCK A               PEDIATR RES                      1   173 967
   023   WILSON GB             DISSERT ABST INTERNAT           35   479 974
   024   WILSON GB             PEDIATR RES                     10    87 976
   025   WILSON GB             PEDIATR RES                      9   635 975
   026   WILSON GB             CF CLUB ABST                    15     1 974
   027   WILSON GB             CLIN CHIM ACTA                  49    79 973
   028   WILSON GB             CLIN RES                        24   295 976
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   WILSON GB             PEDIATR RES                     11   139 977
     3   WILSON GB             PEDIATR RES                     11   317 977
     4   WILSON GB             PEDIATR RES                     11   986 977
     5   WILSON GB             NATURE                         266   463 977
     6   WILSON GB             PEDIATR RES                     12   801 978
     7   WILSON GB             PEDIATR RES                     13  1079 979
     8   BLITZER MG            PEDIATR RES                     16   938 982
     9   BLITZER MG            PEDIATR RES                     16   203 982
    10   SHAPIRA E             ANN NY ACAD SCI                421   352 983

PN 76221
RN 00574 
AN 77060031
AU Harper-B-L.  Barnett-D-R.  Bissett-J-D.
TI Immunochemical studies of the plasma and cultured fibroblast media
   fractions containing the cystic fibrosis ciliary inhibitor.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 73-82.
MJ CILIA: ph.  CYSTIC-FIBROSIS: me.
MN ANIMAL.  BLOOD-PROTEINS: an.  CULTURE-MEDIA.  CYSTIC-FIBROSIS: bl.
   FIBROBLASTS: me.  HEMAGGLUTINATION-TESTS.  HOMOZYGOTE.  HUMAN.
   IGG:  an.  IMMUNE-SERA.  LIPOPROTEINS-HDL: an.  LIPOPROTEINS-LDL: an.
   RABBITS.  SERUM-ALBUMIN: an.
AB The cystic fibrosis ciliary inhibitor (CFCI) has been fractionated
   from plasma of cystic fibrosis (CF) homozygotes and from the media of
   cultured fibroblasts derived from CF homozygotes. Plasma and
   fibroblast media from normal controls have been fractionated in an
   identical manner. Fractions from plasma and fibroblast culture media
   that demonstrate ciliary inhibitory activity contain several proteins
   in a molecular weight range of approximately 5,000-11,000. These
   proteins have been partially characterized by immunochemical analysis
   with antisera to 33 human serum proteins. Immunological determinants
   of albumin, C3 (but not C3a), C4, C5, alpha1-lipoprotein, beta-
   lipoprotein, beta2-microglobulin and immunoglobulin light chains have
   been detected by hemagglutination in fractions of CF plasma that
   inhibited ciliary activity and in analogous fractions from normal
   sera. None of the proteins were detected in media of cultured
   fibroblasts from either genotype. Since the same proteins and protein
   fragments were identified in both CF and normal plasma fractions, and
   were not detected in CF fibroblast media, it appears that none of
   these proteins can be identified as the CFCI. Identification of these
   proteins will permit further purification of the CFCI by
   immunochemical methods.
RF 001   AOKI K                BIOCHEMISTRY                    14  3566 975
   002   BARNETT DR            PEDIATR RES                      8   687 974
   003   BARNETT DR            TEX REP BIOL MED                31   703 973
   004   BARNETT DR            CF CLUB ABST                           5 974
   005   BARNETT DR            TEX REP BIOL MED                31   709 973
   006   BELLON F              BIOCHEM J                      147   585 975
   007   BERATIS NG            PEDIATR RES                      7   958 973
   008   BOLTON WE             AM J HUM GENET                  27   394 975
   009   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   010   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   011   BOWMAN BH             SCIENCE                        164   325 969
   012   BOWMAN BH             SCIENCE                        167   871 970
   013   CARSON SD             TEX REP BIOL MED                34   209 976
   014   CONOD EJ              PEDIATR RES                      9   724 975
   015   CONOVER JH            LANCET                           2  1501 973
   016   CONOVER JH            LIFE SCI                        14   253 974
   017   CUNNINGHAM BA         BIOCHEMISTRY                    12  4811 973
   018   DANES BS              J EXP MED                      137  1538 973
   019   JOUSTRA M             PROTIDES BIOL FLUIDS            17   511 969
   020   LACHMAN PJ            IN: WEIR DM                              973
   021   LIEBERMAN J           AM REV RESPIR DIS              111   100 975
   022   ONKELINX E            IMMUNOLOGY                      16    35 969
   023   PETERS T JR           ADV CLIN CHEM                   13    37 970
   024   PERPER RJ             PROC SOC EXP BIOL MED          125   575 967
   025   SCANLIN TF JR         LANCET                           1  1382 974
   026   WILSON WD             BIOCHEMISTRY                    10  1772 971
   027   WEIR DM               HANDBOOK OF EXPERIMENTAL IMMU            973
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   CARSON SD             TEX REP BIOL MED                34   209 976
     3   BURDON MG             CLIN GENET                      17   249 980
     4   BOWMAN BH             FED PROC                        39  3195 980
     5   CARSON SD             BIOCHIM BIOPHYS ACTA           667    23 981
     6   CARSON SD             PEDIATR RES                     16    13 982

PN 76222
RN 00575 
AN 77060032
AU Ward-J-B-Jr.  Bowman-B-H.
TI Surface enzymes in cultured fibroblasts from cystic fibrosis
   patients.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 83-96.
MJ CYSTIC-FIBROSIS: en.
MN ADENOSINE-MONOPHOSPHATE.  ADENOSINE-TRIPHOSPHATASE: an.  ANIMAL.
   CELL-FRACTIONATION.  FIBROBLASTS: en.
   GLUCOSEPHOSPHATE-DEHYDROGENASE: an.  HUMAN.
   NITROPHENYL-PHOSPHATASE:  an.  OYSTERS.  PHOSPHATASES: an.
   SUPPORT-U-S-GOVT-P-H-S.
AB Membrane function was examined in cultured cells from cystic fibrosis
   patients by assaying several enzymes on intact skin fibroblasts
   attached to culture dishes. This technique required few cells and
   minimized disruption of cellular organization. Comparison of enzyme
   activities of intact and broken cells showed that 12% of total
   glucose-6-phosphate dehydrogenase, a cytoplasmic enzyme, was
   measurable using intact cells, while all adenosine monophosphatase
   was measurable using intact cells. Alkaline
   paranitrophenylphosphatase activity was divided between the cell
   surface and interior. Substrate competition experiments indicated
   that substrate specificities for adenosine monophosphatase and
   paranitrophenylphosphatase activities were different. Adenosine
   monophosphatase activities of 2 control and 2 cystic fibrosis strains
   fluctuated similarly during the cell culture cycle. The apparent Km
   values relative to adenosine monophosphate were similar in all
   strains. A chromatographic fraction of serum from a cystic fibrosis
   patient that was inhibitory to oyster ciliary activity had no effect
   on adenosine monophosphatase activity of normal fibroblasts.
   Furthermore, fractions of media from cystic fibrosis homozygote and
   heterozygote fibroblast cultures were not inhibitory to adenosine
   monophosphatase activities of intact normal fibroblasts or of part
   iculate fractions prepared from them. In light of previous studies
   that showed that factors from cystic fibrosis serum of culture medium
   disrupted specific membrane activities, it is proposed that the
   cystic fibrosis factor interacts with the plasma membrane,
   interfering most conspicuously with the protein functions that are
   sensitive to changes in their membrane environment.
RF 001   BERATIS NG            PEDIATR RES                      7   958 973
   002   BARNETT DR            TEX REP BIOL MED                31   703 973
   003   BOLTON WE             AM J HUM GENET                  27   394 975
   004   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   005   BOWMAN BH             BIOCHEM BIOPHYS RES COMMUN      64  1310 975
   006   BOWMAN BH             SCIENCE                        164   325 969
   007   BOWMAN BH             SCIENCE                        167   871 970
   008   BUTLER KW             BIOCHEM BIOPHYS RES COMMUN      40   770 970
   009   CUATRECASAS P         ANNU REV BIOCHEM                43   169 974
   010   DANES BS              J EXP MED                      129   775 969
   011   DANES BS              J EXP MED                      136  1313 972
   012   DEPIERRE J            IN: LEPOW IH                          55 972
   013   DEPIERRE JW           SCIENCE                        183  1096 974
   014   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   015   EDIDIN M              SYMP SOC EXP BIOL               28     1 974
   016   FISKE CH              J BIOL CHEM                     66   375 925
   017   GRISHAM CM            BIOCHEMISTRY                    12  2635 973
   018   GURD JW               BIOCHEM J                      122   43P 971
   019   HAM RG                EXP CELL RES                    29   515 963
   020   JOHANSEN PG           LANCET                           1   455 968
   021   LOWRY OH              J BIOL CHEM                    193   265 951
   022   MANGOS JA             SCIENCE                        158   135 967
   023   MANGOS JA             PEDIATR RES                      2   378 968
   024   MANGOS JA             PEDIATR RES                      1   436 967
   025   PLAGEMANN PGW         BIOCHIM BIOPHYS ACTA           344   263 974
   026   SCHMOYER IR           BIOCHEM BIOPHYS RES COMMUN      58  1066 974
   027   SHEPPARD JR           J CELL PHYSIOL                  85   163 975
   028   SINGER SJ             SCIENCE                        175   720 972
   029   TENNEY SR             ARCH BIOCHEM BIOPHYS           126    53 968
   030   WARD JB JR            TEX REP BIOL MED                34    11 976
   031   WIDNELL CC            PROC NAT ACAD SCI USA           61  1050 968
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976

PN 76223
RN 00576 
AN 77060033
AU Bolton-W-E.  Barranco-S-C.
TI Review of the growth characteristics of cystic fibrosis and normal
   human diploid fibroblasts in vitro.
SO Tex-Rep-Biol-Med. 1976. 34(1). P 97-105.
MJ CYSTIC-FIBROSIS: pa.
MN CELL-DIVISION.  CELL-LINE.  DIPLOIDY.  FIBROBLASTS: pa.
   HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.  KINETICS.  MODELS-BIOLOGICAL.
   TIME-FACTORS.  SUPPORT-U-S-GOVT-P-H-S.
AB The growth kinetics of human diploid skin fibroblasts derived from
   cystic fibrosis (CF) homozygotes, CF heterozygotes and normal
   individuals was determined. The population doubling times increased
   with time in culture, and no difference was observed between the 3
   genotypes tested. The cell cycle times remained constant through the
   10th subculture, while the growth fraction, or fraction of cells in
   the cell cycle, decreased with culture time; however, changes in the
   growth fraction and population doubling time appear to be related to
   cellular senescence in vitro rather than to cystic fibrosis.
RF 001   BARRANCO SC           CANCER RES                      33   691 973
   002   BARRANCO SC           CANCER RES                      35  1194 975
   003   BARNETT DR            TEX REP BIOL MED                31   691 973
   004   BESLEY GTN            J MED GENET                      6   278 969
   005   BOLTON WE             AM J HUM GENET                  27   394 975
   006   BOWMAN BH             PROC NAT ACAD SCI USA           70   548 973
   007   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969
   008   DANES BS              J EXP MED                      136  1313 972
   009   DELLORCO RT           EXP CELL RES                    84   363 974
   010   DELLORCO RT           EXP CELL RES                    77   356 973
   011   GOLDSTEIN S           EXP CELL RES                    88   359 974
   012   HAM RG                EXP CELL RES                    29   515 963
   013   HAY RJ                ADV GERONTOL RES                 2   121 967
   014   HAY RJ                EXP GERONTOL                     3    35 968
   015   HAYFLICK L            EXP CELL RES                    37   614 965
   016   HAYFLICK L            EXP CELL RES                    25   585 961
   017   HAYFLICK L            EXP GERONTOL                     5   291 970
   018   HODES ME              PEDIATR RES                      8   212 974
   019   HOUCK JC              PROC SOC EXP BIOL MED          147   167 974
   020   HOWARD A              HEREDITY SUPPL                   6   261 953
   021   KLAGSBRUN M           PEDIATR RES                      8   205 974
   022   MACIEIRA-COELHO A     EXP CELL RES                    42   673 966
   023   MCHALE JS             EXP GERONTOL                     6    89 971
   024   MENDELSOHN ML         J NATL CANCER INST              28  1015 962
   025   PUCK TT               J EXP MED                      106   145 957
   026   REED GB               J PATHOL                       101   251 970
   027   RENNERT OM            CLIN PEDIATR                    11   351 972
   028   RUSSELL SB            J MED GENET                      8   441 971
   029   SPOCK A               PEDIATR RES                      1   173 967
   030   TAYSI K               N ENGL J MED                   281  1108 969
CT   1   BOWMAN BH             TEX REP BIOL MED                34     1 976
     2   WARD JB               TEX REP BIOL MED                34    11 976
     3   FEIGAL RJ             PEDIATR RES                     13   764 979

PN 76224
RN 00577 
AN 77105326
AU Clarke-C-W.
TI Aspects of serum and sputum antibody in chronic airways obstruction.
SO Thorax. 1976 Dec. 31(6). P 702-7.
MJ AIRWAY-OBSTRUCTION: im.  ANTIBODIES: an.  SPUTUM: im.
MN BRONCHITIS: im.  CHRONIC-DISEASE.  CYSTIC-FIBROSIS: im.  HUMAN.
   IGA:  an.  IGG: an.  IGM: an.  SPUTUM: mi.
AB Immunoglobulin levels and precipitating antibody against a range of
   microbial antigens were measured in simultaneously collected serum
   and sputum samples from patients with chronic bronchitis (11), cystic
   fibrosis (9), bronchiectasis (9), and asthma (4). Sputum was prepared
   by dialysis and high-speed centrifugation methods. Results showed
   that it was possible to detect precipitating antibody in the sputum,
   and the rate was increased when both methods were used. A discrepancy
   was noted between the detection rate in the sputum and serum. This,
   combined with the lack of correlation between sputum and serum
   immunoglobulins, lack of relationship between bronchial inflammation
   and sputum immunoglobulins, and the lack of IgM in the sputum
   suggested that the antibody and immunoglobulin were locally produced.
   Sputum IgA (7S) in patients with chronic bronchitis was significantly
   lower (P less than 0-05) than that found in patients with cystic
   fibrosis and bronchiectasis. Significant differences (P less than 0-
   05) were also noted in serum IgG levels between patients with chronic
   bronchitis, bronchiectasis, and cystic fibrosis while serum IgM
   levels in patients with chronic bronchitis were significantly lower
   (P less than 0-05) when compared to serum levels in patients with
   cystic fibrosis. The presence of precipitating antibody in the sputum
   raises the possibility that type III reactions may be important in
   the pathogenesis of these conditions.
RF 001   AUSTRIAN R            YALE J BIOL MED                 40   400 968
   002   BIBERFELD G           ACTA PATH MICROBIOL SCAND (B)   79   599 971
   003   BRANEFORS-HELANDER P  ARCH ALLERG APPL IMMUN          44   585 973
   004   BROCKLEHURST WE       IN: ORIE NGM                         279 970
   005   BROGAN TD             THORAX                          30    72 975
   006   BRUMFITT W            LANCET                           2  1306 957
   007   CLARKE CW             POSTGRAD MED J                  51   147 975
   008   COLTON T              STATISTICS IN MEDICINE               174 974
   009   DEUSCHL H             CLIN EXP IMMUNOL                16   401 974
   010   FALK GA               AM REV RESPIR DIS              105    14 972
   011   GOTZE O               J EXP MED                      134   90S 971
   012   GUMP DW               ARCH INTERN MED                132   847 973
   013   KATZ RM               N ENGL J MED                   288   233 973
   014$  KILBURN KH            CHEST SUPPL 61S                 65     4 974
   015   LEES AW               LANCET                           2  1112 959
   016   MCFARLANE H           BR MED J                         1   423 975
   017   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
   018   MAY JR                CHEMOTHERAPY OF CHRONIC BRONC            972
   019   MAY JR                POSTGRAD MED J                  51   144 975
   020   MEDICI TC             AM REV RESPIR DIS              103   784 971
   021   MEREDITH WM           BASIC MATHEMATICAL AND STATIS        288 967
   022   PARISH WE             SYMP SOC GEN MICROBIOL          22   157 972
   023   REED CE               YALE J BIOL MED                 40   507 968
   024   RYLEY HC              BR J EXP PATHOL                 49   625 968
   025   RYLEY HC              J CLIN PATHOL                   26   852 973
   026   SHORE SL              THORAX                          28   721 973
   027   SMITH H               SYMP SOC GEN MICROBIOL          22     1 972
   028   SZETIVANYI I          IN: SAMTER M                     1   356 971
   029   TAGER I               N ENGL J MED                   292   563 975
   030   VAN DER ZAWAN JC      CLIN ALLERGY                     5   225 975
   031   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   032   WARREN CPW            AM REV RESPIR DIS              109   672 974
   033   WITTELS EH            AM REV RESPIR DIS              109   502 974
CT   1   CLARKE CW             CLIN ALLERGY                     7   527 977
     2   TURNBULL LS           CLIN EXP IMMUNOL                32   226 978
     3   NASH DR               ANN CLIN RES                    11    49 979
     4   PALUCH E              INT J CANCER                    23    42 979
     5   MAYANSKY AN           ZH MIKROBIO EPIDEMIO IMMUNOBI 1979    14 979
     6   STOCKLEY RA           THORAX                          35   202 980
     7   STOCKLEY RA           J IMMUNOL METH                  38   151 980
     8   STOCKLEY RA           AM REV RESPIR DIS              122   959 980
     9   PUCHELLE E            BIORHEOLOGY                     18   659 981
    10   CLARKE CW             THORAX                          36   665 981
    11   PRYJMA J              ANN ALLERGY                     54    60 985

PN 76225
RN 00578 
AN 76154742
AU Kerr-A-A.
TI Dead space ventilation in normal children and children with
   obstructive airways diease.
SO Thorax. 1976 Feb. 31(1). P 63-9.
MJ AIRWAY-OBSTRUCTION: pp.  RESPIRATORY-DEAD-SPACE.
MN ADOLESCENCE.  ASTHMA: pp.  BODY-HEIGHT.  CARBON-DIOXIDE: an.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: pp.  HUMAN.  INSPIRATORY-CAPACITY.
   LUNG: ph, pp.  RESPIRATORY-FUNCTION-TESTS: mt.  TIDAL-VOLUME.
AB Anatomical dead space was measured in 72 normal children aged from 5
   to 16 years, using the single breath method. There was a linear
   increase in this measurement with height, weight, and end-inspiratory
   lung volume. Physiological dead space was measured in 52 normal
   children using the Bohr equation and substituting a rebreathing PCO2
   for alveolar PCO2. There was a parallel increase in this measurement
   with height, weight, and end-inspiratory lung volume. The difference
   between the two dead space measurements constitutes the alveolar dead
   space and was constant over the whole age range at 45 +/- 22 ml. The
   ratio of physiological dead space to tidal volume was 33-6 +/-4-6%
   and was unaltered by age or change in lung volume. The effect of
   airways obstruction on the dead space volumes was studied in 36
   children with asthma and 28 with cystic fibrosis. Physiological dead
   space increased with increasing airways obstruction. Anatomical dead
   space remained constant in spite of marked increases in lung volume
   associated with the airways obstruction.
RF 001   BARTELS J             J CLIN INVEST                   33    41 954
   002   BEAUDRY PH            AM REV RESPIR DIS               95   248 967
   003   BODIAN M              FIBROCYSTIC DIS OF THE PANCRE            952
   004   COLLIER CR            J APPL PHYSIOL                   9    25 956
   005   COMROE JH JR          LUNG CLINICAL PHYSIOLOGY AND             962
   006   COOK CD               J CLIN INVEST                   34   975 955
   007   COOK CD               IN: SMITH RM                          32 968
   008   DOWNES JJ             PEDIATR CLIN NORTH AM           19   423 972
   009   DUBOIS AB             J CLIN INVEST                   35   322 956
   010   FOWLER WS             AM J PHYSIOL                   154   405 948
   011   HARRIS EA             CLIN SCI MOL MED                15   375 973
   012   HART MC               J APPL PHYSIOL                  18   519 963
   013   LEVINE G              N ENGL J MED                   282  1277 970
   014   LEVISON H             AM REV RESPIR DIS              101   972 970
   015   LIFSHAY A             J APPL PHYSIOL                  31   478 971
   016   MCEVOY JDS            BR MED J                         4   687 974
   017   MELLEMGAARD K         ACTA PHYSIOL SCAND              67    10 966
   018   NELSON NM             PEDIATRICS                      30   963 962
   019   OLSEN CR              J APPL PHYSIOL                  23    27 967
   020   POLGAR G              PULMONARY FUNCTION TESTING IN            971
   021   RADFORD EP JR         J APPL PHYSIOL                   7   451 955
   022   RAINE JM              J APPL PHYSIOL                  18   284 963
   023   ROBINSON S            ARBEITSPHYSIOLOGIE              10   251 938
   024   SHEPARD RH            J APPL PHYSIOL                  18   284 957
   025   STRANG LB             CLIN SCI                        21   107 961
   026   YOUNG AC              J APPL PHYSIOL                   8    91 955
CT   1   SWINSCOW TDV          BR MED J                         2   680 976
     2   HANCOX AJ             MED BIOL ENG COMPUT             20    58 982
     3   REISER J              PEDIATR PULMONOL                 2   237 986

PN 76226
RN 00579 
AN 77060072
AU Matthay-M-A.  Matthay-R-A.  Mills-D-M.  Lakshminarayan-S.  Cotton-E.
TI Hypertrophic osteoarthropathy in adults with cystic fibrosis.
SO Thorax. 1976 Oct. 31(5). P 572-5.
MJ CYSTIC-FIBROSIS: co.  OSTEOARTHROPATHY-SECONDARY-HYPERTROPHIC: di.
MN ADULT.  ARTHRITIS: di.  CASE-REPORT.  CYSTIC-FIBROSIS: ra.
   DIAGNOSIS-DIFFERENTIAL.  FIBULA: ra.  HUMAN.  MALE.
   OSTEOARTHROPATHY-SECONDARY-HYPERTROPHIC: ra.  TIBIA: ra.
AB Three adult patients with cystic fibrosis presented with arthralgia,
   and investigation for the usual causes of arthritis proved negative.
   Radiographs of long bones revealed periostitis and new bone fromation
   characteristic of hypertrophic osteoarthropathy. Symptomatic
   improvement occurred after analgesic and anti-inflammatory therapy.
   In patients with cystic fibrosis and bone or joint pain, the
   diagnosis of hypertrophic osteoarthropathy should be considered and
   long bone radiographs obtained.
RF 001   BAMBERGER E           WIEN KLIN WOCHENSCHR             2   226 889
   002   COATES EO JR          DIS CHEST                       49   195 966
   003   FISCHER DS            MEDICINE                        43   459 956
   004   GOODMAN DH            ANN ALLERGY                     25   224 967
   005   GROSSMAN H            AM J DIS CHILD                 107     1 964
   006   HAMMARSTEN JF         ARCH INTERN MED                 99   421 957
   007   JONES JD              MAYO CLIN PROC                  45   768 970
   008   KOPEL FB              GASTROENTEROLOGY                62   483 972
   009   MARIE P               REV MEDEC                       10     1 890
   010   SHAPIRO RF            CHEST                           63   912 972
   011   STANLEY NN            BR HEART J                      33   469 971
   012   TREVER RW             ANN INTERN MED                  48   660 958
CT   1   ANON                  BR MED J                         2   785 977
     2   SAGRANSKY DM          AM J DIS CHILD                 134   319 980
     3   DELUMLEY L            ARCH FR PEDIATR                 40   723 983
     4   BRADFORD R            BR J DIS CHEST                  78   275 984
     5   BRAUDE S              BR MED J                       288   822 984
     6   RUSH PJ               SEM ARTHRITIS RHEUM             15   213 986
     7   SUMMERS GD            BR J RHEUMATOL                  25   393 986
     8   PHILLIPS BM           J ROY SOC MED                   79    44 986
     9   COHEN AM              AM J DIS CHILD                 140    74 986

PN 76227
RN 00580 
AN 76272091
AU Islam-N.
TI The differential diagnosis of bronchial asthma in children.
SO Trop-Doct. 1976 Jul. 6(3). P 105-7.
MJ ASTHMA: di.
MN ACUTE-DISEASE.  BRONCHIOLITIS-VIRAL: di.  BRONCHITIS: di.
   BRONCHOGRAPHY.  CHILD.  CYSTIC-FIBROSIS: di.  DIAGNOSIS-DIFFERENTIAL.
   FOREIGN-BODIES: ra.  HELMINTHIASIS: di.  HUMAN.
   PERIARTERITIS-NODOSA: di.  TUBERCULOSIS-PULMONARY: di.
AB Bronchial asthma in children is not uncommon in the tropics.
   Conditions simulating this disease in the tropics have been discussed
   with a view to arriving at a diagnosis without sophisticated
   investigations.
RF 001   HASAN M               DISSERTATION                             975
   002   ISLAM N               TROPICAL EOSINOPHILIA                 96 964
   003   MOSLER                CITED IN: LEUCKART R             2   222 876
   004   TULLIS DCH            N ENGL J MED                   282   370 970

PN 76228
RN 00581 
AN 77129620
AU Bieri-J-G.  Farrell-P-M.
TI Vitamin E.
SO Vitam-Horm. 1976. 34. P 31-75. (REVIEW).
MJ VITAMIN-E: me.
MN ANIMAL.  ANTIOXIDANTS: me.  BLOOD-COAGULATION.  CORONARY-DISEASE: me.
   CYSTIC-FIBROSIS: me.  DIET.  DIETARY-FATS: me.  ERYTHROCYTES: me.
   FATTY-ACIDS-UNSATURATED: me.  HEMOGLOBINS: me.  HUMAN.
   INFANT-NEWBORN.  INFANT-PREMATURE.  LIPOPROTEINS: me.  LYMPH: me.
   MALABSORPTION-SYNDROMES: me.  PROTEIN-CALORIE-MALNUTRITION: me.
   PROTEINS: bi.  RETROLENTAL-FIBROPLASIA: me.  REVIEW.
   CELIAC-DISEASE:  me.  VITAMIN-E-DEFICIENCY: me, th.  VITAMIN-E: tu.
EX In this review, we make a deliberate attempt to put all the
   information on vitamin E requirement, absorption, metabolism, and
   function in both animals and man in better perspective.  The large
   clinical trials in which vitamin E was given at pharmacological
   levels for presumed medical indications, as well as trials of vitamin
   E for bona fide deficiency disease in man, will be extensively
   reviewed.  Nutritional aspects discussed include dietary intake,
   biological activity, the evaluation of nutritional status, and the
   relationship to dietary polyunsaturated fatty acids.  Metabolism
   concerns include absorption, transport and deposition, and cellular
   function.  Clinical aspects include deficiency states, approaches to
   therapy, and possible pharmacological effects.
RF 001   ABRAMS AA             N ENGL J MED                   272  1080 965
   002   ABRAMS BA             ARCH DIS CHILD                  48   721 973
   003   ANDERSON TW           CAN MED ASSOC J                110   401 974
   004   ANDERSON TW           AM J CLIN NUTR                  27  1174 974
   005   ARMSTRONG D           AM NEUROL ASSOC                 98     3 973
   006   BAER S                JAMA                           139   733 949
   007   BAKER SJ              BLOOD                           32   717 968
   008   BARNESS LA            AM J CLIN NUTR                  21    40 968
   009   BASSEN FA             BLOOD                            5   381 950
   010   BAUERNFEIND JC        AM J CLIN NUTR                  27   234 974
   011   BIERI JG              IN: DE LUCA HF                       307 969
   012   BIERI JG              ANN NY ACAD SCI                203   181 972
   013   BIERI JG              J AM DIET ASSOC                 62   147 973
   014   BIERI JG              FED PROC                        34   913 975
   015   BIERI JG              PROC SOC EXP BIOL MED          149   500 975
   016   BIERI JG              J AM DIET ASSOC                 66   134 975
   017   BIERI JG              J NUTR                         100   557 970
   018   BIERI JG              INT J VITAM RES                 40   344 970
   019   BIERI JG              PROC SOC EXP BIOL MED          120   554 965
   020   BIERI JG              PROC SOC EXP BIOL MED          117   131 964
   021   BIERI JG              J NUTR                         106   124 976
   022   BINDER HJ             N ENGL J MED                   273  1289 965
   023   BLANC WA              PEDIATRICS                      22   494 958
   024   BLOMSTRAND R          INT J VITAM RES                 38   328 968
   025   BOYD AM               J BONE JOINT SURG              31B   325 949
   026   BRUBACHER G           WISS VEROEFF DTSCH GES ERNAEH   16    50 967
   027   BUNNELL RH            AM J CLIN NUTR                  17     1 965
   028   BUNYAN J              BIOCHEM J                       77    47 960
   029   BURK RF               US ARMY MED RES NUTR LAB REP   335       973
   030$  CANTAROW A            CLIN BIOCHEM                         180 962
   031   CATIGNANI GL          BIOCHEM BIOPHYS RES COMMUN      67    66 975
   032   CATIGNANI GL          IN: MACHLIN LJ                           976
   033   CATIGNANI GL          PROC NAT ACAD SCI USA           71  1966 974
   034   CHADD MA              INT J VITAM RES                 40   610 970
   035   CHEEKE PR             CAN J ANIM SCI                  49   169 969
   036   CURETON TK            AM J PHYSIOL                   179   628 954
   037   CURRAN JS             PEDIATR RES                      9   364 975
   038   DAM H                 VITAM HORM                      20   527 962
   039   DARBY CW              ARCH DIS CHILD                  48    72 973
   040   DARBY WJ              PROC SOC EXP BIOL MED           63   310 946
   041   DARBY WJ              ANN NY ACAD SCI                 52   328 949
   042   DAVIES T              CLIN CHIM ACTA                  24   431 969
   043   DAVIS KC              AM J CLIN NUTR                  25   933 972
   044   DE LEON AS            PEDIATR CLIN NORTH AM           17   309 970
   045   DE VILLERS A          CAN J BIOCHEM                   51   450 973
   046   DICKS-BUSHNELL MW     AM J CLIN NUTR                  20   262 967
   047   DILLEY RA             J MEMBR BIOL                     2   317 970
   048   DINNING JS            VITAM HORM                      20   511 962
   049   DIPLOCK AT            AM J CLIN NUTR                  27   995 974
   050   DI SANTAGNESE PA      N ENGL J MED                   277  1399 967
   051   EVARTS RP             LIPIDS                           9   860 974
   052   FARRELL PM            AM J CLIN NUTR                  28  1381 975
   053   FARRELL PM            ACTA PAEDIATR SCAND             64   150 975
   054   FERGUSON ME           J NUTR                          55   205 955
   055   FILER LJ JR           AM J CLIN NUTR                  21     3 968
   056   FILER LJ JR           PEDIATRICS                       8   328 951
   057   ANON                  RECOMMENDED DIETARY ALLOWANCE            968
   058   ANON                  RECOMMENDED DIETARY ALLOWANCE            974
   059   FUKUBA H              IN: SHIMAZONO N                       63 972
   060   FUKUBA H              PROC SYMP ON INFLUENCE OF ENV            975
   061   GALLO-TORRES HE       LIPIDS                           5   379 970
   062   GLOOR U               HELV CHIM ACTA                  49  2303 966
   063   GOLDBLOOM RB          CAN MED ASSOC J                 82  1114 960
   064   GOLDBLOOM RB          PEDIATRICS                      32    36 963
   065   GORDON HH             AM J DIS CHILD                  62   328 941
   066   GORDON HH             IN: WOHL MG                          238 968
   067   GORDON HH             AM J DIS CHILD                  90   669 955
   068   GORDON HH             PEDIATRICS                      21   673 958
   069   GROSS S               ANN NY ACAD SCI                203   141 972
   070   HAEGER K              VASA                             2   280 973
   071   HAEGER K              AM J CLIN NUTR                  27  1179 974
   072   HALSTEAD CH           AM J CLIN NUTR                  22  1371 969
   073   HAMILTON M            LANCET                           1   367 953
   074   HARRIES JT            ARCH DIS CHILD                  46   341 971
   075   HARRIS PL             PROC SOC EXP BIOL MED          107   381 961
   076   HARRIS RS             VITAM HORM                      20   603 962
   077   HASHIM SA             AM J CLIN NUTR                  21     7 968
   078   HASSAN H              AM J CLIN NUTR                  19   147 966
   079   HERTING DC            AM J CLIN NUTR                  22   147 969
   080   HODGES RE             J AM DIET ASSOC                 62   638 973
   081   HOEKSTRA WG           FED PROC FED AM SOC EXP BIOL    34  2083 975
   082   HORWITT MK            AM J CLIN NUTR                   8   451 960
   083   HORWITT MK            VITAM HORM                      20   541 962
   084   HORWITT MK            AM J CLIN NUTR                  27  1182 974
   085   HORWITT MK            VITAM HORM                      26   487 968
   086   HORWITT MK            ANN NY ACAD SCI                203   223 972
   087   HYMAN CB              ANN NY ACAD SCI                232   211 974
   088   IKEHATA H             VITAMINS                        38   253 968
   089   JAGER FC              ANN NY ACAD SCI                203   199 972
   090   JOHNSON L             AM J CLIN NUTR                  27  1158 974
   091   JOHNSON P             LIFE SCI                         1   115 962
   092   KANNO C               AGRIC BIOL CHEM                 34   878 970
   093   KATER RMH             AM J CLIN NUTR                  23   913 970
   094   KATTWINKEL J          J PEDIATR                       82   234 973
   095   KAYDEN HJ             ANNU REV MED                    23   285 972
   096   KAYDEN HJ             TRANS ASSOC AM PHYSICIANS       78   334 965
   097   KELLEHER J            BR J NUTR                       24  1033 970
   098   KERNER I              AM J DIS CHILD                  99   597 960
   099   KINSEY VE             ARCH OPHTHALMOL                 56   481 956
   100   KINSEY VE             AM J OPHTHALMOL                 34  1259 951
   101   KLATSKIN G            J CLIN INVEST                   31   159 952
   102   KULAPONGS P           IN: OLSON RE                         263 975
   103   LARSSON H             PHARMACOL CLIN                   1    72 968
   104   LEONARD PJ            AM J CLIN NUTR                  20   795 967
   105   LEONARD PJ            AM J CLIN NUTR                  24   388 971
   106   LEONARD PJ            GUT                              7   578 966
   107   LEVIN S               PEDIATRICS                      27   578 961
   108   LIVINGSTONE PD        LANCET                           2   602 958
   109   LO SS                 ARCH DIS CHILD                  48   360 973
   110   LOSOWSKY MS           ANN NY ACAD SCI                203   212 972
   111   LUCY JA               ANN NY ACAD SCI                203     4 972
   112   MCCORMICK EC          J LIPID RES                      1   221 960
   113   MACDOUGALL LG         J PEDIATR                       80   775 972
   114   MACHLIN LF            PROC SOC EXP BIOL MED          149   275 975
   115   MACKENZIE JB          PEDIATRICS                      13   346 954
   116   MCLAREN DS            AM J CLIN NUTR                  22   863 969
   117   MACMAHON MT           CLIN SCI                        38   197 970
   118   MACMAHON MT           EUR J CLIN INVEST                1   161 970
   119   MACMAHON MT           EUR J CLIN INVEST                1   288 970
   120   MCWHIRTER WR          ACTA PAEDIATR SCAND             64   446 975
   121   MAJAJ AS              AM J CLIN NUTR                  12   374 963
   122   MARKS J               VITAM HORM                      20   573 962
   123   MASON KE              IN: SEBRELL WH JR                5   293 972
   124   MELHORN DK            J LAB CLIN MED                  74   798 969
   125   MELHORN DK            J PEDIATR                       79   581 971
   126   MELHORN DK            BLOOD                           37   438 971
   127   MELLORS A             BR J NUTR                       20    69 966
   128   MENGEL CE             J CLIN INVEST                   46  1715 967
   129   MINOT AS              J LAB CLIN MED                  29   772 944
   130   MODELL CB             BR MED J                         3   259 974
   131   MOLENAAR I            PROC NAT ACAD SCI USA           61   982 969
   132   MOLENAAR I            VITAM HORM                      30    45 972
   133   MOYER WT              PEDIATRICS                       6   893 950
   134   MULLER DPR            BIOCHEM J                      112   28P 969
   135   MULLER DPR            GUT                             15   966 974
   136   MUNSAT TL             JAMA                           226  1536 973
   137   MUSTAJOKI P           JAMA                           221   714 972
   138   NAIR PP               ARCH INTERN MED                128   411 971
   139   NEWMARK HL            J PHARM SCI                     64   655 975
   140   NITOWSKY HM           AM J DIS CHILD                  92   164 956
   141   NITOWSKY HM           AM J CLIN NUTR                  10   368 962
   142   NORDOY A              J LIPID RES                     16   386 975
   143   ANON                  NUTRITION SURVEY OF EAST PAKI            966
   144   OLSON RE              AM J CLIN NUTR                  20   604 967
   145   OLSON RE              CIRCULATION                     48   179 973
   146   OLSON RE              AM J CLIN NUTR                  27  1117 974
   147   OLSON RE              IN: OLSON RE                         275 975
   148   OPPENHEIMER EH        BULL JOHNS HOPKINS HOSP         98   353 956
   149   OSKI FA               J PEDIATR                       70   211 967
   150   OSKI FA               AM J CLIN NUTR                  21    45 968
   151   OSKI FA               HEMATOLOGIC PROBLEMS IN THE N            972
   152   OWENS WC              AM J OPHTHALMOL                 32     1 949
   153   PANOS TC              AM J CLIN NUTR                  21    15 968
   154   PATNAIK RN            EXPERIENTIA                     31  1023 975
   155   PEAKE IR              BIOCHIM BIOPHYS ACTA           260   679 972
   156   PEARSON CK            BR J NUTR                       24   581 970
   157   POUKKA RKH            LIPIDS                           5   757 970
   158   RAJARAM OV            BIOCHEM J                      140   509 974
   159   RAMIREZ I             AM J CLIN NUTR                  26  1045 973
   160   RATCLIFFE AH          LANCET                           2  1128 949
   161   RAVIN IS              N ENGL J MED                   240   331 949
   162   RICHARDS JE           PEDIATRICS                      20    92 957
   163   RINZLER SH            CIRCULATION                      1   288 950
   164   ROSE CS               AM J PHYSIOL                   168   414 952
   165   RUBINSTEIN HM         CLIN CHIM ACTA                  23     1 968
   166   SANDSTEAD HH          AM J CLIN NUTR                  17    27 965
   167   SARTAIN P             SOUTH MED J                     60  1371 967
   168   SCHMANDKE H           INT Z VITAMINFORSCH             34   312 964
   169   SCRIMSHAW NS          JAMA                           164   555 957
   170   SCRIVER CR            PEDIATRICS                      46   493 970
   171   SHARMAN IM            BR J NUTR                       26   265 971
   172   SHUTE WE              MED REC                        160    91 947
   173   SILBER R              J CLIN INVEST                   48  2089 969
   174   SIMON ER              J CLIN INVEST                   43  1311 964
   175   SMITH CL              BR J NUTR                       26    89 971
   176   STEINER M             J CLIN INVEST                   57   732 976
   177   STOCKMAN JA           SEMIN HEMATOL                   12   163 975
   178   TAYLOR BW             ARCH DIS CHILD                  48   657 973
   179   THANANGKUL O          AM J CLIN NUTR                  18   379 966
   180   THOMPSON JN           AM J CLIN NUTR                  26  1349 973
   181   UNDERWOOD BA          PEDIATR RES                      6    26 972
   182   VOGELSANG A           NATURE                         157   772 946
   183   VOGTMANN H            NUTR METAB                      13   271 971
   184   WATSON CJ             ARCH INTERN MED                131   698 973
   185   WEBER F               NUTR DIETA                       8    54 966
   186   WEBER F               Z ERNAEHRUNGSWISS              245     1 964
   187   WEINBERG T            AM J PATHOL                     34   565 958
   188   WEISS P               AM J MED SCI                   258   275 969
   189   WHITAKER JA           AM J CLIN NUTR                  20   783 967
   190   WILLIAMS HTG          SURG GYNECOL OBSTET            132   662 971
   191   WITTING LA            AM J CLIN NUTR                  25   257 972
   192   WITTING LA            J NUTR                          82    19 964
   193   WITTING LA            AM J CLIN NUTR                  28   571 975
   194   WO CKW                AM J CLIN NUTR                  28   808 975
   195   WOODRUFF CW           AM J CLIN NUTR                   4   597 956
   196   WRIGHT SW             PEDIATRICS                       7   386 951
   197   ZANNOS-MARIOLEA L     BR J HAEMATOL                   26   193 974
CT   1   DONOVAN DH            TOXICOL LETT                     1   135 977
     2   HOFFMANNOSTENHOF O    TRENDS BIOCHEM SCI               2   284 977
     3   TANGNEY CC            CONTRACEPTION                   17   499 978
     4   CHO S                 J NUTR SCI VITAMINOL            24   221 978
     5   FARRELL PM            AM J CLIN NUTR                  31  1720 978
     6   EHRENKRANZ RA         N ENGL J MED                   299   564 978
     7   LOW H                 BIOCHIM BIOPHYS ACTA           515   141 978
     8   OGUNMEKAN AO          AM J CLIN NUTR                  32  2269 979
     9   VATASSERY GT          AM J CLIN NUTR                  32  2061 979
    10   ASTRUP H              INT J VIT NUTR RES              49   186 979
    11   PHELPS DL             PEDIATRICS                      63   933 979
    12   TURUNEN S             COMP BIOCHEM PHYSIOL (A)        63   455 979
    13   KONINGS AWT           RADIAT RES                      80   494 979
    14   EHRENKRANZ RA         J PEDIATR                       95   873 979
    15   FARRELL PM            J PEDIATR                       95   869 979
    16   COHEN N               J AM CHEM SOCIETY              101  6710 979
    17   VISSER CM             BIOORGAN CHEM                    9   411 980
    18   PARRISH DB            CRC CRIT REV FOOD SCI NUTR      13   161 980
    19   KAJIWARA M            HETEROCYCLES                    14  1995 980
    20   BAKER H               NUTR REP INT                    21   531 980
    21   PRASAD JS             AM J CLIN NUTR                  33   606 980
    22   BOUGLE D              ANN NUTR ALIMENT                34   505 980
    23   NADIGER HA            BR J NUTR                       44   211 980
    24   OLSON GL              J ORGANIC CHEM                  45   803 980
    25   KILIAN PL             BIOCHEM BIOPHYS RES COMMUN      93   409 980
    26   BURTON GW             J AM CHEM SOCIETY              102  7791 980
    27   LAMBERT JR            ARCH PATHOL LAB MED            104   201 980
    28   EHRENKRANZ RA         AM J DIS CHILD                 134  1157 980
    29   BERTONIFREDDARI C     MECH AGEING DEV                 16   169 981
    30   HESS HH               LAB ANIM SCI                    31   482 981
    31   BELL EF               AM J CLIN NUTR                  34   414 981
    32   JANSSON L             AM J CLIN NUTR                  34     8 981
    33   JANSSON L             ACTA PAEDIATR SCAND             70   297 981
    34   BURTON GW             J AM CHEM SOCIETY              103  6472 981
    35   BIERI JG              J NUTR                         111   458 981
    36   NADIGER HA            CLIN CHIM ACTA                 116     9 981
    37   BATINICHABERLE I      Z ACKER PFLANZEN               150   147 981
    38   NODA Y                NEUROBIOL AGING                  3   173 982
    39   SKLAN D               NUTR REP INT                    25   499 982
    40   WELCH SC              J MED CHEM                      25    81 982
    41   WIMALASENA J          BIOCHEM PHARMACOL               31  3455 982
    42   MCKENNA MC            AM J CLIN NUTR                  35  1010 982
    43   WEERAPRADIST W        ORAL SURG                       54   304 982
    44   SHKLAR G              J NATL CANCER INST              68   791 982
    45   PUKLIN JE             OPHTHALMOLOGY                   89    96 982
    46   GUGGENHEIM MA         J PEDIATR                      100    51 982
    47   SKLAN D               J NUTR                         112  1394 982
    48   EHRENKRANZ RA         ANN NY ACAD SCI                393   452 982
    49   FARRELL PM            ANN NY ACAD SCI                393    96 982
    50   GUGGENHEIM MA         ANN NY ACAD SCI                393    84 982
    51   JANSSON L             ACTA PAEDIATR SCAND SUPPL 296 1982   110 982
    52   TERAO S               J CHEM SOC PERKIN TRANS I     1982  2909 982
    53   PANATTA GB            NUTR REP INT                    27   811 983
    54   VATASSERY GT          AM J CLIN NUTR                  37  1020 983
    55   KIM JE                J PERIODONTOL                   54   305 983
    56   MATHER JP             ACTA ENDOCRINOL                102   470 983
    57   TAJIMA K              BIOCHEM BIOPHYS RES COMMUN     115  1002 983
    58   BURTON GW             ARCH BIOCHEM BIOPHYS           221   281 983
    59   BIERI JG              N ENGL J MED                   308  1063 983
    60   FULLER PA             NUTR RES                         4   333 984
    61   TAKEDA K              CRIT CARE MED                   12   957 984
    62   VOST A                LIPIDS                          19   423 984
    63   MARTINEZ FE           J TROP PEDIATR                  30    92 984
    64   GUTCHER GR            AM J CLIN NUTR                  40  1078 984
    65   BOUGLE D              ARCH FR PEDIATR                 41    63 984
    66   BIERI JG              J AM OIL CHEM SOC               61  1917 984
    67   LABADARIOS D          S AFR MED J                     66   477 984
    68   LABADARIOS D          S AFR J SCI                     80   427 984
    69   NAPOLI JL             ARCH BIOCHEM BIOPHYS           230   194 984
    70   GUTCHER GR            J PEDIATR GASTROENTEROL NUTR     4   604 985
    71   CARPENTER D           SEM NEUROL                       5   271 985
    72   CARPENTER D           SEM NEUROL                       5   283 985
    73   LIBONDI T             OPHTHALM RES                    17    42 985
    74   OBARA H               CAN ANAESTH SOC J               32   358 985
    75   OGUNMEKAN AO          TROP GEOGR MED                  37   175 985
    76   MINO M                AM J CLIN NUTR                  41   631 985
    77   MCGEE CD              AM J CLIN NUTR                  42   432 985
    78   SYVAOJA EL            INT J VIT NUTR RES              55   159 985
    79   KALVARIA I            INT J PANCREATOL                 1   119 986
    80   PIERI C               ARCH GERONTOL GERIATR            5    21 986
    81   GUTCHER G             SEM PERINATOL                   10   196 986
    82   VANDEWOUDE MG         J PARENT ENTERAL NUTR           10   303 986
    83   HERBETH B             CLIN CHEM                       32  1756 986
    84   ARANDA JV             PEDIATR CLIN NORTH AM           33   583 986

PN 76229
RN 00582 
AN 78098519
AU Euler-A-R.  Ament-M-E.
TI Crohn's disease - a cause of arthritis, oxalate stones and fistulae
   in cystic fibrosis.
SO West-J-Med. 1976 Oct. 125(4). P 315-7.
MJ CYSTIC-FIBROSIS: co.  CROHN-DISEASE: co.
MN ADOLESCENCE.  ARTHRITIS-RHEUMATOID: et.  CASE-REPORT.  HUMAN.
   INTESTINAL-FISTULA: et.  MALE.  URETERAL-CALCULI: et.
EX In most patients with cystic fibrosis growth failure occurs because
   of malabsorption or moderate to severe pulmonary disease, or both.
   Occasionally, growth lag is seen in patients that is disproportionate
   to the severity of the primary disease.  Profound growth failure is a
   major characteristic of Crohn's disease in children.  This report
   documents the first association of these two diseases in the same
   patient in the United States and shows how Crohn's disease alters the
   gastrointestinal manifestations of cystic fibrosis.  An adolescent
   patient with cystic fibrosis, anemia, fistulae, arthritis and calcium
   oxalate stones was proven to have Crohn's disease by microscopic
   evaluation of surgically resected terminal ileum and colon.
RF 001   EHRENPREIS TH         ACTA PAEDIATR SCAND             60   209 971
   002   LAPEY A               J PEDIATR                       84   328 974
   003   MATTHEWS LW           J PEDIATR                       65   558 964
   004   LINDSLEY CB           ARTHRITIS RHEUM                 14   398 971
   005   WILLIAMS JA           CLIN GASTROENTEROL               1   469 972
   006   KYLE J                PROC INT CONG GASTROENTER 8TH            968
   007   BOWDEN DH             AM J MED                        38   226 965
   008   SMITH A               J CLIN GASTROENTEROL             1   443 972
   009   MCCAFFERY TD          PEDIATRICS                      45   386 970
   010   DYER N                CLIN GASTROENTEROL               1   449 972
   011   CHADWICK V            N ENGL J MED                   289   172 973
   012   SMITH L               N ENGL J MED                   286  1371 972
   013   EARNEST D             J CLIN INVEST                   51   26A 972
   014   ANON                  GUIDE TO DIAGNOSIS AND MANAGE            971
   015   DOERSHUK CF           IN: GREEN M                          707 968
   016   MONK M                GASTROENTEROLOGY                53   198 967
CT   1   SAGRANSKY DM          AM J DIS CHILD                 134   319 980
     2   DELUMLEY L            ARCH FR PEDIATR                 40   723 983
     3   BERKIN KE             EUR J RESPIR DIS                67   103 985
     4   RUSH PJ               SEM ARTHRITIS RHEUM             15   213 986
     5   OJEDA VJ              DIS COLON RECTUM                29   567 986
     6   PHILLIPS BM           J ROY SOC MED                   79    44 986

